PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Irifune, T; Shinmei, T; McCammon, CA; Miyajima, N; Rubie, DC; Frost, DJ				Irifune, Tetsuo; Shinmei, Toru; McCammon, Catherine A.; Miyajima, Nobuyoshi; Rubie, David C.; Frost, Daniel J.			Iron Partitioning and Density Changes of Pyrolite in Earth's Lower Mantle	SCIENCE			English	Article							MAGNESIUM-SILICATE PEROVSKITE; PHASE-TRANSFORMATIONS; SPIN TRANSITION; MAGNESIOWUSTITE; DISCONTINUITY; FERROPERICLASE; HETEROGENEITY; DYNAMICS; PLUMES; MODEL	Phase transitions and the chemical composition of minerals in Earth's interior influence geophysical interpretations of its deep structure and dynamics. A pressure-induced spin transition in olivine has been suggested to influence iron partitioning and depletion, resulting in a distinct layered structure in Earth's lower mantle. For a more realistic mantle composition (pyrolite), we observed a considerable change in the iron-magnesium partition coefficient at about 40 gigapascals that is explained by a spin transition at much lower pressures. However, only a small depletion of iron is observed in the major high-pressure phase (magnesium silicate perovskite), which may be explained by preferential retention of the iron ion Fe3+. Changes in mineral proportions or density are not associated with the change in partition coefficient. The observed density profile agrees well with seismological models, which suggests that pyrolite is a good model composition for the upper to middle parts of the lower mantle.	[Irifune, Tetsuo; Shinmei, Toru] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [McCammon, Catherine A.; Miyajima, Nobuyoshi; Rubie, David C.; Frost, Daniel J.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	Ehime University; University of Bayreuth	Irifune, T (corresponding author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	irifune@dpc.ehime-u.ac.jp	McCammon, Catherine/B-4983-2010; Frost, Daniel J/B-7526-2016; Shinmei, Toru/AAE-4932-2021	McCammon, Catherine/0000-0001-5680-9106; Frost, Daniel J/0000-0002-4443-8149; 	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Funakoshi, Y. Tange, N. Nishiyama, T. Sanehira, and T. Tsuchiya for technical assistance at SPring-8 and for helpful discussions. T. I. thanks the Alexander von Humboldt Foundation and Bayerisches Geoinstitut for support during this study. Parts of this work were supported by a Grant-in-Aid for Scientific Research and Joint Research Project to T. I. from the Japan Society for the Promotion of Science (JSPS).	Auzende AL, 2008, EARTH PLANET SC LETT, V269, P164, DOI 10.1016/j.epsl.2008.02.001; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Frost DJ, 2002, EARTH PLANET SC LETT, V199, P227, DOI 10.1016/S0012-821X(02)00558-7; Hirose K, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000597; IRIFUNE T, 1994, NATURE, V370, P131, DOI 10.1038/370131a0; Jackson JM, 2005, AM MINERAL, V90, P199, DOI 10.2138/am.2005.1633; Kaneshima S, 1999, SCIENCE, V283, P1888, DOI 10.1126/science.283.5409.1888; Kantor I, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014204; Katsura T, 1996, GEOPHYS RES LETT, V23, P2005, DOI 10.1029/96GL02086; KAWAKATSU H, 1994, NATURE, V371, P301, DOI 10.1038/371301a0; Kesson SE, 1998, NATURE, V393, P252, DOI 10.1038/30466; Kobayashi Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023257; Li J, 2004, P NATL ACAD SCI USA, V101, P14027, DOI 10.1073/pnas.0405804101; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Lin JF, 2008, PHYS EARTH PLANET IN, V170, P248, DOI 10.1016/j.pepi.2008.01.005; McCammon C, 2008, NAT GEOSCI, V1, P684, DOI 10.1038/ngeo309; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Nishiyama N, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002216; Sakai T, 2009, AM MINERAL, V94, P921, DOI 10.2138/am.2009.3123; Sinmyo R, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005730; Tsuchiya T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198501; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3; Wood BJ, 1996, SCIENCE, V273, P1522, DOI 10.1126/science.273.5281.1522	28	163	167	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					193	195		10.1126/science.1181443	http://dx.doi.org/10.1126/science.1181443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965719				2022-12-28	WOS:000273394000032
J	Pollack, SE; Dries, D; Hulet, RG				Pollack, Scott E.; Dries, Daniel; Hulet, Randall G.			Universality in Three- and Four-Body Bound States of Ultracold Atoms	SCIENCE			English	Article							LARGE SCATTERING LENGTH; EFIMOV; RECOMBINATION; CONDENSATION; COLLISIONS; SYSTEM	Under certain circumstances, three or more interacting particles may form bound states. Although the general few-body problem is not analytically solvable, the so-called Efimov trimers appear for a system of three particles with resonant two-body interactions. The binding energies of these trimers are predicted to be universally connected to each other, independent of the microscopic details of the interaction. By exploiting a Feshbach resonance to widely tune the interactions between trapped ultracold lithium atoms, we find evidence for two universally connected Efimov trimers and their associated four-body bound states. A total of 11 precisely determined three- and four-body features are found in the inelastic-loss spectrum. Their relative locations on either side of the resonance agree well with universal theory, whereas a systematic deviation from universality is found when comparing features across the resonance.	[Pollack, Scott E.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; Rice Univ, Rice Quantum Inst, Houston, TX 77005 USA	Rice University; Rice University	Pollack, SE (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.	scott.pollack@rice.edu		Hulet, Randall/0000-0001-7045-8947	NSF, Office of Naval Research; Keck Foundation; Welch Foundation [C-1133]	NSF, Office of Naval Research(Office of Naval Research); Keck Foundation(W.M. Keck Foundation); Welch Foundation(The Welch Foundation)	We thank E. Olson for his contributions to this project and acknowledge useful discussions with E. Braaten, J. P. D'Incao, C. H. Greene, N. P. Mehta, and H. T. C. Stoof. Support for this work was provided by the NSF, Office of Naval Research, the Keck Foundation, and the Welch Foundation ( grant C-1133).	Barontini G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.043201; BRAATEN E, C1133 NSF KECK FDN W; Braaten E, 2006, PHYS REP, V428, P259, DOI 10.1016/j.physrep.2006.03.001; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Burt EA, 1997, PHYS REV LETT, V79, P337, DOI 10.1103/PhysRevLett.79.337; D'Incao JP, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.033004; D'Incao JP, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/4/044016; D'Incao JP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.123201; EFIMOV VN, 1971, SOV J NUCL PHYS+, V12, P589; Esry BD, 1999, PHYS REV LETT, V83, P1751, DOI 10.1103/PhysRevLett.83.1751; Ferlaino F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.140401; Gross N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.163202; Hammer HW, 2007, EUR PHYS J A, V32, P113, DOI 10.1140/epja/i2006-10301-8; Hanna GJ, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063604; Huckans JH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.165302; KAGAN Y, 1985, JETP LETT+, V42, P209; Knoop S, 2009, NAT PHYS, V5, P227, DOI 10.1038/NPHYS1203; Kohler T, 2006, REV MOD PHYS, V78, P1311, DOI 10.1103/RevModPhys.78.1311; Kraemer T, 2006, NATURE, V440, P315, DOI 10.1038/nature04626; Massignan P, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.030701; Mehta NP, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.153201; Nielsen E, 1999, PHYS REV LETT, V83, P1566, DOI 10.1103/PhysRevLett.83.1566; Ottenstein TB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203202; Platter L, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052101; Pollack SE, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.090402; Schuster J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.170404; von Stecher J, 2009, NAT PHYS, V5, P417, DOI 10.1038/NPHYS1253; Wang YJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.133201; Weber T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.123201; Zaccanti M, 2009, NAT PHYS, V5, P586, DOI 10.1038/NPHYS1334	30	266	267	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1683	1686		10.1126/science.1182840	http://dx.doi.org/10.1126/science.1182840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19965389	Green Submitted			2022-12-28	WOS:000272839000050
J	Kellermann, AL; Lewin, LS				Kellermann, Arthur L.; Lewin, Lawrence S.			The Consequences of "No".	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kellermann, Arthur L.] Emory Sch Med, Atlanta, GA USA; [Lewin, Lawrence S.] Emory Sch Med, Chevy Chase, MD USA	Emory University; Emory University	Kellermann, AL (corresponding author), Emory Sch Med, Atlanta, GA USA.							*CONS REP, 2009, HAZ HLTH PLANS CONV; GARRET B, 2009, COST FAILURE ENACT H; *I MED COMM CONS U, 2004, INS AM HLTH; *I MED COMM HLTH I, 2009, AM UN CRIS CONS HLTH; *KAIS FAM FDN HLTH, 2009, KAIS FAM FDN HLTH RE, V7937	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2399	2401		10.1056/NEJMp0910138	http://dx.doi.org/10.1056/NEJMp0910138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	533CE	19923561				2022-12-28	WOS:000272798900002
J	Xu, TH; Yu, XZ; Perlik, AJ; Tobin, WF; Zweig, JA; Tennant, K; Jones, T; Zuo, Y				Xu, Tonghui; Yu, Xinzhu; Perlik, Andrew J.; Tobin, Willie F.; Zweig, Jonathan A.; Tennant, Kelly; Jones, Theresa; Zuo, Yi			Rapid formation and selective stabilization of synapses for enduring motor memories	NATURE			English	Article							DENDRITIC SPINE STABILITY; TERM SYNAPTIC PLASTICITY; FORELIMB CORTEX; CEREBRAL-CORTEX; ADULT CORTEX; IN-VIVO; EXPERIENCE; SYNAPTOGENESIS; REORGANIZATION; NEOCORTEX	Novel motor skills are learned through repetitive practice and, once acquired, persist long after training stops(1,2). Earlier studies have shown that such learning induces an increase in the efficacy of synapses in the primary motor cortex, the persistence of which is associated with retention of the task(3-5). However, how motor learning affects neuronal circuitry at the level of individual synapses and how long-lasting memory is structurally encoded in the intact brain remain unknown. Here we show that synaptic connections in the living mouse brain rapidly respond to motor-skill learning and permanently rewire. Training in a forelimb reaching task leads to rapid (within an hour) formation of postsynaptic dendritic spines on the output pyramidal neurons in the contralateral motor cortex. Although selective elimination of spines that existed before training gradually returns the overall spine density back to the original level, the new spines induced during learning are preferentially stabilized during subsequent training and endure long after training stops. Furthermore, we show that different motor skills are encoded by different sets of synapses. Practice of novel, but not previously learned, tasks further promotes dendritic spine formation in adulthood. Our findings reveal that rapid, but long-lasting, synaptic reorganization is closely associated with motor learning. The data also suggest that stabilized neuronal connections are the foundation of durable motor memory.	[Xu, Tonghui; Yu, Xinzhu; Perlik, Andrew J.; Tobin, Willie F.; Zweig, Jonathan A.; Zuo, Yi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Tennant, Kelly; Jones, Theresa] Univ Texas Austin, Dept Psychol, Inst Neurosci, Austin, TX 78712 USA	University of California System; University of California Santa Cruz; University of Texas System; University of Texas Austin	Zuo, Y (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	zuo@biology.ucsc.edu	Jones, Theresa A/F-1182-2010; Jones, Theresa/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Zuo, Yi/0000-0001-9020-0003; Zweig, Jonathan/0000-0002-7015-9821; Jones, Theresa/0000-0003-2854-8003	Ellison Medical Foundation; DANA Foundation; National Institute on Aging; NATIONAL INSTITUTE ON AGING [R01AG031871] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); DANA Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. States, W. Thompson, L. Hinck, D. Feldheim, J. Ding, X. Li, A. Lin and C. Cirelli for critical comments on this manuscript; A. Sitko for her pilot studies of skilled reaching in mice, and D. Adkins, J. Kleim and N. Thomas for their assistance with intracortical microstimulation procedures. This work was supported by grants from the Ellison Medical Foundation, the DANA Foundation, and the National Institute on Aging to Y. Z.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Dailey ME, 1996, J NEUROSCI, V16, P2983; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harms KJ, 2008, J NEUROSCI, V28, P5686, DOI 10.1523/JNEUROSCI.0584-08.2008; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; KARNI A, 1995, NATURE, V377, P155; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1997, J NEUROSCI, V17, P717; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; WITHERS GS, 1989, NEUROPSYCHOLOGIA, V27, P61, DOI 10.1016/0028-3932(89)90090-0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	31	759	770	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					915	U108		10.1038/nature08389	http://dx.doi.org/10.1038/nature08389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19946267	Green Accepted			2022-12-28	WOS:000272795400042
J	Moscou, MJ; Bogdanove, AJ				Moscou, Matthew J.; Bogdanove, Adam J.			A Simple Cipher Governs DNA Recognition by TAL Effectors	SCIENCE			English	Article							BACTERIAL-BLIGHT; GENE; RICE; RESISTANCE		[Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol & Bioinformat, Ames, IA 50011 USA; Iowa State Univ, Computat Biol Program, Ames, IA 50011 USA	Iowa State University; Iowa State University	Bogdanove, AJ (corresponding author), Iowa State Univ, Dept Plant Pathol & Bioinformat, Ames, IA 50011 USA.	ajbog@iastate.edu	Ha, Dat Thinh/D-4995-2015; Moscou, Matthew/D-5266-2011; Bogdanove, Adam/ABE-6252-2020; Wilson, Matthew H/K-3193-2013	Ha, Dat Thinh/0000-0003-4260-4876; Moscou, Matthew/0000-0003-2098-6818; 				Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Schornack S, 2008, NEW PHYTOL, V179, P546, DOI 10.1111/j.1469-8137.2008.02487.x; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103	7	1342	1838	15	327	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1501	1501		10.1126/science.1178817	http://dx.doi.org/10.1126/science.1178817			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19933106				2022-12-28	WOS:000272623600048
J	Cheer, K; Shearman, C; Jude, EB				Cheer, Kelly; Shearman, Cliff; Jude, Edward B.			Managing complications of the diabetic foot	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ULCERS; AMPUTATIONS; MULTICENTER; NEUROPATHY; ISCHEMIA; PEOPLE		[Cheer, Kelly; Jude, Edward B.] Tameside Hosp NHS Fdn Trust, Ctr Diabet, Ashton Under Lyne OL6 9RW, Lancs, England; [Shearman, Cliff] Univ Southampton, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Jude, EB (corresponding author), Tameside Hosp NHS Fdn Trust, Ctr Diabet, Ashton Under Lyne OL6 9RW, Lancs, England.	Edward.jude@tgh.nhs.uk						Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Fosse S, 2009, DIABETIC MED, V26, P391, DOI 10.1111/j.1464-5491.2009.02698.x; GRAYSON ML, 1995, JAMA-J AM MED ASSOC, V273, P721, DOI 10.1001/jama.273.9.721; Holstein P, 2000, DIABETOLOGIA, V43, P844, DOI 10.1007/s001250051459; *INT DIAB FED, POS STAT DIAB FOOT; Jeffcoate W, 2000, DIABETIC MED, V17, P253, DOI 10.1046/j.1464-5491.2000.00233.x; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Jostel Andreas, 2008, Clin Podiatr Med Surg, V25, P63, DOI 10.1016/j.cpm.2007.09.001; Jude EB, 2004, DRUG AGING, V21, P833, DOI 10.2165/00002512-200421130-00002; Jude EB, 1999, DIABETES REV, V7, P395; Lavery LA, 2009, DIABETES RES CLIN PR, V83, P347, DOI 10.1016/j.diabres.2008.11.030; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/383271; McGill M, 2000, DIABETOLOGIA, V43, P481, DOI 10.1007/s001250051332; Nabuurs-Ranssen MH, 2005, DIABETES CARE, V28, P243, DOI 10.2337/diacare.28.2.243; *NIH CLIN EXC, 2004, TYP 2 DIAB PREV MAN; Steed DL, 2006, WOUND REPAIR REGEN, V14, P680, DOI 10.1111/j.1524-475X.2006.00176.x; Steed DL, 1996, J AM COLL SURGEONS, V183, P61; Tomas MB, 2000, BRIT J RADIOL, V73, P443, DOI 10.1259/bjr.73.868.10844873; Wraight PR, 2005, DIABETIC MED, V22, P127, DOI 10.1111/j.1464-5491.2004.01363.x; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	23	24	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2009	339								b4905	10.1136/bmj.b4905	http://dx.doi.org/10.1136/bmj.b4905			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NS	19955124				2022-12-28	WOS:000272453300003
J	Chang, HY				Chang, Howard Y.			Anatomic Demarcation of Cells: Genes to Patterns	SCIENCE			English	Editorial Material							NONCODING RNAS; POSITIONAL INFORMATION; EXPRESSION PROGRAMS; HOXD GENES; CHROMATIN; DIFFERENTIATION; POLYCOMB; MOUSE; FATE; COLLINEARITY	An organizing principle of the diverse cell types in multicellular organisms is their anatomic location. In turn, anatomic location is patterned by the positional identities of cells along developmental axes. Recent progress in functional genomics and chromatin biology illustrates how cells use specific gene expression programs to encode location. Dynamic chromatin states of key genes, notably the Hox loci, serve as the internal representation in cells of their positional identity within the animal.	[Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ackema KB, 2008, STEM CELLS DEV, V17, P979, DOI 10.1089/scd.2007.0220; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Morey C, 2008, J CELL SCI, V121, P571, DOI 10.1242/jcs.023234; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; WOLPERT L, 1994, DEV GENET, V15, P485, DOI 10.1002/dvg.1020150607; WOLPERT L, 1989, DEVELOPMENT, V107, P3	27	36	38	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1206	1207		10.1126/science.1175686	http://dx.doi.org/10.1126/science.1175686			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	524BD	19965461				2022-12-28	WOS:000272117900032
J	Martinez, E; Antoine, D; D'Ortenzio, F; Gentili, B				Martinez, Elodie; Antoine, David; D'Ortenzio, Fabrizio; Gentili, Bernard			Climate-Driven Basin-Scale Decadal Oscillations of Oceanic Phytoplankton	SCIENCE			English	Article							ZONE COLOR SCANNER; EXPORT PRODUCTION; PACIFIC-OCEAN; PRODUCTIVITY; VARIABILITY	Phytoplankton-the microalgae that populate the upper lit layers of the ocean-fuel the oceanic food web and affect oceanic and atmospheric carbon dioxide levels through photosynthetic carbon fixation. Here, we show that multidecadal changes in global phytoplankton abundances are related to basin-scale oscillations of the physical ocean, specifically the Pacific Decadal Oscillation and the Atlantic Multidecadal Oscillation. This relationship is revealed in similar to 20 years of satellite observations of chlorophyll and sea surface temperature. Interaction between the main pycnocline and the upper ocean seasonal mixed layer is one mechanism behind this correlation. Our findings provide a context for the interpretation of contemporary changes in global phytoplankton and should improve predictions of their future evolution with climate change.	[Martinez, Elodie] Univ Paris 06, UMR 7093, LOV, F-06230 Villefranche Sur Mer, France; CNRS, UMR 7093, LOV, F-06230 Villefranche Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Martinez, E (corresponding author), Univ Paris 06, UMR 7093, LOV, F-06230 Villefranche Sur Mer, France.	martinez@obs-vlfr.fr	Antoine, David/C-3817-2013; Martinez, Elodie/E-3237-2012; Martinez, Elodie/N-3297-2019	Antoine, David/0000-0002-9082-2395; Martinez, Elodie/0000-0001-6507-6119; Martinez, Elodie/0000-0001-6507-6119	NASA (U.S.)	NASA (U.S.)(National Aeronautics & Space Administration (NASA))	We thank the Agence Nationale de la Recherche (Paris) for the financial support for this work carried out within the frame of the Globphy project, NASA (U.S.) for providing the SeaWiFS global chlorophyll data, and the U. S. National Oceanographic and Atmospheric Administration National Climatic Data Center for the ERSST v3 data set. We thank D. Siegel, H. Claustre, Y. Huot, and A. Morel for the comments they provided on early versions of the manuscript, and three anonymous reviewers for their comments and helpful suggestions.	Antoine D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002620; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; EVANS RH, 1994, J GEOPHYS RES-OCEANS, V99, P7293, DOI 10.1029/93JC02151; FALKOWSKI PG, 1992, NATURE, V358, P741, DOI 10.1038/358741a0; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; HOVIS WA, 1980, SCIENCE, V210, P60, DOI 10.1126/science.210.4465.60; Hua Jiang, 2006, Chinese Journal of Oceanology and Limnology, V24, P111, DOI 10.1007/BF02842808; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; McCain C., 2006, EOS T AM GEOPHYSUNIO, V87, P337, DOI DOI 10.1029/2006EO340002; McClain CR, 2004, DEEP-SEA RES PT II, V51, P281, DOI 10.1016/j.dsr2.2003.08.002; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Schneider B, 2008, BIOGEOSCIENCES, V5, P597, DOI 10.5194/bg-5-597-2008; Schneider N, 2005, J CLIMATE, V18, P4355, DOI 10.1175/JCLI3527.1; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Yoder J. A., 2006, OCEANOGRAPHY, V19, P152, DOI [10.5670/oceanog.2006.98, DOI 10.5670/OCEANOG.2006.98]	24	214	215	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1253	1256		10.1126/science.1177012	http://dx.doi.org/10.1126/science.1177012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965473				2022-12-28	WOS:000272117900045
J	Shechner, DM; Grant, RA; Bagby, SC; Koldobskaya, Y; Piccirilli, JA; Bartel, DP				Shechner, David M.; Grant, Robert A.; Bagby, Sarah C.; Koldobskaya, Yelena; Piccirilli, Joseph A.; Bartel, David P.			Crystal Structure of the Catalytic Core of an RNA-Polymerase Ribozyme	SCIENCE			English	Article							LIGASE RIBOZYME; NUCLEOSIDE TRIPHOSPHATES; PRIMER EXTENSION; POLYMERIZATION; CRYSTALLIZATION; RECOGNITION; SEQUENCES; MECHANISM; EVOLUTION; INTRON	Primordial organisms of the putative RNA world would have required polymerase ribozymes able to replicate RNA. Known ribozymes with polymerase activity best approximating that needed for RNA replication contain at their catalytic core the class I RNA ligase, an artificial ribozyme with a catalytic rate among the fastest of known ribozymes. Here we present the 3.0 angstrom crystal structure of this ligase. The architecture resembles a tripod, its three legs converging near the ligation junction. Interacting with this tripod scaffold through a series of 10 minor-groove interactions (including two A-minor triads) is the unpaired segment that contributes to and organizes the active site. A cytosine nucleobase and two backbone phosphates abut the ligation junction; their location suggests a model for catalysis resembling that of proteinaceous polymerases.	[Shechner, David M.; Bagby, Sarah C.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shechner, David M.; Bagby, Sarah C.; Bartel, David P.] Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Shechner, David M.; Grant, Robert A.; Bagby, Sarah C.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Koldobskaya, Yelena; Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Koldobskaya, Yelena; Piccirilli, Joseph A.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Chicago; Howard Hughes Medical Institute; University of Chicago	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	daehun, lee/H-2435-2013	Bagby, Sarah/0000-0002-1795-3161; Shechner, David/0000-0002-0574-256X	NIH [GM61835]; NSF; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM061835, R01GM061835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Ferre-D'Amare, J. Doudna, R. Batey, and K. Zhou for the generous donation of reagents and protocols; K. Rajashankar for assistance in phasing; E. Duguid, V. Malashkevich, C. Drennan, T. Schwartz, U. RajBhandary, J. Cochrane, M. Stahley, S. Strobel, M. Robertson, and W. Scott for advice, encouragement, and helpful discussions; and members of the Bartel laboratory for support and comments. Supported by NIH grant GM61835. X-ray data were collected with the Northeastern Collaborative Access Team at the Advanced Photo Source, Argonne National Laboratory (11). D. M. S. was an NSF predoctoral fellow; S. C. B. was a Howard Hughes Medical Institute (HHMI) predoctoral fellow. D. B. and J. A. P. are HHMI investigators. Coordinates for the U1A-bound and Fab-bound ribozymes are deposited in the Protein Data Bank (3HHN and 3IVK, respectively).	BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bergman NH, 2004, RNA, V10, P176, DOI 10.1261/rna.5177504; Bevilacqua PC, 2006, CURR OPIN CHEM BIOL, V10, P455, DOI 10.1016/j.cbpa.2006.08.014; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Glasner ME, 2002, BIOCHEMISTRY-US, V41, P8103, DOI 10.1021/bi012179b; Glasner ME, 2000, BIOCHEMISTRY-US, V39, P15556, DOI 10.1021/bi002174z; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Muller UF, 2003, CHEM BIOL, V10, P799, DOI 10.1016/S1074-5521(03)00171-6; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Robertson MP, 2007, SCIENCE, V315, P1549, DOI 10.1126/science.1136231; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; STEWART SHEILA A., 2003, RNA, V9, P493, DOI [10.1261/rna.2192803, DOI 10.1261/RNA.2192803, DOI 10.1261/RNA.191250]; Strater N, 1996, ANGEW CHEM INT EDIT, V35, P2024, DOI 10.1002/anie.199620241; Strobel SA, 1999, CURR OPIN STRUC BIOL, V9, P346, DOI 10.1016/S0959-440X(99)80046-3; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; Ye JD, 2008, P NATL ACAD SCI USA, V105, P82, DOI 10.1073/pnas.0709082105; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	27	82	83	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1271	1275		10.1126/science.1174676	http://dx.doi.org/10.1126/science.1174676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965478	Green Accepted			2022-12-28	WOS:000272117900050
J	Hubbell, JA; Thomas, SN; Swartz, MA				Hubbell, Jeffrey A.; Thomas, Susan N.; Swartz, Melody A.			Materials engineering for immunomodulation	NATURE			English	Review							DENDRITIC-CELL SUBSETS; LIVING EMULSION POLYMERIZATION; IN-VIVO; COMPLEMENT ACTIVATION; BLOCK-COPOLYMER; DNA VACCINATION; IMMUNE-RESPONSE; LYMPH-NODES; T-CELLS; ANTIGEN	The engineering of materials that can modulate the immune system is an emerging field that is developing alongside immunology. For therapeutic ends such as vaccine development, materials are now being engineered to deliver antigens through specific intracellular pathways, allowing better control of the way in which antigens are presented to one of the key types of immune cell, T cells. Materials are also being designed as adjuvants, to mimic specific 'danger' signals in order to manipulate the resultant cytokine environment, which influences how antigens are interpreted by T cells. In addition to offering the potential for medical advances, immunomodulatory materials can form well-defined model systems, helping to provide new insight into basic immunobiology.	[Hubbell, Jeffrey A.; Thomas, Susan N.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Hubbell, Jeffrey A.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch; melody.swartz@epfl.ch	Hubbell, Jeffrey A/A-9266-2008; Swartz, Melody/B-7633-2009; Thomas, Susan/A-9947-2009; Thomas, Susan/B-4592-2016; Swartz, Melody A./F-9563-2011	Hubbell, Jeffrey A/0000-0003-0276-5456; Thomas, Susan/0000-0003-4651-232X; 				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cerritelli S, 2008, J POLYM SCI POL CHEM, V46, P2477, DOI 10.1002/pola.22580; Cerritelli S, 2007, BIOMACROMOLECULES, V8, P1966, DOI 10.1021/bm070085x; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Cohen JL, 2008, BIOCONJUGATE CHEM, V19, P876, DOI 10.1021/bc700414j; Cohen JA, 2009, BIOCONJUGATE CHEM, V20, P111, DOI 10.1021/bc800338n; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Flanary S, 2009, BIOCONJUGATE CHEM, V20, P241, DOI 10.1021/bc800317a; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Gadjeva M, 1998, J IMMUNOL, V161, P985; Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3; Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heffernan MJ, 2009, BIOMATERIALS, V30, P910, DOI 10.1016/j.biomaterials.2008.10.034; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033; Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019; Hu Y, 2007, NANO LETT, V7, P3056, DOI 10.1021/nl071542i; Hu YH, 2009, BIOMACROMOLECULES, V10, P756, DOI 10.1021/bm801199z; Huang YB, 2001, J CHEM PHYS, V114, P3809, DOI 10.1063/1.1345723; Huang YB, 2000, J CONTROL RELEASE, V65, P63, DOI 10.1016/S0168-3659(99)00233-3; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kidane A, 1999, J BIOMED MATER RES, V48, P640, DOI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O; Kolla RV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001044; Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lee MS, 2007, MOL CELLS, V23, P1; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Liu FJ, 2004, VACCINE, V22, P1764, DOI 10.1016/j.vaccine.2003.09.054; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Malyala P, 2008, J PHARM SCI-US, V97, P1155, DOI 10.1002/jps.21065; Malyala P, 2009, ADV DRUG DELIVER REV, V61, P218, DOI 10.1016/j.addr.2008.12.009; Manickam DS, 2006, BIOCONJUGATE CHEM, V17, P1395, DOI 10.1021/bc060104k; McKenzie DL, 2000, BIOCONJUGATE CHEM, V11, P901, DOI 10.1021/bc000056i; Meyer Martin, 2006, Expert Opin Drug Deliv, V3, P563, DOI 10.1517/17425247.3.5.563; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Napoli A, 2005, LANGMUIR, V21, P9149, DOI 10.1021/la0512300; Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Novak N, 2008, DRUG NEWS PERSPECT, V21, P158, DOI 10.1358/dnp.2008.21.3.1203412; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Paramonov SE, 2008, BIOCONJUGATE CHEM, V19, P911, DOI 10.1021/bc7004472; PASCUAL M, 1993, BIOMATERIALS, V14, P665, DOI 10.1016/0142-9612(93)90065-A; PEPPAS NA, 1984, INT J PHARMACEUT, V20, P107, DOI 10.1016/0378-5173(84)90222-9; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Rehor A, 2003, J CONTROL RELEASE, V87, P246; Rehor A, 2002, MACROMOLECULES, V35, P8688, DOI 10.1021/ma0211378; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; Salman HH, 2005, J CONTROL RELEASE, V106, P1, DOI 10.1016/j.jconrel.2005.03.033; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Sanders NN, 2002, GENE THER, V9, P363, DOI 10.1038/sj.gt.3301663; Schlosser E, 2008, VACCINE, V26, P1626, DOI 10.1016/j.vaccine.2008.01.030; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Sheng KC, 2008, EUR J IMMUNOL, V38, P424, DOI 10.1002/eji.200737578; Singh A, 2008, MOL THER, V16, P2011, DOI 10.1038/mt.2008.206; Singh Manmohan, 2006, Current Drug Delivery, V3, P115, DOI 10.2174/156720106775197565; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Strindelius L, 2004, VACCINE, V22, P3797, DOI 10.1016/j.vaccine.2003.12.035; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L; Thomsen LL, 2004, VACCINE, V22, P1799, DOI 10.1016/j.vaccine.2003.09.052; Todd CW, 1997, VACCINE, V15, P564, DOI 10.1016/S0264-410X(97)00209-0; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Velluto D, 2008, MOL PHARMACEUT, V5, P632, DOI 10.1021/mp7001297; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Villiers MB, 1999, J IMMUNOL, V162, P3647; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075; Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003; ZUBAY G, 1983, BIOCHEMISTRY-US, P1052	100	436	468	1	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					449	460		10.1038/nature08604	http://dx.doi.org/10.1038/nature08604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940915	Green Published, Bronze			2022-12-28	WOS:000272144200033
J	Kroshinsky, D; Kay, J; Nazarian, RM				Kroshinsky, Daniela; Kay, Jonathan; Nazarian, Rosalynn M.			A 46-Year-Old Woman with Chronic Renal Failure, Leg Swelling, and Skin Changes Nephrogenic systemic fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-THE-LITERATURE; EXTRACORPOREAL PHOTOPHERESIS; EOSINOPHILIC FASCIITIS; GADOLINIUM EXPOSURE; DERMOPATHY; DISEASE; GROWTH; SCLEROMYXEDEMA; DERMATOLOGIST; EXPRESSION		[Kroshinsky, Daniela] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kay, Jonathan] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Kroshinsky, Daniela] Harvard Univ, Sch Med, Dept Dermatol, Cambridge, MA 02138 USA; [Kay, Jonathan] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Nazarian, Rosalynn M.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Kroshinsky, D (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.		Kroshinsky, Daniela/AAM-4608-2020; Nazarian, Rosalynn/AFL-3176-2022; Kay, Jonathan/HGE-1248-2022	Kroshinsky, Daniela/0000-0002-4781-9676; Nazarian, Rosalynn/0000-0003-4003-7193; Kay, Jonathan/0000-0002-8970-4260				Abraham JL, 2008, BRIT J DERMATOL, V158, P273, DOI 10.1111/j.1365-2133.2007.08335.x; Baron PW, 2003, AM J DERMATOPATH, V25, P204, DOI 10.1097/00000372-200306000-00004; Barron GS, 2007, ANN VASC SURG, V21, P652, DOI 10.1016/j.avsg.2007.07.002; Bielsa I, 2007, SEMIN CUTAN MED SURG, V26, P90, DOI 10.1016/j.sder.2007.02.005; Bischoff L, 2008, INT J DERMATOL, V47, P29, DOI 10.1111/j.1365-4632.2007.03544.x; Boin F, 2008, RHEUM DIS CLIN N AM, V34, P199, DOI 10.1016/j.rdc.2007.11.001; Bolognia JL, 2008, DERMATOLOGY, V2nd; Chou RC, 2004, ARTHRITIS RHEUM-US, V50, pS635; Cowper SE, 2001, AM J DERMATOPATH, V23, P383, DOI 10.1097/00000372-200110000-00001; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Deng AC, 2008, J AM ACAD DERMATOL, V58, P336, DOI 10.1016/j.jaad.2007.10.491; DINNEEN AM, 1995, J AM ACAD DERMATOL, V33, P37, DOI 10.1016/0190-9622(95)90007-1; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; DOYLE JA, 1989, MED CLIN N AM, V73, P1157, DOI 10.1016/S0025-7125(16)30625-3; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Fisher DA, 2000, INT J DERMATOL, V39, P490, DOI 10.1046/j.1365-4362.2000.00956.x; Gilliet M, 2005, BRIT J DERMATOL, V152, P531, DOI 10.1111/J.1365-2133.2005.06434.X; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1745, DOI 10.1093/ndt/gfl294; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Grobner T, 2008, SEMIN DIALYSIS, V21, P135, DOI 10.1111/j.1525-139X.2007.00406.x; Introcaso CE, 2007, INT J DERMATOL, V46, P447, DOI 10.1111/j.1365-4632.2007.03301.x; Jimenez SA, 2004, ARTHRITIS RHEUM, V50, P2660, DOI 10.1002/art.20362; Kay J, 2008, ARTHRITIS RHEUM, V58, P2543, DOI 10.1002/art.23696; Knopp EA, 2008, SEMIN DIALYSIS, V21, P123, DOI 10.1111/j.1525-139X.2007.00399.x; Kucher C, 2005, J CUTAN PATHOL, V32, P484, DOI 10.1111/j.0303-6987.2005.00365.x; Mathur K, 2008, J CLIN APHERESIS, V23, P144, DOI 10.1002/jca.20170; Nazarian RM, 2008, MODERN PATHOL, V21, p99A; Penas PF, 2002, ARCH DERMATOL, V138, P924, DOI 10.1001/archderm.138.7.924; Perazella MA, 2008, SEMIN DIALYSIS, V21, P150, DOI 10.1111/j.1525-139X.2007.00403.x; Prasad SR, 2008, J COMPUT ASSIST TOMO, V32, P1, DOI 10.1097/RCT.0b013e31805d08ee; Richmond H, 2007, ARCH DERMATOL, V143, P1565; Richmond H, 2007, ARCH DERMATOL, V143, P1025, DOI 10.1001/archderm.143.8.1025; Scheinfeld N, 2006, AM J CLIN DERMATOL, V7, P237, DOI 10.2165/00128071-200607040-00005; Swartz RD, 2003, AM J MED, V114, P563, DOI 10.1016/S0002-9343(03)00085-8; Todd DJ, 2007, ARTHRITIS RHEUM, V56, P3433, DOI 10.1002/art.22925; Weenig RH, 2007, SEMIN CUTAN MED SURG, V26, P163, DOI 10.1016/j.sder.2007.09.003; Wermuth PJ, 2009, ARTHRITIS RHEUM-US, V60, P1508, DOI 10.1002/art.24471; Yerram P, 2007, CLIN J AM SOC NEPHRO, V2, P258, DOI 10.2215/CJN.03250906; 2004, N ENGL J MED, V351, P2219; 2008, N ENGL J MED, V358, P827	40	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2166	2176		10.1056/NEJMcpc0907802	http://dx.doi.org/10.1056/NEJMcpc0907802			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524BC	19940302				2022-12-28	WOS:000272117800012
J	Peers, G; Truong, TB; Ostendorf, E; Busch, A; Elrad, D; Grossman, AR; Hippler, M; Niyogi, KK				Peers, Graham; Truong, Thuy B.; Ostendorf, Elisabeth; Busch, Andreas; Elrad, Dafna; Grossman, Arthur R.; Hippler, Michael; Niyogi, Krishna K.			An ancient light-harvesting protein is critical for the regulation of algal photosynthesis	NATURE			English	Article							CARBON-CONCENTRATING MECHANISM; CHLAMYDOMONAS-REINHARDTII; PHOTOOXIDATIVE STRESS; BIOENERGETIC PATHWAYS; ENERGY-DISSIPATION; IRON-DEFICIENCY; GENOME REVEALS; GENES; CYCLE; EXPRESSION	Light is necessary for photosynthesis, but its absorption by pigment molecules such as chlorophyll can cause severe oxidative damage and result in cell death. The excess absorption of light energy by photosynthetic pigments has led to the evolution of protective mechanisms that operate on the timescale of seconds to minutes and involve feedback-regulated de-excitation of chlorophyll molecules in photosystem II (qE). Despite the significant contribution of eukaryotic algae to global primary production(1), little is known about their qE mechanism, in contrast to that in flowering plants(2,3). Here we show that a qE-deficient mutant of the unicellular green alga Chlamydomonas reinhardtii, npq4, lacks two of the three genes encoding LHCSR (formerly called LI818). This protein is an ancient member of the light-harvesting complex superfamily, and orthologues are found throughout photosynthetic eukaryote taxa(4), except in red algae and vascular plants. The qE capacity of Chlamydomonas is dependent on environmental conditions and is inducible by growth under high light conditions. We show that the fitness of the npq4 mutant in a shifting light environment is reduced compared to wild-type cells, demonstrating that LHCSR is required for survival in a dynamic light environment. Thus, these data indicate that plants and algae use different proteins to dissipate harmful excess light energy and protect the photosynthetic apparatus from damage.	[Peers, Graham; Truong, Thuy B.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Truong, Thuy B.; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ostendorf, Elisabeth; Busch, Andreas; Hippler, Michael] Univ Munster, Inst Plant Biochem & Biotechnol, D-48143 Munster, Germany; [Elrad, Dafna; Grossman, Arthur R.] Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munster; Carnegie Institution for Science	Niyogi, KK (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	mhippler@uni-muenster.de; niyogi@berkeley.edu		Peers, Graham/0000-0002-3590-7820; Michael, Hippler/0000-0001-9670-6101	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy; Deutsche Forschungsgemeinschaft; National Science Foundation	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	We thank M. Guertin for providing the anti-LHCSR (LI818) antibody. This work was supported by grants from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy ( K. K. N.), the Deutsche Forschungsgemeinschaft ( M. H.), and the National Science Foundation ( A. R. G.).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Allmer J, 2006, PROTEOMICS, V6, P6207, DOI 10.1002/pmic.200600208; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; Casper-Lindley C, 1998, PHOTOSYNTH RES, V56, P277, DOI 10.1023/A:1006037516479; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GAGNE G, 1992, PLANT MOL BIOL, V18, P429, DOI 10.1007/BF00040659; Golan T, 2006, PLANT CELL ENVIRON, V29, P879, DOI 10.1111/j.1365-3040.2005.01467.x; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Savard F, 1996, PLANT MOL BIOL, V32, P461, DOI 10.1007/BF00019098; SCHENCK H, 1957, J OPT SOC AM, V47, P653, DOI 10.1364/JOSA.47.000653; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	33	484	497	4	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					518	U215		10.1038/nature08587	http://dx.doi.org/10.1038/nature08587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940928				2022-12-28	WOS:000272144200047
J	Camposampiero, D; Caramello, G; Indemini, P; Gerten, G; Franch, A; Birattari, F; Donisi, PM; Paolin, A; Ferrari, S; Ponzin, D				Camposampiero, Davide; Caramello, Guido; Indemini, Patricia; Gerten, Georg; Franch, Antonella; Birattari, Federica; Donisi, Pietro Maria; Paolin, Adolfo; Ferrari, Stefano; Ponzin, Diego			Two red eyes and one asymptomatic donor	LANCET			English	Editorial Material							ACANTHAMOEBA-KERATITIS/		[Camposampiero, Davide; Ferrari, Stefano; Ponzin, Diego] Veneto Eye Bank Fdn, I-30174 Venice, Italy; [Caramello, Guido; Indemini, Patricia] Santa Croce & Carla Hosp, Cuneo, Italy; [Gerten, Georg] Augenklin Neumarkt, Cologne, Germany; [Franch, Antonella; Birattari, Federica] SS Giovanni & Paolo Hosp, Dept Ophthalmol, Venice, Italy; [Donisi, Pietro Maria] SS Giovanni & Paolo Hosp, Dept Clin Pathol, Venice, Italy; [Paolin, Adolfo] Reg Tissue Bank S Maria dei Battuti Hosp, Treviso, Italy	IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Istituto Tumori Bari Giovanni Paolo II	Ponzin, D (corresponding author), Veneto Eye Bank Fdn, Via Paccagnella 11,C-O Padiglione Giovanni Rama, I-30174 Venice, Italy.	diego.ponzin@fbov.it	Gerten, Georg/AAK-8376-2020	ponzin, diego/0000-0002-6038-3977; Ferrari, Stefano/0000-0003-3983-3328				Clarke DW, 2006, TRENDS PARASITOL, V22, P175, DOI 10.1016/j.pt.2006.02.004; Roters S, 2001, KLIN MONATSBL AUGENH, V218, P570, DOI 10.1055/s-2001-17140; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Stemberger K, 2007, OPHTHALMOLOGE, V104, P415, DOI 10.1007/s00347-006-1462-0; Tabin G, 2001, CORNEA, V20, P757, DOI 10.1097/00003226-200110000-00017	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1792	1792		10.1016/S0140-6736(09)61373-8	http://dx.doi.org/10.1016/S0140-6736(09)61373-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19932357				2022-12-28	WOS:000272207700028
J	Gore, MA; Chia, JM; Elshire, RJ; Sun, Q; Ersoz, ES; Hurwitz, BL; Peiffer, JA; McMullen, MD; Grills, GS; Ross-Ibarra, J; Ware, DH; Buckler, ES				Gore, Michael A.; Chia, Jer-Ming; Elshire, Robert J.; Sun, Qi; Ersoz, Elhan S.; Hurwitz, Bonnie L.; Peiffer, Jason A.; McMullen, Michael D.; Grills, George S.; Ross-Ibarra, Jeffrey; Ware, Doreen H.; Buckler, Edward S.			A First-Generation Haplotype Map of Maize	SCIENCE			English	Article							ARTIFICIAL SELECTION; ARABIDOPSIS-THALIANA; GENOME; POPULATION; DOMESTICATION; DIVERSITY; DNA; POLYMORPHISM; DIVERGENCE; ZEA	Maize is an important crop species of high genetic diversity. We identified and genotyped several million sequence polymorphisms among 27 diverse maize inbred lines and discovered that the genome was characterized by highly divergent haplotypes and showed 10- to 30-fold variation in recombination rates. Most chromosomes have pericentromeric regions with highly suppressed recombination that appear to have influenced the effectiveness of selection during maize inbred development and may be a major component of heterosis. We found hundreds of selective sweeps and highly differentiated regions that probably contain loci that are key to geographic adaptation. This survey of genetic diversity provides a foundation for uniting breeding efforts across the world and for dissecting complex traits through genome-wide association studies.	[Gore, Michael A.; McMullen, Michael D.; Ware, Doreen H.; Buckler, Edward S.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA; [Gore, Michael A.; Peiffer, Jason A.; Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Gore, Michael A.; Elshire, Robert J.; Ersoz, Elhan S.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Chia, Jer-Ming; Hurwitz, Bonnie L.; Ware, Doreen H.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Grills, George S.] Cornell Univ, Inst Biotechnol & Life Sci Technol, Ithaca, NY 14853 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; Cornell University; Cold Spring Harbor Laboratory; Cornell University; University of Missouri System; University of Missouri Columbia; Cornell University; University of California System; University of California Davis	Ware, DH (corresponding author), Cornell Univ, USDA ARS, Ithaca, NY 14853 USA.	ware@cshl.edu; esb33@cornell.edu	Ross-Ibarra, Jeffrey/D-7782-2011; Chia, Jer-Ming/C-9992-2012; Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Buckler, Edward/0000-0002-3100-371X; Gore, Michael/0000-0001-6896-8024; Elshire, Robert/0000-0003-1753-6920	NSF [DBI-0321467, DBI-0638566, DBI-0820619]; USDA-ARS	NSF(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We thank D. Costich and L. Rigamer Lirette for technical editing of the manuscript; researchers at the Lita Annenberg Hazen Genome Sequencing Center of Cold Spring Harbor Laboratory for discussion about sequencing and library construction; and T. Stelick, P. Schweitzer, and J. I. VanEe for assistance with the SBS data, all of which was generated at the Cornell University Life Sciences Core Laboratories Center. Mention of trade names or commercial products was solely to provide specific information and does not imply recommendation or endorsement by the USDA. This work was supported by NSF grants DBI-0321467, DBI-0638566, and DBI-0820619, and by the USDA-ARS. Sequences have been deposited at National Center for Biotechnology Information Short Read Archive with accession number SRP001145, and SNP calls are available at www.panzea.org.	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242	22	543	562	4	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1115	1117		10.1126/science.1177837	http://dx.doi.org/10.1126/science.1177837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965431				2022-12-28	WOS:000271951000045
J	Blaivas, AJ				Blaivas, Allen J.			Preoperative staging using PET-CT reduced futile thoracotomies more than conventional staging in non-small-cell lung cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POSITRON-EMISSION-TOMOGRAPHY; TRIAL		VA New Jersey Hlth Care Syst, E Orange, NJ USA		Blaivas, AJ (corresponding author), VA New Jersey Hlth Care Syst, E Orange, NJ USA.							Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Viney RC, 2004, J CLIN ONCOL, V22, P2357, DOI 10.1200/JCO.2004.04.126	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-8	10.7326/0003-4819-151-10-200911170-02008	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920266				2022-12-28	WOS:000272145100019
J	Goldston, D				Goldston, David			Science, Policy, and the US Congress	CELL			English	Editorial Material									[Goldston, David] Govt Affairs Nat Resources Def Council, Washington, DC 20005 USA		Goldston, D (corresponding author), Govt Affairs Nat Resources Def Council, Washington, DC 20005 USA.	partyofonecolumn@gmail.com							0	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					647	648		10.1016/j.cell.2009.10.044	http://dx.doi.org/10.1016/j.cell.2009.10.044			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914156	Bronze			2022-12-28	WOS:000271747200005
J	Ogawa, A; Sommer, RJ				Ogawa, Akira; Sommer, Ralf J.			Strategies to Get Arrested	SCIENCE			English	Editorial Material							NUCLEAR RECEPTOR; CAENORHABDITIS; PHEROMONE; DAF-12		[Ogawa, Akira; Sommer, Ralf J.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Max Planck Society	Ogawa, A (corresponding author), Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	akira.ogawa@tuebingen.mpg.de; ralf.sommer@tuebingen.mpg.de						ANDERSON RC, 1984, CAN J ZOOL, V62, P317, DOI 10.1139/z84-050; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Antebi A, 2000, GENE DEV, V14, P1512; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Hu Patrick J, 2007, WormBook, P1; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Robinson-Rechavi M, 2005, J MOL EVOL, V60, P577, DOI 10.1007/s00239-004-0175-8; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106	15	13	13	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					944	945		10.1126/science.1183272	http://dx.doi.org/10.1126/science.1183272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965501				2022-12-28	WOS:000271712300022
J	Hase, K; Kawano, K; Nochi, T; Pontes, GS; Fukuda, S; Ebisawa, M; Kadokura, K; Tobe, T; Fujimura, Y; Kawano, S; Yabashi, A; Waguri, S; Nakato, G; Kimura, S; Murakami, T; Iimura, M; Hamura, K; Fukuoka, SI; Lowe, AW; Itoh, K; Kiyono, H; Ohno, H				Hase, Koji; Kawano, Kazuya; Nochi, Tomonori; Pontes, Gemilson Soares; Fukuda, Shinji; Ebisawa, Masashi; Kadokura, Kazunori; Tobe, Toru; Fujimura, Yumiko; Kawano, Sayaka; Yabashi, Atsuko; Waguri, Satoshi; Nakato, Gaku; Kimura, Shunsuke; Murakami, Takaya; Iimura, Mitsutoshi; Hamura, Kimiyo; Fukuoka, Shin-Ichi; Lowe, Anson W.; Itoh, Kikuji; Kiyono, Hiroshi; Ohno, Hiroshi			Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response	NATURE			English	Article							GRANULE MEMBRANE-PROTEIN; FOLLICLE-ASSOCIATED EPITHELIUM; IMMUNOGLOBULIN-A RESPONSES; TAMM-HORSFALL PROTEIN; PATCH M-CELLS; ESCHERICHIA-COLI; PEYERS-PATCHES; SALMONELLA-TYPHIMURIUM; RECOMBINANT SALMONELLA; ANTIBODY-RESPONSES	The mucosal immune system forms the largest part of the entire immune system, containing about three-quarters of all lymphocytes and producing grams of secretory IgA daily to protect the mucosal surface from pathogens(1-3). To evoke the mucosal immune response, antigens on the mucosal surface must be transported across the epithelial barrier into organized lymphoid structures such as Peyer's patches(4). This function, called antigen transcytosis, is mediated by specialized epithelial M cells(5,6). The molecular mechanisms promoting this antigen uptake, however, are largely unknown. Here we report that glycoprotein 2 (GP2), specifically expressed on the apical plasma membrane of M cells among enterocytes, serves as a transcytotic receptor for mucosal antigens. Recombinant GP2 protein selectively bound a subset of commensal and pathogenic enterobacteria, including Escherichia coli and Salmonella enterica serovar Typhimurium (S. Typhimurium), by recognizing FimH, a component of type I pili on the bacterial outer membrane. Consistently, these bacteria were colocalized with endogenous GP2 on the apical plasma membrane as well as in cytoplasmic vesicles in M cells. Moreover, deficiency of bacterial FimH or host GP2 led to defects in transcytosis of type-I-piliated bacteria through M cells, resulting in an attenuation of antigen-specific immune responses in Peyer's patches. GP2 is therefore a previously unrecognized transcytotic receptor on M cells for type-I-piliated bacteria and is a prerequisite for the mucosal immune response to these bacteria. Given that M cells are considered a promising target for oral vaccination against various infectious diseases(7,8), the GP2-dependent transcytotic pathway could provide a new target for the development of M-cell-targeted mucosal vaccines.	[Hase, Koji; Kawano, Kazuya; Fukuda, Shinji; Ebisawa, Masashi; Kadokura, Kazunori; Fujimura, Yumiko; Kawano, Sayaka; Nakato, Gaku; Kimura, Shunsuke; Murakami, Takaya; Ohno, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Kanagawa 2300045, Japan; [Nochi, Tomonori; Pontes, Gemilson Soares; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Fukuda, Shinji; Ebisawa, Masashi; Kadokura, Kazunori; Nakato, Gaku; Ohno, Hiroshi] Yokohama City Univ, Int Grad Sch Bionanosci, Kanagawa 2300045, Japan; [Tobe, Toru] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yabashi, Atsuko; Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Iimura, Mitsutoshi; Hamura, Kimiyo] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo 1628666, Japan; [Fukuoka, Shin-Ichi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Kanagawa 2298558, Japan; [Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Lowe, Anson W.] Stanford Univ, Ctr Digest Dis, Stanford, CA 94305 USA; [Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	RIKEN; University of Tokyo; Yokohama City University; Osaka University; Fukushima Medical University; Tokyo Women's Medical University; Aoyama Gakuin University; Stanford University; Stanford University; University of Tokyo	Ohno, H (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Kanagawa 2300045, Japan.	ohno@rcai.riken.jp	Kimura, Shunsuke/D-7093-2012; Pontes, Gemilson Soares/B-6103-2016; Nochi, Tomonori/U-2533-2019; Kiyono, Hiroshi/AAC-6735-2022; Ohno, Hiroshi/L-7899-2014	Kimura, Shunsuke/0000-0001-9408-2884; Pontes, Gemilson Soares/0000-0001-9001-7954; Nochi, Tomonori/0000-0003-1800-6972; Ohno, Hiroshi/0000-0001-8776-9661; Fukuda, Shinji/0000-0001-5161-9880; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; NIH [DK56339, DK43294]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339, R01DK043294, R29DK043294] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Kanno and A. Yamada for help in immunoelectron microscopy; Y. Yamada for secretarial assistance; M. Ohmae for technical assistance; H. Watarai for pertinent advice and discussion; P. D. Burrows, T. Takemori, S. Yamasaki and H. Kitamura for critical review of the manuscript; and the National BioResource Project (NIG, Japan) for E. coli (the Keio collection). This study was supported in part by Grants-in-Aid for Young Scientists (B) (K. H.), Scientific research (B) (H. O.), Scientific Research in Priority Areas (H. O. and K. H.), and Scientific Research on Innovative Areas (H. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Takeda Science Foundation (K. H.), and NIH awards DK56339 and DK43294 (A. W. L.).	CARTER PB, 1974, INFECT IMMUN, V9, P851, DOI 10.1128/IAI.9.5.851-857.1974; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ewen SWB, 1997, FEMS IMMUNOL MED MIC, V18, P185, DOI 10.1016/S0928-8244(97)00038-2; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Gulig PA, 1998, INFECT IMMUN, V66, P2471, DOI 10.1128/IAI.66.6.2471-2485.1998; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hashizume T, 2008, INFECT IMMUN, V76, P927, DOI 10.1128/IAI.01145-07; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; JACKSON RJ, 1993, INFECT IMMUN, V61, P4272, DOI 10.1128/IAI.61.10.4272-4279.1993; Kobayashi K, 2004, BIOCHEM BIOPH RES CO, V322, P659, DOI 10.1016/j.bbrc.2004.07.197; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189, DOI 10.1016/s0016-5085(74)80102-2; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; RINDLER MJ, 1990, EUR J CELL BIOL, V53, P154; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Sirard JC, 1999, IMMUNOL REV, V171, P5, DOI 10.1111/j.1600-065X.1999.tb01340.x; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; VanCott JL, 1996, J IMMUNOL, V156, P1504; Verbrugghe P, 2008, HISTOCHEM CELL BIOL, V129, P311, DOI 10.1007/s00418-007-0369-4; Waguri S, 2009, METHOD ENZYMOL, V453, P181, DOI 10.1016/S0076-6879(08)04009-3; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; Yu S, 2004, J BIOL CHEM, V279, P50274, DOI 10.1074/jbc.M410599200; Yu S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-58	39	430	452	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 12	2009	462	7270					226	U101		10.1038/nature08529	http://dx.doi.org/10.1038/nature08529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907495				2022-12-28	WOS:000271655100044
J	Borg, J; Lindstrom, A; Larsson, S				Borg, Johan; Lindstroem, Anna; Larsson, Stig			Assistive technology in developing countries: national and international responsibilities to implement the Convention on the Rights of Persons with Disabilities	LANCET			English	Editorial Material							EDUCATION; POVERTY		[Borg, Johan] Lund Univ, Dept Hlth Sci, SE-22100 Lund, Sweden; [Lindstroem, Anna] Swedish Inst Assist Technol, Vallingby, Sweden	Lund University	Borg, J (corresponding author), Lund Univ, Dept Hlth Sci, Box 157, SE-22100 Lund, Sweden.	johan@propempo.se						[Anonymous], 2005, GUID TRAIN PERS DEV; Beijen J, 2007, CLIN OTOLARYNGOL, V32, P86, DOI 10.1111/j.1365-2273.2007.01411.x; Beiter K. D., 2005, PROTECTION RIGHT ED; Borg J, UN CONVENTI IN PRESS; Burnett N, 2008, ANN NY ACAD SCI, V1136, P269, DOI 10.1196/annals.1425.002; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; CORNISH M, ELDRIDGE BRIT COLUMB; dos Santos-Zingale M, 2006, DISABIL SOC, V21, P243, DOI 10.1080/09687590600617428; Eide A.H., 2003, LIVING CONDITIONS PE; Filmer D, 2008, WORLD BANK ECON REV, V22, P141, DOI 10.1093/wber/lhm021; Hoogeveen JG, 2005, J AFR ECON, V14, P603, DOI 10.1093/jae/eji020; Johnson KL, 2007, AM J PUBLIC HEALTH, V97, P330, DOI 10.2105/AJPH.2004.050955; Langton AJ., 2001, J VOCAT REHABIL, V61, P27; Lindstrom A., 2008, AAOS ATLAS ORTHOSES; Mete C, 2008, EC IMPLICATIONS CHRO; ODERUD T, 1999, 5 EUR C ADV ASS TECH; Parette HP, 2007, EDUC TRAIN DEV DISAB, V42, P387; Scherer M, 2007, DISABIL REHABIL-ASSI, V2, P1, DOI 10.1080/17483100600845414; *WHO, 2004, GUID HEAR AIDS SERV; WHO, 2002, WHOEIPGPECAS013; World Health Organization (WHO) ISPO & USAID, 2008, GUIDELINES PROVISION; Yeager Patricia, 2006, Work, V27, P333	22	74	74	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1863	1865		10.1016/S0140-6736(09)61872-9	http://dx.doi.org/10.1016/S0140-6736(09)61872-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944867				2022-12-28	WOS:000272370200032
J	Groce, NE; Trani, JF				Groce, Nora Ellen; Trani, Jean-Francois			Millennium Development Goals and people with disabilities	LANCET			English	Editorial Material							POVERTY		[Groce, Nora Ellen; Trani, Jean-Francois] UCL, Leonard Cheshire Ctr Disabil & Inclus Dev, London WC1H 0BT, England	University of London; University College London	Groce, NE (corresponding author), UCL, Leonard Cheshire Ctr Disabil & Inclus Dev, London WC1H 0BT, England.	Nora.groce@ucl.ac.uk	Trani, Jean-Francois/M-1946-2014	Groce, Nora/0000-0002-7885-7042				[Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], CONV RIGHTS PERS DIS; Braithwaite J, 2009, ALTER, V3, P219, DOI 10.1016/j.alter.2008.10.002; Elwan A, 1999, POVERTY DISABILITY S; Filmer D, 2008, WORLD BANK ECON REV, V22, P141, DOI 10.1093/wber/lhm021; Hoogeveen JG, 2005, J AFR ECON, V14, P603, DOI 10.1093/jae/eji020; Lang R, 2009, ALTER, V3, P266, DOI 10.1016/j.alter.2009.04.001; Mitra S, 2008, WORLD DEV, V36, P934, DOI 10.1016/j.worlddev.2007.04.022; *UN, UN MILL DEV GOALS EN; *UN, WASH GROUP DIS STAT; *UN, REP EXP GROUP M; UNAIDS WHO OHCHR, 2009, DIS HIV POL BRIEF; *UNESCO, ED ALL INT COORD	13	30	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1800	1801		10.1016/S0140-6736(09)61909-7	http://dx.doi.org/10.1016/S0140-6736(09)61909-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944848				2022-12-28	WOS:000272370200007
J	Gansicke, BT; Koester, D; Girven, J; Marsh, TR; Steeghs, D				Gaensicke, B. T.; Koester, D.; Girven, J.; Marsh, T. R.; Steeghs, D.			Two White Dwarfs with Oxygen-Rich Atmospheres	SCIENCE			English	Article							ELECTRON-DEGENERATE CORES; DIGITAL SKY SURVEY; DOT MODEL STAR; AGB STARS; EVOLUTION; CONSTRAINTS; PROGENITORS; SUPERNOVAE; CATALOG; END	Stars with masses ranging from 7 to 10 times the mass of the Sun end their lives either as massive white dwarfs or weak type II supernovae, but there are only limited observational constraints on either evolutionary channel. Here we report the detection of two white dwarfs with large photospheric oxygen abundances, implying that they are bare oxygen-neon cores and that they may have descended from the most massive progenitors that avoid core collapse.	[Gaensicke, B. T.; Girven, J.; Marsh, T. R.; Steeghs, D.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Koester, D.] Univ Kiel, Inst Theoret Phys & Astrophys, D-24098 Kiel, Germany	University of Warwick; University of Kiel	Gansicke, BT (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	Boris.Gaensicke@warwick.ac.uk	Gaensicke, Boris T/A-9421-2012; Steeghs, Danny T/C-5468-2009	Gaensicke, Boris T/0000-0002-2761-3005; Steeghs, Danny T/0000-0003-0771-4746	Science and Technology Facilities Council (STFC); STFC [ST/F002599/1, PP/D005914/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002599/1, PP/D005914/1] Funding Source: researchfish	Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	J.G. is supported by a Science and Technology Facilities Council (STFC) studentship. B. T. G., T. R. M., and D. S. are supported by an STFC rolling grant. We thank D. Townsley for useful discussions.	Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Althaus LG, 2009, ASTROPHYS J LETT, V693, pL23, DOI 10.1088/0004-637X/693/1/L23; Corsico AH, 2004, ASTRON ASTROPHYS, V427, P923, DOI 10.1051/0004-6361:20040416; Dufour P, 2008, ASTROPHYS J, V683, P978, DOI 10.1086/589855; Dufour P, 2007, NATURE, V450, P522, DOI 10.1038/nature06318; Dufour P, 2005, ASTROPHYS J, V627, P404, DOI 10.1086/430373; Eisenstein DJ, 2006, ASTROPHYS J SUPPL S, V167, P40, DOI 10.1086/507110; Fontaine G, 2002, ASTROPHYS J, V581, pL33, DOI 10.1086/345787; Gansicke BT, 2007, MON NOT R ASTRON SOC, V380, pL35, DOI 10.1111/j.1745-3933.2007.00343.x; GARCIABERRO E, 1994, ASTROPHYS J, V434, P306, DOI 10.1086/174729; GarciaBerro E, 1997, ASTROPHYS J, V485, P765, DOI 10.1086/304444; Gutierrez J, 2005, ASTRON ASTROPHYS, V435, P231, DOI 10.1051/0004-6361:20042254; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Herwig F, 1999, ASTRON ASTROPHYS, V349, pL5; Iben I, 1997, ASTROPHYS J, V489, P772, DOI 10.1086/304822; Koester D, 2006, ASTRON ASTROPHYS, V454, P951, DOI 10.1051/0004-6361:20065287; KOESTER D, 1982, ASTRON ASTROPHYS, V116, P147; Lepine S, 2005, ASTRON J, V129, P1483, DOI 10.1086/427854; Liebert J, 2003, ASTRON J, V126, P2521, DOI 10.1086/378911; Metcalfe TS, 2001, ASTROPHYS J, V557, P1021, DOI 10.1086/321643; NOMOTO K, 1984, ASTROPHYS J, V277, P791, DOI 10.1086/161749; PELLETIER C, 1986, ASTROPHYS J, V307, P242, DOI 10.1086/164410; Smartt SJ, 2009, MON NOT R ASTRON SOC, V395, P1409, DOI 10.1111/j.1365-2966.2009.14506.x; Straniero O, 2003, ASTROPHYS J, V583, P878, DOI 10.1086/345427; Werner K, 2006, PUBL ASTRON SOC PAC, V118, P183, DOI 10.1086/500443; Werner K, 2004, ASTRON ASTROPHYS, V421, P1169, DOI 10.1051/0004-6361:20047154; Williams KA, 2009, ASTROPHYS J, V693, P355, DOI 10.1088/0004-637X/693/1/355; WOOD M, 1995, LECT NOTE PHYS, V443, P41	28	44	44	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					188	190		10.1126/science.1180228	http://dx.doi.org/10.1126/science.1180228			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965382	Green Submitted			2022-12-28	WOS:000273394000030
J	Liu, X; Bushnell, DA; Wang, D; Calero, G; Kornberg, RD				Liu, Xin; Bushnell, David A.; Wang, Dong; Calero, Guillermo; Kornberg, Roger D.			Structure of an RNA Polymerase II-TFIIB Complex and the Transcription Initiation Mechanism	SCIENCE			English	Article							CORE PROMOTER ELEMENT; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; YEAST TFIIB; DNA; HOLOENZYME; ELONGATION; MODEL	Previous x-ray crystal structures have given insight into the mechanism of transcription and the role of general transcription factors in the initiation of the process. A structure of an RNA polymerase II-general transcription factor TFIIB complex at 4.5 angstrom resolution revealed the amino-terminal region of TFIIB, including a loop termed the "B finger," reaching into the active center of the polymerase where it may interact with both DNA and RNA, but this structure showed little of the carboxyl-terminal region. A new crystal structure of the same complex at 3.8 angstrom resolution obtained under different solution conditions is complementary with the previous one, revealing the carboxyl-terminal region of TFIIB, located above the polymerase active center cleft, but showing none of the B finger. In the new structure, the linker between the amino-and carboxyl-terminal regions can also be seen, snaking down from above the cleft toward the active center. The two structures, taken together with others previously obtained, dispel long-standing mysteries of the transcription initiation process.	[Liu, Xin; Bushnell, David A.; Wang, Dong; Calero, Guillermo; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA.	kornberg@stanford.edu	Wang, Dong/C-8943-2012		NIH [GM049985, AI21144, K99 GM085136]; Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH11231, DE-AC02-06CH11357]; NIH; National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM085136, R01GM036659, K99GM085136, R01GM049985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM049985 and AI21144 to R. D. K. X. L. was supported by the Jane Coffin Childs Memorial Fund fellowship. D. W. was supported by the NIH Pathway to Independence Award (K99 GM085136). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under contract DE-AC02-05CH11231. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Coordinates and structure factors have been deposited at the Protein Data Bank under accession code 3K7A.	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Schimanski B, 2006, NUCLEIC ACIDS RES, V34, P1676, DOI 10.1093/nar/gkl090; Shaw SP, 1996, MOL CELL BIOL, V16, P3651; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Wu WH, 1999, GENETICS, V153, P643	28	161	165	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					206	209		10.1126/science.1182015	http://dx.doi.org/10.1126/science.1182015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965383	Green Accepted			2022-12-28	WOS:000273394000036
J	Pinto, DS				Pinto, Duane S.			A 43-Year-Old Man With Angina, Elevated Troponin, and Lateral ST Depression Management of Acute Coronary Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; EARLY INVASIVE MANAGEMENT; HIGH-RISK PATIENTS; GLYCOPROTEIN IIB/IIIA INHIBITORS; SUPPRESS ADVERSE OUTCOMES; UNSTABLE ANGINA; GLOBAL REGISTRY; UNFRACTIONATED HEPARIN; EARLY IMPLEMENTATION; THROMBUS ASPIRATION	Each year, approximately 2 million people in the United States experience acute coronary syndromes related to thrombosis and ulceration of atherosclerotic plaque within a coronary artery. The case of Mr C, a 43-year-old man with non-ST-segment elevation myocardial infarction, which is most often caused by subtotal thrombosis, illustrates the complex decision-making process involved in selecting treatment for each patient and in determining whether invasive procedures are warranted. Cardiac catheterization is performed in moderate-and high-risk individuals to define the extent of disease so the proper strategy-medications alone, percutaneous revascularization, or coronary artery bypass graft surgery-can be selected. Medications to disrupt platelet function as well as the coagulation system are used. Treatments are designed to minimize the extent of infarction and prevent reinfarction, thereby improving outcomes. The timing of cardiac catheterization, for whom catheterization is indicated, and the rationale for medication treatment are discussed. JAMA. 2010; 303(1): 54-63	[Pinto, Duane S.] Beth Israel Deaconess Med Ctr, Intervent Cardiol Sect, Cardiac Catheterizat Lab, Boston, MA 02215 USA; [Pinto, Duane S.] Harvard Univ, Sch Med, Boston, MA USA; [Pinto, Duane S.] Beth Israel Deaconess Med Ctr, Cardiol Fellowship Training Program, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Pinto, DS (corresponding author), Beth Israel Deaconess Med Ctr, Intervent Cardiol Sect, Cardiac Catheterizat Lab, 1 Deaconess Rd,Baker 4, Boston, MA 02215 USA.	dpinto@bidmc.harvard.edu		Pinto, Duane/0000-0002-2309-8480				Alexander KP, 2005, J AM COLL CARDIOL, V46, P1479, DOI 10.1016/j.jacc.2005.05.084; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Baim D.S., 2006, GROSSMANS CARDIAC CA, V7th, P215; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bijsterveld NR, 2003, J AM COLL CARDIOL, V42, P2083, DOI 10.1016/j.jacc.2003.05.014; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; COHEN M, 1994, CIRCULATION, V89, P81, DOI 10.1161/01.CIR.89.1.81; Cohen MG, 2009, AM HEART J, V158, P263, DOI 10.1016/j.ahj.2009.05.016; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Devlin G, 2005, HEART, V91, P1394, DOI 10.1136/hrt.2004.054007; Elbarouni B, 2009, AM HEART J, V158, P392, DOI 10.1016/j.ahj.2009.06.010; Ellis Keith, 2003, J Interv Cardiol, V16, P299, DOI 10.1034/j.1600-6143.2003.08062.x; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Gibson CM, 2001, AM J CARDIOL, V87, P1293, DOI 10.1016/S0002-9149(01)01524-7; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Glaser R, 2002, JAMA-J AM MED ASSOC, V288, P3124, DOI 10.1001/jama.288.24.3124; GOLD HK, 1993, J AM COLL CARDIOL, V21, P1039, DOI 10.1016/0735-1097(93)90222-M; GRANGER CB, 1995, CIRCULATION, V91, P1929, DOI 10.1161/01.CIR.91.7.1929; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; GURFINKEL EP, 1995, J AM COLL CARDIOL, V26, P313, DOI 10.1016/0735-1097(95)80001-W; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859; Khalill R, 2009, EXP CLIN CARDIOL, V14, pE25; Kirtane AJ, 2006, J AM COLL CARDIOL, V47, P2374, DOI 10.1016/j.jacc.2005.09.080; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Mega JL, 2005, AM HEART J, V149, P846, DOI 10.1016/j.ahj.2004.08.042; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; MEHTA SR, 2009, EUR SOC CARD C AUG 2; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Oler A, 1996, JAMA-J AM MED ASSOC, V276, P811, DOI 10.1001/jama.276.10.811; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; Pickard AS, 2008, PHARMACOTHERAPY, V28, P376, DOI 10.1592/phco.28.3.376; Pinto DS, 2008, J AM COLL CARDIOL, V52, P1758, DOI 10.1016/j.jacc.2008.08.021; Pollack CV, 2006, ACAD EMERG MED, V13, P13, DOI 10.1197/j.aem.2005.06.031; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Roe MT, 2006, AM HEART J, V151, P1205, DOI 10.1016/j.ahj.2005.08.006; Sabatine MS, 2006, AM HEART J, V151, P25, DOI 10.1016/j.ahj.2005.02.030; Schiele F, 2005, EUR HEART J, V26, P873, DOI 10.1093/eurheartj/ehi107; Solomon DH, 2001, J AM COLL CARDIOL, V38, P969, DOI 10.1016/S0735-1097(01)01503-0; Steinhubl SR, 2006, J AM COLL CARDIOL, V47, P939, DOI 10.1016/j.jacc.2005.10.047; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8; von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Warkentin TE, 2004, CHEST, V126, p311S, DOI 10.1378/chest.126.3_suppl.311S; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	73	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					54	63		10.1001/jama.2009.1870	http://dx.doi.org/10.1001/jama.2009.1870			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	19952308				2022-12-28	WOS:000273296900019
J	Laguna-Torres, VA; Benavides, JG				Alberto Laguna-Torres, V.; Gomez Benavides, Jorge			Infection and death from influenza A H1N1 virus in Mexico	LANCET			English	Editorial Material							SWINE; SENSITIVITY; TESTS		[Alberto Laguna-Torres, V.] US Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru; [Alberto Laguna-Torres, V.] US Naval Med Res Ctr Detachment, Influenza Sect, Lima, Peru; [Gomez Benavides, Jorge] Univ Nacl Mayor San Marcos, Lima 14, Peru; [Gomez Benavides, Jorge] Minist Hlth Peru, Gen Epidemiol Directorate, Lima, Peru	Universidad Nacional Mayor de San Marcos	Laguna-Torres, VA (corresponding author), US Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru.	laguna_alberto@hotmail.com		LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301				Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDC, 2009, INT GUID DET NOV INF; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Gomez J, 2009, EURO SURVEILL, V4; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; *NAT COMM SAF HLTH, 2007, NAT EX EV RESP CAP I; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; PEREZTRALLERO E, 2009, EURO SURVEILL, V14	13	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2032	2033		10.1016/S0140-6736(09)61916-4	http://dx.doi.org/10.1016/S0140-6736(09)61916-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19913291				2022-12-28	WOS:000273122900006
J	Liu, HZ; Jiang, T; Han, BX; Liang, SG; Zhou, YX				Liu, Huizhen; Jiang, Tao; Han, Buxing; Liang, Shuguang; Zhou, Yinxi			Selective Phenol Hydrogenation to Cyclohexanone Over a Dual Supported Pd-Lewis Acid Catalyst	SCIENCE			English	Article							VAPOR-PHASE HYDROGENATION; PALLADIUM CATALYSTS; CARBON-DIOXIDE; OXIDATION; BENZENE; LIQUID; SILICA; ARENES	Cyclohexanone is an industrially important intermediate in the synthesis of materials such as nylon, but preparing it efficiently through direct hydrogenation of phenol is hindered by over-reduction to cyclohexanol. Here we report that a previously unappreciated combination of two common commercial catalysts. nanoparticulate palladium (supported on carbon, alumina, or NaY zeolite) and a Lewis acid such as AlCl(3-)synergistically promotes this reaction. Conversion exceeding 99.9% was achieved with >99.9% selectivity within 7 hours at 1.0-megapascal hydrogen pressure and 50 degrees C. The reaction was accelerated at higher temperature or in a compressed CO2 solvent medium. Preliminary kinetic and spectroscopic studies suggest that the Lewis acid sequentially enhances the hydrogenation of phenol to cyclohexanone and then inhibits further hydrogenation of the ketone.	[Liu, Huizhen; Jiang, Tao; Han, Buxing; Liang, Shuguang; Zhou, Yinxi] Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS	Jiang, T (corresponding author), Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.	Jiangt@iccas.ac.cn; Hanbx@iccas.ac.cn	jiang, tao/GWC-7108-2022		National Natural Science Foundation of China [20773144, 20733010, 20633080]; National Key Basic Research Project of China [2006CB202504]; Chinese Academy of Sciences [KJCX2.YW.H16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Project of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank the National Natural Science Foundation of China (grants 20773144, 20733010, and 20633080), the National Key Basic Research Project of China (grant 2006CB202504), and the Chinese Academy of Sciences (grant KJCX2.YW.H16) for financial support.	Benkhaled M, 2008, APPL CATAL A-GEN, V346, P36, DOI 10.1016/j.apcata.2008.04.043; Bianchini C, 2003, ANGEW CHEM INT EDIT, V42, P2636, DOI 10.1002/anie.200250667; Claus P, 2000, J CATAL, V192, P88, DOI 10.1006/jcat.2000.2834; COOK D, 1963, CAN J CHEM, V41, P522, DOI 10.1139/v63-072; Deshmukh RR, 2008, ANGEW CHEM INT EDIT, V47, P8615, DOI 10.1002/anie.200803850; Diaz E, 2007, CHEM ENG J, V131, P65, DOI 10.1016/j.cej.2006.12.020; DODGSON I, 1989, CHEM IND-LONDON, P830; GRASSHOFF E, 1985, Patent No. 218092; Hitzler MG, 1997, CHEM COMMUN, P1667, DOI 10.1039/a704371f; HOWEGRANT M, 1991, KIRKOTHMER ENCY CHEM; JESSOP PG, 1999, CHEM SYNTHESIS USING; Koltunov KY, 2002, TETRAHEDRON, V58, P5423, DOI 10.1016/S0040-4020(02)00512-4; Li H, 2008, ADV FUNCT MATER, V18, P3235, DOI 10.1002/adfm.200800667; Liu L, 2009, ANGEW CHEM INT EDIT, V48, P2206, DOI 10.1002/anie.200804891; Lu F, 2008, MATER CHEM PHYS, V108, P369, DOI 10.1016/j.matchemphys.2007.10.010; Makowski P, 2008, CHEM COMMUN, P999, DOI 10.1039/b717928f; Morales J, 2002, IND ENG CHEM RES, V41, P3071, DOI 10.1021/ie0200510; Park C, 2003, J COLLOID INTERF SCI, V266, P183, DOI 10.1016/S0021-9797(03)00171-1; Poliakoff M, 2007, NATURE, V450, P810, DOI 10.1038/450810a; Rode CV, 2003, CHEM COMMUN, P1960, DOI 10.1039/B304344D; Scire S, 2002, APPL CATAL A-GEN, V235, P21, DOI 10.1016/S0926-860X(02)00237-5; Shore SG, 2002, CATAL COMMUN, V3, P77, DOI 10.1016/S1566-7367(02)00052-3; Sikhwivhilu LM, 2007, APPL CATAL A-GEN, V324, P52, DOI 10.1016/j.apcata.2007.03.004; Tarakeshwar P, 1998, J PHYS CHEM A, V102, P2253, DOI 10.1021/jp9807322; Velu S, 2003, APPL CATAL A-GEN, V245, P317, DOI 10.1016/S0926-860X(02)00655-5; Wang HJ, 2008, CATAL COMMUN, V9, P362, DOI 10.1016/j.catcom.2007.07.002; Xu LX, 2008, CATAL COMMUN, V9, P816, DOI 10.1016/j.catcom.2007.09.005; Zhang ZF, 2008, ANGEW CHEM INT EDIT, V47, P1127, DOI 10.1002/anie.200704487; Zhuang L, 2003, CHEM LETT, V32, P1072, DOI 10.1246/cl.2003.1072	29	482	502	27	879	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1250	1252		10.1126/science.1179713	http://dx.doi.org/10.1126/science.1179713			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	524BD	19965472				2022-12-28	WOS:000272117900044
J	Salger, T; Kling, S; Hecking, T; Geckeler, C; Morales-Molina, L; Weitz, M				Salger, Tobias; Kling, Sebastian; Hecking, Tim; Geckeler, Carsten; Morales-Molina, Luis; Weitz, Martin			Directed Transport of Atoms in a Hamiltonian Quantum Ratchet	SCIENCE			English	Article							BROWNIAN MOTORS	Classical ratchet potentials, which alternate a driving potential with periodic random dissipative motion, can account for the operation of biological motors. We demonstrate the operation of a quantum ratchet, which differs from classical ratchets in that dissipative processes are absent within the observation time of the system (Hamiltonian regime). An atomic rubidium Bose-Einstein condensate is exposed to a sawtooth-like optical lattice potential, whose amplitude is periodically modulated in time. The ratchet transport arises from broken spatiotemporal symmetries of the driven potential, resulting in a desymmetrization of transporting eigenstates (Floquet states). The full quantum character of the ratchet transport was demonstrated by the measured atomic current oscillating around a nonzero stationary value at longer observation times, resonances occurring at positions determined by the photon recoil, and dependence of the transport current on the initial phase of the driving potential.	[Salger, Tobias; Kling, Sebastian; Hecking, Tim; Geckeler, Carsten; Weitz, Martin] Inst Angew Phys, D-53115 Bonn, Germany; [Morales-Molina, Luis] Pontificia Univ Catolica Chile, Fac Fis, Santiago 22, Chile	University of Bonn; Pontificia Universidad Catolica de Chile	Salger, T (corresponding author), Inst Angew Phys, Wegelerstr 8, D-53115 Bonn, Germany.	salger@iap.uni-bonn.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the Deutsche Forschungsgemeinschaft for financial support.	Astumian RD, 2002, PHYS TODAY, V55, P33, DOI 10.1063/1.1535005; Berman PR, 1998, PHYS REV A, V58, P4801, DOI 10.1103/PhysRevA.58.4801; Dana I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.024103; Denisov S, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.063424; Flach S, 2000, PHYS REV LETT, V84, P2358, DOI 10.1103/PhysRevLett.84.2358; Gommers R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.240604; Gommers R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.073003; Hanggi P, 2009, REV MOD PHYS, V81, P387, DOI 10.1103/RevModPhys.81.387; Hensinger WK, 2001, NATURE, V412, P52, DOI 10.1038/35083510; Jones PH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.073002; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Linke H, 1999, SCIENCE, V286, P2314, DOI 10.1126/science.286.5448.2314; Majer JB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.056802; Ponomarev AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230601; Reichl L.E., 1992, TRANSITION CHAOS CON; Reimann P, 1997, PHYS REV LETT, V79, P10, DOI 10.1103/PhysRevLett.79.10; Ritt G, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063622; Salger T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190405; Schanz H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026228; Schiavoni M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.094101; Steck DA, 2001, SCIENCE, V293, P274, DOI 10.1126/science.1061569; Weitz M, 1997, EUROPHYS LETT, V37, P517, DOI 10.1209/epl/i1997-00184-7	22	179	181	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1241	1243		10.1126/science.1179546	http://dx.doi.org/10.1126/science.1179546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965469	Green Submitted			2022-12-28	WOS:000272117900041
J	Tawar, RG; Duquerroy, S; Vonrhein, C; Varela, PF; Damier-Piolle, L; Castagne, N; MacLellan, K; Bedouelle, H; Bricogne, G; Bhella, D; Eleouet, JF; Rey, FA				Tawar, Rajiv G.; Duquerroy, Stephane; Vonrhein, Clemens; Varela, Paloma F.; Damier-Piolle, Laurence; Castagne, Nathalie; MacLellan, Kirsty; Bedouelle, Hugues; Bricogne, Gerard; Bhella, David; Eleouet, Jean-Francois; Rey, Felix A.			Crystal Structure of a Nucleocapsid-Like Nucleoprotein-RNA Complex of Respiratory Syncytial Virus	SCIENCE			English	Article							PROTEIN; REPLICATION; TRANSCRIPTION; POLYMERASE	The respiratory syncytial virus (RSV) is an important human pathogen, yet neither a vaccine nor effective therapies are available to treat infection. To help elucidate the replication mechanism of this RNA virus, we determined the three-dimensional (3D) crystal structure at 3.3 angstrom resolution of a decameric, annular ribonucleoprotein complex of the RSV nucleoprotein (N) bound to RNA. This complex mimics one turn of the viral helical nucleocapsid complex, which serves as template for viral RNA synthesis. The RNA wraps around the protein ring, with seven nucleotides contacting each N subunit, alternating rows of four and three stacked bases that are exposed and buried within a protein groove, respectively. Combined with electron microscopy data, this structure provides a detailed model for the RSV nucleocapsid, in which the bases are accessible for readout by the viral polymerase. Furthermore, the nucleoprotein structure highlights possible key sites for drug targeting.	[Castagne, Nathalie; Eleouet, Jean-Francois] INRA, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France; [Tawar, Rajiv G.; Duquerroy, Stephane; Varela, Paloma F.; Damier-Piolle, Laurence; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France; [Tawar, Rajiv G.; Duquerroy, Stephane; Varela, Paloma F.; Damier-Piolle, Laurence; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France; [Duquerroy, Stephane] Univ Paris 11, Fac Orsay, F-91405 Orsay, France; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing, Cambridge CB3 0AX, England; [MacLellan, Kirsty; Bhella, David] Univ Glasgow, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Bedouelle, Hugues] Inst Pasteur, CNRS, URA 3012, F-75724 Paris 15, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eleouet, JF (corresponding author), INRA, Unite Virol & Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France.	jean-francois.eleouet@jouy.inra.fr; rey@pasteur.fr	Bhella, David/J-8514-2012; Eléouët, Jean-François/AAD-1994-2019; Varela, Paloma/AFT-0478-2022; Rey, Felix/B-6497-2012	Bhella, David/0000-0003-2096-8310; Varela, Paloma/0000-0001-5078-7102; Rey, Felix/0000-0002-9953-7988; ELeouet, Jean-Francois/0000-0002-7361-4885; Gibson, Kirsty/0000-0002-6734-4452; Duquerroy, Stephane/0000-0003-4386-8013	Marie-Curie RTN fellowship [MRTN-CT-2006-035599]; French Fondation pour la Recherche Medicale; French Agence Nationale pour la Recherche; Merck-Serono; MRC [MC_U130115834] Funding Source: UKRI	Marie-Curie RTN fellowship(European Commission); French Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Agence Nationale pour la Recherche(French National Research Agency (ANR)); Merck-Serono(Merck & Company); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was initiated as part of the sixth European Union Framework Programme consortium (http://cordis.europa.eu/life/src/control/qlk2-ct-2001-01225.htm). We thank A. Albertini, J. Bernard, D. Gerlier, A. Haouz, J. Lepault, M. Moudjou, C. Schulze-Briese, E. Stura, P. Weber, and R. P. Yeo for help and/or discussion; M. Backovic, D. Kolakovsky, J. Melero, L. Roux, and A. Tortorici for comments on the manuscript. Diffraction data collection was done at beamline X06SA of the Swiss Light Source and ID23-2 of the European Synchrotron Radiation Facility. R. G. T. benefits from a Marie-Curie RTN fellowship (consortium MRTN-CT-2006-035599, acronym EIHCV). This work was also supported by the French Fondation pour la Recherche Medicale (postdoctoral fellowship to P. F. V.), by a grant from the French Agence Nationale pour la Recherche (Programme MIME) to F. A. R., and by Merck-Serono. The coordinates and structure factors of the N-RNA rings were deposited in the Protein Data Bank with accession number 2wj8. The 3D EM reconstruction was deposited in the Electron Microscopy Data Bank with accession code EMD-1622.	Albertini AAV, 2008, CELL MOL LIFE SCI, V65, P282, DOI 10.1007/s00018-007-7298-1; Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; BACHI T, 1973, J VIROL, V12, P1173; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; BRUNT AA, 2005, VIRUS TAXONOMY, P655; Chapman J, 2007, ANTIMICROB AGENTS CH, V51, P3346, DOI 10.1128/AAC.00211-07; Collins PL, 2007, FIELDS VIROLOGY, P1601; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; Dupuy LC, 1999, J VIROL, V73, P8384, DOI 10.1128/JVI.73.10.8384-8392.1999; El Omari K, 2008, ACTA CRYSTALLOGR F, V64, P1019, DOI 10.1107/S1744309108031059; Frogel Michael P, 2008, Manag Care, V17, P7; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; Juozapaitis M, 2006, BIOLOGIJA, V3, P79; MacLellan K, 2007, J VIROL, V81, P9519, DOI 10.1128/JVI.00526-07; Murray J, 2001, VIROLOGY, V289, P252, DOI 10.1006/viro.2001.1150; PRINGLE CR, 2005, VIRUS TAXONOMY, P609; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Rudolph MG, 2003, STRUCTURE, V11, P1219, DOI 10.1016/j.str.2003.08.011	21	237	248	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1279	1283		10.1126/science.1177634	http://dx.doi.org/10.1126/science.1177634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965480				2022-12-28	WOS:000272117900052
J	Pinto-Tomas, AA; Anderson, MA; Suen, G; Stevenson, DM; Chu, FST; Cleland, WW; Weimer, PJ; Currie, CR				Pinto-Tomas, Adrian A.; Anderson, Mark A.; Suen, Garret; Stevenson, David M.; Chu, Fiona S. T.; Cleland, W. Wallace; Weimer, Paul J.; Currie, Cameron R.			Symbiotic Nitrogen Fixation in the Fungus Gardens of Leaf-Cutter Ants	SCIENCE			English	Article							TROPICAL RAIN-FOREST; ATTA-CEPHALOTES; CUTTING ANTS; DIVERSITY; ABUNDANCE; REFUSE; NESTS	Bacteria-mediated acquisition of atmospheric N-2 serves as a critical source of nitrogen in terrestrial ecosystems. Here we reveal that symbiotic nitrogen fixation facilitates the cultivation of specialized fungal crops by leaf-cutter ants. By using acetylene reduction and stable isotope experiments, we demonstrated that N-2 fixation occurred in the fungus gardens of eight leaf-cutter ant species and, further, that this fixed nitrogen was incorporated into ant biomass. Symbiotic N-2-fixing bacteria were consistently isolated from the fungus gardens of 80 leaf-cutter ant colonies collected in Argentina, Costa Rica, and Panama. The discovery of N-2 fixation within the leaf-cutter ant-microbe symbiosis reveals a previously unrecognized nitrogen source in neotropical ecosystems.	[Pinto-Tomas, Adrian A.; Suen, Garret; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Dept Bioquim, Fac Med, San Jose, Costa Rica; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Ctr Invest Estruct Microscop, San Jose, Costa Rica; [Anderson, Mark A.; Chu, Fiona S. T.; Cleland, W. Wallace] Univ Wisconsin, Dept Biochem, Inst Enzyme Res, Madison, WI 53726 USA; [Suen, Garret; Currie, Cameron R.] Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Stevenson, David M.; Weimer, Paul J.] ARS, USDA, US Dairy Forage Res Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Universidad Costa Rica; Universidad Costa Rica; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	currie@bact.wisc.edu	Weimer, Paul James/AAY-6485-2020; Suen, Garret/AAF-2080-2019	Weimer, Paul James/0000-0002-9278-6535; Suen, Garret/0000-0002-6170-711X	NSF [MCB-0731822, MCB-0702025, DEB-0747002]; NIH [GM 18938]; OTS; U. S. Department of Energy's Great Lakes Bioenergy Research Center [DE-FC02-07ER64494]; U. S. Department of Agriculture-Agricultural Research Service Current Research Information System [3655-41000-005-00D]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018938, R01GM018938] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OTS; U. S. Department of Energy's Great Lakes Bioenergy Research Center(United States Department of Energy (DOE)); U. S. Department of Agriculture-Agricultural Research Service Current Research Information System(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Steffensen, L. Schwab, L. Uribe, M. Mora, B. Matarrita, D. Brenes, R. Araya, H. Read, J. Mentzer, D. Maly, and G. Pine for technical assistance; Y. Zhang, E. Pohlmann, and G. Roberts for assistance with acetylene reduction assays; A. Little, S. Price, and U. Mueller for leaf-cutter ant colony collection; M. Rogel-Hernandez and E. Martinez-Romero for providing isolate K. variicola F2R9; B. Ma, A. Charkowski, and N. Perna for assistance with phylogenetic analyses; E. Sanchez, R. Moreira, and T. Escalante for assistance with microscopic analyses; N. Keuler for statistical advice; the sequencing and production teams at the Joint Genome Institute; and S. Adams, F. Aylward, E. Caldera, N. Gerardo, H. Goodrich-Blair, K. Grubbs, S. Marsh, M. Poulsen, K. Raffa, G. Roberts, E. Ruby, T. Schultz, and J. Scott for comments on the manuscript. We acknowledge the Organization for Tropical Studies (OTS) and the Ministerio de Ambiente y Energia in Costa Rica, the Autoridad Nacional del Ambiente in Panama, and the Government of Argentina for facilitating the research and granting collecting permits. This work was funded by NSF grants MCB-0731822, MCB-0702025, and DEB-0747002 to C. R. C.; NIH grant GM 18938 to W. W. C., and an OTS research fellowship to A. A. P.-T. G. S. and C. R. C. were supported by the U. S. Department of Energy's Great Lakes Bioenergy Research Center under contract DE-FC02-07ER64494; D. M. S. and P. J. W. were supported by U. S. Department of Agriculture-Agricultural Research Service Current Research Information System project 3655-41000-005-00D. DNA sequence data were deposited in GenBank under accession numbers FJ593730 to FJ593840 and GQ342603 to GQ342604.	Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; BREZNAK JA, 1973, NATURE, V244, P577, DOI 10.1038/244577a0; Bucher EH, 2004, BIOTROPICA, V36, P327, DOI 10.1646/04005; Burris R H, 1972, Methods Enzymol, V24, P415; Cherrett J.M., 1989, P93; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Davidson D. W., 1996, NEOTROPICAL BIODIVER, P127; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Doolittle M, 2008, BIORESOURCE TECHNOL, V99, P3297, DOI 10.1016/j.biortech.2007.07.013; Farji-Brener AG, 2000, BIOTROPICA, V32, P120, DOI 10.1646/0006-3606(2000)032[0120:TIOWTD]2.0.CO;2; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Garrettson M, 1998, J TROP ECOL, V14, P17, DOI 10.1017/S0266467498000029; HAINES BL, 1978, BIOTROPICA, V10, P270, DOI 10.2307/2387679; Holldobler B., 1990, pi; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; PERFECTO I, 1993, BIOTROPICA, V25, P316, DOI 10.2307/2388789; Schoonhoven L. M., 2005, Insect-plant biology; Schultz Ted R., 2005, P149; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Weber N. A., 1972, GARDENING ANTS ATTIN; Wilson E.O., 1986, P1; Wilson EO., 1990, SUCCESS DOMINANCE EC, V2; Wirth R, 2003, HERBIVORY LEAF CUTTI; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	27	220	229	5	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1120	1123		10.1126/science.1173036	http://dx.doi.org/10.1126/science.1173036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965433				2022-12-28	WOS:000271951000047
J	Deming, D; Seager, S				Deming, Drake; Seager, Sara			Light and shadow from distant worlds	NATURE			English	Review							EXTRASOLAR GIANT PLANETS; INFRARED-EMISSION SPECTRUM; EXOPLANET HD 189733B; HOT JUPITERS; THERMAL EMISSION; TEMPERATURE INVERSION; SUPER-EARTHS; ATMOSPHERIC CIRCULATION; THEORETICAL SPECTRA; TRANSITS	Exoplanets are distant worlds that orbit stars other than our Sun. More than 370 such planets are known, and a growing fraction of them are discovered because they transit their star as seen from Earth. The special transit geometry enables us to measure masses and radii for dozens of planets, and we have identified gases in the atmospheres of several giant ones. Within the next decade, we expect to find and study a 'habitable' rocky planet transiting a cool red dwarf star close to our Sun. Eventually, we will be able to image the light from an Earth-like world orbiting a nearby solar-type star.	[Deming, Drake] NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA; [Seager, Sara] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02138 USA; [Seager, Sara] MIT, Dept Phys, Cambridge, MA 02138 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Deming, D (corresponding author), NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Code 693, Greenbelt, MD 20771 USA.	Leo.D.Deming@nasa.gov			NASA	NASA(National Aeronautics & Space Administration (NASA))	This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Support for this work was provided directly by NASA, and by NASA through an award issued by JPL/Caltech.	Alonso R, 2009, ASTRON ASTROPHYS, V501, pL23, DOI 10.1051/0004-6361/200912505; Bakos GA, 2009, ASTROPHYS J, V696, P1950, DOI 10.1088/0004-637X/696/2/1950; BAKOS GA, 2009, ASTROPHYS J IN PRESS; BALLARD S, 2009, ASTROPHYS J UNPUB; BARNES JR, 2009, MON NOT R A IN PRESS; BORUCKI W., 2009, IAU S, V253, P289; Borucki WJ, 2009, SCIENCE, V325, P709, DOI 10.1126/science.1178312; Burke CJ, 2008, ASTROPHYS J, V686, P1331, DOI 10.1086/591497; Burrows A, 2008, ASTROPHYS J, V678, P1436, DOI 10.1086/533518; Cash W, 2006, NATURE, V442, P51, DOI 10.1038/nature04930; Chabrier G, 2007, ASTROPHYS J, V661, pL81, DOI 10.1086/518473; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Charbonneau D, 2008, ASTROPHYS J, V686, P1341, DOI 10.1086/591635; Chiang E, 2009, ASTROPHYS J, V693, P734, DOI 10.1088/0004-637X/693/1/734; Cowan NB, 2007, MON NOT R ASTRON SOC, V379, P641, DOI 10.1111/j.1365-2966.2007.11897.x; de Mooij EJW, 2009, ASTRON ASTROPHYS, V493, pL35, DOI 10.1051/0004-6361:20081239; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2009, PUBL ASTRON SOC PAC, V121, P952, DOI 10.1086/605913; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Froning CS, 2009, ASTROPHYS SPACE SCI, V320, P181, DOI 10.1007/s10509-008-9758-y; Gillon M, 2007, ASTRON ASTROPHYS, V472, pL13, DOI 10.1051/0004-6361:20077799; GILLON M, ASTRON ASTR IN PRESS; Gould A., 2006, Astrophysical Journal, Letters, V644, pL37, DOI 10.1086/505421; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; Grillmair CJ, 2008, NATURE, V456, P767, DOI 10.1038/nature07574; Guillot T, 2002, ASTRON ASTROPHYS, V385, P156, DOI 10.1051/0004-6361:20011624; Harrington J, 2007, NATURE, V447, P691, DOI 10.1038/nature05863; Harrington J, 2006, SCIENCE, V314, P623, DOI 10.1126/science.1133904; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Hubeny I, 2003, ASTROPHYS J, V594, P1011, DOI 10.1086/377080; Kalas P, 2008, SCIENCE, V322, P1345, DOI 10.1126/science.1166609; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2009, ASTROPHYS J, V703, P769, DOI 10.1088/0004-637X/703/1/769; Knutson HA, 2009, ASTROPHYS J, V691, P866, DOI 10.1088/0004-637X/691/1/866; Laughlin G, 2009, NATURE, V457, P562, DOI 10.1038/nature07649; Lopez-Morales M, 2007, ASTROPHYS J, V667, pL191, DOI 10.1086/522118; Machalek P, 2008, ASTROPHYS J, V684, P1427, DOI 10.1086/590140; Machalek P, 2009, ASTROPHYS J, V701, P514, DOI 10.1088/0004-637X/701/1/514; Marcy GW, 2008, PHYS SCRIPTA, VT130, DOI 10.1088/0031-8949/2008/T130/014001; Marley MS, 2007, ASTROPHYS J, V655, P541, DOI 10.1086/509759; Marley MS, 1999, ASTROPHYS J, V513, P879, DOI 10.1086/306881; Mayor M, 2009, ASTRON ASTROPHYS, V493, P639, DOI 10.1051/0004-6361:200810451; Menou K, 2009, ASTROPHYS J, V700, P887, DOI 10.1088/0004-637X/700/1/887; MILLER N, 2009, ASTROPHYS J UNPUB; Miller-Ricci E, 2009, ASTROPHYS J, V690, P1056, DOI 10.1088/0004-637X/690/2/1056; Nutzman P, 2008, PUBL ASTRON SOC PAC, V120, P317, DOI 10.1086/533420; QUELOZ D, ASTRON ASTR IN PRESS; Richardson LJ, 2007, NATURE, V445, P892, DOI 10.1038/nature05636; Rowe JF, 2008, ASTROPHYS J, V689, P1345, DOI 10.1086/591835; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Seager S, 2000, ASTROPHYS J, V540, P504, DOI 10.1086/309292; Showman AP, 2008, ASTR SOC P, V398, P419; Snellen IAG, 2009, NATURE, V459, P543, DOI 10.1038/nature08045; SPERGEL DN, 2009, B AM ASTRON SOC, V213; Sudarsky D, 2003, ASTROPHYS J, V588, P1121, DOI 10.1086/374331; Swain MR, 2009, ASTROPHYS J LETT, V690, pL114, DOI 10.1088/0004-637X/690/2/L114; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; Tarter JC, 2007, ASTROBIOLOGY, V7, P30, DOI 10.1089/ast.2006.0124; Trauger JT, 2007, NATURE, V446, P771, DOI 10.1038/nature05729; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Winn JN, 2009, ASTROPHYS J LETT, V703, pL99, DOI 10.1088/0004-637X/703/2/L99; Yu QJ, 2001, ASTRON J, V121, P1736, DOI 10.1086/319401; Zahnle K, 2009, ASTROPHYS J LETT, V701, pL20, DOI 10.1088/0004-637X/701/1/L20	75	21	22	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					301	306		10.1038/nature08556	http://dx.doi.org/10.1038/nature08556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924208				2022-12-28	WOS:000271899300035
J	Sime, LC; Wolff, EW; Oliver, KIC; Tindall, JC				Sime, L. C.; Wolff, E. W.; Oliver, K. I. C.; Tindall, J. C.			Evidence for warmer interglacials in East Antarctic ice cores	NATURE			English	Article							CENTER CLIMATE MODEL; PRECIPITATION; VARIABILITY; IMPACT; OCEAN	Stable isotope ratios of oxygen and hydrogen in the Antarctic ice core record have revolutionized our understanding of Pleistocene climate variations and have allowed reconstructions of Antarctic temperature over the past 800,000 years (800 kyr; refs 1, 2). The relationship between the D/H ratio of mean annual precipitation and mean annual surface air temperature is said to be uniform +/- 10% over East Antarctica(3) and constant with time +/- 20% (refs 3-5). In the absence of strong independent temperature proxy evidence allowing us to calibrate individual ice cores, prior general circulation model (GCM) studies have supported the assumption of constant uniform conversion for climates cooler than that of the present day(3,5). Here we analyse the three available 340 kyr East Antarctic ice core records alongside input from GCM modelling. We show that for warmer interglacial periods the relationship between temperature and the isotopic signature varies among ice core sites, and that therefore the conversions must be nonlinear for at least some sites. Model results indicate that the isotopic composition of East Antarctic ice is less sensitive to temperature changes during warmer climates. We conclude that previous temperature estimates from interglacial climates are likely to be too low. The available evidence is consistent with a peak Antarctic interglacial temperature that was at least 6K higher than that of the present day -approximately double the widely quoted 3 +/- 1.5K (refs 5, 6).	[Sime, L. C.; Wolff, E. W.] British Antarctic Survey, Cambridge CB3 0ET, England; [Oliver, K. I. C.] Open Univ, Dept Earth & Environm Sci, Milton Keynes MK7 6AA, Bucks, England; [Tindall, J. C.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Open University - UK; University of Bristol	Sime, LC (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	lsim@bas.ac.uk	Wolff, Eric/AAB-1097-2021; Sime, Louise/F-8058-2012; Wolff, Eric W/D-7925-2014; Sime, Louise/AAX-7730-2021	Wolff, Eric/0000-0002-5914-8531; Sime, Louise/0000-0002-9093-7926; Wolff, Eric W/0000-0002-5914-8531; Sime, Louise/0000-0002-9093-7926	Natural Environment Research Council [NE/D001803/1, bas0100024, NER/T/S/2002/00460] Funding Source: researchfish; NERC [bas0100024, NE/D001803/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; DANSGAARD W, 1964, TELLUS, V16, P436; Delaygue G, 2000, GEOPHYS RES LETT, V27, P2677, DOI 10.1029/2000GL011530; Groll N, 2005, J CLIMATE, V18, P4032, DOI 10.1175/JCLI3469.1; Hirasawa N, 2000, GEOPHYS RES LETT, V27, P1911, DOI 10.1029/1999GL011039; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; JOUZEL J, 2003, J GEOPHYS RES, V108, P26471; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Noone D, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004228; Noone D, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008892; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Paul A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000783; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; ROZANSKI K, 1992, SCIENCE, V258, P981, DOI 10.1126/science.258.5084.981; Schneider DP, 2004, J CLIMATE, V17, P1569, DOI 10.1175/1520-0442(2004)017<1569:RCVIAF>2.0.CO;2; Sime LC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010395; Solomon S., 2007, PHYS SCI BASIS WORKI; Tindall JC, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010825; Turner J, 2006, INT J CLIMATOL, V26, P91, DOI 10.1002/joc.1260; Uemura R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019954; Vimeux F, 2002, EARTH PLANET SC LETT, V203, P829, DOI 10.1016/S0012-821X(02)00950-0; Vimeux F, 1999, NATURE, V398, P410, DOI 10.1038/18860; Watanabe O, 2003, NATURE, V422, P509, DOI 10.1038/nature01525; Werner M, 2001, TELLUS B, V53, P53, DOI 10.1034/j.1600-0889.2001.01154.x	30	101	103	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					342	U105		10.1038/nature08564	http://dx.doi.org/10.1038/nature08564			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924212				2022-12-28	WOS:000271899300042
J	Sadri-Ardekani, H; Mizrak, SC; van Daalen, SKM; Korver, CM; Roepers-Gajadien, HL; Koruji, M; Hovingh, S; de Reijke, TM; de la Rosette, JJMCH; van der Veen, F; de Rooij, DG; Repping, S; van Pelt, AMM				Sadri-Ardekani, Hooman; Mizrak, Sefika C.; van Daalen, Saskia K. M.; Korver, Cindy M.; Roepers-Gajadien, Hermien L.; Koruji, Morteza; Hovingh, Suzanne; de Reijke, Theo M.; de la Rosette, Jean J. M. C. H.; van der Veen, Fulco; de Rooij, Dirk G.; Repping, Sjoerd; van Pelt, Ans M. M.			Propagation of Human Spermatogonial Stem Cells In Vitro	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM CULTURE; SELF-RENEWAL; MOUSE TESTES; GERM-CELLS; TRANSPLANTATION; SPERMATOGENESIS; EXPANSION; MICE; PROLIFERATION; COLONIZATION	Context Young boys treated with high-dose chemotherapy are often confronted with infertility once they reach adulthood. Cryopreserving testicular tissue before chemotherapy and autotransplantation of spermatogonial stem cells at a later stage could theoretically allow for restoration of fertility. Objective To establish in vitro propagation of human spermatogonial stem cells from small testicular biopsies to obtain an adequate number of cells for successful transplantation. Design, Setting, and Participants Study performed from April 2007 to July 2009 using testis material donated by 6 adult men who underwent orchidectomy as part of prostate cancer treatment. Testicular cells were isolated and cultured in supplemented StemPro medium; germline stem cell clusters that arose were subcultured on human placental laminin-coated dishes in the same medium. Presence of spermatogonia was determined by reverse transcriptase polymerase chain reaction and immunofluorescence for spermatogonial markers. To test for the presence of functional spermatogonial stem cells in culture, xenotransplantation to testes of immunodeficient mice was performed, and migrated human spermatogonial stem cells after transplantation were detected by COT-1 fluorescence in situ hybridization. The number of colonized spermatogonial stem cells transplanted at early and later points during culture were counted to determine propagation. Main Outcome Measures Propagation of spermatogonial stem cells over time. Results Testicular cells could be cultured and propagated up to 15 weeks. Germline stem cell clusters arose in the testicular cell cultures from all 6 men and could be subcultured and propagated for up to 28 weeks. Expression of spermatogonial markers on both the RNA and protein level was maintained throughout the entire culture period. In 4 of 6 men, xenotransplantation to mice demonstrated the presence of functional spermatogonial stem cells, even after prolonged in vitro culture. Spermatogonial stem cell numbers increased 53-fold within 19 days in the testicular cell culture and increased 18 450-fold within 64 days in the germline stem cell subculture. Conclusions Long-term culture and propagation of human spermatogonial stem cells in vitro is achievable. JAMA. 2009; 302(19): 2127-2134	[Sadri-Ardekani, Hooman; Mizrak, Sefika C.; van Daalen, Saskia K. M.; Korver, Cindy M.; Roepers-Gajadien, Hermien L.; Koruji, Morteza; Hovingh, Suzanne; van der Veen, Fulco; de Rooij, Dirk G.; Repping, Sjoerd; van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [de Reijke, Theo M.; de la Rosette, Jean J. M. C. H.] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands; [Sadri-Ardekani, Hooman] Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Pelt, AMM (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med F2 131 2, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.m.vanpelt@amc.uva.nl	de Rooij, D.G./AAW-1195-2021; Koruji, Morteza -/AAE-9264-2022; Koruji, Morteza/N-2393-2017	Koruji, Morteza -/0000-0003-2661-0117; Koruji, Morteza/0000-0003-2661-0117; de Rooij, Dirk/0000-0003-3932-4419; Repping, Sjoerd/0000-0002-6959-149X; van Pelt, Ans/0000-0001-9155-548X				Aponte PM, 2008, REPRODUCTION, V136, P543, DOI 10.1530/REP-07-0419; Aponte PM, 2005, APMIS, V113, P727, DOI 10.1111/j.1600-0463.2005.apm_302.x; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; BERES J, 1989, International Urology and Nephrology, V21, P159, DOI 10.1007/BF02550804; Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Creemers LB, 2002, BIOL REPROD, V66, P1579, DOI 10.1095/biolreprod66.6.1579; Dobrinski I, 1999, MOL REPROD DEV, V53, P142, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;142::AID-MRD3&gt;3.0.CO;2-O; Ebata KT, 2008, DIS MARKERS, V24, P267, DOI 10.1155/2008/536020; Fujita K, 2006, CANCER RES, V66, P11166, DOI 10.1158/0008-5472.CAN-06-2326; Geens M, 2007, HUM REPROD, V22, P733, DOI 10.1093/humrep/del418; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Honaramooz A, 2003, MOL REPROD DEV, V64, P422, DOI 10.1002/mrd.10205; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Izadyar F, 2003, REPRODUCTION, V126, P765, DOI 10.1530/rep.0.1260765; Izadyar F, 2002, REPRODUCTION, V124, P85, DOI 10.1530/rep.0.1240085; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kim J, 2008, STEM CELLS, V26, P2516, DOI 10.1634/stemcells.2008-0379; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; MIZRAK SC, HUM REPROD, DOI DOI 10.1093/HUMREP/DEP354; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Orwig KE, 2002, BIOL REPROD, V66, P944, DOI 10.1095/biolreprod66.4.944; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867; van Pelt AMM, 2002, ENDOCRINOLOGY, V143, P1845, DOI 10.1210/en.143.5.1845; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439	37	245	262	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2127	2134		10.1001/jama.2009.1689	http://dx.doi.org/10.1001/jama.2009.1689			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920237	Bronze			2022-12-28	WOS:000271873900022
J	Edwards, AJ; Maskell, GF				Edwards, Andrew J.; Maskell, Giles F.			Rational Imaging Acute lower gastrointestinal haemorrhage	BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; CT		[Edwards, Andrew J.; Maskell, Giles F.] Royal Cornwall Hosp, Truro TR1 3LJ, England	Royal Cornwall Hospital	Maskell, GF (corresponding author), Royal Cornwall Hosp, Truro TR1 3LJ, England.	giles.maskell@rcht.cornwall.nhs.uk						Anthony S, 2007, CLIN RADIOL, V62, P938, DOI 10.1016/j.crad.2007.02.019; Anthony T, 2004, AM J SURG, V188, P485, DOI 10.1016/j.amjsurg.2004.07.020; Bonacker MJ, 2003, ROFO-FORTSCHR RONTG, V175, P524, DOI 10.1055/s-2003-38445; Edelman DA, 2007, SURG ENDOSC, V21, P514, DOI 10.1007/s00464-006-9191-7; Green BT, 2005, GASTROENTEROL CLIN N, V34, P665, DOI 10.1016/j.gtc.2005.10.001; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; Kuhle WG, 2003, RADIOLOGY, V228, P743, DOI 10.1148/radiol.2283020756; Levy R, 2003, ANZ J SURG, V73, P205, DOI 10.1046/j.1445-1433.2002.02567.x; Sandhu C, 1999, AM J ROENTGENOL, V173, P1399, DOI 10.2214/ajr.173.5.10541128; Scottish Intercollegiate Guidelines Network, 2008, MAN AC UPP LOW GASTR	10	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 17	2009	339								b4156	10.1136/bmj.b4156	http://dx.doi.org/10.1136/bmj.b4156			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523SZ	19920014				2022-12-28	WOS:000272096100001
J	Guzman, MG; Kouri, G				Guzman, Maria G.; Kouri, Gustavo			Dengue in Cuba: research strategy to support dengue control	LANCET			English	Editorial Material							HEMORRHAGIC-FEVER; EPIDEMIC		[Guzman, Maria G.; Kouri, Gustavo] Inst Trop Med Pedro Kouri, PAHO WHO Collaborating Ctr Study Dengue & Its Vec, Havana, Cuba		Guzman, MG (corresponding author), Inst Trop Med Pedro Kouri, PAHO WHO Collaborating Ctr Study Dengue & Its Vec, Havana, Cuba.	lupe@ipk.sld.cu						Alvarez M, 2006, AM J TROP MED HYG, V75, P1113, DOI 10.4269/ajtmh.2006.75.1113; Baly A, 2009, AM J TROP MED HYG, V81, P88, DOI 10.4269/ajtmh.2009.81.88; Bisset JA, 2006, ANN TROP MED PARASIT, V100, pS45, DOI 10.1179/136485906X105507; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Guzman MG, 2005, SCIENCE, V309, P1495, DOI 10.1126/science.1115177; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Rodriguez-Roche R, 2005, VIROLOGY, V334, P154, DOI 10.1016/j.virol.2005.01.037; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Sierra BDC, 2006, VIRAL IMMUNOL, V19, P662, DOI 10.1089/vim.2006.0042; Vazquez S, 2007, INT J INFECT DIS, V11, P256, DOI 10.1016/j.ijid.2006.05.005; VAZQUEZ S, 2007, ARCH VENEZOLANOS MED, V5, P4; *WHO, 2007, REP DENG	15	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2009	374	9702					1660	1661		10.1016/S0140-6736(09)61975-9	http://dx.doi.org/10.1016/S0140-6736(09)61975-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	522LP	19914501				2022-12-28	WOS:000271999700007
J	Cheng, J; Pande, G				Cheng, Janice; Pande, Girish			Extensive Bowel Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cheng, Janice; Pande, Girish] Launceston Gen Hosp, Launceston, Tas, Australia		Cheng, J (corresponding author), Launceston Gen Hosp, Launceston, Tas, Australia.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1979	1979		10.1056/NEJMicm0807151	http://dx.doi.org/10.1056/NEJMicm0807151			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907045				2022-12-28	WOS:000271660500012
J	Hartley, S; Finkenflugel, H; Kuipers, P; Thomas, M				Hartley, Sally; Finkenflugel, Harry; Kuipers, Pim; Thomas, Maya			Community-based rehabilitation: opportunity and challenge	LANCET			English	Editorial Material									[Hartley, Sally] Inst Hlth, Norwich NR4 7TJ, Norfolk, England; [Finkenflugel, Harry] Erasmus Univ, Rotterdam, Netherlands; [Kuipers, Pim] Joint Ctr Flinders, Alice Springs, NT, Australia; [Kuipers, Pim] Charles Darwin Univ, Alice Springs, NT, Australia; [Thomas, Maya] Asia Pacific Disabil & Rehabil Journal, Bangalore, Karnataka, India	University of East Anglia; Erasmus University Rotterdam; Charles Darwin University	Hartley, S (corresponding author), Inst Hlth, Norwich NR4 7TJ, Norfolk, England.	s.hartley@uea.ac.uk	Kuipers, Pim/AEQ-7972-2022; Kuipers, Pim/AAG-1269-2022; Kuipers, Pim/GZM-8252-2022	Kuipers, Pim/0000-0003-0340-2286; Kuipers, Pim/0000-0003-0340-2286; Kuipers, Pim/0000-0003-0340-2286				ADEOYE A, 2008, CBR INCLUSIVE POLICY; Evans PJ, 2001, SOC SCI MED, V53, P333, DOI 10.1016/S0277-9536(00)00321-X; Finkenflugel H, 2005, INT J REHABIL RES, V28, P187, DOI 10.1097/00004356-200509000-00001; Finkenflugel H, 2008, DISABIL REHABIL, V30, P348, DOI 10.1080/09638280701257288; HELANDER E, 1980, TRAINING DISABLED PE; *INT LAB ORG UNESC, 2004, CBR STRAT REH EQ OPP; Kassah AK, 1998, DISABIL REHABIL, V20, P66, DOI 10.3109/09638289809166056; KENDALL E, 2009, DISABIL REHABIL; Thomas M, 1999, NEUROREHAB NEURAL RE, V13, P185, DOI 10.1177/154596839901300308; Turmusani M, 2002, DISABIL REHABIL, V24, P558, DOI 10.1080/09638280110113449; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; *WHO, 2001, ICF ITN CLASS FUNCT; *WHO UNESCO ILO ID, CBR GUID CO IN PRESS; Wirz S, 2008, BMC INT HEALTH HUM R, V8, P3, DOI DOI 10.1186/1472-698X-8-3	14	34	34	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1803	1804		10.1016/S0140-6736(09)62036-5	http://dx.doi.org/10.1016/S0140-6736(09)62036-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944850				2022-12-28	WOS:000272370200009
J	Bhalla, R; Kalkut, G				Bhalla, Rohit; Kalkut, Gary			Could Medicare Readmission Policy Exacerbate Health Care System Inequity?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEART-FAILURE	The Centers for Medicare & Medicaid Services recently started publicly reporting hospital readmission rates. Health care reform proposals include readmission provisions as vehicles to promote care coordination and achieve savings. Current approaches ascribe variability in hospital readmission primarily to differences in patient medical risk and hospital performance. These approaches do not adequately account for the effect of patient sociodemographic and community factors that influence health care utilization and outcomes. The evidence base on cost-effective and generalizable care management techniques to reduce readmission is still evolving. Although readmission-related policies may prove to be a transformational force in health care reform, their incorrect application in facilities serving vulnerable communities may increase health care system inequity. Policy options can mitigate this potential.	[Bhalla, Rohit] Montefiore Med Ctr, Orange Zone Res Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Bhalla, R (corresponding author), Montefiore Med Ctr, Orange Zone Res Ctr, Room 131,111 E 210th St, Bronx, NY 10467 USA.	rbhalla@montefiore.org		Kalkut, Gary/0000-0002-6160-2262				*AG HEALTHC RES QU, 2007, NAT HLTH CAR DISP RE; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Centers for Medicare &amp Medicaid Services, 2009, ROADM IMPL VAL HEALT; *CTR MED MED SERV, 2009, PAT MIX COEFF MARCH; *CTR MED MED SERV, 2009, HOSP COMP; Egerter S, 2009, REACHING AM HLTH POT; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Gawande A., 2009, NEW YORKER; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; KRUMHOLZ HM, 2009, CIRC CARDIOVASC QUAL; Krumholz HNS, 2008, HOSP 30 DAY HEART FA; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (full printed version), 2003, UN TREATM CONFR RAC; *US HR, 2009, HOUS TRIC HLTH REF D; *US SEN FIN COMM, 2009, DESCR POL OPT TRANSF; 2009, NY TIMES        0416, pA28	19	69	69	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					114	117		10.7326/0003-4819-152-2-201001190-00185	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00185			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	19949133				2022-12-28	WOS:000273953000006
J	Partridge, AH; Winer, EP				Partridge, Ann H.; Winer, Eric P.			On Mammography - More Agreement Than Disagreement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICES TASK-FORCE; BREAST-CANCER		[Partridge, Ann H.; Winer, Eric P.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Partridge, AH (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009	4	28	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2499	2501		10.1056/NEJMp0911288	http://dx.doi.org/10.1056/NEJMp0911288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	19940286				2022-12-28	WOS:000273003700002
J	Grumbach, K				Grumbach, Kevin			Redesign of the Health Care Delivery System A Bauhaus "Form Follows Function" Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Grumbach, K (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, Ward 83,1001 Potrero Ave, San Francisco, CA 94110 USA.	kgrumbach@fcm.ucsf.edu	Grumbach, Kevin/L-9222-2016		PHS HHS [1-U54-R023566] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abraham M., 2008, PARTNERING PATIENTS; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; Droste M., 2006, BAUHAUS; Kim Y, 2009, J GEN INTERN MED, V24, P614, DOI 10.1007/s11606-009-0955-3; Louis S., 1896, LIPPINCOTTS MAGAZINE; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1042, DOI 10.1001/jama.289.8.1042; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Yaggy SD, 2006, GERONTOLOGIST, V46, P271, DOI 10.1093/geront/46.2.271	8	12	12	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2363	2364		10.1001/jama.2009.1772	http://dx.doi.org/10.1001/jama.2009.1772			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952323				2022-12-28	WOS:000272239000026
J	Hennekens, CH; DeMets, D				Hennekens, Charles H.; DeMets, David			The Need for Large-Scale Randomized Evidence Without Undue Emphasis on Small Trials, Meta-analyses, or Subgroup Analyses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; INTRAVENOUS MAGNESIUM; ATRIAL-FIBRILLATION; PREVENTION		[Hennekens, Charles H.] Florida Atlantic Univ, Dept Clin Sci & Med Educ, Charles E Schmidt Coll Biomed Sci, Boca Raton, FL 33431 USA; [Hennekens, Charles H.] Florida Atlantic Univ, Ctr Excellence, Boca Raton, FL 33431 USA; [DeMets, David] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53706 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; University of Wisconsin System; University of Wisconsin Madison	Hennekens, CH (corresponding author), Florida Atlantic Univ, Dept Clin Sci & Med Educ, Charles E Schmidt Coll Biomed Sci, 777 Glades Rd,Res Pk Ste 310, Boca Raton, FL 33431 USA.	chenneke@auf.edu						COLLINS R, 1995, LANCET, V345, P669; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hennekens CH, 2009, AM J MED, V122, P315, DOI 10.1016/j.amjmed.2008.10.021; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; TEO KK, 1991, BMJ-BRIT MED J, V303, P1499, DOI 10.1136/bmj.303.6816.1499; US Food and Drug Administration, 2008, GUID IND DIAB MELL E	10	110	110	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2361	2362		10.1001/jama.2009.1756	http://dx.doi.org/10.1001/jama.2009.1756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952322				2022-12-28	WOS:000272239000025
J	Islam, MS; Midzi, SM; Charimari, L; Cravioto, A; Endtz, HP				Islam, M. Sirajul; Midzi, Stanley M.; Charimari, Lincoln; Cravioto, Alejandro; Endtz, Hubert P.			Susceptibility to Fluoroquinolones of Vibrio cholerae O1 Isolated From Diarrheal Patients in Zimbabwe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BANGLADESH		[Islam, M. Sirajul; Cravioto, Alejandro; Endtz, Hubert P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Charimari, Lincoln] WHO, Harare, Zimbabwe	International Centre for Diarrhoeal Disease Research (ICDDR); World Health Organization	Islam, MS (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	sislam@icddrb.org						Bhattacharya S, 2009, SCIENCE, V324, P885, DOI 10.1126/science.1173890; FARUQUE SM, 1995, J CLIN MICROBIOL, V33, P2833, DOI 10.1128/JCM.33.11.2833-2838.1995; Garg P, 2001, ANTIMICROB AGENTS CH, V45, P1605, DOI 10.1128/AAC.45.5.1605-1606.2001; Islam MS, 2007, MICROBIOL IMMUNOL, V51, P369, DOI 10.1111/j.1348-0421.2007.tb03924.x; Opintan JA, 2008, J ANTIMICROB CHEMOTH, V62, P929, DOI 10.1093/jac/dkn334; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493	6	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2321	2322		10.1001/jama.2009.1750	http://dx.doi.org/10.1001/jama.2009.1750			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952318	Bronze			2022-12-28	WOS:000272239000015
J	Resnick, M				Resnick, Meredith			Inside the Ward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									LCSW, Irvine, CA USA		Resnick, M (corresponding author), LCSW, Irvine, CA USA.	mjresnick@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2298	2298		10.1001/jama.2009.1646	http://dx.doi.org/10.1001/jama.2009.1646			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952310				2022-12-28	WOS:000272239000001
J	Centor, RM				Centor, Robert M.			Expand the Pharyngitis Paradigm for Adolescents and Young Adults	ANNALS OF INTERNAL MEDICINE			English	Article							FUSOBACTERIUM-NECROPHORUM; MANAGEMENT; THROAT; NECROBACILLOSIS; DIAGNOSIS	Current guidelines and review articles emphasize that clinicians should consider group A beta-hemolytic streptococcus in the diagnosis and management of patients with acute pharyngitis. Recent data suggest that in adolescents and young adults (persons aged 15 to 24 years), Fusobacterium necrophorum causes endemic pharyngitis at a rate similar to that of group A beta-hemolytic streptococcus. On the basis of published epidemiologic data, F. necrophorum is estimated to cause the Lemierre syndrome-a life-threatening suppurative complication-at a higher incidence than that at which group A streptococcus causes acute rheumatic fever. Moreover, these estimates suggest greater morbidity and mortality from the Lemierre syndrome. The diagnostic paradigm for adolescent pharyngitis should therefore be expanded to consider F. necrophorum in addition to group A streptococcus. Expanding the pharyngitis paradigm will have several important implications. Further epidemiologic research is needed on both F. necrophorum pharyngitis (especially clinical presentation) and the Lemierre syndrome. Clinicians need reliable diagnostic techniques for F. necrophorum pharyngitis. In the meantime, adolescents and young adults who develop bacteremic symptoms should be aggressively treated with antibiotics for F. necrophorum infection. Physicians should avoid macrolides if they choose to treat streptococcus-negative pharyngitis empirically. Finally, pediatricians, internists, family physicians, and emergency department physicians should know the red flags for adolescent and young adult pharyngitis: worsening symptoms or neck swelling (especially unilateral neck swelling). Adolescent and young adult pharyngitis is more complicated than previously considered.	[Centor, Robert M.] Univ Alabama Birmingham, Huntsville, AL 35801 USA	University of Alabama System; University of Alabama Birmingham	Centor, RM (corresponding author), Univ Alabama Birmingham, Huntsville Reg Med Campus,301 Governors Dr, Huntsville, AL 35801 USA.	rcentor@uab.edu						Aliyu SH, 2004, J MED MICROBIOL, V53, P1029, DOI 10.1099/jmm.0.45648-0; Amess JA, 2007, BRIT J BIOMED SCI, V64, P63, DOI 10.1080/09674845.2007.11732757; Batty A, 2005, BRIT J BIOMED SCI, V62, P66, DOI 10.1080/09674845.2005.11732687; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Centor RM, 2007, J GEN INTERN MED, V22, P127, DOI 10.1007/s11606-006-0020-4; Cherry Donald K, 2007, Adv Data, P1; Chirinos JA, 2002, MEDICINE, V81, P458, DOI 10.1097/00005792-200211000-00006; EYKYN SJ, 1989, SCAND J INFECT DIS, P41; Gehrt Britta, 2009, Ugeskr Laeger, V171, P991; Hagelskjaer LH, 1998, EUR J CLIN MICROBIOL, V17, P561, DOI 10.1007/BF01708619; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Kristensen LH, 2008, EUR J CLIN MICROBIOL, V27, P779, DOI 10.1007/s10096-008-0496-4; Lemierre A, 1936, LANCET, V1, P701; Neuner JM, 2003, ANN INTERN MED, V139, P113, DOI 10.7326/0003-4819-139-2-200307150-00011; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; Rusan M, 2009, EUR J CLIN MICROBIOL, V28, P243, DOI 10.1007/s10096-008-0619-y; Shah M, 2007, J GEN INTERN MED, V22, P272, DOI 10.1007/s11606-006-0049-4; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018	18	64	65	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					812	815		10.7326/0003-4819-151-11-200912010-00011	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EJ	19949147				2022-12-28	WOS:000272727900007
J	Hawkes, N				Hawkes, Nigel			Health Policy Handing over the prescription pad	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NURSES VIEWS; DOCTORS					nigel.hawkes1@btinternet.com						Courtenay M, 2009, J CLIN NURS, V18, P2668, DOI 10.1111/j.1365-2702.2009.02799.x; Marks D, 2009, ALLIED HLTH PROFESSI; Stenner K, 2009, J ADV NURS, V65, P851, DOI 10.1111/j.1365-2648.2008.04944.x; WATTERSON A, EVALUATION EXPANSION	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2009	339								b4835	10.1136/bmj.b4835	http://dx.doi.org/10.1136/bmj.b4835			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AX	19945998				2022-12-28	WOS:000272186600003
J	Trucco, A; Gaspar, I; Ephrussi, A				Trucco, Alvar; Gaspar, Imre; Ephrussi, Anne			RETRACTED: Assembly of Endogenous oskar mRNA Particles for Motor-Dependent Transport in the Drosophila Oocyte (Retracted article. See vol. 143, pg. 485, 2010)	CELL			English	Article; Retracted Publication							RESTRICTS POLE PLASM; POSTERIOR LOCALIZATION; MAGO NASHI; HNRNPA/B HOMOLOG; CELL-FORMATION; LIGHT-CHAIN; GERM PLASM; KINESIN I; DYNEIN; POLARITY	oskar mRNA localization at the oocyte posterior pole is essential for correct patterning of the Drosophila embryo. Here we show at the ultrastructural level that endogenous oskar ribonucleoprotein complexes (RNPs) assemble sequentially with initial recruitment of Hrp48 and the exon junction complex (EJC) to oskar transcripts in the nurse cell nuclei, and subsequent recruitment of Staufen and microtubule motors, following transport to the cytoplasm. oskar particles are non-membrane-bound structures that coalesce as they move from the oocyte anterior to the posterior pole. Our analysis uncovers a role for the EJC component Barentsz in recruiting Tropomyosin II (TmII) to oskar particles in the ooplasm and reveals that TmII is required for kinesin binding to the RNPs. Finally, we show that both kinesin and dynein associate with oskar particles and are the primary microtubule motors responsible for transport of the RNPs within the oocyte.	[Trucco, Alvar; Gaspar, Imre; Ephrussi, Anne] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Ephrussi, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	ephrussi@embl.de	Ephrussi, Anne/ABD-4393-2021; Gaspar, Imre/N-6808-2019; Ephrussi, Anne/AAG-4075-2020	Ephrussi, Anne/0000-0002-5061-4620; 	FEBS	FEBS	We thank Bram Herpers and Catherine Rabouille for sharing their expertise in ISH-EM, Tom Hays for the PEP1 antibody, and Daniel St Johnston for the oskMS2-GFP flies. We also thank C. Antony, U. Haselmann, J. Richie, and the EMBL EM Core Facility for technical support, the EMBL ALMF for use of the LSM710, and F. Besse, S. Lopez de Quinto, S. De Renzis, S. Ghosh, and V. Marchand for comments on the manuscript and P. Riedinger for Figure S14. A. T. is supported by a FEBS long-term fellowship.	Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Cohen RS, 2005, BIOL CELL, V97, P5; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LI MG, 1994, J CELL BIOL, V126, P1475, DOI 10.1083/jcb.126.6.1475; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Mohr SE, 2001, GENE DEV, V15, P2886; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vanzo N, 2007, DEV CELL, V12, P543, DOI 10.1016/j.devcel.2007.03.002; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	38	9	9	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					983	998		10.1016/j.cell.2009.10.012	http://dx.doi.org/10.1016/j.cell.2009.10.012			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945381	Bronze			2022-12-28	WOS:000272169400021
J	Fletcher, RH				Fletcher, Robert H.			Capsule endoscopy had low sensitivity for detecting colonic lesions and high specificity for large lesions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-11	10.7326/0003-4819-151-10-200911170-02011	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920256				2022-12-28	WOS:000272145100022
J	Druml, C				Druml, Christiane			Stem Cell Research: Toward Greater Unity in Europe?	CELL			English	Editorial Material									Med Univ Vienna, Eth Comm, A-1090 Vienna, Austria	Medical University of Vienna	Druml, C (corresponding author), Med Univ Vienna, Eth Comm, A-1090 Vienna, Austria.	christiane.druml@meduniwien.ac.at						Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Druml C, 2009, INTENS CARE MED, V35, P1636, DOI 10.1007/s00134-009-1544-y; Druml W, 2006, WIEN KLIN WOCHENSCHR, V118, P5, DOI 10.1007/s00508-006-0527-z; Plomer A, 2008, EUR LAW J, V14, P839, DOI 10.1111/j.1468-0386.2008.00447.x	4	9	9	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					649	651		10.1016/j.cell.2009.10.043	http://dx.doi.org/10.1016/j.cell.2009.10.043			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914157	Bronze			2022-12-28	WOS:000271747200006
J	Konopka, G; Bomar, JM; Winden, K; Coppola, G; Jonsson, ZO; Gao, FY; Peng, S; Preuss, TM; Wohlschlegel, JA; Geschwind, DH				Konopka, Genevieve; Bomar, Jamee M.; Winden, Kellen; Coppola, Giovanni; Jonsson, Zophonias O.; Gao, Fuying; Peng, Sophia; Preuss, Todd M.; Wohlschlegel, James A.; Geschwind, Daniel H.			Human-specific transcriptional regulation of CNS development genes by FOXP2	NATURE			English	Article							HUMAN BRAIN; ACCELERATED EVOLUTION; MASS-SPECTROMETRY; LANGUAGE; SPEECH; EXPRESSION; IDENTIFICATION; MICE; MUTATIONS; DYSPRAXIA	The signalling pathways controlling both the evolution and development of language in the human brain remain unknown. So far, the transcription factor FOXP2 (forkhead box P2) is the only gene implicated in Mendelian forms of human speech and language dysfunction(1-3). It has been proposed that the amino acid composition in the human variant of FOXP2 has undergone accelerated evolution, and this two-amino-acid change occurred around the time of language emergence in humans(4,5). However, this remains controversial, and whether the acquisition of these amino acids in human FOXP2 has any functional consequence in human neurons remains untested. Here we demonstrate that these two human-specific amino acids alter FOXP2 function by conferring differential transcriptional regulation in vitro. We extend these observations in vivo to human and chimpanzee brain, and use network analysis to identify novel relationships among the differentially expressed genes. These data provide experimental support for the functional relevance of changes in FOXP2 that occur on the human lineage, highlighting specific pathways with direct consequences for human brain development and disease in the central nervous system (CNS). Because FOXP2 has an important role in speech and language in humans, the identified targets may have a critical function in the development and evolution of language circuitry in humans.	[Konopka, Genevieve; Bomar, Jamee M.; Winden, Kellen; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Konopka, Genevieve; Bomar, Jamee M.; Winden, Kellen; Coppola, Giovanni; Gao, Fuying; Peng, Sophia; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Wohlschlegel, James A.; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Div Neurosci, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Ctr Behav Neurosci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30329 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Emory University; Emory University; Emory University	Konopka, G (corresponding author), Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA 90095 USA.	gena@alum.mit.edu; dhg@ucla.edu	Preuss, Todd/GSI-6571-2022; Jónsson, Zophonías/E-1960-2015; Jónsson, Zophonías Oddur/AAO-1354-2020	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Konopka, Genevieve/0000-0002-3363-7302	A. P. Giannini Foundation Medical Research Fellowship; NARSAD; NIH/NCRR [RR00165]; McDonnell Foundation [JSMF 21002093];  [R21MH075028];  [R37MH60233-06A1];  [T32HD007032];  [T32MH073526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233, T32MH073526, R21MH075028] Funding Source: NIH RePORTER	A. P. Giannini Foundation Medical Research Fellowship; NARSAD(NARSAD); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); McDonnell Foundation; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Oldham for generating the Illumina microarray mask file; J. Ou and E. Spiteri for performing site-directed mutagenesis; L. Chen for technical assistance; and L. Kawaguchi for laboratory management. Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland (NICHD Contract numbers N01-HD-4-3368 and N01-HD-4-3383). The role of the NICHD Brain and Tissue Bank is to distribute tissue, and therefore cannot endorse the studies performed or the interpretation of results. This work was supported by grant R21MH075028, R37MH60233-06A1 (D. H. G.), T32HD007032, an A. P. Giannini Foundation Medical Research Fellowship, and a NARSAD Young Investigator Award (G. K.), T32MH073526 (K. W.) NIH/NCRR grant RR00165 and a James S. McDonnell Foundation grant, JSMF 21002093 (T. M. P).	Acampora D, 1999, DEVELOPMENT, V126, P3795; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; COPPOLA G, 2009, NATURE PROTOCOLS, DOI DOI 10.1038/NPROT.2009.215; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Konopka G, 2007, J BIOL CHEM, V282, P28137, DOI 10.1074/jbc.M703592200; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; Van Camp G, 2006, AM J HUM GENET, V79, P449, DOI 10.1086/506478; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JZ, 2002, GENETICS, V162, P1825	31	265	273	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					213	U89		10.1038/nature08549	http://dx.doi.org/10.1038/nature08549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907493	Green Submitted, Green Accepted			2022-12-28	WOS:000271655100042
J	Lin, YJ; Compton, RL; Jimenez-Garcia, K; Porto, JV; Spielman, IB				Lin, Y. -J.; Compton, R. L.; Jimenez-Garcia, K.; Porto, J. V.; Spielman, I. B.			Synthetic magnetic fields for ultracold neutral atoms	NATURE			English	Article							QUANTUM; VORTICES	Neutral atomic Bose condensates and degenerate Fermi gases have been used to realize important many-body phenomena in their most simple and essential forms(1-3), without many of the complexities usually associated with material systems. However, the charge neutrality of these systems presents an apparent limitation-a wide range of intriguing phenomena arise from the Lorentz force for charged particles in a magnetic field, such as the fractional quantum Hall effect in two-dimensional electron systems(4,5). The limitation can be circumvented by exploiting the equivalence of the Lorentz force and the Coriolis force to create synthetic magnetic fields in rotating neutral systems. This was demonstrated by the appearance of quantized vortices in pioneering experiments(6-9) on rotating quantum gases, a hallmark of superfluids or superconductors in a magnetic field. However, because of technical issues limiting the maximum rotation velocity, the metastable nature of the rotating state and the difficulty of applying stable rotating optical lattices, rotational approaches are not able to reach the large fields required for quantum Hall physics(10-12). Here we experimentally realize an optically synthesized magnetic field for ultracold neutral atoms, which is evident from the appearance of vortices in our Bose-Einstein condensate. Our approach uses a spatially dependent optical coupling between internal states of the atoms, yielding a Berry's phase(13) sufficient to create large synthetic magnetic fields, and is not subject to the limitations of rotating systems. With a suitable lattice configuration, it should be possible to reach the quantum Hall regime, potentially enabling studies of topological quantum computation.	[Lin, Y. -J.; Compton, R. L.; Jimenez-Garcia, K.; Porto, J. V.; Spielman, I. B.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Lin, Y. -J.; Compton, R. L.; Jimenez-Garcia, K.; Porto, J. V.; Spielman, I. B.] Univ Maryland, Gaithersburg, MD 20899 USA; [Jimenez-Garcia, K.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis, Mexico City 07360, DF, Mexico	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Spielman, IB (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	ian.spielman@nist.gov	Porto, Trey/AAH-2101-2021; Lin, Yu-Ju/F-7917-2012	Lin, Yu-Ju/0000-0002-9095-4523; Porto, James/0000-0002-6290-7535	DARPA OLE programme; NSF through the JQI Physics Frontier Center; NIST/ NRC postdoctoral programme; CONACYT	DARPA OLE programme; NSF through the JQI Physics Frontier Center; NIST/ NRC postdoctoral programme(National Institute of Standards & Technology (NIST) - USA); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank W. D. Phillips for discussions. This work was partially supported by ONR, ARO with funds from the DARPA OLE programme, and the NSF through the JQI Physics Frontier Center. R. L. C. acknowledges the NIST/ NRC postdoctoral programme and K. J.- G. thanks CONACYT.	Abo-Shaeer JR, 2001, SCIENCE, V292, P476, DOI 10.1126/science.1060182; Andersen MF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170406; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Blakie PB, 2008, ADV PHYS, V57, P363, DOI 10.1080/00018730802564254; Cheneau M, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/60001; Cooper NR, 2008, ADV PHYS, V57, P539, DOI 10.1080/00018730802564122; Gunter KJ, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.011604; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Juzeliunas G, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.025602; Juzeliunas G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.033602; Leanhardt AE, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.190403; Lin YJ, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063631; Lin YJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.130401; Lundh E, 1997, PHYS REV A, V55, P2126, DOI 10.1103/PhysRevA.55.2126; Madison KW, 2000, PHYS REV LETT, V84, P806, DOI 10.1103/PhysRevLett.84.806; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; Murray DR, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063618; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Schweikhard V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040404; Sorensen AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.086803; Spielman IB, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063613; YARMCHUK EJ, 1979, PHYS REV LETT, V43, P214, DOI 10.1103/PhysRevLett.43.214; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	30	1015	1024	5	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					628	632		10.1038/nature08609	http://dx.doi.org/10.1038/nature08609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956256	Green Submitted			2022-12-28	WOS:000272277900036
J	Boggild, M; Palace, J; Barton, P; Ben-Shlomo, Y; Bregenzer, T; Dobson, C; Gray, R				Boggild, Mike; Palace, Jackie; Barton, Pelham; Ben-Shlomo, Yoav; Bregenzer, Thomas; Dobson, Charles; Gray, Richard			Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator	BRITISH MEDICAL JOURNAL			English	Article							DISABILITY STATUS SCALE	Objective To generate evidence on the longer term cost effectiveness of disease modifying treatments in patients with relapsing-remitting multiple sclerosis. Design Prospective cohort study with historical comparator. Setting Specialist multiple sclerosis clinics in 70 centres in the United Kingdom. Participants Patients with relapsing-remitting multiple sclerosis who started treatment from May 2002 to April 2005 under the UK risk sharing scheme. Interventions Treatment with interferon beta or glatiramer acetate in accordance with guidelines of the UK Association of British Neurologists. Main outcome measures Observed utility weighted progression in disability at two years' follow-up assessed on the expanded disability status scale (EDSS) compared with that expected by applying the progression rates in a comparator dataset, modified for patients receiving treatment by multiplying by the hazard ratio derived separately for each disease modifying treatment from the randomised trials. Results In the primary per protocol analysis, progression in disability was worse than that predicted and worse than that in the untreated comparator dataset ("deviation score" of 113%; excess in mean disability status scale 0.28). In sensitivity analyses, however, the deviation score varied from -72% ( using raw baseline disability status scale scores, rather than applying a "no improvement" algorithm) to 156% ( imputing missing data for year two from progression rates for year one). Conclusions It is too early to reach any conclusion about the cost effectiveness of disease modifying treatments from this first interim analysis. Important methodological issues, including the need for additional comparator datasets, the potential bias from missing data, and the impact of the "no improvement" rule, will need to be addressed and long term follow-up of all patients is essential to secure meaningful results. Future analyses of the cohort are likely to be more informative, not least because they will be less sensitive to short term fluctuations in disability.	[Boggild, Mike] Walton Ctr, Liverpool L9 7LJ, Merseyside, England; [Palace, Jackie] John Radcliffe Hosp, Oxford OX3 9DU, England; [Barton, Pelham] Univ Birmingham, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England; [Ben-Shlomo, Yoav] Dept Social Med, Bristol BS8 2PS, Avon, England; [Bregenzer, Thomas] Parexel Int, Biostat Unit, D-14050 Berlin, Germany; [Dobson, Charles] Dept Hlth, Leeds LS2 7UE, W Yorkshire, England; [Gray, Richard] Univ Birmingham, Clin Trials Unit, Birmingham B15 2TT, W Midlands, England	Walton Centre; University of Oxford; University of Birmingham; Parexel International; University of Birmingham	Boggild, M (corresponding author), Walton Ctr, Liverpool L9 7LJ, Merseyside, England.	mike.boggild@thewaltoncentre.nhs.uk	Ben-Shlomo, Yoav/ABD-2004-2021	Ben-Shlomo, Yoav/0000-0001-6648-3007; Gray, Richard/0000-0003-4440-574X	Department of Health; Bayer Schering Pharma; Biogen; Merck Serono; Teva; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MC_U137686861, G0800808] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [MC_U137686861, G0800808] Funding Source: researchfish	Department of Health; Bayer Schering Pharma(Bayer AG); Biogen(Biogen); Merck Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The central costs of data collection and analysis were shared in five equal amounts between the Department of Health and the four pharmaceutical companies (Bayer Schering Pharma, Biogen, Merck Serono, Teva). Treatment costs ( drug and staff) were largely met by local commissioners, with financial support for nursing and other staff from the companies and the MS Society. Analysis and interpretation of results and drafting of the manuscript	*ASS BRIT NEUR, 2001, GIOD TREATM INT BET; *ASS BRIT NEUR, 2007, GUID TREATM MULT SCL; Chapman S, 2003, BRIT MED J, V326, P707, DOI 10.1136/bmj.326.7391.707; Chilcott J, 2003, BRIT MED J, V326, P522, DOI 10.1136/bmj.326.7388.522; *DEP HLTH, COST EFF PROV DIS MO; *DEP HLTH ABPI, 2009 PHARM PRIC REG; EBERS G, 1998, MCALPINES MULTIPLE S; Hemmett L, 2004, QJM-INT J MED, V97, P671, DOI 10.1093/qjmed/hch105; Hutton J, 2007, INT J TECHNOL ASSESS, V23, P425, DOI 10.1017/S0266462307070651; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kobelt G, 2000, COSTS QUALITY LIFE M; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lechner-Scott J, 2003, MULT SCLER, V9, P154, DOI 10.1191/1352458503ms884oa; *NIH CLIN EXC, 2002, BET INT GLAT AC TREA; *NIH CLIN EXC, 2007, BORT MON REL MULT MY; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ravina B, 2006, NEUROLOGY, V66, P664; Rice GP, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002002; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sudlow CLM, 2003, BRIT MED J, V326, P388, DOI 10.1136/bmj.326.7385.388; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe	21	58	60	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 2	2009	339								b4677	10.1136/bmj.b4677	http://dx.doi.org/10.1136/bmj.b4677			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NS	19955128	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000272453300001
J	Thabut, G; Christie, JD; Ravaud, P; Castier, Y; Dauriat, G; Jebrak, G; Fournier, M; Leseche, G; Porcher, R; Mal, H				Thabut, Gabriel; Christie, Jason D.; Ravaud, Philippe; Castier, Yves; Dauriat, Gaelle; Jebrak, Gilles; Fournier, Michel; Leseche, Guy; Porcher, Raphael; Mal, Herve			Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary Fibrosis	ANNALS OF INTERNAL MEDICINE			English	Article							PROPENSITY SCORE; IMPACT; MODEL	Background: Patients with end-stage idiopathic pulmonary fibrosis (IPF) are increasingly having bilateral rather than single-lung transplantation. Objective: To compare survival after single and bilateral lung transplantation in patients with IPF. Design: Analysis of data from the United Network of Organ Sharing registry. Setting: Transplantation centers in the United States. Patients: 3327 patients with IPF who had single (2146 patients [64.5%]) or bilateral (1181 patients [35.5%]) lung transplantation between 1987 and 2009. Measurements: Survival times and causes of death after lung transplantation. Selection bias was accounted for by multivariate risk adjustment, propensity score risk adjustment, and propensity-based matching. Results: Median survival time was longer after bilateral lung transplantation than single-lung transplantation (5.2 years [CI, 4.3 to 6.7 years] vs. 3.8 years [CI, 3.6 to 4.1 years]; P < 0.001). However, survival times for the 2 procedures did not differ after adjustment for baseline differences, with adjusted hazard ratios (HRs) for mortality with bilateral transplantation ranging from 0.89 (95% CI, 0.79 to 1.02) to 0.96 (CI, 0.77 to 1.20) in different analyses. Bilateral lung transplantation seemed to result in harm within the first year (HR, 1.18 [CI, 0.98 to 1.42]) but survival benefit thereafter (HR, 0.72 [CI, 0.59 to 0.87]). Primary graft failure was a more common cause of death among patients who had bilateral rather than single-lung transplantation (3.7% vs. 1.9%; P = 0.002). Cancer was a more common cause of death among patients who had single rather than bilateral lung transplantation (unadjusted HR for death among single vs. bilateral transplant recipients, 3.60 [CI, 2.16 to 6.05]; P < 0.001). Limitation: Causes of death were ascertained without an adjudication committee and must be interpreted cautiously. Conclusion: Survival did not differ between patients who had single and bilateral lung transplantation. Single-lung transplantation confers short-term survival benefit but long-term harm, whereas bilateral transplantation confers short-term harm but long-term survival benefit.	[Thabut, Gabriel] Hop Bichat Claude Bernard, Serv Pneumol & Transplantat Pulm B, APHP, F-75018 Paris, France; Univ Paris 07, INSERM, U738, U717, Paris, France; Hop St Louis, Paris, France; Univ Penn, Philadelphia, PA 19104 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Thabut, G (corresponding author), Hop Bichat Claude Bernard, Serv Pneumol & Transplantat Pulm B, APHP, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.thabut@bch.aphp.fr	ravaud, philippe/C-1694-2009	Porcher, Raphael/0000-0002-5277-4679; Ravaud, Philippe/0000-0001-8264-9206; Christie, Jason/0000-0003-0519-218X				AALEN OO, 1989, STAT MED, V8, P907, DOI 10.1002/sim.4780080803; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2007, STAT MED, V26, P754, DOI 10.1002/sim.2618; Christie JD, 2008, J HEART LUNG TRANSPL, V27, P957, DOI 10.1016/j.healun.2008.07.018; COOPER JD, 1986, NEW ENGL J MED, V314, P1140; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grambsch PM, 1995, BIOMETRICS, V51, P1469, DOI 10.2307/2533277; GROSSMAN RF, 1990, NEW ENGL J MED, V322, P727, DOI 10.1056/NEJM199003153221104; HOSMER D, 1999, APPL SURVIVAL ANAL R, V1; Little R. J. A., 1987, STAT ANAL MISSING DA; Mant J, 2006, J CLIN EPIDEMIOL, V59, P862, DOI 10.1016/j.jclinepi.2005.11.021; Mason DP, 2007, ANN THORAC SURG, V84, P1121, DOI 10.1016/j.athoracsur.2007.04.096; Meyer DM, 2005, ANN THORAC SURG, V79, P950, DOI 10.1016/j.athoracsur.2004.08.076; Meyers BF, 2000, J THORAC CARDIOV SUR, V120, P99, DOI 10.1067/mtc.2000.106322; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Trulock EP, 1997, AM J RESP CRIT CARE, V155, P789, DOI 10.1164/ajrccm.155.3.9117010; Whelan TPM, 2005, J HEART LUNG TRANSPL, V24, P1269, DOI 10.1016/j.healun.2004.10.014; Williams TJ, 2008, THORAX, V63, P277, DOI 10.1136/thx.2004.031054	25	110	122	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					767	W253		10.7326/0003-4819-151-11-200912010-00004	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EJ	19949142				2022-12-28	WOS:000272727900002
J	Lawton, V				Lawton, Vincent			Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BIAS		Med & Healthcare Prod Regulatory Agcy, London, England	The Medicines & Healthcare Products Regulatory Agency	Lawton, V (corresponding author), Med & Healthcare Prod Regulatory Agcy, London, England.	Vincent.Lawton@btconnect.com						CHOPRA SS, JAMA, V290, P113; Ellenberg SS, 2003, DATA MONITORING COMM; Jatoi A, 2008, EXPERT OPIN INV DRUG, V17, P1787, DOI [10.1517/13543780802513874, 10.1517/13543780802513874 ]; Kealey T., 1996, EC LAWS SCI RES; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; *MED HEALTHC PROD, 2009, GOOD CLIN PRACT; ODONNELL P, 2009, APPL CLIN TRIAL 0901; PEDERSEN TR, 1994, LANCET, V344, P1383; *PIR, 2008, DRUG APPR TRENDS FDA; *PRIV, 2009, RES ETH COMM COUNTR; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; JOINT POSITION DISCL	13	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2009	339								b4953	10.1136/bmj.b4953	http://dx.doi.org/10.1136/bmj.b4953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AY	19946144				2022-12-28	WOS:000272186700003
J	Kozuka, Y; Kim, M; Bell, C; Kim, BG; Hikita, Y; Hwang, HY				Kozuka, Y.; Kim, M.; Bell, C.; Kim, B. G.; Hikita, Y.; Hwang, H. Y.			Two-dimensional normal-state quantum oscillations in a superconducting heterostructure	NATURE			English	Article							DIELECTRIC-PROPERTIES; SRTIO3; ENHANCEMENT; TRANSITION; TITANATE; SURFACE	Semiconductor heterostructures provide an ideal platform for studying high-mobility, low-density electrons in reduced dimensions(1-4). The realization of superconductivity in heavily doped diamond(5), silicon(6), silicon carbide(7) and germanium(8) suggests that Cooper pairs eventually may be directly incorporated in semiconductor heterostructures(9), but these newly discovered superconductors are currently limited by their extremely large electronic disorder. Similarly, the electron mean free path in low-dimensional superconducting thin films is usually limited by interface scattering, in single-crystal or polycrystalline samples, or atomic-scale disorder, in amorphous materials, confining these examples to the extreme 'dirty limit'(10). Here we report the fabrication of a high-quality superconducting layer within a thin-film heterostructure based on SrTiO3 ( the first known superconducting semiconductor(11)). By selectively doping a narrow region of SrTiO3 with the electron-donor niobium, we form a superconductor that is two-dimensional, as probed by the anisotropy of the upper critical magnetic field. Unlike in previous examples, however, the electron mobility is high enough that the normal state resistance exhibits Shubnikov-de Haas oscillations that scale with the perpendicular field, indicating two-dimensional states. These results suggest that delta-doped SrTiO3 provides a model system in which to explore the quantum transport and interplay(12) of both superconducting and normal electrons. They also demonstrate that high-quality complex oxide heterostructures can maintain electron coherence on the macroscopic scales probed by transport, as well as on the microscopic scales demonstrated previously(13).	[Kozuka, Y.; Kim, M.; Bell, C.; Kim, B. G.; Hikita, Y.; Hwang, H. Y.] Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan; [Bell, C.; Hwang, H. Y.] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kim, B. G.] Pusan Natl Univ, Dept Phys, Pusan 609735, South Korea	University of Tokyo; Japan Science & Technology Agency (JST); Pusan National University	Hwang, HY (corresponding author), Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan.	hyhwang@k.u-tokyo.ac.jp	Hwang, Harold Y/I-6943-2012; Bell, Christopher/B-8785-2009; Hikita, Yasuyuki/N-5969-2019; Kim, Minu/AAC-2194-2020; Kozuka, Yusuke/E-6470-2010; Hikita, Yasuyuki/F-5600-2011	Bell, Christopher/0000-0003-4732-0354; Hikita, Yasuyuki/0000-0002-7748-8329; Kim, Minu/0000-0002-6189-033X; Kozuka, Yusuke/0000-0001-7674-600X; Hikita, Yasuyuki/0000-0002-7748-8329; Yusuke, Kozuka/0000-0002-2205-2421				Abrahams E, 2001, REV MOD PHYS, V73, P251, DOI 10.1103/RevModPhys.73.251; ANDERSON PW, 1995, SCIENCE, V268, P1154, DOI 10.1126/science.268.5214.1154; ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; Blase X, 2009, NAT MATER, V8, P375, DOI [10.1038/NMAT2425, 10.1038/nmat2425]; Bustarret E, 2006, NATURE, V444, P465, DOI 10.1038/nature05340; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Chakravarty S, 2004, NATURE, V428, P53, DOI 10.1038/nature02348; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Ekimov EA, 2004, NATURE, V428, P542, DOI 10.1038/nature02449; Goldman AM, 1998, PHYS TODAY, V51, P39, DOI 10.1063/1.882069; Herrmannsdorfer T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.217003; Hulm J. K., 1970, PROGR LOW TEMP PHYS, V6, P205; MATTHEISS LF, 1972, PHYS REV B, V6, P4740, DOI 10.1103/PhysRevB.6.4740; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; Nakamura H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357850; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, APPL PHYS LETT, V84, P1716, DOI 10.1063/1.1668329; RASOLT M, 1992, REV MOD PHYS, V64, P709, DOI 10.1103/RevModPhys.64.709; Ren ZA, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.103710; SAIFI MA, 1970, PHYS REV B, V2, P677, DOI 10.1103/PhysRevB.2.677; SAKUDO T, 1971, PHYS REV LETT, V26, P851, DOI 10.1103/PhysRevLett.26.851; SCHOOLEY JF, 1964, PHYS REV LETT, V12, P474, DOI 10.1103/PhysRevLett.12.474; SCHUBERT EF, 1990, J VAC SCI TECHNOL A, V8, P2980, DOI 10.1116/1.576617; SCHUBERT EF, 1987, SOLID STATE COMMUN, V63, P591, DOI 10.1016/0038-1098(87)90859-3; TINKHAM M, 1963, PHYS REV, V129, P2413, DOI 10.1103/PhysRev.129.2413; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Uwe H., 1985, JPN J APPL PHYS, V24, P335; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; YANG MJ, 1993, PHYS REV B, V47, P1691, DOI 10.1103/PhysRevB.47.1691	30	198	199	5	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					487	490		10.1038/nature08566	http://dx.doi.org/10.1038/nature08566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940921				2022-12-28	WOS:000272144200039
J	Chen, CW; Rondenay, S; Evans, RL; Snyder, DB				Chen, Chin-Wu; Rondenay, Stephane; Evans, Rob. L.; Snyder, David B.			Geophysical Detection of Relict Metasomatism from an Archean (similar to 3.5 Ga) Subduction Zone	SCIENCE			English	Article							SLAVE CRATON; ELECTRICAL-CONDUCTIVITY; MANTLE LITHOSPHERE; CRUSTAL; GNEISSES	When plate tectonics started on Earth has been uncertain, and its role in the assembly of early continents is not well understood. By synthesizing coincident seismic and electrical profiles, we show that subduction processes formed the Archean Slave craton in Canada. The spatial overlap between a seismic discontinuity and a conductive anomaly at similar to 100 kilometers depth, in conjunction with the occurrence of mantle xenoliths rich in secondary minerals representative of a metasomatic front, supports cratonic assembly by subduction and accretion of lithospheric fragments. Although evidence of cratonic assembly is rarely preserved, these results suggest that plate tectonics was operating as early as Paleoarchean times, similar to 3.5 billion years ago (Ga).	[Chen, Chin-Wu; Rondenay, Stephane] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Evans, Rob. L.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Snyder, David B.] Geol Survey Canada, Ottawa, ON K1A 0E9, Canada	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Chen, CW (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cwchen@mit.edu	Rondenay, Stéphane/B-9764-2013; evans, rob/C-6887-2011	Rondenay, Stéphane/0000-0003-0805-249X; Evans, Robert/0000-0001-5585-0684; Snyder, David/0000-0003-3462-5650; CHEN, CHIN-WU/0000-0003-4645-6735	NSF [EAR-0409509]; MIT Praecis Presidential Fellowship; Natural Resources Canada Earth Sciences Sector (ESS) [20090244]	NSF(National Science Foundation (NSF)); MIT Praecis Presidential Fellowship; Natural Resources Canada Earth Sciences Sector (ESS)	We thank S. Bowring for thoughtful and insightful comments on earlier drafts of this paper. We thank A. Jones for permission to use his figure in Fig. 2B. We thank S. Shirey, S. Aulbach, C. Till, L. Elkins-Tanton, and M. Moorkamp for helpful discussions, the POLARIS consortium for making data available, and members in the Northwest Territories Geoscience Office, BHP-Billiton Diamonds Inc., De Beers Canada Inc., and Tahera Diamond Corp. for logistical support of our field work in the Slave province. This work is funded by NSF grant EAR-0409509 (S. R.). C.-W. C. is partially supported by an MIT Praecis Presidential Fellowship. This is Natural Resources Canada Earth Sciences Sector (ESS) contribution 20090244.	Aulbach S, 2007, J PETROL, V48, P1843, DOI 10.1093/petrology/egm041; Bleeker W, 1999, CAN J EARTH SCI, V36, P1083, DOI 10.1139/e98-102; Boerner DE, 1999, SCIENCE, V283, P668, DOI 10.1126/science.283.5402.668; Bostock MG, 1998, J GEOPHYS RES-SOL EA, V103, P21183, DOI 10.1029/98JB01069; BOWRING SA, 1989, GEOLOGY, V17, P971, DOI 10.1130/0091-7613(1989)017<0971:GGFTSP>2.3.CO;2; Davis WJ, 2003, LITHOS, V71, P575, DOI 10.1016/S0024-4937(03)00131-2; Griffin WL, 1999, J PETROL, V40, P705; GRTTER HS, 1999, P 7 INT KIMB C RED R, V1, P307; Guseinov AA, 2005, IZV-PHYS SOLID EART+, V41, P670; Hacker B, 2005, J PETROL, V46, P1661, DOI 10.1093/petrology/egi030; HELMSTAEDT H, 1989, KIMBERLITES RELATED, V1, P358; HOFFMAN PF, 1988, ANNU REV EARTH PL SC, V16, P543, DOI 10.1146/annurev.ea.16.050188.002551; Jones AG, 2001, GEOLOGY, V29, P423, DOI 10.1130/0091-7613(2001)029<0423:ELOTSC>2.0.CO;2; Jones AG, 2009, LITHOS, V109, P131, DOI 10.1016/j.lithos.2008.10.014; JORDAN TH, 1978, NATURE, V274, P544, DOI 10.1038/274544a0; Kerrick DM, 2001, NATURE, V411, P293, DOI 10.1038/35077056; Lee CTA, 2006, GEOPHYS MONOGR SER, V164, P89, DOI 10.1029/164GM08; Lee CTA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002413; MARESCHAL M, 1992, NATURE, V357, P674, DOI 10.1038/357674a0; Mercier JP, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005127; Moorkamp M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030519; Snyder DB, 2008, TECTONICS, V27, DOI 10.1029/2007TC002132; Snyder DB, 2004, LITHOS, V77, P859, DOI 10.1016/j.lithos.2004.03.049; Thybo H, 1997, SCIENCE, V275, P1626, DOI 10.1126/science.275.5306.1626; Wagner LS, 2006, EARTH PLANET SC LETT, V245, P289, DOI 10.1016/j.epsl.2006.02.014; Westerlund KJ, 2006, CONTRIB MINERAL PETR, V152, P275, DOI 10.1007/s00410-006-0101-8	26	53	55	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1089	1091		10.1126/science.1178477	http://dx.doi.org/10.1126/science.1178477			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965424				2022-12-28	WOS:000271951000036
J	Glynn, SE; Martin, A; Nager, AR; Baker, TA; Sauer, RT				Glynn, Steven E.; Martin, Andreas; Nager, Andrew R.; Baker, Tania A.; Sauer, Robert T.			Structures of Asymmetric ClpX Hexamers Reveal Nucleotide-Dependent Motions in a AAA plus Protein-Unfolding Machine	CELL			English	Article							ZINC-BINDING DOMAIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGE; SUBSTRATE-BINDING; PORE LOOPS; ATP; TRANSLOCATION; MECHANISM; CHAPERONE; RECOGNITION	ClpX is a AAA+ machine that uses the energy of ATP binding and hydrolysis to unfold native proteins and translocate unfolded polypeptides into the ClpP peptidase. The crystal structures presented here reveal striking asymmetry in ring hexamers of nucleotide-free and nucleotide-bound ClpX. Asymmetry arises from large changes in rotation between the large and small AAA+ domains of individual subunits. These differences prevent nucleotide binding to two subunits, generate a staggered arrangement of ClpX subunits and pore loops around the hexameric ring, and provide a mechanism for coupling conformational changes caused by ATP binding or hydrolysis in one subunit to flexing motions of the entire ring. Our structures explain numerous solution studies of ClpX function, predict mechanisms for pore elasticity during translocation of irregular polypeptides, and suggest how repetitive conformational changes might be coupled to mechanical work during the ATPase cycle of ClpX and related molecular machines.	[Glynn, Steven E.; Martin, Andreas; Nager, Andrew R.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Martin, Andreas/0000-0003-0923-3284; Sauer, Robert/0000-0002-1719-5399; Glynn, Steven/0000-0001-6247-8913	National Institutes of Health (NIH) [AI-15706]; NIH National Center for Research Resources [RR-15301]; Department of Energy Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, R37AI015706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Grant, S. Harrison, D. Jerulzami, L. Joshua-Tor, H. Saibil, T. Schwartz, J. Whittle, and the staff at the 24-ID-C NE-CAT beamline of the Advanced Photon Source, Argonne National Laboratories for help and discussions. This work was supported by National Institutes of Health (NIH) grant AI-15706. T. A. B. is an employee of the Howard Hughes Medical Institute. Studies using the NE-CAT beamline were supported by award RR-15301 from NIH National Center for Research Resources and by the Department of Energy Office of Basic Energy Sciences under contract W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; DeLano W, 2002, PYMOL 0 99; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Donaldson LW, 2003, J BIOL CHEM, V278, P48991, DOI 10.1074/jbc.M307826200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Farrell CM, 2007, MOL CELL, V25, P161, DOI 10.1016/j.molcel.2006.11.018; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Joshi SA, 2003, MOL MICROBIOL, V48, P67, DOI 10.1046/j.1365-2958.2003.03424.x; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park EY, 2007, J MOL BIOL, V367, P514, DOI 10.1016/j.jmb.2007.01.003; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070	53	205	207	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					744	756		10.1016/j.cell.2009.09.034	http://dx.doi.org/10.1016/j.cell.2009.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914167	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000271747200018
J	Stein, MA; Stein, PJS; Weiss, D; Lang, R				Stein, Michael Ashley; Stein, Penelope J. S.; Weiss, Dorothy; Lang, Raymond			Health care and the UN Disability Rights Convention	LANCET			English	Editorial Material									[Stein, Michael Ashley; Stein, Penelope J. S.] Harvard Univ, Sch Law, Harvard Law Sch Project Disabil, Cambridge, MA 02138 USA; [Weiss, Dorothy] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Cambridge, MA 02138 USA; [Lang, Raymond] UCL, Leonard Cheshire Cente Disabil & Inclus Dev, London, England	Harvard University; Harvard University; University of London; University College London	Stein, MA (corresponding author), Harvard Univ, Sch Law, Harvard Law Sch Project Disabil, Cambridge, MA 02138 USA.	mastein@law.harvard.edu						GROCE N, 2008, ONE 10, V26, P16; Groce N. E., GUIDELINES INCLUSION; Morrison EH, 2008, FAM MED, V40, P645; United Nations Enable, 2006, CONV RIGHTS PERS DIS; WHO, 2001, WHO INT CLASS FUNCT	5	30	31	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1796	1798		10.1016/S0140-6736(09)62033-X	http://dx.doi.org/10.1016/S0140-6736(09)62033-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944846	Green Published			2022-12-28	WOS:000272370200005
J	Sung, JJY; Lau, JYW; Ching, JYL; Wu, JCY; Lee, YT; Chiu, PWY; Leung, VKS; Wong, VWS; Chan, FKL				Sung, Joseph J. Y.; Lau, James Y. W.; Ching, Jessica Y. L.; Wu, Justin C. Y.; Lee, Yuk T.; Chiu, Philip W. Y.; Leung, Vincent K. S.; Wong, Vincent W. S.; Chan, Francis K. L.			Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANTITHROMBOTIC THERAPY; AMERICAN-COLLEGE; TASK-FORCE; RISK; MANAGEMENT; CLOPIDOGREL; HEMORRHAGE; GUIDELINES; OUTCOMES	Background: It is uncertain whether aspirin therapy should be continued after endoscopic hemostatic therapy in patients who develop peptic ulcer bleeding while receiving low-dose aspirin. Objective: To test that continuing aspirin therapy with proton-pump inhibitors after endoscopic control of ulcer bleeding was not inferior to stopping aspirin therapy, in terms of recurrent ulcer bleeding in adults with cardiovascular or cerebrovascular diseases. Design: A parallel randomized, placebo-controlled noninferiority trial, in which both patients and clinicians were blinded to treatment assignment, was conducted from 2003 to 2006 by using computer-generated numbers in concealed envelopes. (ClinicalTrials.gov registration number: NCT00153725) Setting: A tertiary endoscopy center. Patients: Low-dose aspirin recipients with peptic ulcer bleeding. Intervention: 78 patients received aspirin, 80 mg/d, and 78 received placebo for 8 weeks immediately after endoscopic therapy. All patients received a 72-hour infusion of pantoprazole followed by oral pantoprazole. All patients completed follow-up. Measurements: The primary end point was recurrent ulcer bleeding within 30 days confirmed by endoscopy. Secondary end points were all-cause and specific-cause mortality in 8 weeks. Results: 156 patients were included in an intention-to-treat analysis. Three patients withdrew from the trial before finishing follow-up. Recurrent ulcer bleeding within 30 days was 10.3% in the aspirin group and 5.4% in the placebo group (difference, 4.9 percentage points [95% CI,-3.6 to 13.4 percentage points]). Patients who received aspirin had lower all-cause mortality rates than patients who received placebo (1.3% vs. 12.9%; difference, 11.6 percentage points [CI, 3.7 to 19.5 percentage points]). Patients in the aspirin group had lower mortality rates attributable to cardiovascular, cerebrovascular, or gastrointestinal complications than patients in the placebo group (1.3% vs. 10.3%; difference, 9 percentage points [CI, 1.7 to 16.3 percentage points]). Limitations: The sample size is relatively small, and only low-dose aspirin, 80 mg, was used. Two patients with recurrent bleeding in the placebo group did not have further endoscopy. Conclusion: Among low-dose aspirin recipients who had peptic ulcer bleeding, continuous aspirin therapy may increase the risk for recurrent bleeding but potentially reduces mortality rates. Larger trials are needed to confirm these findings.	[Sung, Joseph J. Y.; Lau, James Y. W.; Ching, Jessica Y. L.; Wu, Justin C. Y.; Lee, Yuk T.; Chiu, Philip W. Y.; Leung, Vincent K. S.; Wong, Vincent W. S.; Chan, Francis K. L.] Chinese Univ Hong Kong, Inst Digest Dis, Sha Tin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Sung, JJY (corresponding author), Prince Wales Hosp, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.	joesung@cuhk.edu.hk	Lee, Yeong Yeh/G-2470-2010; Lau, James Y. W./O-2612-2016; Sung, Joseph J. Y./R-3203-2018; Chiu, Philip/A-4019-2009; Chan, Francis K. L./F-4851-2010; Wong, Vincent WS/K-3864-2014; Wu, Justin/N-6916-2015; Chiu, Philip/ABB-1454-2020	Lee, Yeong Yeh/0000-0002-6486-7717; Lau, James Y. W./0000-0003-0122-4068; Sung, Joseph J. Y./0000-0003-3125-5199; Chiu, Philip/0000-0001-9292-112X; Chan, Francis K. L./0000-0001-7388-2436; Wong, Vincent WS/0000-0003-2215-9410; Chiu, Philip/0000-0001-9292-112X	Institute of Digestive Disease, Chinese University of Hong Kong	Institute of Digestive Disease, Chinese University of Hong Kong(Chinese University of Hong Kong)	Primary Funding Source: Institute of Digestive Disease, Chinese University of Hong Kong.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Adler DG, 2004, GASTROINTEST ENDOSC, V60, P497; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Ghaffarinejad Mohammad Hassan, 2007, Cardiol J, V14, P453; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Laine L, 2006, ALIMENT PHARM THER, V24, P897, DOI 10.1111/j.1365-2036.2006.03077.x; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501; Leiva-Pons JL, 2008, Arch. Cardiol. Méx., V78, P178; Manzano-Fernandez S, 2008, CHEST, V134, P559, DOI 10.1378/chest.08-0350; Ng FH, 2008, AM J GASTROENTEROL, V103, P865, DOI 10.1111/j.1572-0241.2007.01715.x; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; Yeomans ND, 2005, ALIMENT PHARM THER, V22, P795, DOI 10.1111/j.1365-2036.2005.02649.x	21	280	297	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					1	W1		10.7326/0003-4819-152-1-201001050-00179	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00179			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FJ	19949136				2022-12-28	WOS:000273556600001
J	Bishop, JF; Murnane, MP; Owen, R				Bishop, James F.; Murnane, Mary P.; Owen, Rhonda			Australia's Winter with the 2009 Pandemic Influenza A (H1N1) Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bishop, James F.; Murnane, Mary P.; Owen, Rhonda] Dept Hlth & Ageing, Canberra, ACT, Australia		Bishop, JF (corresponding author), Dept Hlth & Ageing, Canberra, ACT, Australia.							*AUSTR GOV DEP HLT, 2009, AUSTR INFL SURV REP; Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Shinde V, 2009, NEW ENGL J MED, V361, P102; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	6	132	137	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2591	2594		10.1056/NEJMp0910445	http://dx.doi.org/10.1056/NEJMp0910445			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	19940287				2022-12-28	WOS:000273181300002
J	Iglehart, JK				Iglehart, John K.			Forestalling a Filibuster -- Senate Reform Bill Cleared for Floor Debate.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Balz D., 2009, WASHINGTON POST 1202, pA1	1	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24								10.1056/NEJMp0911439	http://dx.doi.org/10.1056/NEJMp0911439			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	19940293				2022-12-28	WOS:000272547600004
J	Melillo, JM; Reilly, JM; Kicklighter, DW; Gurgel, AC; Cronin, TW; Paltsev, S; Felzer, BS; Wang, XD; Sokolov, AP; Schlosser, CA				Melillo, Jerry M.; Reilly, John M.; Kicklighter, David W.; Gurgel, Angelo C.; Cronin, Timothy W.; Paltsev, Sergey; Felzer, Benjamin S.; Wang, Xiaodong; Sokolov, Andrei P.; Schlosser, C. Adam			Indirect Emissions from Biofuels: How Important?	SCIENCE			English	Article							LAND-USE; CARBON SEQUESTRATION; CLIMATE-CHANGE; CONSEQUENCES; OZONE	A global biofuels program will lead to intense pressures on land supply and can increase greenhouse gas emissions from land-use changes. Using linked economic and terrestrial biogeochemistry models, we examined direct and indirect effects of possible land-use changes from an expanded global cellulosic bioenergy program on greenhouse gas emissions over the 21st century. Our model predicts that indirect land use will be responsible for substantially more carbon loss ( up to twice as much) than direct land use; however, because of predicted increases in fertilizer use, nitrous oxide emissions will be more important than carbon losses themselves in terms of warming potential. A global greenhouse gas emissions policy that protects forests and encourages best practices for nitrogen fertilizer use can dramatically reduce emissions associated with biofuels production.	[Melillo, Jerry M.; Kicklighter, David W.; Cronin, Timothy W.; Felzer, Benjamin S.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Reilly, John M.; Gurgel, Angelo C.; Cronin, Timothy W.; Paltsev, Sergey; Wang, Xiaodong; Sokolov, Andrei P.; Schlosser, C. Adam] MIT, Joint Program Sci & Policy Global Change, Cambridge, MA 02139 USA; [Gurgel, Angelo C.] Univ Sao Paulo, Dept Econ, BR-14049 Ribeirao Preto, Brazil; [Felzer, Benjamin S.] Lehigh Univ, Dept Earth & Environm Sci, Bethlehem, PA 18015 USA; [Wang, Xiaodong] Zhejiang Univ, Sch Publ Adm, Hangzhou 310000, Zhejiang, Peoples R China	Marine Biological Laboratory - Woods Hole; Massachusetts Institute of Technology (MIT); Universidade de Sao Paulo; Lehigh University; Zhejiang University	Melillo, JM (corresponding author), Marine Biol Lab, Ctr Ecosyst, 7 MBL St, Woods Hole, MA 02543 USA.	jmelillo@mbl.edu	Felzer, Benjamin S/AAB-3456-2021; Gurgel, Angelo C/D-9446-2013	Felzer, Benjamin S/0000-0002-3990-3739; Gurgel, Angelo/0000-0001-8331-9508; Paltsev, Sergey/0000-0003-3287-0732	David and Lucile Packard Foundation; Department of Energy, Office of Science (BER) [DE-FG02-94ER61937, DE-FG02-93ER61677, DE-FG02-08ER64648]; EPA [XA-83240101]; NSF [BCS-0410344]; MIT JPSPGC	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Department of Energy, Office of Science (BER)(United States Department of Energy (DOE)); EPA(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); MIT JPSPGC	This research was supported in part by the David and Lucile Packard Foundation to the MBL, Department of Energy, Office of Science (BER) grants DE-FG02-94ER61937, DE-FG02-93ER61677, and DE-FG02-08ER64648; EPA grant XA-83240101; NSF grant BCS-0410344; and the industrial and foundation sponsors of the MIT JPSPGC.	*CA EPA, 2009, PROP REG IMPL LOW CA, V1; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Felzer B, 2005, CLIMATIC CHANGE, V73, P345, DOI 10.1007/s10584-005-6776-4; Felzer B, 2004, TELLUS B, V56, P230, DOI 10.1111/j.1600-0889.2004.00097.x; GURGEL A, J AGR FOOD IND ORG; Herzog H, 2003, CLIMATIC CHANGE, V59, P293, DOI 10.1023/A:1024801618900; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; Leemans R, 1996, GLOBAL ENVIRON CHANG, V6, P335, DOI 10.1016/S0959-3780(96)00028-3; MELILLO J, 2009, 168 MIT JPSPGC; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Paltsev S., 2005, MIT EMISSIONS PREDIC; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Reilly J, 2007, GREENHOUSE GAS SINKS, P115, DOI 10.1079/9781845931896.0115; Renewable Fuels Agency (RFA), 2008, GALL REV IND EFF BIO; Robertson G. Philip, 1997, P347; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Strengers B., 2004, GeoJournal, V61, P381, DOI 10.1007/s10708-004-5054-8; WANG X, 2008, THESIS MIT; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	22	376	385	8	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1397	1399		10.1126/science.1180251	http://dx.doi.org/10.1126/science.1180251			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933101				2022-12-28	WOS:000272351100041
J	Hale, CR; Zhao, P; Olson, S; Duff, MO; Graveley, BR; Wells, L; Terns, RM; Terns, MP				Hale, Caryn R.; Zhao, Peng; Olson, Sara; Duff, Michael O.; Graveley, Brenton R.; Wells, Lance; Terns, Rebecca M.; Terns, Michael P.			RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex	CELL			English	Article							PROVIDES ACQUIRED-RESISTANCE; NONCODING RNAS; PROKARYOTES; REPEATS; DNA; DEFENSE; IDENTIFICATION; INTERFERENCE; ELEMENTS; SYSTEM	Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders. This adaptive prokaryotic immune system arises from the clustered regularly interspaced short palindromic repeats (CRISPRs) found in prokaryotic genomes, which harbor short invader-derived sequences, and the CRISPR-associated (Cas) protein-coding genes. Here, we have identified a CRISPR-Cas effector complex that is comprised of small invader-targeting RNAs from the CRISPR loci (termed prokaryotic silencing (psi) RNAs) and the RAMP module (or Cmr) Cas proteins. The psiRNA-Cmr protein complexes cleave complementary target RNAs at a fixed distance from the 3' end of the integral psiRNAs. In Pyrococcus furiosus, psiRNAs occur in two size forms that share a common 5' sequence tag but have distinct 3' ends that direct cleavage of a given target RNA at two distinct sites. Our results indicate that prokaryotes possess a unique RNA silencing system that functions by homology-dependent cleavage of invader RNAs.	[Hale, Caryn R.; Zhao, Peng; Wells, Lance; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem, Athens, GA 30602 USA; [Hale, Caryn R.; Zhao, Peng; Wells, Lance; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Mol Biol, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Olson, Sara; Duff, Michael O.; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Connecticut	Terns, RM (corresponding author), Univ Georgia, Dept Biochem, Athens, GA 30602 USA.	rterns@bmb.uga.edu; mterns@bmb.uga.edu	Wells, Lance/H-3118-2013; Graveley, Brenton R/C-3108-2013; Terns, Michael/N-6435-2016	Ravel, Jacques/0000-0002-0851-2233; Wells, Lance/0000-0003-4956-5363; Graveley, Brenton/0000-0001-5777-5892; Zhao, Peng/0000-0002-9296-5293	National Institutes of Health [RO1GM54682, R01GM062516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062516, R01GM054682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We extend special thanks to Tim Davies (Director, University of Georgia Bioexpression & Fermentation Facility) for P. furiosus cells, the University of Connecticut Health Center Translational Genomics Core Facility for use of the Illumina Genome Analyzer, Frank Sugar (University of Georgia Bioexpression Facility) for expert advice on chromatography, Mike Adams and the Southeast Collaboratory for Structural Genomics (University of Georgia) for constructs, Lindsay Jones, Joshua Elmore and Sonali Majumdar (Terns Lab, University of Georgia) for generation of protein expression constructs, and Claiborne Glover (University of Georgia) for critical reading. L. W. is a Georgia Cancer Coalition Distinguished Scientist. This work was supported by National Institutes of Health grants RO1GM54682 (M. T. and R. T.) and R01GM062516 (B. R. G.).	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; LILLESTOL RK, 2009, MOL MICROBIOL; Lim JM, 2008, J PROTEOME RES, V7, P1251, DOI 10.1021/pr7006945; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	38	709	834	3	239	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					945	956		10.1016/j.cell.2009.07.040	http://dx.doi.org/10.1016/j.cell.2009.07.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945378	Green Accepted, Bronze			2022-12-28	WOS:000272169400018
J	Macilwain, C				Macilwain, Colin			Experts and democracy	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					275	275		10.1038/462275a	http://dx.doi.org/10.1038/462275a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521DF	19924186	Bronze			2022-12-28	WOS:000271899300012
J	Sousa, RM; Ferri, CP; Acosta, D; Albanese, E; Guerra, M; Huang, YQ; Jacob, KS; Jotheeswaran, AT; Rodriguez, JJL; Pichardo, GR; Rodriguez, MC; Salas, A; Sosa, AL; Williams, J; Zuniga, T; Prince, M				Sousa, Renata M.; Ferri, Cleusa P.; Acosta, Daisy; Albanese, Emiliano; Guerra, Marietta; Huang, Yueqin; Jacob, K. S.; Jotheeswaran, A. T.; Llibre Rodriguez, Juan J.; Rodriguez Pichardo, Guillermina; Calvo Rodriguez, Marina; Salas, Aquiles; Luisa Sosa, Ana; Williams, Joseph; Zuniga, Tirso; Prince, Martin			Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey	LANCET			English	Article							ASSESSMENT SCHEDULE-II; PSYCHOMETRIC PROPERTIES; HEALTH; EPIDEMIOLOGY; METHODOLOGY; PREVALENCE; DEPRESSION; DIAGNOSIS; COSTS; ONSET	Background Disability in elderly people in countries with low and middle incomes is little studied; according to Global Burden of Disease estimates, visual impairment is the leading contributor to years lived with disability in this population. We aimed to assess the contribution of physical, mental, and cognitive chronic diseases to disability, and the extent to which sociodemographic and health characteristics account for geographical variation in disability. Methods We undertook cross-sectional surveys of residents aged older than 65 years (n=15 022) in 11 sites in seven countries with low and middle incomes (China, India, Cuba, Dominican Republic, Venezuela, Mexico, and Peru). Disability was assessed with the 12-item WHO disability assessment schedule 2.0. Dementia, depression, hypertension, and chronic obstructive pulmonary disease were ascertained by clinical assessment; diabetes, stroke, and heart disease by self-reported diagnosis; and sensory, gastrointestinal, skin, limb, and arthritic disorders by self-reported impairment. Independent contributions to disability scores were assessed by zero-inflated negative binomial regression and Poisson regression to generate population-attributable prevalence fractions (PAPF). Findings In regions other than rural India and Venezuela, dementia made the largest contribution to disability (median PAPF 25.1% [IQR 19.2-43.6]). Other substantial contributors were stroke (11.4% [1.8-21.4]), limb impairment (10.5% [5.7-33.8]), arthritis (9.9% [3.2-34.8]), depression (8.3% [0.5-23.0]), eyesight problems (6.8% [1.7-17.6]), and gastrointestinal impairments (6.5% [0.3-23.1]). Associations with chronic diseases accounted for around two-thirds of prevalent disability. When zero inflation was taken into account, between-site differences in disability scores were largely attributable to compositional differences in health and sociodemographic characteristics. Interpretation On the basis of empirical research, dementia, not blindness, is overwhelmingly the most important independent contributor to disability for elderly people in countries with low and middle incomes. Chronic diseases of the brain and mind deserve increased prioritisation. Besides disability, they lead to dependency and present stressful, complex, long-term challenges to carers. Societal costs are enormous.	[Sousa, Renata M.; Ferri, Cleusa P.; Albanese, Emiliano; Prince, Martin] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Publ Mental Hlth, London SE5 8AF, England; [Acosta, Daisy] Univ Nacl Pedro Henriquez Urena, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Marietta] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Huang, Yueqin] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Jotheeswaran, A. T.; Williams, Joseph] Voluntary Hlth Serv, Dept Community Hlth, Madras, Tamil Nadu, India; [Llibre Rodriguez, Juan J.; Calvo Rodriguez, Marina] Med Univ Havana, Fac Med Finlay Albarran, Havana, Cuba; [Rodriguez Pichardo, Guillermina] Colegio Dominicano Estadist & Demografos, Santo Domingo, Dominican Rep; [Salas, Aquiles] Cent Univ Venezuela, Fac Med, Hop Univ Caracas, Dept Med, Caracas, Venezuela; [Luisa Sosa, Ana; Zuniga, Tirso] Univ Nacl Autonoma Mexico, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Central Venezuela; Universidad Nacional Autonoma de Mexico	Sousa, RM (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Publ Mental Hlth, Crespigny Pk,POB 60, London SE5 8AF, England.	r.sousa@iop.kcl.ac.uk	Ortiz, Ana Luisa Sosa/AAU-9376-2021; Prince, Martin J/A-9170-2010; Bryce, Renata/B-1057-2011; Rodriguez, Juan J Llibre/D-2380-2010; Sosa, Ana L/A-8593-2012; Ferri, Cleusa Pinheiro/B-2922-2010	Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prince, Martin J/0000-0003-1379-7146; Rodriguez, Juan J Llibre/0000-0002-8215-3160; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Guerra, Mariella/0000-0001-8923-349X; Zuniga Santamaria, Tirso/0000-0003-2086-8459; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; Acosta Castillo, Gilberto Isaac/0000-0002-8664-9542	Wellcome Trust (UK) [GR066133]; WHO; US Alzheimer's Association [11RG-04-1286]; Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); GlaxoSmithKline; Novartis; Lundbeck; Pfizer; Eisai	Wellcome Trust (UK)(Wellcome Trust); WHO(World Health Organization); US Alzheimer's Association(Alzheimer's Association); Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Eisai(Eisai Co Ltd)	The 10/66 Dementia Research Group population-based surveys were funded by: the Wellcome Trust (UK) (GR066133); WHO; the US Alzheimer's Association (11RG-04-1286); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). The Rockefeller Foundation supported our dissemination meeting in their Bellagio Centre. Alzheimer's Disease International (ADI) has provided support for networking and infrastructure. The 10/66 Dementia Research Group works closely with ADI, which is a non-profit federation of 77 Alzheimer associations around the world. ADI is committed to strengthening Alzheimer associations worldwide, raising awareness regarding dementia and Alzheimer's disease, and advocating for more and better services for people with dementia and their caregivers. ADI is supported in part by grants from GlaxoSmithKline, Novartis, Lundbeck, Pfizer, and Lisai.	Acosta D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-285; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baron M, 2008, ARTHRIT RHEUM-ARTHR, V59, P382, DOI 10.1002/art.23314; Chavez Ligia M, 2005, Ment Health Serv Res, V7, P145, DOI 10.1007/s11020-005-5783-4; Chisolm Theresa H, 2005, Trends Amplif, V9, P111, DOI 10.1177/108471380500900303; Chopra PK, 2004, AUST NZ J PSYCHIAT, V38, P753, DOI 10.1080/j.1440-1614.2004.01448.x; Chwastiak LA, 2003, J CLIN EPIDEMIOL, V56, P507, DOI 10.1016/S0895-4356(03)00051-9; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; Deepa M, 2003, J Assoc Physicians India, V51, P863; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; GEORGE LK, 1985, J AM GERIATR SOC, V33, P607, DOI 10.1111/j.1532-5415.1985.tb06317.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hudson M, 2008, ARTHRIT RHEUM-ARTHR, V59, P270, DOI 10.1002/art.23343; McKibbin C, 2004, J NERV MENT DIS, V192, P405, DOI 10.1097/01.nmd.0000130133.32276.83; Murray CJL, 2000, HEALTH ECON, V9, P69, DOI 10.1002/(SICI)1099-1050(200001)9:1<69::AID-HEC493>3.0.CO;2-I; Ng N, 2006, SCAND J PUBLIC HEALT, V34, P199, DOI 10.1080/14034940500204506; Posl M, 2007, QUAL LIFE RES, V16, P1521, DOI 10.1007/s11136-007-9259-4; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2008, INT REV PSYCHIATR, V20, P332, DOI 10.1080/09540260802094712; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Prince MJ, 1998, PSYCHOL MED, V28, P337, DOI 10.1017/S0033291797006478; Rehm J., 1999, INT J METH PSYCH RES, V8, P110, DOI DOI 10.1002/MPR.61; Rodriguez JL, 2008, NEUROEPIDEMIOLOGY, V31, P243, DOI 10.1159/000165362; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; SOUSA RM, INT J METHO IN PRESS; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Thomas R, 2001, NETW COMPUT, V12, P20; USTUN TB, MEASURING H IN PRESS; van Tubergen A, 2003, ANN RHEUM DIS, V62, P140, DOI 10.1136/ard.62.2.140; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009; WHO, 2001, WHO INT CLASS FUNCT; *WHOSIS, 2006, WORLD HLTH STAT; Wimo A, 2007, ALZHEIMERS DEMENT, V3, P81, DOI 10.1016/j.jalz.2007.02.001; Wolff JL, 2005, J AM GERIATR SOC, V53, P851, DOI 10.1111/j.1532-5415.2005.53262.x; WOO J, 1994, NEUROEPIDEMIOLOGY, V13, P50, DOI 10.1159/000110358	40	281	298	4	90	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1821	1830		10.1016/S0140-6736(09)61829-8	http://dx.doi.org/10.1016/S0140-6736(09)61829-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944863	Green Published			2022-12-28	WOS:000272370200027
J	Schurger, A; Pereira, F; Treisman, A; Cohen, JD				Schurger, Aaron; Pereira, Francisco; Treisman, Anne; Cohen, Jonathan D.			Reproducibility Distinguishes Conscious from Nonconscious Neural Representations	SCIENCE			English	Article							INVISIBLE STIMULI; VISUAL-CORTEX; AWARENESS; PERCEPTION; ATTENTION; ACTIVATION; RESPONSES; PATIENT; FACES; MRI	What qualifies a neural representation for a role in subjective experience? Previous evidence suggests that the duration and intensity of the neural response to a sensory stimulus are factors. We introduce another attribute-the reproducibility of a pattern of neural activity across different episodes-that predicts specific and measurable differences between conscious and nonconscious neural representations indepedently of duration and intensity. We found that conscious neural activation patterns are relatively reproducible when compared with nonconscious neural activation patterns corresponding to the same perceptual content. This is not adequately explained by a difference in signal-to-noise ratio.	[Schurger, Aaron; Pereira, Francisco; Treisman, Anne; Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Schurger, Aaron; Pereira, Francisco; Cohen, Jonathan D.] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08540 USA	Princeton University; Princeton University	Schurger, A (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA.	schurger@princeton.edu	Schurger, Aaron/Y-4459-2018	Schurger, Aaron/0000-0003-2985-3253	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075342] Funding Source: NIH RePORTER; NIMH NIH HHS [MH075342] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Haynes JD, 2009, TRENDS COGN SCI, V13, P194, DOI 10.1016/j.tics.2009.02.004; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Kinsbourne M, 1997, CARN S COGN, P335; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Pessoa L, 2003, J NEUROSCI, V23, P3990; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Sackur J, 2009, COGNITION, V111, P187, DOI 10.1016/j.cognition.2009.01.010; Schurger A, 2008, NEUROPSYCHOLOGIA, V46, P2189, DOI 10.1016/j.neuropsychologia.2008.02.020; Schurger A, 2008, TRENDS COGN SCI, V12, P209, DOI 10.1016/j.tics.2008.02.012; Schurger A, 2009, J NEUROSCI METH, V177, P199, DOI 10.1016/j.jneumeth.2008.09.028; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008	22	96	98	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					97	99		10.1126/science.1180029	http://dx.doi.org/10.1126/science.1180029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19965385				2022-12-28	WOS:000273395400040
J	Gill, M; Stott, R				Gill, Mike; Stott, Robin			Health professionals must act to tackle climate change	LANCET			English	Editorial Material									[Gill, Mike] Univ Surrey, Fac Med & Hlth Sci, Surrey, England	University of Surrey		stott@dircon.co.uk						*CHATH HOUS, 2009, POL CLIM CHANG AGREE; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; *DEP EN CLIM CHANG, 2009, ROAD COP UK GOV CAS; *GLOB HUM FOR, 2009, HUM IMP REP AN SIL C; Global Commons Institute, CONTR CONV GLOB SOL; Haines A, 2009, LANCET, V374, P2035, DOI 10.1016/S0140-6736(09)61667-6; McMichael A.J., 1996, CLIMATE CHANGE HUMAN; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ	8	19	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1953	1955		10.1016/S0140-6736(09)61830-4	http://dx.doi.org/10.1016/S0140-6736(09)61830-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19942275				2022-12-28	WOS:000272727000008
J	Nepstad, D; Soares, BS; Merry, F; Lima, A; Moutinho, P; Carter, J; Bowman, M; Cattaneo, A; Rodrigues, H; Schwartzman, S; McGrath, DG; Stickler, CM; Lubowski, R; Piris-Cabezas, P; Rivero, S; Alencar, A; Almeida, O; Stella, O				Nepstad, Daniel; Soares-Filho, Britaldo S.; Merry, Frank; Lima, Andre; Moutinho, Paulo; Carter, John; Bowman, Maria; Cattaneo, Andrea; Rodrigues, Hermann; Schwartzman, Stephan; McGrath, David G.; Stickler, Claudia M.; Lubowski, Ruben; Piris-Cabezas, Pedro; Rivero, Sergio; Alencar, Ane; Almeida, Oriana; Stella, Osvaldo			The End of Deforestation in the Brazilian Amazon	SCIENCE			English	Editorial Material							FORESTS		[Nepstad, Daniel; Merry, Frank; Moutinho, Paulo; Bowman, Maria; Cattaneo, Andrea; McGrath, David G.; Stickler, Claudia M.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Nepstad, Daniel; Merry, Frank; Lima, Andre; Moutinho, Paulo; Bowman, Maria; McGrath, David G.; Stickler, Claudia M.; Alencar, Ane; Almeida, Oriana; Stella, Osvaldo] Inst Pesquisa Ambiental Amazonia, BR-71503505 Brasilia, DF, Brazil; [Soares-Filho, Britaldo S.; Rodrigues, Hermann] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil; [Carter, John] Alianca Terra, BR-74670600 Goiania, Go, Brazil; [Schwartzman, Stephan; Lubowski, Ruben; Piris-Cabezas, Pedro] Environm Def Fund, Washington, DC 20009 USA; [McGrath, David G.; Lubowski, Ruben; Piris-Cabezas, Pedro] Univ Florida, Gainesville, FL 32611 USA; [Stickler, Claudia M.; Alencar, Ane] Univ Rey Juan Carlos, Mostoles 28933, Spain; [Piris-Cabezas, Pedro] Fed Univ Para, BR-66075110 Belem, Para, Brazil	Woods Hole Research Center; Universidade Federal de Minas Gerais; Environmental Defense Fund; State University System of Florida; University of Florida; Universidad Rey Juan Carlos; Universidade Federal do Para	Nepstad, D (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.	dnepstad@whrc.org; britaldo@csr.ufmg.br	/AAX-3684-2020	/0000-0001-5605-7469				Angelsen A., 2009, REDUCING EMISSIONS D; *GOV BRAZ, 2008, NAT CLIM CHANG PLAN; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Houghton R.A., 2005, TROPICAL DEFORESTATI, P13; IBGE-Instituto Brasileiro de Geografia e Estatistica, CENS AGR 2006; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; LIMA A, 2005, ZONEAMENTO ECOLOGICO; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; NEPSTAD DC, 2007, COSTS BENEFITS REDUC; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares-Filho BS, 2008, REDUCING CARBON EMIS; Stickler CM, 2009, GLOBAL CHANGE BIOL, V15, P2803, DOI 10.1111/j.1365-2486.2009.02109.x; Tollefson J, 2009, NATURE, V460, P936, DOI 10.1038/460936a; [No title captured]	15	351	364	1	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1350	1351		10.1126/science.1182108	http://dx.doi.org/10.1126/science.1182108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965742				2022-12-28	WOS:000272351100023
J	Slaughter, MS; Rogers, JG; Milano, CA; Russell, SD; Conte, JV; Feldman, D; Sun, B; Tatooles, AJ; Delgado, RM; Long, JW; Wozniak, TC; Ghumman, W; Farrar, DJ; Frazier, OH				Slaughter, Mark S.; Rogers, Joseph G.; Milano, Carmelo A.; Russell, Stuart D.; Conte, John V.; Feldman, David; Sun, Benjamin; Tatooles, Antone J.; Delgado, Reynolds M., III; Long, James W.; Wozniak, Thomas C.; Ghumman, Waqas; Farrar, David J.; Frazier, O. Howard		HeartMate II Investigators	Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; MECHANICAL CIRCULATORY SUPPORT; DESTINATION THERAPY; DEFIBRILLATOR; IMPLANTATION; OUTCOMES; MORBIDITY; MORTALITY; SURVIVAL; STROKE	BACKGROUND Patients with advanced heart failure have improved survival rates and quality of life when treated with implanted pulsatile-flow left ventricular assist devices as compared with medical therapy. New continuous-flow devices are smaller and may be more durable than the pulsatile-flow devices. METHODS In this randomized trial, we enrolled patients with advanced heart failure who were ineligible for transplantation, in a 2: 1 ratio, to undergo implantation of a continuous-flow device (134 patients) or the currently approved pulsatile-flow device (66 patients). The primary composite end point was, at 2 years, survival free from disabling stroke and reoperation to repair or replace the device. Secondary end points included survival, frequency of adverse events, the quality of life, and functional capacity. RESULTS Preoperative characteristics were similar in the two treatment groups, with a median age of 64 years (range, 26 to 81), a mean left ventricular ejection fraction of 17%, and nearly 80% of patients receiving intravenous inotropic agents. The primary composite end point was achieved in more patients with continuous-flow devices than with pulsatile-flow devices (62 of 134 [46%] vs. 7 of 66 [11%]; P<0.001; hazard ratio, 0.38; 95% confidence interval, 0.27 to 0.54; P<0.001), and patients with continuous-flow devices had superior actuarial survival rates at 2 years (58% vs. 24%, P = 0.008). Adverse events and device replacements were less frequent in patients with the continuous-flow device. The quality of life and functional capacity improved significantly in both groups. CONCLUSIONS Treatment with a continuous-flow left ventricular assist device in patients with advanced heart failure significantly improved the probability of survival free from stroke and device failure at 2 years as compared with a pulsatile device. Both devices significantly improved the quality of life and functional capacity. (ClinicalTrials.gov number, NCT00121485.)	[Slaughter, Mark S.; Tatooles, Antone J.] Advocate Christ Med Ctr, Oak Lawn, IL USA; [Rogers, Joseph G.; Milano, Carmelo A.] Duke Univ, Med Ctr, Durham, NC USA; [Russell, Stuart D.; Conte, John V.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Feldman, David; Sun, Benjamin] Ohio State Univ, Columbus, OH 43210 USA; [Delgado, Reynolds M., III; Frazier, O. Howard] Texas Heart Inst, Houston, TX 77025 USA; [Long, James W.] Intermt Med Ctr, Salt Lake City, UT USA; [Wozniak, Thomas C.; Ghumman, Waqas] Clarian Methodist Hosp, Indianapolis, IN USA; [Farrar, David J.] Thoratec, Pleasanton, CA USA	Duke University; Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; Ohio State University; Texas Heart Institute; Intermountain Healthcare; Intermountain Medical Center; Indiana University System; Thoratec	Slaughter, MS (corresponding author), Univ Louisville, Div Thorac & Cardiovasc Surg, 201 Abraham Flexner Way,Suite 1200, Louisville, KY 40202 USA.	mark.slaughter@louisville.edu	Ghumman, Waqas/AAH-2951-2020	Dordunoo, Dzifa/0000-0002-0290-8261; Ehsan, Afshin/0000-0003-1470-6760; Jessup, Mariell/0000-0002-3010-0112; Zucker, Mark/0000-0002-2999-0146	Thoratec; Heartware; Abiomed; Edwards Life Sciences and Sorin; Paracor; Terumo Heart; Jarvik Heart	Thoratec; Heartware; Abiomed; Edwards Life Sciences and Sorin; Paracor; Terumo Heart; Jarvik Heart	Dr. Slaughter reports receiving grant support from Thoratec and Heartware; Dr. Rogers, consulting fees and grant support from Thoratec; Dr. Milano, research and training grant support from Thoratec, Abiomed, and St. Jude and research grant support from Edwards Life Sciences and Sorin; Dr. Russell, training and consulting fees from Thoratec; Dr. Conte, training and consulting fees from Thoratec and grant support from Paracor; Dr. Feldman, grant support from Thoratec; and Dr. Sun, training grant support from Thoratec. Dr. Farrar reports being an employee of Thoratec with equity ownership in the company. Dr. Frazier reports receiving consulting and lecture fees from Thoratec, Terumo Heart, and Jarvik Heart. No other potential conflict of interest relevant to this article was reported.	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Baughman KL, 2007, NEW ENGL J MED, V357, P846, DOI 10.1056/NEJMp078131; Boyle AJ, 2009, J HEART LUNG TRANSPL, V28, P881, DOI 10.1016/j.healun.2009.05.018; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cox JL, 1999, J THORAC CARDIOV SUR, V118, P833, DOI 10.1016/S0022-5223(99)70052-8; Gorcideski EZ, 2009, CIRC-HEART FAIL, V2, P320, DOI 10.1161/CIRCHEARTFAILURE.108.839076; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hershberger RE, 2003, J CARD FAIL, V9, P180, DOI 10.1054/jcaf.2003.24; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; Lietz K, 2009, CIRC-HEART FAIL, V2, P3, DOI 10.1161/CIRCHEARTFAILURE.108.796128; Lindenfeld J, 2007, CIRCULATION, V115, P204, DOI 10.1161/CIRCULATIONAHA.106.629261; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pullicino PM, 2000, NEUROLOGY, V54, P288, DOI 10.1212/WNL.54.2.288; Rogers JG, 2007, J AM COLL CARDIOL, V50, P741, DOI 10.1016/j.jacc.2007.03.063; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	22	2179	2207	4	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2241	2251		10.1056/NEJMoa0909938	http://dx.doi.org/10.1056/NEJMoa0909938			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19920051				2022-12-28	WOS:000272257100007
J	Carette, JE; Guimaraes, CP; Varadarajan, M; Park, AS; Wuethrich, I; Godarova, A; Kotecki, M; Cochran, BH; Spooner, E; Ploegh, HL; Brummelkamp, TR				Carette, Jan E.; Guimaraes, Carla P.; Varadarajan, Malini; Park, Annie S.; Wuethrich, Irene; Godarova, Alzbeta; Kotecki, Maciej; Cochran, Brent H.; Spooner, Eric; Ploegh, Hidde L.; Brummelkamp, Thijn R.			Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens	SCIENCE			English	Article							ADP-RIBOSYLATING TOXINS; SACCHAROMYCES-CEREVISIAE; DIPHTHERIA-TOXIN; PROTEIN; IDENTIFICATION; DIPHTHAMIDE; BIOSYNTHESIS; INFLUENZA; RECEPTOR; TARGET	Loss-of-function genetic screens in model organisms have elucidated numerous biological processes, but the diploid genome of mammalian cells has precluded large-scale gene disruption. We used insertional mutagenesis to develop a screening method to generate null alleles in a human cell line haploid for all chromosomes except chromosome 8. Using this approach, we identified host factors essential for infection with influenza and genes encoding important elements of the biosynthetic pathway of diphthamide, which are required for the cytotoxic effects of diphtheria toxin and exotoxin A. We also identified genes needed for the action of cytolethal distending toxin, including a cell-surface protein that interacts with the toxin. This approach has both conceptual and practical parallels with genetic approaches in haploid yeast.	[Carette, Jan E.; Guimaraes, Carla P.; Varadarajan, Malini; Park, Annie S.; Wuethrich, Irene; Godarova, Alzbeta; Spooner, Eric; Ploegh, Hidde L.; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kotecki, Maciej; Cochran, Brent H.] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; [Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Tufts University; Massachusetts Institute of Technology (MIT)	Brummelkamp, TR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	brummelkamp@wi.mit.edu		Cochran, Brent/0000-0002-7598-5604; Carette, Jan/0000-0002-5187-8070				Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; CHEN JYC, 1988, J BIOL CHEM, V263, P11692; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532	31	362	395	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1231	1235		10.1126/science.1178955	http://dx.doi.org/10.1126/science.1178955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965467				2022-12-28	WOS:000272117900039
J	Mani, RS; Tomlins, SA; Callahan, K; Ghosh, A; Nyati, MK; Varambally, S; Palanisamy, N; Chinnaiyan, AM				Mani, Ram-Shankar; Tomlins, Scott A.; Callahan, Kaitlin; Ghosh, Aparna; Nyati, Mukesh K.; Varambally, Sooryanarayana; Palanisamy, Nallasivam; Chinnaiyan, Arul M.			Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer	SCIENCE			English	Article									[Mani, Ram-Shankar; Tomlins, Scott A.; Callahan, Kaitlin; Ghosh, Aparna; Varambally, Sooryanarayana; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Mani, Ram-Shankar; Tomlins, Scott A.; Callahan, Kaitlin; Ghosh, Aparna; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nyati, Mukesh K.; Varambally, Sooryanarayana; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Nyati, Mukesh K.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Tomlins, Scott/0000-0001-8661-9821; Mani, Ram/0000-0003-3552-7905; Varambally, Sooryanarayana/0000-0002-2277-1127	NIH [P50CA69568, R01CA132874, DOD W81XWH-09-2-0014]; NATIONAL CANCER INSTITUTE [R01CA132874, P50CA069568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants P50CA69568, R01CA132874, and DOD W81XWH-09-2-0014. A. M. C. is a paid consultant to Gen-Probe, Incorporated. A. M. C. and S. A. T. are named as co-inventors on a patent related to gene fusions in prostate cancer that is licensed to Gen-Probe, Incorporated.	Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	4	289	299	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1230	1230		10.1126/science.1178124	http://dx.doi.org/10.1126/science.1178124			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19933109	Green Accepted			2022-12-28	WOS:000272117900038
J	Mackway-Jones, K				Mackway-Jones, Kevin			Ethical debate Are advance directives legally binding or simply the starting point for discussion on patients' best interests? Medical opinion	BRITISH MEDICAL JOURNAL			English	Editorial Material									Manchester Royal Infirm, Manchester M13 9WL, Lancs, England	University of Manchester	Mackway-Jones, K (corresponding author), Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England.	kevin.mackway-jones@nhs.net							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2009	339								b4697	10.1136/bmj.b4697	http://dx.doi.org/10.1136/bmj.b4697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AW	19942670				2022-12-28	WOS:000272186500001
J	Purdy, D; Leedham, W				Purdy, Debbie; Leedham, Wendy			A Patient's Journey Multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leedham, Wendy] Farrow Med Ctr, Bradford BD3 0HX, W Yorkshire, England			debbie.purdy@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2009	339								b4470	10.1136/bmj.b4470	http://dx.doi.org/10.1136/bmj.b4470			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AW	19942666				2022-12-28	WOS:000272186500011
J	Lane, NF; Matthews, KRW				Lane, Neal F.; Matthews, Kirstin R. W.			The President's Scientist	CELL			English	Editorial Material									[Lane, Neal F.; Matthews, Kirstin R. W.] Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA	Rice University	Lane, NF (corresponding author), Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA.	stpolicy@rice.edu	Matthews, Kirstin RW/D-2496-2017	Matthews, Kirstin RW/0000-0002-3702-0414				BROMLEY DA, 2004, PRESIDENTS SCI REMIN; BROOKS H, 1988, SCI TECHN ADV PRES C, P51; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; GIBBONS JH, 1997, THIS GIFTED AGE SCI; Killian J., 1977, SPUTNIK SCI EISENHOW; STEVER HG, 2002, WAR PEACE MY LIFE SC	6	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					847	850		10.1016/j.cell.2009.11.024	http://dx.doi.org/10.1016/j.cell.2009.11.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945370	Bronze			2022-12-28	WOS:000272169400007
J	Sessions, SY; Detsky, AS				Sessions, Samuel Y.; Detsky, Allan S.			The Proposed Excise Tax on Employee Health Insurance Good Idea, or Too Clever by 40%?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Detsky, Allan S.] Univ Toronto, Dept Med, Mt Sinai Hosp, Dept Hlth Policy & Management, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Mt Sinai Hosp, Dept Evaluat & Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, Dept Psychiat & Biobehav Sci, Torrance, CA 90509 USA; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, LA Biomed, Torrance, CA 90509 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Detsky, AS (corresponding author), Univ Toronto, Dept Med, Mt Sinai Hosp, Dept Hlth Policy & Management, 600 Univ Ave,Ste 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						ABELSON R, 2009, NY TIMES        0921; Burman LE, 2008, USING TAXES TO REFORM HEALTH INSURANCE: PITFALLS AND PROMISES, P36; FELDSTEIN MS, 1973, J POLIT ECON, V81, P251, DOI 10.1086/260027; Gruber J, 2009, NEW ENGL J MED, V361, P4, DOI 10.1056/NEJMp0904855; Sessions SY, 2008, J HEALTH POLIT POLIC, V33, P155, DOI 10.1215/03616878-2007-052; SLEMROD J, 2008, TAXING OURSELVES CIT, P222; Wells DA, 2007, JAMA-J AM MED ASSOC, V298, P2785, DOI 10.1001/jama.298.23.2785	7	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2252	2253		10.1001/jama.2009.1712	http://dx.doi.org/10.1001/jama.2009.1712			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934427				2022-12-28	WOS:000272080500031
J	Khatiwala, S; Primeau, F; Hall, T				Khatiwala, S.; Primeau, F.; Hall, T.			Reconstruction of the history of anthropogenic CO2 concentrations in the ocean	NATURE			English	Article							DEEP-WATER; CARBON; TRANSPORT	The release of fossil fuel CO2 to the atmosphere by human activity has been implicated as the predominant cause of recent global climate change(1). The ocean plays a crucial role in mitigating the effects of this perturbation to the climate system, sequestering 20 to 35 per cent of anthropogenic CO2 emissions(2-4). Although much progress has been made in recent years in understanding and quantifying this sink, considerable uncertainties remain as to the distribution of anthropogenic CO2 in the ocean, its rate of uptake over the industrial era, and the relative roles of the ocean and terrestrial biosphere in anthropogenic CO2 sequestration. Here we address these questions by presenting an observationally based reconstruction of the spatially resolved, time-dependent history of anthropogenic carbon in the ocean over the industrial era. Our approach is based on the recognition that the transport of tracers in the ocean can be described by a Green's function, which we estimate from tracer data using a maximum entropy deconvolution technique. Our results indicate that ocean uptake of anthropogenic CO2 has increased sharply since the 1950s, with a small decline in the rate of increase in the last few decades. We estimate the inventory and uptake rate of anthropogenic CO2 in 2008 at 140 +/- 25 Pg C and 2.3 +/- 0.6 Pg C yr(-1), respectively. We find that the Southern Ocean is the primary conduit by which this CO2 enters the ocean (contributing over 40 per cent of the anthropogenic CO2 inventory in the ocean in 2008). Our results also suggest that the terrestrial biosphere was a source of CO2 until the 1940s, subsequently turning into a sink. Taken over the entire industrial period, and accounting for uncertainties, we estimate that the terrestrial biosphere has been anywhere from neutral to a net source of CO2, contributing up to half as muchCO(2) as has been taken up by the ocean over the same period.	[Khatiwala, S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Primeau, F.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Hall, T.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA	Columbia University; University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Khatiwala, S (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	spk@ldeo.columbia.edu	Primeau, Francois W/A-7310-2011	Primeau, Francois W/0000-0001-7452-9415; Hall, Timothy/0000-0003-1755-4889	US NSF [OCE 06-23366, OCE 07-26871]	US NSF(National Science Foundation (NSF))	This work was supported by US NSF grants OCE 06-23366 (to S. K. and T. H.) and OCE 07-26871 (to F. P.).	Antonov JI, 2006, NOAA ATLAS NESDIS, V62; Boden T. A., 2012, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V2012, DOI 10.3334/CDIAC/00001, 10.3334/CDIAC/00001]; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; BREWER PG, 1978, GEOPHYS RES LETT, V5, P997, DOI 10.1029/GL005i012p00997; Broecker WS, 1998, J GEOPHYS RES-OCEANS, V103, P15833, DOI 10.1029/98JC00248; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cao L, 2009, BIOGEOSCIENCES, V6, P375, DOI 10.5194/bg-6-375-2009; *CARB DIOX INF AN, 2009, ATM TRAC GAS CARB DI; CHEN GT, 1979, NATURE, V277, P205, DOI 10.1038/277205a0; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Fletcher SEM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002530; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Garcia H. E., 2006, NOAA ATLAS NESDIS, V64; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Hall TM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002120; Hall TM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001835; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton R.A., 2008, TRENDS COMPENDIUM DA; Joos F, 1999, GEOPHYS RES LETT, V26, P1437, DOI 10.1029/1999GL900250; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Khatiwala S, 2001, DEEP-SEA RES PT I, V48, P1423, DOI 10.1016/S0967-0637(00)00094-7; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; LOCARNINI RA, 2006, NOAA ATLAS NESDIS, V61; LOMONACO C, 2005, J GEOPHYS RES, V110, P9502, DOI DOI 10.1029/2004JC002571; Lovenduski NS, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002900; Matsumoto K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002397; Matsumoto K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018970; Rhein M, 2002, J PHYS OCEANOGR, V32, P648, DOI 10.1175/1520-0485(2002)032<0648:LSWPCI>2.0.CO;2; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SARMIENTO JL, 1992, J GEOPHYS RES-OCEANS, V97, P3621, DOI 10.1029/91JC02849; Smethie WM, 2001, DEEP-SEA RES PT I, V48, P189, DOI 10.1016/S0967-0637(00)00048-0; Solomon S., 2007, PHYS SCI BASIS WORKI; Sweeney C, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002784; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tanhua T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004868; Tarantola A, 2005, INVERSE PROBLEM THEO; Walker SJ, 2000, J GEOPHYS RES-OCEANS, V105, P14285, DOI 10.1029/1999JC900273; Wallace DWR, 2001, GLOBAL BIOGEOCHEM CY, V15, P3, DOI 10.1029/2000GB001354; Waugh DW, 2006, TELLUS B, V58, P376, DOI 10.1111/j.1600-0889.2006.00222.x; Waugh DW, 2004, DEEP-SEA RES PT I, V51, P1475, DOI [10.1016/S0967-0637(04)00145-1, 10.1016/j.dsr.2004.06.011]; Zickfeld K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028797	41	381	397	8	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					346	U110		10.1038/nature08526	http://dx.doi.org/10.1038/nature08526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924213	Green Published			2022-12-28	WOS:000271899300043
J	Drost, J; Agami, R				Drost, Jarno; Agami, Reuven			Transformation Locked in a Loop	CELL			English	Editorial Material							CELLS; LOCUS		[Drost, Jarno; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Agami, Reuven] Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Netherlands Cancer Institute	Agami, R (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.agami@nki.nl	Drost, Jarno/M-6964-2017; agami, reuven/GOG-8289-2022; Drost, Jarno/J-9758-2012	Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; Agami, Reuven/0000-0002-2848-2473				Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293	9	8	8	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					654	656		10.1016/j.cell.2009.10.035	http://dx.doi.org/10.1016/j.cell.2009.10.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914159	Bronze			2022-12-28	WOS:000271747200008
J	Bushby, K; Lochmuller, H; Lynn, S; Straub, V				Bushby, Kate; Lochmueller, Hanns; Lynn, Stephen; Straub, Volker			Interventions for muscular dystrophy: molecular medicines entering the clinic	LANCET			English	Review							SARCOGLYCAN-DEFICIENT MICE; RECOMBINANT ADENOASSOCIATED VIRUS; GENE-THERAPY; MOUSE MODEL; MUSCLE APOPTOSIS; SKELETAL-MUSCLE; MESSENGER-RNA; DYSTROGLYCAN GLYCOSYLATION; AUTOLOGOUS TRANSPLANTATION; NONSENSE MUTATIONS	Muscular dystrophies are individually rare genetic disorders that cause much chronic disability, affecting young children and adults. In the past 20 years, more than 30 genetic types of muscular dystrophy have been defined. During this time, precise diagnosis, genetic counselling, and medical management have improved. These advances in medical practice have occurred while definitive therapies based on an improved knowledge of disease pathogenesis are awaited. A wide range of therapeutic options have been tested in animal models, and some are being tested in clinical trials. Various therapeutic targets are being investigated, from personalised. medicines targeting specific mutations and drugs targeting cellular pathways to gene-based and cell-based therapies.	[Bushby, Kate] Univ Newcastle, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK	Bushby, K (corresponding author), Univ Newcastle, Inst Human Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	kate.bushby@ncl.ac.uk		Straub, Volker/0000-0001-9046-3540; Lochmuller, Hanns/0000-0003-2324-8001	German Ministry of Education and Research (Bonn, Germany); MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	German Ministry of Education and Research (Bonn, Germany)(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Michael Hails for his help with the original artwork. VS and HL are members of the German Muscular Dystrophy Network (MD-NET 01GM0601) funded by the German Ministry of Education and Research (Bonn, Germany). The University of Newcastle and MD-NET are partners of TREAT-NMD (European Commission. sixth framework programme, proposal 036825). The neuromuscular team at the University of Newcastle is part of the Medical Research Council Centre for Neuromuscular Diseases and the MDEX consortium.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-43; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Alagaratnam S, 2008, PROTEOMICS, V8, P1552, DOI 10.1002/pmic.200700857; Allamand V, 2008, J GENE MED, V10, P217, DOI 10.1002/jgm.1140; Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Anderson C, 2009, DEVELOPMENT, V136, P3495, DOI 10.1242/dev.036087; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Bartoli M, 2006, MOL THER, V13, P250, DOI 10.1016/j.ymthe.2005.09.017; Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016; BLAU HM, 1993, NATURE, V364, P673; Bonnemann Carsten G, 2002, Semin Pediatr Neurol, V9, P81, DOI 10.1053/spen.2002.33795; Braun S, 2008, CURR GENE THER, V8, P391, DOI 10.2174/156652308786070998; Brockington M, 2005, Acta Myol, V24, P217; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; BUSHBY K, LANCET NEUR IN PRESS; Butcher J, 2007, LANCET NEUROL, V6, P298, DOI 10.1016/S1474-4422(07)70067-4; Cecchini S, 2008, GENE THER, V15, P823, DOI 10.1038/gt.2008.61; CHAMBERLAIN JS, 1992, CURR OPIN NEUROL NEU, V5, P610; Cordier L, 2000, MOL THER, V1, P119, DOI 10.1006/mthe.1999.0019; Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422; Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242; del Gaudio D, 2008, HUM MUTAT, V29, P1100, DOI 10.1002/humu.20841; Denti MA, 2008, HUM GENE THER, V19, P601, DOI 10.1089/hum.2008.012; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Duboc D, 2007, AM HEART J, V154, P596, DOI 10.1016/j.ahj.2007.05.014; Eagle M, 2007, NEUROMUSCULAR DISORD, V17, P470, DOI 10.1016/j.nmd.2007.03.002; Fougerousse F, 2007, MOL THER, V15, P53, DOI 10.1038/sj.mt.6300022; Gebski BL, 2003, HUM MOL GENET, V12, P1801, DOI 10.1093/hmg/ddg196; Goehringer C, 2009, CARDIOVASC RES, V82, P404, DOI 10.1093/cvr/cvp061; Goyenvalle A, 2009, MOL THER, V17, P1234, DOI 10.1038/mt.2009.113; Guglieri M, 2008, HUM MUTAT, V29, P258, DOI 10.1002/humu.20642; Hamed SA, 2006, AM J MED GENET B, V141B, P44, DOI 10.1002/ajmg.b.30234; Hamed SA, 2006, IDRUGS, V9, P783; Helderman-van den Enden ATJM, 2009, CLIN GENET, V75, P465, DOI 10.1111/j.1399-0004.2009.01173.x; HELLIWELL TR, 1992, NEUROMUSCULAR DISORD, V2, P177, DOI 10.1016/0960-8966(92)90004-P; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Hirst R C, 2005, Acta Myol, V24, P209; Hoffman EP, 2002, RHEUM DIS CLIN N AM, V28, P743, DOI 10.1016/S0889-857X(02)00031-5; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kaplan Jean-Claude, 2009, Neuromuscul Disord, V19, P77; KARPATI G, 1993, MUSCLE NERVE, V16, P1141, DOI 10.1002/mus.880161102; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Khoo B, 2009, CURR OPIN MOL THER, V11, P108; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kobinger GP, 2003, HUM GENE THER, V14, P1441, DOI 10.1089/104303403769211655; Krahn M, 2009, HUM MUTAT, V30, pE345, DOI 10.1002/humu.20910; Kunkel LM, 2006, J HUM GENET, V51, P397, DOI 10.1007/s10038-006-0374-9; Lai KKS, 2006, CLIN BIOCHEM, V39, P367, DOI 10.1016/j.clinbiochem.2005.11.019; Lalic T, 2005, EUR J HUM GENET, V13, P1231, DOI 10.1038/sj.ejhg.5201465; LOVE DR, 1991, J MED GENET, V28, P860, DOI 10.1136/jmg.28.12.860; Manzur AY, 2008, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD14003725.PUB14651853; Markert CD, 2009, PM&R, V1, P547, DOI 10.1016/j.pmrj.2009.02.013; MARTIN PT, 2009, AM J PHYSIOL, V296, P4762; Mercado ML, 2006, FASEB J, V20, P1724, DOI 10.1096/fj.05-5124fje; Mercuri E, 2008, Neuromuscul Disord, V18, P894, DOI 10.1016/j.nmd.2008.07.003; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; Muir LA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001100; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157; Nagaraju Kanneboyina, 2009, Neuromuscul Disord, V19, P502, DOI 10.1016/j.nmd.2009.05.003; Nishiyama A, 2008, HUM GENE THER, V19, P719, DOI 10.1089/hum.2007.184; Odom GL, 2007, BBA-MOL BASIS DIS, V1772, P243, DOI 10.1016/j.bbadis.2006.09.007; Ohsawa Y, 2006, J CLIN INVEST, V116, P2924, DOI 10.1172/JCI28520; Pacak CA, 2007, MOL THER, V15, P1775, DOI 10.1038/sj.mt.6300246; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102; Quenneville SP, 2007, MOL THER, V15, P431, DOI 10.1038/sj.mt.6300047; Rahbek Jes, 2005, Pediatr Rehabil, V8, P17, DOI 10.1080/13638490400010191; Rodino-Klapac LR, 2008, NEUROLOGY, V71, P240, DOI 10.1212/01.wnl.0000306309.85301.e2; Rodino-Klapac LR, 2007, ARCH NEUROL-CHICAGO, V64, P1236, DOI 10.1001/archneur.64.9.1236; Romero NB, 2004, HUM GENE THER, V15, P1065, DOI 10.1089/hum.2004.15.1065; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sarkozy A, 2008, NEUROMUSCULAR DISORD, V18, P819, DOI 10.1016/j.nmd.2008.07.006; Schwartz M, 2004, GENET TEST, V8, P361, DOI 10.1089/gte.2004.8.361; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Stockley TL, 2006, GENET TEST, V10, P229, DOI 10.1089/gte.2006.10.229; Straub V, 2008, NEUROTHERAPEUTICS, V5, P619, DOI 10.1016/j.nurt.2008.08.003; t' Hoen PAC, 2006, PHARMACOGENOMICS, V7, P281, DOI 10.2217/14622416.7.3.281; Thornhill P, 2008, BRAIN, V131, P1551, DOI 10.1093/brain/awn078; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064; Trabelsi M, 2008, EUR J HUM GENET, V16, P793, DOI 10.1038/ejhg.2008.9; Tsuchida K, 2008, CURR OPIN DRUG DISC, V11, P487; Turk R, 2005, FASEB J, V19, P127, DOI 10.1096/fj.05-4678fje; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Vainzof M, 2005, NEUROMUSCULAR DISORD, V15, P588, DOI 10.1016/j.nmd.2005.04.009; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Vogiatzakis N, 2007, MOL BIOTECHNOL, V37, P212, DOI 10.1007/s12033-007-0065-6; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wang ZJ, 2009, ILAR J, V50, P187, DOI 10.1093/ilar.50.2.187; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wheeler MA, 2008, BIOCHEM SOC T, V36, P1354, DOI 10.1042/BST0361354; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Xu R, 2007, AM J PATHOL, V171, P181, DOI 10.2353/ajpath.2007.060927; Xu R, 2009, AM J PATHOL, V175, P235, DOI 10.2353/ajpath.2009.080967; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zeng FY, 2008, HUM MUTAT, V29, P190, DOI 10.1002/humu.20613; Zhang B, 2009, BIOINFORMATICS, V25, P526, DOI 10.1093/bioinformatics/btn660	116	27	30	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1849	1856		10.1016/S0140-6736(09)61834-1	http://dx.doi.org/10.1016/S0140-6736(09)61834-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527MC	19944865				2022-12-28	WOS:000272370200030
J	Horton, R				Horton, Richard			The climate dividend	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Lim V, 2009, LANCET, V374, P973, DOI 10.1016/S0140-6736(09)61641-X; Pencheon D, 2009, GUARDIAN        1021, P31	3	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 5	2009	374	9705					1869	1870		10.1016/S0140-6736(09)61994-2	http://dx.doi.org/10.1016/S0140-6736(09)61994-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19942279				2022-12-28	WOS:000272646900004
J	Collins, SL				Collins, Scott L.			Biodiversity Under Global Change	SCIENCE			English	Editorial Material							NITROGEN DEPOSITION; ELEVATED CO2; DIVERSITY; RESPONSES		Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Collins, SL (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	scollins@sevilleta.unm.edu	Collins, Scott L/P-7742-2014	Collins, Scott L/0000-0002-0193-2892				Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100	9	5	8	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1353	1354		10.1126/science.1183271	http://dx.doi.org/10.1126/science.1183271			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965744				2022-12-28	WOS:000272351100025
J	Chi, KR				Chi, Kelly Rae			Microscopy: Ever-increasing resolution	NATURE			English	Editorial Material																		Baddeley D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp901; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Han KY, 2009, NANO LETT, V9, P3323, DOI 10.1021/nl901597v; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; van de Linde S, 2009, PHOTOCH PHOTOBIO SCI, V8, P465, DOI 10.1039/b822533h; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228	16	13	13	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					675	678		10.1038/462675a	http://dx.doi.org/10.1038/462675a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956265	Bronze			2022-12-28	WOS:000272277900049
J	Tzoulaki, I; Molokhia, M; Curcin, V; Little, MP; Millett, CJ; Ng, A; Hughes, RI; Khunti, K; Wilkins, MR; Majeed, A; Elliott, P				Tzoulaki, Ioanna; Molokhia, Mariam; Curcin, Vasa; Little, Mark P.; Millett, Christopher J.; Ng, Anthea; Hughes, Robert I.; Khunti, Kamlesh; Wilkins, Martin R.; Majeed, Azeem; Elliott, Paul			Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; SULFONYLUREA DRUGS; GLYCEMIC CONTROL; OLDER PATIENTS; PIOGLITAZONE; THIAZOLIDINEDIONES; ROSIGLITAZONE; METFORMIN; OUTCOMES	Objective To investigate the risk of incident myocardial infarction, congestive heart failure, and all cause mortality associated with prescription of oral antidiabetes drugs. Design Retrospective cohort study. Setting UK general practice research database, 1990-2005. Participants 91 521 people with diabetes. Main outcome measures Incident myocardial infarction, congestive heart failure, and all cause mortality. Person time intervals for drug treatment were categorised by drug class, excluding non-drug intervals and intervals for insulin. Results 3588 incident cases of myocardial infarction, 6900 of congestive heart failure, and 18 548 deaths occurred. Compared with metformin, monotherapy with first or second generation sulphonylureas was associated with a significant 24% to 61% excess risk for all cause mortality (P<0.001) and second generation sulphonylureas with an 18% to 30% excess risk for congestive heart failure (P=0.01 and P<0.001). The thiazolidinediones were not associated with risk of myocardial infarction; pioglitazone was associated with a significant 31% to 39% lower risk of all cause mortality (P=0.02 to P<0.001) compared with metformin. Among the thiazolidinediones, rosiglitazone was associated with a 34% to 41% higher risk of all cause mortality (P=0.14 to P=0.01) compared with pioglitazone. A large number of potential confounders were accounted for in the study; however, the possibility of residual confounding or confounding by indication (differences in prognostic factors between drug groups) cannot be excluded. Conclusions Our findings suggest a relatively unfavourable risk profile of sulphonylureas compared with metformin for all outcomes examined. Pioglitazone was associated with reduced all cause mortality compared with metformin. Pioglitazone also had a favourable risk profile compared with rosiglitazone; although this requires replication in other studies, it may have implications for prescribing within this class of drugs.	[Tzoulaki, Ioanna; Little, Mark P.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Molokhia, Mariam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Curcin, Vasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2AZ, England; [Millett, Christopher J.; Ng, Anthea; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London SW7 2AZ, England; [Hughes, Robert I.; Wilkins, Martin R.] Univ London Imperial Coll Sci Technol & Med, Dept Expt Med & Toxicol, London SW7 2AZ, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Elliott, Paul] MRC HPA Ctr Environm & Hlth, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Imperial College London; Imperial College London; University of Leicester; Imperial College London	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England.	p.elliott@imperial.ac.uk	Tzoulaki, Ioanna/ABE-6269-2020; Tzoulaki, Ioanna/C-1381-2008; YAMAMOTO, MASAHIRO/F-9094-2011; /ABC-9527-2021	Tzoulaki, Ioanna/0000-0002-4275-9328; YAMAMOTO, MASAHIRO/0000-0003-3859-0125; Little, Mark/0000-0003-0980-7567; Majeed, Azeem/0000-0002-2357-9858; Millett, Christopher/0000-0002-0793-9884; Elliott, Paul/0000-0002-7511-5684; Curcin, Vasa/0000-0002-8308-2886; Khunti, Kamlesh/0000-0003-2343-7099	Medical Research Council's license agreement with the UK Medicines and Healthcare Products Regulatory Agency	Medical Research Council's license agreement with the UK Medicines and Healthcare Products Regulatory Agency	No funding was obtained for this study. This study is based on data from the full feature general practice research database funded through the Medical Research Council's license agreement with the UK Medicines and Healthcare Products Regulatory Agency. The interpretation and conclusions contained in this study are those of the authors alone.	[Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; Barton S, 2000, BRIT MED J, V321, P255, DOI 10.1136/bmj.321.7256.255; Bell DSH, 2006, CAN MED ASSOC J, V174, P185, DOI 10.1503/cmaj.051237; Betteridge DJ, 2008, EUR HEART J, V29, P969, DOI 10.1093/eurheartj/ehn114; BOYD AE, 1990, AM J MED, V89, pS3, DOI 10.1016/0002-9343(90)90330-G; *CLIN GUID TASK FO, 2008, GLOB GUID TYP 2 DIAB, pCH9; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Donnelly R, 2007, INT J CLIN PRACT, V61, P1160, DOI 10.1111/j.1742-1241.2007.01396.x; Engler RL, 1996, CIRCULATION, V94, P2297, DOI 10.1161/01.CIR.94.9.2297; Evans JMM, 2006, DIABETOLOGIA, V49, P930, DOI 10.1007/s00125-006-0176-9; Gerber P, 2003, CURR MED RES OPIN, V19, P532, DOI 10.1185/030079903125002180; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; *GLAXOSMITHKLINE, 2008, GLAXOSMITHKLINE CLIN; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Hernandez AV, 2008, AM HEART J, V156, P23, DOI 10.1016/j.ahj.2008.03.002; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Johannes CB, 2007, PHARMACOEPIDEM DR S, V16, P504, DOI 10.1002/pds.1356; JOHNSEN SP, 2006, AM J THER, V3, P134; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kintscher U, 2008, J AM COLL CARDIOL, V52, P882, DOI 10.1016/j.jacc.2008.06.012; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Langenfeld MR, 2005, CIRCULATION, V111, P2525, DOI 10.1161/01.CIR.0000165072.01672.21; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Little R.J.A., 2002, STAT ANAL MISSING DA; Maru S, 2005, DIABETES CARE, V28, P20, DOI 10.2337/diacare.28.1.20; Masoudi FA, 2005, CIRCULATION, V111, P583, DOI 10.1161/01.CIR.0000154542.13412.B1; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Meier CR, 1999, JAMA-J AM MED ASSOC, V281, P427, DOI 10.1001/jama.281.5.427; MEINERT CL, 1970, DIABETES S830, V19; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Orasanu G, 2008, J AM COLL CARDIOL, V52, P869, DOI 10.1016/j.jacc.2008.04.055; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141; Turner RC, 1999, LANCET, V354, P602; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; *WHO, 2008, DIABA; 2009, GEN PRACTICE RES DAT	45	284	290	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2009	339								b4731	10.1136/bmj.b4731	http://dx.doi.org/10.1136/bmj.b4731			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NT	19959591	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000272453400006
J	Jaffar, S; Amuron, B; Foster, S; Birungi, J; Levin, J; Namara, G; Nabiryo, C; Ndembi, N; Kyomuhangi, R; Opio, A; Bunnell, R; Tappero, JW; Mermin, J; Coutinho, A; Grosskurth, H				Jaffar, Shabbar; Amuron, Barbara; Foster, Susan; Birungi, Josephine; Levin, Jonathan; Namara, Geoffrey; Nabiryo, Christine; Ndembi, Nicaise; Kyomuhangi, Rosette; Opio, Alex; Bunnell, Rebecca; Tappero, Jordan W.; Mermin, Jonathan; Coutinho, Alex; Grosskurth, Heiner		Jinja Trial Team	Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SCALING-UP; EARLY MORTALITY; FOLLOW-UP; 1ST YEAR; PROGRAM; ADULTS; ADHERENCE; OUTCOMES	Background Identification of new ways to increase access to antiretroviral therapy in Africa is an urgent priority. We assessed whether home-based HIV care was as effective as was facility-based care. Methods We undertook a cluster-randomised equivalence trial in Jinja, Uganda. 44 geographical areas in nine strata, defined according to ratio of urban and rural participants and distance from the clinic, were randomised to home-based or facility-based care by drawing sealed cards from a box. The trial was integrated into normal service delivery. All patients with WHO stage IV or late stage III disease or CD4-cell counts fewer than 200 cells per mu L who started antiretroviral therapy between Feb 15, 2005, and Dec 19, 2006, were eligible, apart from those living on islands. Follow-up continued until Jan 31, 2009. The primary endpoint was virological failure, defined as RNA more than 500 copies per mL after 6 months of treatment. The margin of equivalence was 9% (equivalence limits 0.69-1.45). Analyses were by intention to treat and adjusted for baseline CD4-cell count and study stratum. This trial is registered at http://isrctn.org, number ISRCTN 17184129. Findings 859 patients (22 clusters) were randomly assigned to home and 594 (22 clusters) to facility care. During the first year, 93 (11%) receiving home care and 66 (11%) receiving facility care died, 29 (3%) receiving home and 36 (6%) receiving facility care withdrew, and 8 (1%) receiving home and 9 (2%) receiving facility care were lost to follow-up. 117 of 729 (16%) in home care had virological failure versus 80 of 483 (17%) in facility care: rates per 100 person-years were 8.19 (95% CI 6.84-9.82) for home and 8.67 (6.96-10.79) for facility care (rate ratio [RR] 1.04, 0.78-1.40; equivalence shown). Two patients from each group were immediately lost to follow-up. Mortality rates were similar between groups (0.95 [0.71-1.28]). 97 of 857 (11%) patients in home and 75 of 592 (13%) in facility care were admitted at least once (0.91, 0.64-1.28). Interpretation This home-based HIV-care strategy is as effective as is a clinic-based strategy, and therefore could enable improved and equitable access to HIV treatment, especially in areas with poor infrastructure and access to clinic care.	[Jaffar, Shabbar; Grosskurth, Heiner] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Amuron, Barbara; Levin, Jonathan; Namara, Geoffrey; Ndembi, Nicaise; Kyomuhangi, Rosette; Grosskurth, Heiner] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Foster, Susan] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA USA; [Birungi, Josephine; Nabiryo, Christine] AIDS Support Org, Kampala, Uganda; [Opio, Alex] Minist Hlth, Dept Natl Dis Control, Kampala, Uganda; [Bunnell, Rebecca; Mermin, Jonathan] US Ctr Dis Control & Prevent, Nairobi, Kenya; [Tappero, Jordan W.] US Ctr Dis Control & Prevent, Entebbe, Uganda; [Coutinho, Alex] Mulago Hosp, Infect Dis Inst, Kampala, Uganda	University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; Boston University; Mulago National Referral Hospital	Jaffar, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	shabbar.jaffar@lshtm.ac.uk	NDEMBI, Nicaise/AAE-4383-2020; Mermin, Jonathan/J-9847-2012	Foster, Susan/0000-0002-2751-7582; Grosskurth, Heiner/0000-0001-9960-7280; Jaffar, Shabbar/0000-0002-9615-1588	MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: Medline; NCHHSTP CDC HHS [IU01-PS000065-01, U01 PS000065] Funding Source: Medline; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U01PS000065] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCHHSTP CDC HHS; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Amuron Barbara, 2007, Open AIDS J, V1, P21, DOI 10.2174/1874613600701010021; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gimbel-Sherr Sarah O, 2007, Hum Resour Health, V5, P7, DOI 10.1186/1478-4491-5-7; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Jaffar S, 1999, VACCINE, V18, P633, DOI 10.1016/S0264-410X(99)00277-7; Jaffar S, 2008, TROP MED INT HEALTH, V13, P795, DOI 10.1111/j.1365-3156.2008.02068.x; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; MEDINALARA A, 2009, 5 IAS C HIV PATH TRE; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; *UN GEN ASS, 2006, 60262 UN GEN ASS; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO, 2007, TREAT TRAIN RET TASK; WHO, 2008, WORLD HLTH REP PRIM; World Health Organization, INT STAT CLASS DIS R, V10th; World Health Organization, 2008, UN ACC SCAL PRIOR HI; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	32	190	191	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2080	2089		10.1016/S0140-6736(09)61674-3	http://dx.doi.org/10.1016/S0140-6736(09)61674-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19939445	Green Published, Green Accepted			2022-12-28	WOS:000273122900031
J	Lee, JW; Kang, YW; Lee, J; Lee, YW				Lee, Jae-Woo; Kang, Young-Woon; Lee, Jina; Lee, Young-Wook			Enrichment by supernovae in globular clusters with multiple populations	NATURE			English	Article							OMEGA-CENTAURI; CHEMICAL INHOMOGENEITY; STELLAR POPULATIONS; STAR-CLUSTERS; M22; PHOTOMETRY; SYSTEM; GALAXY; EVOLUTION; GIANTS	The most massive globular cluster in the Milky Way, omega Centauri, is thought to be the remaining core of a disrupted dwarf galaxy(1,2), as expected within the model of hierarchical merging(3,4). It contains several stellar populations having different heavy elemental abundances supplied by supernovae(5)-a process known as metal enrichment. Although M 22 appears to be similar to omega Cen(6), other peculiar globular clusters do not(7,8). Therefore omega Cen and M 22 are viewed as exceptional, and the presence of chemical inhomogeneities in other clusters is seen as 'pollution' from the intermediate-mass asymptotic-giant-branch stars expected in normal globular clusters(9). Here we report Ca abundances for seven globular clusters and compare them to omega Cen. Calcium and other heavy elements can only be supplied through numerous supernovae explosions of massive stars in these stellar systems(10), but the gravitational potentials of the present-day clusters cannot preserve most of the ejecta from such explosions(11). We conclude that these globular clusters, like omega Cen, are most probably the relics of more massive primeval dwarf galaxies that merged and disrupted to form the proto-Galaxy.	[Lee, Jae-Woo; Kang, Young-Woon; Lee, Jina] Sejong Univ, ARCSEC, Dept Astron & Space Sci, Seoul 143747, South Korea; [Lee, Young-Wook] Yonsei Univ, Ctr Space Astrophys, Seoul 120749, South Korea	Sejong University; Yonsei University	Lee, JW (corresponding author), Sejong Univ, ARCSEC, Dept Astron & Space Sci, Seoul 143747, South Korea.	jaewoolee@sejong.ac.kr; ywlee2@yonsei.ac.kr		Lee, Young-Wook/0000-0002-2210-1238	National Research Foundation of Korea	National Research Foundation of Korea(National Research Foundation of Korea)	J.-W.L. thanks A. Walker for providing the CTIO Ca filter transmission curve, D. Yong for NGC 1851 spectroscopic data before publication, and A. Yushchenko for discussions on spectrum synthesis. Support for this work was provided by the National Research Foundation of Korea to the Astrophysical Research Center for the Structure and Evolution of the Cosmos (ARCSEC). This work was based on observations made with the CTIO 1.0-m telescope, which is operated by the SMARTS consortium.	ANTHONYTWAROG BJ, 1995, PUBL ASTRON SOC PAC, V107, P32, DOI 10.1086/133513; ANTHONYTWAROG BJ, 1991, ASTRON J, V101, P1902, DOI 10.1086/115815; Baumgardt H, 2008, MON NOT R ASTRON SOC, V384, P1231, DOI 10.1111/j.1365-2966.2007.12811.x; Bekki K, 2003, MON NOT R ASTRON SOC, V346, pL11, DOI 10.1046/j.1365-2966.2003.07275.x; BROWN JA, 1992, ASTRON J, V104, P1818, DOI 10.1086/116360; CARRETTA E, 2008, PROPERTIES 2 GENERAT; CUDWORTH KM, 1986, ASTRON J, V92, P348, DOI 10.1086/114164; Decressin T, 2007, ASTRON ASTROPHYS, V475, P859, DOI 10.1051/0004-6361:20078425; Diemand J, 2007, ASTROPHYS J, V667, P859, DOI 10.1086/520573; FREEMAN KC, 1993, ASTR SOC P, V48, P608; Georgiev IY, 2009, MON NOT R ASTRON SOC, V396, P1075, DOI 10.1111/j.1365-2966.2009.14776.x; Johnson CI, 2009, ASTROPHYS J, V698, P2048, DOI 10.1088/0004-637X/698/2/2048; Lee JW, 2009, ASTROPHYS J LETT, V695, pL78, DOI 10.1088/0004-637X/695/1/L78; Lee YW, 2007, ASTROPHYS J, V661, pL49, DOI 10.1086/518653; Lee YW, 1999, NATURE, V402, P55, DOI 10.1038/46985; Marino AF, 2009, ASTRON ASTROPHYS, V505, P1099, DOI 10.1051/0004-6361/200911827; NORRIS J, 1983, ASTROPHYS J, V266, P130, DOI 10.1086/160764; Pflamm-Altenburg J, 2009, MON NOT R ASTRON SOC, V397, P488, DOI 10.1111/j.1365-2966.2009.14954.x; Piotto G, 2005, ASTROPHYS J, V621, P777, DOI 10.1086/427796; Richter P, 1999, ASTRON ASTROPHYS, V350, P476; STETSON PB, 1994, PUBL ASTRON SOC PAC, V106, P250, DOI 10.1086/133378; TIMMES FX, 1995, ASTROPHYS J SUPPL S, V98, P617, DOI 10.1086/192172; Ventura P, 2001, ASTROPHYS J, V550, pL65, DOI 10.1086/319496; Yong D, 2008, ASTROPHYS J LETT, V672, pL29, DOI 10.1086/525850; ZINN R, 1980, ASTROPHYS J SUPPL S, V42, P19, DOI 10.1086/190643; ZINN R, 1984, ASTROPHYS J SUPPL S, V55, P45, DOI 10.1086/190947	27	121	121	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 26	2009	462	7272					480	482		10.1038/nature08565	http://dx.doi.org/10.1038/nature08565			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940919	Green Submitted			2022-12-28	WOS:000272144200037
J	Taylor, AJ; Villines, TC; Stanek, EJ; Devine, PJ; Griffen, L; Miller, M; Weissman, NJ; Turco, M				Taylor, Allen J.; Villines, Todd C.; Stanek, Eric J.; Devine, Patrick J.; Griffen, Len; Miller, Michael; Weissman, Neil J.; Turco, Mark			Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY ATHEROSCLEROSIS; CHOLESTEROL ABSORPTION; ENDOTHELIAL FUNCTION; SCAVENGER RECEPTOR; COLESTIPOL-NIACIN; RANDOMIZED-TRIAL; STATIN; THERAPY; METAANALYSIS; MEMBRANE	BACKGROUND Treatment added to statin monotherapy to further modify the lipid profile may include combination therapy to either raise the high-density lipoprotein (HDL) cholesterol level or further lower the low-density lipoprotein (LDL) cholesterol level. METHODS We enrolled patients who had coronary heart disease or a coronary heart disease risk equivalent, who were receiving long-term statin therapy, and in whom an LDL cholesterol level under 100 mg per deciliter (2.6 mmol per liter) and an HDL cholesterol level under 50 mg per deciliter for men or 55 mg per deciliter for women (1.3 or 1.4 mmol per liter, respectively) had been achieved. The patients were randomly assigned to receive extended-release niacin (target dose, 2000 mg per day) or ezetimibe (10 mg per day). The primary end point was the between-group difference in the change from baseline in the mean common carotid intima-media thickness after 14 months. The trial was terminated early, on the basis of efficacy, according to a prespecified analysis conducted after 208 patients had completed the trial. RESULTS The mean HDL cholesterol level in the niacin group increased by 18.4% over the 14-month study period, to 50 mg per deciliter (P<0.001), and the mean LDL cholesterol level in the ezetimibe group decreased by 19.2%, to 66 mg per deciliter (1.7 mmol per liter) (P<0.001). Niacin therapy significantly reduced LDL cholesterol and triglyceride levels; ezetimibe reduced the HDL cholesterol and triglyceride levels. As compared with ezetimibe, niacin had greater efficacy regarding the change in mean carotid intima-media thickness over 14 months (P=0.003), leading to significant reduction of both mean (P=0.001) and maximal carotid intima-media thickness (P=0.001 for all comparisons). Paradoxically, greater reductions in the LDL cholesterol level in association with ezetimibe were significantly associated with an increase in the carotid intima-media thickness (R=-0.31, P<0.001). The incidence of major cardiovascular events was lower in the niacin group than in the ezetimibe group (1% vs. 5%, P=0.04 by the chi-square test). CONCLUSIONS This comparative-effectiveness trial shows that the use of extended-release niacin causes a significant regression of carotid intima-media thickness when combined with a statin and that niacin is superior to ezetimibe. (ClinicalTrials.gov number, NCT00397657.)	[Taylor, Allen J.] Washington Hosp Ctr, Medstar Res Inst, Dept Med Cardiol, Washington, DC 20010 USA; [Taylor, Allen J.; Villines, Todd C.; Devine, Patrick J.; Miller, Michael] Walter Reed Army Med Ctr, Serv Cardiol, Washington, DC 20307 USA; [Stanek, Eric J.] Medco Hlth Solut, Franklin Lakes, NJ USA; [Griffen, Len] Cardiac Associates, Rockville, MD USA; [Miller, Michael] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Turco, Mark] Washington Adventist Hosp, Takoma Pk, MD USA	MedStar Washington Hospital Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; University System of Maryland; University of Maryland Baltimore	Taylor, AJ (corresponding author), Washington Hosp Ctr, Medstar Res Inst, Dept Med Cardiol, 110 Irving St NW,Rm 1E12, Washington, DC 20010 USA.	allen.taylor@medstar.net	Villines, Todd/AAJ-3744-2021; Miller, Michael/AGX-6773-2022	Miller, Michael/0000-0002-1679-2095; Villines, Todd/0000-0003-2674-3702	Abbott	Abbott(Abbott Laboratories)	Supported by Abbott.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BLANKENHORN DH, 1988, JAMA-J AM MED ASSOC, V259, P2698; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; CASHINHEMPHILL L, 1990, JAMA-J AM MED ASSOC, V264, P3013, DOI 10.1001/jama.264.23.3013; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Devine PJ, 2007, CARDIOVASC DRUG THER, V21, P221, DOI 10.1007/s10557-007-6020-8; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Ghandehari H, 2008, AM HEART J, V156, P112, DOI 10.1016/j.ahj.2008.03.005; Green PS, 2008, CIRCULATION, V118, P1259, DOI 10.1161/CIRCULATIONAHA.108.770669; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1977; Knoepfel M, 2007, BBA-MOL CELL BIOL L, V1771, P1140, DOI 10.1016/j.bbalip.2007.05.011; Labonte ED, 2007, BBA-MOL CELL BIOL L, V1771, P1132, DOI 10.1016/j.bbalip.2007.03.002; Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541; Liu PY, 2009, CIRCULATION, V119, P131, DOI 10.1161/CIRCULATIONAHA.108.813311; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Mosca, 2007, CIRCULATION, V115, pE407, DOI 10.1161/CIRCULATIONAHA.107.183403; Mosca Lori, 2007, Circulation, V115, P1481, DOI 10.1161/CIRCULATIONAHA.107.181546; Nissen SE, 2006, NEW ENGL J MED, V355, P638; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Schweikert B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-187; Spener F, 2007, BBA-MOL CELL BIOL L, V1771, P1113, DOI 10.1016/j.bbalip.2007.08.006; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Taylor AJ, 2005, CIRCULATION, V111, P1727; Taylor AJ, 2002, CIRCULATION, V106, P2055, DOI 10.1161/01.CIR.0000034508.55617.65; Taylor AJ, 2006, CURR MED RES OPIN, V22, P2243, DOI 10.1185/030079906X148508; Thoenes M, 2007, INT J CLIN PRACT, V61, P1942, DOI 10.1111/j.1742-1241.2007.01597.x; van Heek M, 2000, BRIT J PHARMACOL, V129, P1748, DOI 10.1038/sj.bjp.0703235; Whitney EJ, 2005, ANN INTERN MED, V142, P95, DOI 10.7326/0003-4819-142-2-200501180-00008	43	517	535	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2113	2122		10.1056/NEJMoa0907569	http://dx.doi.org/10.1056/NEJMoa0907569			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524BC	19915217				2022-12-28	WOS:000272117800005
J	Farese, RV; Walther, TC				Farese, Robert V., Jr.; Walther, Tobias C.			Lipid Droplets Finally Get a Little R-E-S-P-E-C-T	CELL			English	Article							INFECTIOUS VIRUS; NEUTRAL LIPIDS; CORE PROTEIN; TRIACYLGLYCEROL; BIOGENESIS; STORAGE; METABOLISM; PERILIPIN; YEAST; BIOSYNTHESIS		[Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Walther, Tobias C.] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society	Farese, RV (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu; twalther@biochem.mpg.de		Walther, Tobias/0000-0003-1442-1327	NIH [DK-056084]; Max Planck Society; German Research Council (DFG); Human Frontier Science Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056084, R56DK056084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); German Research Council (DFG)(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Farese and Walther laboratories, and in particular E. Currie, N. Krahmer, and C. Harris, for helpful discussions, and G. Howard for editorial assistance. This work was supported by NIH grant DK-056084 and the J. David Gladstone Institutes (to R. V. F.) and the Max Planck Society, the German Research Council (DFG), and the Human Frontier Science Program (to T. C. W.).	Altmann R, 1890, ELEMENTARORGANISEM I; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Service RF, 2009, SCIENCE, V325, P379, DOI 10.1126/science.325_379a; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Takeda Y, 2008, J BIOCHEM, V143, P803, DOI 10.1093/jb/mvn034; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wilson EB., 1896, CELL DEV INHERITANCE; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	46	664	676	4	166	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					855	860		10.1016/j.cell.2009.11.005	http://dx.doi.org/10.1016/j.cell.2009.11.005			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945371	Bronze, Green Accepted			2022-12-28	WOS:000272169400008
J	Memish, ZA; McNabb, SJN; Mahoney, F; Alrabiah, F; Marano, N; Ahmed, QA; Mahjour, J; Hajjeh, RA; Formenty, P; Harmanci, FH; El Bushra, H; Uyeki, TM; Nunn, M; Isla, N; Barbeschi, M				Memish, Z. A.; McNabb, S. J. N.; Mahoney, F.; Alrabiah, F.; Marano, N.; Ahmed, Q. A.; Mahjour, J.; Hajjeh, R. A.; Formenty, P.; Harmanci, F. H.; El Bushra, H.; Uyeki, T. M.; Nunn, M.; Isla, N.; Barbeschi, M.		Jeddah Hajj Consultancy Grp	Establishment of public health security in Saudi Arabia for the 2009 Hajj in response to pandemic influenza A H1N1	LANCET			English	Article							CRITICALLY-ILL PATIENTS; RESPIRATORY-INFECTIONS; A(H1N1) INFECTION; PILGRIMS; VIRUS; EPIDEMIOLOGY; PREPAREDNESS; VACCINE; DISEASE; UK	Mass gatherings of people challenge public health capacities at host locations and the visitors' places of origin. Hajj-the yearly pilgrimage by Muslims to Saudi Arabia-is one of the largest, most culturally and geographically diverse mass gatherings in the world. With the 2009 pandemic influenza A H1N1 and upcoming Hajj, the Saudi Arabian Ministry of Health (MoH) convened a preparedness consultation in June, 2009. Consultants from global public health agencies met in their official capacities with their Saudi Arabian counterparts. The MoH aimed to pool and share public health knowledge about mass gatherings, and review the country's preparedness plans, focusing on the prevention and control of pandemic influenza. This process resulted in several practical recommendations, many to be put into practice before the start of Hajj and the rest during Hajj. These preparedness plans should ensure the optimum provision of health services for pilgrims to Saudi Arabia, and minimum disease transmission on their return home. Review of the implementation of these recommendations and their effect will not only inform future mass gatherings in Saudi Arabia, but will also strengthen preparedness efforts in other settings.	[Memish, Z. A.] Minist Hlth, Riyadh 11176, Saudi Arabia; [McNabb, S. J. N.] Ctr Dis Control & Prevent, Off Surveillance Serv, Atlanta, GA USA; [McNabb, S. J. N.] Ctr Dis Control & Prevent, Epidemiol Serv, Atlanta, GA USA; [McNabb, S. J. N.] Ctr Dis Control & Prevent, Lab Serv, Atlanta, GA USA; [Mahoney, F.] US Ctr Dis Control & Prevent Off, Jakarta, Indonesia; [Mahoney, F.; Hajjeh, R. A.; Uyeki, T. M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Alrabiah, F.] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia; [Marano, N.] Ctr Dis Control & Prevent, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA USA; [Ahmed, Q. A.] Winthrop Univ Hosp, Dept Med, Div Pulm Dis, Mineola, NY 11501 USA; [Mahjour, J.; El Bushra, H.] WHO, Div Communicable Dis Control, Eastern Mediterranean Reg Off, Cairo, Egypt; [Formenty, P.; Nunn, M.; Isla, N.; Barbeschi, M.] WHO, Dept Global Alert & Response, CH-1211 Geneva, Switzerland; [Harmanci, F. H.] WHO, Global Influenza Program, CH-1211 Geneva, Switzerland	Ministry of Health - Saudi Arabia; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; King Faisal Specialist Hospital & Research Center; Centers for Disease Control & Prevention - USA; Winthrop University Hospital; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; World Health Organization; World Health Organization	Memish, ZA (corresponding author), Minist Hlth, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714; Erondu, Ngozi/0000-0003-0268-6838				A-Asmary S, 2007, INT J INFECT DIS, V11, P268, DOI 10.1016/j.ijid.2006.04.008; Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Ahmed QA, 2009, TRAVEL MED INFECT DI, V7, P226, DOI 10.1016/j.tmaid.2009.01.005; Alborzi A, 2009, J TRAVEL MED, V16, P239, DOI 10.1111/j.1708-8305.2009.00301.x; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P453; Arbon P, 2007, PREHOSP DISASTER MED, V22, P131, DOI 10.1017/S1049023X00004507; Balkhy HH, 2004, J TRAVEL MED, V11, P82, DOI 10.2310/7060.2004.17027; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Duguet Firmin, 1932, PELERINAGE MECQUE PO; El Bashir H, 2004, EMERG INFECT DIS, V10, P1882, DOI 10.3201/eid1010.040151; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Fizzell J, 2008, MED J AUSTRALIA, V189, P633, DOI 10.5694/j.1326-5377.2008.tb02222.x; Hadjichristoulou C, 2005, J ENVIRON HEALTH, V67, P52; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; *HUM INF NEW INF A, 2009, WEEKLY EPIDEMIOL REC, V84, P269; ITOH Y, 2007, WKLY EPIDEMIOL REC, V82, P384; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; KAISER R, 2006, EUROSURVEILLANCE, V11, P3; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Landry Pierre, 2008, Rev Med Suisse, V4, P1192; Long David Edwin, 1979, HAJJ TODAY SURVEY CO; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Madani TA, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-80; Marti F, 2008, EXPERT REV VACCINES, V7, P679, DOI 10.1586/14760584.7.5.679; Memish ZA, 2003, INT J ANTIMICROB AG, V21, P96, DOI 10.1016/S0924-8579(02)00364-3; Memish ZA, 2002, J TRAVEL MED, V9, P202, DOI 10.2310/7060.2002.24557; Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403; Rashid H, 2008, CLIN MICROBIOL INFEC, V14, P569, DOI 10.1111/j.1469-0691.2008.01987.x; Rashid H, 2008, VACCINE, V26, P4809, DOI 10.1016/j.vaccine.2008.07.001; Rashid H, 2008, LANCET INFECT DIS, V8, P526, DOI 10.1016/S1473-3099(08)70186-5; Rashid Harunor, 2007, Travel Med Infect Dis, V5, P310, DOI 10.1016/j.tmaid.2007.07.006; Rashid H, 2008, INT J INFECT DIS, V12, P102, DOI 10.1016/j.ijid.2007.03.009; Savoia E, 2009, DISASTER MED PUBLIC, V3, P104, DOI 10.1097/DMP.0b013e3181a539bc; Schenkel K, 2006, Euro Surveill, V11, P15, DOI 10.2807/esm.11.12.00670-en; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; *WHO, BEH INT RED TRANSM I; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; WHO, 2009, WHO GUID PHARM MAN P; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P305; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P384; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P341; World Health Organization (WHO), 2016, INT HLTH REG 2005	50	65	66	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1786	1791		10.1016/S0140-6736(09)61927-9	http://dx.doi.org/10.1016/S0140-6736(09)61927-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19914707				2022-12-28	WOS:000272207700027
J	Willett, LR				Willett, Laura Rees			Screening for abdominal aortic aneurysm (AAA) in men 65 to 74 years of age was cost-effective for AAA mortality at 10 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							REPAIR		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Willett, LR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA.							Ehlers L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2243; Huber TS, 2001, J VASC SURG, V33, P304, DOI 10.1067/mva.2001.112703; Lederle FA, 2007, ANN INTERN MED, V146, P735, DOI 10.7326/0003-4819-146-10-200705150-00007; Wanhainen A, 2005, J VASC SURG, V41, P741, DOI 10.1016/j.jvs.2005.01.055	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-15	10.7326/0003-4819-151-10-200911170-02015	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920260				2022-12-28	WOS:000272145100026
J	Gwatkin, DR				Gwatkin, Davidson R.			Where next for family planning?	LANCET			English	Editorial Material									Results Dev Inst, Washington, DC 20009 USA		Gwatkin, DR (corresponding author), Results Dev Inst, Washington, DC 20009 USA.	dgwatkin@resultsfordevelopment.org						Bernstein S., 2006, PUBLIC CHOICES PRIVA; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Gillespie D, 2007, B WORLD HEALTH ORGAN, V85, P100, DOI 10.2471/BLT.06.033829; ORTAYLI N, 2008, EXP GROUP M RED IN E; *UN, 2010, UN REV PROGR MILL DE; 2009, INT C FAM PLANN RES	6	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 14	2009	374	9702					1663	1664		10.1016/S0140-6736(09)61960-7	http://dx.doi.org/10.1016/S0140-6736(09)61960-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	522LP	19914503				2022-12-28	WOS:000271999700009
J	van den Broeke, M; Bamber, J; Ettema, J; Rignot, E; Schrama, E; van de Berg, WJ; van Meijgaard, E; Velicogna, I; Wouters, B				van den Broeke, Michiel; Bamber, Jonathan; Ettema, Janneke; Rignot, Eric; Schrama, Ernst; van de Berg, Willem Jan; van Meijgaard, Erik; Velicogna, Isabella; Wouters, Bert			Partitioning Recent Greenland Mass Loss	SCIENCE			English	Article							ICE-SHEET; MELT; ACCELERATION	Mass budget calculations, validated with satellite gravity observations [from the Gravity Recovery and Climate Experiment (GRACE) satellites], enable us to quantify the individual components of recent Greenland mass loss. The total 2000-2008 mass loss of similar to 1500 gigatons, equivalent to 0.46 millimeters per year of global sea level rise, is equally split between surface processes (runoff and precipitation) and ice dynamics. Without the moderating effects of increased snowfall and refreezing, post-1996 Greenland ice sheet mass losses would have been 100% higher. Since 2006, high summer melt rates have increased Greenland ice sheet mass loss to 273 gigatons per year (0.75 millimeters per year of equivalent sea level rise). The seasonal cycle in surface mass balance fully accounts for detrended GRACE mass variations, confirming insignificant subannual variation in ice sheet discharge.	[van den Broeke, Michiel; Ettema, Janneke; van de Berg, Willem Jan] Univ Utrecht, Inst Marine & Atmospher Res, NL-3508 TC Utrecht, Netherlands; [Bamber, Jonathan] Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol, Avon, England; [Rignot, Eric; Velicogna, Isabella] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Rignot, Eric; Velicogna, Isabella] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Schrama, Ernst; Wouters, Bert] Delft Univ Technol, Delft Inst Earth Observat & Space Syst, Delft, Netherlands; [van Meijgaard, Erik; Wouters, Bert] Royal Netherlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands	Utrecht University; University of Bristol; University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Delft University of Technology; Royal Netherlands Meteorological Institute	van den Broeke, M (corresponding author), Univ Utrecht, Inst Marine & Atmospher Res, NL-3508 TC Utrecht, Netherlands.	m.r.vandenbroeke@uu.nl	Rignot, Eric/A-4560-2014; Bamber, Jonathan/C-7608-2011; van de Berg, Willem Jan/H-4385-2011; Wouters, Bert/AAA-4254-2019; Wouters, Bert/A-5301-2017; Ettema, Janneke/F-7950-2010; Velicogna, Isabella/R-5561-2018; Van den Broeke, Michiel R./F-7867-2011	Rignot, Eric/0000-0002-3366-0481; Bamber, Jonathan/0000-0002-2280-2819; van de Berg, Willem Jan/0000-0002-8232-2040; Wouters, Bert/0000-0002-1086-2435; Wouters, Bert/0000-0002-1086-2435; Velicogna, Isabella/0000-0002-9020-1898; Van den Broeke, Michiel R./0000-0003-4662-7565; SCHRAMA, ERNST/0000-0002-9654-4082; Ettema, Janneke/0000-0002-8621-6624	Utrecht University; Netherlands Polar Program of the Netherlands Organization of Scientific Research (NWO/ALW) through the international RAPID project; UK Natural Environment Research Council [NE/C509474/1]; Royal Netherlands Meteorological Institute; Netherlands Institute for Space Research [SRON/EO-076]; NASA's Cryosphere Science Program; Natural Environment Research Council [NE/C51631X/1] Funding Source: researchfish	Utrecht University; Netherlands Polar Program of the Netherlands Organization of Scientific Research (NWO/ALW) through the international RAPID project(Netherlands Organization for Scientific Research (NWO)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Netherlands Meteorological Institute; Netherlands Institute for Space Research; NASA's Cryosphere Science Program(National Aeronautics & Space Administration (NASA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is funded by Utrecht University (M.v.d.B. and W.J.v.d.B.) and the Netherlands Polar Program of the Netherlands Organization of Scientific Research (NWO/ALW) through the international RAPID project (J.E.), UK Natural Environment Research Council grant NE/C509474/1 (J.L.B.), the Royal Netherlands Meteorological Institute ( E. v. M.), and Netherlands Institute for Space Research grant SRON/EO-076 ( B. W.). E. R. and I. V. performed their work at the University of California, Irvine, and Caltech's Jet Propulsion Laboratory under a contract with NASA's Cryosphere Science Program. Climate data are available from the RAPID data repository at the British Atmospheric Data Centre (badc.nerc.ac.uk).	Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Box JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025723; BOX JE, 2005, 8 INT C POL MET OC S; Cazenave A, 2006, SCIENCE, V314, P1250, DOI 10.1126/science.1133325; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; Hanna E, 2008, J CLIMATE, V21, P331, DOI 10.1175/2007JCLI1964.1; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; Howat IM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024737; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Krabill W, 1999, SCIENCE, V283, P1522, DOI 10.1126/science.283.5407.1522; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; Luckman A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022519; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019474; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035417; Slobbe DC, 2008, REMOTE SENS ENVIRON, V112, P4204, DOI 10.1016/j.rse.2008.07.004; Stearns LA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028982; Thomas R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026075; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	27	608	608	3	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					984	986		10.1126/science.1178176	http://dx.doi.org/10.1126/science.1178176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965509	Green Submitted			2022-12-28	WOS:000271712300037
J	Terret, ME; Sherwood, R; Rahman, S; Qin, J; Jallepalli, PV				Terret, Marie-Emilie; Sherwood, Rebecca; Rahman, Sadia; Qin, Jun; Jallepalli, Prasad V.			Cohesin acetylation speeds the replication fork	NATURE			English	Article							SISTER-CHROMATID COHESION; XENOPUS EGG EXTRACTS; HUMAN-CELLS; S-PHASE; SACCHAROMYCES-CEREVISIAE; ESTABLISHMENT; YEAST; CTCF; DNA; SENESCENCE	Cohesin not only links sister chromatids but also inhibits the transcriptional machinery's interaction with and movement along chromatin(1-6). In contrast, replication forks must traverse such cohesin-associated obstructions to duplicate the entire genome in S phase. How this occurs is unknown. Through single-molecule analysis, we demonstrate that the replication factor C (RFC)-CTF18 clamp loader (RFCCTF18)(1,7) controls the velocity, spacing and restart activity of replication forks in human cells and is required for robust acetylation of cohesin's SMC3 subunit and sister chromatid cohesion. Unexpectedly, we discovered that cohesin acetylation itself is a central determinant of fork processivity, as slow-moving replication forks were found in cells lacking the Eco1-related acetyltransferases ESCO1 or ESCO2 (refs 8 -10) (including those derived from Roberts' syndrome patients, in whom ESCO2 is biallelically mutated(11)) and in cells expressing a form of SMC3 that cannot be acetylated. This defect was a consequence of cohesin's hyperstable interaction with two regulatory cofactors, WAPL and PDS5A (refs 12, 13); removal of either cofactor allowed forks to progress rapidly without ESCO1, ESCO2, or RFCCTF18. Our results show a novel mechanism for clamp-loader-dependent fork progression, mediated by the post-translational modification and structural remodelling of the cohesin ring. Loss of this regulatory mechanism leads to the spontaneous accrual of DNA damage and may contribute to the abnormalities of the Roberts' syndrome cohesinopathy.	[Terret, Marie-Emilie; Sherwood, Rebecca; Rahman, Sadia; Jallepalli, Prasad V.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Qin, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Ctr Mol Discovery, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Baylor College of Medicine	Jallepalli, PV (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	jallepap@mskcc.org	TERRET, Marie-Emilie/R-5782-2017	TERRET, Marie-Emilie/0000-0001-5843-925X	National Institutes of Health; Pew Scholar in the Biochemical Sciences award; NATIONAL CANCER INSTITUTE [R01CA107342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in the Biochemical Sciences award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Galloway, J. Hurwitz, J. Petrini, H. Nakao and H. Zou for reagents, and S. Keeney, K. Marians and J. Petrini for discussions and reading of the manuscript. We thank A. Viale, M. Hassimi and the MSKCC Genomics Core Laboratory for assistance with microarray experiments. This work was supported by a grant from the National Institutes of Health and a Pew Scholar in the Biochemical Sciences award to P. V. J.	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	35	171	179	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					231	U106		10.1038/nature08550	http://dx.doi.org/10.1038/nature08550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907496	Green Accepted			2022-12-28	WOS:000271655100045
J	Crowley, S; Rollins, N; Shaffer, N; Guerma, T; Vitoria, M; Lo, YR				Crowley, Siobhan; Rollins, Nigel; Shaffer, Nathan; Guerma, Teguest; Vitoria, Marco; Lo, Ying-ru			New WHO HIV treatment and prevention guidelines	LANCET			English	Editorial Material									[Crowley, Siobhan; Shaffer, Nathan; Guerma, Teguest; Vitoria, Marco; Lo, Ying-ru] WHO, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland; [Rollins, Nigel] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland	World Health Organization; University of Geneva; World Health Organization	Crowley, S (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland.	crowleys@who.int						*GLOB HIV TREATM W, 2009, TREATM WHIT PAP; Severe P, 2009, 49 INT C ANT AG CHEM; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; *UN, 2001, DECL COMM HIV AIDS; *UNAIDS, 2009, 09 HIV EP UPD; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO, 2009, ANT THER HIV PREV; World Health Organization, ANT THER; 2008, BMJ, V336, P924	9	13	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					874	875		10.1016/S0140-6736(09)62064-X	http://dx.doi.org/10.1016/S0140-6736(09)62064-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	574NA	19954834				2022-12-28	WOS:000275995300008
J	Knebelmann, B; Kurschat, C; Thadhani, R				Knebelmann, Bertrand; Kurschat, Christine; Thadhani, Ravi			Enzyme therapy for Fabry's disease: registered for success?	LANCET			English	Editorial Material							REPLACEMENT THERAPY; AGALSIDASE-BETA; NEPHROPATHY; ALPHA		[Thadhani, Ravi] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit, Boston, MA 02144 USA; [Knebelmann, Bertrand] Paris Descartes Univ, Necker Hosp, AP HP, Paris, France; [Kurschat, Christine] Univ Hosp Cologne, Dept Nephrol, Cologne, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Cologne	Thadhani, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit, Boston, MA 02144 USA.	thadhani.r@mgh.harvard.edu						Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Linhart A, 2001, J INHERIT METAB DIS, V24, P75, DOI 10.1023/A:1012428009627; Mehta A, 2009, LANCET, V374, P1986, DOI 10.1016/S0140-6736(09)61493-8; Ortiz A, 2008, NAT CLIN PRACT NEPHR, V4, P327, DOI 10.1038/ncpneph0806; Pastores GM, 2001, LANCET, V358, P601, DOI 10.1016/S0140-6736(01)05816-0; Schicho J, 2007, APPL ALGEBR ENG COMM, V18, P1, DOI 10.1007/s00200-006-0022-9; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Tahir H, 2007, J AM SOC NEPHROL, V18, P2609, DOI 10.1681/ASN.2006121400; Thadhani R, 2002, KIDNEY INT, V61, P249, DOI 10.1046/j.1523-1755.2002.00097.x; Warnock DG, 2007, J AM SOC NEPHROL, V18, P1368, DOI 10.1681/ASN.2007030312; West M, 2009, J AM SOC NEPHROL, V20, P1132, DOI 10.1681/ASN.2008080870; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	14	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1950	1951		10.1016/S0140-6736(09)61838-9	http://dx.doi.org/10.1016/S0140-6736(09)61838-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EA	19959220				2022-12-28	WOS:000272727000006
J	Galiana, I; Green, C				Galiana, Isabel; Green, Christopher			Let the global technology race begin	NATURE			English	Editorial Material							ENERGY; STABILIZATION; EMISSION		[Galiana, Isabel; Green, Christopher] McGill Univ, Dept Econ, Montreal, PQ H3A 2T7, Canada	McGill University	Galiana, I (corresponding author), McGill Univ, Dept Econ, Montreal, PQ H3A 2T7, Canada.	isabel.galiana@mail.mcgill.ca; chris.green@mcgill.ca						Barrett AJ, 2009, LEUKEMIA, V23, P53, DOI 10.1038/leu.2008.273; Caldeira K, 2003, SCIENCE, V299, P2052, DOI 10.1126/science.1078938; Galiana I., 2009, ANAL TECHNOLOGY LED; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Nemet GF, 2009, RES POLICY, V38, P700, DOI 10.1016/j.respol.2009.01.004; Pielke R, 2008, NATURE, V452, P531, DOI 10.1038/452531a; Schlesinger ME, 2007, HUMAN-INDUCED CLIMATE CHANGE: AN INTERDISCIPLINARY ASSESSMENT, P1, DOI 10.1017/CBO9780511619472; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0	10	34	34	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					570	571		10.1038/462570a	http://dx.doi.org/10.1038/462570a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	526HH	19956241				2022-12-28	WOS:000272277900018
J	Seal, RP; Wang, XD; Guan, Y; Raja, SN; Woodbury, CJ; Basbaum, AI; Edwards, RH				Seal, Rebecca P.; Wang, Xidao; Guan, Yun; Raja, Srinivasa N.; Woodbury, C. Jeffery; Basbaum, Allan I.; Edwards, Robert H.			Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors	NATURE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; SPINAL DORSAL-HORN; SUBSTANTIA-GELATINOSA; SENSORY NEURONS; MICE LACKING; INFLAMMATORY PAIN; NEUROPATHIC PAIN; AFFERENT-FIBERS; MARGINAL ZONE; PKC-GAMMA	Mechanical pain contributes to the morbidity associated with inflammation and trauma, but primary sensory neurons that convey the sensation of acute and persistentmechanical pain have not been identified. Dorsal root ganglion (DRG) neurons transmit sensory information to the spinal cord using the excitatory transmitter glutamate(1), a process that depends on glutamate transport into synaptic vesicles for regulated exocytotic release. Here we report that a small subset of cells in the DRG expresses the low abundance vesicular glutamate transporter VGLUT3 (also known as SLC17A8). In the dorsal horn of the spinal cord, these afferents project to lamina I and the innermost layer of lamina II, which has previously been implicated in persistent pain caused by injury(2). Because the different VGLUT isoforms generally have a non-redundant pattern of expression(3), we used Vglut3 knockout mice to assess the role of VGLUT3(+) primary afferents in the behavioural response to somatosensory input. The loss of VGLUT3 specifically impairs mechanical pain sensation, and in particular the mechanical hypersensitivity to normally innocuous stimuli that accompanies inflammation, nerve injury and trauma. Direct recording from VGLUT3(+) neurons in the DRG further identifies them as a poorly understood population of unmyelinated, low threshold mechanoreceptors (C-LTMRs)(4,5). The analysis of Vglut3(-/-) mice now indicates a critical role for C-LTMRs in the mechanical hypersensitivity caused by injury.	[Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, San Francisco Sch Med, Dept Physiol, San Francisco, CA 94143 USA; [Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, San Francisco Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Wang, Xidao; Basbaum, Allan I.] Univ Calif San Francisco, San Francisco Sch Med, Dept Anat, San Francisco, CA 94158 USA; [Wang, Xidao; Basbaum, Allan I.] Univ Calif San Francisco, San Francisco Sch Med, Dept Physiol, San Francisco, CA 94158 USA; [Guan, Yun; Raja, Srinivasa N.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Woodbury, C. Jeffery] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University of Wyoming	Edwards, RH (corresponding author), Univ Calif San Francisco, San Francisco Sch Med, Dept Physiol, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu		Yang, Shuman/0000-0002-9638-0890; Seal, Rebecca/0000-0003-4955-703X	Johns Hopkins Blaustein Pain Research Fund; NARSAD; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712, F32MH068085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044094] Funding Source: NIH RePORTER	Johns Hopkins Blaustein Pain Research Fund; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Bautista, D. Julius and members of the Basbaum and Edwards laboratories for advice, and D. Woodbury and C. Cassidy from the Woodbury laboratory for help with experiments. The work was supported by the Johns Hopkins Blaustein Pain Research Fund (Y.G.) and by grants from NARSAD ( R. P. S., R. H. E.) and NIH ( R. P. S., Y. G., S. N. R., C. J. W., A. I. B. and R. H. E.).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Albers KM, 2006, J NEUROSCI, V26, P2981, DOI 10.1523/JNEUROSCI.4863-05.2006; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; Boada MD, 2008, J NEUROSCI, V28, P2006, DOI 10.1523/JNEUROSCI.5609-07.2008; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; CHUNG JM, 1979, J NEUROPHYSIOL, V42, P1354, DOI 10.1152/jn.1979.42.5.1354; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gras C, 2002, J NEUROSCI, V22, P5442; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; IGGO A, 1968, J PHYSL, V198; KAYSER V, 1987, PAIN, V28, P99, DOI 10.1016/0304-3959(87)91064-5; Li JL, 2003, J COMP NEUROL, V457, P236, DOI 10.1002/cne.10556; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Neumann S, 1996, NATURE, V384, P360, DOI 10.1038/384360a0; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; Schaible HG, 2002, ANN NY ACAD SCI, V966, P343, DOI 10.1111/j.1749-6632.2002.tb04234.x; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293	30	295	301	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					651	655		10.1038/nature08505	http://dx.doi.org/10.1038/nature08505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19915548	Green Accepted, Green Submitted			2022-12-28	WOS:000272277900041
J	Tavani, M; Bulgarelli, A; Piano, G; Sabatini, S; Striani, E; Evangelista, Y; Trois, A; Pooley, G; Trushkin, S; Nizhelskij, NA; McCollough, M; Koljonen, KII; Pucella, G; Giuliani, A; Chen, AW; Costa, E; Vittorini, V; Trifoglio, M; Gianotti, F; Argan, A; Barbiellini, G; Caraveo, P; Cattaneo, PW; Cocco, V; Contessi, T; D'Ammando, F; Del Monte, E; De Paris, G; Di Cocco, G; Di Persio, G; Donnarumma, I; Feroci, M; Ferrari, A; Fuschino, F; Galli, M; Labanti, C; Lapshov, I; Lazzarotto, F; Lipari, P; Longo, F; Mattaini, E; Marisaldi, M; Mastropietro, M; Mauri, A; Mereghetti, S; Morelli, E; Morselli, A; Pacciani, L; Pellizzoni, A; Perotti, F; Picozza, P; Pilia, M; Prest, M; Rapisarda, M; Rappoldi, A; Rossi, E; Rubini, A; Scalise, E; Soffitta, P; Vallazza, E; Vercellone, S; Zambra, A; Zanello, D; Pittori, C; Verrecchia, F; Giommi, P; Colafrancesco, S; Santolamazza, P; Antonelli, A; Salotti, L				Tavani, M.; Bulgarelli, A.; Piano, G.; Sabatini, S.; Striani, E.; Evangelista, Y.; Trois, A.; Pooley, G.; Trushkin, S.; Nizhelskij, N. A.; McCollough, M.; Koljonen, K. I. I.; Pucella, G.; Giuliani, A.; Chen, A. W.; Costa, E.; Vittorini, V.; Trifoglio, M.; Gianotti, F.; Argan, A.; Barbiellini, G.; Caraveo, P.; Cattaneo, P. W.; Cocco, V.; Contessi, T.; D'Ammando, F.; Del Monte, E.; De Paris, G.; Di Cocco, G.; Di Persio, G.; Donnarumma, I.; Feroci, M.; Ferrari, A.; Fuschino, F.; Galli, M.; Labanti, C.; Lapshov, I.; Lazzarotto, F.; Lipari, P.; Longo, F.; Mattaini, E.; Marisaldi, M.; Mastropietro, M.; Mauri, A.; Mereghetti, S.; Morelli, E.; Morselli, A.; Pacciani, L.; Pellizzoni, A.; Perotti, F.; Picozza, P.; Pilia, M.; Prest, M.; Rapisarda, M.; Rappoldi, A.; Rossi, E.; Rubini, A.; Scalise, E.; Soffitta, P.; Vallazza, E.; Vercellone, S.; Zambra, A.; Zanello, D.; Pittori, C.; Verrecchia, F.; Giommi, P.; Colafrancesco, S.; Santolamazza, P.; Antonelli, A.; Salotti, L.			Extreme particle acceleration in the microquasar Cygnus X-3	NATURE			English	Article							FALSE-DISCOVERY RATE; X-RAY; EMISSION-LINES; RADIO; JET	Super-massive black holes in active galaxies can accelerate particles to relativistic energies(1), producing jets with associated c-ray emission. Galactic 'microquasars', which are binary systems consisting of a neutron star or stellar-mass black hole accreting gas from a companion star, also produce relativistic jets, generally together with radio flares(2). Apart from an isolated event detected(3) in Cygnus X-1, there has hitherto been no systematic evidence for the acceleration of particles to gigaelectronvolt or higher energies in a microquasar, with the consequence that we are as yet unsure about the mechanism of jet energization. Here we report four gamma-ray flares with energies above 100 MeV from the microquasar Cygnus X-3 (an exceptional X-ray binary(4-6) that sporadically produces radio jets(7-9)). There is a clear pattern of temporal correlations between the c-ray flares and transitional spectral states of the radio-frequency and X-ray emission. Particle acceleration occurred a few days before radio-jet ejections for two of the four flares, meaning that the process of jet formation implies the production of very energetic particles. In Cygnus X-3, particle energies during the flares can be thousands of times higher than during quiescent states.	[Tavani, M.; Piano, G.; Evangelista, Y.; Trois, A.; Costa, E.; Vittorini, V.; Argan, A.; D'Ammando, F.; Del Monte, E.; De Paris, G.; Di Persio, G.; Donnarumma, I.; Feroci, M.; Lazzarotto, F.; Pacciani, L.; Rubini, A.; Scalise, E.; Soffitta, P.] INAF IASF Roma, I-00133 Rome, Italy; [Tavani, M.; Sabatini, S.; Striani, E.; Cocco, V.; D'Ammando, F.; Picozza, P.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Tavani, M.; Chen, A. W.; Vittorini, V.; Barbiellini, G.; Ferrari, A.; Zambra, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Tavani, M.; Piano, G.; Sabatini, S.; Striani, E.; Morselli, A.; Picozza, P.] INFN Roma Tor Vergata, I-00133 Rome, Italy; [Bulgarelli, A.; Trifoglio, M.; Gianotti, F.; Di Cocco, G.; Fuschino, F.; Labanti, C.; Marisaldi, M.; Mauri, A.; Morelli, E.] INAF IASF Bologna, I-40129 Bologna, Italy; [Pooley, G.] Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England; [Trushkin, S.; Nizhelskij, N. A.] RAS, Special Astrophys Observ, Nizhnii Arkhyz 36916, Russia; [McCollough, M.] Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Koljonen, K. I. I.] TKK Metsahovi Radio Observ, Kylmala 02540, Finland; [Pucella, G.; Rapisarda, M.] ENEA Frascati, I-00044 Frascati, RM, Italy; [Giuliani, A.; Chen, A. W.; Caraveo, P.; Contessi, T.; Mereghetti, S.; Perotti, F.; Zambra, A.] INAF IASF Milano, I-20133 Milan, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.; Vallazza, E.] INFN Trieste, I-34012 Trieste, Italy; [Cattaneo, P. W.; Rappoldi, A.] INFN Pavia, I-27100 Pavia, Italy; [Ferrari, A.] Univ Turin, Dipartimento Fis, I-10125 Turin, Italy; [Galli, M.] ENEA Bologna, I-40128 Bologna, Italy; [Lapshov, I.] IKI, Moscow 117997, Russia; [Lipari, P.; Zanello, D.] INFN Roma 1, I-00185 Rome, Italy; [Lipari, P.; Zanello, D.] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Mastropietro, M.] CNR, IMIP, I-00016 Rome, Italy; [Pellizzoni, A.; Pilia, M.] INAF Osservatorio Astron Cagliari, I-09012 Cagliari, Italy; [Pilia, M.; Prest, M.] Univ Insubria, Dipartimento Fis, I-22100 Como, Italy; [Vercellone, S.] INAF IASF Palermo, I-90146 Palermo, Italy; [Pittori, C.; Verrecchia, F.; Giommi, P.; Colafrancesco, S.; Santolamazza, P.] ESRIN, ASI Sci Data Ctr, I-00044 Frascati, Italy; [Antonelli, A.] Osserv Astron Roma, I-00040 Monte Porzio Catone, Italy; [Salotti, L.] Agenzia Spaziale Italiana, I-00198 Rome, Italy	Istituto Nazionale Astrofisica (INAF); University of Rome Tor Vergata; University of Rome Tor Vergata; Istituto Nazionale Astrofisica (INAF); University of Cambridge; Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; Smithsonian Institution; Aalto University; Italian National Agency New Technical Energy & Sustainable Economics Development; Istituto Nazionale Astrofisica (INAF); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia; University of Turin; Italian National Agency New Technical Energy & Sustainable Economics Development; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); University of Insubria; Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); European Space Agency; Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI)	Tavani, M (corresponding author), INAF IASF Roma, Via Fosso Cavaliere 100, I-00133 Rome, Italy.	pi.agile@iasf-roma.inaf.it	Pittori, Carlotta/C-7710-2016; Trushkin, Sergei Anatol'evich/AAM-3444-2021; Vercellone, Stefano/ABC-7250-2020; Vallazza, Erik Silvio/V-1732-2017; Caraveo, Patrizia/AAL-5708-2020; Lazzarotto, Francesco/J-4670-2012; Prest, Michela/V-1736-2017; Cattaneo, Paolo Walter/AAG-9097-2020; Chen, Andrew/AAC-3979-2020; Trushkin, Sergei A/I-6384-2017; Trifoglio, Massimo/F-5302-2015; cattaneo, Paolo/AAC-4200-2021; Morselli, Aldo/G-6769-2011; Lazzarotto, Francesco/R-4124-2019; Soffitta, Paolo/AAA-7514-2021; giommi, paolo/L-1006-2018	Pittori, Carlotta/0000-0001-6661-9779; Vercellone, Stefano/0000-0003-1163-1396; Vallazza, Erik Silvio/0000-0002-7465-7430; Caraveo, Patrizia/0000-0003-2478-8018; Lazzarotto, Francesco/0000-0003-4871-4072; Prest, Michela/0000-0003-3161-4454; Cattaneo, Paolo Walter/0000-0001-6877-6882; Trushkin, Sergei A/0000-0002-7586-5856; Trifoglio, Massimo/0000-0002-2505-3630; Morselli, Aldo/0000-0002-7704-9553; Soffitta, Paolo/0000-0002-7781-4104; Pacciani, Luigi/0000-0001-6897-5996; Evangelista, Yuri/0000-0001-6096-6710; Labanti, Claudio/0000-0002-5086-3619; Gianotti, Fulvio/0000-0003-4666-119X; vittorini, valerio/0000-0002-1208-8818; Costa, Enrico/0000-0003-4925-8523; Feroci, Marco/0000-0002-7617-3421; Rappoldi, Andrea/0000-0001-9702-7645; Picozza, Piergiorgio/0000-0002-7986-3321; Koljonen, Karri/0000-0002-9677-1533; Nizhel'skij, Nikolay/0000-0002-6419-7223; Pilia, Maura/0000-0001-7397-8091; Argan, Andrea/0000-0002-6230-665X; Sabatini, Sabina/0000-0003-2076-5767; Verrecchia, Francesco/0000-0003-3455-5082; galli, marcello/0000-0002-9135-3228; Del Monte, Ettore/0000-0002-3013-6334; Giuliani, Andrea/0000-0002-4315-1699; Antonelli, Lucio Angelo/0000-0002-5037-9034; MEREGHETTI, SANDRO/0000-0003-3259-7801; giommi, paolo/0000-0002-2265-5003; Bulgarelli, Andrea/0000-0001-6347-0649; trois, alessio/0000-0002-3180-6002; Tavani, Marco/0000-0003-2893-1459; Piano, Giovanni/0000-0002-9332-5319; Marisaldi, Martino/0000-0002-4000-3789; Pellizzoni, Alberto Paolo/0000-0002-4590-0040; Chen, Andrew/0000-0001-6425-5692; Fuschino, Fabio/0000-0003-2139-3299; D'Ammando, Filippo/0000-0001-7618-7527; Donnarumma, Immacolata/0000-0002-4700-4549; Scalise, Emanuele/0000-0002-3058-9720	Italian Institute of Astrophysics and the Italian Institute of Nuclear Physics	Italian Institute of Astrophysics and the Italian Institute of Nuclear Physics	The AGILE mission is funded by the Italian Space Agency with scientific and programmatic participation by the Italian Institute of Astrophysics and the Italian Institute of Nuclear Physics.	Abdo AA, 2009, SCIENCE, V325, P840, DOI 10.1126/science.1175558; Albert J, 2007, ASTROPHYS J, V665, pL51, DOI 10.1086/521145; Atoyan AM, 1999, MON NOT R ASTRON SOC, V302, P253, DOI 10.1046/j.1365-8711.1999.02172.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONNETBIDAUD JM, 1988, PHYS REP, V170, P325, DOI 10.1016/0370-1573(88)90083-X; Coppi PS, 1999, ASTR SOC P, V161, P375; GIACCONI R, 1967, ASTROPHYS J, V148, pL119, DOI 10.1086/180028; GIULIANI A, 2004, MEM SAIT S, V5, P135; Hjalmarsdotter L, 2009, MON NOT R ASTRON SOC, V392, P251, DOI 10.1111/j.1365-2966.2008.14036.x; Krolik J.H., 1998, ACTIVE GALACTIC NUCL; Markoff S, 2001, ASTRON ASTROPHYS, V372, pL25, DOI 10.1051/0004-6361:20010420; Marti J, 2000, ASTROPHYS J, V545, P939, DOI 10.1086/317858; McCollough ML, 1999, ASTROPHYS J, V517, P951, DOI 10.1086/307241; Miller CJ, 2001, ASTRON J, V122, P3492, DOI 10.1086/324109; Mioduszewski AJ, 2001, ASTROPHYS J, V553, P766, DOI 10.1086/320965; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; PAL S, 2008, ASTRON TELEGR, V1486; POOLEY G, 2008, ASTRON TELEGR, V1828; Romero GE, 2003, ASTRON ASTROPHYS, V410, pL1, DOI [10.1051/0004-6361:20031314-1, 10.1051/0004-6361:20031314]; Szostek A, 2008, MON NOT R ASTRON SOC, V388, P1001, DOI 10.1111/j.1365-2966.2008.13479.x; Tavani M, 2009, ASTRON ASTROPHYS, V502, P995, DOI 10.1051/0004-6361/200810527; TRUSHKIN S, 2008, ASTRON TELEGR, V1483; VANKERKWIJK MH, 1992, NATURE, V355, P703, DOI 10.1038/355703a0; Vilhu O, 2009, ASTRON ASTROPHYS, V501, P679, DOI 10.1051/0004-6361/200811293; WALTMAN EB, 1994, ASTRON J, V108, P179, DOI 10.1086/117056; Zdziarski AA, 2004, PROG THEOR PHYS SUPP, P99	26	148	149	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					620	623		10.1038/nature08578	http://dx.doi.org/10.1038/nature08578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19935645	Green Accepted			2022-12-28	WOS:000272277900034
J	Vincent, JL; Rello, J; Marshall, J; Silva, E; Anzueto, A; Martin, CD; Moreno, R; Lipman, J; Gomersall, C; Sakr, Y; Reinhart, K				Vincent, Jean-Louis; Rello, Jordi; Marshall, John; Silva, Eliezer; Anzueto, Antonio; Martin, Claude D.; Moreno, Rui; Lipman, Jeffrey; Gomersall, Charles; Sakr, Yasser; Reinhart, Konrad		EPIC II Grp Investigators	International Study of the Prevalence and Outcomes of Infection in Intensive Care Units	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE SEPSIS; ACINETOBACTER-BAUMANNII; EUROPEAN PREVALENCE; EPIDEMIOLOGY; MORTALITY; ENGLAND; WALES; SCORE	Context Infection is a major cause of morbidity and mortality in intensive care units (ICUs) worldwide. However, relatively little information is available about the global epidemiology of such infections. Objective To provide an up-to-date, international picture of the extent and patterns of infection in ICUs. Design, Setting, and Patients The Extended Prevalence of Infection in Intensive Care (EPIC II) study, a 1-day, prospective, point prevalence study with follow-up conducted on May 8, 2007. Demographic, physiological, bacteriological, therapeutic, and outcome data were collected for 14 414 patients in 1265 participating ICUs from 75 countries on the study day. Analyses focused on the data from the 13 796 adult (>18 years) patients. Results On the day of the study, 7087 of 13 796 patients (51%) were considered infected; 9084 (71%) were receiving antibiotics. The infection was of respiratory origin in 4503 (64%), and microbiological culture results were positive in 4947 (70%) of the infected patients; 62% of the positive isolates were gram-negative organisms, 47% were gram-positive, and 19% were fungi. Patients who had longer ICU stays prior to the study day had higher rates of infection, especially infections due to resistant staphylococci, Acinetobacter, Pseudomonas species, and Candida species. The ICU mortality rate of infected patients was more than twice that of noninfected patients (25% [1688/6659] vs 11% [682/6352], respectively; P < .001), as was the hospital mortality rate (33% [2201/6659] vs 15% [942/6352], respectively; P < .001) (adjusted odds ratio for risk of hospital mortality, 1.51; 95% confidence interval, 1.36-1.68; P < .001). Conclusions Infections are common in patients in contemporary ICUs, and risk of infection increases with duration of ICU stay. In this large cohort, infection was independently associated with an increased risk of hospital death. JAMA. 2009;302(21):2323-2329	[Vincent, Jean-Louis] Univ Libre Bruxelles, Dept Intens Care, Erasme Hosp, Brussels, Belgium; [Rello, Jordi] URV IISPV Tarragona, CIBERes, Joan XXIII Univ Hosp, Crit Care Dept, Tarragona, Spain; [Marshall, John] Univ Toronto, St Michaels Hosp, Interdepartmental Div Care Med, Dept Surg, Toronto, ON M5B 1W8, Canada; [Silva, Eliezer] Hosp Israelita Albert Einstein, Dept Intens Care, Sao Paulo, Brazil; [Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, Dept Pulm Crit Care, San Antonio, TX 78229 USA; [Martin, Claude D.] Hop Nord Marseille, Dept Anesthesiol & Intens Care, Marseille, France; [Moreno, Rui] EPE, Ctr Hosp Lisboa Cent, Hosp St Antonio dos Capuchos, Dept Intens Care, Lisbon, Portugal; [Lipman, Jeffrey] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Gomersall, Charles] Chinese Univ Hong Kong, Dept Anesthesia & Intens Care, Shatin, Hong Kong, Peoples R China; [Gomersall, Charles] Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Sakr, Yasser; Reinhart, Konrad] Univ Jena, Dept Anesthesiol & Intens Care, Jena, Germany	Universite Libre de Bruxelles; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Hospital Israelita Albert Einstein; University of Texas System; University of Texas Health San Antonio; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; University of Queensland; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Friedrich Schiller University of Jena	Vincent, JL (corresponding author), Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be	Gomersall, Charles D/J-1540-2012; Sakr, Yasser/D-9802-2013; Rello, Jordi/P-2402-2019; Lage, Silvia HG/D-4068-2012; Van Haren, Frank/G-1335-2015; Lipman, Jeffrey/G-2211-2010; Monedero, Pablo/A-1696-2008; Sierra, Rafael/I-3441-2015	Gomersall, Charles D/0000-0002-8494-8063; Rello, Jordi/0000-0003-0676-6210; Lage, Silvia HG/0000-0003-2870-6999; Van Haren, Frank/0000-0001-8037-4229; Lipman, Jeffrey/0000-0002-5965-9876; Monedero, Pablo/0000-0002-1596-5644; Sierra, Rafael/0000-0002-6021-396X; Breen, Dorothy/0000-0001-5010-4017; Micallef, Sharon/0000-0002-8496-2324; Vincent, Jean-Louis/0000-0001-6011-6951; /0000-0002-4157-5148				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barchitta M, 2009, INT J HYG ENVIR HEAL, V212, P330, DOI 10.1016/j.ijheh.2008.07.001; Beardsley JR, 2006, CHEST, V130, P787, DOI 10.1378/chest.130.3.787; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; HARTSTEIN AI, 1988, AM J MED, V85, P624, DOI 10.1016/S0002-9343(88)80233-X; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2008, INTENS CARE MED, V34, P496, DOI 10.1007/s00134-007-0943-1; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Spencer RC, 1996, EUR J CLIN MICROBIOL, V15, P281, DOI 10.1007/BF01695658; Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80; van Gestel A, 2004, CRIT CARE, V8, pR153, DOI 10.1186/cc2858; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vincent JL, 2002, CRIT CARE, V6, pS1, DOI 10.1186/cc1860; Weycker D, 2003, CRIT CARE MED, V31, P2316, DOI 10.1097/01.CCM.0000085178.80226.0B; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Zahorec R, 2005, INFECTION, V33, P122, DOI 10.1007/s15010-005-4019-2	31	2135	2283	9	156	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2323	2329		10.1001/jama.2009.1754	http://dx.doi.org/10.1001/jama.2009.1754			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952319	Bronze, Green Submitted			2022-12-28	WOS:000272239000020
J	Shapiro, L; McAdams, HH; Losick, R				Shapiro, L.; McAdams, H. H.; Losick, R.			Why and How Bacteria Localize Proteins	SCIENCE			English	Review							CELL-CYCLE PROGRESSION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CHROMOSOME SEGREGATION; POLAR LOCALIZATION; SUBCELLULAR-LOCALIZATION; CHEMOTAXIS RECEPTOR; PROTEASE COMPLEX; DNA REPLICATION; VIBRIO-CHOLERAE	Despite their small size, bacteria have a remarkably intricate internal organization. Bacteria deploy proteins and protein complexes to particular locations and do so in a dynamic manner in lockstep with the organized deployment of their chromosome. The dynamic subcellular localization of protein complexes is an integral feature of regulatory processes of bacterial cells.	[Shapiro, L.; McAdams, H. H.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Losick, R.] Harvard Univ, BioLabs, Cambridge, MA 02138 USA	Stanford University; Harvard University	Shapiro, L (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	shapiro@stanford.edu			NIH [GM51426, GM325062, GM07311, GM18568]; U.S. Department of Energy Office of Science [DE-FG02-05ER64136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM51426 and GM325062 (L. S.), NIH grant GM07311 (H. H. M. and L. S.), U.S. Department of Energy Office of Science grant DE-FG02-05ER64136 (H. H. M. and L. S.), and NIH grant GM18568 (R. L.).	ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Ames P, 2006, P NATL ACAD SCI USA, V103, P9292, DOI 10.1073/pnas.0602135103; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Briegel A, 2008, MOL MICROBIOL, V69, P30, DOI 10.1111/j.1365-2958.2008.06219.x; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Kain J, 2008, J BACTERIOL, V190, P6749, DOI 10.1128/JB.00589-08; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kobayashi H, 2009, MOL MICROBIOL, V73, P586, DOI 10.1111/j.1365-2958.2009.06794.x; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; MADDOCK JR, 1993, SCIENCE, V259, P1717; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Niki H, 2000, GENE DEV, V14, P212; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; Sun Q, 2004, J BACTERIOL, V186, P3951, DOI 10.1128/JB.186.12.3951-3959.2004; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; WU LJ, 1940, EMBO J, V28, P2009; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104	49	204	205	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1225	1228		10.1126/science.1175685	http://dx.doi.org/10.1126/science.1175685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965466	Green Accepted			2022-12-28	WOS:000272117900037
J	Smith, DP; King, MT; Egger, S; Berry, MP; Stricker, PD; Cozzi, P; Ward, J; O'Connell, DL; Armstrong, BK				Smith, David P.; King, Madeleine T.; Egger, Sam; Berry, Martin P.; Stricker, Phillip D.; Cozzi, Paul; Ward, Jeanette; O'Connell, Dianne L.; Armstrong, Bruce K.			Quality of life three years after diagnosis of localised prostate cancer: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RADICAL PROSTATECTOMY; HEALTH; OUTCOMES; URINARY; MEN; RECALL	Objective To quantify the risk and severity of negative effects of treatment for localised prostate cancer on long term quality of life. Design Population based, prospective cohort study with follow-up over three years. Setting New South Wales, Australia. Participants Men with localised prostate cancer were eligible if aged less than 70 years, diagnosed between October 2000 and October 2002, and notified to the New South Wales central cancer registry. Controls were randomly selected from the New South Wales electoral roll and matched to cases by age and postcode. Main outcome measures General health specific and disease specific function up to three years after diagnosis, according to the 12 item short form health survey and the University of California, Los Angeles prostate cancer index. Results 1642 (64%) cases and 495 (63%) eligible and contacted controls took part in the study. After adjustment for confounders, all active treatment groups had low odds of having better sexual function than controls, in particular men on androgen deprivation therapy ( adjusted odds ratio ( OR) 0.02, 95% CI 0.01 to 0.07). Men treated surgically reported the worst urinary function ( adjusted OR 0.17, 95% CI 0.13 to 0.22). Bowel function was poorest in cases who had external beam radiotherapy (adjusted OR 0.44, 95% CI 0.30 to 0.64). General physical and mental health scores were similar across treatment groups, but poorest in men who had androgen deprivation therapy. Conclusions The various treatments for localised prostate cancer each have persistent effects on quality of life. Sexual dysfunction three years after diagnosis was common in all treatment groups, whereas poor urinary function was less common. Bowel function was most compromised in those who had external beam radiotherapy. Men with prostate cancer and the clinicians who treat them should be aware of the effects of treatment on quality of life, and weigh them up against the patient's age and the risk of progression of prostate cancer if untreated to make informed decisions about treatment.	[Smith, David P.; Egger, Sam; O'Connell, Dianne L.] NSW Canc Council, Kings Cross, NSW 1340, Australia; [King, Madeleine T.] Univ Sydney, PoCoG, Qual Life Off, Sydney, NSW 2006, Australia; [Berry, Martin P.] Liverpool Canc Therapy Ctr, Canc Serv, Liverpool, NSW 2170, Australia; [Stricker, Phillip D.] St Vincents Clin, St Vincents Prostate Canc Ctr, Darlinghurst, NSW 2010, Australia; [Cozzi, Paul] St George Hosp, Dept Urol, Kogarah, NSW 2217, Australia; [Ward, Jeanette] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Armstrong, Bruce K.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	Cancer Council New South Wales; University of Sydney; St George Hospital; University of Ottawa; University of Sydney	Smith, DP (corresponding author), NSW Canc Council, Kings Cross, NSW 1340, Australia.	dsmith@nswcc.org.au	Armstrong, Bruce K/K-9464-2015	Armstrong, Bruce K/0000-0001-8940-7525; Stricker, Phillip/0000-0002-0934-0656; Egger, Sam/0000-0003-1808-6909; Smith, David/0000-0002-1474-3214	Australian Commonwealth Department of Veterans Affairs; National Health and Medical Research Council of Australia [387700]; University of Sydney Medical Foundation	Australian Commonwealth Department of Veterans Affairs; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Medical Foundation(University of Sydney)	This research was funded by grants from the Australian Commonwealth Department of Veterans Affairs and project grant 387700 from the National Health and Medical Research Council of Australia. BKA is supported by a University of Sydney Medical Foundation Program Grant. The funder had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of data; the writing of the manuscript; or the decision to submit the manuscript for publication.	*AIHW, 2007, ACIM AUSTR CANC INC; Arredondo SA, 2004, J UROLOGY, V172, P1830, DOI 10.1097/01.ju.0000140758.04424.77; *AUSTR BUR STAT, 2004, 81593 AUSTR BUR STAT; *AUSTR CANC NETW W, 2002, CLIN PRACT GUID EV B; Australian Bureau of Statistics, 1997, NAT HLTH SURV SF 36; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Eton DT, 2002, PSYCHO-ONCOL, V11, P307, DOI 10.1002/pon.572; Hoffman RM, 2004, CANCER, V101, P2011, DOI 10.1002/cncr.20608; Johnson TK, 2004, J CLIN ONCOL, V22, P4193, DOI 10.1200/JCO.2004.09.127; Korfage IJ, 2005, INT J CANCER, V116, P291, DOI 10.1002/ijc.21043; Legler J, 2000, MED CARE, V38, P847, DOI 10.1097/00005650-200008000-00008; Litwin MS, 1999, J CLIN ONCOL, V17, P2882, DOI 10.1200/JCO.1999.17.9.2882; Litwin MS, 1998, J UROLOGY, V159, P1988, DOI 10.1016/S0022-5347(01)63222-1; LITWIN MS, 2002, RAND 12 ITEM HLTH SU; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mols F, 2006, CANCER-AM CANCER SOC, V107, P2186, DOI 10.1002/cncr.22231; Penson DF, 2007, CANCER J, V13, P318, DOI 10.1097/PPO.0b013e3181570121; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Penson DF, 2003, J CLIN ONCOL, V21, P1147, DOI 10.1200/JCO.2003.07.139; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; Rabbani F, 2000, J UROLOGY, V164, P1929, DOI 10.1016/S0022-5347(05)66921-2; Ries LAG, 2007, SEER CANC STAT REV 1; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schwartz CE, 2000, ADAPTATION CHANGING; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Tracey E, 2007, CANC NEW S WALES INC; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Walsh PC, 2000, UROLOGY, V55, P58, DOI 10.1016/S0090-4295(99)00397-0; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Wei J T, 2000, Semin Urol Oncol, V18, P76; Wilt T, 2008, COMP EFFECTIVENESS T; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Zeliadt SB, 2007, MED CARE, V45, P154, DOI 10.1097/01.mlr.0000241044.09778.3f	39	190	190	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2009	339								b4817	10.1136/bmj.b4817	http://dx.doi.org/10.1136/bmj.b4817			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525AX	19945997	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000272186600001
J	Ferraro, FR; Dalessandro, E; Mucciarelli, A; Beccari, G; Rich, RM; Origlia, L; Lanzoni, B; Rood, RT; Valenti, E; Bellazzini, M; Ransom, SM; Cocozza, G				Ferraro, F. R.; Dalessandro, E.; Mucciarelli, A.; Beccari, G.; Rich, R. M.; Origlia, L.; Lanzoni, B.; Rood, R. T.; Valenti, E.; Bellazzini, M.; Ransom, S. M.; Cocozza, G.			The cluster Terzan 5 as a remnant of a primordial building block of the Galactic bulge	NATURE			English	Article							HST NICMOS PHOTOMETRY; GLOBULAR-CLUSTERS; OMEGA-CENTAURI; RELATIVE AGES; GIANT BRANCH; MILKY-WAY; POPULATION; SAGITTARIUS; TELESCOPE; GRADIENTS	Globular star clusters are compact and massive stellar systems old enough to have witnessed the entire history of our Galaxy, the Milky Way. Although recent results(1-3) suggest that their formation may have been more complex than previously thought, they still are the best approximation to a stellar population formed over a relatively short timescale (less than 1 Gyr) and with virtually no dispersion in the iron content. Indeed, only one cluster-like system (omega Centauri) in the Galactic halo is known to have multiple stellar populations with a significant spread in iron abundance and age(4,5). Similar findings in the Galactic bulge have been hampered by the obscuration arising from thick and varying layers of interstellar dust. Here we report that Terzan 5, a globular-cluster-like system in the Galactic bulge, has two stellar populations with different iron contents and ages. Terzan 5 could be the surviving remnant of one of the primordial building blocks that are thought to merge and form galaxy bulges.	[Ferraro, F. R.; Dalessandro, E.; Mucciarelli, A.; Lanzoni, B.] Univ Bologna, Dept Astron, I-40127 Bologna, Italy; [Beccari, G.] ESA, Dept Space Sci, NL-2200 AG Noordwijk, Netherlands; [Rich, R. M.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Origlia, L.; Bellazzini, M.; Cocozza, G.] INAF Osservatorio Astron Bologna, I-40127 Bologna, Italy; [Rood, R. T.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Valenti, E.] European So Observ, Santiago 19, Chile; [Valenti, E.] Pontificia Univ Catolica Chile, Dept Astron, Santiago 7820436, Chile; [Ransom, S. M.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA	University of Bologna; University of California System; University of California Los Angeles; Istituto Nazionale Astrofisica (INAF); University of Virginia; European Southern Observatory; Pontificia Universidad Catolica de Chile; National Radio Astronomy Observatory (NRAO)	Ferraro, FR (corresponding author), Univ Bologna, Dept Astron, Via Ranzani 1, I-40127 Bologna, Italy.	francesco.ferraro3@unibo.it	ORIGLIA, LIVIA/O-9883-2015; Bellazzini, Michele/O-9373-2015; mucciarelli, alessio/ABG-9282-2020; ORIGLIA, LIVIA/AAJ-8351-2020	ORIGLIA, LIVIA/0000-0002-6040-5849; Bellazzini, Michele/0000-0001-8200-810X; ORIGLIA, LIVIA/0000-0002-6040-5849; Mucciarelli, Alessio/0000-0001-9158-8580; Beccari, Giacomo/0000-0002-3865-9906; Dalessandro, Emanuele/0000-0003-4237-4601; Valenti, Elena/0000-0002-6092-7145; Ransom, Scott/0000-0001-5799-9714	"Progetti Strategici di Ateneo 2006'' (University of Bologna); "Progetti di Ricerca di Interesse Nazionale; Agenzia Spaziale Italiana; Ministero dell'Istruzione; dell'Universita e della Ricerca; ESTEC; NSF; STScI; W. M. Keck Foundation	"Progetti Strategici di Ateneo 2006'' (University of Bologna); "Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); ESTEC; NSF(National Science Foundation (NSF)); STScI(Space Telescope Science Institute); W. M. Keck Foundation(W.M. Keck Foundation)	We thank the MAD team at ESO and in particular P. D'Amico for performing the observations with MAD. This research was supported by "Progetti Strategici di Ateneo 2006'' (University of Bologna), "Progetti di Ricerca di Interesse Nazionale 2007 and 2008'' (Istituto Nazionale di Astrofisica), Agenzia Spaziale Italiana, and the Ministero dell'Istruzione, dell'Universita e della Ricerca. We also acknowledge support from the ESTEC Faculty Visiting Scientist Programme. R. M. R. is supported by the NSF and STScI; and R. T. R. is partially supported by STScI. This research has made use of the ESO/ST-ECF Science Archive facility, which is a joint collaboration of the ESO and the Space Telescope European Coordinating Facility. Part of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The Observatory was made possible by the financial support of the W. M. Keck Foundation.	Beccari G, 2006, ASTROPHYS J, V652, pL121, DOI 10.1086/510019; Bellazzini M, 2008, ASTRON J, V136, P1147, DOI 10.1088/0004-6256/136/3/1147; Belokurov V, 2007, ASTROPHYS J, V654, P897, DOI 10.1086/509718; Cohn HN, 2002, ASTROPHYS J, V571, P818, DOI 10.1086/339874; Gratton R, 2004, ANNU REV ASTRON ASTR, V42, P385, DOI 10.1146/annurev.astro.42.053102.133945; Harbeck D, 2001, ASTRON J, V122, P3092, DOI 10.1086/324232; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; Hurley-Keller D, 2001, ASTR SOC P, V245, P322; IBATA RA, 1994, NATURE, V370, P194, DOI 10.1038/370194a0; ICKE V, 1988, ASTRON ASTROPHYS, V204, P115; Immeli A, 2004, ASTRON ASTROPHYS, V413, P547, DOI 10.1051/0004-6361:20034282; Lanzoni B, 2007, ASTROPHYS J, V668, pL139, DOI 10.1086/522927; Marchetti E., 2007, MESSENGER, V129, P8; Marin-Franch A, 2009, ASTROPHYS J, V694, P1498, DOI 10.1088/0004-637X/694/2/1498; McLean IS, 1998, P SOC PHOTO-OPT INS, V3354, P566, DOI 10.1117/12.317283; NORRIS JE, 1995, ASTROPHYS J, V447, P680, DOI 10.1086/175909; Origlia L, 2004, ASTRON J, V127, P3422, DOI 10.1086/420704; Ortolani S, 2007, ASTRON ASTROPHYS, V470, P1043, DOI 10.1051/0004-6361:20066628; Ortolani S, 2001, ASTRON ASTROPHYS, V376, P878, DOI 10.1051/0004-6361:20011045; Ortolani S, 1996, ASTRON ASTROPHYS, V308, P733; Pietrinferni A, 2004, ASTROPHYS J, V612, P168, DOI 10.1086/422498; Piotto G, 1999, ASTRON J, V118, P1727, DOI 10.1086/301031; Piotto G, 2009, IAU SYMP P SERIES, P233, DOI 10.1017/S1743921309031883; Sollima A, 2005, ASTROPHYS J, V634, P332, DOI 10.1086/496945; Valenti E, 2007, ASTRON J, V133, P1287, DOI 10.1086/511271	25	190	190	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 26	2009	462	7272					483	486		10.1038/nature08581	http://dx.doi.org/10.1038/nature08581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940920	Green Submitted			2022-12-28	WOS:000272144200038
J	McLean, SAM				McLean, Sheila A. M.			Ethical debate Are advance directives legally binding or simply the starting point for discussion on patients' best interests? Ethical view	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, Ctr Appl Eth & Legal Philosophy, Glasgow G12 8GE, Lanark, Scotland	University of Glasgow	McLean, SAM (corresponding author), Univ Glasgow, Ctr Appl Eth & Legal Philosophy, Glasgow G12 8GE, Lanark, Scotland.	s.mclean@lbss.gla.ac.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2009	339								b4695	10.1136/bmj.b4695	http://dx.doi.org/10.1136/bmj.b4695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AW	19942669				2022-12-28	WOS:000272186500010
J	Hergott, LJ				Hergott, Lawrence J.			Feeding the Turkey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lhergott@comcast.net						Hergott LJ, 2009, ANN INTERN MED, V151, P753	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2188	2189		10.1001/jama.2009.1586	http://dx.doi.org/10.1001/jama.2009.1586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934409				2022-12-28	WOS:000272080500001
J	Hollands, H; Johnson, D; Brox, AC; Almeida, D; Simel, DL; Sharma, S				Hollands, Hussein; Johnson, Davin; Brox, Anya C.; Almeida, David; Simel, David L.; Sharma, Sanjay			Acute-Onset Floaters and Flashes Is This Patient at Risk for Retinal Detachment?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTERIOR VITREOUS DETACHMENT; NATURAL-HISTORY; EPIDEMIOLOGY; COMPLICATIONS; BREAKS; PREVALENCE; MINNESOTA; SYMPTOMS; PIGMENT; CHINA	Context Acute onset of monocular floaters and/or flashes represents a common presentation to primary care physicians, and the most likely diagnosis is posterior vitreous detachment (PVD). A significant proportion of patients with acute PVD develop an associated retinal tear that can lead to retinal detachment and permanent vision loss if left untreated. Objective To quantify the association between relevant clinical variables and risk of retinal tear in patients presenting with acute-onset floaters and/or flashes and PVD. Data Sources Structured MEDLINE (January 1950-September 2009) and EMBASE (January 1980-September 2009) searches and a hand search of references and citations of retrieved articles yielded 17 relevant studies. Study Selection Studies of high-level methods that related elements of the history or physical examination in patients presenting with floaters and/or flashes and PVD to the likelihood of retinal tear. Results For patients with acute onset of floaters and/or flashes who are self-referred or referred to an ophthalmologist, the prevalence of retinal tear is 14% (95% confidence interval [CI], 12%-16%). Subjective visual reduction is the most important symptom associated with retinal tear (likelihood ratio [LR], 5.0; 95% CI, 3.1-8.1). Vitreous hemorrhage on slitlamp biomicroscopy is the best-studied finding with the narrowest positive LR for retinal tear (summary LR, 10; 95% CI, 5.1-20). Absence of vitreous pigment during this examination is the best-studied finding with the narrowest negative LR (summary LR, 0.23; 95% CI, 0.12-0.43). Patients initially diagnosed as having uncomplicated PVD have a 3.4% chance of a retinal tear within 6 weeks. The risk increases with new onset of at least 10 floaters (summary LR, 8.1-36) or subjective visual reduction (summary LR, 2.3-17) during this period. Conclusions Primary care physicians should evaluate patients with acute-onset floaters and/or flashes due to suspected PVD, or patients with known PVD and a change in symptoms, for high-risk features of retinal tear and detachment. Physicians should always assess these patients' visual acuity. Patients at increased risk should be triaged for urgent ophthalmologic assessment. JAMA. 2009; 302(20): 2243-2249	[Hollands, Hussein; Johnson, Davin; Brox, Anya C.; Almeida, David; Sharma, Sanjay] Queens Univ, Dept Ophthalmol, Kingston, ON, Canada; [Sharma, Sanjay] Hop Hotel Dieu, Unit Cost Effect Ocular Hlth Policy, Kingston, ON K7L 5S9, Canada; [Simel, David L.] Duke Univ, Durham, NC USA; [Simel, David L.] Durham Dept Vet Affairs Med Ctr, Durham, NC USA	Queens University - Canada; Queens University - Canada; Duke University	Hollands, H (corresponding author), Hop Hotel Dieu, Dept Ophthalmol, 166 Brock St, Kingston, ON K7L 5S9, Canada.	hussein.hollands@yahoo.com						BOLDREY EE, 1983, AM J OPHTHALMOL, V96, P783, DOI 10.1016/S0002-9394(14)71924-5; BROD RD, 1991, OPHTHALMOLOGY, V98, P1366; BYER NE, 1994, OPHTHALMOLOGY, V101, P1503; Chuo JY, 2006, AM J OPHTHALMOL, V142, P931, DOI 10.1016/j.ajo.2006.08.002; COLYEAR B H Jr, 1960, Trans Pac Coast Otoophthalmol Soc Annu Meet, V41, P193; DAVIS MD, 1974, ARCH OPHTHALMOL-CHIC, V92, P183; Dayan MR, 1996, EYE, V10, P456, DOI 10.1038/eye.1996.100; Detsky ME, 2006, JAMA-J AM MED ASSOC, V296, P1274, DOI 10.1001/jama.296.10.1274; DIAMOND JP, 1992, EYE, V6, P102, DOI 10.1038/eye.1992.21; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; HAIMANN MH, 1982, ARCH OPHTHALMOL-CHIC, V100, P289; HIKICHI T, 1994, AM J OPHTHALMOL, V117, P593, DOI 10.1016/S0002-9394(14)70065-0; HIKICHI T, 1995, OPHTHALMIC SURG LAS, V26, P39; JAFFE NS, 1968, ARCH OPHTHALMOL-CHIC, V79, P568; KANSKI JJ, 1975, AM J OPHTHALMOL, V80, P44, DOI 10.1016/0002-9394(75)90866-1; Li XX, 2003, OPHTHALMOLOGY, V110, P2413, DOI 10.1016/S0161-6420(03)00867-4; Lindner, 1966, ACTA OPHTHALMOL    S, V87, P1; NOVAK MA, 1984, AM J OPHTHALMOL, V97, P308, DOI 10.1016/0002-9394(84)90628-7; Polkinghorne PJ, 2004, CLIN EXP OPHTHALMOL, V32, P159, DOI 10.1111/j.1442-9071.2004.00003.x; Richardson PSR, 1999, EYE, V13, P237, DOI 10.1038/eye.1999.58; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; Ryan S. J., 2006, RETINA; Sharma S, 1999, ARCH OPHTHALMOL-CHIC, V117, P343, DOI 10.1001/archopht.117.3.343; Shea M, 1974, Mod Probl Ophthalmol, V12, P97; TABOTABO MM, 1980, ANN OPHTHALMOL, V12, P59; Tanner V, 2000, BRIT J OPHTHALMOL, V84, P1264, DOI 10.1136/bjo.84.11.1264; Tasman W S, 1968, Trans Am Acad Ophthalmol Otolaryngol, V72, P217; Thomas HA, 2008, ACAD EMERG MED, V15, P776, DOI 10.1111/j.1553-2712.2008.00194.x; TORNQUIST R, 1987, ACTA OPHTHALMOL, V65, P213; van Overdam KA, 2005, ARCH OPHTHALMOL-CHIC, V123, P479, DOI 10.1001/archopht.123.4.479; van Overdam KA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1483; WILKES SR, 1982, AM J OPHTHALMOL, V94, P670, DOI 10.1016/0002-9394(82)90013-7; Wong TY, 1999, ARCH OPHTHALMOL-CHIC, V117, P379, DOI 10.1001/archopht.117.3.379; Zou H, 2002, RETINA-J RET VIT DIS, V22, P294, DOI 10.1097/00006982-200206000-00007	34	73	79	1	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2243	2249		10.1001/jama.2009.1714	http://dx.doi.org/10.1001/jama.2009.1714			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934426	Green Published			2022-12-28	WOS:000272080500029
J	Sato, A; Isaac, B; Phillips, CM; Rillo, R; Carlton, PM; Wynne, DJ; Kasad, RA; Dernburg, AF				Sato, Aya; Isaac, Berith; Phillips, Carolyn M.; Rillo, Regina; Carlton, Peter M.; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.			Cytoskeletal Forces Span the Nuclear Envelope to Coordinate Meiotic Chromosome Pairing and Synapsis	CELL			English	Article							C-ELEGANS MEIOSIS; FISSION YEAST; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; BOUQUET FORMATION; PROPHASE; RECOMBINATION; MOVEMENT; PROTEIN; MICROTUBULES	During meiosis, each chromosome must pair with its unique homologous partner, a process that usually culminates with the formation of the synaptonemal complex (SC). In the nematode Caenorhabditis elegans, special regions on each chromosome known as pairing centers are essential for both homologous pairing and synapsis. We report that during early meiosis, pairing centers establish transient connections to the cytoplasmic microtubule network. These connections through the intact nuclear envelope require the SUN/KASH domain protein pair SUN-1 and ZYG-12. Disruption of microtubules inhibits chromosome pairing, indicating that these connections promote interhomolog interactions. Dynein activity is essential to license formation of the SC once pairing has been accomplished, most likely by overcoming a barrier imposed by the chromosome-nuclear envelope connection. Our findings thus provide insight into how homolog pairing is accomplished in meiosis and into the mechanisms regulating synapsis so that it occurs selectively between homologs. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Sato, Aya; Rillo, Regina; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Sato, Aya; Phillips, Carolyn M.; Rillo, Regina; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Sato, Aya; Isaac, Berith; Rillo, Regina; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Isaac, Berith] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Carlton, Peter M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Weizmann Institute of Science; University of California System; University of California San Francisco	Dernburg, AF (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	afdernburg@lbl.gov	Carlton, Peter/AAD-2403-2021; Phillips, Carolyn/E-8305-2011	Carlton, Peter/0000-0002-5320-6024; Phillips, Carolyn/0000-0002-6228-6468; Wynne, David/0000-0001-6061-0730; Dernburg, Abby/0000-0001-8037-1079; Sato-Carlton, Aya/0000-0003-0593-5238	Japan Society for the Promotion of Science; National Science Foundation; Keck Laboratory for Advanced Microscopy at the University of California, San Francisco; American Cancer Society [RSG-07-187-01-GMC]; National Institutes of Health/National Institute of General Medical Sciences [R01 GM065591]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065591] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); Keck Laboratory for Advanced Microscopy at the University of California, San Francisco; American Cancer Society(American Cancer Society); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by graduate research fellowships from the Japan Society for the Promotion of Science (A. S.) and the National Science Foundation (C. M. P., D. J. W and R. K.), by a research grant from the Keck Laboratory for Advanced Microscopy at the University of California, San Francisco, to P. M. C, and by research grants from the American Cancer Society (RSG-07-187-01-GMC) and the National Institutes of Health/National Institute of General Medical Sciences (R01 GM065591) to A. F. D. We are grateful to John Sedat for the use of the OMX microscope and to Kent McDonald for expert assistance with EM sample preparation. We thank Chris Malone, Miles Pfaff, Verena Jantsch, Tito Fojo, Eva Nogales, Bruce Bowerman, Yossi Gruenbaum, Pierre Gonczy, Ahna Skop, Anthony Hyman, Anne Villeneuve, and the Caenorhabditis Genetic Center for providing antibodies, strains, reagents, and technical assistance. We thank Dan Starr, Aaron Severson, Anne Villeneuve, and members of the Dernburg lab for helpful discussions.	Bhalla N, 2008, ANNU REV CELL DEV BI, V24, P397, DOI 10.1146/annurev.cellbio.23.090506.123245; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; Corredor E, 2007, CHROMOSOME RES, V15, P231, DOI 10.1007/s10577-006-1117-7; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Cowan CR, 2002, J CELL SCI, V115, P3747, DOI 10.1242/jcs.00055; Cowan CR, 2002, J CELL SCI, V115, P3757, DOI 10.1242/jcs.00054; Davis L, 2006, GENETICS, V174, P167, DOI 10.1534/genetics.106.059733; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding DQ, 1998, J CELL SCI, V111, P701; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Kosaka H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000196; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Lo MC, 2004, J AM CHEM SOC, V126, P9898, DOI 10.1021/ja048619e; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Penkner AM, 2009, CELL, V139, P920, DOI 10.1016/j.cell.2009.10.045; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Smith CD, 1996, J BIOL CHEM, V271, P6192, DOI 10.1074/jbc.271.11.6192; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Tepperberg JH, 1997, CHROMOSOMA, V106, P183, DOI 10.1007/s004120050238; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188; Yamamoto A, 2001, MOL BIOL CELL, V12, P3933, DOI 10.1091/mbc.12.12.3933; Zhou K, 2009, J CELL BIOL, V186, P229, DOI 10.1083/jcb.200902101; Zubovych I, 2006, P NATL ACAD SCI USA, V103, P15523, DOI 10.1073/pnas.0607338103	47	194	216	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					907	919		10.1016/j.cell.2009.10.039	http://dx.doi.org/10.1016/j.cell.2009.10.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19913287	Green Accepted, Bronze			2022-12-28	WOS:000272169400015
J	Richter, DD; Mobley, ML				Richter, Daniel deB., Jr.; Mobley, Megan L.			Monitoring Earth's Critical Zone	SCIENCE			English	Editorial Material									[Richter, Daniel deB., Jr.; Mobley, Megan L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University	Richter, DD (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	drichter@duke.edu	Richter, D.D./AAN-4583-2021; Mobley, Megan/AAF-3560-2020; Mobley, Megan L/A-5402-2010	Mobley, Megan/0000-0002-6046-8380; Mobley, Megan L/0000-0002-6046-8380				[Anonymous], 2001, UNDERSTANDING SOIL C; [Anonymous], 2009, INTEGRATED CROP RESO; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Franzluebbers AJ, 2005, SOIL TILL RES, V83, P1, DOI 10.1016/j.still.2005.02.020; Fuchs JW, 2009, J ENVIRON QUAL, V38, P473, DOI 10.2134/jeq2008.0201; Janzen HH, 2009, GLOBAL CHANGE BIOL, V15, P2770, DOI 10.1111/j.1365-2486.2009.01971.x; National Research Council, 2009, OBS WEATH CLIM GROUN; National Research Council, 2001, BAS RES OPP EARTH SC; National Research Council, 2009, RESTR FED CLIM RES M; Richter DD, 2007, SOIL SCI SOC AM J, V71, P266, DOI 10.2136/sssaj2006.0181; Robertson GP, 2008, BIOSCIENCE, V58, P640, DOI 10.1641/B580711; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Weaver JE., 1922, DEV ACTIVITIES ROOTS; Zalasiewicz J., 2008, GSA TODAY, V18, P4, DOI [DOI 10.1130/GSAT01802A.1, 10.1130/GSAT01802A.1]; Zhao XR, 2007, GEODERMA, V142, P237, DOI 10.1016/j.geoderma.2007.07.012	15	84	92	15	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1067	1068		10.1126/science.1179117	http://dx.doi.org/10.1126/science.1179117			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521UW	19965414				2022-12-28	WOS:000271951000025
J	Yamamoto-Kawai, M; McLaughlin, FA; Carmack, EC; Nishino, S; Shimada, K				Yamamoto-Kawai, Michiyo; McLaughlin, Fiona A.; Carmack, Eddy C.; Nishino, Shigeto; Shimada, Koji			Aragonite Undersaturation in the Arctic Ocean: Effects of Ocean Acidification and Sea Ice Melt	SCIENCE			English	Article							IMPACT; CYCLE	The increase in anthropogenic carbon dioxide emissions and attendant increase in ocean acidification and sea ice melt act together to decrease the saturation state of calcium carbonate in the Canada Basin of the Arctic Ocean. In 2008, surface waters were undersaturated with respect to aragonite, a relatively soluble form of calcium carbonate found in plankton and invertebrates. Undersaturation was found to be a direct consequence of the recent extensive melting of sea ice in the Canada Basin. In addition, the retreat of the ice edge well past the shelf-break has produced conditions favorable to enhanced upwelling of subsurface, aragonite-undersaturated water onto the Arctic continental shelf. Undersaturation will affect both planktonic and benthic calcifying biota and therefore the composition of the Arctic ecosystem.	[Yamamoto-Kawai, Michiyo; McLaughlin, Fiona A.; Carmack, Eddy C.] Inst Ocean Sci, Dept Fisheries & Oceans, Sidney, BC V8L 4B2, Canada; [Nishino, Shigeto; Shimada, Koji] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan; [Shimada, Koji] Tokyo Univ Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Fisheries & Oceans Canada; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tokyo University of Marine Science & Technology	Yamamoto-Kawai, M (corresponding author), Inst Ocean Sci, Dept Fisheries & Oceans, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.	michiyo.kawai@dfo-mpo.gc.ca	Yamamoto-Kawai, Michiyo/F-7611-2013; SHIMADA, Koji/O-1913-2014	Yamamoto-Kawai, Michiyo/0000-0002-1035-2179; NISHINO, Shigeto/0000-0002-0560-241X	Fisheries and Oceans Canada; Canadian International Polar Year program; NSF	Fisheries and Oceans Canada; Canadian International Polar Year program; NSF(National Science Foundation (NSF))	We thank A. Proshutinsky as coinvestigator of the Beaufort Gyre project and acknowledge support provided by Fisheries and Oceans Canada, the Canadian International Polar Year program, and NSF. We are grateful to S. Zimmerman and other members of the scientific teams as well as the officers and crews on the CCGS Louis S. St-Laurent. We thank M. Davelaar, A. Ross, J. McKay, and K. Tamura for their careful analyses of TA, DIC, and delta<SUP>18</SUP>O and H. Yoshikawa, S. Noriki, N. Kurita, and T. Takamura for their help in delta<SUP>18</SUP>O analysis.	Anderson LG, 2001, POLAR RES, V20, P225, DOI 10.1111/j.1751-8369.2001.tb00060.x; Anderson LG, 1998, GLOBAL BIOGEOCHEM CY, V12, P455, DOI 10.1029/98GB01372; Bates NR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027028; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Cooper LW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035007; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Jutterstrom S, 2005, MAR CHEM, V94, P101, DOI 10.1016/j.marchem.2004.08.010; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; KOBAYASHI HA, 1974, MAR BIOL, V26, P295, DOI 10.1007/BF00391513; McLaughlin FA, 2004, DEEP-SEA RES PT I, V51, P107, DOI 10.1016/j.dsr.2003.09.010; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Solomon S., 2007, PHYS SCI BASIS WORKI; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Stroeve J., 2008, EOS T AM GEOPHYS UN, V89, P13, DOI [DOI 10.1029/2008E0020001, 10.1029/2008EO020001, DOI 10.1029/2008EO020001]; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; The Royal Society, 2005, 1205 ROYAL SOC; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000; Yamamoto-Kawai M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003858	22	230	248	3	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1098	1100		10.1126/science.1174190	http://dx.doi.org/10.1126/science.1174190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965425				2022-12-28	WOS:000271951000039
J	Smith, RD; Keogh-Brown, MR; Barnett, T; Tait, J				Smith, Richard D.; Keogh-Brown, Marcus R.; Barnett, Tony; Tait, Joyce			The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MACROECONOMIC IMPACT; SCHOOL CLOSURE; SARS; OUTBREAK; COSTS; FLU	Objectives To estimate the potential economic impact of pandemic influenza, associated behavioural responses, school closures, and vaccination on the United Kingdom. Design A computable general equilibrium model of the UK economy was specified for various combinations of mortality and morbidity from pandemic influenza, vaccine efficacy, school closures, and prophylactic absenteeism using published data. Setting The 2004 UK economy (the most up to date available with suitable economic data). Main outcome measures The economic impact of various scenarios with different pandemic severity, vaccination, school closure, and prophylactic absenteeism specified in terms of gross domestic product, output from different economic sectors, and equivalent variation. Results The costs related to illness alone ranged between 0.5% and 1.0% of gross domestic product (8.4bn pound to 16.8bn) pound for low fatality scenarios, 3.3% and 4.3% (55.5bn pound to 72.3bn) pound for high fatality scenarios, and larger still for an extreme pandemic. School closure increases the economic impact, particularly for mild pandemics. If widespread behavioural change takes place and there is large scale prophylactic absence from work, the economic impact would be notably increased with few health benefits. Vaccination with a pre-pandemic vaccine could save 0.13% to 2.3% of gross domestic product (2.2bn pound to 38.6bn); pound a single dose of a matched vaccine could save 0.3% to 4.3% (5.0bn pound to 72.3bn); pound and two doses of a matched vaccine could limit the overall economic impact to about 1% of gross domestic product for all disease scenarios. Conclusion Balancing school closure against "business as usual" and obtaining sufficient stocks of effective vaccine are more important factors in determining the economic impact of an influenza pandemic than is the disease itself. Prophylactic absence from work in response to fear of infection can add considerably to the economic impact.	[Smith, Richard D.; Barnett, Tony] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England; [Barnett, Tony] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Tait, Joyce] Univ Edinburgh, ESRC Innogen Ctr, Edinburgh EH1 1LZ, Midlothian, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Edinburgh	Smith, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559; Barnett, Tony/0000-0001-9399-9607; Keogh-Brown, Marcus/0000-0002-7556-0016	ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2005, HHS PAND INFL PLAN; ARNDT C, 1999, 40 PERD U IFPRI U CO; Butler D, 2009, NATURE, V460, P562, DOI 10.1038/460562a; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Cheng C, 2004, ASIAN J SOC PSYCHOL, V7, P3, DOI 10.1111/j.1467-839X.2004.00130.x; COKER R, 2009, BMJ-BRIT MED J, V338, pB1797; DELAUWE PHC, 1953, REV FRANCAISE SCI PO, V3, P630; *DEP HLTH, 2007, PREP PAND INFL VACC; *DEP HLTH, 2009, AGR SEC PREP VACC UK; *DEP HLTH, 2005, UK HLTH DEP INFL PAN; *DEP HLTH, 2007, PAND INFL NAT FRAM R; *DEP HLTH SCI PAND, 2008, SUBGR MOD MOD SUMM; Dervis K., 1982, GEN EQUILIBRIUM MODE; *EUR CTR DIS PREV, 2007, TECHN REP EXP ADV GR; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FOFONA I, 2005, BALANCING SOCIAL ACC; *HLTH PROT AG, 2006, PAND INFL CONT PLAN; Horridge M, 2008, EXERCISES CONTRIBUTI; Keogh-Brown MR, 2010, HEALTH ECON, V19, P1345, DOI 10.1002/hec.1554; Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Ko CH, 2006, PSYCHIAT CLIN NEUROS, V60, P397, DOI 10.1111/j.1440-1819.2006.01522.x; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Lofgren H., 2001, STANDARD COMPUTABLE; Macfarlane JT, 2005, BMJ-BRIT MED J, V331, P975, DOI 10.1136/bmj.38649.389005.DE; McLean AR., 2005, SARS CASE STUDY EMER, DOI [10.1093/shm/hki055, DOI 10.1093/SHM/HKI055]; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Postma MJ, 2005, VACCINE, V23, P5365, DOI 10.1016/j.vaccine.2005.06.007; Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Spencer L., 2006, RETHINKING FRIENDSHI; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; The Public Health Agency of Canada, 2006, CAN PAND INFL PLAN H; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; WANG H, AM BEHAV SC IN PRESS	36	106	110	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2009	339								b4571	10.1136/bmj.b4571	http://dx.doi.org/10.1136/bmj.b4571			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TD	19926697	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000272096500005
J	Kitamura, T; Saitoh, Y; Takashima, N; Murayama, A; Niibori, Y; Ageta, H; Sekiguchi, M; Sugiyama, H; Inokuchi, K				Kitamura, Takashi; Saitoh, Yoshito; Takashima, Noriko; Murayama, Akiko; Niibori, Yosuke; Ageta, Hiroshi; Sekiguchi, Mariko; Sugiyama, Hiroyuki; Inokuchi, Kaoru			Adult Neurogenesis Modulates the Hippocampus-Dependent Period of Associative Fear Memory	CELL			English	Article							LONG-TERM POTENTIATION; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; CONTEXTUAL FEAR; DENTATE GYRUS; RETROGRADE-AMNESIA; SPATIAL MEMORY; DENDRITIC SPINE; NEURONS BORN; BRAIN	Acquired memory initially depends on the hippocampus (HPC) for the process of cortical permanent memory formation. The mechanisms through which memory becomes progressively independent from the HPC remain unknown. In the HPC, adult neurogenesis has been described in many mammalian species, even at old ages. Using two mouse models in which hippocampal neurogenesis is physically or genetically suppressed, we show that decreased neurogenesis is accompanied by a prolonged HPC-dependent period of associative fear memory. Inversely, enhanced neurogenesis by voluntary exercise sped up the decay rate of HPC dependency of memory, without loss of memory. Consistently, decreased neurogenesis facilitated the long-lasting maintenance of rat hippocampal long-term potentiation in vivo. These independent lines of evidence strongly suggest that the level of hippocampal neurogenesis play a role in determination of the HPC-dependent period of memory in adult rodents. These observations provide a framework for understanding the mechanisms of the hippocampal-cortical complementary learning systems.	[Kitamura, Takashi; Saitoh, Yoshito; Takashima, Noriko; Murayama, Akiko; Niibori, Yosuke; Ageta, Hiroshi; Sekiguchi, Mariko; Inokuchi, Kaoru] MITILS, Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Kitamura, Takashi; Saitoh, Yoshito; Inokuchi, Kaoru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Med, Dept Biochem, Toyama 9300194, Japan; [Kitamura, Takashi; Saitoh, Yoshito; Takashima, Noriko; Murayama, Akiko; Niibori, Yosuke; Sekiguchi, Mariko; Inokuchi, Kaoru] CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Sugiyama, Hiroyuki] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Toyama; Japan Science & Technology Agency (JST); Kyushu University	Inokuchi, K (corresponding author), MITILS, Mitsubishi Kagaku Inst Life Sci, 11 Minamiooya, Tokyo 1948511, Japan.	inokuchi@med.u-toyama.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Kitamura, Takashi/AAR-7837-2021	Inokuchi, Kaoru/0000-0002-5393-3133; Kitamura, Takashi/0000-0001-5597-859X	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank T. Hino, R. Migishima, and K. Nakamura from the Mouse Genome Technology Centre at Mitsubishi Kagaku Institute of Life Sciences (MITILS) for in vitro fertilization and embryo transfer; F. Hayashi for technical assistance with X-ray irradiation; R. Okubo-Suzuki for programming for the data analysis; and S. Kamijo and M. Matsuo for maintenance of the transgenic mice. We also thank N. Ohkawa for reading of the manuscript and discussion, and all members of the Inokuchi laboratory for daily discussion and advice; and P. W. Frankland, B.-K. Kaang, and A. J. Silva for critically reading the manuscript. This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST) to K. I., a Grant-in-Aid for Scientific Research in Priority Area in "Molecular Brain Science'' to K. I., and by a Grant-in-Aid for Young Scientists B to T. K. T. K. was a fellow of the Japan Society for the Promotion of Science.	Abraham WC, 2002, J NEUROSCI, V22, P9626; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; FRANKLAND PW, 2007, DEV NEUROSCI, V1, P67, DOI DOI 10.1007/S11559-007-9004-8; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kitamura T, 2003, NEUROSCI RES, V47, P55, DOI 10.1016/S0168-0102(03)00171-8; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Takehara K, 2003, J NEUROSCI, V23, P9897; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WILLSHAW DJ, 1990, PHILOS T R SOC B, V329, P205, DOI 10.1098/rstb.1990.0165; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Winocur G, 2007, NAT NEUROSCI, V10, P555, DOI 10.1038/nn1880; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	71	349	369	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					814	827		10.1016/j.cell.2009.10.020	http://dx.doi.org/10.1016/j.cell.2009.10.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914173	Bronze			2022-12-28	WOS:000271747200024
J	Guzman, J				Guzman, Jaime			Neck pain and low-level laser: does it work and how?	LANCET			English	Editorial Material									Univ British Columbia, Vancouver, BC V6H 3X5, Canada	University of British Columbia	Guzman, J (corresponding author), Univ British Columbia, Vancouver, BC V6H 3X5, Canada.	jaime@ohsah.bc.ca	Guzman, Jaime/P-1836-2014	Guzman, Jaime/0000-0001-8977-2581				Carragee EJ, 2008, SPINE, V33, pS153, DOI 10.1097/BRS.0b013e31816445ea; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Gross AR, 2007, J RHEUMATOL, V34, P1083; Guzman J, 2008, SPINE, V33, pS199, DOI 10.1097/BRS.0b013e3181644641; Hawkins D, 2005, ANN NY ACAD SCI, V1056, P486, DOI 10.1196/annals.1352.040; Hurwitz EL, 2008, SPINE, V33, pS123, DOI 10.1097/BRS.0b013e3181644b1d; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]	7	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1875	1876		10.1016/S0140-6736(09)61837-7	http://dx.doi.org/10.1016/S0140-6736(09)61837-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19913901				2022-12-28	WOS:000272646900008
J	Desai, AS; Chutkow, WA; Edelman, E; Economy, KE; Dec, GW				Desai, Akshay S.; Chutkow, William A.; Edelman, Elazer; Economy, Katherine E.; Dec, G. William, Jr.			A Crisis in Late Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHEOCHROMOCYTOMA; CARDIOMYOPATHY; MYOCARDITIS; PREVALENCE		[Desai, Akshay S.; Chutkow, William A.; Edelman, Elazer] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Economy, Katherine E.] Brigham & Womens Hosp, Ctr Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Dec, G. William, Jr.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Desai, AS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, PBB-A3,AB370,75 Francis St, Boston, MA 02115 USA.	adesai@partners.org	Desai, Akshay/ABE-7250-2020					Ahlawat S K, 1999, Obstet Gynecol Surv, V54, P728, DOI 10.1097/00006254-199911000-00025; ANDERSON GH, 1994, J HYPERTENS, V12, P609, DOI 10.1097/00004872-199405000-00015; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; HARPER MA, 1989, BRIT J OBSTET GYNAEC, V96, P594, DOI 10.1111/j.1471-0528.1989.tb03262.x; IMPERATOMCGINLEY J, 1987, NEW ENGL J MED, V316, P793, DOI 10.1056/NEJM198703263161307; Kinney MAO, 2000, ANESTH ANALG, V91, P1118, DOI 10.1097/00000539-200011000-00013; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lo CY, 2000, AM J SURG, V179, P212, DOI 10.1016/S0002-9610(00)00296-8; Mootha V K, 2000, Circulation, V102, pE11; SALATHE M, 1992, BRIT HEART J, V68, P527; Schenker J G, 1971, Obstet Gynecol Surv, V26, P739, DOI 10.1097/00006254-197111000-00001; STEIN PP, 1991, MEDICINE, V70, P46, DOI 10.1097/00005792-199101000-00004; SUTTON MGS, 1981, MAYO CLIN PROC, V56, P354; SZAKACS JE, 1958, AM J CLIN PATHOL, V30, P425; VANVLIET PD, 1966, NEW ENGL J MED, V274, P1102, DOI 10.1056/NEJM196605192742002	15	20	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2271	2277		10.1056/NEJMcps0708258	http://dx.doi.org/10.1056/NEJMcps0708258			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19955528				2022-12-28	WOS:000272257100012
J	Depuydt, M; Leonard, SE; Vertommen, D; Denoncin, K; Morsomme, P; Wahni, K; Messens, J; Carroll, KS; Collet, JF				Depuydt, Matthieu; Leonard, Stephen E.; Vertommen, Didier; Denoncin, Katleen; Morsomme, Pierre; Wahni, Khadija; Messens, Joris; Carroll, Kate S.; Collet, Jean-Francois			A Periplasmic Reducing System Protects Single Cysteine Residues from Oxidation	SCIENCE			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; IN-VIVO; THIOREDOXIN; PROTEINS; PEPTIDOGLYCAN; MECHANISMS; DIVERSITY; ISOMERASE; PEROXIDE	The thiol group of the amino acid cysteine can be modified to regulate protein activity. The Escherichia coli periplasm is an oxidizing environment in which most cysteine residues are involved in disulfide bonds. However, many periplasmic proteins contain single cysteine residues, which are vulnerable to oxidation to sulfenic acids and then irreversibly modified to sulfinic and sulfonic acids. We discovered that DsbG and DsbC, two thioredoxin-related proteins, control the global sulfenic acid content of the periplasm and protect single cysteine residues from oxidation. DsbG interacts with the YbiS protein and, along with DsbC, regulates oxidation of its catalytic cysteine residue. Thus, a potentially widespread mechanism controls sulfenic acid modification in the cellular environment.	[Depuydt, Matthieu; Vertommen, Didier; Denoncin, Katleen; Collet, Jean-Francois] Univ Catholique Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Leonard, Stephen E.; Carroll, Kate S.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Morsomme, Pierre] Univ Catholique Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Wahni, Khadija; Messens, Joris] Vrije Univ Brussel VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium	Universite Catholique Louvain; University of Michigan System; University of Michigan; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Collet, JF (corresponding author), Univ Catholique Louvain, de Duve Inst, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Collet, Jean Francois/F-2105-2010; Messens, Joris/AAH-3008-2020; Morsomme, Pierre/AAD-9600-2019	Messens, Joris/0000-0002-2128-8264; Morsomme, Pierre/0000-0001-7780-7230; Vertommen, Didier/0000-0001-7648-8282; Carroll, Kate/0000-0002-7624-9617; Depuydt, Matthieu/0000-0002-4069-3521; Collet, Jean-Francois/0000-0001-8069-7036	FNRS; Leukemia and Lymphoma Society [3100-07]; American Heart Association [0835419N]	FNRS(Fonds de la Recherche Scientifique - FNRS); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association)	We thank G. Connerotte and H. Degand for technical help, and E. VanSchaftingen, M. VeigadaCunha, F. Swisser, P. Leverrier, A. Hiniker, J. Bardwell, and U. Jakob for discussions. J. F. C. and P. M. are Chercheur Qualifie and D. V. is Collaborateur Logistique of the Fonds de la Recherche Scientifique. M. D. is a research fellow of the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, and J. M. is a project leader of the VIB. This research was supported by grants from the FNRS to J. F. C. and from the Leukemia and Lymphoma Society (Special Fellows Award 3100-07) and the American Heart Association (Scientist Development Grant 0835419N) to K. S. C. Conflict of Interest Statement: Patent protection has been applied for for the DAz-1 and DAz-2 chemical probes. These compounds will soon be commercially available from Cayman Chemical (Ann Arbor, MI, USA). For inquiries regarding the DAz probes: katesc@umich.edu.	Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eser M, 2009, P NATL ACAD SCI USA, V106, P1572, DOI 10.1073/pnas.0812596106; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; Mainardi JL, 2007, J BIOL CHEM, V282, P30414, DOI 10.1074/jbc.M704286200; Messens J, 2004, J MOL BIOL, V339, P527, DOI 10.1016/j.jmb.2004.04.016; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reddie KG, 2008, MOL BIOSYST, V4, P521, DOI 10.1039/b719986d; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Takanishi CL, 2007, BIOCHEMISTRY-US, V46, P14725, DOI 10.1021/bi701625s	19	133	141	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1109	1111		10.1126/science.1179557	http://dx.doi.org/10.1126/science.1179557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965429				2022-12-28	WOS:000271951000043
J	Johnson, C				Johnson, Christopher			Megafaunal Decline and Fall	SCIENCE			English	Editorial Material							NORTH-AMERICA; EXTINCTIONS; CLIMATE; CLOVIS		James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Johnson, C (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	christopher.johnson@jcu.edu.au	Johnson, Chris N/A-7275-2008; Johnson, Chris/J-7894-2014	Johnson, Chris/0000-0002-9719-3771				Fiedel Stuart, 2009, P21, DOI 10.1007/978-1-4020-8793-6_2; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Johnson CN, 2009, P ROY SOC B-BIOL SCI, V276, P2509, DOI 10.1098/rspb.2008.1921; Marlon JR, 2009, P NATL ACAD SCI USA, V106, P2519, DOI 10.1073/pnas.0808212106; Robinson GS, 2005, ECOL MONOGR, V75, P295, DOI 10.1890/03-4064; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Williams JW, 2001, ECOLOGY, V82, P3346	10	10	11	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1072	1073		10.1126/science.1182770	http://dx.doi.org/10.1126/science.1182770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965418				2022-12-28	WOS:000271951000029
J	Lapointe, CP; Mason, TG; Smalyukh, II				Lapointe, Clayton P.; Mason, Thomas G.; Smalyukh, Ivan I.			Shape-Controlled Colloidal Interactions in Nematic Liquid Crystals	SCIENCE			English	Article								Robust control over the positions, orientations, and assembly of nonspherical colloids may aid in the creation of new types of structured composite materials that are important from both technological and fundamental standpoints. With the use of lithographically fabricated equilateral polygonal platelets, we demonstrate that colloidal interactions and self-assembly in anisotropic nematic fluids can be effectively tailored via control over the particles' shapes. The particles disturb the uniform alignment of the surrounding nematic host, resulting in both a distinct equilibrium alignment and highly directional pair interactions. Interparticle forces between polygonal platelets exhibit either dipolar or quadrupolar symmetries, depending on whether their number of sides is odd or even, and drive the assembly of a number of ensuing self-assembled colloidal structures.	[Lapointe, Clayton P.; Smalyukh, Ivan I.] Univ Colorado, Dept Phys, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Lapointe, Clayton P.; Smalyukh, Ivan I.] Univ Colorado, Liquid Crystals Mat Res Ctr, Boulder, CO 80309 USA; [Lapointe, Clayton P.; Mason, Thomas G.] Univ Calif Los Angeles, Dept Chem & Biochem, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Lapointe, Clayton P.; Mason, Thomas G.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Smalyukh, II (corresponding author), Univ Colorado, Dept Phys, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA.	ivan.smalyukh@colorado.edu	Liu, Qing/GWC-9222-2022; Smalyukh, Ivan I/C-2955-2011; Lapointe, Clayton/G-7455-2011; Smalyukh, Ivan/AAC-9232-2020; Lapointe, Clayton/E-3609-2013	Smalyukh, Ivan I/0000-0003-3444-1966; Smalyukh, Ivan/0000-0003-3444-1966; 	Institute for Complex and Adaptive Matter; NSF [DMR 0645461, DMR 0847782, CHE 0450022, DMR 0820579]; Division Of Materials Research [0847782] Funding Source: National Science Foundation	Institute for Complex and Adaptive Matter; NSF(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank K. Zhao for assistance with the fabrication of colloids, and we acknowledge support from the Institute for Complex and Adaptive Matter and from NSF grants DMR 0645461, DMR 0847782, CHE 0450022, and DMR 0820579.	Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; Blinov LM., 1996, ELECTROOPTIC EFFECTS; BROCHARD F, 1970, J PHYS-PARIS, V31, P691, DOI 10.1051/jphys:01970003107069100; Chaikin P. M., 2000, PRINCIPLES CONDENSED; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dierking I, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011702; Glotzer SC, 2004, SCIENCE, V306, P419, DOI 10.1126/science.1099988; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; HALSEY TC, 1992, SCIENCE, V258, P761, DOI 10.1126/science.258.5083.761; Hernandez CJ, 2007, J PHYS CHEM C, V111, P4477, DOI 10.1021/jp0672095; Lapointe C, 2004, SCIENCE, V303, P652, DOI 10.1126/science.1092608; Lev BI, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021709; Loudet JC, 2000, NATURE, V407, P611, DOI 10.1038/35036539; Lubensky TC, 1998, PHYS REV E, V57, P610, DOI 10.1103/PhysRevE.57.610; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Nych AB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057801; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Smalyukh II, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.157801; Smalyukh II, 2001, CHEM PHYS LETT, V336, P88, DOI 10.1016/S0009-2614(00)01471-8; Smalyukh II, 2006, P NATL ACAD SCI USA, V103, P18048, DOI 10.1073/pnas.0608698103; Stark H, 2001, PHYS REP, V351, P387, DOI 10.1016/S0370-1573(00)00144-7; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Tkalec U, 2008, SOFT MATTER, V4, P2402, DOI 10.1039/b807979j; Tsakonas C, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713140; Vilfan M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.237801; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zhao K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.268301	27	255	255	4	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1083	1086		10.1126/science.1176587	http://dx.doi.org/10.1126/science.1176587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965422				2022-12-28	WOS:000271951000034
J	Mead, S; Whitfield, J; Poulter, M; Shah, P; Uphill, J; Campbell, T; Al-Dujaily, H; Hummerich, H; Beck, J; Mein, CA; Verzilli, C; Whittaker, J; Alpers, MP; Collinge, J				Mead, Simon; Whitfield, Jerome; Poulter, Mark; Shah, Paresh; Uphill, James; Campbell, Tracy; Al-Dujaily, Huda; Hummerich, Holger; Beck, Jon; Mein, Charles A.; Verzilli, Claudio; Whittaker, John; Alpers, Michael P.; Collinge, John			A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; AGE	BACKGROUND Kuru is a devastating epidemic prion disease that affected a highly restricted geographic area of the Papua New Guinea highlands; at its peak, it predominantly affected adult women and children of both sexes. Its incidence has steadily declined since the cessation of its route of transmission, endocannibalism. METHODS We performed genetic and selected clinical and genealogic assessments of more than 3000 persons from Eastern Highland populations, including 709 who participated in cannibalistic mortuary feasts, 152 of whom subsequently died of kuru. RESULTS Persons who were exposed to kuru and survived the epidemic in Papua New Guinea are predominantly heterozygotes at the known resistance factor at codon 129 of the prion protein gene ( PRNP). We now report a novel PRNP variant - G127V - that was found exclusively in people who lived in the region in which kuru was prevalent and that was present in half of the otherwise susceptible women from the region of highest exposure who were homozygous for methionine at PRNP codon 129. Although this allele is common in the area with the highest incidence of kuru, it is not found in patients with kuru and in unexposed population groups worldwide. Genealogic analysis reveals a significantly lower incidence of kuru in pedigrees that harbor the protective allele than in geographically matched control families. CONCLUSIONS The 127V polymorphism is an acquired prion disease resistance factor selected during the kuru epidemic, rather than a pathogenic mutation that could have triggered the kuru epidemic. Variants at codons 127 and 129 of PRNP demonstrate the population genetic response to an epidemic of prion disease and represent a powerful episode of recent selection in humans.	[Mead, Simon; Whitfield, Jerome; Poulter, Mark; Shah, Paresh; Uphill, James; Campbell, Tracy; Al-Dujaily, Huda; Hummerich, Holger; Beck, Jon; Alpers, Michael P.; Collinge, John] UCL, MRC, Inst Neurol, Prion Unit,Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England; [Mein, Charles A.] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, John Vane Sci Ctr, London, England; [Verzilli, Claudio; Whittaker, John] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Whitfield, Jerome; Alpers, Michael P.] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Alpers, Michael P.] Curtin Univ, Ctr Int Hlth, Perth, WA, Australia	University of London; University College London; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; PNG Institute Of Medical Research; Curtin University	Collinge, J (corresponding author), UCL, MRC, Inst Neurol, Prion Unit,Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Beck, Jon/GRX-8457-2022; Whittaker, John C/B-8609-2012; Mead, Simon/E-9414-2011	Whittaker, John C/0000-0002-3529-2379; Mead, Simon/0000-0002-4326-1468; Mein, Charles/0000-0003-0811-9658	Wellcome Trust Principal Research Fellowship; Department of Health National Institute for Health Research Biomedical Research Centres; Medical Research Council [MC_U123192748, MC_U123160651, MC_U123160657] Funding Source: researchfish; MRC [MC_U123192748, MC_U123160657, MC_U123160651] Funding Source: UKRI	Wellcome Trust Principal Research Fellowship(Wellcome Trust); Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported initially by a Wellcome Trust Principal Research Fellowship in the Clinical Sciences ( to Dr. Collinge) and since 2001 by the Medical Research Council. Some of this work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme.	Alpers MP, 2005, COMMUN DIS INTELL, V29, P391; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collinge J, 2008, PHILOS T R SOC B, V363, P3725, DOI 10.1098/rstb.2008.0068; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Colombo R, 2000, AM J HUM GENET, V67, P528, DOI 10.1086/303021; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hedrick P, 2004, J EVOLUTION BIOL, V17, P221, DOI 10.1046/j.1420-9101.2003.00635.x; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2008, HUM MUTAT, V29, P1452, DOI 10.1002/humu.20782; PALMER MS, 1991, NATURE, V352, P547, DOI 10.1038/352547a0; Poso D, 2000, J BIOL CHEM, V275, P35723, DOI 10.1074/jbc.M001747200; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; ZIGAS V., 1959, Papua and New Guinea Medical Journal, V3, P1	30	117	119	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2056	2065		10.1056/NEJMoa0809716	http://dx.doi.org/10.1056/NEJMoa0809716			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19923577	Green Accepted			2022-12-28	WOS:000271898600010
J	O'Rahilly, S				O'Rahilly, Stephen			Human genetics illuminates the paths to metabolic disease	NATURE			English	Review							GENOME-WIDE ASSOCIATION; SEVERE INSULIN-RESISTANCE; II DIABETES-MELLITUS; EARLY-ONSET OBESITY; BODY-MASS INDEX; FTO GENE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; RISK LOCI; ENDOPLASMIC-RETICULUM	Metabolic diseases represent a growing threat to world-wide public health. In general, these disorders result from the interaction of heritable factors with environmental influences. Here, I will focus on two important metabolic disorders, namely type 2 diabetes and obesity, and explore the extent to which human molecular genetic research has illuminated our understanding of their underlying pathophysiological mechanisms.	Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Hills Rd, Cambridge CB2 0QQ, England.	so104@medschl.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449	MRC Centre for Obesity and Related Metabolic Diseases; Wellcome Trust; NIHR Cambridge Biomedical Research Centre; EU; MRC [G9824984] Funding Source: UKRI; Medical Research Council [G9824984] Funding Source: researchfish	MRC Centre for Obesity and Related Metabolic Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	I thank M. Adams for assistance with this manuscript. I also thank A. Hattersley for many helpful suggestions, and I. Barroso, T. Coll, S. Farooqi, R. Loos, J. Rochford, D. Savage, R. Semple, N. Wareham and G. Yeo for discussions over many years. I acknowledge the support of the MRC Centre for Obesity and Related Metabolic Diseases, the Wellcome Trust, the NIHR Cambridge Biomedical Research Centre, and the EU for their continuing support of our work in this area.	ACCILI D, 1992, J ENDOCRINOL INVEST, V15, P857, DOI 10.1007/BF03348820; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Beales P, 2009, GENETICS OBESITY SYN; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gill-Carey O, 2007, PEDIATR DIABETES, V8, P42, DOI 10.1111/j.1399-5448.2007.00331.x; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Han JC, 2008, NEW ENGL J MED, V359, P1414; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hattersley AT, 2006, ENDOCRINOLOGY, V147, P2657, DOI 10.1210/en.2006-0152; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Holder JL, 2000, HUM MOL GENET, V9, P101; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; JEQUIER E, 1984, CLIN ENDOCRINOL META, V13, P563, DOI 10.1016/S0300-595X(84)80038-9; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Krakoff J, 2008, DIABETES, V57, P3267, DOI 10.2337/db08-0577; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; O'Rahilly S, 2008, DIABETES, V57, P2905, DOI 10.2337/db08-0210; Palmer ND, 2008, J CLIN ENDOCR METAB, V93, P304, DOI 10.1210/jc.2007-1225; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; PORTE D, 1995, CLIN INVEST MED, V18, P247; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; REAVEN GM, 1995, DIABETOLOGIA, V38, P3, DOI 10.1007/BF02369347; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SPIEGEL AM, 1990, NEW ENGL J MED, V322, P1461, DOI 10.1056/NEJM199005173222010; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tattersall R, 1998, DIABETIC MED, V15, P11, DOI 10.1002/(SICI)1096-9136(199801)15:1<11::AID-DIA561>3.0.CO;2-0; TEMPLE IK, 1995, NAT GENET, V9, P110, DOI 10.1038/ng0295-110; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; TURNER RC, 1988, BAILLIERE CLIN ENDOC, V2, P327, DOI 10.1016/S0950-351X(88)80035-1; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	108	225	230	0	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					307	314		10.1038/nature08532	http://dx.doi.org/10.1038/nature08532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924209				2022-12-28	WOS:000271899300036
J	Keenan, NG; Sheppard, MN; Nott, DM; Pennell, DJ; Mohiaddin, RH				Keenan, Niall G.; Sheppard, Mary N.; Nott, David M.; Pennell, Dudley J.; Mohiaddin, Raad H.			Carotid plaque rupture	LANCET			English	Editorial Material									[Keenan, Niall G.; Pennell, Dudley J.; Mohiaddin, Raad H.] Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England; [Sheppard, Mary N.] Royal Brompton Hosp, Dept Pathol, London SW3 6NP, England; [Nott, David M.] Chelsea & Westminster Hosp, Dept Vasc Surg, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London	Keenan, NG (corresponding author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, Sydney St, London SW3 6NP, England.	n.keenan@rbht.nhs.uk	Keenan, Niall/AAG-3376-2020; Sheppard, Mary N/AAB-3364-2019	Sheppard, Mary N/0000-0003-2724-3881; Pennell, Dudley/0000-0001-5523-1314; Keenan, Niall/0000-0002-0841-6989					0	5	5	3	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 14	2009	374	9702					1703	1703		10.1016/S0140-6736(09)60291-9	http://dx.doi.org/10.1016/S0140-6736(09)60291-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522LP	19914514				2022-12-28	WOS:000271999700026
J	Nigg, EA; Raff, JW				Nigg, Erich A.; Raff, Jordan W.			Centrioles, Centrosomes, and Cilia in Health and Disease	CELL			English	Review							NEURAL STEM-CELLS; DE-NOVO FORMATION; INTRAFLAGELLAR TRANSPORT PROTEINS; POLYCYSTIC KIDNEY-DISEASE; LEFT-RIGHT ASYMMETRY; C-ELEGANS; TUMOR-SUPPRESSOR; BASAL BODY; PERICENTRIOLAR MATERIAL; CAENORHABDITIS-ELEGANS	Centrioles are barrel-shaped structures that are essential for the formation of centrosomes, cilia, and flagella. Here we review recent advances in our understanding of the function and biogenesis of these organelles, and we emphasize their connection to human disease. Deregulation of centrosome numbers has long been proposed to contribute to genome instability and tumor formation, whereas mutations in centrosomal proteins have recently been genetically linked to microcephaly and dwarfism. Finally, structural or functional centriole aberrations contribute to ciliopathies, a variety of complex diseases that stem from the absence or dysfunction of cilia.	[Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Raff, Jordan W.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Basel; University of Oxford	Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	erich.nigg@unibas.ch; jordan.raff@path.ox.ac.uk		nigg, erich/0000-0003-4835-5719	Cancer Research UK [10530] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; ANDERSON CT, 2009, CURR BIOL, DOI DOI 10.1016/J.CUB.2006.07.34; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; CALLAINI G, 1990, J CELL SCI, V97, P539; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Feldman JL, 2007, PLOS BIOL, V5, P1284, DOI [10.1371/journal.pbio.0050149, 10.1371/journal.pbio.0050286]; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; FRY AM, 2004, CENTROSOMES DEV DIS, P143; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Gisselsson D, 2003, ADV CANCER RES, V87, P1; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gomez-Ferreria MA, 2008, CELL CYCLE, V7, P1507, DOI 10.4161/cc.7.11.5957; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Gonzalez C, 2008, CURR OPIN CELL BIOL, V20, P694, DOI 10.1016/j.ceb.2008.10.003; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KLOTZ C, 1990, J CELL BIOL, V110, P405, DOI 10.1083/jcb.110.2.405; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Kuriyama R, 2009, CELL MOTIL CYTOSKEL, V66, P588, DOI 10.1002/cm.20368; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Mogensen M.M., 2004, CENTROSOMES DEV DIS; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; Wakefield JG, 2000, CURR BIOL, V10, P1367, DOI 10.1016/S0960-9822(00)00776-4; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Wessely O, 2008, FRONT BIOSCI-LANDMRK, V13, P1866, DOI 10.2741/2806; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	164	648	663	3	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					663	678		10.1016/j.cell.2009.10.036	http://dx.doi.org/10.1016/j.cell.2009.10.036			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914163	Bronze			2022-12-28	WOS:000271747200012
J	Alvarez, HM; Xue, Y; Robinson, CD; Canalizo-Hernandez, MA; Marvin, RG; Kelly, RA; Mondragon, A; Penner-Hahn, JE; O'Halloran, TV				Alvarez, Hamsell M.; Xue, Yi; Robinson, Chandler D.; Canalizo-Hernandez, Monica A.; Marvin, Rebecca G.; Kelly, Rebekah A.; Mondragon, Alfonso; Penner-Hahn, James E.; O'Halloran, Thomas V.			Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation	SCIENCE			English	Article							WILSONS-DISEASE; ATX1 METALLOCHAPERONE; CELL-PROLIFERATION; SUPEROXIDE-DISMUTASE-1; THIOMOLYBDATE; ANGIOGENESIS; RESOLUTION; THERAPY; GROWTH; CANCER	Tetrathiomolybdate (TM) is an orally active agent for treatment of disorders of copper metabolism. Here we describe how TM inhibits proteins that regulate copper physiology. Crystallographic results reveal that the surprising stability of the drug complex with the metallochaperone Atx1 arises from formation of a sulfur-bridged copper-molybdenum cluster reminiscent of those found in molybdenum and iron sulfur proteins. Spectroscopic studies indicate that this cluster is stable in solution and corresponds to physiological clusters isolated from TM-treated Wilson's disease animal models. Finally, mechanistic studies show that the drug-metallochaperone inhibits metal transfer functions between copper-trafficking proteins. The results are consistent with a model wherein TM can directly and reversibly down-regulate copper delivery to secreted metalloenzymes and suggest that proteins involved in metal regulation might be fruitful drug targets.	[Alvarez, Hamsell M.; Xue, Yi; Robinson, Chandler D.; Canalizo-Hernandez, Monica A.; Marvin, Rebecca G.; O'Halloran, Thomas V.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Mondragon, Alfonso; O'Halloran, Thomas V.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Kelly, Rebekah A.; Penner-Hahn, James E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Northwestern University; Northwestern University; University of Michigan System; University of Michigan	O'Halloran, TV (corresponding author), Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.	t-ohalloran@northwestern.edu	Penner-Hahn, James/GYD-3750-2022; Kelly, Rebekah/AAD-8651-2020; O'Halloran, Thomas/ABE-6125-2021	Penner-Hahn, James/0000-0003-0314-1274; O'Halloran, Thomas/0000-0001-8732-5059	NIH [GM54222, GM38784, GM38047]; Robert H. Lurie Comprehensive Cancer Center; U.S. Department of Energy, Office of Basic Energy Sciences; National Center for Research Resources, NIH; National Aeronautics and Space Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038784, R01GM038047, R01GM038784, R37GM038784, R29GM038047, R01GM054111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert H. Lurie Comprehensive Cancer Center; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This manuscript is dedicated to the memory of E. Stiefel and his contributions to the field of molybdenum sulfide chemistry. This work was supported by grant GM54222 and GM38784 (T. V. O.) and GM38047 (J. E. P.-H.) from the NIH. The Robert H. Lurie Comprehensive Cancer Center provided a Malkin Fellowship (H. M. A.) and support for Structural Biology Facility. Use of the Advanced Photon Source [Structural Biology Center-Collaborative Access Team (CAT) and Industrial Macromolecular Crystallography Association CAT] and the Stanford Synchrotron Radiation Laboratory (SSRL) was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, with additional support (at SSRL) from the National Center for Research Resources, NIH. Use of the Chicago Biomedical Consortium (CBC)-University of Illinois at Chicago Proteomics Facility was supported by The Searle Funds at the CBC, and use of LA-ICP-MS was supported by a National Aeronautics and Space Administration grant to the Quantitative Bioelement Imaging Center in the Chemistry of Life Processes Institute at Northwestern University. We thank P. Focia for assistance with x-ray diffraction collection, M. Clausen for assistance in the early stages of XAS measurements, Y. Wang for assistance with the protein MS, A. Davis for providing apo-Ccc2a, and A. Mazar for helpful discussions. The atomic coordinates have been deposited at the Protein Data Bank with code 3K7R.	Bissig KD, 2001, FEBS LETT, V507, P367, DOI 10.1016/S0014-5793(01)03009-5; Brewer GJ, 2000, CLIN CANCER RES, V6, P1; BREWER GJ, 1991, ARCH NEUROL-CHICAGO, V48, P42, DOI 10.1001/archneur.1991.00530130050019; Brewer GJ, 2001, EXP BIOL MED, V226, P665, DOI 10.1177/153537020222600712; CHIDAMBARAM MV, 1984, J INORG BIOCHEM, V22, P231, DOI 10.1016/0162-0134(84)85008-4; *CLINICALTRIALS GO, 2006, ACT TRIALS TM 2001 A; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Ferguson WS, 1938, NATURE, V141, P553, DOI 10.1038/141553a0; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; JIGUO L, 1991, J CHEM SOC CHEM COMM, P249; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Juarez JC, 2006, CLIN CANCER RES, V12, P4974, DOI 10.1158/1078-0432.CCR-06-0171; Lee VE, 2007, J INORG BIOCHEM, V101, P1707, DOI 10.1016/j.jinorgbio.2007.07.015; Mandinov L, 2003, P NATL ACAD SCI USA, V100, P6700, DOI 10.1073/pnas.1231994100; MARSTON HR, 1952, PHYSIOL REV, V32, P66, DOI 10.1152/physrev.1952.32.1.66; MILLS CF, 1979, PHILOS T ROY SOC B, V288, P51, DOI 10.1098/rstb.1979.0090; MILLS CF, 1960, NATURE, V185, P20, DOI 10.1038/185020a0; Pan Q, 2002, CANCER RES, V62, P4854; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Quagraine EK, 2001, J INORG BIOCHEM, V85, P53, DOI 10.1016/S0162-0134(00)00223-3; Redman BG, 2003, CLIN CANCER RES, V9, P1666; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Sadler P. J, 2007, BIOL INORGANIC CHEM, P95; SUZUKI KT, 1995, RES COMMUN MOL PATH, V88, P187; Walshe JM, 1986, ORPHAN DIS ORPHAN DR, P76; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; ZHANG C, 2002, EUR J INORG CHEM, V55, P2002; Zhang LM, 2009, BIOCHEMISTRY-US, V48, P891, DOI 10.1021/bi801926e	31	120	124	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					331	334		10.1126/science.1179907	http://dx.doi.org/10.1126/science.1179907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	19965379	Green Accepted			2022-12-28	WOS:000273629700043
J	Gisin, N				Gisin, Nicolas			Quantum Nonlocality: How Does Nature Do It?	SCIENCE			English	Editorial Material									Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland	University of Geneva	Gisin, N (corresponding author), Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland.	nicolas.gisin@unige.ch						ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Ekert A. K., 2009, PHYS WORLD       SEP, P28; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Gisin N, 2000, ANN PHYS-BERLIN, V9, P831, DOI 10.1002/1521-3889(200011)9:11/12<831::AID-ANDP831>3.0.CO;2-7; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Pironio S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045021; Salart D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.220404; Salart D, 2008, NATURE, V454, P861, DOI 10.1038/nature07121; Stefanov A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120404	12	40	41	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1357	1358		10.1126/science.1182103	http://dx.doi.org/10.1126/science.1182103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965747				2022-12-28	WOS:000272351100028
J	Kramer, GJ; Haigh, M				Kramer, Gert Jan; Haigh, Martin			No quick switch to low-carbon energy	NATURE			English	Editorial Material									[Kramer, Gert Jan] Shell Global Solut Int, NL-1031 CM Amsterdam, Netherlands; [Haigh, Martin] Shell Int, NL-2596 HR The Hague, Netherlands	Royal Dutch Shell; Royal Dutch Shell	Kramer, GJ (corresponding author), Shell Global Solut Int, Grasweg 31, NL-1031 CM Amsterdam, Netherlands.	gertjan.kramer@gmail.com	Kramer, Gert Jan/J-7104-2017	Kramer, Gert Jan/0000-0002-8983-4516				Friedman Thomas L., 2008, HOT FLAT CROWDED WHY; GORE A, 2009, NY TIMES        1109; *INT EN AG, 2008, EN TECHN PERSP 2008, pCH6; Jacobson MZ, 2009, SCI AM, V301, P58, DOI 10.1038/scientificamerican1109-58; MacKay D., 2008, SUSTAINABLE ENERGY H; Valencia J A, 1990, SCIENCE, Patent No. 4923493; [No title captured]	7	156	158	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	2009	462	7273					568	569		10.1038/462568a	http://dx.doi.org/10.1038/462568a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	526HH	19956240				2022-12-28	WOS:000272277900017
J	van Klaveren, RJ; Oudkerk, M; Prokop, M; Scholten, ET; Nackaerts, K; Vernhout, R; van Iersel, CA; van den Bergh, KAM; van't Westeinde, S; van der Aalst, C; Thunnissen, E; Xu, DM; Wang, Y; Zhao, YR; Gietema, HA; de Hoop, BJ; Groen, HJM; de Bock, GH; van Ooijen, P; Weenink, C; Verschakelen, J; Lammers, JWJ; Timens, W; Willebrand, D; Vink, A; Mali, W; de Koning, HJ				van Klaveren, Rob J.; Oudkerk, Matthijs; Prokop, Mathias; Scholten, Ernst T.; Nackaerts, Kristiaan; Vernhout, Rene; van Iersel, Carola A.; van den Bergh, Karien A. M.; van't Westeinde, Susan; van der Aalst, Carlijn; Thunnissen, Erik; Xu, Dong Ming; Wang, Ying; Zhao, Yingru; Gietema, Hester A.; de Hoop, Bart-Jan; Groen, Harry J. M.; de Bock, Geertruida H.; van Ooijen, Peter; Weenink, Carla; Verschakelen, Johny; Lammers, Jan-Willem J.; Timens, Wim; Willebrand, Dik; Vink, Aryan; Mali, Willem; de Koning, Harry J.			Management of Lung Nodules Detected by Volume CT Scanning	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; PULMONARY NODULES; SPIRAL CT; RANDOMIZED FEASIBILITY; SCREENING-PROGRAM; GROWTH-RATE; DOSE CT; CANCER; TRIAL	BACKGROUND The use of multidetector computed tomography (CT) in lung-cancer screening trials involving subjects with an increased risk of lung cancer has highlighted the problem for the clinician of deciding on the best course of action when noncalcified pulmonary nodules are detected by CT. METHODS A total of 7557 participants underwent CT screening in years 1, 2, and 4 of a randomized trial of lung-cancer screening. We used software to evaluate a noncalcified nodule according to its volume or volume-doubling time. Growth was defined as an increase in volume of at least 25% between two scans. The first-round screening test was considered to be negative if the volume of a nodule was less than 50 mm(3), if it was 50 to 500 mm3 but had not grown by the time of the 3-month follow-up CT, or if, in the case of those that had grown, the volume-doubling time was 400 days or more. RESULTS In the first and second rounds of screening, 2.6% and 1.8% of the participants, respectively, had a positive test result. In round one, the sensitivity of the screen was 94.6% (95% confidence interval [CI], 86.5 to 98.0) and the negative predictive value 99.9% (95% CI, 99.9 to 100.0). In the 7361 subjects with a negative screening result in round one, 20 lung cancers were detected after 2 years of follow-up. CONCLUSIONS Among subjects at high risk for lung cancer who were screened in three rounds of CT scanning and in whom noncalcified pulmonary nodules were evaluated according to volume and volume-doubling time, the chances of finding lung cancer 1 and 2 years after a negative first-round test were 1 in 1000 and 3 in 1000, respectively. (Current Controlled Trials number, ISRCTN63545820.)	[van Klaveren, Rob J.; Vernhout, Rene; van Iersel, Carola A.; van't Westeinde, Susan; van der Aalst, Carlijn] Erasmus MC, Dept Pulmonol, NL-3000 CA Rotterdam, Netherlands; [van Iersel, Carola A.; van den Bergh, Karien A. M.; van der Aalst, Carlijn; de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Oudkerk, Matthijs; Xu, Dong Ming; Wang, Ying; Zhao, Yingru; van Ooijen, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands; [de Bock, Geertruida H.] Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [Groen, Harry J. M.] Univ Med Ctr Groningen, Dept Pulmonol, NL-9713 AV Groningen, Netherlands; [Timens, Wim] Univ Med Ctr Groningen, Dept Pathol, NL-9713 AV Groningen, Netherlands; [Prokop, Mathias; Gietema, Hester A.; de Hoop, Bart-Jan; Mali, Willem] Univ Med Ctr, Dept Radiol, Utrecht, Netherlands; [Lammers, Jan-Willem J.] Univ Med Ctr, Dept Pulmonol, Utrecht, Netherlands; [Vink, Aryan] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands; [Scholten, Ernst T.] Kennemer Gasthuis, Dept Radiol, Haarlem, Netherlands; [Weenink, Carla] Kennemer Gasthuis, Dept Pulmonol, Haarlem, Netherlands; [Willebrand, Dik] Kennemer Gasthuis, Dept Pathol, Haarlem, Netherlands; [Thunnissen, Erik] Free Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Nackaerts, Kristiaan] Univ Hosp Gasthuisberg, Dept Pulmonol, B-3000 Louvain, Belgium; [Verschakelen, Johny] Univ Hosp Gasthuisberg, Dept Radiol, B-3000 Louvain, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Spaarne Hospital; Spaarne Hospital; Spaarne Hospital; Vrije Universiteit Amsterdam; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	van Klaveren, RJ (corresponding author), Erasmus MC, Dept Pulmonol, NL-3000 CA Rotterdam, Netherlands.	r.j.vanklaveren@erasmusmc.nl	van Ooijen, Peter/B-9150-2008; Timens, Wim/K-5570-2013; Mali, Willem PThM/I-1123-2014; Groen, Harry/AAP-2242-2021; Vink, Aryan/E-3585-2010; van der Aalst, Carlijn/AAG-7522-2019; de Bock, Geertruida Hendrika/F-6529-2014; de+Koning, Harry/AAF-9062-2019; Prokop, W.M./H-8081-2014	van Ooijen, Peter/0000-0002-8995-1210; Timens, Wim/0000-0002-4146-6363; Mali, Willem PThM/0000-0003-4391-0904; de Bock, Geertruida Hendrika/0000-0003-3104-4471; de+Koning, Harry/0000-0003-4682-3646; Thunnissen, Erik/0000-0001-5355-8508; Groen, Harry J.M./0000-0002-2978-5265; Verschakelen, Johny/0000-0001-9573-9614; Oudkerk, Matthijs/0000-0003-2800-4110; Prokop, Mathias/0000-0001-8157-8055	Zorg Onderzoek Nederland-Medische Wetenschappen; KWF Kankerbestrijding; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; G. Ph. Verhagen Foundation; Rotterdam Oncologic Thoracic Study Group; Erasmus Trust; Foundation against Cancer; Flemish League against Cancer; Lokaal Gezondheids Overleg (LOGO) Leuven and Hageland; Eli Lilly; Roche Pharmaceuticals; Roche Diagnostics; Mundipharma; Novartis; Utrecht University; GlaxoSmithKline; Nycomed; AstraZeneca	Zorg Onderzoek Nederland-Medische Wetenschappen; KWF Kankerbestrijding(KWF Kankerbestrijding); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; G. Ph. Verhagen Foundation; Rotterdam Oncologic Thoracic Study Group; Erasmus Trust; Foundation against Cancer; Flemish League against Cancer; Lokaal Gezondheids Overleg (LOGO) Leuven and Hageland; Eli Lilly(Eli Lilly); Roche Pharmaceuticals(Roche Holding); Roche Diagnostics; Mundipharma; Novartis(Novartis); Utrecht University; GlaxoSmithKline(GlaxoSmithKline); Nycomed; AstraZeneca(AstraZeneca)	Supported by Zorg Onderzoek Nederland-Medische Wetenschappen, KWF Kankerbestrijding, Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen, G. Ph. Verhagen Foundation, Rotterdam Oncologic Thoracic Study Group, Erasmus Trust Fund, Foundation against Cancer, Flemish League against Cancer, and Lokaal Gezondheids Overleg (LOGO) Leuven and Hageland. Roche Diagnostics provided an unrestricted research grant. Siemens Germany provided four digital workstations and accompanying software but had no other role in the study.; Dr. van Klaveren reports receiving advisory board fees, lecture fees, and grant support from Eli Lilly, Roche Pharmaceuticals, and Roche Diagnostics; Dr. Weenink, lecture fees from Mundipharma; and Dr. Lammers, lecture fees from Novartis and grant support from a public-private partnership (Utrecht University, GlaxoSmithKline, Nycomed, and AstraZeneca). No other potential conflict of interest relevant to this article was reported.	AANDERIJN A, 2004, CBO GUIDELINE NONSMA; Black WC, 2007, CANCER-AM CANCER SOC, V110, P2370, DOI 10.1002/cncr.23059; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Bolte H, 2007, BRIT J RADIOL, V80, P414, DOI 10.1259/bjr/23933268; Fischbach F, 2003, EUR RADIOL, V13, P2378, DOI 10.1007/s00330-003-1915-7; Gietema HA, 2007, RADIOLOGY, V245, P888, DOI 10.1148/radiol.2452061054; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Goodman LR, 2006, AM J ROENTGENOL, V186, P989, DOI 10.2214/AJR.04.1821; Henschke CI, 2008, NEW ENGL J MED, V358, P1875; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Henschke CI, 2008, NEW ENGL J MED, V359, P871, DOI 10.1056/NEJMc086327; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Infante M, 2008, LUNG CANCER, V59, P355, DOI 10.1016/j.lungcan.2007.08.040; *INT EARL LUNG CAN, 2008, JAMA-J AM MED ASSOC, V299, P1775; *INT EARL LUNG CAN, 2008, NEW ENGL J MED, V358, P1862; Lindell RM, 2007, RADIOLOGY, V242, P555, DOI 10.1148/radiol.2422052090; LINDELL RM, 2009, CHEST           0706; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; MENEZES RJ, 2009, LUNG CANC       0506; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; *NAT CANC I, 2009, NAT LUNG SCREEN TRIA; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Revel MP, 2006, AM J ROENTGENOL, V187, P135, DOI 10.2214/AJR.05.1228; Sone S, 2007, LUNG CANCER, V58, P329, DOI 10.1016/j.lungcan.2007.06.022; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2002, LUNG CANCER, V38, P243, DOI 10.1016/S0169-5002(02)00222-2; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2008, J THORAC CARDIOV SUR, V136, P611, DOI 10.1016/j.jtcvs.2008.02.082; Veronesi G, 2007, ANN THORAC SURG, V84, P959, DOI 10.1016/j.athoracsur.2007.04.058; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Winer-Muram HT, 2002, RADIOLOGY, V223, P798, DOI 10.1148/radiol.2233011026; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Xu DM, 2006, LUNG CANCER, V54, P177, DOI 10.1016/j.lungcan.2006.08.006; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185	38	622	627	3	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2221	2229		10.1056/NEJMoa0906085	http://dx.doi.org/10.1056/NEJMoa0906085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19955524	Green Published			2022-12-28	WOS:000272257100005
J	Li, WL; Tucker, AE; Sung, W; Thomas, WK; Lynch, M				Li, Wenli; Tucker, Abraham E.; Sung, Way; Thomas, W. Kelley; Lynch, Michael			Extensive, Recent Intron Gains in Daphnia Populations	SCIENCE			English	Article							EUKARYOTIC EVOLUTION; SPLICEOSOMAL INTRON; GENES; POSITIONS; CAENORHABDITIS; CONSERVATION; PATTERNS; PULEX	Rates and mechanisms of intron gain and loss have traditionally been inferred from alignments of highly conserved genes sampled from phylogenetically distant taxa. We report a population-genomic approach that detected 24 discordant intron/exon boundaries between the whole-genome sequences of two Daphnia pulex isolates. Sequencing of presence/absence loci across a collection of D. pulex isolates and outgroup Daphnia species shows that most polymorphisms are a consequence of recent gains, with parallel gains often occurring at the same locations in independent allelic lineages. More than half of the recent gains are associated with short sequence repeats, suggesting an origin via repair of staggered double-strand breaks. By comparing the allele-frequency spectrum of intron-gain alleles with that for derived single-base substitutions, we also provide evidence that newly arisen introns are intrinsically deleterious and tend to accumulate in population-genetic settings where random genetic drift is a relatively strong force.	[Li, Wenli; Tucker, Abraham E.; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Sung, Way; Thomas, W. Kelley] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA	Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	milynch@indiana.edu		Li, Wenli/0000-0002-9006-0634	NSF [MCB-0342431, EF-082741, EF-0328516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NSF grants MCB-0342431, EF-082741, and EF-0328516 (M. L.). We thank F. Catania, T. Doak, J. Colbourne, and K. Montooth for discussions, and A. Seyfert, S. Schaack, A. Omilian, and E. Williams for early contributions to this project. Genome sequences and annotation are available through the collaboration of JGI and the Daphnia Genomics Consortium at http://genome.jgi-psf.org/Dappu1/Dappu1. home.html. Intron data are provided in the online supplement. Sequences have been deposited in GenBank, accession numbers GQ984366 to GQ985204 (for details see tables S6 and S7).	Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Hazkani-Covo E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000237; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Lynch M, 1999, EVOLUTION, V53, P100, DOI 10.1111/j.1558-5646.1999.tb05336.x; Lynch M, 2007, ORIGINS GENOME ARCHI; Nguyen HD, 2005, PLOS COMPUT BIOL, V1, P631, DOI 10.1371/journal.pcbi.0010079; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Paland S, 2005, EVOLUTION, V59, P800; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2007, MOL BIOL EVOL, V24, P1447, DOI 10.1093/molbev/msm048; Roy SW, 2007, MOL BIOL EVOL, V24, P1926, DOI 10.1093/molbev/msm102; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Tarrio R, 2003, P NATL ACAD SCI USA, V100, P6580, DOI 10.1073/pnas.0731952100; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4	30	99	100	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1260	1262		10.1126/science.1179302	http://dx.doi.org/10.1126/science.1179302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965475	Green Accepted			2022-12-28	WOS:000272117900047
J	Ochman, H; Raghavan, R				Ochman, Howard; Raghavan, Rahul			Excavating the Functional Landscape of Bacterial Cells	SCIENCE			English	Editorial Material							COMPLETE GENOME SEQUENCE		[Ochman, Howard; Raghavan, Rahul] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85718 USA	University of Arizona	Ochman, H (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85718 USA.	hochman@email.arizona.edu						Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuo CH, 2009, GENOME BIOL EVOL, V1, P145, DOI 10.1093/gbe/evp016; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	12	9	10	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1200	1201		10.1126/science.1183757	http://dx.doi.org/10.1126/science.1183757			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965458				2022-12-28	WOS:000272117900029
J	Fratzl, P; Barth, FG				Fratzl, Peter; Barth, Friedrich G.			Biomaterial systems for mechanosensing and actuation	NATURE			English	Review							ARTHROPOD FILIFORM HAIRS; CUPIENNIUS-SALEI KEYS; ARACHNID SLIT SENSILLA; MECHANICAL-PROPERTIES; SPIDER TRICHOBOTHRIA; STRUCTURAL-MATERIALS; TOUCH RECEPTION; FLOW-SENSORS; WHEAT AWNS; PINE-CONES	Living organisms use composite materials for various functions, such as mechanical support, protection, motility and the sensing of signals. Although the individual components of these materials may have poor mechanical qualities, they form composites of polymers and minerals with a remarkable variety of functional properties. Researchers are now using these natural systems as models for artificial mechanosensors and actuators, through studying both natural structures and their interactions with the environment. In addition to inspiring the design of new materials, analysis of natural structures on this basis can provide insight into evolutionary constraints on structure-function relationships in living organisms and the variety of structural solutions that emerged from these constraints.	[Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany; [Barth, Friedrich G.] Univ Vienna, Dept Neurobiol & Cognit Res, A-1090 Vienna, Austria	Max Planck Society; University of Vienna	Fratzl, P (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Res Campus Golm, D-14424 Potsdam, Germany.	fratzl@mpikg.mpg.de; friedrich.g.barth@univie.ac.at	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830	Austrian Science Fund; US Defense Advanced Research Projects Agency; Alexander von Humboldt Foundation	Austrian Science Fund(Austrian Science Fund (FWF)); US Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The work of F. G. B. was generously supported by the Austrian Science Fund and the BioSenSE programme of the US Defense Advanced Research Projects Agency. The productive collaboration with engineers, in particular J.A.C. Humphrey, F. G. Rammerstorfer and V. V. Tsukruk and their research groups, is gratefully acknowledged. P. F. was supported by the Alexander von Humboldt Foundation in the framework of the Max Planck Research Prize. He is grateful for discussions with, and advice from, co-workers and colleagues, in particular I. Burgert, R. Elbaum, O. Paris, J. Dunlop and L. Mahadevan.	AIZENBERG J, 2009, ADV MAT, V21; Albert JT, 2001, J COMP PHYSIOL A, V187, P303, DOI 10.1007/s003590100202; BARBOSA CAS, 2007, 20 NOVEMBRO 1910 REV, P1; BARTH FG, 1993, PHILOS T R SOC B, V340, P445, DOI 10.1098/rstb.1993.0084; BARTH FG, 1973, Z ZELLFORSCH MIK ANA, V144, P409, DOI 10.1007/BF00307585; BARTH FG, 1988, OECOLOGIA, V77, P194, DOI 10.1007/BF00379186; Barth FG, 1999, PHILOS T R SOC B, V354, P183, DOI 10.1098/rstb.1999.0370; Barth FG, 1998, SPR HDB AUD, V10, P228; BARTH FG, 1995, PHILOS T R SOC B, V347, P397, DOI 10.1098/rstb.1995.0032; BARTH FG, 1997, ORIENTATION COMMUNIC, P247; BECKWITH TG, 1993, MECH MEASUREMENTS; BLECKMANN H, 2006, SENSORY SYSTEMS NEUR, P411; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Burgert I, 2007, PLANTA, V226, P981, DOI 10.1007/s00425-007-0544-9; Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003; Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307; Chen NN, 2007, J MICROELECTROMECH S, V16, P999, DOI 10.1109/JMEMS.2007.902436; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; Dechant HE, 2001, J COMP PHYSIOL A, V187, P313, DOI 10.1007/s003590100203; DECHANT HE, 2001, THESIS VIENNA TU; den Toonder J, 2008, LAB CHIP, V8, P533, DOI 10.1039/b717681c; Dijkstra M, 2005, J MICROMECH MICROENG, V15, pS132, DOI 10.1088/0960-1317/15/7/019; Dong LX, 2007, NANO TODAY, V2, P12, DOI 10.1016/S1748-0132(07)70169-X; Elbaum R, 2008, J STRUCT BIOL, V164, P101, DOI 10.1016/j.jsb.2008.06.008; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; Evans BA, 2007, NANO LETT, V7, P1428, DOI 10.1021/nl070190c; Fan ZF, 2002, J MICROMECH MICROENG, V12, P655, DOI 10.1088/0960-1317/12/5/322; Farber J, 2001, J MATER SCI, V36, P5087, DOI 10.1023/A:1012465005607; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Fratzl P, 2008, FARADAY DISCUSS, V139, P275, DOI 10.1039/b716663j; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218; Friedel T, 1997, J COMP PHYSIOL A, V180, P223, DOI 10.1007/s003590050043; FRIEDRICH OC, 2001, THESIS U VIENNA; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Goswami L, 2008, PLANT J, V56, P531, DOI 10.1111/j.1365-313X.2008.03617.x; GULCH RW, 1994, INT J SPORTS MED, V15, pS2, DOI 10.1055/s-2007-1021103; Haupt W, 1977, BEWEGUNGSPHYSIOLOGIE; HILL AV, 1953, PROC R SOC SER B-BIO, V141, P104, DOI 10.1098/rspb.1953.0027; Hossl B, 2006, J BIOMECH, V39, P1761, DOI 10.1016/j.jbiomech.2005.05.031; Hossl B, 2007, J COMP PHYSIOL A, V193, P445, DOI 10.1007/s00359-006-0201-y; Humphrey JAC, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P129; Humphrey JAC, 2007, ADV INSECT PHYSIOL, V34, P1, DOI 10.1016/S0065-2806(07)34001-0; Johnson EAC, 2009, PHILOS T R SOC A, V367, P1559, DOI 10.1098/rsta.2009.0005; KLOPSCH C, 2007, P 5 INT S TURB SHEAR, P1023; Krijnen GJM, 2006, NANOTECHNOLOGY, V17, pS84, DOI 10.1088/0957-4484/17/4/013; Kulic IM, 2009, P ROY SOC B-BIOL SCI, V276, P2243, DOI 10.1098/rspb.2008.1685; Li DB, 2009, MRS BULL, V34, P671, DOI 10.1557/mrs2009.179; McConney ME, 2007, J R SOC INTERFACE, V4, P1135, DOI 10.1098/rsif.2007.1000; McConney ME, 2009, ADV FUNCT MATER, V19, P2527, DOI 10.1002/adfm.200900606; McConney ME, 2009, J R SOC INTERFACE, V6, P681, DOI 10.1098/rsif.2008.0463; Messersmith PB, 2008, SCIENCE, V319, P1767, DOI 10.1126/science.1155122; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Neville A.C., 1975, BIOL ARTHROPOD CUTIC; Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295; Pennycuick CJ, 1992, NEWTON RULES BIOL PH, P30; Pokroy B, 2009, SCIENCE, V323, P237, DOI 10.1126/science.1165607; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schwille P, 2009, CRIT REV BIOCHEM MOL, V44, P223, DOI 10.1080/10409230903074549; Seidel R, 2008, MICRON, V39, P198, DOI 10.1016/j.micron.2007.02.004; Shimozawa T, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P145; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; SPERLING LH, 1997, POLYM MULTICOMPONENT; Suh JW, 1999, J MICROELECTROMECH S, V8, P483, DOI 10.1109/84.809064; THURM U, 1982, BIOPHYSIK, P691; Vaia R, 2008, SCIENCE, V319, P420, DOI 10.1126/science.1152931; VOGEL E, 2009, THESIS U VIENNA; Wheeler TD, 2008, NATURE, V455, P208, DOI 10.1038/nature07226; Whitesides GM, 2009, FARADAY DISCUSS, V143, P373, DOI 10.1039/b917540g; Zwaag S.v.d., 2007, SELF HEALING MAT ALT	73	480	487	15	470	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					442	448		10.1038/nature08603	http://dx.doi.org/10.1038/nature08603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940914				2022-12-28	WOS:000272144200032
J	Krahmer, N; Guo, Y; Farese, RV; Walther, TC				Krahmer, Natalie; Guo, Yi; Farese, Robert V., Jr.; Walther, Tobias C.			SnapShot: Lipid Droplets	CELL			English	Editorial Material							TRIACYLGLYCEROL; PROTEINS		[Krahmer, Natalie; Walther, Tobias C.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Guo, Yi; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, San Francisco, CA 94158 USA	Max Planck Society; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Krahmer, N (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.		Krahmer, Natalie/AAL-9467-2020	Krahmer, Natalie/0000-0003-4063-7367; Walther, Tobias/0000-0003-1442-1327				Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; ZIMMERMANN R, 2008, BIOCHIM BIOPHYS ACTA, V1791, P494	7	51	53	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					1024	U192		10.1016/j.cell.2009.11.023	http://dx.doi.org/10.1016/j.cell.2009.11.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945384	Bronze			2022-12-28	WOS:000272169400026
J	Hingorani, AD; Psaty, BM				Hingorani, Aroon D.; Psaty, Bruce M.			Primary Prevention of Cardiovascular Disease Time to Get More or Less Personal?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; INDIVIDUALS		[Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 9BT, England; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London WC1E 9BT, England; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Ctr Hlth Studies, Seattle, WA USA	University of London; University College London; University of London; University College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hingorani, AD (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, 1-19 Torrington Pl, London WC1E 9BT, England.	a.hingorani@ucl.ac.uk		Hingorani, Aroon/0000-0001-8365-0081	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, R01HL080295, R01HL087652, R01HL085251, U01HL080295] Funding Source: NIH RePORTER; British Heart Foundation [FS05/125] Funding Source: Medline; NHLBI NIH HHS [HL080295, HL087652, HL74745, HL085251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Committee on Comparative Effectiveness Research Prioritization Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; *NAT I HLTH CLIN E, PUTT PREV 1 VASC CHE; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Wald NJ, 2005, J MED SCREEN, V12, P197, DOI 10.1258/096914105775220642; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	10	22	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2144	2145		10.1001/jama.2009.1698	http://dx.doi.org/10.1001/jama.2009.1698			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920239				2022-12-28	WOS:000271873900024
J	Sasaki, T; Tsunoda, K				Sasaki, Toru; Tsunoda, Koichi			Time to revisit mumps vaccination in Japan?	LANCET			English	Editorial Material									[Sasaki, Toru] Tokyo Kita Social Insurance Hosp, Dept Otolaryngol, Kita Ku, Tokyo 1150053, Japan; [Tsunoda, Koichi] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan		Sasaki, T (corresponding author), Tokyo Kita Social Insurance Hosp, Dept Otolaryngol, Kita Ku, 4-17-56 Akabane Dai, Tokyo 1150053, Japan.	torusasaki-tky@umin.ac.jp	Tsunoda, Koichi/L-4188-2019					[Anonymous], 2005, Wkly Epidemiol Rec, V80, P418; *INF DIS SURV CTR, 2003, INFECT AGENTS SURVEI, V24, P103; Ishida M, 2006, LARYNGOSCOPE, V116, P2221, DOI 10.1097/01.mlg.0000246189.38777.2c; Kimura M, 2006, J JPN BRONCHOESOPHAG, V57, P502; KOBAYASHI T, 2008, OTORHINOLARYNGOLOGY, V51, P49; MALDONADO Y, 2004, NELSON TXB PEDIAT, P1035	6	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2009	374	9702					1722	1722		10.1016/S0140-6736(09)61341-6	http://dx.doi.org/10.1016/S0140-6736(09)61341-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	522LP	19914517				2022-12-28	WOS:000271999700029
J	Baden, LR; Digumarthy, SR; Guimaraes, ASR; Branda, JA				Baden, Lindsey R.; Digumarthy, Subba R.; Guimaraes, Alexander S. R.; Branda, John A.			Case 35-2009: A 60-Year-Old Male Renal-Transplant Recipient with Renal Insufficiency, Diabetic Ketoacidosis, and Mental-Status Changes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COCCIDIOIDES-IMMITIS; NECROSIS-FACTOR; INFECTION; SEROLOGY; DISEASE		[Baden, Lindsey R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Digumarthy, Subba R.; Guimaraes, Alexander S. R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Baden, Lindsey R.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Digumarthy, Subba R.; Guimaraes, Alexander S. R.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Baden, LR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.		Branda, John/ABD-5620-2020					Assi MA, 2006, LIVER TRANSPLANT, V12, P1290, DOI 10.1002/lt.20820; Baden LR, 2004, TRANSPLANTATION, V77, P356, DOI 10.1097/01.TP.0000101436.76588.D4; Barker BM, 2007, ANN NY ACAD SCI, V1111, P147, DOI 10.1196/annals.1406.040; Blair JE, 2007, ANN NY ACAD SCI, V1111, P411, DOI 10.1196/annals.1406.010; Blair JE, 2006, MYCOPATHOLOGIA, V162, P317, DOI 10.1007/s11046-006-0062-5; Blair JE, 2004, DIGEST DIS SCI, V49, P1981, DOI 10.1007/s10620-004-9605-0; Blair JE, 2003, LIVER TRANSPLANT, V9, P843, DOI 10.1053/jlts.2003.50125; *FDA, FDA REQ STRONG FUNG; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Galgiani JN, 2005, CLIN INFECT DIS, V41, P1217, DOI 10.1086/496991; Jewell K, 2008, MED MYCOL, V46, P449, DOI 10.1080/13693780801961337; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kuberski T, 2007, CLIN INFECT DIS, V44, P50, DOI 10.1086/511684; Marty FM, 2009, MED MYCOL, V47, pS233, DOI 10.1080/13693780802308454; Mertz LE, 2007, ANN NY ACAD SCI, V1111, P343, DOI 10.1196/annals.1406.027; PAPPAGIANIS D, 1990, CLIN MICROBIOL REV, V3, P247, DOI 10.1128/CMR.3.3.247-268.1990; Ramani R, 2007, MYCOPATHOLOGIA, V163, P315, DOI 10.1007/s11046-007-9018-7; Rodriguez M, 2005, CLIN INFECT DIS, V41, pE112, DOI 10.1086/498154; Saubolle MA, 2007, ANN NY ACAD SCI, V1111, P301, DOI 10.1196/annals.1406.049; STEVENS DA, 1995, NEW ENGL J MED, V332, P1077, DOI 10.1056/NEJM199504203321607; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989	23	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1980	1989		10.1056/NEJMcpc0900645	http://dx.doi.org/10.1056/NEJMcpc0900645			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907046				2022-12-28	WOS:000271660500015
J	Hren, MT; Tice, MM; Chamberlain, CP				Hren, M. T.; Tice, M. M.; Chamberlain, C. P.			Oxygen and hydrogen isotope evidence for a temperate climate 3.42 billion years ago	NATURE			English	Article							SOUTH-AFRICA; WATER; EVOLUTION; RATIOS; CHERT; GEOCHEMISTRY; TRANSVAAL; SEAWATER; BEARING; ORIGIN	Stable oxygen isotope ratios (delta O-18) of Precambrian cherts have been used to establish much of our understanding of the early climate history of Earth(1-3) and suggest that ocean temperatures during the Archaean era (similar to 3.5 billion years ago) were between 55 degrees C and 85 degrees C (ref. 2). But, because of uncertainty in the delta O-18 of the primitive ocean, there is considerable debate regarding this conclusion. Examination of modern and ancient cherts indicates that another approach, using a combined analysis of delta O-18 and hydrogen isotopes (delta D) rather than delta O-18 alone, can provide a firmer constraint on formational temperatures without independent knowledge of the isotopic composition of ambient waters(4,5). Here we show that delta O-18 and delta D sampled from 3.42-billion-year-old Buck Reef Chert rocks in South Africa are consistent with formation from waters at varied low temperatures. The most O-18-enriched Buck Reef Chert rocks record the lowest diagenetic temperatures and were formed in equilibrium with waters below similar to 40 degrees C. Geochemical and sedimentary evidence suggests that the Buck Reef Chert was formed in shallow to deep marine conditions, so our results indicate that the Palaeoarchaean ocean was isotopically depleted relative to the modern ocean and far cooler (<= 40 degrees) than previously thought(2).	[Hren, M. T.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Tice, M. M.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Chamberlain, C. P.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	Yale University; Texas A&M University System; Texas A&M University College Station; Stanford University	Hren, MT (corresponding author), Univ Michigan, Dept Geol Sci, 2534 CC Little Bldg,1100 N Univ Ave, Ann Arbor, MI 48109 USA.	mhren@umich.edu; tice@geo.tamu.edu		Hren, Michael/0000-0002-2866-8892				Abruzzese MJ, 2005, GEOCHIM COSMOCHIM AC, V69, P1377, DOI 10.1016/j.gca.2004.08.036; CLAYTON RN, 1972, J GEOPHYS RES, V77, P3057, DOI 10.1029/JB077i017p03057; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Genda H, 2008, ICARUS, V194, P42, DOI 10.1016/j.icarus.2007.09.007; Hofmann A, 2008, CHEM GEOL, V257, P224, DOI 10.1016/j.chemgeo.2008.09.015; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; KNAUTH LP, 1976, GEOCHIM COSMOCHIM AC, V40, P1095, DOI 10.1016/0016-7037(76)90051-X; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; KNAUTH LP, 1975, EARTH PLANET SC LETT, V25, P1, DOI 10.1016/0012-821X(75)90204-6; KNAUTH LP, 1978, EARTH PLANET SC LETT, V41, P209, DOI 10.1016/0012-821X(78)90011-0; KNAUTH LP, 1982, AM MINERAL, V67, P510; KNAUTH LP, 1973, THESIS CALTECH, P1; LILJESTRAND FL, 1999, GEOL S AM S, P83, DOI 10.1130/0-8137-2329-9.83; Lowe DR, 2007, EARTH PLANET SC LETT, V253, P530, DOI 10.1016/j.epsl.2006.11.006; LOWE DR, 1977, J GEOL, V85, P699, DOI 10.1086/628358; PERRY EC, 1967, EARTH PLANET SC LETT, V3, P62, DOI 10.1016/0012-821X(67)90012-X; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Sharp ZD, 2002, GEOCHIM COSMOCHIM AC, V66, P2865, DOI 10.1016/S0016-7037(02)00873-6; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266; Sleep NH, 2006, EARTH PLANET SC LETT, V241, P594, DOI 10.1016/j.epsl.2005.11.020; SUZUOKI T, 1976, GEOCHIM COSMOCHIM AC, V40, P1229, DOI 10.1016/0016-7037(76)90158-7; TAYLOR HP, 1974, ECON GEOL, V69, P843, DOI 10.2113/gsecongeo.69.6.843; Tice MM, 2006, EARTH-SCI REV, V76, P259, DOI 10.1016/j.earscirev.2006.03.003; Tice MM, 2006, GEOLOGY, V34, P37, DOI 10.1130/G22012.1; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; van den Boorn SHJM, 2007, GEOLOGY, V35, P939, DOI 10.1130/G24096A.1; WALKER JCG, 1989, GEOPHYS RES LETT, V16, P323, DOI 10.1029/GL016i004p00323; WALLMAN K, 2004, GEOCHEM GEOPHYS GEOS, V5; Xie XG, 1997, CONTRIB MINERAL PETR, V126, P275, DOI 10.1007/s004100050250	30	117	119	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					205	208		10.1038/nature08518	http://dx.doi.org/10.1038/nature08518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907491				2022-12-28	WOS:000271655100040
J							UNAIDS Reference Grp Estimates Mod	HIV: consensus indicators are needed for concurrency	LANCET			English	Editorial Material							SEXUAL PARTNERSHIPS							McGrath, Nuala/0000-0002-1039-0159; Eaton, Jeffrey/0000-0001-7728-728X; Hallett, Timothy/0000-0002-9681-0424	MRC [MC_U950080926] Funding Source: UKRI; Medical Research Council [MC_U950080926] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AIDSSTAR One, 2009, ADDR MULT CONC SEX P; [Anonymous], [No title captured]; CARAEL M, 1995, SOC AS AIDS, P75; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Gorbach PM, 2002, SEX TRANSM DIS, V29, P453, DOI 10.1097/00007435-200208000-00004; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; SHEKHAR N, 2008, MEASURING SEXUAL PAR; Shelton JD, 2009, LANCET, V374, P367, DOI 10.1016/S0140-6736(09)61399-4; UNAIDS (United National Programme on AIDS), 2009, CONS CONC SEX PARTN	13	78	78	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					621	622		10.1016/S0140-6736(09)62040-7	http://dx.doi.org/10.1016/S0140-6736(09)62040-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	19954832	Green Accepted			2022-12-28	WOS:000275210900009
J	Harrington, RA; Stone, GW; McNulty, S; White, HD; Lincoff, AM; Gibson, CM; Pollack, CV; Montalescot, G; Mahaffey, KW; Kleiman, NS; Goodman, SG; Amine, M; Angiolillo, DJ; Becker, RC; Chew, DP; French, WJ; Leisch, F; Parikh, KH; Skerjanec, S; Bhatt, DL				Harrington, Robert A.; Stone, Gregg W.; McNulty, Steven; White, Harvey D.; Lincoff, A. Michael; Gibson, C. Michael; Pollack, Charles V., Jr.; Montalescot, Gilles; Mahaffey, Kenneth W.; Kleiman, Neal S.; Goodman, Shaun G.; Amine, Maged; Angiolillo, Dominick J.; Becker, Richard C.; Chew, Derek P.; French, William J.; Leisch, Franz; Parikh, Keyur H.; Skerjanec, Simona; Bhatt, Deepak L.			Platelet Inhibition with Cangrelor in Patients Undergoing PCI.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; RECEPTOR ANTAGONISTS; END-POINTS; CLOPIDOGREL; ASPIRIN; AGGREGATION; THERAPY; TRIAL; PRASUGREL	Background: Cangrelor, a nonthienopyridine adenosine triphosphate analogue, is an intravenous blocker of the adenosine diphosphate receptor P2Y(sub 12). This agent might have a role in the treatment of patients who require rapid, predictable, and profound but reversible platelet inhibition. Methods: We performed a large-scale international trial comparing cangrelor with 600 mg of oral clopidogrel administered before percutaneous coronary intervention (PCI) in patients with acute coronary syndromes. The primary efficacy end point was a composite of death from any cause, myocardial infarction, or ischemia-driven revascularization at 48 hours. Results: We enrolled 8877 patients, and 8716 underwent PCI. At 48 hours, cangrelor was not superior to clopidogrel with respect to the primary composite end point, which occurred in 7.5% of patients in the cangrelor group and 7.1% of patients in the clopidogrel group (odds ratio, 1.05; 95% confidence interval [CI], 0.88 to 1.24; P=0.59). Likewise, cangrelor was not superior at 30 days. The rate of major bleeding (according to Acute Catheterization and Urgent Intervention Triage Strategy criteria) was higher with cangrelor, a difference that approached statistical significance (3.6% vs. 2.9%; odds ratio, 1.26; 95% CI, 0.99 to 1.60; P=0.06), but this was not the case with major bleeding (according to the Thrombolysis in Myocardial Infarction criteria) or severe or life-threatening bleeding (according to Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries criteria). A secondary exploratory end point of death from any cause, Q-wave myocardial infarction, or ischemia-driven revascularization showed a trend toward a reduction with cangrelor, but it was not significant (0.6% vs. 0.9%; odds ratio, 0.67; 95% CI, 0.39 to 1.14; P=0.14). Conclusions: Cangrelor, when administered intravenously 30 minutes before PCI and continued for 2 hours after PCI, was not superior to an oral loading dose of 600 mg of clopidogrel, administered 30 minutes before PCI, in reducing the composite end point of death from any cause, myocardial infarction, or ischemia-driven revascularization at 48 hours. (ClinicalTrials.gov number, NCT00305162.) N Engl J Med 2009;361:2318-29.	[Harrington, Robert A.; McNulty, Steven; Mahaffey, Kenneth W.; Becker, Richard C.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; [Lincoff, A. Michael] Cleveland Clin, Cleveland, OH USA; [Gibson, C. Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Pollack, Charles V., Jr.] Univ Penn, Penn Hosp, Philadelphia, PA 19104 USA; [Montalescot, Gilles] Hop La Pitie Salpetriere, Inst Cardiol, Paris, France; [Kleiman, Neal S.] Methodist Hosp, Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Amine, Maged] NW Heart Ctr, Tomball, TX USA; [Goodman, Shaun G.] St Michaels Hosp, Terrence Donnelly Heart Ctr, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Goodman, Shaun G.] Canadian Heart Res Ctr, Toronto, ON, Canada; [Angiolillo, Dominick J.] Univ Florida, Coll Med, Jacksonville, FL USA; [Chew, Derek P.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Chew, Derek P.] Flinders Med Ctr, Adelaide, SA, Australia; [French, William J.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Leisch, Franz] City Hosp Linz, Div Cardiovasc, Linz, Austria; [Parikh, Keyur H.] Heart Care Clin, Ahmadabad, Gujarat, India; [Skerjanec, Simona] Medicines Co, Parsippany, NJ USA	Duke University; Columbia University; Cardiovascular Research Foundation (CRF); Auckland City Hospital; Cleveland Clinic Foundation; Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Canadian Heart Research Centre; University of Toronto; State University System of Florida; University of Florida; Flinders University South Australia; Flinders Medical Centre; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Harrington, RA (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	robert.harrington@duke.edu	Gibson, C. Michael/AAE-8212-2019	Chew, Derek/0000-0003-3593-296X				Behan MWH, 2005, PLATELETS, V16, P73, DOI 10.1080/09537100400005634; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Cannon CP, 2007, J AM COLL CARDIOL, V50, P1844, DOI 10.1016/j.jacc.2007.07.053; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; *FOOD DRUG ADM, INT C HARM ICH GUID; Greenbaum AB, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.014; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; Gurbel PA, 2005, J AM COLL CARDIOL, V45, P1392, DOI 10.1016/j.jacc.2005.01.030; Gurbel PA, 2006, NAT CLIN PRACT CARD, V3, P387, DOI 10.1038/ncpcardio0602; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Mahaffey KW, 2002, AM HEART J, V143, P242, DOI 10.1067/mhj.2002.120145; Maisel WH, 2007, NEW ENGL J MED, V356, P981, DOI 10.1056/NEJMp068305; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Popma JJ, 2004, CHEST, V126, p576S, DOI 10.1378/chest.126.3_suppl.576S; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Storey RF, 2002, PLATELETS, V13, P407, DOI 10.1080/0953710021000024402; Tcheng JE, 1997, LANCET, V349, P1422; Tcheng JE, 2000, LANCET, V356, P2037; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Windecker S, 2007, CIRCULATION, V116, P1952, DOI 10.1161/CIRCULATIONAHA.106.683995; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494; [No title captured]	35	426	457	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2318	2329		10.1056/NEJMoa0908628	http://dx.doi.org/10.1056/NEJMoa0908628			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	19915221				2022-12-28	WOS:000272547600006
J	Echevarria-Zuno, S; Mejia-Arangure, JM; Mar-Obeso, AJ; Grajales-Muniz, C; Robles-Perez, E; Gonzalez-Leon, M; Ortega-Alvarez, MC; Gonzalez-Bonilla, C; Rascon-Pacheco, RA; Borja-Aburto, VH				Echevarria-Zuno, Santiago; Manuel Mejia-Arangure, Juan; Mar-Obeso, Alvaro J.; Grajales-Muniz, Concepcion; Robles-Perez, Eduardo; Gonzalez-Leon, Margot; Carlos Ortega-Alvarez, Manuel; Gonzalez-Bonilla, Cesar; Alberto Rascon-Pacheco, Ramon; Hugo Borja-Aburto, Victor			Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis	LANCET			English	Article							SWINE; OUTBREAK; HUMANS	Background in April, 2009, the first cases of influenza A H1N1 were registered in Mexico and associated with an unexpected number of deaths. We report the timing and spread of H1N1 in cases, and explore protective and risk factors for infection, severe disease, and death. Methods We analysed information gathered by the influenza surveillance system from April 28 to July 31, 2009, for patients with influenza-like illness who attended clinics that were part of the Mexican Institute for Social Security network. We calculated odds ratios (ORs) to compare risks of testing positive for H1N1 in those with influenza-like illness at clinic visits, the risk of admission for laboratory-confirmed cases of H1N1, and of death for inpatients according to demographic characteristics, clinical symptoms, seasonal influenza vaccine status, and elapsed time from symptom onset to admission. Findings By July 31, 63 479 cases of influenza-like illness were reported; 6945 (11%) cases of H1N1 were confirmed, 6407 (92%) were outpatients, 475 (7%) were admitted and survived, and 63 (<1%) died. Those aged 10-39 years were most affected (3922 [56%]). Mortality rates showed a J-shaped curve, with greatest risk in those aged 70 years and older (10.3%). Risk of infection was lowered in those who had been vaccinated for seasonal influenza (OR 0.65 [95% CI 0.55-0.77]). Delayed admission (1.19 [1.11-1.28] per day) and presence of chronic diseases (6.1 [2.37-15.99]) were associated with increased risk of dying. Interpretation Risk communication and hospital preparedness are key factors to reduce mortality from H1N1 infection. Protective effects of seasonal influenza vaccination for the virus need to be investigated.	[Manuel Mejia-Arangure, Juan; Mar-Obeso, Alvaro J.; Grajales-Muniz, Concepcion; Robles-Perez, Eduardo; Gonzalez-Leon, Margot; Carlos Ortega-Alvarez, Manuel; Gonzalez-Bonilla, Cesar; Alberto Rascon-Pacheco, Ramon; Hugo Borja-Aburto, Victor] Inst Mexicano Seguro Social, Direcc Prestaciones Med, Unidad Salud Publ, Mexico City 03100, DF, Mexico	Instituto Mexicano del Seguro Social	Borja-Aburto, VH (corresponding author), Inst Mexicano Seguro Social, Direcc Prestaciones Med, Unidad Salud Publ, Mier & Pesado 120, Mexico City 03100, DF, Mexico.	victor.borja@imss.gob.mx	León, Margot González/ABD-4622-2020; Mejia-Arangure, Juan Manuel/T-6743-2019	León, Margot González/0000-0002-3798-6729; Mejia-Arangure, Juan Manuel/0000-0001-8027-6231; Grajales Muniz, Concepcion/0000-0001-7923-5344; Gonzalez Bonilla, Cesar/0000-0002-2225-5069				Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cohen J, 2009, SCIENCE, V324, P996, DOI 10.1126/science.324_996; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, P2840; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Lopez-Cervantes M, 2009, J INFECT DEV COUNTR, V3, P327, DOI 10.3855/jidc.238; Mangtani P, 2009, LANCET, V374, P429, DOI 10.1016/S0140-6736(09)61431-8; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; *NOV SWIN ORG INFL, 2009, NEW ENGL J MED, V260, P2605; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *SECR SAL, 2009, 252 SECR SAL; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; World Health Organization, 2009, PAND H1N1 2009 UPD 6; World Health Organization, 2009, WHO INF LAB DIAGN PA; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; ZIMMER SM, 2000, NEW ENGL J MED, V361, P279; 2009, LANCET INFECT DIS, V9, P331; INTERIM GUIDANCE DET	25	281	299	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2072	2079		10.1016/S0140-6736(09)61638-X	http://dx.doi.org/10.1016/S0140-6736(09)61638-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19913290				2022-12-28	WOS:000273122900030
J	Graf, C; Battisti, WP; Bridges, D; Bruce-Winkler, V; Conaty, JM; Ellison, JM; Field, EA; Gurr, JA; Marx, ME; Patel, M; Sanes-Miller, C; Yarker, YE				Graf, Chris; Battisti, Wendy P.; Bridges, Dan; Bruce-Winkler, Victoria; Conaty, Joanne M.; Ellison, John M.; Field, Elizabeth A.; Gurr, James A.; Marx, Mary-Ellen; Patel, Mina; Sanes-Miller, Carol; Yarker, Yvonne E.		Int Soc Med Publication Profession	Good publication practice for communicating company sponsored medical research: the GPP2 guidelines	BRITISH MEDICAL JOURNAL			English	Article							DOCUMENTS		[Graf, Chris] Wiley Blackwell, John Wiley & Sons, Oxford OX4 2DQ, England; [Battisti, Wendy P.] Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ USA; [Bridges, Dan] Elsevier, Excerpta Med, London, England; [Conaty, Joanne M.; Sanes-Miller, Carol] AstraZeneca, Wilmington, DE USA; [Ellison, John M.] LifeScan, Milpitas, CA USA; [Field, Elizabeth A.] Field Adv Med Commun, Chapel Hill, NC USA; [Gurr, James A.] Pfizer Collegeville, Collegeville, PA USA; [Marx, Mary-Ellen] PharmaWrite, Princeton, NJ USA; [Patel, Mina] Cephalon, Frazer, PA USA; [Yarker, Yvonne E.] Knowledgepoint 360 Grp, Newtown, PA USA	Johnson & Johnson; Johnson & Johnson USA; Reed Elsevier; Elsevier; AstraZeneca; Johnson & Johnson; Johnson & Johnson USA; Pfizer; Teva Pharmaceutical Industries; Cephalon Inc.	Graf, C (corresponding author), Wiley Blackwell, John Wiley & Sons, Oxford OX4 2DQ, England.	chris.graf@wiley.com		Graf, Chris/0000-0002-4699-4333; Bridges, Daniel/0000-0003-3850-9809				Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; Association of American Medical Colleges, 2008, IND FUND MED ED REP; *BMJ, SUBM ART BMJ; *COUNC SCI ED, 1999, CSE TASK FORC AUTH D; DRAZEN JW, 2009, N ENGL J MED    1013; EQUATOR Network, LIB HLTH RES REP; Gotzsche PC, 2009, PLOS MED, V6, P122, DOI 10.1371/journal.pmed.1000023; Hamilton C, 2003, AMWA J, V18, P13; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; International Committee of Medical Journal Editors, 2011, BIOM J UNPUB; International Federation of Pharmaceutical Manufacturers and Associations European Federation of Pharmaceutical Industries and Associations Juvenile Products Manufacturers Association Pharmaceutical Research and Manufacturers of America, JOINT POS DISCL CLIN; Jacobs A, 2005, CURR MED RES OPIN, V21, P317, DOI 10.1185/030079905X25578; Lee Kirby, 2008, BMJ, V336, P477, DOI 10.1136/bmj.39491.391215.94; *LEG ARG, CREAS REG ENS CLIN S; Lo B, 2009, CONFLICT INTEREST ME; Norris R, 2007, CURR MED RES OPIN, V23, P1837, DOI 10.1185/030079907X210642; Rennie D, 2000, JAMA-J AM MED ASSOC, V284, P89, DOI 10.1001/jama.284.1.89; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; *SOC BRAS PROF PES, LEG BRAS SECR VIG SA; Stossel TP, 2008, BRIT MED J, V336, P476, DOI 10.1136/bmj.39493.489213.AD; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; Wager E, 2003, CURR MED RES OPIN, V19, P149, DOI 10.1185/030079903125001767; WHO, INT CLIN TRIALS REG; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; World Association of Medical Editors, POL STAT; World Medical Association, 2008, DECL HELS ETH PRINC	26	85	87	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 29	2009	339								b4330	10.1136/bmj.b4330	http://dx.doi.org/10.1136/bmj.b4330			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525AY	19946142	Green Submitted, Bronze			2022-12-28	WOS:000272186700001
J	Scott, JD; Pawson, T				Scott, John D.; Pawson, Tony			Cell Signaling in Space and Time: Where Proteins Come Together and When They're Apart	SCIENCE			English	Review							NF-KAPPA-B; UBIQUITIN-BINDING DOMAINS; MAP KINASE; STRUCTURAL BASIS; REGULATORY SUBUNITS; TYROSINE KINASE; ACTIVATION; SCAFFOLD; RECOGNITION; ACETYLATION	Signal transduction can be defined as the coordinated relay of messages derived from extracellular cues to intracellular effectors. More simply put, information received on the cell surface is processed across the plasma membrane and transmitted to intracellular targets. This requires that the activators, effectors, enzymes, and substrates that respond to cellular signals come together when they need to.	[Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Scott, JD (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Box 357750, Seattle, WA 98195 USA.	scottjdw@u.washington.edu; pawson@lunenfeld.ca	Pawson, Tony J/E-4578-2013		NIH [GM48231]; Leducq transatlantic network [06CVD02]; National Cancer Institute of Canada; Canadian Cancer Society; Canadian Institutes for Health Research [6849, 57793]; Genome Canada; Terry Fox Program Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048231, R01GM048231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq transatlantic network(Leducq Foundation); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Terry Fox Program Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge C. Pawson and M. Milnes for evaluation of this manuscript and L. Langeberg for design of the figures. J.D.S. is supported by NIH grant GM48231 and Leducq transatlantic network 06CVD02. T. P. is supported by the National Cancer Institute of Canada, Canadian Cancer Society, Canadian Institutes for Health Research (grants 6849 and 57793), Genome Canada, and a Terry Fox Program Project grant.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; CHOI KY, 1994, CELL, V78, P499; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CIECHANOYER A, 1980, J BIOL CHEM, V255, P7525; COHEN P, 1989, J BIOL CHEM, V264, P21435; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; George DJ, 2003, NEW ENGL J MED, V349, P419, DOI 10.1056/NEJMp030061; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Grabbe C, 2008, SCIENCE, V322, P872, DOI 10.1126/science.1166845; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; MAYER BJ, 1988, COLD SPRING HARB SYM, V53, P907, DOI 10.1101/SQB.1988.053.01.104; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wong W, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000026; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 1999, NATURE, V402, P30; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	56	442	456	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1220	1224		10.1126/science.1175668	http://dx.doi.org/10.1126/science.1175668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965465	Green Accepted			2022-12-28	WOS:000272117900036
J	Bonner, S; Tremlett, M; Bell, D				Bonner, Stephen; Tremlett, Michael; Bell, Dominic			Ethical debate Are advance directives legally binding or simply the starting point for discussion on patients' best interests?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Bonner, Stephen; Tremlett, Michael] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [Bell, Dominic] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	James Cook University Hospital; Leeds General Infirmary; University of Leeds	Bonner, S (corresponding author), James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England.	stephen.bonner@stees.nhs.uk						*BRIT MED ASS, 1995, ADV STAT MED TREATM; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; *DEP HLTH, 2001, GOOD PRACT CONS; General Medical Council, 2002, WITHH WITHDR LIF PRO; Gmc-uk.org, 2022, ETH GUID; *HOUS LORDS, 1994, REP SEL COMM MED ETH, V1, P54; Kolarik RC, 2002, J GEN INTERN MED, V17, P618, DOI 10.1046/j.1525-1497.2002.10933.x; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; *STAND COMM DOCT E, 1993, CP9383 STAND COMM DO	10	16	16	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2009	339								b4667	10.1136/bmj.b4667	http://dx.doi.org/10.1136/bmj.b4667			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AW	19942667				2022-12-28	WOS:000272186500003
J	Miller, AI; Foote, M				Miller, Arnold I.; Foote, Michael			Epicontinental Seas Versus Open-Ocean Settings: The Kinetics of Mass Extinction and Origination	SCIENCE			English	Article							ENVIRONMENTAL DETERMINANTS; ORDOVICIAN RADIATION; GEOGRAPHIC-VARIATION; NORTH-AMERICA; SELECTIVITY; RECOVERY; DYNAMICS; FOSSIL	Environmental perturbations during mass extinctions were likely manifested differently in epicontinental seas than in open-ocean-facing habitats of comparable depth. Here, we present a dissection of origination and extinction in epicontinental seas versus open-ocean-facing coastal regions in the Permian through Cretaceous periods, an interval through which both settings are well represented in the fossil record. Results demonstrate that extinction rates were significantly higher in open-ocean settings than in epicontinental seas during major mass extinctions but not at other times and that origination rates were significantly higher in open-ocean settings for a protracted interval from the Late Jurassic through the Late Cretaceous. These patterns are manifested even when other paleogeographic and environmental variables are held fixed, indicating that epicontinental seas and open-ocean-facing coastlines carry distinct macroevolutionary signatures.	[Miller, Arnold I.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Foote, Michael] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Cincinnati; University of Chicago	Miller, AI (corresponding author), Univ Cincinnati, Dept Geol, POB 210013, Cincinnati, OH 45221 USA.	arnold.miller@uc.edu			NASA; NSF	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank D. Buick, W. Kiessling, S. Kolbe, A. Lagomarcino, and J. Wittmer for discussions; two anonymous reviewers for helpful comments; A. Lagomarcino for assistance in drafting figures; and NASA (program in Exobiology) and NSF (programs in Biocomplexity and in Geology and Paleontology) for financial support. This is Paleobiology Database publication no. 102.	Allison PA, 2006, PALAIOS, V21, P513, DOI 10.2110/palo.2006.S06; Clapham ME, 2009, PALEOBIOLOGY, V35, P32, DOI 10.1666/08033.1; Emery K.O., 1984, GEOLOGY ATLANTIC OCE; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2003, P ROY SOC B-BIOL SCI, V270, P401, DOI 10.1098/rspb.2002.2243; Kiessling W, 2007, PALEOBIOLOGY, V33, P414, DOI 10.1666/06069.1; Krug AZ, 2007, PALEOBIOLOGY, V33, P435, DOI 10.1666/06039.1; Krug AZ, 2009, ASTROBIOLOGY, V9, P113, DOI 10.1089/ast.2008.0253; Miller AI, 1997, PALEOBIOLOGY, V23, P410, DOI 10.1017/S0094837300019813; Miller AI, 2001, PALEOBIOLOGY, V27, P768, DOI 10.1666/0094-8373(2001)027<0768:SAOHTA>2.0.CO;2; Miller AI, 2009, PALEOBIOLOGY, V35, P612, DOI 10.1666/0094-8373-35.4.612; Miller Arnold I., 1997, Geobios Memoire Special (Villeurbanne), V20, P397; Peters SE, 2008, NATURE, V454, P626, DOI 10.1038/nature07032; Peters SE, 2007, PALEOBIOLOGY, V33, P165, DOI 10.1666/06067.1; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; Shen SZ, 2002, PALEOBIOLOGY, V28, P449, DOI 10.1666/0094-8373(2002)028<0449:PEPOPB>2.0.CO;2; SLINGERLAND R, 1986, SEDIMENTOLOGY, V33, P487, DOI 10.1111/j.1365-3091.1986.tb00756.x; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; Wells MR, 2007, J SEDIMENT RES, V77, P843, DOI 10.2110/jsr.2007.075	21	33	33	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1106	1109		10.1126/science.1180061	http://dx.doi.org/10.1126/science.1180061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965428				2022-12-28	WOS:000271951000042
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, AJ; Gregory, KD; Grossman, D; Isham, G; LeFevre, ML; Leipzig, RM; Marion, LN; Melnyk, B; Moyer, VA; Ockene, JK; Sawaya, GF; Schwartz, JS; Wilt, T				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen J.; Gregory, Kimberly D.; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne M.; Marion, Lucy N.; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Schwartz, J. Sanford; Wilt, Timothy		US Preventive Serv Task Force	Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							CLIENT-DIRECTED INTERVENTIONS; MAMMOGRAPHY; WOMEN; PERFORMANCE; POPULATION; THERAPY	Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population. Methods: The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update the 2002 recommendation. To accomplish this update, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review of 6 selected questions relating to benefits and harms of screening, and 2) a decision analysis that used population modeling techniques to compare the expected health outcomes and resource requirements of starting and ending mammography screening at different ages and using annual versus biennial screening intervals. Recommendations: The USPSTF recommends against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. (Grade C recommendation) The USPSTF recommends biennial screening mammography for women between the ages of 50 and 74 years. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening mammography in women 40 years or older. (I statement) The USPSTF recommends against clinicians teaching women how to perform breast self-examination. (Grade D recommendation) The USPSTF concludes that the current evidence is insufficient to assess additional benefits and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement)	[Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [US Preventive Serv Task Force] Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; [Isham, George] HealthPartners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne M.] Mt Sinai Sch Med, New York, NY USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Melnyk, Bernadette] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA; [Moyer, Virginia A.] Baylor Coll Med, Houston, TX 77030 USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schwartz, J. Sanford] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Wilt, Timothy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Wilt, Timothy] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	Colorado Department of Public Health & Environment; Agency for Healthcare Research & Quality; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; Group Health Cooperative; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University System of Georgia; Augusta University; Arizona State University; Arizona State University-Downtown Phoenix; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.		Paul, Steven/ABB-4864-2020; Melnyk, Bernadette J/E-9868-2013		USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	(ACOG) American College of Obstetricians and Gynecologists, 2003, Obstet Gynecol, V101, P821; *AM AC FAM PHYS, 2009, A E REC CLIN PREV SE; *AM CANC SOC, 2009, MAN WOM GET BREAST C; *AM CANC SOC, 2009, AM CANC SOC GUID EAR; *AM MED ASS, 2002, H 525 993 MAMM SCREE; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Baron RC, 2008, AM J PREV MED, V35, pS56, DOI 10.1016/j.amepre.2008.04.001; Baron RC, 2008, AM J PREV MED, V35, pS26, DOI 10.1016/j.amepre.2008.04.003; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Breast Cancer Surveillance Consortium, 2004, EV SCREEN PERF PRACT; Chagpar AB, 2007, J SURG RES, V140, P214, DOI 10.1016/j.jss.2007.01.034; Horner MJ, 2009, SEER CANC STAT REV 1; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; *NAT COMPR CANC NE, 2009, NCCN CLIN PRACT GUID; National Cancer Institute, 2009, EFF SCREEN BREAST CA; Nelson HD, 2009, AHRQ PUBLICATION, V10-05142-EF-1; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Ringash J, 2001, CAN MED ASSOC J, V164, P469; Saslow D, 2004, CA-CANCER J CLIN, V54, P327, DOI 10.3322/canjclin.54.6.327; Semiglazov V. F., 2003, Voprosy Onkologii (St. Petersburg), V49, P434; Surveillance Epidemiology and End Results (SEER), 2013, CANC STAT FACTS MYEL; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; World Health Organization, 2009, SCREEN BREAST CANC	32	1083	1094	1	57	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					716	W236		10.7326/0003-4819-151-10-200911170-00008	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920272	Green Submitted			2022-12-28	WOS:000272145100005
J	Baldi, C; Cho, S; Ellis, RE				Baldi, Chris; Cho, Soochin; Ellis, Ronald E.			Mutations in Two Independent Pathways Are Sufficient to Create Hermaphroditic Nematodes	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS HERMAPHRODITES; SEX DETERMINATION; REPRODUCTIVE ISOLATION; MOLECULAR ANALYSIS; SPERM ACTIVATION; GERM-LINE; C-ELEGANS; EVOLUTION; GENE; TRA-2	Although the nematode Caenorhabditis elegans produces self-fertile hermaphrodites, it descended from a male/female species, so hermaphroditism provides a model for the origin of novel traits. In the related species C. remanei, which has only male and female sexes, lowering the activity of tra-2 by RNA interference created XX animals that made spermatids as well as oocytes, but their spermatids could not activate without the addition of male seminal fluid. However, by lowering the expression of both tra-2 and swm-1, a gene that regulates sperm activation in C. elegans, we produced XX animals with active sperm that were self-fertile. Thus, the evolution of hermaphroditism in Caenorhabditis probably required two steps: a mutation in the sex-determination pathway that caused XX spermatogenesis and a mutation that allowed these spermatids to self-activate.	[Ellis, Ronald E.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA; [Baldi, Chris] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Cho, Soochin] Creighton Univ, Dept Biol, Omaha, NE 68178 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Creighton University	Ellis, RE (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA.	ron.ellis@umdnj.edu			NSF [0543828]	NSF(National Science Foundation (NSF))	We thank the NSF for support ( grant 0543828), D. Greenstein for antibodies, Y. Shifmann for technical assistance, A. Singson and S. L'Hernault for advice, and E. Moss and R. Dutch for comments on this manuscript.	BAIRD SE, 1992, EVOLUTION, V46, P585, DOI [10.2307/2409629, 10.1111/j.1558-5646.1992.tb02067.x]; Baird SE, 2000, EVOL DEV, V2, P9, DOI 10.1046/j.1525-142x.2000.00031.x; Barriere A, 2009, GENOME RES, V19, P470, DOI 10.1101/gr.081851.108; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Chen PJ, 2001, GENETICS, V158, P1513; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Ellis RE, 2008, CURR TOP DEV BIOL, V83, P41, DOI 10.1016/S0070-2153(08)00402-X; Geldziler B, 2006, DEV GENES EVOL, V216, P198, DOI 10.1007/s00427-005-0045-4; Geldziler B, 2005, DEV BIOL, V283, P424, DOI 10.1016/j.ydbio.2005.04.036; GUO Y, CURRENT BIO IN PRESS; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Haag ES, 2000, GENETICS, V155, P105; Hansen D, 1998, GENETICS, V149, P1353; Hill RC, 2006, DEV CELL, V10, P531, DOI 10.1016/j.devcel.2006.02.002; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Kuwabara PE, 1996, GENETICS, V144, P597; LHERNAULT SW, 2006, WORMBOOK C ELEGANS R, DOI DOI 10.1895/WORMBOOK.1.85.1; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Minniti AN, 1996, GENETICS, V143, P213; Nayak S, 2005, PLOS BIOL, V3, P57, DOI 10.1371/journal.pbio.0030006; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; ROBERTS TM, 1995, CURR OPIN CELL BIOL, V7, P13, DOI 10.1016/0955-0674(95)80039-5; SCHEDL T, 1988, GENETICS, V119, P43; SHAKES DC, 1989, DEV BIOL, V134, P189, DOI 10.1016/0012-1606(89)90088-2; Stanfield GM, 2006, CURR BIOL, V16, P252, DOI 10.1016/j.cub.2005.12.041; Stothard P, 2006, J MOL EVOL, V62, P281, DOI 10.1007/s00239-005-0084-5; Wang SP, 2001, EMBO J, V20, P1363, DOI 10.1093/emboj/20.6.1363; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; ZARKOWER D, 2006, WORMBOOK C ELEGANS R, DOI DOI 10.1895/WORMBOOK.1.84.1; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812	31	54	57	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					1002	1005		10.1126/science.1176013	http://dx.doi.org/10.1126/science.1176013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965511				2022-12-28	WOS:000271712300042
J	Israelian, G; Mena, ED; Santos, NC; Sousa, SG; Mayor, M; Udry, S; Cerdena, CD; Rebolo, R; Randich, S				Israelian, Garik; Mena, Elisa Delgado; Santos, Nuno C.; Sousa, Sergio G.; Mayor, Michel; Udry, Stephane; Cerdena, Carolina Dominguez; Rebolo, Rafael; Randich, Sofia			Enhanced lithium depletion in Sun-like stars with orbiting planets	NATURE			English	Article							EXOPLANET HOST STARS; OPEN CLUSTERS; ABUNDANCES; SOLAR; SAMPLE; DWARF; FE/H; AGES; IX	The surface abundance of lithium on the Sun is 140 times less than the protosolar value(1), yet the temperature at the base of the surface convective zone is not hot enough to burn-and hence deplete-Li (refs 2, 3). A large range of Li abundances is observed(4,5) in solar-type stars of the same age, mass and metallicity as the Sun, but such a range is theoretically difficult to understand(3,6,7). An earlier suggestion(8-10) that Li is more depleted in stars with planets was weakened by the lack of a proper comparison sample of stars without detected planets. Here we report Li abundances for an unbiased sample of solar-analogue stars with and without detected planets. We find that the planet-bearing stars have less than one per cent of the primordial Li abundance, while about 50 per cent of the solar analogues without detected planets have on average ten times more Li. The presence of planets may increase the amount of mixing and deepen the convective zone to such an extent that the Li can be burned.	[Israelian, Garik; Mena, Elisa Delgado; Sousa, Sergio G.; Cerdena, Carolina Dominguez; Rebolo, Rafael] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Spain; [Israelian, Garik; Mena, Elisa Delgado; Cerdena, Carolina Dominguez; Rebolo, Rafael] Univ La Laguna, Dept Astrofis, E-38205 San Cristobal la Laguna, Spain; [Santos, Nuno C.; Sousa, Sergio G.] Univ Porto, Ctr Astrofis, P-4150762 Oporto, Portugal; [Santos, Nuno C.; Mayor, Michel; Udry, Stephane] Univ Geneva, Observ Geneva, CH-1290 Versoix, Switzerland; [Rebolo, Rafael] CSIC, E-28006 Madrid, Spain; [Randich, Sofia] Osserv Astrofis Arcetri, Inst Nazl Astrofis, I-59125 Florence, Italy	Instituto de Astrofisica de Canarias; Universidad de la Laguna; Universidade do Porto; University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); Istituto Nazionale Astrofisica (INAF)	Israelian, G (corresponding author), Inst Astrofis Canarias, Via Lactea S-N, E-38200 San Cristobal la Laguna, Spain.	gil@iac.es	Sousa, Sérgio G./I-7466-2013; Rebolo, Rafael/S-1563-2019; Santos, Nuno C/E-9957-2011; Mena, Elisa Delgado/M-9178-2013	Sousa, Sérgio G./0000-0001-9047-2965; Santos, Nuno C/0000-0003-4422-2919; Mena, Elisa Delgado/0000-0003-4434-2195; Randich, Sofia/0000-0003-2438-0899; Israelian, Garik/0000-0002-9443-0532; udry, Stephane/0000-0001-7576-6236; Rebolo, Rafael/0000-0003-3767-7085	Spanish Ministry of Science and Innovation; Fundacao para a Ciencia e a Tecnologia, Portugal [Ciencia 2007]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This research has been supported by The Spanish Ministry of Science and Innovation (MICINN). N. C. S. and S. G. S. acknowledge support from the Fundacao para a Ciencia e a Tecnologia, Portugal, through the programme 'Ciencia 2007'.	ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Bouvier J, 2008, ASTRON ASTROPHYS, V489, pL53, DOI 10.1051/0004-6361:200810574; Cutispoto G, 2003, ASTRON ASTROPHYS, V397, P987, DOI 10.1051/0004-6361:20021562; DANTONA F, 1994, ASTROPHYS J SUPPL S, V90, P467, DOI 10.1086/191867; Ecuvillon A, 2006, ASTRON ASTROPHYS, V445, P633, DOI 10.1051/0004-6361:20053469; Favata F, 1996, ASTRON ASTROPHYS, V311, P951; FEIGELSON ED, 1985, ASTROPHYS J, V293, P192, DOI 10.1086/163225; Gonzalez G, 2008, MON NOT R ASTRON SOC, V386, P928, DOI 10.1111/j.1365-2966.2008.13067.x; Gray RO, 2006, ASTRON J, V132, P161, DOI 10.1086/504637; Israelian G, 2004, ASTRON ASTROPHYS, V414, P601, DOI 10.1051/0004-6361:20034398; MAEDER A, 2009, PHYS FORMATION EVOLU, P215; Mayor M., 2003, MESSENGER, V114, P20; Pace G, 2009, ASTRON ASTROPHYS, V499, pL9, DOI [10.1051/0004-6361/200912090, 10.1051/0004-6361/2009-12090]; Pasquini L, 2008, ASTRON ASTROPHYS, V489, P677, DOI 10.1051/0004-6361:200809714; Paulson DB, 2002, ASTRON J, V124, P572, DOI 10.1086/341171; Piau L, 2002, ASTROPHYS J, V566, P419, DOI 10.1086/324277; Pinsonneault M, 1997, ANNU REV ASTRON ASTR, V35, P557, DOI 10.1146/annurev.astro.35.1.557; PINSONNEAULT MH, 1989, ASTROPHYS J, V338, P424, DOI 10.1086/167210; RANDICH S, 2008, MEM SOC ASTRON ITAL, V79, P516; Saffe C, 2005, ASTRON ASTROPHYS, V443, P609, DOI 10.1051/0004-6361:20053452; Santos NC, 2002, ASTRON ASTROPHYS, V392, P215, DOI 10.1051/0004-6361:20020876; Sestito P, 2007, ASTRON ASTROPHYS, V465, P185, DOI 10.1051/0004-6361:20066643; Sestito P, 2005, ASTRON ASTROPHYS, V442, P615, DOI 10.1051/0004-6361:20053482; Sousa SG, 2008, ASTRON ASTROPHYS, V487, P373, DOI 10.1051/0004-6361:200809698; Takeda Y, 2007, ASTRON ASTROPHYS, V468, P663, DOI 10.1051/0004-6361:20077220; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500; Wright JT, 2004, ASTROPHYS J SUPPL S, V152, P261, DOI 10.1086/386283; Yadav RKS, 2008, ASTRON ASTROPHYS, V484, P609, DOI 10.1051/0004-6361:20079245; ZAPPALA RR, 1972, ASTROPHYS J, V172, P57, DOI 10.1086/151328	30	121	121	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					189	191		10.1038/nature08483	http://dx.doi.org/10.1038/nature08483			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907489	Green Submitted			2022-12-28	WOS:000271655100036
J	Chopra, V; Flanders, SA; Froehlich, JB; Lau, WC; Eagle, KA				Chopra, Vineet; Flanders, Scott A.; Froehlich, James B.; Lau, Wei C.; Eagle, Kim A.			Perioperative Practice: Time to Throttle Back	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MAJOR VASCULAR-SURGERY; NONCARDIAC SURGERY; CARDIAC RISK; CORONARY-ARTERY; PREOPERATIVE ASSESSMENT; MYOCARDIAL-INFARCTION; GUIDELINES; THERAPY; TRIAL; REVASCULARIZATION	The United States spends more on health care than other nations, yet our health outcomes remain inferior to those of many countries. Change is therefore necessary. One approach to health care reform is to identify and eliminate practices associated with high cost and limited benefit. Recent research has shown that many perioperative practices meet this definition. An opportunity thus exists for rational reduction of perioperative expenditure. Perioperative tests and treatments improve outcomes only when targeted at specific patient subsets. For example, routine perioperative stress testing provides no incremental diagnostic yield in patients at low risk for cardiac events, and indiscriminate perioperative therapy with beta-blockers can increase mortality in otherwise stable patients. Thus, many "accepted" perioperative practices conflict with the evidence and can be safely discontinued while preserving outcomes and reducing costs. Implementation of the American College of Cardiology/American Heart Association perioperative guidelines ensures cost-effective management and promises the greatest benefit for our patients. Our society demands better care at lower cost; in perioperative medicine, it is time for us to throttle back.	[Chopra, Vineet] Univ Michigan Hlth Syst, Taubman Ctr 3119, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chopra, V (corresponding author), Univ Michigan Hlth Syst, Taubman Ctr 3119, 1500 E Med Ctr Dr,SPC 5376, Ann Arbor, MI 48109 USA.	vineetc@med.umich.edu		Lau, Wei/0000-0001-5084-6790; Chopra, Vineet/0000-0001-8670-9376				Almanaseer Y, 2005, CARDIOLOGY, V103, P24, DOI 10.1159/000081848; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boersma E, 2001, JAMA-J AM MED ASSOC, V285, P1865, DOI 10.1001/jama.285.14.1865; Chopra V, 2009, AM J MED, V122, P222, DOI 10.1016/j.amjmed.2008.11.004; Cohen MC, 1999, CARDIOVASC PATHOL, V8, P133, DOI 10.1016/S1054-8807(98)00032-5; Dawood MM, 1996, INT J CARDIOL, V57, P37, DOI 10.1016/S0167-5273(96)02769-6; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Eagle KA, 1997, CIRCULATION, V96, P1882, DOI 10.1161/01.CIR.96.6.1882; EAGLE KA, 1989, ANN INTERN MED, V110, P859, DOI 10.7326/0003-4819-110-11-859; FLEISCHMANN KE, 2009, CIRCULATION; Fleisher LA, 2007, CIRCULATION, V116, P1971, DOI 10.1161/CIRCULATIONAHA.107.185700; Froehlich JB, 2002, J VASC SURG, V36, P758, DOI 10.1067/mva.2002.127344; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Garcia S, 2009, CIRC-CARDIOVASC QUAL, V2, P73, DOI 10.1161/CIRCOUTCOMES.108.827683; HERTZER NR, 1979, ARCH SURG-CHICAGO, V114, P1336; Leibowitz D, 2006, AM J CARDIOL, V97, P1188, DOI 10.1016/j.amjcard.2005.11.037; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; Mowatt G, 2008, HEALTH TECHNOL ASSES, V12, P1; Mowatt G, 2008, HEALTH TECHNOL ASSES, V12, pix; Poldermans D, 2007, J AM COLL CARDIOL, V49, P1763, DOI 10.1016/j.jacc.2006.11.052; RIHAL CS, 1995, CIRCULATION, V91, P46, DOI 10.1161/01.CIR.91.1.46; Schouten O, 2009, AM J CARDIOL, V103, P897, DOI 10.1016/j.amjcard.2008.12.018	25	15	15	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					47	51		10.7326/0003-4819-152-1-201001050-00184	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00184			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FJ	19949135	Green Published			2022-12-28	WOS:000273556600007
J	Yang, G; Pan, F; Gan, WB				Yang, Guang; Pan, Feng; Gan, Wen-Biao			Stably maintained dendritic spines are associated with lifelong memories	NATURE			English	Article							CEREBRAL-CORTEX; SOMATOSENSORY CORTEX; SYNAPTIC PLASTICITY; OCULAR DOMINANCE; DIVERSE REGIONS; STRIATE CORTEX; MOTOR CORTEX; ADULT CORTEX; IN-VIVO; SYNAPSES	Changes in synaptic connections are considered essential for learning and memory formation(1-6). However, it is unknown how neural circuits undergo continuous synaptic changes during learning while maintaining lifelong memories. Here we show, by following postsynaptic dendritic spines over time in the mouse cortex(7,8), that learning and novel sensory experience lead to spine formation and elimination by a protracted process. The extent of spine remodelling correlates with behavioural improvement after learning, suggesting a crucial role of synaptic structural plasticity in memory formation. Importantly, a small fraction of new spines induced by novel experience, together with most spines formed early during development and surviving experience-dependent elimination, are preserved and provide a structural basis for memory retention throughout the entire life of an animal. These studies indicate that learning and daily sensory experience leave minute but permanent marks on cortical connections and suggest that lifelong memories are stored in largely stably connected synaptic networks.	[Yang, Guang; Pan, Feng; Gan, Wen-Biao] NYU, Sch Med,Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Dept Physiol & Neurosci, Mol Neurobiol Program, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med,Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Dept Physiol & Neurosci, Mol Neurobiol Program, New York, NY 10016 USA.	gan@saturn.med.nyu.edu		Yang, Guang/0000-0002-5739-9126	National Institutes of Health [R01 NS047325]; Dart Foundation Fellowship; Ellison/AFAR Postdoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dart Foundation Fellowship; Ellison/AFAR Postdoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health R01 NS047325 and a Dart Foundation Fellowship to W.-B. G. and by an Ellison/AFAR Postdoctoral Fellowship to G. Y. We thank members of the Gan laboratory for their comments.	Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Grossman AW, 2002, PROG BRAIN RES, V138, P91, DOI 10.1016/S0079-6123(02)38073-7; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kleim JA, 1997, J NEUROSCI, V17, P717; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P290, DOI 10.1006/nlme.1998.3828; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	35	751	759	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					920	U114		10.1038/nature08577	http://dx.doi.org/10.1038/nature08577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19946265	Green Accepted			2022-12-28	WOS:000272795400043
J	Silva, JP; von Meyenn, F; Howell, J; Thorens, B; Wolfrum, C; Stoffel, M				Silva, Jose P.; von Meyenn, Ferdinand; Howell, Jessica; Thorens, Bernard; Wolfrum, Christian; Stoffel, Markus			Regulation of adaptive behaviour during fasting by hypothalamic Foxa2	NATURE			English	Article							MELANIN-CONCENTRATING HORMONE; CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; COGNITIVE FUNCTION; MICE; OREXIN; OBESITY; POPULATION; METABOLISM	The lateral hypothalamic area is considered the classic 'feeding centre', regulating food intake, arousal and motivated behaviour through the actions of orexin and melanin-concentrating hormone (MCH)(1-3). These neuropeptides are inhibited in response to feeding-related signals and are released during fasting. However, the molecular mechanisms that regulate and integrate these signals remain poorly understood. Here we show that the forkhead box transcription factor Foxa2,a downstream target of insulin signalling(4-6), regulates the expression of orexin and MCH. During fasting, Foxa2 binds to MCH and orexin promoters and stimulates their expression. In fed and in hyperinsulinemic obese mice, insulin signalling leads to nuclear exclusion of Foxa2 and reduced expression of MCH and orexin. Constitutive activation of Foxa2 in the brain (Nes-Cre/1; Foxa2T156A(flox/flox) genotype) results in increased neuronal MCH and orexin expression and increased food consumption, metabolism and insulin sensitivity. Spontaneous physical activity of these animals in the fed state is significantly increased and is similar to that in fasted mice. Conditional activation of Foxa2 through the T156A mutation expression in the brain of obese mice also resulted in improved glucose homeostasis, decreased fat and increased lean body mass. Our results demonstrate that Foxa2 can act as a metabolic sensor in neurons of the lateral hypothalamic area to integrate metabolic signals, adaptive behaviour and physiological responses.	[Silva, Jose P.; Howell, Jessica; Stoffel, Markus] Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; [von Meyenn, Ferdinand; Howell, Jessica; Wolfrum, Christian; Stoffel, Markus] ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Rockefeller University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.	stoffel@imsb.biol.ethz.ch	von Meyenn, Ferdinand/O-4517-2017	von Meyenn, Ferdinand/0000-0001-9920-3075; Wolfrum, Christian/0000-0002-3862-6805; Stoffel, Markus/0000-0003-1304-5817	SystemsX; Swiss National Science Foundation	SystemsX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants from SystemsX and the Swiss National Science Foundation (LiverX grant). We would like to thank S. Metref for technical support and expertise.	Aadahl M, 2007, EUR J EPIDEMIOL, V22, P369, DOI 10.1007/s10654-006-9100-3; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; Assah FK, 2008, DIABETOLOGIA, V51, P1399, DOI 10.1007/s00125-008-1033-9; Baranowska B, 2005, NEUROENDOCRINOL LETT, V26, P293; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Byberg L, 2001, DIABETOLOGIA, V44, P2134, DOI 10.1007/s001250100022; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gomori A, 2003, AM J PHYSIOL-ENDOC M, V284, pE583, DOI 10.1152/ajpendo.00350.2002; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Komulainen P, 2007, DEMENT GERIATR COGN, V23, P29, DOI 10.1159/000096636; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Young SE, 2006, DIABETES CARE, V29, P2688, DOI 10.2337/dc06-0915	22	56	60	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					646	U119		10.1038/nature08589	http://dx.doi.org/10.1038/nature08589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956259				2022-12-28	WOS:000272277900040
J	Chun, YS; Vauthey, JN; Boonsirikamchai, P; Maru, DM; Kopetz, S; Palavecino, M; Curley, SA; Abdalla, EK; Kaur, H; Charnsangavej, C; Loyer, EM				Chun, Yun Shin; Vauthey, Jean-Nicolas; Boonsirikamchai, Piyaporn; Maru, Dipen M.; Kopetz, Scott; Palavecino, Martin; Curley, Steven A.; Abdalla, Eddie K.; Kaur, Harmeet; Charnsangavej, Chusilp; Loyer, Evelyne M.			Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OXALIPLATIN-BASED CHEMOTHERAPY; ANTIANGIOGENIC THERAPY; CANCER; PERFUSION; CT; IRINOTECAN; RESECTION; TUMORS	Context The standard criteria used to evaluate tumor response, the Response Evaluation Criteria in Solid Tumors (RECIST), were developed to assess tumor shrinkage after cytotoxic chemotherapy and may be limited in assessing response to biologic agents, which have a cytostatic mechanism of action. Objective To validate novel tumor response criteria based on morphologic changes observed on computed tomography (CT) in patients with colorectal liver metastases treated with bevacizumab-containing chemotherapy regimens. Design, Setting, and Patients A total of 234 colorectal liver metastases were analyzed from 50 patients who underwent hepatic resection after preoperative chemotherapy that included bevacizumab at a comprehensive US cancer center from 2004 to 2007; date of last follow-up was March 2008. All patients underwent routine contrast-enhanced CT at the start and end of preoperative therapy. Three blinded, independent radiologists evaluated images for morphologic response, based on metastases changing from heterogeneous masses with ill-defined margins into homogeneous hypoattenuating lesions with sharp borders. These criteria were validated with a separate cohort of 82 patients with unresectable colorectal liver metastases treated with bevacizumab-containing chemotherapy. Main Outcome Measures Response determined using morphologic criteria and RECIST was correlated with pathologic response in resected liver specimens and with patient survival. Results Interobserver agreement for scoring morphologic changes was good among 3 radiologists (kappa, 0.68-0.78; 95% confidence interval [CI], 0.51-0.93). In resected tumor specimens, the median (interquartile range [IQR]) percentages of residual tumor cells for optimal morphologic response was 20% (10%-30%); for incomplete response, 50% (30%-60%); and no response, 70% (60%-70%; P < .001). With RECIST, the median (IQR) percentages of residual tumor cells were for partial response 30% (10%-60%); for stable disease, 50% (20%-70%); and for progressive disease, 70% (65%-70%; P = .04). Among patients who underwent hepatic resection, median overall survival was not yet reached with optimal morphologic response and 25 months (95% CI, 20.2-29.8 months) with incomplete or no morphologic response (P = .03). In the validation cohort, patients with optimal morphologic response had median overall survival of 31 months (95% CI, 26.8-35.2 months) compared with 19 months (95% CI, 14.6-23.4 months) with incomplete or no morphologic response (P = .009). RECIST did not correlate with survival in either the surgical or validation cohort. Conclusion Among patients with colorectal liver metastases treated with bevacizumab-containing chemotherapy, CT-based morphologic criteria had a statistically significant association with pathologic response and overall survival. JAMA. 2009;302(21):2338-2344	[Chun, Yun Shin; Vauthey, Jean-Nicolas; Palavecino, Martin; Curley, Steven A.; Abdalla, Eddie K.] Baylor Coll Med, Dept Surg Oncol, Houston, TX 77030 USA; [Boonsirikamchai, Piyaporn; Kaur, Harmeet; Charnsangavej, Chusilp; Loyer, Evelyne M.] Baylor Coll Med, Dept Diagnost Radiol, Houston, TX 77030 USA; [Maru, Dipen M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Kopetz, Scott] Baylor Coll Med, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Vauthey, JN (corresponding author), Baylor Coll Med, Dept Surg Oncol, 1515 Holcombe Blvd,Unit 444, Houston, TX 77030 USA.	jvauthey@mdanderson.org; eloyer@mdanderson.org	Kopetz, Scott/AAC-1387-2019	Kopetz, Scott/0000-0001-9647-3416; Kaur, Harmeet/0000-0002-3461-5316; Palavecino, Martin/0000-0002-5152-0159	AstraZeneca; Genentech; Roche; Sanofi-Aventis; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Kopetz reports receiving research grants and honoraria from AstraZeneca and honoraria from Genentech, Roche, and Sanofi-Aventis. Dr Abdalla reports receiving honoraria from Sanofi-Aventis. Dr Vauthey reports receiving grants and honoraria from Sanofi-Aventis, Genentech, and Roche. No other authors reported disclosures.	Adam R, 2004, ANN SURG, V240, P1052, DOI 10.1097/01.sla.0000145964.08365.01; Adam R, 2008, J CLIN ONCOL, V26, P1635, DOI 10.1200/JCO.2007.13.7471; Ajani JA, 2005, J CLIN ONCOL, V23, P1237, DOI 10.1200/JCO.2005.01.305; Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299; Charnsangavej C, 2006, ANN SURG ONCOL, V13, P1261, DOI 10.1245/s10434-006-9023-y; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Grothey A, 2008, J CLIN ONCOL, V26, P183, DOI 10.1200/JCO.2007.13.8099; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kan ZX, 2005, RADIOLOGY, V237, P151, DOI 10.1148/radiol.2363041293; Miles KA, 1998, BRIT J RADIOL, V71, P276, DOI 10.1259/bjr.71.843.9616236; MURAMATSU Y, 1986, RADIOLOGY, V160, P49, DOI 10.1148/radiology.160.1.3012632; OUTWATER E, 1991, RADIOLOGY, V180, P327, DOI 10.1148/radiology.180.2.2068294; Provenzale JM, 2007, AM J ROENTGENOL, V188, P11, DOI 10.2214/AJR.06.0280; Ribero D, 2007, CANCER-AM CANCER SOC, V110, P2761, DOI 10.1002/cncr.23099; Rubbia-Brandt L, 2007, ANN ONCOL, V18, P299, DOI 10.1093/annonc/mdl386; Sabir A, 2008, AM J ROENTGENOL, V191, P133, DOI 10.2214/AJR.07.2848; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sathornsumetee S, 2008, J CLIN ONCOL, V26, P271, DOI 10.1200/JCO.2007.13.3652; Swisher SG, 2005, ANN SURG, V241, P810, DOI 10.1097/01.sla.0000161983.82345.85; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205	20	371	380	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2338	2344		10.1001/jama.2009.1755	http://dx.doi.org/10.1001/jama.2009.1755			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952320	Bronze, Green Accepted			2022-12-28	WOS:000272239000022
J	Smith, LK; Draper, ES; Manktelow, BN; Field, DJ				Smith, Lucy K.; Draper, Elizabeth S.; Manktelow, Bradley N.; Field, David J.			Socioeconomic inequalities in survival and provision of neonatal care: population based study of very preterm infants	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH; DEPRIVATION; COSTS; UK	Objectives To assess socioeconomic inequalities in survival and provision of neonatal care among very preterm infants. Design Prospective cohort study in a geographically defined population. Setting Former Trent health region of the United Kingdom (covering about a twelfth of UK births). Participants All infants born between 22+0 and 32+6 weeks' gestation from 1 January 1998 to 31 December 2007 who were alive at the onset of labour and followed until discharge from neonatal care. Main outcome measures Survival to discharge from neonatal care per 1000 total births and per 1000 very preterm births. Neonatal care provision for very preterm infants surviving to discharge measured with length of stay, provision of ventilation, and respiratory support. Deprivation measured with the UK index of multiple deprivation 2004 score at super output area level. Results 7449 very preterm singleton infants were born in the 10 year period. The incidence of very preterm birth was nearly twice as high in the most deprived areas compared with the least deprived areas. Consequently rates of mortality due to very preterm birth per 1000 total births were almost twice as high in the most deprived areas compared with the least deprived (incidence rate ratio 1.94, 95% confidence interval 1.62 to 2.32). Mortality rates per 1000 very preterm births, however, showed little variation across all deprivation fifths ( incidence rate ratio for most deprived fifth versus least deprived 1.02, 0.86 to 1.20). For infants surviving to discharge from neonatal care, measures of length of stay and provision of ventilation and respiratory support were similar across all deprivation fifths. Conclusions The burden of mortality and morbidity is greater among babies born to women from deprived areas because of increased rates of very preterm birth. After very preterm birth, however, survival rates and neonatal care provision is similar for infants from all areas.	[Draper, Elizabeth S.; Manktelow, Bradley N.; Field, David J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England	University of Leicester		lks1@leicester.ac.uk	Smith, Lucy K/I-6300-2018; Manktelow, Bradley N/G-2794-2011; Draper, Elizabeth/S-6874-2019; Draper, Elizabeth S/I-6304-2018; Smith, Lucy K/S-6593-2019	Smith, Lucy K/0000-0001-9470-0793; Manktelow, Bradley N/0000-0002-3264-0323; Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Smith, Lucy K/0000-0001-9470-0793	healthcare commissioners in the Trent region; National Institute for Health Research [RP-PG-0407-10029] Funding Source: researchfish	healthcare commissioners in the Trent region; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by NHS research and development funds from healthcare commissioners in the Trent region.	*COMM UND PREM BIR, 2006, PRET BIRTH CAUS CONS; Craig ED, 2002, ARCH DIS CHILD-FETAL, V86, P142, DOI 10.1136/fn.86.3.F142; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; Draper ES, 2003, BRIT MED J, V327, P872, DOI 10.1136/bmj.327.7419.872; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Hanratty B, 2007, INT J HEALTH SERV, V37, P89, DOI 10.2190/TTX2-3572-UL81-62W7; Health Inequalities Unit, 2007, REV HLTH IN INF MORT; Janghorbani M, 2006, J MATERN-FETAL NEO M, V19, P85, DOI 10.1080/14767050500363428; Kramer MS, 2001, PAEDIATR PERINAT EP, V15, P104, DOI 10.1046/j.1365-3016.2001.00012.x; Lloyd, 2004, ENGLISH INDICES DEPR; Lumley T., 2006, RELATIVE RISK REGRES, V293; Manning D, 2005, ARCH DIS CHILD-FETAL, V90, pF337, DOI 10.1136/adc.2005.071530; Moser Kath, 2007, Health Stat Q, P13; Petrou S, 2005, J EPIDEMIOL COMMUN H, V59, P591, DOI 10.1136/jech.2004.025395; Petrou S, 2003, PEDIATRICS, V112, P1290, DOI 10.1542/peds.112.6.1290; Smith LK, 2007, ARCH DIS CHILD-FETAL, V92, pF11, DOI 10.1136/adc.2005.090308; *TRENT NEON SURV, 2005, TRENT NEON SURV REP; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675; Weindling AM, 2003, ARCH DIS CHILD, V88, P1034, DOI 10.1136/adc.88.12.1034	20	30	30	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2009	339								b4702	10.1136/bmj.b4702	http://dx.doi.org/10.1136/bmj.b4702			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NR	19952036	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000272453200002
J	Okada, C; Yamashita, E; Lee, SJ; Shibata, S; Katahira, J; Nakagawa, A; Yoneda, Y; Tsukihara, T				Okada, Chimari; Yamashita, Eiki; Lee, Soo Jae; Shibata, Satoshi; Katahira, Jun; Nakagawa, Atsushi; Yoneda, Yoshihiro; Tsukihara, Tomitake			A High-Resolution Structure of the Pre-microRNA Nuclear Export Machinery	SCIENCE			English	Article							TRANSFER-RNA; C-ELEGANS; BINDING; PROTEIN; COMPLEX; RANGTP; KARYOPHERIN; PRECURSORS; LIN-14; DOMAIN	Nuclear export of microRNAs (miRNAs) by exportin-5 (Exp-5) is an essential step in miRNA biogenesis. Here, we present the 2.9 angstrom structure of the pre-miRNA nuclear export machinery formed by pre-miRNA complexed with Exp-5 and a guanine triphosphate (GTP)-bound form of the small nuclear guanine triphosphatase (GTPase) Ran (RanGTP). The x-ray structure shows that Exp-5: RanGTP recognizes the 2-nucleotide 3' overhang structure and the double-stranded stem of the pre-miRNA. Exp-5: RanGTP shields the pre-miRNA stem from degradation in a baseball mitt-like structure where it is held by broadly distributed weak interactions, whereas a tunnel-like structure of Exp-5 interacts strongly with the 2-nucleotide 3' overhang through hydrogen bonds and ionic interactions. RNA recognition by Exp-5: RanGTP does not depend on RNA sequence, implying that Exp-5: RanGTP can recognize a variety of pre-miRNAs.	[Lee, Soo Jae] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Okada, Chimari; Yamashita, Eiki; Nakagawa, Atsushi; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Shibata, Satoshi; Katahira, Jun; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan; [Katahira, Jun; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan; [Yoneda, Yoshihiro] Osaka Univ, Grad Sch Frontier Biosci, CREST, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; [Okada, Chimari; Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Chungbuk National University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; University of Hyogo	Lee, SJ (corresponding author), Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea.	sjlee@chungbuk.ac.kr; yyoneda@anat3.med.osaka-u.ac.jp; tsuki@protein.osaka-u.ac.jp	Nakagawa, Atsushi/M-5731-2019; Yamashita, Eiki/V-6758-2019; Nakagawa, Atsushi/D-4329-2009	Nakagawa, Atsushi/0000-0002-1700-7861; Yamashita, Eiki/0000-0002-4278-0039; Nakagawa, Atsushi/0000-0002-1700-7861; Katahira, Jun/0000-0001-5188-0368	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [A-041]; Japan Science and Technology Agency; Takeda Science Foundation; Chungbuk BIT Research-Oriented University Consortium;  [16087101];  [16087206];  [21227003]	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Chungbuk BIT Research-Oriented University Consortium; ; ; 	This work was supported in part by grants-in-aid for scientific research (16087101, 16087206, and 21227003), the GCOE program (A-041) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (to T. T.), the Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency (to T. T.), a grant from Takeda Science Foundation (to Y. Y.), and a grant from Chungbuk BIT Research-Oriented University Consortium (to S. J. L.). Coordinates and structure factures have been deposited to the PDB under accession code 3A6P.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Gwizdek C, 2003, J BIOL CHEM, V278, P5505, DOI 10.1074/jbc.C200668200; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Ruvkun Gary B, 2003, Harvey Lect, V99, P1; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824	25	264	271	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1275	1279		10.1126/science.1178705	http://dx.doi.org/10.1126/science.1178705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965479				2022-12-28	WOS:000272117900051
J	van der Oost, J; Brouns, SJJ				van der Oost, John; Brouns, Stan J. J.			RNAi: Prokaryotes Get in on the Act	CELL			English	Editorial Material							INTERFERENCE; MACHINERY; DEFENSE		[van der Oost, John; Brouns, Stan J. J.] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands	Wageningen University & Research	van der Oost, J (corresponding author), Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands.	john.vanderoost@wur.nl	van+der+Oost, John/Y-2548-2019	Brouns, Stan/0000-0002-9573-1724				Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434	9	17	19	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					863	865		10.1016/j.cell.2009.11.018	http://dx.doi.org/10.1016/j.cell.2009.11.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945373	Bronze			2022-12-28	WOS:000272169400010
J	Nutt, D				Nutt, David			Government vs science over drug and alcohol policy	LANCET			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neuropsychopharmacol Unit, London W12 0NN, England	Imperial College London	Nutt, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neuropsychopharmacol Unit, London W12 0NN, England.	d.nutt@imperial.ac.uk		nutt, david/0000-0002-1286-1401				Advisory Council on the Misuse of Drugs, 2008, CANN CLASS PUBL HLTH; Frisher M, 2009, SCHIZOPHR RES, V113, P123, DOI 10.1016/j.schres.2009.05.031; HENCKE D, 2009, GUARDIAN        0316; *INN U SCI SKILLS, 2009, PUTT SCI ENG HEART G, V1; MURRAY R, 2009, TIMES           1103; Nutt D., 2009, CTR CRIME JUSTICE ST, P10; Nutt DJ, 2009, J PSYCHOPHARMACOL, V23, P3, DOI 10.1177/0269881108099672; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; 1963, LANCET, V282, P989	9	13	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 21	2009	374	9703					1731	1733		10.1016/S0140-6736(09)61956-5	http://dx.doi.org/10.1016/S0140-6736(09)61956-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ID	19910043				2022-12-28	WOS:000272207700008
J	Joshi, D; Center, JR; Eisman, JA				Joshi, Devina; Center, Jacqueline R.; Eisman, John A.			Rational Testing Investigation of incidental hypercalcaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY HYPERPARATHYROIDISM; GUIDELINES; SCAN		[Joshi, Devina; Center, Jacqueline R.; Eisman, John A.] Garvan Inst Med Res, Osteoporosis & Bone Biol Program, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research	Eisman, JA (corresponding author), Garvan Inst Med Res, Osteoporosis & Bone Biol Program, 384 Victoria St, Sydney, NSW 2010, Australia.	j.eisman@garvan.org.au	Center, Jacqueline/AAY-8712-2021; Eisman, John A/C-2886-2014	Center, Jacqueline/0000-0002-5278-4527; 				Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bilezikian JP, 2005, J INTERN MED, V257, P6, DOI 10.1111/j.1365-2796.2004.01422.x; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Gordon Leonie, 2002, J Nucl Med Technol, V30, P179; Hinnie J, 2001, CALCIFIED TISSUE INT, V68, P216, DOI 10.1007/s002230001201; Johnston LB, 1996, J CLIN ENDOCR METAB, V81, P346, DOI 10.1210/jc.81.1.346; Kamaya Aya, 2006, Ultrasound Q, V22, P253, DOI 10.1097/01.ruq.0000237260.33509.4f; *NAT COMM CLIN LAB, 1986, EP7P NCCLS; Rodgers SE, 2008, CURR OPIN ONCOL, V20, P52, DOI 10.1097/CCO.0b013e3282f2838f; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Shepard MM, 2007, AM J MED SCI, V334, P381, DOI 10.1097/MAJ.0b013e31812f4947; Silverberg SJ, 2008, PRIMER METABOLIC BON, P302; SINCLAIR D, 1989, ANN EMERG MED, V18, P556, DOI 10.1016/S0196-0644(89)80843-1; Sukan A, 2008, ANN NUCL MED, V22, P123, DOI 10.1007/s12149-007-0086-z; Wermers RA, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.07.044	15	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2009	339								b4613	10.1136/bmj.b4613	http://dx.doi.org/10.1136/bmj.b4613			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TI	19933303				2022-12-28	WOS:000272097000001
J	Sukhdev, P				Sukhdev, Pavan			Costing the Earth	NATURE			English	Editorial Material									Econ Ecosyst & Biodivers TEEB Project, D-53113 Bonn, Germany		Sukhdev, P (corresponding author), Econ Ecosyst & Biodivers TEEB Project, United Nations Campus,Hermann Ehlers Str 10, D-53113 Bonn, Germany.	teeb@unep-teeb.org							0	36	38	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					277	277		10.1038/462277a	http://dx.doi.org/10.1038/462277a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521DF	19915547	Bronze			2022-12-28	WOS:000271899300017
J	Thavendiranathan, P; Bagai, A; Khoo, C; Dorian, P; Choudhry, NK				Thavendiranathan, Paaladinesh; Bagai, Akshay; Khoo, Clarence; Dorian, Paul; Choudhry, Niteesh K.			Does This Patient With Palpitations Have a Cardiac Arrhythmia?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES COMMITTEE; NODAL REENTRANT TACHYCARDIA; IMPLANTABLE LOOP RECORDER; GENERAL-PRACTICE; EVENT RECORDERS; SUPRAVENTRICULAR TACHYCARDIA; AMERICAN-COLLEGE; OUTPATIENT TELEMETRY; MEDICAL OUTPATIENTS	Context Many patients have palpitations and seek advice from general practitioners. Differentiating benign causes from those resulting from clinically significant cardiac arrhythmia can be challenging and the clinical examination may aid in this process. Objective To systematically review the accuracy of historical features, physical examination, and cardiac testing for the diagnosis of cardiac arrhythmia in patients with palpitations. Data Source, Study Selection, and Data Extraction MEDLINE (1950 to August 25, 2009) and EMBASE (1947 to August 2009) searches of English-language articles that compared clinical features and diagnostic tests in patients with palpitations with a reference standard for cardiac arrhythmia. Of the 277 studies identified by the search strategy, 7 studies were used for accuracy analysis and 16 studies for diagnostic yield analysis. Two authors independently reviewed articles for study data and quality and a third author resolved disagreements. Data Synthesis Most data were obtained from single studies with small sample sizes. A known history of cardiac disease (likelihood ratio [LR], 2.03; 95% confidence interval [CI], 1.33-3.11), having palpitations affected by sleeping (LR, 2.29; 95% CI, 1.33-3.94), or while the patient is at work (LR, 2.17; 95% CI, 1.19-3.96) slightly increase the likelihood of a cardiac arrhythmia. A known history of panic disorder (LR, 0.26; 95% CI, 0.07-1.01) or having palpitations lasting less than 5 minutes (LR, 0.38; 95% CI, 0.22-0.63) makes the diagnosis of cardiac arrhythmia slightly less likely. The presence of a regular rapid-pounding sensation in the neck (LR, 177; 95% CI, 25-1251) or visible neck pulsations (LR, 2.68; 95% CI, 1.25-5.78) in association with palpitations increases the likelihood of a specific type of arrhythmia (atrioventricular nodal reentry tachycardia). The absence of a regular rapid-pounding sensation in the neck makes detecting the same arrhythmia less likely (LR, 0.07; 95% CI, 0.03-0.19). No other features significantly alter the probability of clinically significant arrhythmia. Diagnostic tests for prolonged periods of electrocardiographic monitoring vary in their yield depending on the modality used, duration of monitoring, and occurrence of typical symptoms during monitoring. Loop monitors have the highest diagnostic yield (34%-84%) for identifying an arrhythmia. Conclusions While the presence of a regular rapid-pounding sensation in the neck or visible neck pulsations associated with palpitations makes the diagnosis of atrioventricular nodal reentry tachycardia likely, the reviewed studies suggest that the clinical examination is not sufficiently accurate to exclude clinically significant arrhythmias in most patients. Thus, prolonged electrocardiographic monitoring with demonstration of symptom-rhythm correlation is required to make the diagnosis of a cardiac arrhythmia for most patients with recurrent palpitations. JAMA. 2009; 302(19): 2135-2143	[Choudhry, Niteesh K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA; [Choudhry, Niteesh K.] Harvard Univ, Sch Med, Boston, MA USA; [Thavendiranathan, Paaladinesh] Univ Toronto, Dept Med, Div Cardiol, Toronto, ON, Canada; [Bagai, Akshay; Dorian, Paul] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Khoo, Clarence] Univ British Columbia, Div Cardiol, Dept Med, Vancouver, BC V5Z 1M9, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of British Columbia	Choudhry, NK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	nchoudhry@partners.org		Thavendiranathan, Paaladinesh/0000-0002-6497-1098				Abbott AV, 2005, AM FAM PHYSICIAN, V71, P743; Abe H, 1997, PACE, V20, P2783, DOI 10.1111/j.1540-8159.1997.tb05436.x; Barrionuevo JDA, 2002, REV ESP CARDIOL, V55, P107; BARSKY AJ, 1994, J NERV MENT DIS, V182, P63, DOI 10.1097/00005053-199402000-00001; BARSKY AJ, 1995, ARCH INTERN MED, V155, P1782, DOI 10.1001/archinte.155.16.1782; BARSKY AJ, 1994, J GEN INTERN MED, V9, P306, DOI 10.1007/BF02599176; Barsky AJ, 1996, J FAM PRACTICE, V42, P465; Barsky AJ, 1997, ARCH FAM MED, V6, P241, DOI 10.1001/archfami.6.3.241; Blomstrom-Lundqvist C, 2003, CIRCULATION, V108, P1871, DOI 10.1161/01.CIR.0000091380.04100.84; BRUGADA P, 1993, LANCET, V341, P1254, DOI 10.1016/0140-6736(93)91155-F; COOK DJ, 2009, RATIONAL CLIN EXAMIN, P125; COUMEL P, 1990, CLIN CARDIOL, V13, P209, DOI 10.1002/clc.4960130311; Crawford MH, 1999, CIRCULATION, V100, P886, DOI 10.1161/01.CIR.100.8.886; De Ponti F, 2002, DRUG SAFETY, V25, P263; Fogel RI, 1997, AM J CARDIOL, V79, P207, DOI 10.1016/S0002-9149(96)00717-5; Giada F, 2007, J AM COLL CARDIOL, V49, P1951, DOI 10.1016/j.jacc.2007.02.036; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; GOLDREYER BN, 1976, CIRCULATION, V54, P783, DOI 10.1161/01.CIR.54.5.783; Gonzalez-Torrecilla E, 2009, J AM COLL CARDIOL, V53, P2353, DOI 10.1016/j.jacc.2009.02.059; GURSOY S, 1992, NEW ENGL J MED, V327, P772, DOI 10.1056/NEJM199209103271105; Hansson Anders, 2004, BMC Cardiovasc Disord, V4, P13, DOI 10.1186/1471-2261-4-13; Hermida JS, 1997, AM J CARDIOL, V79, P1375, DOI 10.1016/S0002-9149(97)00143-4; Hoefman E, 2005, FAM PRACT, V22, P478, DOI 10.1093/fampra/cmi048; Hoefman E, 2007, FAM PRACT, V24, P636, DOI 10.1093/fampra/cmm056; Hoefman E, 2007, FAM PRACT, V24, P11, DOI 10.1093/fampra/cml065; Joshi AK, 2005, AM J CARDIOL, V95, P878, DOI 10.1016/j.amjcard.2004.12.015; Kinlay S, 1996, ANN INTERN MED, V124, P16, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00003; Lampert R, 2002, CIRCULATION, V106, P1800, DOI 10.1161/01.CIR.0000031733.51374.C1; Laurent G, 2009, J CARDIOVASC ELECTR, V20, P176, DOI 10.1111/j.1540-8167.2008.01276.x; LEITCH JW, 1992, CIRCULATION, V85, P1064, DOI 10.1161/01.CIR.85.3.1064; Lessmeier TJ, 1997, ARCH INTERN MED, V157, P537, DOI 10.1001/archinte.157.5.537; Marcus GM, 2008, HEART RHYTHM, V5, P826, DOI 10.1016/j.hrthm.2008.02.016; Mayou R, 2003, QJM-INT J MED, V96, P115, DOI 10.1093/qjmed/hcg017; Olson JA, 2007, J CARDIOVASC ELECTR, V18, P473, DOI 10.1111/j.1540-8167.2007.00779.x; Porter MJ, 2004, HEART RHYTHM, V1, P393, DOI 10.1016/j.hrthm.2004.05.007; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rutten FH, 2000, INT J CARDIOL, V74, P199, DOI 10.1016/S0167-5273(00)00284-9; Sakhuja Rahul, 2009, Clin Cardiol, V32, pE13, DOI 10.1002/clc.20455; Scalvini S, 2005, J TELEMED TELECARE, V11, P14, DOI 10.1258/1357633054461930; Seidl K, 2000, EUROPACE, V2, P256, DOI 10.1053/eupc.2000.0108; Simel DL., 2009, RATIONAL CLIN EXAMIN, V2 ed, P9; Summerton N, 2001, FAM PRACT, V18, P383, DOI 10.1093/fampra/18.4.383; Varma N, 1997, J CARDIOVASC ELECTR, V8, P104; Weber BE, 1996, AM J MED, V100, P138, DOI 10.1016/S0002-9343(97)89451-X; Wu CC, 2003, J INTERV CARD ELECTR, V8, P117, DOI 10.1023/A:1023604816368; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; Zimetbaum P, 1998, NEW ENGL J MED, V338, P1369, DOI 10.1056/NEJM199805073381907; Zimetbaum P, 1997, AM J CARDIOL, V79, P371, DOI 10.1016/S0002-9149(96)00766-7; Zimetbaum PJ, 1998, ANN INTERN MED, V128, P890, DOI 10.7326/0003-4819-128-11-199806010-00002; ZIPES DP, 1995, J AM COLL CARDIOL, V26, P555, DOI 10.1016/0735-1097(95)80037-H; Zwietering PJ, 1998, FAM PRACT, V15, P343, DOI 10.1093/fampra/15.4.343	52	29	31	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2135	2143		10.1001/jama.2009.1673	http://dx.doi.org/10.1001/jama.2009.1673			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920238				2022-12-28	WOS:000271873900023
J	Moellering, RE; Cornejo, M; Davis, TN; Del Bianco, C; Aster, JC; Blacklow, SC; Kung, AL; Gilliland, DG; Verdine, GL; Bradner, JE				Moellering, Raymond E.; Cornejo, Melanie; Davis, Tina N.; Del Bianco, Cristina; Aster, Jon C.; Blacklow, Stephen C.; Kung, Andrew L.; Gilliland, D. Gary; Verdine, Gregory L.; Bradner, James E.			Direct inhibition of the NOTCH transcription factor complex	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; T-CELL LEUKEMIA; PROGENITOR CELLS; HUMAN HOMOLOG; C-MYC; MUTATIONS; GENE; MASTERMIND; ACTIVATION	Direct inhibition of transcription factor complexes remains a central challenge in the discipline of ligand discovery. In general, these proteins lack surface involutions suitable for high-affinity binding by small molecules. Here we report the design of synthetic, cell-permeable, stabilized alpha-helical peptides that target a critical protein-protein interface in the NOTCH transactivation complex. We demonstrate that direct, high-affinity binding of the hydrocarbon-stapled peptide SAHM1 prevents assembly of the active transcriptional complex. Inappropriate NOTCH activation is directly implicated in the pathogenesis of several disease states, including T-cell acute lymphoblastic leukaemia (T-ALL). The treatment of leukaemic cells with SAHM1 results in genome-wide suppression of NOTCH-activated genes. Direct antagonism of the NOTCH transcriptional program causes potent, NOTCH-specific anti-proliferative effects in cultured cells and in a mouse model of NOTCH1-driven T-ALL.	[Moellering, Raymond E.; Bradner, James E.] Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA 02142 USA; [Moellering, Raymond E.; Verdine, Gregory L.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Moellering, Raymond E.; Verdine, Gregory L.; Bradner, James E.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Cornejo, Melanie; Gilliland, D. Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Del Bianco, Cristina; Aster, Jon C.; Blacklow, Stephen C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Davis, Tina N.; Kung, Andrew L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Davis, Tina N.; Kung, Andrew L.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematol Neoplasia, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Bradner, JE (corresponding author), Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA 02142 USA.	gregory_verdine@harvard.edu; james_bradner@dfci.harvard.edu	Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022; Del Bianco, Cristina/J-4665-2012	Kung, Andrew L/0000-0002-9091-488X; Moellering, Raymond/0000-0002-2043-7838; Cornejo, Melanie/0000-0001-6094-2719	Leukaemia & Lymphoma Society; AACR Centennial Pre-doctoral Research Fellowship in Cancer Research; American Society of Hematology; MCCB-NIH [5T32GM007598]; Human Frontier Science Program; Harvard & Dana Farber Program in Cancer Chemical Biology; National Cancer Institute's Initiative for Chemical Genetics, National Institutes of Health [N01-CO-12400]; NATIONAL CANCER INSTITUTE [R56CA092433, R01CA092433, P01CA119070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598] Funding Source: NIH RePORTER	Leukaemia & Lymphoma Society; AACR Centennial Pre-doctoral Research Fellowship in Cancer Research; American Society of Hematology; MCCB-NIH; Human Frontier Science Program(Human Frontier Science Program); Harvard & Dana Farber Program in Cancer Chemical Biology; National Cancer Institute's Initiative for Chemical Genetics, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Schreiber and the Broad Institute Chemical Biology Program for discussions and access to instrumentation; J. Rocnik for assistance in the establishment of the T-ALL murine model; A. Ferrando for providing GSI microarray data; M. Hancock and Invitrogen for providing beta-lactamase HeLa reporter clones; K. Ross and A. Subramanian for conversations and guidance about GSEA; and S. Gupta and the Broad Institute Microarray Core. This work was supported by a Specialized Center of Research grant from the Leukaemia & Lymphoma Society (to J. E. B., J. C. A., S. C. B.), an AACR Centennial Pre-doctoral Research Fellowship in Cancer Research (to R. E. M.), the American Society of Hematology (to J. E. B.), MCCB-NIH Training Grant No. 5T32GM007598 (to R. E. M.), the Human Frontier Science Program (to C. D.), and the Harvard & Dana Farber Program in Cancer Chemical Biology (to J. E. B., R. E. M., G. L. V.). The project has been funded in part with Federal funds from the National Cancer Institute's Initiative for Chemical Genetics, National Institutes of Health, under Contract No. N01-CO-12400. Histology and immunohistochemical staining was performed in the Dana Farber/Harvard Cancer Center Specialized Histopathology Services Core Laboratory.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Becker CM, 2006, AM J PATHOL, V168, P2074, DOI 10.2353/ajpath.2006.051133; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DE SB, 1999, NATURE, V398, P518; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hallis TM, 2007, J BIOMOL SCREEN, V12, P635, DOI 10.1177/1087057107301499; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lleo A, 2008, CURR TOP MED CHEM, V8, P9; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WILLIAMS RM, 1991, J AM CHEM SOC, V113, P9276, DOI 10.1021/ja00024a038; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	50	607	653	4	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					182	U57		10.1038/nature08543	http://dx.doi.org/10.1038/nature08543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907488	Green Accepted			2022-12-28	WOS:000271655100035
J	Wang, DH; Engle, KM; Shi, BF; Yu, JQ				Wang, Dong-Hui; Engle, Keary M.; Shi, Bing-Feng; Yu, Jin-Quan			Ligand-Enabled Reactivity and Selectivity in a Synthetically Versatile Aryl C-H Olefination	SCIENCE			English	Article							CARBON-HYDROGEN BONDS; KEDARCIDIN CHROMOPHORE; ACTIVATION; FUNCTIONALIZATION; ACIDS; CYCLIZATION; LITHIATION; ARYLATION	The Mizoroki-Heck reaction, which couples aryl halides with olefins, has been widely used to stitch together the carbogenic cores of numerous complex organic molecules. Given that the position-selective introduction of a halide onto an arene is not always straightforward, direct olefination of aryl carbon-hydrogen (C-H) bonds would obviate the inefficiencies associated with generating halide precursors or their equivalents. However, methods for carrying out such a reaction have suffered from narrow substrate scope and low positional selectivity. We report an operationally simple, atom-economical, carboxylate-directed Pd(II)-catalyzed C-H olefination reaction with phenylacetic acid and 3-phenylpropionic acid substrates, using oxygen at atmospheric pressure as the oxidant. The positional selectivity can be tuned by introducing amino acid derivatives as ligands. We demonstrate the versatility of the method through direct elaboration of commercial drug scaffolds and efficient syntheses of 2-tetralone and naphthoic acid natural product cores.	[Wang, Dong-Hui; Engle, Keary M.; Shi, Bing-Feng; Yu, Jin-Quan] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Shi, Bing-Feng/E-4248-2012; Engle, Keary/A-9223-2015	Shi, Bing-Feng/0000-0003-0375-955X; Wang, Dong-Hui/0000-0002-4318-5450; Engle, Keary/0000-0003-2767-6556	A. P. Sloan Foundation; NSF [CHE-0910014]; U.S. Department of Defense; Scripps Research Institute; Skaggs Oxford Scholarship program; National Institute of General Medical Sciences [1 R01 GM084019-02]; Amgen; Eli Lilly Co; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	A. P. Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); U.S. Department of Defense(United States Department of Defense); Scripps Research Institute; Skaggs Oxford Scholarship program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Amgen(Amgen); Eli Lilly Co(Eli Lilly); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by an A. P. Sloan Foundation fellowship (J.-Q. Y.); predoctoral fellowships from NSF, the U.S. Department of Defense, the Scripps Research Institute, and the Skaggs Oxford Scholarship program (K. M. E.); and the Scripps Research Institute, National Institute of General Medical Sciences grant 1 R01 GM084019-02, NSF grant CHE-0910014, Amgen, and Eli Lilly & Co.	Baran PS, 2002, J AM CHEM SOC, V124, P7904, DOI 10.1021/ja026663t; BEAK P, 1982, ACCOUNTS CHEM RES, V15, P306, DOI 10.1021/ar00082a002; Beck EM, 2008, ANGEW CHEM INT EDIT, V47, P3004, DOI 10.1002/anie.200705005; Boele MDK, 2002, J AM CHEM SOC, V124, P1586, DOI 10.1021/ja0176907; Bowie AL, 2005, ORG LETT, V7, P5207, DOI 10.1021/ol052033v; Campeau LC, 2007, ALDRICHIM ACTA, V40, P35; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Dangel BD, 2002, J AM CHEM SOC, V124, P11856, DOI 10.1021/ja027311p; Daugulis O, 2006, SYNLETT, P3382, DOI 10.1055/s-2006-956468; Davies HML, 2006, J AM CHEM SOC, V128, P2485, DOI 10.1021/ja056877l; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; Garg NK, 2004, J AM CHEM SOC, V126, P9552, DOI 10.1021/ja046695b; Gorka A, 2005, SYNTHETIC COMMUN, V35, P2371, DOI 10.1080/00397910500187753; Gorth FC, 2000, EUR J ORG CHEM, V2000, P2605; Hartwig JF, 2008, NATURE, V455, P314, DOI 10.1038/nature07369; Hinman A, 2003, J AM CHEM SOC, V125, P11510, DOI 10.1021/ja0368305; Ji N, 2004, ORG LETT, V6, P4551, DOI 10.1021/ol048075l; Jia CG, 2000, SCIENCE, V287, P1992, DOI 10.1126/science.287.5460.1992; Kawata S, 1997, J AM CHEM SOC, V119, P12012, DOI 10.1021/ja973231n; Martin R, 2008, ACCOUNTS CHEM RES, V41, P1461, DOI 10.1021/ar800036s; Mei TS, 2008, ANGEW CHEM INT EDIT, V47, P5215, DOI 10.1002/anie.200705613; Miura M, 1998, J ORG CHEM, V63, P5211, DOI 10.1021/jo980584b; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Myers AG, 1997, TETRAHEDRON LETT, V38, P4363, DOI 10.1016/S0040-4039(97)00844-7; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Shi BF, 2008, ANGEW CHEM INT EDIT, V47, P4882, DOI 10.1002/anie.200801030; Stang EM, 2009, NAT CHEM, V1, P547, DOI [10.1038/NCHEM.351, 10.1038/nchem.351]; TROST BM, 1978, J AM CHEM SOC, V100, P3930, DOI 10.1021/ja00480a047; Tsai AS, 2008, J AM CHEM SOC, V130, P6316, DOI 10.1021/ja8012159; Wang DH, 2008, J AM CHEM SOC, V130, P17676, DOI 10.1021/ja806681z; Yu JQ, 2006, ORG BIOMOL CHEM, V4, P4041, DOI 10.1039/b611094k; Zhang YH, 2009, J AM CHEM SOC, V131, P5072, DOI 10.1021/ja900327e	33	614	615	9	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					315	319		10.1126/science.1182512	http://dx.doi.org/10.1126/science.1182512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	544CM	19965380	Green Accepted			2022-12-28	WOS:000273629700038
J	Romanowski, B; de Borba, PC; Naud, PS; Roteli-Martins, CM; De Carvalho, NS; Teixeira, JC; Aoki, F; Ramjattan, B; Shier, RM; Somani, R; Barbier, S; Blatter, MM; Chambers, C; Ferris, D; Gall, SA; Guerra, FA; Harper, DM; Hedrick, JA; Henry, DC; Korn, AP; Kroll, R; Moscicki, AB; Rosenfeld, WD; Sullivan, BJ; Thoming, CS; Tyring, SK; Wheeler, CM; Dubin, G; Schuind, A; Zahaf, T				Romanowski, B.; de Borba, P. Colares; Naud, P. S.; Roteli-Martins, C. M.; De Carvalho, N. S.; Teixeira, J. C.; Aoki, F.; Ramjattan, B.; Shier, R. M.; Somani, R.; Barbier, S.; Blatter, M. M.; Chambers, C.; Ferris, D.; Gall, S. A.; Guerra, F. A.; Harper, D. M.; Hedrick, J. A.; Henry, D. C.; Korn, A. P.; Kroll, R.; Moscicki, A-B; Rosenfeld, W. D.; Sullivan, B. J.; Thoming, C. S.; Tyring, S. K.; Wheeler, C. M.; Dubin, G.; Schuind, A.; Zahaf, T.		GlaxoSmithKline Vaccine HPV-007 St	Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years	LANCET			English	Article							SUBSEQUENT HPV INFECTION; PARTICLE VACCINE; CERVICAL-CANCER; YOUNG-WOMEN; NATURAL-HISTORY; ANTIBODY-LEVELS; DOUBLE-BLIND; HEPATITIS-B; TYPE-16; RISK	Background Prophylactic human papillomavirus (HPV) vaccines have to provide sustained protection. We assessed efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine up to 6.4 years. Methods Women aged 15-25 years, with normal cervical cytology, who were HPV-16/18 seronegative and oncogenic HPV DNA-negative (14 types) at screening participated in a double-blind, randomised, placebo-controlled initial study (n=1113; 560 vaccine group vs 553 placebo group) and follow-up study (n=776; 393 vs 383). 27 sites in three countries participated in the follow-up study. Cervical samples were tested every 6 months for HPV DNA. Management of abnormal cytologies was prespecified, and HPV-16/18 antibody titres were assessed. The primary objective was to assess long-term vaccine efficacy in the prevention of incident cervical infection with HPV 16 or HPV 18, or both. We report the analyses up to 6.4 years of this follow-up study and combined with the initial study. For the primary endpoint, the efficacy analysis was done in the according-to-protocol (ATP) cohort; the analysis of cervical intraepithelial neoplasia grade 2 and above (CIN2+) was done in the total vaccinated cohort (TVC). The study is registered with ClinicalTrials.gov, number NCT00120848. Findings For the combined analysis of the initial and follow-up studies, the ATP efficacy cohort included 465 women in the vaccine group and 454 in the placebo group; the TVC included 560 women in the vaccine group and 553 in the placebo group. Vaccine efficacy against incident infection with HPV 16/18 was 95.3% (95% C1 87.4-98.7) and against 12-month persistent infection was 100% (81.8-100). Vaccine efficacy against CIN2+ was 100% (51.3-100) for lesions associated with HPV-16/18 and 71.9% (20.6-91.9) for lesions independent of HPV DNA. Antibody concentrations by ELISA remained 12-fold or more higher than after natural infection (both antigens). Safety outcomes were similar between groups: during the follow-up study, 30 (8%) participants reported a serious adverse event in the vaccine group versus 37 (10%) in the placebo group. None was judged related or possibly related to vaccination, and no deaths occurred. Interpretation Our findings show excellent long-term efficacy, high and sustained immunogenicity and favourable safety of the HPV-16/18 AS04-adjuvanted vaccine up to 6.4 years.	[Romanowski, B.] Univ Alberta, Edmonton, AB T6G 2C8, Canada; [de Borba, P. Colares] Ceara Canc Prevent Inst, Fortaleza, Ceara, Brazil; [Naud, P. S.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Roteli-Martins, C. M.] Leonor Mendes de Barros Hosp, Hlth State Dept, Sao Paulo, Brazil; [De Carvalho, N. S.] Univ Fed Parana, Dept Obstet & Gynaecol, BR-80060000 Curitiba, Parana, Brazil; [De Carvalho, N. S.] Clin Hosp, Obstetr Gynecol & Infect Dis Sector, Curitiba, Parana, Brazil; [Teixeira, J. C.] Univ Estadual Campinas, CAISM, Dept Gynaecol, Div Oncol, Campinas, SP, Brazil; [Aoki, F.] Univ Manitoba, Winnipeg, MB, Canada; [Ramjattan, B.] Cowan Ave Med Clin, St John, NF, Canada; [Shier, R. M.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Somani, R.] Glover Med Clin, Langley, BC, Canada; [Barbier, S.] Womens Clin Res Ctr, Seattle, WA USA; [Blatter, M. M.] Primary Phys Res, Pittsburgh, PA USA; [Chambers, C.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Ferris, D.] Med Coll Georgia, Augusta, GA 30912 USA; [Gall, S. A.] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Guerra, F. A.] San Antonio Metropolitan Hlth Dist, San Antonio, TX USA; [Harper, D. M.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Hedrick, J. A.] Kentucky Pediat & Adult Res, Bardstow, KY USA; [Henry, D. C.] J Lewis Res, Salt Lake City, UT USA; [Korn, A. P.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Kroll, R.] Womens Clin Res Ctr, Seattle, WA USA; [Moscicki, A-B] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Rosenfeld, W. D.] Goryeb Childrens Hosp, Atlantic Hlth, Dept Pediat, Morristown, NJ USA; [Sullivan, B. J.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Thoming, C. S.] Westover Hts Clin, Portland, OR USA; [Tyring, S. K.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Wheeler, C. M.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Dubin, G.; Schuind, A.] GSK Biol, King Of Prussia, PA USA; [Zahaf, T.] GSK Biol, Rixensart, Belgium	University of Alberta; Universidade Federal do Rio Grande do Sul; Universidade Federal do Parana; Universidade Estadual de Campinas; University of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Jefferson University; University System of Georgia; Augusta University; University of Louisville; Dartmouth College; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Atlantic Health System; Marshfield Clinic; University of Texas System; University of Texas Health Science Center Houston; University of New Mexico; University of New Mexico's Health Sciences Center; GlaxoSmithKline; GlaxoSmithKline	Romanowski, B (corresponding author), Univ Alberta, 1000-8215 112 St, Edmonton, AB T6G 2C8, Canada.	broman@docromanowski.com	Moscicki, Anna-Barbara/AAP-3806-2021; de carvalho, newton/G-5045-2013; Teixeira, Julio Cesar/H-3151-2013; Harper, Diane M./I-2180-2014	Teixeira, Julio Cesar/0000-0002-0979-376X; Harper, Diane M./0000-0001-7648-883X	GlaxoSmith Kline Biologicals; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	GlaxoSmith Kline Biologicals(GlaxoSmithKline); NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded and coordinated by GlaxoSmith Kline Biologicals. We thank the staff members of the 27 sites that participated in this study. A-B Moscicki's research centre is supported by NIH/NCRR UCSF-CTSI grant number UL1 RR024131; the contents of publications arising from work at this centre are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Banatvala J, 2000, VACCINE, V19, P877, DOI 10.1016/S0264-410X(00)00224-3; Carter JJ, 1996, J INFECT DIS, V174, P927, DOI 10.1093/infdis/174.5.927; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; GALL SA, 2007, AM ASS CANC RES ANN; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Ho GYF, 2002, J INFECT DIS, V186, P737, DOI 10.1086/342972; Joura EA, 2008, VACCINE, V26, P6844, DOI 10.1016/j.vaccine.2008.09.073; Kemp TJ, 2008, VACCINE, V26, P3608, DOI 10.1016/j.vaccine.2008.04.074; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Levie K, 2002, SCAND J INFECT DIS, V34, P610, DOI 10.1080/00365540110080881; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pedersen C, 2007, J ADOLESCENT HEALTH, V40, P564, DOI 10.1016/j.jadohealth.2007.02.015; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; SCHWARZ TF, GYNECOL ONCOL S1, V110, pS1; Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stanley M, 2006, VACCINE, V24, P106, DOI 10.1016/j.vaccine.2006.05.110; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Viscidi RP, 2005, CANCER EPIDEM BIOMAR, V14, P283; Viscidi RP, 2004, CANCER EPIDEM BIOMAR, V13, P324, DOI 10.1158/1055-9965.EPI-03-0166; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, 2007, HUM PAP HPV VACC TEC; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	37	281	286	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1975	1985		10.1016/S0140-6736(09)61567-1	http://dx.doi.org/10.1016/S0140-6736(09)61567-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EA	19962185				2022-12-28	WOS:000272727000021
J	Lin, CR; Yang, LQ; Tanasa, B; Hutt, K; Ju, BG; Ohgi, K; Zhang, J; Rose, DW; Fu, XD; Glass, CK; Rosenfeld, MG				Lin, Chunru; Yang, Liuqing; Tanasa, Bogdan; Hutt, Kasey; Ju, Bong-gun; Ohgi, Kenny; Zhang, Jie; Rose, David W.; Fu, Xiang-Dong; Glass, Christopher K.; Rosenfeld, Michael G.			Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer	CELL			English	Article							CLASS-SWITCH RECOMBINATION; GENOME INSTABILITY; ANDROGEN RECEPTOR; HISTONE H3; TRANSCRIPTION; GENE; FUSION; MECHANISM; LEUKEMIA; DYNAMICS	Chromosomal translocations are a hallmark of leukemia/lymphoma and also appear in solid tumors, but the underlying mechanism remains elusive. By establishing a cellular model that mimics the relative frequency of authentic translocation events without proliferation selection, we report mechanisms of nuclear receptor-dependent tumor translocations. Intronic binding of liganded androgen receptor (AR) first juxtaposes translocation loci by triggering intra-and interchromosomal interactions. AR then promotes site-specific DNA double-stranded breaks (DSBs) at translocation loci by recruiting two types of enzymatic activities induced by genotoxic stress and liganded AR, including activation-induced cytidine deaminase and the LINE-1 repeat-encoded ORF2 endonuclease. These enzymes synergistically generate site-selective DSBs at juxtaposed translocation loci that are ligated by nonhomologous end joining pathway for specific translocations. Our data suggest that the confluence of two parallel pathways initiated by liganded nuclear receptor and genotoxic stress underlies nonrandom tumor translocations, which may function in many types of tumors and pathological processes.	[Lin, Chunru; Yang, Liuqing; Tanasa, Bogdan; Ju, Bong-gun; Ohgi, Kenny; Zhang, Jie; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Hutt, Kasey] Univ Calif San Diego, Sch Med, Bioinformat Grad Program, La Jolla, CA 92093 USA; [Rose, David W.; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Fu, Xiang-Dong; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ju, Bong-gun] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sogang University	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Yang, Liuqing/B-7935-2011; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	National Institutes of Health (NIH) [DK39949, DK18477, CA97134, NS34934]; Department of Defense (DoD) [00325108]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DoD)(United States Department of Defense); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Nelson for various cell culture assistance, J. Hightower for artwork, D. Benson for assistance with the manuscript, V. Lunyak and X. Zhu for critical comments, M. Schwartz and E. Nunez for assistance with fluorescence microscopy and FISH technology, Y. Zhang for providing the FLAG-DOT1L construct, M. B. Kastan for providing the HA-ER-I-PpoI construct, J. L. Goodier for providing LINE-1 ORF1, ORF2 constructs, Ankara vaccinia virus that expresses T7 polymerase, and polyclonal antibody against ORF2, S. Heinz for providing PIWIL1 and PIWIL2 expression constructs, and AstraZeneca for providing Casodex. M. G. R. is a Howard Hughes Medical Institute Investigator. This study was funded by grants from The National Institutes of Health (NIH; DK39949, DK18477, CA97134, NS34934), the Department of Defense (DoD), and Prostate Cancer Foundation to M. G. R., and X. D. F., and NIH grants to X. D. F. and C. K. G. C. L. is a fellow of Susan G. Komen for the Cure (KG080247), and L. Yang is an awardee of Era of Hope Postdoctoral Award supported by the DoD (grant 00325108).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Deininger MWN, 1998, CANCER RES, V58, P421; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goodier JL, 2004, HUM MOL GENET, V13, P1041, DOI 10.1093/hmg/ddh118; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hofmann WA, 2006, J CELL BIOL, V172, P495, DOI 10.1083/jcb.200601095; Holzinger A, 2001, METH MOL B, V161, P109; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lucas J, 2008, J PATHOL, V215, P118, DOI 10.1002/path.2330; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Prak NL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/37049; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rajewsky K, 2008, CURR OPIN IMMUNOL, V20, P127, DOI 10.1016/j.coi.2008.04.005; Rizk RS, 2005, CURR BIOL, V15, pR841, DOI 10.1016/j.cub.2005.10.004; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Santourlidis S, 1999, PROSTATE, V39, P166; Shaffer DR, 2006, NAT MED, V12, P14, DOI 10.1038/nm0106-14; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193	55	428	454	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1069	1083		10.1016/j.cell.2009.11.030	http://dx.doi.org/10.1016/j.cell.2009.11.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	19962179	Bronze, Green Accepted			2022-12-28	WOS:000272622800010
J	Graf, T; Enver, T				Graf, Thomas; Enver, Tariq			Forcing cells to change lineages	NATURE			English	Review							HEMATOPOIETIC STEM-CELLS; GENE REGULATORY NETWORKS; TRANSCRIPTION FACTORS; PROGENITOR CELLS; SELF-RENEWAL; IN-VIVO; HAEMOGENIC ENDOTHELIUM; INDUCED PLURIPOTENCY; CHROMATIN-STRUCTURE; C/EBP-ALPHA	The ability to produce stem cells by induced pluripotency (iPS reprogramming) has rekindled an interest in earlier studies showing that transcription factors can directly convert specialized cells from one lineage to another. Lineage reprogramming has become a powerful tool to study cell fate choice during differentiation, akin to inducing mutations for the discovery of gene functions. The lessons learnt provide a rubric for how cells may be manipulated for therapeutic purposes.	[Graf, Thomas] Ctr Genom Regulat, Barcelona 08003, Spain; [Graf, Thomas] ICREA, Barcelona 08003, Spain; [Enver, Tariq] John Radcliffe Hosp, MRC, Mol Haematol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; University of Oxford	Graf, T (corresponding author), Ctr Genom Regulat, Barcelona 08003, Spain.	thomas.graf@crg.es	Wilson, Matthew H/K-3193-2013; Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117	LRF; MRC [MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137973817] Funding Source: researchfish; ICREA Funding Source: Custom	LRF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ICREA(ICREA)	We would like to thank J. Sharpe, C. Peterson, J. Brickman and D. Thieffry for feedback and suggestions. T. G. is an ICREA professor and T. E. is supported by an LRF specialist programme.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Alon U., 2006, INTRO SYSTEMS BIOL D; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BLAU HM, 1989, TRENDS GENET, V5, P268, DOI 10.1016/0168-9525(89)90100-5; BOUKAMP P, 1992, J CELL BIOL, V116, P1257, DOI 10.1083/jcb.116.5.1257; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Frontelo P, 2007, BLOOD, V110, P3871, DOI 10.1182/blood-2007-03-082065; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kitajima K, 2006, GENE DEV, V20, P654, DOI 10.1101/gad.1378206; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; LAGHA M, DEV CELL IN PRESS; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Ptashne M, 2004, GENETIC SWITCH PHAGE; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; SMITH J, 2007, CURR PROTOCOLS STEM, V1; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Waddington C., 1957, STRATEGY GENES; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	98	623	675	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					587	594		10.1038/nature08533	http://dx.doi.org/10.1038/nature08533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956253				2022-12-28	WOS:000272277900029
J	Johansson, K; Neovius, M; Lagerros, YT; Harlid, R; Rossner, S; Granath, F; Hemmingsson, E				Johansson, Kari; Neovius, Martin; Lagerros, Ylva Trolle; Harlid, Richard; Roessner, Stephan; Granath, Fredrik; Hemmingsson, Erik			Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-CALORIE DIET; WEIGHT-REDUCTION PROGRAM; LONG-TERM MAINTENANCE; RISK-FACTORS; BARIATRIC SURGERY; MEDICAL THERAPY; LIFE-STYLE; EPIDEMIOLOGY; POPULATION; MORTALITY	Objective To assess the effect of weight loss induced by a very low energy diet on moderate and severe obstructive sleep apnoea in obese men. Design Single centre, two arm, parallel, randomised, controlled, open label trial. Blocked randomisation procedure used for treatment allocation. Setting Outpatient obesity clinic in a university hospital in Stockholm, Sweden. Participants 63 obese men (body mass index 30-40, age 30-65 years) with moderate to severe obstructive sleep apnoea (apnoea-hypopnoea index (AHI) >= 15), treated with continuous positive airway pressure. Interventions The intervention group received a liquid very low energy diet (2.3 MJ/day) for seven weeks to promote weight loss, followed by two weeks of gradual introduction of normal food, reaching 6.3 MJ/day at week 9. The control group adhered to their usual diet during the nine weeks of follow-up. Main outcome measure AHI, the major disease severity index for obstructive sleep apnoea. Data from all randomised patients were included in an intention to treat analysis ( baseline carried forward for missing data). Results Of the 63 eligible patients, 30 were randomised to intervention and 33 to control. Two patients in the control group were dissatisfied with allocation and immediately discontinued. All other patients completed the trial. Both groups had a mean AHI of 37 events/h (SD 15) at baseline. At week 9, the intervention group's mean body weight was 20 kg (95% confidence interval 18 to 21) lower than that of the control group, while its mean AHI was 23 events/h ( 15 to 30) lower. In the intervention group, five of 30 ( 17%) were disease free after the energy restricted diet ( AHI < 5), with 15 of 30 (50%) having mild disease (AHI 5-14.9), whereas the AHI of all patients in the control group except one remained at 15 or higher. In a subgroup analysis of the intervention group, baseline AHI significantly modified the effectiveness of treatment, with a greater improvement in AHI in patients with severe obstructive sleep apnoea (AHI > 30) at baseline compared with those with moderate (AHI 15-30) sleep apnoea (AHI -38 v -12, P<0.001), despite similar weight loss (-19.2 v -18.2 kg, P=0.55). Conclusion Treatment with a low energy diet improved obstructive sleep apnoea in obese men, with the greatest effect in patients with severe disease. Long term treatment studies are needed to validate weight loss as a primary treatment strategy for obstructive sleep apnoea. Trial registration Current Controlled Trials ISRCTN70090382.	[Johansson, Kari; Roessner, Stephan] Karolinska Inst, Dept Med, Obes Unit, SE-14186 Stockholm, Sweden; [Lagerros, Ylva Trolle; Granath, Fredrik] Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-14186 Stockholm, Sweden; [Harlid, Richard] Aleris Fysiologlab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Johansson, K (corresponding author), Karolinska Inst, Dept Med, Obes Unit, M73, SE-14186 Stockholm, Sweden.	kari.johansson@ki.se	Johanson, Kari/AAZ-4397-2020; Lagerros, Ylva Trolle/AAH-7683-2020	Lagerros, Ylva Trolle/0000-0001-6816-7577; Hemmingsson, Erik/0000-0001-7335-3796; Neovius, Martin/0000-0003-2300-3055	Cambridge Manufacturing Company Limited; Novo Nordisk Scandinavia AB	Cambridge Manufacturing Company Limited; Novo Nordisk Scandinavia AB(Novo Nordisk)	This study was partly supported by a grant from Cambridge Manufacturing Company Limited and Novo Nordisk Scandinavia AB. The funders played no part in the analysis or write up of this paper.	Apfelbaum M, 1999, AM J MED, V106, P179, DOI 10.1016/S0002-9343(98)00411-2; Banno K, 2007, SLEEP MED, V8, P400, DOI 10.1016/j.sleep.2007.03.003; Bar A, 2003, CHEST, V123, P695, DOI 10.1378/chest.123.3.695; de Sousa AGP, 2008, OBES REV, V9, P340, DOI 10.1111/j.1467-789X.2008.00478.x; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Fritscher LG, 2007, RESPIRATION, V74, P647, DOI 10.1159/000107736; Hakala K, 2000, CLIN PHYSIOL, V20, P50; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kajaste S, 2004, SLEEP MED, V5, P125, DOI 10.1016/j.sleep.2003.07.007; Kansanen M, 1998, CLIN PHYSIOL, V18, P377, DOI 10.1046/j.1365-2281.1998.00114.x; Kemppainen T, 2008, AM J RHINOL, V22, P410, DOI 10.2500/ajr.2008.22.3203; Lettieri CJ, 2008, J CLIN SLEEP MED, V4, P333; Lojander J, 1998, J INTERN MED, V244, P251; Marshall NS, 2008, SLEEP, V31, P1079; Mathus-Vliegen EMH, 2005, EUR J CLIN NUTR, V59, pS31, DOI 10.1038/sj.ejcn.1602172; Morgenthaler TI, 2006, SLEEP, V29, P1031; Neovius M, 2007, MED SCI SPORT EXER, V39, P2199, DOI 10.1249/mss.0b013e3181579.38a; Newman AB, 2005, ARCH INTERN MED, V165, P2408, DOI 10.1001/archinte.165.20.2408; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; PILLAR G, 1994, CHEST, V106, P1702, DOI 10.1378/chest.106.6.1702; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Richelsen B, 2007, DIABETES CARE, V30, P27, DOI 10.2337/dc06-0210; *SCI COOP QUEST RE, SCOOP VLCD TASK 7 3; Shaw JE, 2008, DIABETES RES CLIN PR, V81, P2, DOI 10.1016/j.diabres.2008.04.025; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SURATT PM, 1992, AM J CLIN NUTR, V56, P182; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Tuomilehto HPI, 2009, AM J RESP CRIT CARE, V179, P320, DOI 10.1164/rccm.200805-669OC; Valencia-Flores M, 2004, OBES SURG, V14, P755, DOI 10.1381/0960892041590773; Veasey SC, 2006, SLEEP, V29, P1036, DOI 10.1093/sleep/29.8.1036; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2008, SLEEP, V31, P1071; Zou D, 2006, SLEEP, V29, P367, DOI 10.1093/sleep/29.3.367	36	147	150	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2009	339								b4609	10.1136/bmj.b4609	http://dx.doi.org/10.1136/bmj.b4609			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NT	19959590	Green Published, hybrid			2022-12-28	WOS:000272453400005
J	Haines, A; McMichael, AJ; Smith, KR; Roberts, I; Woodcock, J; Markandya, A; Armstrong, BG; Campbell-Lendrum, D; Dangour, AD; Davies, M; Bruce, N; Tonne, C; Barrett, M; Wilkinson, P				Haines, Andy; McMichael, Anthony J.; Smith, Kirk R.; Roberts, Ian; Woodcock, James; Markandya, Anil; Armstrong, Ben G.; Campbell-Lendrum, Diarmid; Dangour, Alan D.; Davies, Michael; Bruce, Nigel; Tonne, Cathryn; Barrett, Mark; Wilkinson, Paul			Health and Climate Change 6 Public health benefits of strategies to reduce greenhouse-gas emissions: overview and implications for policy makers	LANCET			English	Article							ENERGY; MORTALITY; BIOFUELS; BURDEN	This Series has examined the health implications of policies aimed at tackling climate change. Assessments of mitigation strategies in four domains-household energy, transport, food and agriculture, and electricity generation-suggest an important message: that actions to reduce greenhouse-gas emissions often, although not always, entail net benefits for health. In some cases, the potential benefits seem to be substantial. This evidence provides an additional and immediate rationale for reductions in greenhouse-gas emissions beyond that of climate change mitigation alone. Climate change is an increasing and evolving threat to the health of populations worldwide. At the same time, major public health burdens remain in many regions. Climate change therefore adds further urgency to the task of addressing international health priorities, such as the UN Millennium Development Goals. Recognition that mitigation strategies can have substantial benefits for both health and climate protection offers the possibility of policy choices that are potentially both more cost effective and socially attractive than are those that address these priorities independently.	[Haines, Andy; Roberts, Ian; Woodcock, James; Armstrong, Ben G.; Dangour, Alan D.; Tonne, Cathryn; Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [McMichael, Anthony J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Smith, Kirk R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Markandya, Anil] BC3, Bilbao, Spain; [Markandya, Anil] Univ Bath, Bath BA2 7AY, Avon, England; [Campbell-Lendrum, Diarmid] WHO, CH-1211 Geneva, Switzerland; [Bruce, Nigel] Univ Liverpool, Sch Populat Community & Behav Sci, Liverpool L69 3BX, Merseyside, England; [Davies, Michael] UCL, Bartlett Sch Grad Studies, London, England; [Barrett, Mark] UCL, Energy Inst, London, England	University of London; London School of Hygiene & Tropical Medicine; Australian National University; University of California System; University of California Berkeley; Basque Centre for Climate Change (BC3); University of Bath; World Health Organization; University of Liverpool; University of London; University College London; University of London; University College London	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	andy.haines@lshtm.ac.uk	Markandya, Anil/K-9381-2013; Davies, Michael/GWV-2527-2022; Tonne, Cathryn/F-5020-2017; Woodcock, James/AAH-6753-2021; Azkarate, Ainhoa/K-9087-2013	Tonne, Cathryn/0000-0003-3919-8264; Azkarate, Ainhoa/0000-0003-0471-3094; Haines, Andy/0000-0002-8053-4605; armstrong, benedict/0000-0003-4407-0409; Woodcock, James/0000-0003-4769-5375; Wilkinson, Paul/0000-0001-7456-259X; Barrett, Mark/0000-0003-3655-2424; Dangour, Alan/0000-0001-6908-1273; Davies, Michael/0000-0003-2173-7063	Wellcome Trust; Department of Health; National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project that led to this Series was funded by the Wellcome Trust (coordinating funder): Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences: the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies or the US Health Effects Institute or its sponsors.	[Anonymous], 2009, PROT HLTH CLIM CHANG; BOYD F, 2007, CLEAN DEV MECH ASSES; Butland BJ, 2007, FORESIGHT TACKLING O; Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; DOBSON R, 2009, BRIT MED J, V339, P417; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2004, COMP QUANTIFICATION; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Griffiths J, 2009, HLTH PRACTITIONERS G; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Lin BR, 2007, IET ELECTR POWER APP, V1, P17, DOI 10.1049/iet-epa:20050545; Lovelock J, 2009, VANISHING FACE GAIA; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; Marland G., 2007, TRENDS COMPENDIUM DA; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; SMITH KR, 2009, MITIGATING CLIMATE M, P59; Smith MC, 2008, AM BOOK REV, V29, P25, DOI 10.1353/abr.2008.0001; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; *UN FRAM CONV CLIM, 2009, NAIR FRAM CAT CDM AF; *UNDP, 2008, MDG CARB FAC; United Nations, 2021, CLIM CHANG REC THREA; United Nations, 2009, MILL DEV GOALS REP 2; *US BUR CENS, POP REG COUNTR 1950; WHO, 2006, AIR QUAL GUID; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; [No title captured]	33	322	328	7	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2104	2114		10.1016/S0140-6736(09)61759-1	http://dx.doi.org/10.1016/S0140-6736(09)61759-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19942281				2022-12-28	WOS:000273122900034
J	Holt, CE; Bullock, SL				Holt, Christine E.; Bullock, Simon L.			Subcellular mRNA Localization in Animal Cells and Why It Matters	SCIENCE			English	Review							XENOPUS-OOCYTES; PROTEIN-SYNTHESIS; ACTIN; TRANSLATION; TRANSPORT; DROSOPHILA; REVEALS; TRAFFICKING; TRANSLOCATION; DETERMINANTS	Subcellular localization of messenger RNAs (mRNAs) can give precise control over where protein products are synthesized and operate. However, just 10 years ago many in the broader cell biology community would have considered this a specialized mechanism restricted to a very small fraction of transcripts. Since then, it has become clear that subcellular targeting of mRNAs is prevalent, and there is mounting evidence for central roles for this process in many cellular events. Here, we review current knowledge of the mechanisms and functions of mRNA localization in animal cells.	[Bullock, Simon L.] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 0QH, England; [Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	MRC Laboratory Molecular Biology; University of Cambridge	Bullock, SL (corresponding author), MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 0QH, England.	sbullock@mrc-lmb.cam.ac.uk	Bullock, Simon/K-6885-2012	Holt, Christine Elizabeth/0000-0003-2829-121X; Bullock, Simon/0000-0001-9491-4548	Wellcome Trust; MRC and a Lister Institute Prize Fellowship; MRC [MC_U105178790, G0501592] Funding Source: UKRI; Medical Research Council [G0501592, MC_U105178790] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC and a Lister Institute Prize Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We apologize to those whose primary work could not be cited because of space constraints. We acknowledge the continued importance of research in yeast for informing and inspiring studies on mRNA localization in animal cells. We thank C. Dix, A. Lin, and F. van Horck for comments on the manuscript, those who provided images, and many colleagues for answering queries. Work in our laboratories is supported by a Wellcome Trust Programme grant (C. H.) and the MRC and a Lister Institute Prize Fellowship (S. B.).	Amiel A, 2009, DEV BIOL, V327, P191, DOI 10.1016/j.ydbio.2008.12.007; Babu K, 2004, GENE DEV, V18, P138, DOI 10.1101/gad.282604; Bashirullah A, 2001, P NATL ACAD SCI USA, V98, P7025, DOI 10.1073/pnas.111145698; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bullock SL, 2007, SEMIN CELL DEV BIOL, V18, P194, DOI 10.1016/j.semcdb.2007.01.004; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Hu JY, 2002, J NEUROSCI, V22, P2669, DOI 10.1523/JNEUROSCI.22-07-02669.2002; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; JEFFERY WR, 1983, DEV BIOL, V99, P408, DOI 10.1016/0012-1606(83)90290-7; King ML, 2005, BIOL CELL, V97, P19; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lewis RA, 2008, MOL CELL BIOL, V28, P678, DOI 10.1128/MCB.00999-07; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Okita TW, 2002, CURR OPIN PLANT BIOL, V5, P553, DOI 10.1016/S1369-5266(02)00304-7; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Sardet C, 2005, BIOL CELL, V97, P35; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; Vogt N, 2006, DEVELOPMENT, V133, P3963, DOI 10.1242/dev.02570; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Zarnack K, 2007, MOL GENET GENOMICS, V278, P347, DOI 10.1007/s00438-007-0271-8; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	50	277	283	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1212	1216		10.1126/science.1176488	http://dx.doi.org/10.1126/science.1176488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965463	Green Accepted			2022-12-28	WOS:000272117900034
J	Wen, CY; Reuter, MC; Bruley, J; Tersoff, J; Kodambaka, S; Stach, EA; Ross, FM				Wen, C. -Y.; Reuter, M. C.; Bruley, J.; Tersoff, J.; Kodambaka, S.; Stach, E. A.; Ross, F. M.			Formation of Compositionally Abrupt Axial Heterojunctions in Silicon-Germanium Nanowires	SCIENCE			English	Article							SI/SIGE SUPERLATTICE NANOWIRES; HETEROSTRUCTURE NANOWIRES; GE NANOWIRES; GROWTH; SI; TEMPERATURE; CATALYST; SYSTEM	We have formed compositionally abrupt interfaces in silicon-germanium (Si-Ge) and Si-SiGe heterostructure nanowires by using solid aluminum-gold alloy catalyst particles rather than the conventional liquid semiconductor-metal eutectic droplets. We demonstrated single interfaces that are defect-free and close to atomically abrupt, as well as quantum dots (i.e., Ge layers tens of atomic planes thick) embedded within Si wires. Real-time imaging of growth kinetics reveals that a low solubility of Si and Ge in the solid particle accounts for the interfacial abruptness. Solid catalysts that can form functional group IV nanowire-based structures may yield an extended range of electronic applications.	[Reuter, M. C.; Bruley, J.; Tersoff, J.; Ross, F. M.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Wen, C. -Y.; Stach, E. A.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Wen, C. -Y.; Stach, E. A.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Kodambaka, S.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA	International Business Machines (IBM); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Los Angeles	Ross, FM (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	fmross@us.ibm.com	Stach, Eric A/D-8545-2011; Bruley, John/L-2677-2013; Stach, Eric Andrew/M-6455-2019; Ross, Frances/P-8919-2015	Stach, Eric A/0000-0002-3366-2153; Bruley, John/0000-0001-9802-4016; Stach, Eric Andrew/0000-0002-3366-2153; Ross, Frances/0000-0003-0838-9770	NSF [DMR-0606395, DMR-0907483]; University of California Energy Institute; Division Of Materials Research [0907483] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of California Energy Institute(University of California System); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge A. Ellis and L. Gignac of IBM for their assistance with experimental aspects of this work. Supported by NSF grants DMR-0606395 and DMR-0907483 and by the University of California Energy Institute.	Arbiol J, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/30/305606; Bjork MT, 2002, APPL PHYS LETT, V81, P4458, DOI 10.1063/1.1527995; Bjork MT, 2004, NANO LETT, V4, P1621, DOI 10.1021/nl049230s; Bjork MT, 2002, NANO LETT, V2, P87, DOI 10.1021/nl010099n; Clark TE, 2008, NANO LETT, V8, P1246, DOI 10.1021/nl072849k; DAVIS JR, 1980, IEEE T ELECTRON DEV, V27, P677, DOI 10.1109/T-ED.1980.19922; Dujardin R, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360225; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; HOCH M, 1995, J ALLOY COMPD, V220, P27, DOI 10.1016/0925-8388(94)06012-6; Hofmann S, 2008, NAT MATER, V7, P372, DOI 10.1038/nmat2140; Joy DC, 1986, PRINCIPLES ANAL ELEC; Kamins TI, 2001, J APPL PHYS, V89, P1008, DOI 10.1063/1.1335640; Kang K, 2008, ADV MATER, V20, P4684, DOI 10.1002/adma.200801764; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; Lensch-Falk JL, 2007, J AM CHEM SOC, V129, P10670, DOI 10.1021/ja074276j; Li DY, 2003, APPL PHYS LETT, V83, P3186, DOI 10.1063/1.1619221; Li N, 2008, APPL PHYS A-MATER, V90, P591, DOI 10.1007/s00339-007-4376-z; Lieber CM, 2002, NANO LETT, V2, P81, DOI 10.1021/nl020289d; Piao H, 2002, APPL SURF SCI, V187, P266, DOI 10.1016/S0169-4332(01)01038-8; Ross FM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146104; Samuelson L, 2004, PHYSICA E, V25, P313, DOI 10.1016/j.physe.2004.06.030; Thelander C, 2003, APPL PHYS LETT, V83, P2052, DOI 10.1063/1.1606889; Wacaser BA, 2009, NANO LETT, V9, P3296, DOI 10.1021/nl9015792; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wang YW, 2006, NAT NANOTECHNOL, V1, P186, DOI 10.1038/nnano.2006.133; Wu YY, 2002, NANO LETT, V2, P83, DOI 10.1021/nl0156888; Yang C, 2005, SCIENCE, V310, P1304, DOI 10.1126/science.1118798; Zakharov ND, 2006, J CRYST GROWTH, V290, P6, DOI 10.1016/j.jcrysgro.2005.12.096; Zangenberg NR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.125901	29	270	270	3	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1247	1250		10.1126/science.1178606	http://dx.doi.org/10.1126/science.1178606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965471				2022-12-28	WOS:000272117900043
J	Schluter, H; Kaur, P				Schlueter, Holger; Kaur, Pritinder			Bioengineered human skin from embryonic stem cells	LANCET			English	Editorial Material							HUMAN BLASTOCYSTS; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION; KERATINOCYTES; EPITHELIUM; LINES		[Schlueter, Holger; Kaur, Pritinder] Peter MacCallum Canc Inst, Div Res, Epithelial Stem Cell Biol Lab, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center	Kaur, P (corresponding author), Peter MacCallum Canc Inst, Div Res, Epithelial Stem Cell Biol Lab, Melbourne, Vic 3002, Australia.	pritinder.kaur@petermac.org	Kaur, Pritinder/I-2605-2013	Kaur, Pritinder/0000-0002-4994-2782				Bagutti C, 2001, DEV BIOL, V231, P321, DOI 10.1006/dbio.2000.0149; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	14	6	15	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1725	1726		10.1016/S0140-6736(09)61707-4	http://dx.doi.org/10.1016/S0140-6736(09)61707-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19932344				2022-12-28	WOS:000272207700004
J	Wechsler, ME; Kunselmon, SJ; Chinchilli, VM; Bleecker, E; Boushey, HA; Calhoun, WJ; Ameredes, BT; Castro, M; Craig, TJ; Denlinger, L; Fahy, JV; Jarjour, N; Kazani, S; Kim, S; Kraft, M; Lazarus, SC; Lemanske, RF; Markezich, A; Martin, RJ; Permaul, P; Peters, SP; Ramsdell, J; Sorkness, CA; Sutherland, ER; Szefler, SJ; Walter, MJ; Wasserman, SI; Israel, E				Wechsler, Michael E.; Kunselmon, Susan J.; Chinchilli, Vernon M.; Bleecker, Eugene; Boushey, Homer A.; Calhoun, William J.; Ameredes, Bill T.; Castro, Mario; Craig, Timothy J.; Denlinger, Loren; Fahy, John V.; Jarjour, Nizar; Kazani, Shamsah; Kim, Sophia; Kraft, Monica; Lazarus, Stephen C.; Lemanske, Robert F., Jr.; Markezich, Amy; Martin, Richard J.; Permaul, Perdita; Peters, Stephen P.; Ramsdell, Joe; Sorkness, Christine A.; Sutherland, E. Rand; Szefler, Stanley J.; Walter, Michael J.; Wasserman, Stephen I.; Israel, Elliot		National Heart Lung & Blood Inst	Effect of beta(2)-adrenergic receptor polymorphism on response to longacting beta(2) agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial	LANCET			English	Article							INHALED CORTICOSTEROIDS; REGULAR USE; SALMETEROL; ALBUTEROL; EXACERBATIONS; FORMOTEROL; METHACHOLINE; THERAPY	Background Some studies suggest that patients with asthma who are homozygous for arginine at the 16th aminoacid position of the beta(2)-adrenergic receptor (B16 Arg/Arg) benefit less from treatment with longacting beta(2) agonists and inhaled corticosteroids than do those homozygous for glycine (B16 Gly/Gly). We investigated whether there is a genotype-specific response to treatment with a longacting beta(2) agonist in combination with inhaled corticosteroid. Methods In this multicentre, randomised, double-blind, placebo-controlled trial, adult patients with moderate asthma were enrolled in pairs matched for forced expiratory volume in 1 s and ethnic origin, according to whether they had the B16 Arg/Arg (n=42) or B16 Gly/Gly (n=45) genotype. Individuals in a matched pair were randomly assigned by computer-generated randomisation sequence to receive inhaled longacting beta(2) agonist (salmeterol 50 mu g twice a day) or placebo given in a double-blind, crossover design for two 18-week periods. Open-label inhaled corticosteroid (hydrofluoroalkane beclometasone 240 mu g twice a day) was given to all participants during the treatment periods. The primary endpoint was morning peak expiratory flow (PEF). Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00200967. Findings After 18 weeks of treatment, mean morning PEF in Arg/Arg participants was 21.4 L/min (95% CI 11.8-31.1) higher when participants were assigned to receive salmeterol than when assigned to receive placebo (p<0.0001). In Gly/Gly participants, morning PEF was 21.5 L/min (11.0-32.1) higher when participants were assigned to receive salmeterol than when assigned to receive placebo (p<0.0001). The improvement in PEF did not differ between genotypes (difference [Arg/Arg-Gly/Gly] -0.1, -14.4 to 14.2; p=0.99). In Gly/Gly participants, methacholine PC20 (20% reduction in forced expiratory volume in 1 s; a prespecified secondary outcome) was 2.4 times higher when participants were assigned to salmeterol than when assigned to placebo (p<0.0001). Responsiveness to methacholine did not differ between salmeterol and placebo in Arg/Arg participants (p=0.87). The 2.5 times higher genotype-specific difference in responsiveness to methacholine was significant (1.32 doubling dose difference between genotypes, 9.43-2.21, p=0.0038). Seven Arg/Arg participants (placebo, n=5; salmeterol, n=2) and six Gly/Gly participants (placebo, n=3; salmeterol, n=3) had an asthma exacerbation. Five serious adverse events were reported, one each during the pre-match and run-in phases on open-label inhaled corticosteroid, two during double-blind treatment with salmeterol/inhaled corticosteroid, and one during double-blind treatment with placebo/inhaled corticosteroid. None of the serious events was asthma-related or related to study drugs or procedures. Interpretation In asthma patients with B16 Arg/Arg and B16 Gly/Gly genotypes, combination treatment with salmeterol and inhaled corticosteroid improved airway function when compared with inhaled corticosteroid therapy alone. These findings suggest that patients should continue to be treated with longacting beta(2) agonists plus moderate-dose inhaled corticosteroids irrespective of B16 genotype. Further investigation is needed to establish the importance of the genotype-specific difference in responsiveness to methacholine.	[Wechsler, Michael E.; Kazani, Shamsah; Kim, Sophia; Markezich, Amy; Permaul, Perdita; Israel, Elliot] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Kunselmon, Susan J.; Chinchilli, Vernon M.; Craig, Timothy J.] Penn State Coll Med, Hershey, PA USA; [Bleecker, Eugene; Peters, Stephen P.] Wake Forest Univ, Hlth Sci Ctr, Winston Salem, NC 27109 USA; [Boushey, Homer A.; Fahy, John V.; Lazarus, Stephen C.; Ramsdell, Joe; Wasserman, Stephen I.] Univ Calif San Francisco, San Francisco Med Ctr, San Francisco, CA 94143 USA; [Calhoun, William J.; Ameredes, Bill T.] Univ Texas Galveston, Galveston, TX 77555 USA; [Castro, Mario; Walter, Michael J.] Washington Univ, Sch Med, St Louis, MO USA; [Denlinger, Loren; Jarjour, Nizar; Lemanske, Robert F., Jr.; Sorkness, Christine A.] Univ Wisconsin, Madison, WI USA; [Kraft, Monica] Duke Univ, Med Ctr, Durham, NC USA; [Martin, Richard J.; Sutherland, E. Rand; Szefler, Stanley J.] Natl Jewish Med Ctr, Denver, CO USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Wake Forest University; University of California System; University of California San Francisco; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; Duke University; National Jewish Health	Wechsler, ME (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, 75 Francis St, Boston, MA 02115 USA.	mwechsler@partners.org	Sutherland, Everett Rand/B-7666-2008; Wechsler, Michael/B-3979-2013; Wechsler, Michael/AAC-5506-2019	Wechsler, Michael/0000-0003-3505-2946; Calhoun, William/0000-0001-7075-712X	National Heart, Lung, and Blood Institute (NHLBI) of the US National Institutes of Health (NIH) [K23-HL04285, U10-HL74227, U10-HL74231, U10-HL074204, U10-HL74212, U10-HL74073, U10-HL074206, U10-HL074208, U10-HL74225, U10-HL74218]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL074212, U10HL074206, U10HL074231, U10HL074225, U10HL074227, U10HL074218, U10HL074073, U10HL074204, U10HL074208, K23HL004285] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by the National Heart, Lung, and Blood Institute (NHLBI) of the US National Institutes of Health (NIH). An NHLBI-appointed protocol review committee approved the study design and reviewed the final manuscript. Funding references: US NIH/NHLBI: K23-HL04285, U10-HL74227, U10-HL74231, U10-HL074204, U10-HL74212, U10-HL74073, U10-HL074206, U10-HL074208, U10-HL74225, U10-HL74218. Open-label ipratropium bromide was provided by Boehringer Ingelheim Pharmaceuticals (Ridgefield, CT USA), and open-label beclometasone hydrofluoroalkane was provided by Teva Pharmaceuticals Industry (Petach Tikva. Israel). The ACRN data safety monitoring board reviewed the final version of the report. We thank the Asthma Clinical Research Network research coordinators and study staff.	Bailey W, 2008, CURR MED RES OPIN, V24, P1669, DOI 10.1185/03007990802119111; Bleecker ER, 2008, J ALLERGY CLIN IMMUN, V121, pS143, DOI 10.1016/j.jaci.2007.12.1109; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; COCKCROFT DW, 1995, AM J RESP CRIT CARE, V152, P1485, DOI 10.1164/ajrccm.152.5.7582281; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; *FDA, 2008, LONG ACT BET AG ADV; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Israel E, 2001, INT ARCH ALLERGY IMM, V124, P183, DOI 10.1159/000053705; Laird N M, 1992, Stat Methods Med Res, V1, P225, DOI 10.1177/096228029200100302; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lee DKC, 2004, BRIT J CLIN PHARMACO, V57, P68, DOI 10.1046/j.1365-2125.2003.01955.x; LEMANSKE J, 2001, JAMA-J AM MED ASSOC, V285, P2594; Lipworth B, 1998, AM J MED, V104, P431, DOI 10.1016/S0002-9343(98)00086-2; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Shore SA, 2003, J CLIN INVEST, V112, P495, DOI 10.1172/JCI200319642; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Vaughan J, 2003, EUR RESPIR J, V22, P889, DOI 10.1183/09031936.03.00038803; VONESH EF, 1992, BIOMETRICS, V48, P1, DOI 10.2307/2532734; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC	26	172	178	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 21	2009	374	9703					1754	1764		10.1016/S0140-6736(09)61492-6	http://dx.doi.org/10.1016/S0140-6736(09)61492-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19932356	Green Accepted			2022-12-28	WOS:000272207700024
J	Bekker, A; Barley, ME; Fiorentini, ML; Rouxel, OJ; Rumble, D; Beresford, SW				Bekker, Andrey; Barley, Mark E.; Fiorentini, Marco L.; Rouxel, Olivier J.; Rumble, Douglas; Beresford, Stephen W.			Atmospheric Sulfur in Archean Komatiite-Hosted Nickel Deposits	SCIENCE			English	Article							MICROBIAL SULFATE REDUCTION; IRON ISOTOPE FRACTIONATION; WESTERN-AUSTRALIA; SOUTH-AFRICA; FE-ISOTOPE; SULFIDE; ORIGIN; TECTONICS; GENESIS; OXYGEN	Some of Earth's largest iron-nickel (Fe-Ni) sulfide ore deposits formed during the Archean and early Proterozoic. Establishing the origin of the metals and sulfur in these deposits is critical for understanding their genesis. Here, we present multiple sulfur isotope data implying that the sulfur in Archean komatiite-hosted Fe-Ni sulfide deposits was previously processed through the atmosphere and then accumulated on the ocean floor. High-temperature, mantle-derived komatiite magmas were then able to incorporate the sulfur from seafloor hydrothermal sulfide accumulations and sulfidic shales to form Neoarchean komatiite-hosted Fe-Ni sulfide deposits at a time when the oceans were sulfur-poor.	[Bekker, Andrey; Rumble, Douglas] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada; [Barley, Mark E.; Fiorentini, Marco L.; Beresford, Stephen W.] Univ Western Australia, Ctr Explorat Targeting, Sch Earth & Environm, Crawley, WA 6009, Australia; [Rouxel, Olivier J.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	Carnegie Institution for Science; University of Manitoba; University of Western Australia; Woods Hole Oceanographic Institution	Bekker, A (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	bekker@cc.umanitoba.ca	Rumble, Douglas/AAU-3930-2020; Fiorentini, Marco/G-2165-2011; Barley, Mark/A-3803-2008; Rouxel, Olivier J/F-3954-2014	Rumble, Douglas/0000-0002-7440-9189; Rouxel, Olivier J/0000-0002-1431-222X; Bekker, Andrey/0000-0002-1154-0585; Fiorentini, Marco/0000-0001-8079-9606	NAI International Collaboration; AMIRA; Australian Research Council [DP 0988326]; NSF [EAR-937 05-45484, OCE-0622982, EAR-0820661]; NAI [NNA04CC09A]; Natural Sciences and Engineering Research Council of Canada [938]; Carnegie Institution of Washington Node; NASA	NAI International Collaboration; AMIRA; Australian Research Council(Australian Research Council); NSF(National Science Foundation (NSF)); NAI; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Carnegie Institution of Washington Node; NASA(National Aeronautics & Space Administration (NASA))	Supported by a NAI International Collaboration grant (M. L. F.); AMIRA and the Australian Research Council DP 0988326 grants (M. E. B., M. L. F., and S. W. B.); NSF grant EAR-937 05-45484 (A. B.); NAI award NNA04CC09A (A. B.); Natural Sciences and Engineering Research Council of Canada 938 Discovery grant (A. B.); NAI, Carnegie Institution of Washington Node, and NASA Cosmochemistry program (D. R.); and NSF OCE-0622982 and EAR-0820661 grants (O. J. R.). We acknowledge R. Cas, M. Houle, M. Lesher, J. Farquhar, A. L. Masterson, and M. Auro for helpful discussions and experimental assistance and two anonymous reviewers for constructive comments.	Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; Bao HM, 2007, GEOCHIM COSMOCHIM AC, V71, P4868, DOI 10.1016/j.gca.2007.05.032; Barley ME, 1998, PRECAMBRIAN RES, V91, P65, DOI 10.1016/S0301-9268(98)00039-4; Barley ME, 2005, EARTH PLANET SC LETT, V238, P156, DOI 10.1016/j.epsl.2005.06.062; Beard BL, 2003, CHEM GEOL, V195, P87, DOI 10.1016/S0009-2541(02)00390-X; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; Farquhar J, 2005, GEOL SOC SPEC PUBL, V248, P167, DOI 10.1144/GSL.SP.2005.248.01.09; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Foster JG, 1996, NATURE, V382, P703, DOI 10.1038/382703a0; Hannington M.D., 1999, EC GEOLOGY MONOGRAPH, V10, P163, DOI DOI 10.5382/Mono.10.07; Jamieson JW, 2006, ECON GEOL, V101, P1055, DOI 10.2113/gsecongeo.101.5.1055; Johnson CM, 2003, CONTRIB MINERAL PETR, V144, P523, DOI 10.1007/s00410-002-0418-x; Lesher C., 1989, REV EC GEOLOGY, V4, P45; Lesher CM, 2001, CAN MINERAL, V39, P421, DOI 10.2113/gscanmin.39.2.421; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Naldrett A.J., 1981, EC GEOLOGY 75 ANNIVE, P628; NALDRETT AJ, 1973, CIM BULL, V66, P45; NALDRETT AJ, 1977, PRECAMBRIAN RES, V5, P43, DOI 10.1016/0301-9268(77)90022-5; Ono SH, 2009, PRECAMBRIAN RES, V169, P48, DOI 10.1016/j.precamres.2008.10.012; Penniston-Dorland SC, 2008, GEOLOGY, V36, P979, DOI 10.1130/G25098A.1; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Rosengren NM, 2005, ECON GEOL, V100, P149, DOI 10.2113/100.1.0149; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; Rouxel O, 2008, CHEM GEOL, V252, P214, DOI 10.1016/j.chemgeo.2008.03.009; Schuessler JA, 2007, GEOCHIM COSMOCHIM AC, V71, P417, DOI 10.1016/j.gca.2006.09.012; Seal RR, 2006, REV MINERAL GEOCHEM, V61, P633, DOI 10.2138/rmg.2006.61.12; Shen YN, 2009, EARTH PLANET SC LETT, V279, P383, DOI 10.1016/j.epsl.2009.01.018; Teng FZ, 2008, SCIENCE, V320, P1620, DOI 10.1126/science.1157166; Ueno Y, 2008, GEOCHIM COSMOCHIM AC, V72, P5675, DOI 10.1016/j.gca.2008.08.026; WENDLANDT RF, 1982, AM MINERAL, V67, P877	31	136	146	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1086	1089		10.1126/science.1177742	http://dx.doi.org/10.1126/science.1177742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965423				2022-12-28	WOS:000271951000035
J	Dilks, P; Shawyer, A; Booth, TC				Dilks, Philip; Shawyer, Andrew; Booth, Thomas C.			Picture Quiz An unusual cause of acute renal failure	BRITISH MEDICAL JOURNAL			English	Editorial Material							IDIOPATHIC RETROPERITONEAL FIBROSIS; URETEROLYSIS; NEPHROSTOMY; DIAGNOSIS		[Dilks, Philip; Shawyer, Andrew] Barts & London NHS Trust, London EC1A 7BE, England; [Booth, Thomas C.] Royal Free Hosp NHS Trust, London NW3 2XA, England	Barts Health NHS Trust; University of London; University College London	Dilks, P (corresponding author), Barts & London NHS Trust, London EC1A 7BE, England.	philip.dilks@bartsandthelondon.nhs.uk						Cronin CG, 2008, AM J ROENTGENOL, V191, P423, DOI 10.2214/AJR.07.3629; DIXON AK, 1984, CLIN RADIOL, V35, P39, DOI 10.1016/S0009-9260(84)80231-7; Fong BC, 2006, J ENDOUROL, V20, P820, DOI 10.1089/end.2006.20.820; GOODWIN WE, 1955, JAMA-J AM MED ASSOC, V157, P891, DOI 10.1001/jama.1955.02950280015005; Hausegger KA, 2006, EUR RADIOL, V16, P2016, DOI 10.1007/s00330-005-0136-7; Moroni G, 2006, NEPHROL DIAL TRANSPL, V21, P2485, DOI 10.1093/ndt/gfl228; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; Srinivasan AK, 2008, J UROLOGY, V179, P1875, DOI 10.1016/j.juro.2008.01.030; Staios D, 2007, EXPERT REV MED DEVIC, V4, P99, DOI 10.1586/17434440.4.2.99; SWARZ RD, 2009, AM J KIDNEY DIS; Vaglio A, 2005, ARTHRIT RHEUM-ARTHR, V53, P122, DOI 10.1002/art.20914; Vaglio A, 2009, MEDICINE, V88, P208, DOI 10.1097/MD.0b013e3181afc4d1; van Bommel EFH, 2007, J INTERN MED, V262, P224, DOI 10.1111/j.1365-2796.2007.01805.x; van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420; Vivas I, 2000, BRIT J RADIOL, V73, P214, DOI 10.1259/bjr.73.866.10884739; ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6	16	0	0	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2009	339								b4574	10.1136/bmj.b4574	http://dx.doi.org/10.1136/bmj.b4574			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TA	19923149				2022-12-28	WOS:000272096200003
J	Houk, AR; Millius, A; Weiner, OD				Houk, Andrew R.; Millius, Arthur; Weiner, Orion D.			Compete Globally, Bud Locally	CELL			English	Editorial Material							SPONTANEOUS CELL POLARIZATION; EXCHANGE FACTOR CDC24; KINASE; DYNAMICS; YEAST		[Houk, Andrew R.; Millius, Arthur; Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Houk, Andrew R.; Millius, Arthur; Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weiner, OD (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	orion.weiner@ucsf.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543; Millius, Arthur/0000-0002-5280-6730	NIGMS NIH HHS [GM084040, R01 GM084040, R01 GM084040-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944	9	0	0	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					656	658		10.1016/j.cell.2009.10.028	http://dx.doi.org/10.1016/j.cell.2009.10.028			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914160	Green Accepted, Bronze			2022-12-28	WOS:000271747200009
J	Wulf, WA; Jones, AK				Wulf, William A.; Jones, Anita K.			Reflections on Cybersecurity	SCIENCE			English	Editorial Material									[Wulf, William A.; Jones, Anita K.] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	University of Virginia	Wulf, WA (corresponding author), Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA.	wulf@virginia.edu; jones@virginia.edu						Brooks F. P., 1975, MYTHICAL MAN MONTH; *NRL, 1993, NRLFR5542939591; PARNAS DL, 1972, COMMUN ACM, V15, P1053, DOI 10.1145/361598.361623; SALTZER JH, 1984, ACM T COMPUT SYST, V2, P277, DOI 10.1145/357401.357402	4	18	18	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					943	944		10.1126/science.1181643	http://dx.doi.org/10.1126/science.1181643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518SB	19965500				2022-12-28	WOS:000271712300021
J	Verma, S; Mesana, TG				Verma, Subodh; Mesana, Thierry G.			Mitral-Valve Repair for Mitral-Valve Prolapse	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR FUNCTION; VALVULAR HEART-DISEASE; FLAIL LEAFLETS; EARLY SURGERY; TASK-FORCE; REGURGITATION; REPLACEMENT; OUTCOMES; SOCIETY; LOCUS	A 55-year-old man with a holosystolic murmur of increasing intensity has been seen regularly by his family physician for the past 3 years. He is referred to a cardiologist. The patient reports no shortness of breath, chest pain, or palpitations. An electrocardiogram shows normal sinus rhythm. A transthoracic echocardiogram reveals severe, anteriorly directed mitral regurgitation with isolated prolapse of the middle scallop of the posterior leaflet. Flow reversal is detected in the pulmonary veins. The calculated regurgitant volume is 75 ml, the regurgitant fraction 63%, and the effective regurgitant orifice 53 mm(2), features consistent with severe mitral regurgitation. The transthoracic echocardiogram also shows mildly depressed left ventricular function (ejection fraction, 58%), slightly elevated left ventricular dimensions (end-systolic dimension, 42 mm), and normal right ventricular systolic pressure. The patient is referred to a cardiac surgeon for consideration of mitral-valve repair.	[Verma, Subodh] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada; [Mesana, Thierry G.] Univ Ottawa, Div Cardiac Surg, Ottawa Heart Inst, Ottawa, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; University of Ottawa Heart Institute	Verma, S (corresponding author), Univ Toronto, St Michaels Hosp, Div Cardiac Surg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	subodh.verma@sympatico.ca						ABRAMS J, 1976, AM HEART J, V92, P413, DOI 10.1016/S0002-8703(76)80039-7; Adams DH, 2003, J THORAC CARDIOV SUR, V125, P1197, DOI 10.1016/S0022-5223(03)00576-2; AKINS CW, 1994, ANN THORAC SURG, V58, P668, DOI 10.1016/0003-4975(94)90725-0; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Avierinos JF, 2008, ANN INTERN MED, V149, P787, DOI 10.7326/0003-4819-149-11-200812020-00003; BARLOW JB, 1979, AM HEART J, V97, P277, DOI 10.1016/0002-8703(79)90425-3; Barnett SD, 2009, J THORAC CARDIOV SUR, V137, P1422, DOI 10.1016/j.jtcvs.2008.08.071; Braunwald E., 2002, HARRISONS ADV CARDIO, P317; DAVID TE, 1983, CIRCULATION, V68, P76; David TE, 2007, SEMIN THORAC CARDIOV, V19, P116, DOI 10.1053/j.semtcvs.2007.04.004; DEVEREUX RB, 1982, ANN INTERN MED, V97, P826, DOI 10.7326/0003-4819-97-6-826; Disse S, 1999, AM J HUM GENET, V65, P1242, DOI 10.1086/302624; DURAN CG, 1980, J THORAC CARDIOV SUR, V79, P326; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; FILSOUFI F, 2005, SABISTON SPENCER SUR, P1299; Filsoufi F, 2007, SEMIN THORAC CARDIOV, V19, P103, DOI 10.1053/j.semtcvs.2007.04.003; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Freed LA, 2003, AM J HUM GENET, V72, P1551, DOI 10.1086/375452; Gammie JS, 2007, CIRCULATION, V115, P881, DOI 10.1161/CIRCULATIONAHA.106.634436; Gillinov AM, 2008, J THORAC CARDIOV SUR, V135, P885, DOI 10.1016/j.jtcvs.2007.11.039; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; Gillinov AM, 2003, J THORAC CARDIOV SUR, V125, P1350, DOI 10.1016/S0022-5223(02)73274-1; GOLDMAN ME, 1987, J AM COLL CARDIOL, V10, P568, DOI 10.1016/S0735-1097(87)80199-7; Grigioni F, 2008, JACC-CARDIOVASC IMAG, V1, P133, DOI 10.1016/j.jcmg.2007.12.005; Hayek E, 2005, LANCET, V365, P507; Jokinen JJ, 2007, ANN THORAC SURG, V84, P451, DOI 10.1016/j.athoracsur.2007.03.058; Kang DH, 2009, CIRCULATION, V119, P797, DOI 10.1161/CIRCULATIONAHA.108.802314; Lee EM, 1997, EUR HEART J, V18, P655; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; Ling LH, 1997, CIRCULATION, V96, P1819, DOI 10.1161/01.CIR.96.6.1819; Mesana T, 2005, ANN THORAC SURG, V79, P720, DOI 10.1016/j.athoracsur.2003.11.031; Mesana TG, 2007, ANN THORAC SURG, V83, P322, DOI 10.1016/j.athoracsur.2006.03.076; MOHTY D, 2001, CIRCULATION S1, V104, P1, DOI 10.1161/hc37t1.094903; Nesta F, 2005, CIRCULATION, V112, P2022, DOI 10.1161/CIRCULATIONAHA.104.516930; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Okita Y, 1993, J Heart Valve Dis, V2, P159; PITARYS CJ, 1990, J AM COLL CARDIOL, V15, P557, DOI 10.1016/0735-1097(90)90625-Y; ROSEN SE, 1994, AM J CARDIOL, V74, P374, DOI 10.1016/0002-9149(94)90406-5; Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175; Seeburger J, 2008, EUR J CARDIO-THORAC, V34, P760, DOI 10.1016/j.ejcts.2008.05.015; SHELL WE, 1969, CIRCULATION, V39, P327, DOI 10.1161/01.CIR.39.3.327; Shernan SK, 2007, CRIT CARE MED, V35, pS372, DOI 10.1097/01.CCM.0000270248.34274.AB; Shuhaiber J, 2007, EUR J CARDIO-THORAC, V31, P267, DOI 10.1016/j.ejcts.2006.11.014; STARLING MR, 1993, J AM COLL CARDIOL, V22, P239, DOI 10.1016/0735-1097(93)90840-W; *STS, SOC THOR SURG STS ON; Suri RM, 2006, ANN THORAC SURG, V82, P819, DOI 10.1016/j.athoracsur.2006.03.091; Talwalkar NG, 2004, CHEST, V126, P709, DOI 10.1378/chest.126.3.709; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; YACOUB M, 1981, CIRCULATION, V64, P210; Zhao LP, 2007, J THORAC CARDIOV SUR, V133, P1257, DOI 10.1016/j.jtcvs.2006.12.048; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	53	52	54	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2261	2269		10.1056/NEJMct0806111	http://dx.doi.org/10.1056/NEJMct0806111			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19955526				2022-12-28	WOS:000272257100009
J	Hynes, RO				Hynes, Richard O.			The Extracellular Matrix: Not Just Pretty Fibrils	SCIENCE			English	Review							GROWTH-FACTOR-BETA; BINDING-PROTEINS; FIBRONECTIN; INTEGRIN; DOMAINS; MICROFIBRILS; RECEPTOR; DISEASE; ACTIVATION; SIGNALS	The extracellular matrix (ECM) and ECM proteins are important in phenomena as diverse as developmental patterning, stem cell niches, cancer, and genetic diseases. The ECM has many effects beyond providing structural support. ECM proteins typically include multiple, independently folded domains whose sequences and arrangement are highly conserved. Some of these domains bind adhesion receptors such as integrins that mediate cell-matrix adhesion and also transduce signals into cells. However, ECM proteins also bind soluble growth factors and regulate their distribution, activation, and presentation to cells. As organized, solid-phase ligands, ECM proteins can integrate complex, multivalent signals to cells in a spatially patterned and regulated fashion. These properties need to be incorporated into considerations of the functions of the ECM.	MIT, Howard Hughes Med Inst, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Hynes, RO (corresponding author), MIT, Howard Hughes Med Inst, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	rohynes@mit.edu			Howard Hughes Medical Institute; NIH; NATIONAL CANCER INSTITUTE [R01CA017007, U54CA126515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	I thank A. Naba and K. Certel for constructive criticisms of the text and figures, and I gratefully acknowledge support from the Howard Hughes Medical Institute and NIH.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Astrof S, 2007, DEV BIOL, V311, P11, DOI 10.1016/j.ydbio.2007.07.005; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Campanelli JT, 1996, DEVELOPMENT, V122, P1663; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dustin ML, 2008, ANNU REV CELL DEV BI, V24, P577, DOI 10.1146/annurev.cellbio.24.110707.175226; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Hynes RO, 1990, FIBRONECTINS; Ishitsuka T, 2009, BIOL PHARM BULL, V32, P1004, DOI 10.1248/bpb.32.1004; Iyer AKV, 2008, J CELL PHYSIOL, V214, P504, DOI 10.1002/jcp.21232; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; Rahman S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-8; Ramirez F, 2007, CELL MOL LIFE SCI, V64, P2437, DOI 10.1007/s00018-007-7166-z; Ramirez F, 2009, J BIOL CHEM, V284, P14677, DOI 10.1074/jbc.R900004200; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Sheppard D, 2005, CANCER METAST REV, V24, P395, DOI 10.1007/s10555-005-5131-6; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; *SMART, SMART DAT; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Whittaker CA, 2006, DEV BIOL, V300, P252, DOI 10.1016/j.ydbio.2006.07.044; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	41	2149	2206	19	463	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1216	1219		10.1126/science.1176009	http://dx.doi.org/10.1126/science.1176009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965464	Green Submitted, Green Accepted			2022-12-28	WOS:000272117900035
J	Stewart, M				Stewart, Murray			Nuclear Export of Small RNAs	SCIENCE			English	Editorial Material									MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114	5	11	11	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1195	1196		10.1126/science.1183273	http://dx.doi.org/10.1126/science.1183273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965455				2022-12-28	WOS:000272117900026
J	Frulloni, L; Lunardi, C; Simone, R; Dolcino, M; Scattolini, C; Falconi, M; Benini, L; Vantini, I; Corrocher, R; Puccetti, A				Frulloni, Luca; Lunardi, Claudio; Simone, Rita; Dolcino, Marzia; Scattolini, Chiara; Falconi, Massimo; Benini, Luigi; Vantini, Italo; Corrocher, Roberto; Puccetti, Antonio			Identification of a Novel Antibody Associated with Autoimmune Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HELICOBACTER-PYLORI INFECTION; CARBONIC-ANHYDRASE I; SERUM IGG4; AUTOANTIBODIES; APOPTOSIS; DIAGNOSIS; FEATURES	BACKGROUND Autoimmune pancreatitis is characterized by an inflammatory process that leads to organ dysfunction. The cause of the disease is unknown. Its autoimmune origin has been suggested but never proved, and little is known about the pathogenesis of this condition. METHODS To identify pathogenetically relevant autoantigen targets, we screened a random peptide library with pooled IgG obtained from 20 patients with autoimmune pancreatitis. Peptide-specific antibodies were detected in serum specimens obtained from the patients. RESULTS Among the detected peptides, peptide AIP(1-7) was recognized by the serum specimens from 18 of 20 patients with autoimmune pancreatitis and by serum specimens from 4 of 40 patients with pancreatic cancer, but not by serum specimens from healthy controls. The peptide showed homology with an amino acid sequence of plasminogen-binding protein (PBP) of Helicobacter pylori and with ubiquitin-protein ligase E3 component n-recognin 2 (UBR2), an enzyme highly expressed in acinar cells of the pancreas. Antibodies against the PBP peptide were detected in 19 of 20 patients with autoimmune pancreatitis (95%) and in 4 of 40 patients with pancreatic cancer (10%). Such reactivity was not detected in patients with alcohol-induced chronic pancreatitis or intraductal papillary mucinous neoplasm. The results were validated in another series of patients with autoimmune pancreatitis or pancreatic cancer: 14 of 15 patients with autoimmune pancreatitis (93%) and 1 of 70 patients with pancreatic cancer (1%) had a positive test for anti-PBP peptide antibodies. When the training and validation groups were combined, the test was positive in 33 of 35 patients with autoimmune pancreatitis (94%) and in 5 of 110 patients with pancreatic cancer (5%). CONCLUSIONS The antibody that we identified was detected in most patients with autoimmune pancreatitis but also in some patients with pancreatic cancer, making it an imperfect test to distinguish between these two conditions.	[Frulloni, Luca; Scattolini, Chiara; Benini, Luigi; Vantini, Italo] Univ Verona, Gastroenterol Sect, I-37100 Verona, Italy; [Lunardi, Claudio; Simone, Rita; Corrocher, Roberto] Univ Verona, Sect Internal Med, I-37100 Verona, Italy; [Falconi, Massimo] Univ Verona, Sect Endocrine Surg, I-37100 Verona, Italy; [Dolcino, Marzia; Puccetti, Antonio] Giannina Gaslini Inst, Clin & Expt Immunol Unit, I-16147 Genoa, Italy; [Puccetti, Antonio] Univ Genoa, Sect Histol, Genoa, Italy	University of Verona; University of Verona; University of Verona; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Puccetti, A (corresponding author), Giannina Gaslini Inst, Clin & Expt Immunol Unit, Largo Gerolamo Gaslini 5, I-16147 Genoa, Italy.	antonio.puccetti@unige.it	Falconi, Massimo/B-7359-2011; Frulloni, Luca/E-5244-2012; Falconi, Massimo/K-2194-2016	Frulloni, Luca/0000-0001-7417-2655; Falconi, Massimo/0000-0001-9654-7243				Asada M, 2006, PANCREAS, V33, P20, DOI 10.1097/01.mpa.0000226881.48204.fd; Chari ST, 2007, J GASTROENTEROL, V42, P39, DOI 10.1007/s00535-007-2046-8; Choi EK, 2007, PANCREAS, V35, P158; Finkelberg DL, 2006, NEW ENGL J MED, V355, P2670, DOI 10.1056/NEJMra061200; Frulloni L, 2000, PANCREAS, V20, P382, DOI 10.1097/00006676-200005000-00008; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Guarneri F, 2005, J CELL MOL MED, V9, P741, DOI 10.1111/j.1582-4934.2005.tb00506.x; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Kim MH, 2007, J GASTROENTEROL, V42, P42, DOI 10.1007/s00535-007-2050-z; KinoOhsaki J, 1996, GASTROENTEROLOGY, V110, P1579, DOI 10.1053/gast.1996.v110.pm8613065; Kountouras J, 2005, J CELL MOL MED, V9, P196, DOI 10.1111/j.1582-4934.2005.tb00349.x; Kountouras J, 2005, PANCREAS, V30, P192, DOI 10.1097/01.mpa.0000151576.91790.f8; Kountouras J, 2007, GASTROENTEROLOGY, V133, P368, DOI 10.1053/j.gastro.2007.05.044; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Manfredi R, 2008, RADIOLOGY, V247, P435, DOI 10.1148/radiol.2472070598; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Okazaki K, 2007, J GASTROENTEROL, V42, P32, DOI 10.1007/s00535-007-2049-5; Puccetti A, 2005, CLIN EXP ALLERGY, V35, P1599, DOI 10.1111/j.1365-2222.2005.02380.x; Rieder G, 2007, WORLD J GASTROENTERO, V13, P3939, DOI 10.3748/wjg.v13.i29.3939; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Wolfson D, 2005, PANCREAS, V31, P203, DOI 10.1097/01.mpa.0000180613.07948.ca; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	24	246	288	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2135	2142		10.1056/NEJMoa0903068	http://dx.doi.org/10.1056/NEJMoa0903068			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524BC	19940298				2022-12-28	WOS:000272117800007
J	Hakoyama, T; Niimi, K; Watanabe, H; Tabata, R; Matsubara, J; Sato, S; Nakamura, Y; Tabata, S; Li, JC; Matsumoto, T; Tatsumi, K; Nomura, M; Tajima, S; Ishizaka, M; Yano, K; Imaizumi-Anraku, H; Kawaguchi, M; Kouchi, H; Suganuma, N				Hakoyama, Tsuneo; Niimi, Kaori; Watanabe, Hirokazu; Tabata, Ryohei; Matsubara, Junichi; Sato, Shusei; Nakamura, Yasukazu; Tabata, Satoshi; Li Jichun; Matsumoto, Tsuyoshi; Tatsumi, Kazuyuki; Nomura, Mika; Tajima, Shigeyuki; Ishizaka, Masumi; Yano, Koji; Imaizumi-Anraku, Haruko; Kawaguchi, Masayoshi; Kouchi, Hiroshi; Suganuma, Norio			Host plant genome overcomes the lack of a bacterial gene for symbiotic nitrogen fixation	NATURE			English	Article							ALPHA-ISOPROPYLMALATE SYNTHASE; IRON-MOLYBDENUM COFACTOR; SOYBEAN ROOT-NODULES; LOTUS-JAPONICUS; HOMOCITRATE SYNTHASE; FIXING SYMBIOSIS; RHIZOBIUM; PURIFICATION; MUTANTS; LEGUMES	Homocitrate is a component of the iron-molybdenum cofactor in nitrogenase, where nitrogen fixation occurs(1,2). NifV, which encodes homocitrate synthase (HCS)(3), has been identified from various diazotrophs but is not present in most rhizobial species that perform efficient nitrogen fixation only in symbiotic association with legumes. Here we show that the FEN1 gene of a model legume, Lotus japonicus, overcomes the lack of NifV in rhizobia for symbiotic nitrogen fixation. A Fix(-) (non-fixing) plant mutant, fen1, forms morphologically normal but ineffective nodules(4,5). The causal gene, FEN1, was shown to encode HCS by its ability to complement a HCS-defective mutant of Saccharomyces cerevisiae. Homocitrate was present abundantly in wild-type nodules but was absent from ineffective fen1 nodules. Inoculation with Mesorhizobium loti carrying FEN1 or Azotobacter vinelandii NifV rescued the defect in nitrogen-fixing activity of the fen1 nodules. Exogenous supply of homocitrate also recovered the nitrogen-fixing activity of the fen1 nodules through de novo nitrogenase synthesis in the rhizobial bacteroids. These results indicate that homocitrate derived from the host plant cells is essential for the efficient and continuing synthesis of the nitrogenase system in endosymbionts, and thus provide a molecular basis for the complementary and indispensable partnership between legumes and rhizobia in symbiotic nitrogen fixation.	[Hakoyama, Tsuneo; Niimi, Kaori; Watanabe, Hirokazu; Tabata, Ryohei; Matsubara, Junichi; Suganuma, Norio] Aichi Univ Educ, Dept Life Sci, Aichi 4488542, Japan; [Hakoyama, Tsuneo; Yano, Koji; Imaizumi-Anraku, Haruko; Kouchi, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Sato, Shusei; Nakamura, Yasukazu; Tabata, Satoshi] Kazusa DNA Res Inst, Chiba 2920812, Japan; [Li Jichun; Matsumoto, Tsuyoshi; Tatsumi, Kazuyuki] Nagoya Univ, Grad Sch Sci, Dept Chem, Aichi 4648602, Japan; [Li Jichun; Matsumoto, Tsuyoshi; Tatsumi, Kazuyuki] Nagoya Univ, Res Ctr Mat Sci, Aichi 4648602, Japan; [Nomura, Mika; Tajima, Shigeyuki] Kagawa Univ, Fac Agr, Kita Ku, Kagawa 7610795, Japan; [Ishizaka, Masumi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Kawaguchi, Masayoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Aichi University Education; National Institute of Agrobiological Sciences - Japan; Kazusa DNA Research Institute; Nagoya University; Nagoya University; Kagawa University; National Institute for Agro-Environmental Sciences (NIAES) Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Suganuma, N (corresponding author), Aichi Univ Educ, Dept Life Sci, Aichi 4488542, Japan.	nsuganum@auecc.aichi-edu.ac.jp	Nakamura, Yasukazu/T-9038-2019; Sato, Shusei/A-3616-2015; Matsumoto, Tsuyoshi/E-8638-2013	Sato, Shusei/0000-0002-0293-5366; Nakamura, Yasukazu/0000-0002-6782-5715; Kawaguchi, Masayoshi/0000-0002-1032-6261; Yano, Koji/0000-0002-4322-3525	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank E. Casalone and E. Dubois for providing Saccharomyces cerevisiae mutants; T. Bisseling for providing nitrogenase antibodies; Y. Kawaharada and H. Mitsui for technical help; and R. W. Ridge for critical reading of the manuscript. This work was supported by the Special Coordination Funds for Promoting Science and Technology of the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Asamizu E, 2004, PLANT MOL BIOL, V54, P405, DOI 10.1023/B:PLAN.0000036372.46942.b8; Casalone E, 2000, YEAST, V16, P539, DOI 10.1002/(SICI)1097-0061(200004)16:6<539::AID-YEA547>3.0.CO;2-K; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; Diaz CL, 2005, LOTUS JAPONICUS HANDBOOK, P261, DOI 10.1007/1-4020-3735-X_26; DREYFUS BL, 1983, APPL ENVIRON MICROB, V45, P711, DOI 10.1128/AEM.45.2.711-713.1983; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; GAUTHIER D, 1981, APPL ENVIRON MICROB, V41, P306, DOI 10.1128/AEM.41.1.306-308.1981; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Hata S, 1998, PLANT J, V13, P267, DOI 10.1046/j.1365-313X.1998.00022.x; HOOVER TR, 1988, BIOCHEMISTRY-US, V27, P3647, DOI 10.1021/bi00410a019; HOOVER TR, 1989, BIOCHEMISTRY-US, V28, P2768, DOI 10.1021/bi00433a004; HOOVER TR, 1987, NATURE, V329, P855, DOI 10.1038/329855a0; ImaizumiAnraku H, 1997, PLANT CELL PHYSIOL, V38, P871, DOI 10.1093/oxfordjournals.pcp.a029246; JACOBSENLYON K, 1995, PLANT CELL, V7, P213, DOI 10.1105/tpc.7.2.213; Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Kneip C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-55; KOHLHAW G, 1969, J BIOL CHEM, V244, P2218; KOUCHI H, 1995, MOL PLANT MICROBE IN, V8, P172, DOI 10.1094/MPMI-8-0172; KOUCHI H, 1991, J GEN MICROBIOL, V137, P2901, DOI 10.1099/00221287-137-12-2901; Kumagai H, 2007, PLANT PHYSIOL, V143, P1293, DOI 10.1104/pp.106.095356; KURZ WGW, 1975, NATURE, V256, P407, DOI 10.1038/256407a0; MCCOMB JA, 1975, NATURE, V256, P409, DOI 10.1038/256409a0; PAGAN JD, 1975, NATURE, V256, P406, DOI 10.1038/256406a0; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Shimomura K, 2006, PLANT CELL PHYSIOL, V47, P1572, DOI 10.1093/pcp/pcl022; Suganuma N, 2003, MOL GENET GENOMICS, V269, P312, DOI 10.1007/s00438-003-0840-4; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Takane K, 1997, MOL PLANT MICROBE IN, V10, P735, DOI 10.1094/MPMI.1997.10.6.735; ULM EH, 1972, J BACTERIOL, V110, P1118, DOI 10.1128/JB.110.3.1118-1126.1972; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691; Xu PF, 2005, TETRAHEDRON LETT, V46, P3815, DOI 10.1016/j.tetlet.2005.03.180; Zheng LM, 1997, J BACTERIOL, V179, P5963, DOI 10.1128/jb.179.18.5963-5966.1997	35	70	72	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					514	U210		10.1038/nature08594	http://dx.doi.org/10.1038/nature08594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940927				2022-12-28	WOS:000272144200046
J	Lutolf, MP; Gilbert, PM; Blau, HM				Lutolf, Matthias P.; Gilbert, Penney M.; Blau, Helen M.			Designing materials to direct stem-cell fate	NATURE			English	Review							MULTICELLULAR ORGANIZATION; PROGENITOR CELLS; BIOMATERIALS; HYDROGELS; GROWTH; SHAPE; DIFFERENTIATION; THROUGHPUT; NANOPARTICLES; CULTURE	Proper tissue function and regeneration rely on robust spatial and temporal control of biophysical and biochemical microenvironmental cues through mechanisms that remain poorly understood. Biomaterials are rapidly being developed to display and deliver stem-cell-regulatory signals in a precise and near-physiological fashion, and serve as powerful artificial microenvironments in which to study and instruct stem-cell fate both in culture and in vivo. Further synergism of cell biological and biomaterials technologies promises to have a profound impact on stem-cell biology and provide insights that will advance stem-cell-based clinical approaches to tissue regeneration.	[Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Gilbert, Penney M.; Blau, Helen M.] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Dept Microbiol & Immunol,Inst Stem Cells & Regene, Stanford, CA 94305 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stanford University	Lutolf, MP (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.	matthias.lutolf@epfl.ch; hblau@stanford.edu	Lutolf, Matthias P/E-5914-2010	Gilbert, Penney/0000-0001-5509-9616	US National Institutes of Health (NIH) [CA09151, AG009521, AG020961, HL096113]; Leukemia and Lymphoma Society Fellowship [5367-07]; European Young Investigator award; Juvenile Diabetes Research Foundation [34-2008-623]; Muscular Dystrophy Association [4320]; California Institute for Regenerative Medicine (CIRM) Tools and Technologies [RT1-01001]; Stanford Bio-X award [IIP3-34]; Baxter Foundation; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R01AG009521, R37AG009521] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Fellowship(Leukemia and Lymphoma Society); European Young Investigator award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Muscular Dystrophy Association(Muscular Dystrophy Association); California Institute for Regenerative Medicine (CIRM) Tools and Technologies(California Institute for Regenerative Medicine); Stanford Bio-X award; Baxter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge a US National Institutes of Health (NIH) postdoctoral training grant (CA09151) ( P. M. G.); a Leukemia and Lymphoma Society Fellowship (5367-07) and the European Young Investigator award ( M. P. L.); and NIH grants (AG009521, AG020961 and HL096113), a Juvenile Diabetes Research Foundation Grant (34-2008-623), a Muscular Dystrophy Association grant ( 4320), a California Institute for Regenerative Medicine (CIRM) Tools and Technologies grant (RT1-01001), a Stanford Bio-X award (IIP3-34), and the Baxter Foundation ( H. M. B.).	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760; BLAU HM, ESSENTIALS IN PRESS, P249; BLAU HM, ENCY STEM C IN PRESS; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254; Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Gidrol X, 2009, CURR OPIN PHARMACOL, V9, P664, DOI 10.1016/j.coph.2009.05.002; Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203; Glauche I, 2009, CELL PROLIFERAT, V42, P248, DOI 10.1111/j.1365-2184.2009.00586.x; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gomi K, 2004, J BIOMED MATER RES A, V71A, P602, DOI 10.1002/jbm.a.30174; Gu F, 2008, P NATL ACAD SCI USA, V105, P2586, DOI 10.1073/pnas.0711714105; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647; Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/j.addr.2012.09.009; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4; Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284; Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035; Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kopecek J, 2007, POLYM INT, V56, P1078, DOI 10.1002/pi.2253; LaBarge MA, 2009, INTEGR BIOL-UK, V1, P70, DOI 10.1039/b816472j; Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105; Lee W, 2009, NEUROREPORT, V20, P798, DOI 10.1097/WNR.0b013e32832b8be4; Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732; Lii J, 2008, ANAL CHEM, V80, P3640, DOI 10.1021/ac8000034; Lin CC, 2009, PHARM RES-DORDR, V26, P631, DOI 10.1007/s11095-008-9801-2; Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t; Lutolf MP, 2009, MATER RES SOC SYMP P, V1140, P125; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Lutolf MP, 2009, INTEGR BIOL, V1, P235, DOI 10.1039/b902243k; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; LUTOLF MP, ADV TISSUE IN PRESS, pCH9; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mironov V, 2008, REGEN MED, V3, P93, DOI 10.2217/17460751.3.1.93; Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030; Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nur-E-Kamal A, 2008, MOL CELL BIOCHEM, V309, P157, DOI 10.1007/s11010-007-9654-8; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Peret BJ, 2008, ADV FUNCT MATER, V18, P3410, DOI 10.1002/adfm.200800218; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Rothenfluh DA, 2008, NAT MATER, V7, P248, DOI 10.1038/nmat2116; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820; Suzuki T, 2006, STEM CELLS, V24, P2456, DOI 10.1634/stemcells.2006-0258; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Underhill GH, 2007, CURR OPIN CHEM BIOL, V11, P357, DOI 10.1016/j.cbpa.2007.05.036; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; van Noort D, 2009, BIOTECHNOL PROGR, V25, P52, DOI 10.1002/btpr.171; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400	90	1110	1138	9	499	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					433	441		10.1038/nature08602	http://dx.doi.org/10.1038/nature08602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940913	Green Accepted			2022-12-28	WOS:000272144200031
J	Kumbhani, DJ; Cannon, CP; Fonarow, GC; Liang, L; Askari, AT; Peacock, WF; Peterson, ED; Bhatt, DL				Kumbhani, Dharam J.; Cannon, Christopher P.; Fonarow, Gregg C.; Liang, Li; Askari, Arman T.; Peacock, W. Frank; Peterson, Eric D.; Bhatt, Deepak L.		Get Guidelines Steering Comm Inves	Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality and Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; MORTALITY	Context Earlier studies indicate an inverse relationship between hospital volume and mortality after primary angioplasty for patients presenting with ST-segment elevation myocardial infarction (STEMI). However, contemporary data are lacking. Objective To assess the relationship between hospital primary angioplasty volume and outcomes and quality of care measures in patients presenting with STEMI. Design, Setting, and Patients An observational analysis of data on 29 513 patients presenting with STEMI and undergoing primary angioplasty in the American Heart Association's Get With the Guidelines registry. Patients were treated between July 5, 2001, and December 31, 2007, at 166 angioplasty-capable hospitals across the United States. Hospitals were divided into tertiles (<36 procedures per year, 36-70 procedures per year, and >70 procedures per year) based on their annual primary angioplasty volume. Main Outcome Measures Door-to-balloon (DTB) times, length of hospital stay, adherence with evidence-based quality of care measures, and in-hospital mortality. Results Compared with low-and medium-volume centers, high-volume centers had better median DTB times (98 vs 90 vs 88 minutes, respectively; P for trend <.001). High-volume centers were more likely than low-volume centers to follow evidence-based guidelines at discharge. Length of stay was similar between the 3 groups (P for trend = .13). There was no significant difference in the crude mortality between the tertiles of volume (incidence rate, 3.9% vs 3.2% vs 3.0% for low-, medium-, and high-volume centers, respectively; P = .26 and P = .99 for low-and medium-vs high-volume hospitals, respectively). Sequential multivariable modeling using generalized estimating equations revealed no significant association between hospital primary angioplasty volume and in-hospital mortality (adjusted odds ratio [OR], 1.22; 95% confidence interval [CI], 0.78-1.91; P = .38 and adjusted OR, 1.14; 95% CI, 0.78-1.66; P = .49 for low-and medium-vs high-volume hospitals, respectively). Conclusion In a contemporary registry of patients with STEMI, higher-volume primary angioplasty centers vs lower-volume centers were associated with shorter DTB times and more use of evidence-based therapies, but not with adjusted in-hospital mortality or length of hospital stay. JAMA. 2009;302(20):2207-2213	[Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA 02115 USA; [Kumbhani, Dharam J.; Askari, Arman T.; Peacock, W. Frank] Cleveland Clin, Cleveland, OH 44106 USA; [Cannon, Christopher P.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [Fonarow, Gregg C.] Ahmanson Univ Calif Los Angeles, Univ Calif Los Angeles, Cardiomyopathy Ctr, Div Cardiol, Los Angeles, CA USA; [Liang, Li; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; Duke University	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 75 Francis St,PBB 146, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu	Cannon, Christopher P/AAY-7644-2020; Peterson, Eric David/ABF-5033-2021; Fonarow, Gregg C/D-5988-2014	Cannon, Christopher P/0000-0003-4596-2791; Fonarow, Gregg C/0000-0002-3192-8093	Merck/Schering-Plough Pharmaceutical; AHA	Merck/Schering-Plough Pharmaceutical(Merck & Company); AHA(American Heart Association)	The Get With the Guidelines-Coronary Artery Disease is a program of the American Heart Association (AHA) and is supported by an unrestricted educational grant from Merck/Schering-Plough Pharmaceutical. Data collection and management were performed by Outcome Inc (Cambridge, Massachusetts). The analysis of registry data was performed at Duke Clinical Research Institute (Durham, North Carolina), which also receives funding from the AHA.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Antman EM, 2008, J AM COLL CARDIOL, V52, P1216, DOI 10.1016/j.jacc.2008.07.011; Bhatt DL, 2000, JAMA-J AM MED ASSOC, V284, P1549, DOI 10.1001/jama.284.12.1549; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Califf RM, 2009, J AM COLL CARDIOL, V53, P831, DOI 10.1016/j.jacc.2008.10.056; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Epstein AJ, 2004, J AM COLL CARDIOL, V43, P1755, DOI 10.1016/j.jacc.2003.09.070; Kansagra SM, 2007, AM J CARDIOL, V99, P339, DOI 10.1016/j.amjcard.2006.08.037; Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402; Khuri SF, 2005, WORLD J SURG, V29, P1222, DOI 10.1007/s00268-005-7987-6; Kumbhani D, 2005, J AM COLL SURGEONS, V201, pS65, DOI 10.1016/j.jamcollsurg.2005.06.150; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; *LEAPFROG GROUP, EV BAS HOSP REF; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; Pottenger BC, 2008, ANN EMERG MED, V52, P677, DOI 10.1016/j.annemergmed.2008.06.004; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056; Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668; Venkitachalam L, 2009, CIRC-CARDIOVASC INTE, V2, P6, DOI 10.1161/CIRCINTERVENTIONS.108.825323; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	24	69	70	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2207	2213		10.1001/jama.2009.1715	http://dx.doi.org/10.1001/jama.2009.1715			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934421				2022-12-28	WOS:000272080500024
J	Sennik, DK; Suresh, D; Goodall, E; Lane, RJM				Sennik, D. K.; Suresh, D.; Goodall, E.; Lane, R. J. M.			Picture Quiz A case of diplopia and arm weakness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MYASTHENIA-GRAVIS		[Sennik, D. K.; Suresh, D.; Lane, R. J. M.] Ashford & St Peters Hosp NHS Trust, Chertsey KT16 OPZ, England; [Goodall, E.] Royal Surrey Cty Hosp, Intens Treatment Unit, Guildford GU2 7XX, Surrey, England	Royal Surrey County Hospital	Sennik, DK (corresponding author), Ashford & St Peters Hosp NHS Trust, Chertsey KT16 OPZ, England.	deveshsennik@hotmail.com						Benatar M, 2006, NEUROMUSCULAR DISORD, V16, P459, DOI 10.1016/j.nmd.2006.05.006; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Hart IK, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005224.pub2; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Nelson H, 2009, LANCET ONCOL, V10, P7, DOI 10.1016/S1470-2045(08)70319-X; OH SJ, 1992, MUSCLE NERVE, V15, P720, DOI 10.1002/mus.880150616; Palace J, 1998, NEUROLOGY, V50, P1778, DOI 10.1212/WNL.50.6.1778; *ROYAL COLL PHYS G, 2002, GLUC IND OST GUID PR; Scheider-Gold C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002828.pub2; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Vincent A, 2003, J NEUROL NEUROSUR PS, V74, P1105, DOI 10.1136/jnnp.74.8.1105; WARRELL DA, 2004, OXFORD TXB MED	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2009	339								b4555	10.1136/bmj.b4555	http://dx.doi.org/10.1136/bmj.b4555			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525AV	19939896				2022-12-28	WOS:000272186400001
J	Horton, R				Horton, Richard			Ann Veneman: a second term at UNICEF?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 21	2009	374	9703					1733	1734		10.1016/S0140-6736(09)61997-8	http://dx.doi.org/10.1016/S0140-6736(09)61997-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ID	19932346				2022-12-28	WOS:000272207700009
J	Chen, L; Kwon, YD; Zhou, TQ; Wu, XL; O'Dell, S; Cavacini, L; Hessell, AJ; Pancera, M; Tang, M; Xu, L; Yang, ZY; Zhang, MY; Arthos, J; Burton, DR; Dimitrov, DS; Nabel, GJ; Posner, MR; Sodroski, J; Wyatt, R; Mascola, JR; Kwong, PD				Chen, Lei; Kwon, Young Do; Zhou, Tongqing; Wu, Xueling; O'Dell, Sijy; Cavacini, Lisa; Hessell, Ann J.; Pancera, Marie; Tang, Min; Xu, Ling; Yang, Zhi-Yong; Zhang, Mei-Yun; Arthos, James; Burton, Dennis R.; Dimitrov, Dimiter S.; Nabel, Gary J.; Posner, Marshall R.; Sodroski, Joseph; Wyatt, Richard; Mascola, John R.; Kwong, Peter D.			Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; NEUTRALIZING ANTIBODIES; BINDING-SITE; EFFICIENT NEUTRALIZATION; ENVELOPE GLYCOPROTEINS; INFECTED INDIVIDUALS; PROTEIN; PANEL; CRYSTALLIZATION	The site on HIV-1 gp120 that binds to the CD4 receptor is vulnerable to antibodies. However, most antibodies that interact with this site cannot neutralize HIV-1. To understand the basis of this resistance, we determined co-crystal structures for two poorly neutralizing, CD4-binding site (CD4BS) antibodies, F105 and b13, in complexes with gp120. Both antibodies exhibited approach angles to gp120 similar to those of CD4 and a rare, broadly neutralizing CD4BS antibody, b12. Slight differences in recognition, however, resulted in substantial differences in F105- and b13-bound conformations relative to b12-bound gp120. Modeling and binding experiments revealed these conformations to be poorly compatible with the viral spike. This incompatibility, the consequence of slight differences in CD4BS recognition, renders HIV-1 resistant to all but the most accurately targeted antibodies.	[Chen, Lei; Kwon, Young Do; Zhou, Tongqing; Wu, Xueling; O'Dell, Sijy; Pancera, Marie; Tang, Min; Xu, Ling; Yang, Zhi-Yong; Nabel, Gary J.; Wyatt, Richard; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Cavacini, Lisa; Posner, Marshall R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Head & Neck Oncol Program, Boston, MA 02115 USA; [Hessell, Ann J.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Hessell, Ann J.; Burton, Dennis R.] Scripps Res Inst, Dept Microbial Sci, La Jolla, CA 92037 USA; [Hessell, Ann J.; Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Zhang, Mei-Yun; Dimitrov, Dimiter S.] NCI, Ctr Canc Res, Frederick, MD 21702 USA; [Arthos, James] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02114 USA; [Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	pdkwong@nih.gov; pdkwong@nih.gov	Zhang, Mei-Yun/E-9908-2010; Zhou, Tongqing/A-6880-2010; Mascola, John/AAI-7193-2021; Do Kwon, Young/A-6957-2010	Zhou, Tongqing/0000-0002-3935-4637; Do Kwon, Young/0000-0002-1188-7458; Hessell, Ann/0000-0001-7471-9366	NIH; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation Grand Challenges in Global Heath Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005023, ZIAAI005089, ZIAAI005095, ZIAAI000883, ZIAAI005010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation Grand Challenges in Global Heath Initiative(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L. Chen produced and assessed for crystallization CD4BS antibodies with unconstrained gp120, crystallized the F105-gp120 complex, assisted with F105-gp120 data collection and structure solution, and carried out mutagenesis and SPR binding experiments. Y. D. K. assisted with F105-gp120 crystallization, data collection, and structure solution and refined and analyzed the F105-gp120 structure. T. Z. purified, crystallized, solved, and analyzed the b13-gp120 complex. X. W., S. O.' D. and J. R. M. assessed neutralization potency and breadth of CD4, patient sera, and CD4BS antibodies. L. Chen and M. P. carried out cell-surface JR-FL binding experiments. M. T. and R. W. provided YU2 core gp120; L. X. and G. J. N. provided stabilized-core gp120; Z.-Y. Y. and G. J. N. converted b13 from Fab to IgG format and provided b13 IgG; L. Cavacini and M. R. P. provided F105; M.-Y. Z. and D. S. D. provided m6, m14, and m18; A. J. H. and D. R. B. provided b3, b6, b11, b12; and J. A. provided dodecameric CD4. J. A., D. R. B., D. S. D., G. J. N., M. R. P., J. S., R. W., and J. R. M. assisted with analysis and writing, and P. D. K. assisted with crystallography and experimental planning and wrote the first draft. Figures, tables, and supporting online material were produced by L. Chen, Y. D. K., M. P., T. Z. and X. W. We thank L. Shapiro and members of the Structural Biology Section, Vaccine Research Center (VRC), for discussions and comments on the manuscript, M. Connors for patient serum, M. Fung for antibodies G3-42 and G3-299, J. Robinson for antibodies 1.5e and F91, J. Stuckey for assistance with figures and tables, S. Subramaniam for EM tomograms, C. Winter and C. Huang for S2 production of core YU2 gp120, X. Yang for preparation of JR-FL gp120, and the Flow Cytometry Core, VRC, for assistance with antibody binding to cell-surface-expressed HIV-1 spikes. Support for this work was provided by the Intramural Research Program of NIH, the International AIDS Vaccine Initiative, a grant from the Bill and Melinda Gates Foundation Grand Challenges in Global Heath Initiative, and grants from NIH. The use of insertion device 22 (Southeast Region Collaborative Access Team) at the Advanced Photon Source was supported by the U. S. Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. Coordinates and structure factors for the F105-gp120 complex (accession code 3HI1) and the b13-gp120 complexes (accession codes 3IDX and 3IDY for C222 and C2221 forms, respectively) have been deposited with the Protein Data Bank.	Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Kabat EA, 1991, SEQUENCES PROTEINS I; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; MORRIS DW, 1989, BIOTECHNIQUES, V7, P522; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; POSNER MR, 1991, J IMMUNOL, V146, P4325; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0; UNAIDS, 2006, REP GLOB AIDS EP; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	33	233	255	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1123	1127		10.1126/science.1175868	http://dx.doi.org/10.1126/science.1175868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965434	Green Accepted			2022-12-28	WOS:000271951000048
J	Perepezko, JH				Perepezko, John H.			The Hotter the Engine, the Better	SCIENCE			English	Editorial Material							SI-B ALLOYS; HIGH-TEMPERATURE; COATINGS		Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Perepezko, JH (corresponding author), Univ Wisconsin, Dept Mat Sci & Engn, 1509 Univ Ave, Madison, WI 53706 USA.	perepezk@engr.wisc.edu						Akinc M, 1999, MAT SCI ENG A-STRUCT, V261, P16, DOI 10.1016/S0921-5093(98)01045-4; Berczik D. M., 1997, US Patets, Patent No. 5595616; Berczik D. M., 1997, US Patets, Patent No. 5693156; BEWLAY B, N000140711083 OFF NA; Bewlay B.W., 2003, MRS BULL, V28, P622; Bewlay BP, 2003, METALL MATER TRANS A, V34A, P2043, DOI 10.1007/s11661-003-0269-8; Buckman Jr RW, 1988, ALLOYING, P419; Dimiduk DM, 2003, MRS BULL, V28, P639, DOI 10.1557/mrs2003.191; FLEISCHER RL, 1985, JOM-J MIN MET MAT S, V37, P16, DOI 10.1007/BF03259961; Fu CL, 2000, PHIL MAG LETT, V80, P683, DOI 10.1080/09500830050143787; FURRER D, FA95500610233 AIR FO; Jehanno P, 2005, METALL MATER TRANS A, V36A, P515, DOI 10.1007/s11661-005-0165-5; Medvedeva NI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.136402; Middlemas MR, 2008, JOM-US, V60, P19, DOI 10.1007/s11837-008-0084-1; Naslain R, 2004, COMPOS SCI TECHNOL, V64, P155, DOI 10.1016/S0266-3538(03)00230-6; Padture NP, 2002, SCIENCE, V296, P280, DOI 10.1126/science.1068609; ROSS EW, 1987, SUPERALLOYS, V2, P97; Sakidja R, 2008, ACTA MATER, V56, P5223, DOI 10.1016/j.actamat.2008.07.015; Sakidja R, 2005, SCRIPTA MATER, V53, P723, DOI 10.1016/j.scriptamat.2005.05.015; Schneibel JH, 2005, METALL MATER TRANS A, V36A, P525, DOI 10.1007/s11661-005-0166-4; Soboyejo W., 2007, ADV STRUCTURAL MAT P, P437	21	587	617	29	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1068	1069		10.1126/science.1179327	http://dx.doi.org/10.1126/science.1179327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965415				2022-12-28	WOS:000271951000026
J	Gheorghiade, M; Braunwald, E				Gheorghiade, Mihai; Braunwald, Eugene			Reconsidering the Role for Digoxin in the Management of Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; TRIAL; MORBIDITY		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Dept Med, Ctr Cardiovasc Qual & Outcomes, Chicago, IL 60611 USA; [Braunwald, Eugene] Harvard Univ, Sch Med, Dept Med, Div Cardiovasc Med, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Ctr Cardiovasc Qual & Outcomes, 676 N St Clair,Ste 600, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Adams KF, 2005, J AM COLL CARDIOL, V46, P497, DOI 10.1016/j.jacc.2005.02.091; Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2006, CIRCULATION, V113, P2556, DOI 10.1161/CIRCULATIONAHA.105.560110; Gheorghiade M, 2009, AM HEART J, V157, P957, DOI 10.1016/j.ahj.2009.04.010; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; OCONNOR MC, 2009, 13 ANN SCI M HEART F; Perry G, 1997, NEW ENGL J MED, V336, P525; Rathore SS, 2002, NEW ENGL J MED, V347, P1403, DOI 10.1056/NEJMoa021266; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900	10	45	48	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2146	2147		10.1001/jama.2009.1657	http://dx.doi.org/10.1001/jama.2009.1657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920240				2022-12-28	WOS:000271873900025
J	de Lange, T				de Lange, Titia			How Telomeres Solve the End-Protection Problem	SCIENCE			English	Article							DNA-DAMAGE CHECKPOINT; BINDING-PROTEIN; FISSION YEAST; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; DYSFUNCTIONAL TELOMERES; UNPROTECTED TELOMERES; MAMMALIAN TELOMERES; POT1 PROTEINS	The ends of eukaryotic chromosomes have the potential to be mistaken for damaged or broken DNA and must therefore be protected from cellular DNA damage response pathways. Otherwise, cells might permanently arrest in the cell cycle, and attempts to "repair" the chromosome ends would have devastating consequences for genome integrity. This end-protection problem is solved by protein-DNA complexes called telomeres. Studies of mammalian cells have recently uncovered the mechanism by which telomeres disguise the chromosome ends. Comparison to unicellular eukaryotes reveals key differences in the DNA damage response systems that inadvertently threaten chromosome ends. Telomeres appear to be tailored to these variations, explaining their variable structure and composition.	Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10021 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [CA076027, GM049046, AG016642]; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank M. Wellinger, J. Petrini, J. Haber, V. Lundblad, and M. Godinho Ferreira for helpful discussion; Y. Doksani, P. Wu, F. Lottersberger, and A. Sfeir for their comments on this manuscript; and J. Griffith for providing the t-loop EM in Fig. 1. Supported by NIH grants CA076027, GM049046, and AG016642.	Attwooll CL, 2009, MOL CELL BIOL, V29, P5540, DOI 10.1128/MCB.00479-09; Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Barrientos KS, 2008, MOL CELL BIOL, V28, P5251, DOI 10.1128/MCB.00048-08; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; Cesare AJ, 2008, MOL CELL BIOL, V28, P20, DOI 10.1128/MCB.01122-07; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Stansel RM, 2001, EMBO J, V20, P5532; Stern JL, 2008, CYTOGENET GENOME RES, V122, P243, DOI 10.1159/000167810; Subramanian L, 2008, MOL CELL BIOL, V28, P1443, DOI 10.1128/MCB.01614-07; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Vodenicharov MD, 2007, CELL CYCLE, V6, P1161, DOI 10.4161/cc.6.10.4224; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037	64	573	577	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					948	952		10.1126/science.1170633	http://dx.doi.org/10.1126/science.1170633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965504	Green Accepted			2022-12-28	WOS:000271712300025
J	Tikkanen, JT; Anttonen, O; Junttila, J; Aro, AL; Kerola, T; Rissanen, HA; Reunanen, A; Huikuri, HV				Tikkanen, Jani T.; Anttonen, Olli; Junttila, Juhani; Aro, Aapo L.; Kerola, Tuomas; Rissanen, Harri A.; Reunanen, Antti; Huikuri, Heikki V.			Long-Term Outcome Associated with Early Repolarization on Electrocardiography	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CLINICAL CHARACTERISTICS; MYOCARDIAL-INFARCTION; DEATH; FIBRILLATION; POPULATION; ELEVATION; RISK	BACKGROUND Early repolarization, which is characterized by an elevation of the QRS-ST junction (J point) in leads other than V-1 through V-3 on 12-lead electrocardiography, has been associated with vulnerability to ventricular fibrillation, but little is known about the prognostic significance of this pattern in the general population. METHODS We assessed the prevalence and prognostic significance of early repolarization on 12-lead electrocardiography in a community-based general population of 10,864 middle-aged subjects (mean [+/- SD] age, 44 +/- 8 years). The primary end point was death from cardiac causes, and secondary end points were death from any cause and death from arrhythmia during a mean follow-up of 30 +/- 11 years. Early repolarization was stratified according to the degree of J-point elevation (>= 0.1 mV or >0.2 mV) in either inferior or lateral leads. RESULTS The early-repolarization pattern of 0.1 mV or more was present in 630 subjects (5.8%): 384 (3.5%) in inferior leads and 262 (2.4%) in lateral leads, with elevations in both leads in 16 subjects (0.1%). J-point elevation of at least 0.1 mV in inferior leads was associated with an increased risk of death from cardiac causes (adjusted relative risk, 1.28; 95% confidence interval [CI], 1.04 to 1.59; P=0.03); 36 subjects (0.3%) with J-point elevation of more than 0.2 mV in inferior leads had a markedly elevated risk of death from cardiac causes (adjusted relative risk, 2.98; 95% CI, 1.85 to 4.92; P<0.001) and from arrhythmia (adjusted relative risk, 2.92; 95% CI, 1.45 to 5.89; P=0.01). Other electrocardiographic risk markers, such as a prolonged QT interval corrected for heart rate (P=0.03) and left ventricular hypertrophy (P=0.004), were weaker predictors of the primary end point. CONCLUSIONS An early-repolarization pattern in the inferior leads of a standard electrocardiogram is associated with an increased risk of death from cardiac causes in middle-aged subjects.	[Huikuri, Heikki V.] Univ Oulu, Dept Internal Med, Inst Clin Med, Ctr Excellence Res, Oulu 90014, Finland; [Anttonen, Olli; Aro, Aapo L.; Kerola, Tuomas] Paijat Hame Cent Hosp, Dept Internal Med, Lahti, Finland; [Rissanen, Harri A.; Reunanen, Antti] Natl Inst Hlth & Welf, Helsinki, Finland	University of Oulu; Paijat Hame Central Hospital; Finland National Institute for Health & Welfare	Huikuri, HV (corresponding author), Univ Oulu, Dept Internal Med, Inst Clin Med, Ctr Excellence Res, POB 5000, Oulu 90014, Finland.	heikki.huikuri@oulu.fi		Aro, Aapo/0000-0001-7030-6740	Sigrid Juselius Foundation; Instrumentarium Science Foundation; Orion Pharmos Science Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instrumentarium Science Foundation; Orion Pharmos Science Foundation	Supported by a research grant from the Sigrid Juselius Foundation.; Dr. Junttila reports receiving grant support from the Instrumentarium Science Foundation and Orion Pharmos Science Foundation. No other potential conflict of interest relevant to this article was reported.	ALGRA A, 1991, CIRCULATION, V83, P1888, DOI 10.1161/01.CIR.83.6.1888; Boineau JP, 2007, J ELECTROCARDIOL, V40, P392, DOI 10.1016/j.jelectrocard.2007.07.012; GREENE HL, 1989, AM J CARDIOL, V63, P1, DOI 10.1016/0002-9149(89)91065-5; Gussak I, 2000, J ELECTROCARDIOL, V33, P299, DOI 10.1054/jelc.2000.18106; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Jousilahti P, 2003, EUR HEART J, V24, P685, DOI 10.1016/S0195-668X(03)96131-8; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Myerburg RJ, 2008, NAT CLIN PRACT CARD, V5, P760, DOI 10.1038/ncpcardio1354; Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; REUNANEN A, 1983, ACTA MED SCAND, P1; Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; SUHONEN O, 1985, ACTA MED SCAND, V217, P457; Sullivan JM, 1993, J AM COLL CARDIOL, V22, P508, DOI 10.1016/0735-1097(93)90057-8; Takagi M, 2000, J CARDIOVASC ELECTR, V11, P844, DOI 10.1111/j.1540-8167.2000.tb00062.x; Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372	18	572	591	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2529	2537		10.1056/NEJMoa0907589	http://dx.doi.org/10.1056/NEJMoa0907589			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	19917913				2022-12-28	WOS:000273003700008
J	Kuroda, R; Endo, B; Abe, M; Shimizu, M				Kuroda, Reiko; Endo, Bunshiro; Abe, Masanori; Shimizu, Miho			Chiral blastomere arrangement dictates zygotic left-right asymmetry pathway in snails	NATURE			English	Article							LEFT-RIGHT AXIS; NODAL FLOW; UNCONVENTIONAL MYOSIN; HANDEDNESS; DROSOPHILA; MECHANISM; ELEGANS; EMBRYO; ORIGIN; SHELL	Most animals display internal and/or external left-right asymmetry. Several mechanisms for left-right asymmetry determination have been proposed for vertebrates(1-10) and invertebrates(1,2,4,9,11-14) but they are still not well characterized, particularly at the early developmental stage. The gastropods Lymnaea stagnalis and the closely related Lymnaea peregra have both the sinistral (recessive) and the dextral (dominant) snails within a species and the chirality is hereditary, determined by a single locus that functions maternally(15-18). Intriguingly, the handedness-determining gene(s) and the mechanisms are not yet identified. Here we show that in L. stagnalis, the chiral blastomere arrangement at the eight-cell stage (but not the two-or four-cell stage) determines the left-right asymmetry throughout the developmental programme, and acts upstream of the Nodal signalling pathway. Thus, we could demonstrate that mechanical micromanipulation of the third cleavage chirality (from the four-to the eight-cell stage) leads to reversal of embryonic handedness. These manipulated embryos grew to 'dextralized' sinistral and 'sinistralized' dextral snails-that is, normal healthy fertile organisms with all the usual left-right asymmetries reversed to that encoded by the mothers' genetic information. Moreover, manipulation reversed the embryonic nodal expression patterns. Using backcrossed F-7 congenic animals, we could demonstrate a strong genetic linkage between the handedness-determining gene( s) and the chiral cytoskeletal dynamics at the third cleavage that promotes the dominant-type blastomere arrangement. These results establish the crucial importance of the maternally determined blastomere arrangement at the eight-cell stage in dictating zygotic signalling pathways in the organismal chiromorphogenesis. Similar chiral blastomere configuration mechanisms may also operate upstream of the Nodal pathway in left-right patterning of deuterostomes/vertebrates.	[Kuroda, Reiko] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kuroda, Reiko; Endo, Bunshiro; Abe, Masanori; Shimizu, Miho] JST, ERATO SORST, Kuroda Chiromorphol Team, Meguro Ku, Tokyo 1530041, Japan; [Kuroda, Reiko] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Kuroda, R (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan.	ckuroda@mail.ecc.u-tokyo.ac.jp	Shimizu, Miho/O-9903-2019; Shimizu, Miho/Q-8522-2017	Shimizu, Miho/0000-0003-4070-8209; Shimizu, Miho/0000-0003-4070-8209; Kuroda, Reiko/0000-0002-0268-7729				Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; BOYCOTT A. E., 1930, PHIL TRANS ROY SOC LONDON B, V219, P51; BROWN NA, 1990, DEVELOPMENT, V109, P1; Christiaen L, 2002, GENE, V287, P107, DOI 10.1016/S0378-1119(01)00865-4; Crampton H. E., 1894, Annals of the New York Academy of Sciences, Vviii, P167; Duboc V, 2008, J EXP ZOOL PART B, V310B, P41, DOI 10.1002/jez.b.21121; FREEMAN G, 1992, J EVOLUTION BIOL, V5, P205, DOI 10.1046/j.1420-9101.1992.5020205.x; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hosoiri Y, 2003, DEV GENES EVOL, V213, P193, DOI 10.1007/s00427-003-0315-y; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; MESHCHERYAKOV VN, 1975, ROUX ARCH DEV BIOL, V177, P193, DOI 10.1007/BF00848080; Nederbragt AJ, 2002, DEV BIOL, V246, P341, DOI 10.1006/dbio.2002.0653; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Speder P, 2007, CURR OPIN GENET DEV, V17, P351, DOI 10.1016/j.gde.2007.05.008; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; Vandenberg LN, 2009, SEMIN CELL DEV BIOL, V20, P456, DOI 10.1016/j.semcdb.2008.11.010; Wandelt J, 2004, CURR BIOL, V14, pR654, DOI 10.1016/j.cub.2004.08.010; WOOD WB, 1991, NATURE, V349, P536, DOI 10.1038/349536a0	27	131	134	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					790	U112		10.1038/nature08597	http://dx.doi.org/10.1038/nature08597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19940849				2022-12-28	WOS:000272559900039
J	Kleinert, S				Kleinert, Sabine			COPE's retraction guidelines	LANCET			English	Editorial Material							MISCONDUCT		The Lancet, London NW1 7BY, England		Kleinert, S (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2008, LANCET, V372, P778; Atlas MC, 2004, J MED LIBR ASSOC, V92, P242; Committee on Publication Ethics (COPE), COD COND; Corbyn Z., 2009, TIMES HIGHER ED 0820; Nath SB, 2006, MED J AUSTRALIA, V185, P152, DOI 10.5694/j.1326-5377.2006.tb00504.x; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Wager E, RETRACTIONS GUIDANCE	7	11	12	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 5	2009	374	9705					1876	1877		10.1016/S0140-6736(09)62074-2	http://dx.doi.org/10.1016/S0140-6736(09)62074-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19962558				2022-12-28	WOS:000272646900009
J	Pierce, NW; Kleiger, G; Shan, SO; Deshaies, RJ				Pierce, Nathan W.; Kleiger, Gary; Shan, Shu-ou; Deshaies, Raymond J.			Detection of sequential polyubiquitylation on a millisecond timescale	NATURE			English	Article							SUBSTRATE UBIQUITINATION; CONJUGATING ENZYME; COMPLEX; SCF; MECHANISM; RECOGNITION	The pathway by which ubiquitin chains are generated on substrate through a cascade of enzymes consisting of an E1, E2 and E3 remains unclear. Multiple distinct models involving chain assembly on E2 or substrate have been proposed. However, the speed and complexity of the reaction have precluded direct experimental tests to distinguish between potential pathways. Here we introduce new theoretical and experimental methodologies to address both limitations. A quantitative framework based on product distribution predicts that the really interesting new gene (RING) E3 enzymes SCFCdc4 and SCF beta-TrCP work with the E2 Cdc34 to build polyubiquitin chains on substrates by sequential transfers of single ubiquitins. Measurements with millisecond time resolution directly demonstrate that substrate polyubiquitylation proceeds sequentially. Our results present an unprecedented glimpse into the mechanism of RING ubiquitin ligases and illuminate the quantitative parameters that underlie the rate and pattern of ubiquitin chain assembly.	[Pierce, Nathan W.; Kleiger, Gary; Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, MC 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	Gordon Ross Fellowship; National Institutes of Health [GM065997]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER	Gordon Ross Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Vielmetter for providing SCF<SUP>Cdc4</SUP>, beta-TrCP-Skp1 and human E1; S. Hess, R. L. J. Graham and the Proteome Exploration Laboratory for providing assistance with mass spectrometry of CYCE and Cdc34 thioester. We thank S. Schwarz, B. Schulman and G. Wu for gifts of reagents. We thank D. Sprinzak and all the members of the Deshaies and Shan laboratories for support and discussions. N.W.P. was supported by the Gordon Ross Fellowship and a National Institutes of Health Training Grant. R. J. D. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by National Institutes of Health GM065997.	Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; FERSHT A, 1999, STRUCTURE MECH PROTE, pCH14; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; KATI WM, 1992, J BIOL CHEM, V267, P25988; KLEIGER G, CELL IN PRESS; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	22	157	160	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					615	U85		10.1038/nature08595	http://dx.doi.org/10.1038/nature08595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956254	Green Accepted			2022-12-28	WOS:000272277900033
J	Lamont, T; Surkitt-Parr, M; Scarpello, J; Durand, M; Hooper, C; Maskell, N				Lamont, Tara; Surkitt-Parr, Michael; Scarpello(A), John; Durand, Marcus; Hooper, Clare; Maskell, Nick			Safety Alerts Insertion of chest drains: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Surkitt-Parr, Michael; Durand, Marcus] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Hooper, Clare; Maskell, Nick] Southmead Hosp, N Bristol Lung Ctr, Bristol BS10 5NB, Avon, England	Southmead Hospital	Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk		maskell, nick/0000-0002-1276-6500				[Anonymous], 2005, ULTR TRAIN REC MED S; *BRIT THOR SOC, 2008, NPSA2008RRR003 BRIT; Harris A, 2008, THORAX, V63, pA86; HOOPER C, 2009, PILOT PLEUR IN PRESS; LAWS D, 2003, THORAX S2, V58, P53, DOI DOI 10.1136/THX.58.SUPPL_2.II53; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Waydhas C, 2007, RESUSCITATION, V72, P11, DOI 10.1016/j.resuscitation.2006.06.025	7	15	15	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 2	2009	339								b4923	10.1136/bmj.b4923	http://dx.doi.org/10.1136/bmj.b4923			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NS	19955139				2022-12-28	WOS:000272453300004
J	Korenromp, EL; Viisainen, KM				Korenromp, Eline L.; Viisainen, Kirsi M.			ART in rural Uganda-efficient scale-up with home-based care?	LANCET			English	Editorial Material							MORTALITY; PROGRAM; SERVICE		[Korenromp, Eline L.; Viisainen, Kirsi M.] Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Korenromp, EL (corresponding author), Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland.	eline.korenromp@theglobalfund.org						Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; *GLOB FUND FIGHT A, 2009, VAL MON GLOB FUND SU; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Koenig SP, 2008, COST EFF RESOUR ALLO, V6, P3; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; *UK DEP INT DEV, 2009, ACH UN ACC UKS STRAT; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS WORLD BANK, 2009, GLOB EC CRIS HIV PRE; *US PEPFAR, 2009, ACT AUTH APPR FISC Y; Vitoria M, 2006, ANTIRETROVIRAL THERA; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2034	2035		10.1016/S0140-6736(09)62027-4	http://dx.doi.org/10.1016/S0140-6736(09)62027-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	19939444				2022-12-28	WOS:000273122900007
J	Banfield, JF; Young, M				Banfield, Jillian F.; Young, Mark			Variety-the Splice of Life-in Microbial Communities	SCIENCE			English	Editorial Material							ACQUIRED-RESISTANCE; PROKARYOTES; VIRUSES; DEFENSE; GENOMES; SYSTEM		[Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Young, Mark] Montana State Univ, Dept Plant Sci, Bozeman, MT 59715 USA; [Young, Mark] Montana State Univ, Dept Microbiol, Bozeman, MT 59715 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu; myoung@montana.edu						Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27	15	17	17	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1198	1199		10.1126/science.1181501	http://dx.doi.org/10.1126/science.1181501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965457				2022-12-28	WOS:000272117900028
J	Letvin, NL				Letvin, Norman L.			Moving Forward in HIV Vaccine Development	SCIENCE			English	Editorial Material									Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Letvin, NL (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02115 USA.	nletvin@bidmc.harvard.edu						Belshe R, 2004, SCIENCE, V305, P177; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MICHAEL N, COMMUNICATION; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff	8	21	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1196	1198		10.1126/science.1183278	http://dx.doi.org/10.1126/science.1183278			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	524BD	19965456				2022-12-28	WOS:000272117900027
J	Riddoch, CJ; Leary, SD; Ness, AR; Blair, SN; Deere, K; Mattocks, C; Griffiths, A; Smith, GD; Tilling, K				Riddoch, Chris J.; Leary, Sam D.; Ness, Andy R.; Blair, Steven N.; Deere, Kevin; Mattocks, Calum; Griffiths, Alex; Smith, George Davey; Tilling, Kate			Prospective associations between objective measures of physical activity and fat mass in 12-14 year old children: the Avon Longitudinal Study of Parents and Children (ALSPAC)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR RISK; METABOLIC SYNDROME; COMPUTER-SCIENCE; ACTIVITY MONITOR; OBESITY; CHILDHOOD; GROWTH	Objective To investigate associations between physical activity at age 12 and subsequent adiposity at age 14. Design Prospective birth cohort study with data collected between 2003 and 2007. Setting Original recruitment in 1991-2 of 14 541 pregnant women living in the former County of Avon (United Kingdom). Participants At age 12, 11 952 children were invited to attend the research clinic. Of these, 7159 attended, and 4150 (1964 boys, 2186 girls) provided sufficient data on exposure, outcome, and confounding variables. Main outcome measure Fat mass at age 14, measured by dual emission x ray absorptiometry, associated with physical activity at age 12, measured by accelerometry. Results Prospective associations of fat mass at age 14 (outcome) with physical activity at age 12 (exposure) were strong for both total activity (accelerometer counts/min) and for daily amount of moderate-vigorous physical activity (min/day). An extra 15 minutes of moderate-vigorous physical activity per day at age 12 was associated with lower fat mass at age 14 in boys (by 11.9% (95% confidence interval 9.5% to 14.3%)) and girls (by 9.8% (6.7% to 12.8%)). The proportion of physical activity due to moderate-vigorous physical activity was between 20% and 30% in boys and girls at the two ages. Conclusions Higher levels of physical activity, in particular activity of moderate to higher intensities, are prospectively associated with lower levels of fat mass in early adolescence. Interventions to raise levels of physical activity in children are likely to be important in the fight against obesity.	[Riddoch, Chris J.] Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England; [Leary, Sam D.; Ness, Andy R.; Griffiths, Alex] Univ Bristol, Dept Oral & Dent Sci, Bristol BS8 1TH, Avon, England; [Smith, George Davey] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 1TH, Avon, England; [Blair, Steven N.] Univ N Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC USA; [Blair, Steven N.] Univ N Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC USA	University of Bath; University of Bristol; University of Bristol; University of North Carolina; University of North Carolina	Riddoch, CJ (corresponding author), Univ Bath, Sch Hlth, Norwood House, Bath BA2 7AY, Avon, England.	C.J.Riddoch@bath.ac.uk	Tilling, Kate/AAY-1578-2021; Leary, Sam/B-4456-2016; Ness, Andy R/M-7612-2013; Davey Smith, George/A-7407-2013; Berryman, Katie/J-4236-2014	Ness, Andy R/0000-0003-3548-9523; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Mattocks, Calum/0000-0003-1262-5780; Tilling, Kate/0000-0002-1010-8926; Leary, Sam/0000-0002-1706-0689; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Medical Research Council; Wellcome Trust [GR068049MA]; UK Department of Health; Department of the Environment; Department of Education and the Environment; National Institutes of Health; US National Heart, Lung and Blood Institute [R01HL071248-01A1]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G9815508, G0600705] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071248] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UK Department of Health; Department of the Environment; Department of Education and the Environment; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	ALSPAC is supported by the Medical Research Council, Wellcome Trust, UK Department of Health, Department of the Environment, Department of Education and the Environment, National Institutes of Health, and a variety of medical research charities and commercial companies. This research was specifically funded by grants from the US National Heart, Lung and Blood Institute (R01HL071248-01A1) and the Wellcome Trust (GR068049MA).; All researchers are independent of the main funding body. The funding sources had no input to the study design, apart from changes required by external peer reviewers.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Department of Health, 2004, LEAST 5 WEEK PHYS AC; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Fairweather SC, 1999, PEDIATR EXERC SCI, V11, P413, DOI 10.1123/pes.11.4.413; *FOR PAN, 2007, TACKL OB FUT CHOIC P; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Jackson-Leach R, 2006, INT J PEDIATR OBES, V1, P26, DOI 10.1080/17477160600586614; JOTANGIA D, 2006, OBESITY CHILDREN 11; Levine JA, 2004, AM J PHYSIOL-ENDOC M, V286, pE675, DOI 10.1152/ajpendo.00562.2003; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Metcalf BS, 2008, ARCH DIS CHILD, V93, P772, DOI 10.1136/adc.2007.135012; Molnar D, 2000, EUR J PEDIATR, V159, pS45, DOI 10.1007/PL00014365; Moore LL, 2003, PREV MED, V37, P10, DOI 10.1016/S0091-7435(03)00048-3; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Ness AR, 2004, EUR J ENDOCRINOL, V151, pU141, DOI 10.1530/eje.0.151U141; Rasbash J., 2004, USERS GUIDE MLWIN VE; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; STAMATAKIS E, 2003, HLTH SURVEY ENGLAND, V1; Stevens J, 2004, OBES RES, V12, P1974, DOI 10.1038/oby.2004.248; TANNER JM, 1986, CLIN ENDOCRINOL META, V15, P411, DOI 10.1016/S0300-595X(86)80005-6; Tilling K, 2001, STAT MED, V20, P685, DOI 10.1002/sim.697.abs; Wareham N, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2007.00328.x; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049	32	134	135	0	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2009	339								b4544	10.1136/bmj.b4544	http://dx.doi.org/10.1136/bmj.b4544			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525AW	19942665	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000272186500002
J	Guenou, H; Nissan, X; Larcher, F; Feteira, J; Lemaitre, G; Saidani, M; Del Rio, M; Barrault, CC; Bernard, FX; Peschanski, M; Baldeschi, C; Waksman, G				Guenou, Hind; Nissan, Xavier; Larcher, Fernando; Feteira, Jessica; Lemaitre, Gilles; Saidani, Manoubia; Del Rio, Marcelo; Barrault, Christine C.; Bernard, Francois-Xavier; Peschanski, Marc; Baldeschi, Christine; Waksman, Gilles			Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study	LANCET			English	Article							GENE-EXPRESSION; RETINOIC ACID; SKIN; DIFFERENTIATION; KERATINOCYTES; LINES; REGENERATION; MECHANISMS; BANKING; BURNS	Background Cell therapy for large burns is dependent upon autologous epidermis reconstructed in vitro. However, the effectiveness of current procedures is limited by the delay needed to culture the patient's own keratinocytes. To assess whether the keratinocyte progeny of human embryonic stem cells (hESCs) could be used to form a temporary skin substitute for use in patients awaiting autologous grafts, we investigated the cells' capability of constructing a pluristratified epidermis. Methods hESCs from lines H9 and SA01 were seeded at least in triplicate on fibroblast feeder cells for 40 days in a medium supplemented with bone morphogenetic protein 4 and ascorbic acid. Molecular characterisation of cell differentiation was done throughout the process by quantitative PCR, fluorescence-activated cell sorting, and immunocytochemical techniques. Keratinocyte molecular differentiation and functional capacity to construct a human epidermis were assessed in vitro and in vivo. Findings From hESCs, we generated a homogeneous population of cells that showed phenotypic characteristics of basal keratinocytes. Expression levels of genes encoding keratin 14, keratin 5, integrin alpha 6, integrin beta 4, Collagen VII, and laminin 5 in these cells were similar to those in basal keratinocytes. After seeding on an artificial matrix, keratinocytes derived from hESCs (K-hESCs) formed a pluristratified epidermis. Keratin-14 immunostaining was seen in the basal compartment, with keratin 10 present in layers overlying the basal layer. Involucrin and filaggrin, late markers of epidermal differentiation, were detected in the uppermost layers only. 12 weeks after grafting onto five immunodeficient mice, epidermis derived from K-hESCs had a structure consistent with that of mature human skin. Human involucrin was appropriately located in spinous and granular layers and few Ki67-positive cells were detected in the basal layer. Interpretation hESCs can be differentiated into basal keratinocytes that are fully functional-ie, able to construct a pluristratified epidermis. This resource could be developed to provide temporary skin substitutes for patients awaiting autologous grafts.	[Guenou, Hind; Nissan, Xavier; Feteira, Jessica; Lemaitre, Gilles; Saidani, Manoubia; Peschanski, Marc; Baldeschi, Christine; Waksman, Gilles] INSERM, I STEM, Inst Stem Cell Therapy & Explorat Monogen Dis, AFM,UEVE U 861, F-91030 Evry, France; [Larcher, Fernando; Del Rio, Marcelo] CIEMAT CIBER ER, Epithelial Biomed Div, Madrid, Spain; [Barrault, Christine C.; Bernard, Francois-Xavier] BIOalternat SAS, Gencay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Baldeschi, C (corresponding author), INSERM, I STEM, Inst Stem Cell Therapy & Explorat Monogen Dis, AFM,UEVE U 861, 5 Rue Henri Desbrueres, F-91030 Evry, France.	cbaldeschi@istem.genethon.fr	Larcher, Fernando/J-1527-2016; Nissan, Xavier/C-2304-2018; Lemaître, Gilles/AAL-5889-2021; baldeschi, christine/U-9386-2018; Guenou, Hind/Q-3811-2018	Larcher, Fernando/0000-0002-6771-3561; Nissan, Xavier/0000-0003-3374-6274; baldeschi, christine/0000-0001-6624-0507; Del Rio Nechaevsky, Marcela/0000-0003-2910-7189; Guenou, Hind/0000-0003-3906-2519; Saidani, Manoubia/0000-0002-2805-4639; Lemaitre, Gilles/0000-0002-0898-1582	Institut National de la Sante et de la Recherche Medicale (INSERM); University Evry Val d'Essonne (UEVE); Association Francaise contre les Myopathies (AFM); Fondation Rene Touraine; Genopole	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Evry Val d'Essonne (UEVE); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Rene Touraine; Genopole	We thank G Meneguzzi and L Gagnoux for providing biological resources. M Martin for constant support, and C Hechard for managing partnerships of this project. This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), University Evry Val d'Essonne (UEVE), Association Francaise contre les Myopathies (AFM), Fondation Rene Touraine, and Genopole.	Aberdam D, 2008, CELL TISSUE RES, V331, P103, DOI 10.1007/s00441-007-0497-0; ALSBJORN B, 1984, SCAND J PLAST RECONS, V18, P127, DOI 10.3109/02844318409057414; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Bamberger C, 2002, J INVEST DERMATOL, V118, P133, DOI 10.1046/j.0022-202x.2001.01649.x; Blome-Eberwein S, 2002, Burns, V28 Suppl 1, pS10; Burd A, 2005, CLIN DERMATOL, V23, P376, DOI 10.1016/j.clindermatol.2004.07.019; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Catani MV, 2005, NUTR REV, V63, P81, DOI 10.1111/j.1753-4887.2005.tb00125.x; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069; FUCHS E, 1993, J CELL SCI, P197; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; *GER, GER REC FDA CLEAR BE; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3; Iuchi S, 2006, P NATL ACAD SCI USA, V103, P1792, DOI 10.1073/pnas.0510953103; Kearney JN, 2001, BURNS, V27, P545, DOI 10.1016/S0305-4179(01)00020-1; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Stottmann RW, 2006, DEV BIOL, V295, P647, DOI 10.1016/j.ydbio.2006.03.051; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Tomfscot A, 2007, STEM CELLS, V25, P2200, DOI 10.1634/stemcells.2007-0133; Turksen K, 1998, BIOCHEM CELL BIOL, V76, P889, DOI 10.1139/bcb-76-6-889	31	165	186	3	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1745	1753		10.1016/S0140-6736(09)61496-3	http://dx.doi.org/10.1016/S0140-6736(09)61496-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19932355				2022-12-28	WOS:000272207700023
J	Ofri, D				Ofri, Danielle			The Emotional Epidemiology of H1N1 Influenza Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, New York, NY 10016 USA; [Ofri, Danielle] Bellevue Hosp Ctr, New York, NY 10016 USA	New York University; Bellevue Hospital Center	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10016 USA.			Ofri, Danielle/0000-0001-9865-7104				Wald P., 2008, CONTAGIOUS CULTURES, DOI [10.1215/9780822390572, DOI 10.1215/9780822390572]	1	58	58	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2594	2595		10.1056/NEJMp0911047	http://dx.doi.org/10.1056/NEJMp0911047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	19940291	Bronze			2022-12-28	WOS:000273181300003
J	Cokkinos, P; Doulaptsis, C; Chrissos, D; Zarmakoupis, C; Voudris, V				Cokkinos, Philip; Doulaptsis, Constantinos; Chrissos, Dimitrios; Zarmakoupis, Constantinos; Voudris, Vassilis			Listen to my kidney!	LANCET			English	Editorial Material									[Cokkinos, Philip; Doulaptsis, Constantinos; Voudris, Vassilis] Onassis Cardiac Surg Ctr, Cardiol Dept 2, Athens 17674, Greece; [Zarmakoupis, Constantinos] Onassis Cardiac Surg Ctr, Dept Vasc Surg, Athens 17674, Greece; [Chrissos, Dimitrios] Tripoli Gen Hosp, Dept Cardiol, Tripoli, Greece	Onassis Cardiac Surgery Center; Onassis Cardiac Surgery Center	Cokkinos, P (corresponding author), Onassis Cardiac Surg Ctr, Cardiol Dept 2, 356 Syngrou Ave, Athens 17674, Greece.	philipcokkinos@yahoo.com						Arias Jose Gregorio Pereira, 2007, Archivos Espanoles de Urologia, V60, P589; Campbell JE, 2009, VASCULAR, V17, P40, DOI 10.2310/6670.2008.00071; Hilson AJW, 2002, ABDOM IMAGING, V28, P176, DOI 10.1007/s00261-001-0184-7; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Seitz Michael, 2008, J Med Case Rep, V2, P326, DOI 10.1186/1752-1947-2-326	5	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1944	1944		10.1016/S0140-6736(09)61524-5	http://dx.doi.org/10.1016/S0140-6736(09)61524-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19962568				2022-12-28	WOS:000272646900027
J	Narteau, C; Byrdina, S; Shebalin, P; Schorlemmer, D				Narteau, Clement; Byrdina, Svetlana; Shebalin, Peter; Schorlemmer, Danijel			Common dependence on stress for the two fundamental laws of statistical seismology	NATURE			English	Article							EARTHQUAKE CATALOGS; RUPTURE AREA; AFTERSHOCKS; SEISMICITY; CALIFORNIA; MAGNITUDE; MODELS; DECAY	Two of the long-standing relationships of statistical seismology are power laws: the Gutenberg-Richter relation(1) describing the earthquake frequency-magnitude distribution, and the Omori-Utsu law(2) characterizing the temporal decay of aftershock rate following a main shock. Recently, the effect of stress on the slope (the b value) of the earthquake frequency-magnitude distribution was determined(3) by investigations of the faulting-style dependence of the b value. In a similar manner, we study here aftershock sequences according to the faulting style of their main shocks. We show that the time delay before the onset of the power-law aftershock decay rate ( the c value) is on average shorter for thrust main shocks than for normal fault earthquakes, taking intermediate values for strike-slip events. These similar dependences on the faulting style indicate that both of the fundamental power laws are governed by the state of stress. Focal mechanisms are known for only 2 per cent of aftershocks. Therefore, c and b values are independent estimates and can be used as new tools to infer the stress field, which remains difficult to measure directly.	[Narteau, Clement; Byrdina, Svetlana; Shebalin, Peter] Univ P7, UMR 7154, CNRS, Inst Phys Globe, F-75252 Paris 05, France; [Byrdina, Svetlana] Univ Savoie, IRD, CNRS, Lab Geophys Interne & Tectonophys,UMR 5559, F-73376 Le Bourget Du Lac, France; [Shebalin, Peter] Int Inst Earthquake Predict Theory & Math Geophys, Moscow 117997, Russia; [Schorlemmer, Danijel] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Savoie; Russian Academy of Sciences; Institute of Earthquake Prediction Theory & Mathematical Geophysics; University of Southern California	Narteau, C (corresponding author), Univ P7, UMR 7154, CNRS, Inst Phys Globe, 4 Pl Jussieu, F-75252 Paris 05, France.	narteau@ipgp.jussieu.fr	Shebalin, Peter/G-6695-2011; Narteau, Clement/C-6912-2011	Shebalin, Peter/0000-0002-3361-3773; Narteau, Clement/0000-0002-9556-9544				Amitrano D, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000680; ATKINSON BK, 1984, J GEOPHYS RES, V89, P4077, DOI 10.1029/JB089iB06p04077; Ben-Zion Y, 2006, GEOPHYS J INT, V165, P197, DOI 10.1111/j.1365-246X.2006.02878.x; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Enescu B, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004629; GARDNER J, 1974, B SEISMOL SOC AM, V5, P1363; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Hauksson E, 2000, J GEOPHYS RES-SOL EA, V105, P13875, DOI 10.1029/2000JB900016; Kagan YY, 2004, B SEISMOL SOC AM, V94, P1207, DOI 10.1785/012003098; Kilb D, 2007, B SEISMOL SOC AM, V97, P780, DOI 10.1785/0120060116; Lolli B, 2006, TECTONOPHYSICS, V423, P43, DOI 10.1016/j.tecto.2006.03.025; Nanjo KZ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004754; Narteau C, 2008, NONLINEAR PROC GEOPH, V15, P245, DOI 10.5194/npg-15-245-2008; Narteau C, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001868; O'Connell DRH, 2007, B SEISMOL SOC AM, V97, P1970, DOI 10.1785/0120070042; Peng ZG, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004386; Peng ZG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026744; REASENBERG P, 1985, J GEOPHYS RES-SOLID, V90, P5479, DOI 10.1029/JB090iB07p05479; SCHOLZ CH, 1968, B SEISMOL SOC AM, V58, P1117; Schorlemmer D, 2008, B SEISMOL SOC AM, V98, P2103, DOI 10.1785/0120070105; Schorlemmer D, 2005, NATURE, V434, P1086, DOI 10.1038/4341086a; Schorlemmer D, 2005, NATURE, V437, P539, DOI 10.1038/nature04094; Shcherbakov R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019808; Shcherbakov R, 2004, PURE APPL GEOPHYS, V161, P2379, DOI 10.1007/s00024-004-2570-x; SIBSON RH, 1974, NATURE, V249, P542, DOI 10.1038/249542a0; Utsu T., 1971, J FACULTY SCI HOKKAI, V3, P379; VIDALE JE, 2004, EOS T AGU S, V85; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Wiemer S, 2000, B SEISMOL SOC AM, V90, P859, DOI 10.1785/0119990114	29	103	111	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	2009	462	7273					642	U113		10.1038/nature08553	http://dx.doi.org/10.1038/nature08553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956258				2022-12-28	WOS:000272277900039
J	Sweetland, S; Green, J; Liu, B; de Gonzalez, AB; Canonico, M; Reeves, G; Beral, V				Sweetland, Sian; Green, Jane; Liu, Bette; de Gonzalez, Amy Berrington; Canonico, Marianne; Reeves, Gillian; Beral, Valerie		Million Women Study Collaborators	Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; TOTAL HIP; KNEE REPLACEMENT; TIME-COURSE; PROPHYLAXIS; SURGERY; PREVENTION; CANCER; CARE	Objective To examine the duration and magnitude of increased risk of venous thromboembolism after different types of surgery. Design Prospective cohort study ( Million Women Study). Setting Questionnaire data from the Million Women Study linked with hospital admission and death records. Participants 947 454 middle aged women in the United Kingdom recruited in 1996-2001 and followed by record linkage to routinely collected NHS data on hospital admissions and deaths. During follow-up 239 614 admissions were for surgery; 5419 women were admitted, and a further 270 died, from venous thromboembolism. Main outcome measures Adjusted relative risks and standardised incidence rates for hospital admission or death from venous thromboembolism ( pulmonary embolism or deep vein thrombosis), by time since and type of surgery. Results Compared with not having surgery, women were 70 times more likely to be admitted with venous thromboembolism in the first six weeks after an inpatient operation ( relative risk 69.1, 95% confidence interval 63.1 to 75.6) and 10 times more likely after a day case operation (9.6, 8.0 to 11.5). The risks were lower but still substantially increased 7-12 weeks after surgery (19.6, 16.6 to 23.1 and 5.5, 4.3 to 7.0, respectively). This pattern of risk was similar for pulmonary embolism (n=2487) and deep venous thrombosis (n=3529). The postoperative risks of venous thromboembolism varied considerably by surgery type, with highest relative risks after inpatient surgery for hip or knee replacement and for cancer - 1-6 weeks after surgery the relative risks were, respectively, 220.6 (187.8 to 259.2) and 91.6 (73.9 to 113.4). Conclusion The risk of deep vein thrombosis and pulmonary embolism after surgery is substantially increased in the first 12 postoperative weeks, and varies considerably by type of surgery. An estimated 1 in 140 middle aged women undergoing inpatient surgery in the UK will be admitted with venous thromboembolism during the 12 weeks after surgery ( 1 in 45 after hip or knee replacement and 1 in 85 after surgery for cancer), compared with 1 in 815 after day case surgery and only 1 in 6200 women during a 12 week period without surgery.	[Sweetland, Sian; Green, Jane; de Gonzalez, Amy Berrington; Canonico, Marianne; Reeves, Gillian; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [de Gonzalez, Amy Berrington] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Canonico, Marianne] INSERM, Cardiovasc Epidemiol Unit, U780, Villejuif, France	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm)	Beral, V (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	pa.valerie.beral@ceu.ox.ac.uk	Beau Yon de Jonage - Canonico, Marianne/ABE-4279-2021; de gonzalez, amy berrington/L-7017-2017; Canonico, Marianne/F-9138-2013; Liu, Bette C/A-7581-2013	Beau Yon de Jonage - Canonico, Marianne/0000-0002-2843-8640; de gonzalez, amy berrington/0000-0002-7332-8387; Canonico, Marianne/0000-0002-2843-8640; Liu, Bette C/0000-0002-0787-5825; Balkwill, Angela/0000-0002-6327-6245	Cancer Research UK [C570/A5028]; Medical Research Council [G0700474]; MRC [G9900923, G0700474] Funding Source: UKRI; Medical Research Council [G9900923] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Cancer Research UK ( grant No C570/A5028) and the Medical Research Council ( grant No G0700474). Marianne Canonico was additionally supported by Leem Recherche. The funders did not participate in the study design and conduct, in the collection, management, analysis and interpretation of the data, nor was there any funder input into the preparation, review or approval of this manuscript.	Ahonen J, 2007, CURR OPIN ANESTHESIO, V20, P535, DOI 10.1097/ACO.0b013e3282f0ffc3; Bergqvist D, 2007, J SURG ONCOL, V95, P167, DOI 10.1002/jso.20625; Bjornara BT, 2006, J BONE JOINT SURG BR, V88B, P386, DOI 10.1302/0301-620X.88B3.17207; Campbell IA, 2003, THORAX, V58, P470; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit John A, 2005, Cancer Control, V12 Suppl 1, P5; Hoppener MR, 2003, J THROMB HAEMOST, V1, P863, DOI 10.1046/j.1538-7836.2003.t01-9-00115.x; House of Commons Health Committee, 2005, PREV VEN THROMB HOSP; Howie C, 2005, J BONE JOINT SURG BR, V87B, P1675, DOI 10.1302/0301-620X.87B12.16298; HUBER O, 1992, ARCH SURG-CHICAGO, V127, P310; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; *INF SERV DIV, 2007, ASS SMR01 ASS DAT 20; JOHNSON R, 1977, CLIN ORTHOP RELAT R, P123; Kearon C, 2003, CHEST, V124, p386S, DOI 10.1378/chest.124.6_suppl.386S; Kendall R.A., 1993, CONTEMP MUSIC REV, V9, P51, DOI DOI 10.1080/07494469300640341; Lee AYY, 2008, J THROMB THROMBOLYS, V25, P33, DOI 10.1007/s11239-007-0102-0; Liu B, 2007, J CLIN EPIDEMIOL, V60, P1190, DOI 10.1016/j.jclinepi.2007.02.007; McEleny P, 1998, SCOT MED J, V43, P23, DOI 10.1177/003693309804300108; *NHS INF CTR, 2008, HESONLINE HOSP EP ST; *NHS SCOTL RES ALL, 2005, PRIV HLTH SECT SERV; *NIH CLIN EXC, 2007, RED RISK VEN THROMB; Office of Population Censuses and Surveys, 1990, TAB LIST CLASS SURG; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; *SCOTT INT GUID NE, 2002, PROPH VEN THROMB NAT; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Townsend PP., 1988, HLTH DEPRIVATION INE; Walker A, 1999, Health Bull (Edinb), V57, P141; Warwick D, 2007, J BONE JOINT SURG BR, V89B, P799, DOI 10.1302/0301-620X.89B6.18844; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; Williams B, 2000, J PUBLIC HEALTH MED, V22, P68, DOI 10.1093/pubmed/22.1.68	32	251	256	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2009	339								b4583	10.1136/bmj.b4583	http://dx.doi.org/10.1136/bmj.b4583			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NT	19959589	hybrid, Green Published			2022-12-28	WOS:000272453400004
J	[Anonymous]				[Anonymous]			Microscopy: Breaking the light barrier	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					676	676		10.1038/462676a	http://dx.doi.org/10.1038/462676a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956266	Bronze			2022-12-28	WOS:000272277900050
J	Hollingsworth, MD				Hollingsworth, Mark D.			Calcite Biocomposites Up Close	SCIENCE			English	Editorial Material							ELECTRON TOMOGRAPHY; BIOLOGICAL-CONTROL; CRYSTALS; CRYSTALLIZATION; MICROSCOPY		Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA	Kansas State University	Hollingsworth, MD (corresponding author), Kansas State Univ, Dept Chem, 213 CBC Bldg, Manhattan, KS 66506 USA.	mdholl@ksu.edu			Division Of Chemistry [0809845] Funding Source: National Science Foundation	Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Addadi L, 2001, NATURE, V411, P753, DOI 10.1038/35081227; Aizenberg J, 1997, J AM CHEM SOC, V119, P881, DOI 10.1021/ja9628821; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; Henriksen K, 2004, AM MINERAL, V89, P1709, DOI 10.2138/am-2004-11-1217; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; Kahr B, 2001, CHEM REV, V101, P893, DOI 10.1021/cr980088n; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Li HY, 2009, ADV MATER, V21, P470, DOI 10.1002/adma.200801498; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; *NSF, CHE0809845 NSF; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Thomas JM, 2004, ANGEW CHEM INT EDIT, V43, P6745, DOI 10.1002/anie.200461453	16	7	7	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1194	1195		10.1126/science.1183122	http://dx.doi.org/10.1126/science.1183122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965454				2022-12-28	WOS:000272117900025
J	Kleiger, G; Saha, A; Lewis, S; Kuhlman, B; Deshaies, RJ				Kleiger, Gary; Saha, Anjanabha; Lewis, Steven; Kuhlman, Brian; Deshaies, Raymond J.			Rapid E2-E3 Assembly and Disassembly Enable Processive Ubiquitylation of Cullin-RING Ubiquitin Ligase Substrates	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CONJUGATING ENZYME; CDC34 UBC3; MULTIUBIQUITIN CHAIN; STRUCTURAL BASIS; PROTEIN; COMPLEX; DOMAIN; SCF; ASSOCIATION	Degradation by the ubiquitin-proteasome system requires assembly of a polyubiquitin chain upon substrate. However, the structural and mechanistic features that enable template-independent processive chain synthesis are unknown. We show that chain assembly by ubiquitin ligase SCF and ubiquitin-conjugating enzyme Cdc34 is facilitated by the unusual nature of Cdc34-SCF transactions: Cdc34 binds SCF with nanomolar affinity, nevertheless the complex is extremely dynamic. These properties are enabled by rapid association driven by electrostatic interactions between the acidic tail of Cdc34 and a basic 'canyon' in the Cul1 subunit of SCF. Ab initio docking between Cdc34 and Cul1 predicts intimate contact between the tail and the basic canyon, an arrangement confirmed by crosslinking and kinetic analysis of mutants. Basic canyon residues are conserved in both Cul1 paralogs and orthologs, suggesting that the same mechanism underlies processivity for all cullin-RING ubiquitin ligases. We discuss different strategies by which processive ubiquitin chain synthesis may be achieved.	[Kleiger, Gary; Saha, Anjanabha; Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kleiger, Gary; Saha, Anjanabha; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Lewis, Steven; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship [F32 GM074471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074471, R01GM065997] Funding Source: NIH RePORTER	National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Sonja Hess and members of the Caltech PEL for mass spectrometry analysis. We also thank Jost Vielmetter and members of the Caltech PEC for protein expression. We thank Shu-ou Shan for expert advice on the kinetic analysis of the data, and members of the Deshaies lab for comments on the manuscript. G. K. is a recipient of a National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship (F32 GM074471-01). R. J. D. is an Investigator of the Howard Hughes Medical Institute. R. J. D. is also a founder and shareholder of Proteolix.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Creighton T. E., 1993, PROTEINS STRUCTURES; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Harel M, 2009, BIOPHYS J, V96, P4237, DOI 10.1016/j.bpj.2009.02.054; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; Pohl C, 2008, Ernst Schering Found Symp Proc, P115; PTAK C, 1994, J BIOL CHEM, V269, P26539; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; SCHREIBER G, 2009, CHEM REV; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	51	146	148	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					957	968		10.1016/j.cell.2009.10.030	http://dx.doi.org/10.1016/j.cell.2009.10.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945379	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000272169400019
J	Sologub, M; Litonin, D; Anikin, M; Mustaev, A; Temiakov, D				Sologub, Marina; Litonin, Dmitry; Anikin, Michael; Mustaev, Arkady; Temiakov, Dmitry			TFB2 Is a Transient Component of the Catalytic Site of the Human Mitochondrial RNA Polymerase	CELL			English	Article							TRANSCRIPTION FACTOR; RIBOSOMAL-RNA; STRUCTURAL BASIS; METHYLTRANSFERASE ACTIVITY; PROMOTER CLEARANCE; ACTIVE-CENTER; INITIATION; SPECIFICITY; DNA; SUBUNIT	Transcription in human mitochondria is carried out by a single-subunit, T7-like RNA polymerase assisted by several auxiliary factors. We demonstrate that an essential initiation factor, TFB2, forms a network of interactions with DNA near the transcription start site and facilitates promoter melting but may not be essential for promoter recognition. Unexpectedly, catalytic autolabeling reveals that TFB2 interacts with the priming substrate, suggesting that TFB2 acts as a transient component of the catalytic site of the initiation complex. Mapping of TFB2 identifies a region of its N-terminal domain that is involved in simultaneous interactions with the priming substrate and the templating (+1) DNA base. Our data indicate that the transcriptional machinery in human mitochondria has evolved into a system that combines features inherited from self-sufficient, T7-like RNA polymerase and those typically found in systems comprising cellular multi-subunit polymerases, and provide insights into the molecular mechanisms of transcription regulation in mitochondria.	[Sologub, Marina; Litonin, Dmitry; Anikin, Michael; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA; [Mustaev, Arkady] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem, Newark, NJ 07103 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Temiakov, D (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, 2 Med Ct Dr, Stratford, NJ 08084 USA.	d.temiakov@umdnj.edu			UMDNJ Foundation; National Institutes of Health [GM30317, GM38147]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030717, R01GM038147, R01GM030317] Funding Source: NIH RePORTER	UMDNJ Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to Drs Vadim G Nikiforov, William T McAllister and Patrick Cramer for fruitful discussion and critical reading of the manuscript. This work was supported in part by UMDNJ Foundation Grant (to D. T.) and by National Institutes of Health Grants GM30317 (to A. M.) and GM38147 (to W. T. M).	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; GAINES G, 1987, J BIOL CHEM, V262, P1907; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; MAKSIMOVA T G, 1989, Bioorganicheskaya Khimiya, V15, P18; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; OSUMIDAVIS PA, 1992, J MOL BIOL, V226, P37, DOI 10.1016/0022-2836(92)90122-Z; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; RIVA M, 1990, J BIOL CHEM, V265, P16498; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Woody AYM, 1998, BIOCHEMISTRY-US, V37, P15958, DOI 10.1021/bi9805801	35	98	102	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					934	944		10.1016/j.cell.2009.10.031	http://dx.doi.org/10.1016/j.cell.2009.10.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945377	Bronze, Green Accepted			2022-12-28	WOS:000272169400017
J	Mandelblatt, JS; Cronin, KA; Bailey, S; Berry, DA; de Koning, HJ; Draisma, G; Huang, H; Lee, SJ; Munsell, M; Plevritis, SK; Ravdin, P; Schechter, CB; Sigal, B; Stoto, MA; Stout, NK; van Ravesteyn, NT; Venier, J; Zelen, M; Feuer, EJ				Mandelblatt, Jeanne S.; Cronin, Kathleen A.; Bailey, Stephanie; Berry, Donald A.; de Koning, Harry J.; Draisma, Gerrit; Huang, Hui; Lee, Sandra J.; Munsell, Mark; Plevritis, Sylvia K.; Ravdin, Peter; Schechter, Clyde B.; Sigal, Bronislava; Stoto, Michael A.; Stout, Natasha K.; van Ravesteyn, Nicolien T.; Venier, John; Zelen, Marvin; Feuer, Eric J.		Canc Intervention Surveillance Mod	Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE	Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.	[Mandelblatt, Jeanne S.] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; NIH, Bethesda, MD 20892 USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Erasmus Univ, Med Ctr, Rotterdam, Netherlands; Harvard Univ, Sch Publ Hlth, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Stanford Univ, Palo Alto, CA 94304 USA; Albert Einstein Coll Med, New York, NY USA	Georgetown University; National Institutes of Health (NIH) - USA; University of Texas System; UTMD Anderson Cancer Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard Pilgrim Health Care; Stanford University; Yeshiva University	Mandelblatt, JS (corresponding author), Lombardi Comprehens Canc Ctr, 3300 Whitehaven St,NW,Suite 4100, Washington, DC 20007 USA.	mandelbj@georgetown.edu	de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646; Bailey, Ph.D., Stephanie L./0000-0003-0451-2057	NCI [2U01CA088270, 2U01CA088283, 2U01CA088248, F32 CA125984, HHSN261200800769P, HHSN261200800002C]; NCI-funded BCSC [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; U.S. state public health departments and cancer registries; NATIONAL CANCER INSTITUTE [U01CA063736, U01CA063740, U01CA088270, U01CA088248, U01CA069976, U01CA088283, U01CA070040, U01CA086076, U01CA063731, U01CA086082, U01CA070013, F32CA125984] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-funded BCSC; U.S. state public health departments and cancer registries; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By NCI cooperative agreements (2U01CA088270, 2U01CA088283, 2U01CA088248, and F32 CA125984). Portions of this work were performed under contract HHSN261200800769P. Data collection in the BCSC was supported by NCI-funded BCSC cooperative agreements (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040) and several U.S. state public health departments and cancer registries. CISNET data management and Web site support were provided by Cornerstone Systems Northwest (NCI contract HHSN261200800002C).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; [Anonymous], PREV SERV COV PRIV H; Badgwell BD, 2008, J CLIN ONCOL, V26, P2482, DOI 10.1200/JCO.2007.12.8058; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry Donald A, 2006, J Natl Cancer Inst Monogr, P30, DOI 10.1093/jncimonographs/lgj006; Berry DA, 2009, J CLIN ONCOL, V27, P639, DOI 10.1200/JCO.2008.17.9341; Boer R, 1995, EUR J CANCER, V31A, P2040, DOI 10.1016/0959-8049(95)00457-2; Bonomi AE, 2008, QUAL LIFE RES, V17, P801, DOI 10.1007/s11136-008-9353-2; Breast Cancer Surveillance Consortium Website, PERF MEAS 3 884 059; Bryan BB, 2006, MODERN PATHOL, V19, P617, DOI 10.1038/modpathol.3800570; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Clarke Lauren D, 2006, J Natl Cancer Inst Monogr, P96, DOI 10.1093/jncimonographs/lgj013; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Cronin Kathleen A, 2006, J Natl Cancer Inst Monogr, P112, DOI 10.1093/jncimonographs/lgj015; de Koning HJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1369; El-Tamer MB, 2007, ANN SURG, V245, P665, DOI 10.1097/01.sla.0000245833.48399.9a; Elmore JG, 2005, JNCI-J NATL CANCER I, V97, P1035, DOI 10.1093/jnci/dji183; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Feuer EJ, 2004, STAT METHODS MED RES, V13, P421, DOI 10.1191/0962280204sm376ra; Fracheboud J, 2006, INT J CANCER, V118, P2020, DOI 10.1002/ijc.21560; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones JL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1397; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Lash TL, 2007, J CLIN ONCOL, V25, P3001, DOI 10.1200/JCO.2006.09.9572; Lee S, 2004, STAT METHODS MED RES, V13, P443, DOI 10.1191/0962280204sm377ra; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2009, J CLIN ONCOL, V27, P487, DOI 10.1200/JCO.2008.19.4928; Mandelblatt JS, 1997, J GEN INTERN MED, V12, P551, DOI 10.1046/j.1525-1497.1997.07107.x; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 2009, DIS BREAST; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; McCarthy EP, 2000, J AM GERIATR SOC, V48, P1226, DOI 10.1111/j.1532-5415.2000.tb02595.x; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; *NAT CANC I, 2002, NCI STAT MAMM SCREEN; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Norman SA, 2007, CANCER CAUSE CONTROL, V18, P909, DOI 10.1007/s10552-007-9006-8; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rosenberg Marjorie A, 2006, J Natl Cancer Inst Monogr, P15, DOI 10.1093/jncimonographs/lgj004; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Schonberg MA, 2009, J CLIN ONCOL, V27, P640, DOI 10.1200/JCO.2008.17.9374; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Smith-Bindman R, 2005, J MED SCREEN, V12, P50, DOI 10.1258/0969141053279130; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; VAINIO H, 2002, INT AGENCY RES CANC; Wai ES, 2005, BRIT J CANCER, V92, P961, DOI 10.1038/sj.bjc.6602393; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337	62	464	477	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					738	W247		10.7326/0003-4819-151-10-200911170-00010	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00010			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920274	Green Accepted			2022-12-28	WOS:000272145100007
J	Pasman, HRW; Rurup, ML; Willems, DL; Onwuteaka-Philipsen, BD				Pasman, H. R. W.; Rurup, M. L.; Willems, D. L.; Onwuteaka-Philipsen, B. D.			Concept of unbearable suffering in context of ungranted requests for euthanasia: qualitative interviews with patients and physicians	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NETHERLANDS	Objective To obtain in-depth information about the views of patients and physicians on suffering in patients who requested euthanasia in whom the request was not granted or granted but not performed. Design In-depth interviews with a topic list. Setting Patients' homes and physicians' offices. Participants 10 patients who explicitly requested euthanasia but whose request was not granted or performed and eight physicians of these patients; and eight physicians of patients who had requested euthanasia but had died before the request had been granted or performed or had died after the request was refused by the physician or after the patient had withdrawn his or her request. Results Not all patients who requested euthanasia thought their suffering was unbearable, although they had a lasting wish to die. Patients and physicians seemed to agree about this. In cases in which patients said they suffered unbearably there was less agreement about what constitutes unbearable suffering; patients put more emphasis on psychosocial suffering, such as dependence and deterioration, whereas physicians referred more often to physical suffering. In some cases the physician thought that the suffering was not unbearable because the patient's behaviour seemed incompatible with unbearable suffering-for instance, because the patient was still reading books. Conclusions Patients do not always think that their suffering is unbearable, even if they have a lasting wish to die. Physicians seem to have a narrower perspective on unbearable suffering than patients and than case law suggests. In an attempt to solve the problem of different perspectives, physicians should take into account the different aspects of suffering as described in the literature and a framework for assessing the suffering of patients who ask for euthanasia.	[Pasman, H. R. W.; Rurup, M. L.; Onwuteaka-Philipsen, B. D.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth,Expertise Ctr Palliat Ca, NL-1081 BT Amsterdam, Netherlands; [Willems, D. L.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pasman, HRW (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth,Expertise Ctr Palliat Ca, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	hrw.pasman@vumc.nl			Right to Die-NL (NVVE); Pieter van Foreest Foundation	Right to Die-NL (NVVE); Pieter van Foreest Foundation	This study was supported by a grant from Right to Die-NL (NVVE) and the Pieter van Foreest Foundation. The funders approved the study design and were not involved in the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the article for publication. The researchers were independent from the funders.	Baines B K, 2000, Am J Hosp Palliat Care, V17, P319, DOI 10.1177/104990910001700509; *BOARD ROYAL DUTCH, 2003, VIS EUTH; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Haverkate I, 2000, BRIT MED J, V321, P865, DOI 10.1136/bmj.321.7265.865; KIMSMA GK, 2000, MEDISCH CONTACT, V55, P1757; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Onwuteaka-Philipsen BD, 2007, EVALUATION LAW REV E; Strauss A., 1990, BASICS QUALITATIVE R; VANDAM H, 2005, DIFFERENT LOOK PRACT; Weide MCJV, 2005, ARCH INTERN MED, V165, P1698, DOI 10.1001/archinte.165.15.1698; 2007, REGIONAL EUTHANASIA	12	51	52	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2009	339								b4362	10.1136/bmj.b4362	http://dx.doi.org/10.1136/bmj.b4362			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523SU	19917578	Green Published, hybrid			2022-12-28	WOS:000272095600002
J	Zeches, RJ; Rossell, MD; Zhang, JX; Hatt, AJ; He, Q; Yang, CH; Kumar, A; Wang, CH; Melville, A; Adamo, C; Sheng, G; Chu, YH; Ihlefeld, JF; Erni, R; Ederer, C; Gopalan, V; Chen, LQ; Schlom, DG; Spaldin, NA; Martin, LW; Ramesh, R				Zeches, R. J.; Rossell, M. D.; Zhang, J. X.; Hatt, A. J.; He, Q.; Yang, C. -H.; Kumar, A.; Wang, C. H.; Melville, A.; Adamo, C.; Sheng, G.; Chu, Y. -H.; Ihlefeld, J. F.; Erni, R.; Ederer, C.; Gopalan, V.; Chen, L. Q.; Schlom, D. G.; Spaldin, N. A.; Martin, L. W.; Ramesh, R.			A Strain-Driven Morphotropic Phase Boundary in BiFeO3	SCIENCE			English	Article							1ST-PRINCIPLES CALCULATIONS; POLARIZATION; CRYSTAL; FILMS; MECHANISM; ORIGIN	Piezoelectric materials, which convert mechanical to electrical energy and vice versa, are typically characterized by the intimate coexistence of two phases across a morphotropic phase boundary. Electrically switching one to the other yields large electromechanical coupling coefficients. Driven by global environmental concerns, there is currently a strong push to discover practical lead-free piezoelectrics for device engineering. Using a combination of epitaxial growth techniques in conjunction with theoretical approaches, we show the formation of a morphotropic phase boundary through epitaxial constraint in lead-free piezoelectric bismuth ferrite (BiFeO3) films. Electric field-dependent studies show that a tetragonal-like phase can be reversibly converted into a rhombohedral-like phase, accompanied by measurable displacements of the surface, making this new lead-free system of interest for probe-based data storage and actuator applications.	[Zeches, R. J.; Zhang, J. X.; Ramesh, R.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Rossell, M. D.; Erni, R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Hatt, A. J.; Spaldin, N. A.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [He, Q.; Yang, C. -H.; Ramesh, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Kumar, A.; Melville, A.; Adamo, C.; Sheng, G.; Ihlefeld, J. F.; Gopalan, V.; Chen, L. Q.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Melville, A.; Adamo, C.; Ihlefeld, J. F.; Schlom, D. G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Wang, C. H.; Chu, Y. -H.] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30010, Taiwan; [Ederer, C.] Univ Dublin Trinity Coll, Sch Phys, Coll Green, Dublin 2, Ireland; [Martin, L. W.; Ramesh, R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Martin, L. W.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61822 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; National Yang Ming Chiao Tung University; Trinity College Dublin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign	Zeches, RJ (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	rzeches@berkeley.edu	Martin, Lane W./H-2409-2011; Sheng, Guang/C-2043-2012; Schlom, Darrell G/J-2412-2013; Erni, Rolf/P-7435-2014; YANG, CHAN-HO/C-2079-2011; Hatt, Alison/B-4652-2010; Ying-Hao, Chu/A-4204-2008; Chen, LongQing/I-7536-2012; Ihlefeld, Jon/W-7416-2019; Ramesh, Ramamoorthy/ABI-4883-2020; He, Qing/E-3202-2010; Ihlefeld, Jon F/B-3117-2009; Spaldin, Nicola A/A-1017-2010; Kumar, Amit/C-9662-2012; Ederer, Claude/F-5420-2010; Rossell, Marta D/E-9785-2017	Martin, Lane W./0000-0003-1889-2513; Schlom, Darrell G/0000-0003-2493-6113; Erni, Rolf/0000-0003-2391-5943; YANG, CHAN-HO/0000-0002-3384-4272; Hatt, Alison/0000-0003-3487-194X; Ying-Hao, Chu/0000-0002-3435-9084; Chen, LongQing/0000-0003-3359-3781; Ihlefeld, Jon/0000-0003-0166-8136; He, Qing/0000-0002-0563-6134; Spaldin, Nicola A/0000-0003-0709-9499; Kumar, Amit/0000-0002-1194-5531; Ederer, Claude/0000-0002-2280-8022; , Alexander Melville/0000-0003-1158-9036; Rossell, Marta D/0000-0001-8610-8853	Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the U. S. Department of Energy [DE-AC02-05CH11231]; National Center for Electron Microscopy, Lawrence Berkeley National Laboratory; National Science Council, R. O. C. [98-2119-M-009-016]; National Science Foundation [DMR-0820404, DMR-0507146, NIRT-0609377]; Science Foundation of Ireland [SFI-07/YI2/I1051]; Department of Energy Basic Sciences [DE- FG02-07ER46417]	Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the U. S. Department of Energy(United States Department of Energy (DOE)); National Center for Electron Microscopy, Lawrence Berkeley National Laboratory; National Science Council, R. O. C.(Ministry of Science and Technology, Taiwan); National Science Foundation(National Science Foundation (NSF)); Science Foundation of Ireland(Science Foundation Ireland); Department of Energy Basic Sciences(United States Department of Energy (DOE))	The work at Berkeley is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the U. S. Department of Energy under contract DE-AC02-05CH11231. The authors from Berkeley acknowledge the support of the National Center for Electron Microscopy, Lawrence Berkeley National Laboratory. Y. H. C. also acknowledges the support of the National Science Council, R. O. C., under contract NSC 98-2119-M-009-016. V. G. and D. G. S. acknowledge support from National Science Foundation grants DMR-0820404 and DMR-0507146. A. H. and N. S. acknowledge support from the National Science Foundation under DMR-0820404 and NIRT-0609377. Theoretical work used the SGI Altix [ Cobalt] system and the TeraGrid Linux Cluster [ Mercury] at the National Center for Supercomputing Applications under grant DMR-0940420. C. E. acknowledges support from the Science Foundation of Ireland ( grant SFI-07/YI2/I1051).The work of G. S. and L. Q. C. is supported by Department of Energy Basic Sciences under contract DE- FG02-07ER46417.	Ahart M, 2008, NATURE, V451, P545, DOI 10.1038/nature06459; Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P767, DOI 10.1088/0953-8984/9/4/002; Bea H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.217603; Bea H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.020101; Belik AA, 2006, CHEM MATER, V18, P798, DOI 10.1021/cm052334z; CHISHOLM MF, 2004, MICROSC MICROANAL S2, V10, P256; CHRISTY AG, 1995, ACTA CRYSTALLOGR B, V51, P753, DOI 10.1107/S0108768195001728; Chu YH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2750524; Csaba G, 2002, IEEE T NANOTECHNOL, V1, P209, DOI 10.1109/TNANO.2002.807380; Ederer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257601; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; Goldschmidt VM, 1929, T FARADAY SOC, V25, P0253, DOI 10.1039/tf9292500253; Groth P., 1870, ANN PHYS CHEM, V217, P31; Guo R, 2000, PHYS REV LETT, V84, P5423, DOI 10.1103/PhysRevLett.84.5423; Hong SB, 2004, NANOSCALE PHENOMENA IN FERROELECTRIC THIN FILMS, P111; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Newnham RE, 1997, MRS BULL, V22, P20, DOI 10.1557/S0883769400033170; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Ramesh R, 2007, NAT MATER, V6, P21, DOI 10.1038/nmat1805; Ravindran P, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.224412; Ricinschi D, 2006, J PHYS-CONDENS MAT, V18, pL97, DOI 10.1088/0953-8984/18/6/L03; Schlom DG, 2007, ANNU REV MATER RES, V37, P589, DOI 10.1146/annurev.matsci.37.061206.113016; Shpanchenko RV, 2004, CHEM MATER, V16, P3267, DOI 10.1021/cm049310x; Xu GY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1924891; Yun KY, 2004, J APPL PHYS, V96, P3399, DOI 10.1063/1.1775045; Zavaliche F, 2006, PHASE TRANSIT, V79, P991, DOI 10.1080/01411590601067144	27	956	980	24	897	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					977	980		10.1126/science.1177046	http://dx.doi.org/10.1126/science.1177046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965507	Green Published			2022-12-28	WOS:000271712300035
J	Salvador-Carulla, L; Saxena, S				Salvador-Carulla, Luis; Saxena, Shekhar			Intellectual disability: between disability and clinical nosology	LANCET			English	Editorial Material							MENTAL-RETARDATION; ADULTS; PREVALENCE; DISORDERS; SERVICES		[Salvador-Carulla, Luis] Univ Cadiz, Cadiz 11003, Spain; [Saxena, Shekhar] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	Universidad de Cadiz; World Health Organization	Salvador-Carulla, L (corresponding author), Univ Cadiz, Cadiz 11003, Spain.	luis.salvador@telefonica.net	Salvador-Carulla, Luis/K-6512-2013; PRISMA, Grupo/AAI-6753-2021	Salvador-Carulla, Luis/0000-0002-5742-9866; 				Bouras N, 2004, BRIT J PSYCHIAT, V184, P291, DOI 10.1192/bjp.184.4.291; Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P57, DOI DOI 10.1016/S1479-3547(03)03011-2; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; Fletcher RJ, 2009, J CLIN PSYCHIAT, V70, P967, DOI 10.4088/JCP.08m04429; Hemmings CP, 2009, J INTELL DISABIL RES, V53, P677, DOI 10.1111/j.1365-2788.2008.01146.x; Luckasson R, 2002, MENTAL RETARDATION D; Salvador-Carulla L, 2009, PSYCHIATRY, V8, P452; Salvador-Carulla L, 2008, PSYCHOPATHOLOGY, V41, P10, DOI 10.1159/000109950; Simonoff E, 2006, J CHILD PSYCHOL PSYC, V47, P828, DOI 10.1111/j.1469-7610.2006.01630.x; Smiley E, 2003, J INTELL DISABIL RES, V47, P62, DOI 10.1046/j.1365-2788.47.s1.26.x; Ustun B, 2009, WORLD PSYCHIATRY, V8, P82; Wehmeyer ML, 2008, INTELLECT DEV DISAB, V46, P311, DOI 10.1352/1934-9556(2008)46[311:TIDCAI]2.0.CO;2; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; *WHO, 2007, ATL GLOB RES PERS IN	14	23	23	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1798	1799		10.1016/S0140-6736(09)62034-1	http://dx.doi.org/10.1016/S0140-6736(09)62034-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944847				2022-12-28	WOS:000272370200006
J	van Wolfswinkel, ME; Banda, PK; Glover, SJ; van Oosterhout, JJ				van Wolfswinkel, Marlies E.; Banda, Peter K.; Glover, Simon J.; van Oosterhout, Joep J.			White blood: the tip of the iceberg?	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; PREVALENCE		[van Wolfswinkel, Marlies E.; Banda, Peter K.; van Oosterhout, Joep J.] Univ Malawi, Coll Med, Dept Med, Blantyre 3, Malawi; [Glover, Simon J.] Univ Malawi, Coll Med, Dept Anat, Blantyre 3, Malawi	University of Malawi; University of Malawi	van Oosterhout, JJ (corresponding author), Univ Malawi, Coll Med, Dept Med, Private Bag 360, Blantyre 3, Malawi.	joepvanoosterhout@gmail.com						*MIN HLTH MAL HIV, 2008Q4 ART MIN HLTH; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1866	1866		10.1016/S0140-6736(09)61423-9	http://dx.doi.org/10.1016/S0140-6736(09)61423-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527MC	19944868				2022-12-28	WOS:000272370200033
J	Antonova, P; Jacobs, DI; Bojar, M; Cerny, R; Ciharova, K; Frick, MA; Fintel, B; DeHovitz, J; Bennett, CL				Antonova, Petra; Jacobs, Daniel I.; Bojar, Martin; Cerny, Rudolf; Ciharova, Katerina; Frick, Melissa A.; Fintel, Bara; DeHovitz, Jack; Bennett, Charles L.			Czech health two decades on from the Velvet Revolution	LANCET			English	Editorial Material									[Bennett, Charles L.] Northwestern Univ, Feinberg Sch Med, Dept Hematol Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Antonova, Petra] Univ Hosp Motol, Ctr Cardiovasc, Prague, Czech Republic; [Jacobs, Daniel I.; Frick, Melissa A.; Fintel, Bara; Bennett, Charles L.] Northwestern Univ, Feinberg Sch Med, Buehler Ctr Aging Hlth & Soc, Chicago, IL 60611 USA; [Bojar, Martin; Cerny, Rudolf] Charles Univ Prague, Dept Neurol, Prague, Czech Republic; [DeHovitz, Jack] Suny Downstate Med Ctr, Sch Publ Hlth, Brooklyn, NY 11203 USA; [Ciharova, Katerina] Innovat Leadership Advisors, Prague, Czech Republic	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Motol University Hospital; Northwestern University; Feinberg School of Medicine; Charles University Prague; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Bennett, CL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Hematol Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	cbenne@northwestern.edu	Antonova, Petra Frank/AAW-7962-2021; Antonová, Petra/AAS-7714-2021; , Rudolf/GYR-1318-2022; Cerny, Rudolf B/C-7759-2014	Antonova, Petra Frank/0000-0003-3272-7928; Cerny, Rudolf B/0000-0002-6583-0836; Cerny, Rudolf/0000-0002-6498-4200; DeHovitz, Jack/0000-0001-7307-0614	FOGARTY INTERNATIONAL CENTER [D43TW000233] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000233-05, D43 TW000233] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		HFA-DB, 2009, EUROPEAN HLTH ALL DA; *I HLTH INF STAT C, 2008, HLTH CAR HLTH SERV C; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (OECD), 2009, OECD FACTB 2009; *WHO, WHO STAT INF SYST CZ; *WHO REG OFF EUR, 2009, HIGHL HLTH; 2009, PRAGUE DAILY MO 0617; 2009, CESKE NOVINY    0618; 2009, MED NEWS TODAY  0130	8	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					179	181		10.1016/S0140-6736(09)61293-9	http://dx.doi.org/10.1016/S0140-6736(09)61293-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	19913289	Green Accepted			2022-12-28	WOS:000273853800008
J	Bayes, JJ; Malik, HS				Bayes, Joshua J.; Malik, Harmit S.			Altered Heterochromatin Binding by a Hybrid Sterility Protein in Drosophila Sibling Species	SCIENCE			English	Article							SPECIATION GENE; ODYSSEUS LOCUS; MEIOTIC DRIVE; MELANOGASTER; SPERMATOGENESIS; SEGREGATION; DISTORTION; HOMEOBOX; COMPLEX; ORIGIN	Hybrid sterility of the heterogametic sex is one of the first postzygotic reproductive barriers to evolve during speciation, yet the molecular basis of hybrid sterility is poorly understood. We show that the hybrid male sterility gene Odysseus-site homeobox (OdsH) encodes a protein that localizes to evolutionarily dynamic loci within heterochromatin and leads to their decondensation. In Drosophila mauritiana x Drosophila simulans male hybrids, OdsH from D. mauritiana (OdsHmau) acts as a sterilizing factor by associating with the heterochromatic Y chromosome of D. simulans, whereas D. simulans OdsH (OdsHsim) does not. Characterization of sterile hybrid testes revealed that OdsH abundance and localization in the premeiotic phases of spermatogenesis differ between species. These results reveal that rapid heterochromatin evolution affects the onset of hybrid sterility.	[Bayes, Joshua J.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Bayes, Joshua J.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98185 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; 	NIH [PHS NRSA T32 GM07270, R01-GM74108]; Mathers foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM074108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C-I. Wu for the D. simulans fertile and sterile introgression lines; C. Ting for scientific discussions and sharing data; G. Findlay for initial observations on OdsH cytology; and K. Ahmad, S. Biggins, N. Elde, S. Henikoff, N. Phadnis, T. Tsukiyama, and D. Vermaak for comments on the manuscript. Supported by NIH training grant PHS NRSA T32 GM07270 (J. J. B.), and grants from the Mathers foundation and NIH R01-GM74108 (H. S. M.). H. S. M. is an Early-Career Scientist of the Howard Hughes Medical Institute.	Ashburner M., 2004, DROSOPHILA LAB HDB; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; CENCI G, 1994, J CELL SCI, V107, P3521; Coyne J.A., 2004, SPECIATION; Daniel A, 2002, AM J MED GENET, V111, P450, DOI 10.1002/ajmg.10618; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Henikoff S, 2002, NATURE, V417, P227, DOI 10.1038/417227a; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Kliman RM, 2000, GENETICS, V156, P1913; Laurie CC, 1997, GENETICS, V147, P937; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Mayr E, 1942, SYSTEMATICS ORIGIN S; McKee BD, 1998, CURR TOP DEV BIOL, V37, P77; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Nei M, 1998, SCIENCE, V282, P1428, DOI 10.1126/science.282.5393.1428; PEREZ DE, 1993, GENETICS, V134, P261; PEREZ DE, 1995, GENETICS, V140, P201; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; SAWAMURA K, 1993, GENETICS, V133, P307; Sun S, 2004, SCIENCE, V305, P81, DOI 10.1126/science.1093904; Tabuchi K, 1998, NEUROSCI LETT, V257, P49, DOI 10.1016/S0304-3940(98)00799-X; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Ting CT, 2004, P NATL ACAD SCI USA, V101, P12232, DOI 10.1073/pnas.0401975101; Tomkiel JE, 2000, GENETICA, V109, P95, DOI 10.1023/A:1026544402411	28	118	121	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1538	1541		10.1126/science.1181756	http://dx.doi.org/10.1126/science.1181756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19933102	Green Accepted			2022-12-28	WOS:000272623600058
J	Fuchs, GD; Dobrovitski, VV; Toyli, DM; Heremans, FJ; Awschalom, DD				Fuchs, G. D.; Dobrovitski, V. V.; Toyli, D. M.; Heremans, F. J.; Awschalom, D. D.			Gigahertz Dynamics of a Strongly Driven Single Quantum Spin	SCIENCE			English	Article							COHERENT DYNAMICS; 2-LEVEL SYSTEM; ELECTRON-SPIN; NUCLEAR-SPIN; DIAMOND; MANIPULATION; STATES; DOT	Two-level systems are at the core of numerous real-world technologies such as magnetic resonance imaging and atomic clocks. Coherent control of the state is achieved with an oscillating field that drives dynamics at a rate determined by its amplitude. As the strength of the field is increased, a different regime emerges where linear scaling of the manipulation rate breaks down and complex dynamics are expected. By calibrating the spin rotation with an adiabatic passage, we have measured the room-temperature "strong-driving" dynamics of a single nitrogen vacancy center in diamond. With an adiabatic passage to calibrate the spin rotation, we observed dynamics on sub-nanosecond time scales. Contrary to conventional thinking, this breakdown of the rotating wave approximation provides opportunities for time-optimal quantum control of a single spin.	[Fuchs, G. D.; Toyli, D. M.; Heremans, F. J.; Awschalom, D. D.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA; [Dobrovitski, V. V.] Ames Lab, Ames, IA 50011 USA; [Dobrovitski, V. V.] Iowa State Univ, Ames, IA 50011 USA	University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA.	awsch@physics.ucsb.edu	Heremans, F. Joseph/D-5555-2009		Air Force Office of Scientific Research; Army Research Office; Defense Advanced Research Projects Agency; U.S. Department of Energy Basic Energy Sciences [DE-AC02-07CH11358]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Department of Energy Basic Energy Sciences(United States Department of Energy (DOE))	We gratefully acknowledge support from the Air Force Office of Scientific Research, Army Research Office, and Defense Advanced Research Projects Agency. Work at the Ames Laboratory was supported by the U. S. Department of Energy Basic Energy Sciences under contract no. DE-AC02-07CH11358. We also thank R. Hanson and D. D'Alessandro for helpful discussions.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Ashhab S, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.063414; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Boscain U, 2006, J MATH PHYS, V47, DOI 10.1063/1.2203236; Boyd JK, 2000, J MATH PHYS, V41, P4330, DOI 10.1063/1.533345; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; D'Alessandro D, 2001, IEEE T AUTOMAT CONTR, V46, P866, DOI 10.1109/9.928587; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Gorman J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090502; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Khaneja N, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.032308; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Rogers LJ, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/10/103024; SPREEUW RJC, 1990, PHYS REV LETT, V65, P2642, DOI 10.1103/PhysRevLett.65.2642; Stegner AR, 2006, NAT PHYS, V2, P835, DOI 10.1038/nphys465; Xu XD, 2008, NAT PHYS, V4, P692, DOI 10.1038/nphys1054; [No title captured]	24	293	301	4	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1520	1522		10.1126/science.1181193	http://dx.doi.org/10.1126/science.1181193			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19965386				2022-12-28	WOS:000272623600053
J	Gal-Yam, A; Mazzali, P; Ofek, EO; Nugent, PE; Kulkarni, SR; Kasliwal, MM; Quimby, RM; Filippenko, AV; Cenko, SB; Chornock, R; Waldman, R; Kasen, D; Sullivan, M; Beshore, EC; Drake, AJ; Thomas, RC; Bloom, JS; Poznanski, D; Miller, AA; Foley, RJ; Silverman, JM; Arcavi, I; Ellis, RS; Deng, J				Gal-Yam, A.; Mazzali, P.; Ofek, E. O.; Nugent, P. E.; Kulkarni, S. R.; Kasliwal, M. M.; Quimby, R. M.; Filippenko, A. V.; Cenko, S. B.; Chornock, R.; Waldman, R.; Kasen, D.; Sullivan, M.; Beshore, E. C.; Drake, A. J.; Thomas, R. C.; Bloom, J. S.; Poznanski, D.; Miller, A. A.; Foley, R. J.; Silverman, J. M.; Arcavi, I.; Ellis, R. S.; Deng, J.			Supernova 2007bi as a pair-instability explosion	NATURE			English	Article							CORE-COLLAPSE SUPERNOVAE; SPECTRA; STARS	Stars with initialmasses such that 10M(circle dot) <= M(initial) <= 100M(circle dot), where M(circle dot) is the solar mass, fuse progressively heavier elements in their centres, until the core is inert iron. The core then gravitationally collapses to a neutron star or a black hole, leading to an explosion-an iron-core-collapse supernova(1,2). By contrast, extremely massive stars with M(initial) >= 140M(circle dot) (if such exist) develop oxygen cores with masses, M(core), that exceed 50M(circle dot), where high temperatures are reached at relatively low densities. Conversion of energetic, pressure-supporting photons into electron-positron pairs occurs before oxygen ignition and leads to a violent contraction which triggers a nuclear explosion(3-5) that unbinds the star in a pair-instability supernova. Transitional objects with 100M(circle dot) < M(initial) < 140M(circle dot) may end up as iron-core-collapse supernovae following violent mass ejections, perhaps as a result of brief episodes of pair instability, and may already have been identified(6-8). Here we report observations of supernova SN 2007bi, a luminous, slowly evolving object located within a dwarf galaxy. We estimate the exploding core mass to be M(core) approximate to 100M(circle dot), in which case theory unambiguously predicts a pair-instability supernova. We show that >3M(circle dot) of radioactive (56)Ni was synthesized during the explosion and that our observations are well fitted by models of pair-instability supernovae(9,10). This indicates that nearby dwarf galaxies probably host extremely massive stars, above the apparent Galactic stellar mass limit(11), which perhaps result from processes similar to those that created the first stars in the Universe.	[Gal-Yam, A.; Arcavi, I.] Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Mazzali, P.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Mazzali, P.] Scuola Normale Super Pisa, I-56127 Pisa, Italy; [Ofek, E. O.; Kulkarni, S. R.; Kasliwal, M. M.; Quimby, R. M.; Drake, A. J.; Ellis, R. S.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Nugent, P. E.; Thomas, R. C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Filippenko, A. V.; Cenko, S. B.; Chornock, R.; Bloom, J. S.; Poznanski, D.; Miller, A. A.; Silverman, J. M.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Waldman, R.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Kasen, D.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Sullivan, M.] Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England; [Beshore, E. C.] Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Foley, R. J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Deng, J.] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China	Weizmann Institute of Science; Max Planck Society; Scuola Normale Superiore di Pisa; California Institute of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Hebrew University of Jerusalem; University of California System; University of California Santa Cruz; University of Oxford; University of Arizona; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Gal-Yam, A (corresponding author), Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel.	avishay.gal-yam@weizmann.ac.il	Nugent, Peter Edward/AGG-8472-2022; Waldman, Roni/AAN-6027-2021; Kasen, Daniel/I-3443-2015	Mazzali, Paolo/0000-0001-6876-8284; Nugent, Peter/0000-0002-3389-0586; Kasen, Daniel/0000-0002-5981-1022; Sullivan, Mark/0000-0001-9053-4820; Gal-Yam, Avishay/0000-0002-3653-5598; Bloom, Joshua/0000-0002-7777-216X; Foley, Ryan/0000-0002-2445-5275; Poznanski, Dovi/0000-0003-1470-7173; Chornock, Ryan/0000-0002-7706-5668	US National Aeronautics and Space Administration ( NASA); Weizmann-Minerva grant; Israeli Science Foundation; European Union Seventh Framework Programme Marie Curie IRG fellowship; Benoziyo Center for Astrophysics; Peter and Patricia Gruber Awards; William Z. and Eda Bess Novick New Scientists Fund; US Department of Energy's Scientific Discovery; US National Science Foundation; US Department of Energy; TABASGO Foundation; Gary and Cynthia Bengier; Richard and Rhoda Goldman Fund; National Natural Science Foundation of China; Chinese 973 Program; W. M. Keck Foundation; NASA	US National Aeronautics and Space Administration ( NASA)(National Aeronautics & Space Administration (NASA)); Weizmann-Minerva grant; Israeli Science Foundation(Israel Science Foundation); European Union Seventh Framework Programme Marie Curie IRG fellowship(European Commission); Benoziyo Center for Astrophysics; Peter and Patricia Gruber Awards; William Z. and Eda Bess Novick New Scientists Fund; US Department of Energy's Scientific Discovery(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); TABASGO Foundation; Gary and Cynthia Bengier; Richard and Rhoda Goldman Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 973 Program(National Basic Research Program of China); W. M. Keck Foundation(W.M. Keck Foundation); NASA(National Aeronautics & Space Administration (NASA))	We gratefully acknowledge advice and help from E. Pian and discussions with Z. Barkat, E. Livne, E. Nakar, N. Langer and P. Podsiadlowski. This work benefited from useful interaction during the Fireworks meetings held at the Weizmann Institute ( 2008) and at the University of Bonn ( 2009). Work related to the CSS data reported here was supported by the US National Aeronautics and Space Administration ( NASA) under a grant issued through the Science Mission Directorate Near-Earth Object Observations program. The joint work of A. G.-Y. and P. M. is supported by a Weizmann-Minerva grant. A. G.-Y. acknowledges support from the Israeli Science Foundation, a European Union Seventh Framework Programme Marie Curie IRG fellowship, the Benoziyo Center for Astrophysics, a research grant from the Peter and Patricia Gruber Awards, and the William Z. and Eda Bess Novick New Scientists Fund at the Weizmann Institute. P. E. N. is supported by the US Department of Energy's Scientific Discovery through Advanced Computing programme. The A. V. F. group at the University of California, Berkeley is grateful for financial support from the US National Science Foundation, the US Department of Energy, the TABASGO Foundation, Gary and Cynthia Bengier, and the Richard and Rhoda Goldman Fund. J. D. is supported by the National Natural Science Foundation of China and by the Chinese 973 Program. This work is based in part on data from the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA; it was made possible by the generous financial support of the W. M. Keck Foundation. This work made use of the NASA/IPAC Extragalactic Database, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. R. C. T. is a Luis W. Alvarez Fellow at the Lawrence Berkeley National Laboratory. R. J. F is a Clay Fellow at the Harvard-Smithsonian Center for Astrophysics.	Agnoletto I, 2009, ASTROPHYS J, V691, P1348, DOI 10.1088/0004-637X/691/2/1348; BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; CENKO SB, 2009, COLLIMATION ENERGETI; Drake AJ, 2009, ASTROPHYS J, V696, P870, DOI 10.1088/0004-637X/696/1/870; Figer DF, 2005, NATURE, V434, P192, DOI 10.1038/nature03293; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Foley RJ, 2009, ASTRON J, V138, P376, DOI 10.1088/0004-6256/138/2/376; Gal-Yam A, 2009, NATURE, V458, P865, DOI 10.1038/nature07934; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; KASEN D, 2004, THESIS U CALIFORNIA; Kasen D, 2008, AIP CONF PROC, V990, P263; Langer N, 2007, ASTRON ASTROPHYS, V475, pL19, DOI 10.1051/0004-6361:20078482; LAW NM, 2009, PUBL ASTRON IN PRESS; Mazzali PA, 2001, ASTROPHYS J, V559, P1047, DOI 10.1086/322420; Miller AA, 2009, ASTROPHYS J, V690, P1303, DOI 10.1088/0004-637X/690/2/1303; MILLER AA, 2009, NEW OBSERVATIONS VER; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; PERETS HB, 2009, NEW TYPE STELLAR EXP; PUN CSJ, 1995, ASTROPHYS J SUPPL S, V99, P223, DOI 10.1086/192185; RAKAVY G, 1967, ASTROPHYS J, V148, P803, DOI 10.1086/149204; RAU A, PUBL ASTRON IN PRESS; Smartt SJ, 2009, ANNU REV ASTRON ASTR, V47, P63, DOI 10.1146/annurev-astro-082708-101737; SMITH N, 2009, SPECTRAL EVOLUTION E; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Umeda H, 2008, ASTROPHYS J, V673, P1014, DOI 10.1086/524767; Waldman R, 2008, ASTROPHYS J, V685, P1103, DOI 10.1086/591267; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333; Young DR, 2008, ASTRON ASTROPHYS, V489, P359, DOI 10.1051/0004-6361:20078662; YOUNG DR, ASTRON ASTROPH UNPUB	30	357	358	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	2009	462	7273					624	627		10.1038/nature08579	http://dx.doi.org/10.1038/nature08579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956255	Green Accepted			2022-12-28	WOS:000272277900035
J	Sax, PE; Tierney, C; Collier, AC; Fischl, MA; Mollan, K; Peeples, L; Godfrey, C; Jahed, NC; Myers, L; Katzenstein, D; Farajallah, A; Rooney, JF; Ha, B; Woodward, WC; Koletar, SL; Johnson, VA; Geiseler, PJ; Daar, ES				Sax, Paul E.; Tierney, Camlin; Collier, Ann C.; Fischl, Margaret A.; Mollan, Katie; Peeples, Lynne; Godfrey, Catherine; Jahed, Nasreen C.; Myers, Laurie; Katzenstein, David; Farajallah, Awny; Rooney, James F.; Ha, Belinda; Woodward, William C.; Koletar, Susan L.; Johnson, Victoria A.; Geiseler, P. Jan; Daar, Eric S.		AIDS Clinical Trials Grp Study	Abacavir-Lamivudine versus Tenofovir-Emtricitabine for Initial HIV-1 Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; INFECTED ADULTS; NAIVE PATIENTS; LOPINAVIR/RITONAVIR; ZIDOVUDINE; DF; EFAVIRENZ; EFFICACY; SAFETY	BACKGROUND The use of fixed-dose combination nucleoside reverse-transcriptase inhibitors (NRTIs) with a nonnucleoside reverse-transcriptase inhibitor or a ritonavir-boosted protease inhibitor is recommended as initial therapy in patients with human immunodeficiency virus type 1 (HIV-1) infection, but which NRTI combination has greater efficacy and safety is not known. METHODS In a randomized, blinded equivalence study involving 1858 eligible patients, we compared four once-daily anti-retroviral regimens as initial therapy for HIV-1 infection: abacavir-lamivudine or tenofovir disoproxil fumarate (DF)-emtricitabine plus efavirenz or ritonavir-boosted atazanavir. The primary efficacy end point was the time from randomization to virologic failure (defined as a confirmed HIV-1 RNA level >= 1000 copies per milliliter at or after 16 weeks and before 24 weeks, or = 200 copies per milliliter at or after 24 weeks). RESULTS A scheduled interim review by an independent data and safety monitoring board showed significant differences in virologic efficacy, according to the NRTI combination, among patients with screening HIV-1 RNA levels of 100,000 copies per milliliter or more. At a median follow-up of 60 weeks, among the 797 patients with screening HIV-1 RNA levels of 100,000 copies per milliliter or more, the time to virologic failure was significantly shorter in the abacavir-lamivudine group than in the tenofovir DF-emtricitabine group (hazard ratio, 2.33; 95% confidence interval, 1.46 to 3.72; P<0.001), with 57 virologic failures (14%) in the abacavir-lamivudine group versus 26 (7%) in the tenofovir DF-emtricitabine group. The time to the first adverse event was also shorter in the abacavir-lamivudine group (P<0.001). There was no significant difference between the study groups in the change from the baseline CD4 cell count at week 48. CONCLUSIONS In patients with screening HIV-1 RNA levels of 100,000 copies per milliliter or more, the times to virologic failure and the first adverse event were both significantly shorter in patients randomly assigned to abacavir-lamivudine than in those assigned to tenofovir DF-emtricitabine. (ClinicalTrials.gov number, NCT00118898.)	[Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sax, Paul E.] Harvard Univ, Sch Med, Boston, MA USA; [Tierney, Camlin; Mollan, Katie; Peeples, Lynne] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Collier, Ann C.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Fischl, Margaret A.] Univ Miami, Sch Med, Miami, FL USA; [Godfrey, Catherine] NIAID, Div Aids, Bethesda, MD 20892 USA; [Jahed, Nasreen C.] Social & Sci Syst, Silver Spring, MD USA; [Myers, Laurie] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; [Katzenstein, David] Stanford Univ, Palo Alto, CA 94304 USA; [Rooney, James F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Geiseler, P. Jan] Univ So Calif, Los Angeles, CA USA; [Daar, Eric S.] Univ Calif Los Angeles, Los Angeles, CA USA; [Daar, Eric S.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Farajallah, Awny] Bristol Myers Squibb Co, Plainsboro, NJ USA; [Ha, Belinda] GlaxoSmithKline, Res Triangle Pk, NC USA; [Woodward, William C.] Abbott Labs, Abbott Pk, IL 60064 USA; [Koletar, Susan L.] Ohio State Univ, Columbus, OH 43210 USA; [Johnson, Victoria A.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Johnson, Victoria A.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Social & Scientific Systems; Frontier Science Foundation; Stanford University; Gilead Sciences; University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Bristol-Myers Squibb; GlaxoSmithKline; Abbott Laboratories; University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Sax, PE (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	psax@partners.org	Johnson, Victoria/GVU-7127-2022	Pahwa, Savita/0000-0002-4470-4216; Yin, Michael T/0000-0002-9346-9056; Stapleton, Jack/0000-0002-2302-9055; Meier, Jeffery/0000-0001-9491-1697; katzenstein, david/0000-0002-8593-4560	GlaxoSmithKline; Pfizer; Merck Laboratories; Abbott Laboratories; Bristol-Myers Squibb; Gilead Sciences; Tibotec; Johnson Johnson; Koronis; Schering-Plough; Bionor Immuno AS; Cytheris; Siemens Medical Solutions Diagnostics and Roche Diagnostics; Boehringer Ingelheim; Panacos Pharmaceuticals; National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI38858, AI68636, AI68634]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635, M01RR000046, UL1RR024156, UL1RR024979, UL1RR024160, UL1RR025747, UL1RR025777, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068636, U01AI069477, U01AI069452, U01AI046370, U01AI032782, N01AI072626, U01AI069447, U01AI069474, U01AI069450, U01AI038855, UM1AI069465, UM1AI069423, U01AI025868, U01AI069501, U01AI027661, U01AI069432, U01AI069424, U01AI027664, U01AI068634, P30AI050409, UM1AI069419, U01AI069513, U01AI069467, U01AI069502, U01AI069511, U01AI027675, U01AI069465, U01AI069418, UM1AI069471, R01AI058740, U01AI069532, U01AI069471, UM1AI069472, UM1AI069474, UM1AI069501, U01AI069423, U01AI069470, U01AI038858, UM1AI068634, UM1AI069556, U01AI025924, U01AI034853, U01AI069494, UM1AI069439, UM1AI069495, UM1AI069477, U01AI069419, U01AI069428, P30AI054907, P30AI060354, U01AI069484, U01AI069439, U01AI025859, U01AI069415, U01AI069434, UM1AI069450, UM1AI069434, UM1AI069532, U01AI069556, UM1AI069424, U01AI027666, P30AI073961, UM1AI069432, U01AI046376, UM1AI069513, UM1AI068636, P30AI045008, U01AI069495, U01AI069472, P30AI050410] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Merck Laboratories(Merck & Company); Abbott Laboratories(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Tibotec; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Koronis; Schering-Plough(Merck & CompanySchering Plough Corporation); Bionor Immuno AS; Cytheris; Siemens Medical Solutions Diagnostics and Roche Diagnostics; Boehringer Ingelheim(Boehringer Ingelheim); Panacos Pharmaceuticals; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Sax reports receiving grant support from GlaxoSmithKline, Pfizer, and Merck Laboratories and consulting fees from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Laboratories, and Tibotec and serving as a member of the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents; Dr. Tierney, serving on a data and safety monitoring board for Tibotec; Dr. Collier, receiving grant support from Johnson & Johnson (Tibotec), Koronis, Merck Laboratories, Schering-Plough, and Gilead Sciences and consulting fees from GlaxoSmithKline, Pfizer, Merck Laboratories; Dr. Fischl, receiving grant support from Abbott Laboratories, Bionor Immuno AS, Bristol-Myers Squibb, Cytheris, GlaxoSmithKline, and Tibotec and grant support and lecture and consulting fees from Merck Laboratories; Dr. Katzenstein, receiving grant support from Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, and Gilead Sciences; Dr. Farajallah, being an employee of Bristol-Myers Squibb; Dr. Rooney, being an employee of Gilead Sciences; Dr. Ha, being an employee of GlaxoSmithKline; Dr. Woodward, being an employee of Abbott Laboratories; Dr. Johnson, receiving grant support from Siemens Medical Solutions Diagnostics and Roche Diagnostics; Dr. Geiseler, receiving lecture fees from Cubist Pharmaceuticals; Dr. Daar, receiving grant support from Abbott Laboratories, Merck Laboratories, GlaxoSmithKline, and Gilead Sciences and consulting fees from Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, Pfizer, Merck Laboratories, Tibotec, Boehringer Ingelheim, and Schering-Plough, and serving as a member of the data and safety monitoring board for Ardea Biosciences and of the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents; and Dr. Koletar, receiving grant support from Panacos Pharmaceuticals. No other potential conflict of interest relevant to this article was reported. Supported by grants (AI38858, to the AIDS Clinical Trials Group [ACTG] Central Group; AI68636, to the ACTG Network; and AI68634 and AI38855, to the ACTG Statistical and Data Analysis Center) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, with additional support from the General Clinical Research Center units funded by the National Center for Research Resources.	DeJesus E, 2004, CLIN INFECT DIS, V39, P1038, DOI 10.1086/424009; *DEP HLTH HUM SERV, 2008, PAN ANT GUID AD AD G, P1; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; HILL A, 2008, 17 INT AIDS C MEX CI; Johnson Victoria A, 2008, Top HIV Med, V16, P62; King MS, 2004, J INFECT DIS, V190, P280, DOI 10.1086/422037; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Rousseau FS, 2003, J INFECT DIS, V188, P1652, DOI 10.1086/379667; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; STASZEWSKI S, 2001, JAMA-J AM MED ASSOC, V285, P2858; Whitcomb JM, 2003, J INFECT DIS, V188, P992, DOI 10.1086/378281	16	237	239	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2230	2240		10.1056/NEJMoa0906768	http://dx.doi.org/10.1056/NEJMoa0906768			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19952143	Green Accepted			2022-12-28	WOS:000272257100006
J	Frihagen, F; Nordsletten, L; Bahr, R				Frihagen, Frede; Nordsletten, Lars; Bahr, Roald			Picture Quiz An 80 year old woman who fell in her home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIP-FRACTURES; HEMIARTHROPLASTY; OSTEOPOROSIS; DIAGNOSIS; SURGERY		[Frihagen, Frede; Nordsletten, Lars] Oslo Univ Hosp, Orthopaed Ctr, N-0407 Oslo, Norway; [Nordsletten, Lars] Univ Oslo, Fac Med, N-0318 Oslo, Norway; [Bahr, Roald] Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway	University of Oslo; University of Oslo; Norwegian School of Sport Sciences	Frihagen, F (corresponding author), Oslo Univ Hosp, Orthopaed Ctr, N-0407 Oslo, Norway.	j.f.frihagen@medisin.uio.no	Bahr, Roald/B-6964-2014	Frihagen, Frede/0000-0002-4811-669X; Bahr, Roald/0000-0001-5725-4237				Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; Figved W, 2009, CLIN ORTHOP RELAT R, V467, P2426, DOI 10.1007/s11999-008-0672-y; Frihagen F, 2005, ACTA ORTHOP, V76, P524, DOI 10.1080/17453670510041510; Frihagen F, 2007, BMJ-BRIT MED J, V335, P1251, DOI 10.1136/bmj.39399.456551.25; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001708.pub2; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub3; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; PARVIZI J, 1999, CLIN ORTHOP RELAT R, V369, P39; Rogmark C, 2009, INJURY, V40, P274, DOI 10.1016/j.injury.2008.05.023; Woolf AD, 2003, BMJ-BRIT MED J, V327, P89, DOI 10.1136/bmj.327.7406.89	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2009	339								b4839	10.1136/bmj.b4839	http://dx.doi.org/10.1136/bmj.b4839			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NS	19955129				2022-12-28	WOS:000272453300002
J	Haines, A; Wilkinson, P; Tonne, C; Roberts, I				Haines, Andy; Wilkinson, Paul; Tonne, Cathryn; Roberts, Ian			Aligning climate change and public health policies	LANCET			English	Editorial Material							ENERGY		[Haines, Andy] Univ London London Sch Hyg & Trop Med, Directors Off, London WC1E 7HT, England; [Wilkinson, Paul; Tonne, Cathryn] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Roberts, Ian] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Directors Off, Keppel St, London WC1E 7HT, England.	Andy.Haines@lshtm.ac.uk	Tonne, Cathryn/F-5020-2017	Tonne, Cathryn/0000-0003-3919-8264; Haines, Andy/0000-0002-8053-4605; Wilkinson, Paul/0000-0001-7456-259X				CAMPBELLLENDRUM D, 2003, MUCH DIS COULD CLIMA; Committee on Climate Change, 2008, BUILD LOW CARB EC UK; *DEP EN CLIM CHANG, 2009, ROAD COP GOV CAS AMB; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Global Commons Institute, CONTR CONV GLOB SOL; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; HMGovernment, 2009, UK LOW CARB TRANS PL; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; Intergovernmental Panel on Climate Change Climate, 2007, CLIM CHANG 2007 MIT; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Stern N. H., 2006, STERN REV EC CLIMATE; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; 2009, NATURE, V460, P12	21	38	38	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2035	2038		10.1016/S0140-6736(09)61667-6	http://dx.doi.org/10.1016/S0140-6736(09)61667-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	19942274				2022-12-28	WOS:000273122900008
J	Smith, KR; Jerrett, M; Anderson, HR; Burnett, RT; Stone, V; Derwent, R; Atkinson, RW; Cohen, A; Shonkoff, SB; Krewski, D; Pope, CA; Thun, MJ; Thurston, G				Smith, Kirk R.; Jerrett, Michael; Anderson, H. Ross; Burnett, Richard T.; Stone, Vicki; Derwent, Richard; Atkinson, Richard W.; Cohen, Aaron; Shonkoff, Seth B.; Krewski, Daniel; Pope, C. Arden, III; Thun, Michael J.; Thurston, George			Health and Climate Change 5 Public health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutants	LANCET			English	Article							ULTRAFINE CARBON-BLACK; DIESEL-EXHAUST INHALATION; OUTDOOR AIR-POLLUTION; SHORT-TERM INHALATION; PARTICULATE MATTER; OZONE EXPOSURE; TRANSITION-METALS; AMBIENT OZONE; MORTALITY; CHILDREN	In this report we review the health effects of three short-lived greenhouse pollutants-black carbon, ozone, and sulphates. We under-took new meta-analyses of existing time-series studies and an analysis of a cohort of 352000 people in 66 US cities during 18 years of follow-up. This cohort study provides estimates of mortality effects from long-term exposure to elemental carbon, an indicator of black carbon mass, and evidence that ozone exerts an independent risk of mortality. Associations among these pollutants make drawing conclusions about their individual health effects difficult at present, but sulphate seems to have the most robust effects in multiple-pollutant models. Generally, the toxicology of the pure compounds and their epidemiology diverge because atmospheric black carbon, ozone, and sulphate are associated and could interact with related toxic species. Although sulphate is a cooling agent, black carbon and ozone could together exert nearly half as much global warming as carbon dioxide. The complexity of these health and climate effects needs to be recognised in mitigation policies.	[Smith, Kirk R.; Jerrett, Michael; Shonkoff, Seth B.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Shonkoff, Seth B.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Anderson, H. Ross; Atkinson, Richard W.] Univ London, Div Community Hlth Sci, MRC HPA Ctr Environm & Hlth, London, England; [Anderson, H. Ross] Kings Coll London, Environm Res Grp, MRC HPA Ctr Environm & Hlth, London WC2R 2LS, England; [Burnett, Richard T.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Stone, Vicki] Edinburgh Napier Univ, Edinburgh, Midlothian, Scotland; [Derwent, Richard] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA; [Krewski, Daniel] Univ Ottawa, Ottawa, ON, Canada; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Thun, Michael J.] Amer Canc Soc, Atlanta, GA 30329 USA; [Thurston, George] NYU, Sch Med, New York, NY USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Imperial College London; University of London; Imperial College London; University of London; King's College London; Health Canada; Edinburgh Napier University; Imperial College London; Health Effects Institute (HEI); University of Ottawa; Brigham Young University; American Cancer Society; New York University	Smith, KR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 747 Univ Hall, Berkeley, CA 94720 USA.	krksmith@berkeley.edu	Anderson, Hugh R/A-7417-2016; Jerrett, Michael/CAA-2482-2022; Thurston, George/ABB-1359-2021; Pope, C. Arden/ABD-5522-2021	Derwent, Richard/0000-0003-4498-645X; Atkinson, Richard/0000-0001-8352-2207; Stone, Vicki/0000-0001-8346-7471	Wellcome Trust; UK Department of Health; National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; California Air Resources Board; US National Institute of Environmental Health Sciences Center [ES00260]; Health Effects Institute; Clean Air Task Force; Medical Research Council [G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); California Air Resources Board; US National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Health Effects Institute; Clean Air Task Force; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	External funding for this work was obtained solely from the government agencies and non-profit foundations listed below. The project that led to this Series was funded by the Wellcome Trust (coordinating funder); UK Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council: the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by all unrestricted educational grant from Pfizer. Additional support was obtained from the California Air Resources Board, the US National Institute of Environmental Health Sciences Center grant (number ES00260), Health Effects Institute's National Particle Component Toxicity Initiative, and the Clean Air Task Force. The. funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies or the Health Effects Institute or its sponsors. We thank Milena Simic-Lawson, St George's, University of London, for her work oil the time-series meta-analysis: Bernard Beckerman, University of California, Berkeley, for his help with the ACS spatial analysis; Yuanli Shi, University of Ottawa, who did tire statistical modelling for the case studies; Zev Ross, of ZevRoss Spatial Analysis, for assistance with preparation of the elemental carbon estimates; and Tami Bond, University of Illinois, for data from her emissions inventory database. Daniel Krewski holds the NSERC Chair in Risk Science.	Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; [Anonymous], 2007, HLTH REL PART MATT V; Bagate K, 2004, INHAL TOXICOL, V16, P431, DOI 10.1080/08958370490439588; BAILEY DLR, 1982, ATMOS ENVIRON, V16, P2683, DOI 10.1016/0004-6981(82)90350-X; Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bennett DH, 2002, ENVIRON SCI TECHNOL, V36, p206A, DOI 10.1021/es0222770; BOND TC, 2009, BLACK CARBON EMISSIO; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Campen MJ, 2002, J TOXICOL ENV HEAL A, V65, P1615, DOI 10.1080/00984100290071694; Chen TM, 2007, AM J MED SCI, V333, P244, DOI 10.1097/MAJ.0b013e31803b8e8c; CHOW JC, 1995, J AIR WASTE MANAGE, V45, P320, DOI 10.1080/10473289.1995.10467369; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; *COM EAP, 2009, LONG TERM EXP AIR PO; Delfino RJ, 2004, ENVIRON HEALTH PERSP, V112, P932, DOI 10.1289/ehp.6815; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Elliott P, 2007, THORAX, V62, P1088, DOI 10.1136/thx.2006.076851; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gilmour PS, 2004, TOXICOL APPL PHARM, V195, P35, DOI 10.1016/j.taap.2003.10.003; GODLESKI JJ, 2000, 91 HLTH EFF I; Gong H, 1998, AM J RESP CRIT CARE, V158, P538, DOI 10.1164/ajrccm.158.2.9709034; Hart JE, 2006, ENVIRON HEALTH PERSP, V114, P1013, DOI 10.1289/ehp.8743; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Highwood EJ, 2006, ENVIRON INT, V32, P560, DOI 10.1016/j.envint.2005.12.003; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jacobson MZ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031101; Jacobson MZ, 2007, ENVIRON SCI TECHNOL, V41, P4150, DOI 10.1021/es062085v; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2009, ENVIRON HEALTH PERSP, V117, P772, DOI 10.1289/ehp.11533; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Khoder MI, 2002, CHEMOSPHERE, V49, P675, DOI 10.1016/S0045-6535(02)00391-0; Kleeman MJ, 1997, J GEOPHYS RES-ATMOS, V102, P21355, DOI 10.1029/97JD01261; Kleeman MJ, 2000, ENVIRON SCI TECHNOL, V34, P1132, DOI 10.1021/es981276y; KREWSKI D, 2009, EXTENDED ANAL AM CAN; Krewski D, 2000, REANALYSIS HARVARD 2; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Li XH, 2009, ENVIRON SCI TECHNOL, V43, P6076, DOI 10.1021/es803330j; Li XY, 1999, INHAL TOXICOL, V11, P709; Lipsett M, 1999, AM J PUBLIC HEALTH, V89, P1009, DOI 10.2105/AJPH.89.7.1009; *MAAPE, 1992, SULPH DIOX AC AER PA; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Moffet RC, 2009, P NATL ACAD SCI USA, V106, P11872, DOI 10.1073/pnas.0900040106; Molina M, 2009, P NATL ACAD SCI USA, V106, P20616, DOI 10.1073/pnas.0902568106; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Muggenburg BA, 2003, INHAL TOXICOL, V15, P357, DOI 10.1080/08958370304456; National Academy of Sciences Committee on Estimating Mortality Risk Reduction Benefits from Decreasing Tropospheric Ozone Exposure (NAS), 2008, EST MORT RISK RED EC; Niwa Y, 2007, CIRC J, V71, P1157, DOI 10.1253/circj.71.1157; Oberdorster G, 2007, NANOTOXICOLOGY, V1, P2, DOI 10.1080/17435390701314761; Quincey P, 2007, ATMOS ENVIRON, V41, P7964, DOI 10.1016/j.atmosenv.2007.09.033; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rasch PJ, 2008, PHILOS T R SOC A, V366, P4007, DOI 10.1098/rsta.2008.0131; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Schaap M, 2007, ATMOS ENVIRON, V41, P5908, DOI 10.1016/j.atmosenv.2007.03.042; SCHINDLER DW, 1988, SCIENCE, V239, P149, DOI 10.1126/science.239.4836.149; Schlesinger RB, 2006, INHAL TOXICOL, V18, P95, DOI 10.1080/08958370500306016; Schlesinger RB, 2003, INHAL TOXICOL, V15, P197, DOI 10.1080/08958370304503; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Smit C.S., 2008, 9 INT NAV ENG C EXHI; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; SMITH KR, 2009, NEW SCI, P2714; SPEKTOR DM, 1988, AM REV RESPIR DIS, V137, P313, DOI 10.1164/ajrccm/137.2.313; Stone V, 1998, TOXICOL IN VITRO, V12, P649, DOI 10.1016/S0887-2333(98)00050-2; Straif K, 2000, AM J EPIDEMIOL, V152, P297, DOI 10.1093/aje/152.4.297; Tager IB, 2005, EPIDEMIOLOGY, V16, P751, DOI 10.1097/01.ede.0000183166.68809.b0; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; Tollefson J, 2009, NATURE, V460, P29, DOI 10.1038/460029a; Tuck AF, 2008, CLIMATIC CHANGE, V90, P315, DOI 10.1007/s10584-008-9411-3; UNGER N, 2008, J GEOPHYS RES, V113, P1; van Tongeren MJA, 2002, EUR RESPIR J, V20, P417, DOI 10.1183/09031936.02.00224502; World Health Organization, 2006, AIR QUAL GUID GLOB U; Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129; Yang QY, 2003, INHAL TOXICOL, V15, P1297, DOI 10.1080/08958370390241768; Zidek JV, 1996, ENVIRONMETRICS, V7, P441, DOI 10.1002/(SICI)1099-095X(199607)7:4<441::AID-ENV226>3.0.CO;2-V	81	294	296	7	135	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2091	2103		10.1016/S0140-6736(09)61716-5	http://dx.doi.org/10.1016/S0140-6736(09)61716-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19942276	Green Accepted			2022-12-28	WOS:000273122900033
J	Kuhner, S; van Noort, V; Betts, MJ; Leo-Macias, A; Batisse, C; Rode, M; Yamada, T; Maier, T; Bader, S; Beltran-Alvarez, P; Castano-Diez, D; Chen, WH; Devos, D; Guell, M; Norambuena, T; Racke, I; Rybin, V; Schmidt, A; Yus, E; Aebersold, R; Herrmann, R; Bottcher, B; Frangakis, AS; Russell, RB; Serrano, L; Bork, P; Gavin, AC				Kuehner, Sebastian; van Noort, Vera; Betts, Matthew J.; Leo-Macias, Alejandra; Batisse, Claire; Rode, Michaela; Yamada, Takuji; Maier, Tobias; Bader, Samuel; Beltran-Alvarez, Pedro; Castano-Diez, Daniel; Chen, Wei-Hua; Devos, Damien; Gueell, Marc; Norambuena, Tomas; Racke, Ines; Rybin, Vladimir; Schmidt, Alexander; Yus, Eva; Aebersold, Ruedi; Herrmann, Richard; Boettcher, Bettina; Frangakis, Achilleas S.; Russell, Robert B.; Serrano, Luis; Bork, Peer; Gavin, Anne-Claude			Proteome Organization in a Genome-Reduced Bacterium	SCIENCE			English	Article							TRANSFER-RNA SYNTHETASES; MYCOPLASMA-PNEUMONIAE; ESCHERICHIA-COLI; INTERACTION MAP; HELICOBACTER-PYLORI; COMPLEX-FORMATION; CELL-CYCLE; PROTEINS; SEQUENCE; DNA	The genome of Mycoplasma pneumoniae is among the smallest found in self-replicating organisms. To study the basic principles of bacterial proteome organization, we used tandem affinity purification-mass spectrometry (TAP-MS) in a proteome-wide screen. The analysis revealed 62 homomultimeric and 116 heteromultimeric soluble protein complexes, of which the majority are novel. About a third of the heteromultimeric complexes show higher levels of proteome organization, including assembly into larger, multiprotein complex entities, suggesting sequential steps in biological processes, and extensive sharing of components, implying protein multifunctionality. Incorporation of structural models for 484 proteins, single-particle electron microscopy, and cellular electron tomograms provided supporting structural details for this proteome organization. The data set provides a blueprint of the minimal cellular machinery required for life.	[Kuehner, Sebastian; van Noort, Vera; Betts, Matthew J.; Leo-Macias, Alejandra; Batisse, Claire; Rode, Michaela; Yamada, Takuji; Bader, Samuel; Beltran-Alvarez, Pedro; Castano-Diez, Daniel; Chen, Wei-Hua; Devos, Damien; Racke, Ines; Rybin, Vladimir; Boettcher, Bettina; Frangakis, Achilleas S.; Russell, Robert B.; Bork, Peer; Gavin, Anne-Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Maier, Tobias; Gueell, Marc; Yus, Eva; Serrano, Luis] Univ Pompeu Fabra, Ctr Regulac Genom, Barcelona 08003, Spain; [Norambuena, Tomas] Pontificia Univ Catolica Chile, Santiago, Chile; [Schmidt, Alexander; Aebersold, Ruedi] ETH, CH-8093 Zurich, Switzerland; [Herrmann, Richard] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Serrano, Luis] ICREA, Barcelona 08010, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pontificia Universidad Catolica de Chile; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg; ICREA	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; gavin@embl.de	Chen, Weihua/GRS-9256-2022; Schmidt, Alexander/D-6426-2011; Herrmann, Richard/K-2809-2016; Güell, Marc/AAB-3054-2021; Leo-Macias, Alejandra/B-3159-2017; devos, damien/ABH-5348-2020; Bottcher, Bettina/E-9397-2010; Russell, Rob/AAH-9145-2019; Güell, Marc/J-2970-2017; Bork, Peer/F-1813-2013; van Noort, Vera/GWZ-9038-2022; Serrano, Luis/B-3355-2013; van Noort, Vera/E-1053-2011; Beltran-Alvarez, Pedro/AAU-5826-2021; Russell, Robert/GWU-6389-2022	Schmidt, Alexander/0000-0002-3149-2381; Herrmann, Richard/0000-0003-2788-3715; Güell, Marc/0000-0003-4000-7912; Leo-Macias, Alejandra/0000-0002-7579-9764; Bottcher, Bettina/0000-0002-7962-4849; Russell, Rob/0000-0002-1905-4717; Güell, Marc/0000-0003-4000-7912; Bork, Peer/0000-0002-2627-833X; Serrano, Luis/0000-0002-5276-1392; van Noort, Vera/0000-0002-8436-6602; Russell, Robert/0000-0002-7213-1398; Chen, Wei-Hua/0000-0003-2168-6147; Beltran-Alvarez, Pedro/0000-0001-8136-8963; Frangakis, Achilleas/0000-0002-8067-6611; Devos, Damien/0000-0002-9453-4753; Castano-Diez, Daniel/0000-0002-0197-163X; Norambuena, Tomas/0000-0001-6477-0301; BATISSE, Claire/0000-0003-3064-6569; Betts, Matthew/0000-0003-4583-9814; Gavin, Anne-Claude/0000-0003-4917-2340	European Commission; SystemsX.ch, the Swiss initiative for systems biology; Netherlands Organization for Scientific Research (NWO); Foundation Marcelino Botin; Spanish Ministry of Education and Science (MEC)-Consolider; European Research Council; ICREA Funding Source: Custom	European Commission(European CommissionEuropean Commission Joint Research Centre); SystemsX.ch, the Swiss initiative for systems biology; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation Marcelino Botin; Spanish Ministry of Education and Science (MEC)-Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	We are grateful to M. Wilm, T. Franz, F. Thommen, E. Dalton, M. Schulz, E. Sawa, M. Diepholz, E. Pirkl, A. Seybert, C. Davis, J. Stulke, Gavin's and Bork's groups, and the EMBL Proteomic and Gene Core Facilities for expert help and discussion. This work is in part supported by the European Commission 6th and 7th Framework Integrated Projects "3D-Repertoire" and "Prospects," respectively; SystemsX.ch, the Swiss initiative for systems biology; the Netherlands Organization for Scientific Research (NWO); the Foundation Marcelino Botin; the Spanish Ministry of Education and Science (MEC)-Consolider; and the European Research Council. The data set has been submitted to the International Molecular Exchange Consortium (http://imex.sf.net) through IntAct (pmid is 17145710; identifier is IM-11644). The electron microscopy maps have been submitted to the Electron Microscopy Data Bank (www.ebi.ac.uk/pdbe-srv/emsearch/) (identification codes EMD-1637, EMD-1638, and EMD-1639).	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bork P, 2005, CELL, V121, P507, DOI 10.1016/j.cell.2005.05.001; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim DS, 2005, J CERAM PROCESS RES, V6, P63; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Praetorius-Ibba M, 2007, J BIOL CHEM, V282, P3680, DOI 10.1074/jbc.M609988200; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Resing KA, 2004, ANAL CHEM, V76, P3556, DOI 10.1021/ac035229m; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Seto S, 2001, J BACTERIOL, V183, P1621, DOI 10.1128/JB.183.5.1621-1630.2001; Seybert A, 2006, J STRUCT BIOL, V156, P342, DOI 10.1016/j.jsb.2006.04.010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terradot L, 2004, MOL CELL PROTEOMICS, V3, P809, DOI 10.1074/mcp.M400048-MCP200; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	48	356	360	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1235	1240		10.1126/science.1176343	http://dx.doi.org/10.1126/science.1176343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965468				2022-12-28	WOS:000272117900040
J	de Kieviet, JF; Piek, JP; Aarnoudse-Moens, CS; Oosterlaan, J				de Kieviet, Jorrit F.; Piek, Jan P.; Aarnoudse-Moens, Cornelieke S.; Oosterlaan, Jaap			Motor Development in Very Preterm and Very Low-Birth-Weight Children From Birth to Adolescence A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BRONCHOPULMONARY DYSPLASIA; COORDINATION DISORDER; EXTREMELY PREMATURE; RISK-FACTORS; FOLLOW-UP; INFANTS; OUTCOMES; BORN; GROWTH; NEURODEVELOPMENT	Context Infants who are very preterm (born <= 32 weeks of gestation) and very low birth weight (VLBW) (weighing <= 1500 g) are at risk for poor developmental outcomes. There is increasing evidence that very preterm birth and VLBW have a considerable effect on motor development, although findings are inconsistent. Objective To investigate the relationship between very preterm birth and VLBW and motor development. Data Sources The computerized databases EMBASE, PubMed, and Web of Knowledge were used to search for English-language peer-reviewed articles published between January 1992 and August 2009. Study Selection Studies were included if they reported motor scores of very preterm and VLBW children without congenital anomalies using 1 of 3 established and widely used motor tests: the Bayley Scales of Infant Development II (BSID-II), the Movement Assessment Battery for Children (MABC), and the Bruininks-Oseretsky Test of Motor Proficiency (BOTMP). Forty-one articles were identified, encompassing 9653 children. Results In comparison with term-born peers, very preterm and VLBW children obtained significantly lower scores on all 3 motor tests: BSID-II: d=-0.88 (95% confidence interval [CI],-0.96 to-0.80; P<.001), MABC: d=-0.65 (95% CI,-0.70 to -0.60; P<.001), and BOTMP: d=-0.57 (95% CI,-0.68 to-0.46; P<.001). Whereas motor outcomes on the BSID-II show a catch-up effect in the first years of development (r=0.50, P=.01), the results on the MABC demonstrate a nonsignificantly greater deficit with increasing age during elementary school and early adolescence (r=-0.59, P=.07). Conclusion Being born preterm or VLBW is associated with significant motor impairment persisting throughout childhood. JAMA. 2009; 302(20): 2235-2242	[de Kieviet, Jorrit F.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands; [Piek, Jan P.] Curtin Univ, Sch Psychol & Speech Pathol, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Aarnoudse-Moens, Cornelieke S.] Erasmus Univ, Sophia Childrens Hosp, Med Ctr, Dept Pediat, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Curtin University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	de Kieviet, JF (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	jf.de.kieviet@psy.vu.nl		Piek, Jan/0000-0003-3838-6773				Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Adams-Chapman I, 2008, PEDIATRICS, V121, pE1167, DOI 10.1542/peds.2007-0423; Bayley N, 1993, BAYLEY SCALES INFANT; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Borenstein M., 1999, COMPREHENSIVE META A; Bracewell M, 2002, MENT RETARD DEV D R, V8, P241, DOI 10.1002/mrdd.10049; BRUININKSOSERET.R, 1978, TEST MOTOR PROFICIEN; Chamnanvanakij S, 2000, PEDIATR NEUROL, V23, P129, DOI 10.1016/S0887-8994(00)00146-6; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Chuang YC, 2007, J CHILD NEUROL, V22, P402, DOI 10.1177/0883073807301924; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; Darlow BA, 2009, J PAEDIATR CHILD H, V45, P187, DOI 10.1111/j.1440-1754.2008.01457.x; Davis NM, 2007, DEV MED CHILD NEUROL, V49, P325, DOI 10.1111/j.1469-8749.2007.00325.x; Dewey D, 1999, J CLIN EXP NEUROPSYC, V21, P851, DOI 10.1076/jcen.21.6.851.859; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esbjorn BH, 2006, J DEV BEHAV PEDIATR, V27, P477, DOI 10.1097/00004703-200612000-00004; Fanaroff AA, 2006, SEMIN PERINATOL, V30, P151, DOI 10.1053/j.semperi.2006.04.006; Feder KP, 2005, DEV MED CHILD NEUROL, V47, P163, DOI 10.1017/S0012162205000307; Feldman R, 2002, PEDIATRICS, V110, P16, DOI 10.1542/peds.110.1.16; Furman L, 2004, J DEV BEHAV PEDIATR, V25, P247, DOI 10.1097/00004703-200408000-00004; Gaddlin PO, 2008, EARLY HUM DEV, V84, P343, DOI 10.1016/j.earlhumdev.2007.09.013; Gliner JA, 2003, J AM ACAD CHILD PSY, V42, P1376, DOI 10.1097/01.chi.0000085750.71002.01; Goyen TA, 2009, ARCH DIS CHILD, V94, P298, DOI 10.1136/adc.2007.134692; Grunau RE, 2006, DEV MED CHILD NEUROL, V48, P471, DOI 10.1017/S0012162206001010; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Harris SR, 2005, DEV MED CHILD NEUROL, V47, P820, DOI 10.1017/S0012162205001738; Henderson S., 1992, MOVEMENT ASSESSMENT; Holsti L, 2002, J DEV BEHAV PEDIATR, V23, P9, DOI 10.1097/00004703-200202000-00002; Horsch S, 2005, ACTA PAEDIATR, V94, P1815, DOI 10.1080/08035250500297745; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jakobson LS, 2006, NEUROPSYCHOLOGIA, V44, P1777, DOI 10.1016/j.neuropsychologia.2006.03.011; Janssen AJWM, 2008, DEV MED CHILD NEUROL, V50, P926, DOI 10.1111/j.1469-8749.2008.03108.x; Johnson S, 2005, ARCH DIS CHILD, V90, P909, DOI 10.1136/adc.2004.057620; Jongmans M, 1997, ARCH DIS CHILD-FETAL, V76, pF9, DOI 10.1136/fn.76.1.F9; Losch H, 2004, J CHILD NEUROL, V19, P318, DOI 10.1177/088307380401900502; Maguire CM, 2009, PEDIATRICS, V123, P1081, DOI 10.1542/peds.2008-1950; MARLOW N, 1989, ARCH DIS CHILD, V64, P839, DOI 10.1136/adc.64.6.839; O'Connor DL, 2001, PEDIATRICS, V108, P359, DOI 10.1542/peds.108.2.359; Patra K, 2006, J PEDIATR-US, V149, P169, DOI 10.1016/j.jpeds.2006.04.002; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Polam S, 2005, ARCH PEDIAT ADOL MED, V159, P1032, DOI 10.1001/archpedi.159.11.1032; POWLS A, 1995, ARCH DIS CHILD-FETAL, V73, pF62, DOI 10.1136/fn.73.2.F62; Rademaker KJ, 2004, SEMIN PERINATOL, V28, P279, DOI 10.1053/j.semperi.2004.08.005; Riethmuller AM, 2009, PEDIATRICS, V124, pE782, DOI 10.1542/peds.2009-0333; Rose J, 2009, DEV MED CHILD NEUROL, V51, P526, DOI 10.1111/j.1469-8749.2008.03231.x; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Sattler, 2018, ASSESSMENT CHILDREN; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Singer L, 1997, PEDIATRICS, V100, P987, DOI 10.1542/peds.100.6.987; Skranes J, 2008, EUR J PAEDIATR NEURO, V12, P273, DOI 10.1016/j.ejpn.2007.08.008; Stoelhorst GMSJ, 2003, EARLY HUM DEV, V72, P83, DOI 10.1016/S0378-3782(03)00011-2; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tessier R, 1997, INT J BEHAV DEV, V21, P795, DOI 10.1080/016502597384677; Treyvaud K, 2009, PEDIATRICS, V123, P555, DOI 10.1542/peds.2008-0477; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Watterberg KL, 2007, PEDIATRICS, V120, P40, DOI 10.1542/peds.2006-3158; Wells G., NEWCASTLE OTTAWA SCA; Whitfield MF, 1997, ARCH DIS CHILD-FETAL, V77, pF85, DOI 10.1136/fn.77.2.F85; Wielenga JM, 2009, ACTA PAEDIATR, V98, P291, DOI 10.1111/j.1651-2227.2008.01038.x; Wilson BN, 2000, ADAPT PHYS ACT Q, V17, P95, DOI 10.1123/apaq.17.1.95; Wocadlo C, 2008, EARLY HUM DEV, V84, P769, DOI 10.1016/j.earlhumdev.2008.06.001; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	67	317	325	3	101	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2235	2242		10.1001/jama.2009.1708	http://dx.doi.org/10.1001/jama.2009.1708			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523NI	19934425	Green Published			2022-12-28	WOS:000272080500028
J	Boyd, RW; Gauthier, DJ				Boyd, Robert W.; Gauthier, Daniel J.			Controlling the Velocity of Light Pulses	SCIENCE			English	Review							SBS SLOW LIGHT; WAVELENGTH CONVERSION; PROPAGATION; DELAY; AMPLIFICATION; SPEED	It is now possible to exercise a high degree of control over the velocity at which light pulses pass through material media. This velocity, known as the group velocity, can be made to be very different from the speed of light in a vacuum c. Specifically, the group velocity of light can be made much smaller than c, greater than c, or even negative. We present a survey of methods for establishing extreme values of the group velocity, concentrating especially on methods that work in room-temperature solids. We also describe some applications of slow light.	[Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Boyd, Robert W.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Gauthier, Daniel J.] Duke Univ, Dept Phys, Durham, NC 27708 USA	University of Rochester; University of Rochester; Duke University	Boyd, RW (corresponding author), Univ Rochester, Inst Opt, Rochester, NY 14627 USA.	boyd@optics.rochester.edu	Gauthier, Daniel J/G-1336-2011	Gauthier, Daniel J/0000-0002-4473-217X	Defense Advanced Research Projects Agency Defense Sciences Office; NSF	Defense Advanced Research Projects Agency Defense Sciences Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF))	We acknowledge valuable discussions with A. M. C. Dawes, A. L. Gaeta, G. M. Gehring, S. E. Harris, J. C. Howell, A. Liapis, J. R. Lowell, M. A. Neifeld, M. Scully, Z. Shi, M. D. Stenner, J. E. Vornehm Jr., A. E. Willner, and Z. Zhu and financial support through the Defense Advanced Research Projects Agency Defense Sciences Office slow-light program and through NSF.	BASOV NG, 1966, SOV PHYS JETP-USSR, V23, P16; Bigelow MS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.113903; Bigelow MS, 2003, SCIENCE, V301, P200, DOI 10.1126/science.1084429; Boyd R. W., 2008, NONLINEAR OPTICS, P11; Boyd RW, 2002, PROG OPTICS, V43, P497, DOI 10.1016/S0079-6638(02)80030-0; Brillouin L., 1960, WAVE PROPAGATION GRO; Cabrera-Granado E, 2008, OPT EXPRESS, V16, P16032, DOI 10.1364/OE.16.016032; Camacho RM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153601; CHIAO RY, 1997, PROGR OPTICS, V37, P347; CHU S, 1982, PHYS REV LETT, V48, P738, DOI 10.1103/PhysRevLett.48.738; Dogariu A, 2001, OPT EXPRESS, V8, P344, DOI 10.1364/OE.8.000344; FAXVOG FR, 1970, APPL PHYS LETT, V17, P192, DOI 10.1063/1.1653360; Fazal I, 2007, OPT EXPRESS, V15, P10492, DOI 10.1364/OE.15.010492; GARRETT CGB, 1970, PHYS REV A, V1, P305, DOI 10.1103/PhysRevA.1.305; Gehring GM, 2006, SCIENCE, V312, P895, DOI 10.1126/science.1124524; HARRIS SE, 1990, PHYS REV LETT, V64, P1107, DOI 10.1103/PhysRevLett.64.1107; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Inouye S, 2000, PHYS REV LETT, V85, P4225, DOI 10.1103/PhysRevLett.85.4225; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Khurgin J., 2008, SLOW LIGHT SCI APPL, V1st; Ku PC, 2004, OPT LETT, V29, P2291, DOI 10.1364/OL.29.002291; Kurosu T, 2009, OPT LETT, V34, P1441, DOI 10.1364/OL.34.001441; Macke B, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.013817; Miller DAB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.203903; Milonni P. W., 2005, SER OPT OPTOELECTRON; Ohman F, 2007, IEEE PHOTONIC TECH L, V19, P1145, DOI 10.1109/LPT.2007.901435; Okawachi Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.153902; Pesala B, 2009, OPT EXPRESS, V17, P2188, DOI 10.1364/OE.17.002188; SEGARD B, 1985, PHYS LETT A, V109, P213, DOI 10.1016/0375-9601(85)90305-6; Sharping JE, 2005, OPT EXPRESS, V13, P7872, DOI 10.1364/OPEX.13.007872; Shi ZM, 2007, OPT LETT, V32, P915, DOI 10.1364/OL.32.000915; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Song KY, 2005, OPT EXPRESS, V13, P9758, DOI 10.1364/OPEX.13.009758; STEINBERG AM, 1994, PHYS REV A, V49, P2071, DOI 10.1103/PhysRevA.49.2071; Stenner MD, 2003, NATURE, V425, P695, DOI 10.1038/nature02016; Su H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2171652; Thevenaz L, 2008, NAT PHOTONICS, V2, P474, DOI 10.1038/nphoton.2008.147; Wang LJ, 2000, NATURE, V406, P277, DOI 10.1038/35018520; Xue WQ, 2009, OPT LETT, V34, P929, DOI 10.1364/OL.34.000929; Zhu ZM, 2007, J LIGHTWAVE TECHNOL, V25, P201, DOI 10.1109/JLT.2006.887188	40	249	254	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1074	1077		10.1126/science.1170885	http://dx.doi.org/10.1126/science.1170885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965419	Green Submitted			2022-12-28	WOS:000271951000030
J	Borzak, S				Borzak, Steven			Early transfer for angiography after fibrinolysis reduced ischemic events in patients with STEMI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Miami, Miller Sch Med, Atlantis, FL USA		Borzak, S (corresponding author), Univ Miami, Miller Sch Med, Atlantis, FL USA.							Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Verheugt FWA, 2009, NEW ENGL J MED, V360, P2779, DOI 10.1056/NEJMe0902460	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-4	10.7326/0003-4819-151-10-200911170-02004	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920262				2022-12-28	WOS:000272145100015
J	Sobieraj-Teague, M; Eikelboom, J				Sobieraj-Teague, Magdalena; Eikelboom, John			Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sobieraj-Teague, Magdalena; Eikelboom, John] McMaster Univ, Hamilton, ON, Canada	McMaster University	Sobieraj-Teague, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285				Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-10	10.7326/0003-4819-151-10-200911170-02010	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920255				2022-12-28	WOS:000272145100021
J	Matlin, SA; Samuels, GMR				Matlin, Stephen A.; Samuels, Gill M. R.			The Global Health Research and Innovation System (GHRIS)	LANCET			English	Editorial Material									[Matlin, Stephen A.; Samuels, Gill M. R.] Global Forum Hlth Res, CH-1211 Geneva 2, Switzerland		Matlin, SA (corresponding author), Global Forum Hlth Res, CH-1211 Geneva 2, Switzerland.	stephen.matlin@globalforumhealth.org						[Anonymous], MONITORING FINANCIAL; *GLOB FOR HLTH RES, 2009, FOR 2009 INN HLTH AL; *GLOB FOR HLTH RES, 2009, GLOSS INN; *GLOB MIN FOR RES, 2008, STRENGTH RES HLTH DE; Mahoney Richard, 2006, INNOVATION STRATEGY, V2, P1; MATLIN SA, 2008, MONITORING FINANCIAL; Matlin SA, 2008, LANCET, V372, P1521, DOI 10.1016/S0140-6736(08)61630-X; Rottingen JA, 2009, LANCET, V373, P193, DOI 10.1016/S0140-6736(09)60054-4; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; WHO Global Report, 2005, PREV CHRON DIS VIT I	10	7	7	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 14	2009	374	9702					1662	1663		10.1016/S0140-6736(09)61912-7	http://dx.doi.org/10.1016/S0140-6736(09)61912-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	522LP	19914502				2022-12-28	WOS:000271999700008
J	Wallace, JE; Lemaire, JB; Ghali, WA				Wallace, Jean E.; Lemaire, Jane B.; Ghali, William A.			Physician wellness: a missing quality indicator	LANCET			English	Review							US MEDICAL-STUDENTS; JOB-SATISFACTION; GENERAL-PRACTITIONERS; WOMEN PHYSICIANS; PATIENT-CARE; PROFESSIONAL AUTONOMY; RESIDENCY PROGRAM; UNHAPPY DOCTORS; WORK HOURS; OF-CARE	When physicians are unwell, the performance of health-care systems can be suboptimum. Physician wellness might not only benefit the individual physician, it could also be vital to the delivery of high-quality health care. We review the work stresses faced by physicians, the barriers to attending to wellness, and the consequences of unwell physicians to the individual and to health-care systems. We show that health systems should routinely measure physician wellness, and discuss the challenges associated with implementation.	[Wallace, Jean E.] Univ Calgary, Dept Sociol, Fac Social Sci, Calgary, AB T2N 1N4, Canada; [Lemaire, Jane B.] Univ Calgary, Dept Med, Fac Med, Calgary, AB T2N 1N4, Canada; [Ghali, William A.] Univ Calgary, Dept Community Hlth Sci, Fac Med, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; University of Calgary	Wallace, JE (corresponding author), Univ Calgary, Dept Sociol, Fac Social Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	jwallace@ucalgary.ca			Killam Resident Fellowship at the University of Calgary; Canada Research Chair in Health Services Research; Alberta Heritage Foundation for Medical Research	Killam Resident Fellowship at the University of Calgary; Canada Research Chair in Health Services Research(Canada Research Chairs); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	JEW was supported by a Killam Resident Fellowship at the University of Calgary during writing of this report. WAG is supported by a Canada Research Chair in Health Services Research and by a Senior Health Scholar Award from the Alberta Heritage Foundation for Medical Research. We thank John Conly, Chair of the Department of Medicine, University of Calgary, for his vision and support of physician wellness research through the creation of JBL's departmental appointment of Vice-Chair in this domain, and JEW's adjunct position in the Department of Medicine. We also thank research librarian Diane Lorenzetti for her expert assistance, and Garielle Brown and Michael DeSouza for their help in preparation of the report.	[Anonymous], SENT EV AL BEH UND C; Arnetz BB, 2005, PSYCHONEUROENDOCRINO, V30, P1022, DOI 10.1016/j.psyneuen.2005.03.016; Arnetz BB, 1999, INT J QUAL HEALTH C, V11, P345, DOI 10.1093/intqhc/11.4.345; Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Baldisseri MR, 2007, CRIT CARE MED, V35, pS106, DOI 10.1097/01.CCM.0000252918.87746.96; Baldwin PJ, 1997, SOC SCI MED, V45, P41, DOI 10.1016/S0277-9536(96)00307-3; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Canadian Medical Association, 2003, GUID PHYS HLTH WELL; Center C, 2003, JAMA-J AM MED ASSOC, V289, P3161, DOI 10.1001/jama.289.23.3161; Cohen Jordan S, 2005, BMC Med Educ, V5, P21, DOI 10.1186/1472-6920-5-21; Committee on Redesigning Health Insurance Performance Measures Payment and Performance Improvement Programs, 2006, PATHW QUAL HLTH CAR; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Cornuz J, 2000, FAM PRACT, V17, P535, DOI 10.1093/fampra/17.6.535; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Duffy RD, 2006, J VOCAT BEHAV, V68, P548, DOI 10.1016/j.jvb.2005.12.001; Dunn PM, 2007, J GEN INTERN MED, V22, P1544, DOI 10.1007/s11606-007-0363-5; Dunstone DC, 2001, SOC SCI MED, V52, P825, DOI 10.1016/S0277-9536(00)00186-6; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Edwards N, 2002, BMJ-BRIT MED J, V324, P835, DOI 10.1136/bmj.324.7341.835; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Farber NJ, 2005, SOC SCI MED, V61, P1772, DOI 10.1016/j.socscimed.2005.03.029; Firth-Cozens J, 1998, BRIT J GEN PRACT, V48, P1647; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; Firth-Cozens J, 2006, UNDERSTANDING DOCTOR, P61; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Frank E, 1999, AM J PSYCHIAT, V156, P1887; Frank E, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2155; FRANKE CA, 2008, ANN FAM MED, V5, pS28; Gardiner M, 2004, FAM PRACT, V21, P545, DOI 10.1093/fampra/cmh511; Gardiner Maria, 2005, Aust J Rural Health, V13, P149, DOI 10.1111/j.1440-1854.2005.00677.x; Gerdes J, 2008, AM J SURG, V196, P813, DOI 10.1016/j.amjsurg.2008.07.030; Goehring C, 2005, SWISS MED WKLY, V135, P101; Goitein L, 2005, ARCH INTERN MED, V165, P2601, DOI 10.1001/archinte.165.22.2601; Graham J, 2001, STRESS HEALTH, V17, P85, DOI 10.1002/smi.884; Gross R, 2007, SOC SCI MED, V64, P1450, DOI 10.1016/j.socscimed.2006.11.012; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P29, DOI 10.1097/01.HMR.0000304493.87898.72; Hampton T, 2005, JAMA-J AM MED ASSOC, V294, P1189, DOI 10.1001/jama.294.10.1189; Hendin H., 2007, J MED LICENSURE DISC, V93, P6; HENRY J, 2004, ONTARIO MED REV, V71, P1; Hoff T, 2002, J HEALTH SOC BEHAV, V43, P72, DOI 10.2307/3090246; Hoff TJ, 2001, HEALTH CARE MANAGE R, V26, P53, DOI 10.1097/00004010-200110000-00006; HSU K, 1987, AM J PSYCHIAT, V144, P1561; JONES JW, 1988, J APPL PSYCHOL, V73, P727, DOI 10.1037/0021-9010.73.4.727; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, P442, DOI 10.1001/jama.289.4.442; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Le Blanc PM, 2007, J APPL PSYCHOL, V92, P213, DOI 10.1037/0021-9010.92.1.213; Levin S, 2007, ANN EMERG MED, V50, P419, DOI 10.1016/j.annemergmed.2007.04.007; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; McKevitt C, 1997, J PUBLIC HEALTH MED, V19, P295, DOI 10.1093/oxfordjournals.pubmed.a024633; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; McManus IC, 1999, LANCET, V354, P1358, DOI 10.1016/S0140-6736(99)02112-1; McMurray JE, 2000, J GEN INTERN MED, V15, P372, DOI 10.1111/j.1525-1497.2000.im9908009.x; McMurray JE, 1997, J GEN INTERN MED, V12, P711, DOI 10.1046/j.1525-1497.1997.07145.x; Nylenna M, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-44; O'Connor C, 2009, J HOSP MED, V4, P81, DOI 10.1002/jhm.399; Ozdas A, 2006, J AM MED INFORM ASSN, V13, P188, DOI 10.1197/jamia.M1656; Panagopoulou E, 2006, EUR J INTERN MED, V17, P195, DOI 10.1016/j.ejim.2005.11.013; Parthasarathy S, 2005, CURR OPIN PULM MED, V11, P507; PULLEN D, 1995, MED J AUSTRALIA, V162, P481, DOI 10.5694/j.1326-5377.1995.tb140011.x; Renzi C, 2005, J EUR ACAD DERMATOL, V19, P153, DOI 10.1111/j.1468-3083.2005.01029.x; Ro KEI, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2004; Roberts LW, 2005, COMPR PSYCHIAT, V46, P229, DOI 10.1016/j.comppsych.2004.08.008; Robinson GE, 2003, DEPRESS ANXIETY, V17, P180, DOI 10.1002/da.10069; Rowe MM, 1999, J BEHAV MED, V22, P511, DOI 10.1023/A:1018661508593; Sargent MC, 2004, J BONE JOINT SURG AM, V86A, P1579, DOI 10.2106/00004623-200407000-00032; Schroeder R, 2009, ACAD MED, V84, P776, DOI 10.1097/ACM.0b013e3181a43bb2; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; SHI L, 2006, MANAGING HUMAN RESOU; SUNDQUIST J, 2008, SCAND J PUBLIC HEALT, V28, P123; Taub S, 2006, OCCUP MED-OXFORD, V56, P77, DOI 10.1093/occmed/kqj025; The Joint Commission, 2009, COMPR ACCR MAN HOSP; Thompson WT, 2001, BRIT MED J, V323, P728, DOI 10.1136/bmj.323.7315.728; Tyssen R, 2009, SOC PSYCH PSYCH EPID, V44, P47, DOI 10.1007/s00127-008-0403-4; UALLACHAIN GN, 2008, IRISH MED J, V100, P489; Umehara K, 2007, J OCCUP HEALTH, V49, P467, DOI 10.1539/joh.49.467; van der Heijden F, 2008, ARCH SUICIDE RES, V12, P344, DOI 10.1080/13811110802325349; Virtanen P, 2008, OCCUP ENVIRON MED, V65, P364, DOI 10.1136/oem.2007.034793; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; Wallace JE, 2007, SOC SCI MED, V64, P2565, DOI 10.1016/j.socscimed.2007.03.016; Warren MG, 1998, J HEALTH SOC BEHAV, V39, P356, DOI 10.2307/2676344; Weiner EL, 2001, WESTERN J MED, V174, P19, DOI 10.1136/ewjm.174.1.19; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Wetterneck TB, 2002, ARCH INTERN MED, V162, P649, DOI 10.1001/archinte.162.6.649; Williams ES, 2007, HEALTH SERV MANAG RE, V20, P261, DOI 10.1258/095148407782219067; Williams ES, 2003, HEALTH CARE MANAGE R, V28, P119, DOI 10.1097/00004010-200304000-00004; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649; Winston James, 2008, BMC Res Notes, V1, P69, DOI 10.1186/1756-0500-1-69; Worley LLM, 2008, ACAD PSYCHIATR, V32, P8, DOI 10.1176/appi.ap.32.1.8	98	935	948	2	124	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2009	374	9702					1714	1721		10.1016/S0140-6736(09)61424-0	http://dx.doi.org/10.1016/S0140-6736(09)61424-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	522LP	19914516				2022-12-28	WOS:000271999700028
J	Gibson, JM				Gibson, J. Murray			Viewing the Seeds of Crystallization	SCIENCE			English	Editorial Material							MEDIUM-RANGE ORDER; FLUCTUATION MICROSCOPY		Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Gibson, JM (corresponding author), Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA.	jmgibson@aps.anl.gov	Gibson, Murray/E-5855-2013	Gibson, Murray/0000-0002-0807-6224; Gibson, John/0000-0003-2519-0528				[Anonymous], 2008, NEW SCI SEC SUST EN; Gibson JM, 1997, PHYS REV LETT, V78, P1074, DOI 10.1103/PhysRevLett.78.1074; Iwai T, 1999, PHYS REV B, V60, P191, DOI 10.1103/PhysRevB.60.191; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jesson DE, 2000, PHYS REV LETT, V84, P330, DOI 10.1103/PhysRevLett.84.330; Kaschiev D., 2000, NUCL BASIC THEORY AP; Kelton KF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.195504; Lee BS, 2009, SCIENCE, V326, P980, DOI 10.1126/science.1177483; OVSHINSKY SR, 1968, PHYS REV LETT, V21, P1450, DOI 10.1103/PhysRevLett.21.1450; PETERSON I, 1986, SCI NEWS, V130, P330; Raoux S, 2009, ANNU REV MATER RES, V39, P25, DOI [10.1146/annurev-matsci-082908-145405, 10.1146/annurev.matsci.082908-145405]; Treacy MMJ, 2005, REP PROG PHYS, V68, P2899, DOI 10.1088/0034-4885/68/12/R06; Treacy MMJ, 1996, ACTA CRYSTALLOGR A, V52, P212, DOI 10.1107/S0108767395012876; WOLCHNER P, 2009, P NATL ACAD SCI USA, V106, P11611	14	15	16	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					942	943		10.1126/science.1182817	http://dx.doi.org/10.1126/science.1182817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965499				2022-12-28	WOS:000271712300020
J	Fang, C; Frontiera, RR; Tran, R; Mathies, RA				Fang, Chong; Frontiera, Renee R.; Tran, Rosalie; Mathies, Richard A.			Mapping GFP structure evolution during proton transfer with femtosecond Raman spectroscopy	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; EXCITED-STATE DYNAMICS; STIMULATED RAMAN; MOLECULAR-DYNAMICS; AEQUOREA; ISOMERIZATION; PERTURBATION; VISION; LIGHT	Tracing the transient atomic motions that lie at the heart of chemical reactions requires high-resolution multidimensional structural information on the timescale of molecular vibrations, which commonly range from 10 fs to 1 ps. For simple chemical systems, it has been possible to map out in considerable detail the reactive potential-energy surfaces describing atomic motions and resultant reaction dynamics(1), but such studies remain challenging for complex chemical and biological transformations(2). A case in point is the green fluorescent protein (GFP)(3-5) from the jellyfish Aequorea victoria, which is a widely used gene expression marker owing to its efficient bioluminescence. This feature is known to arise from excited-state proton transfer (ESPT)(6-8), yet the atomistic details of the process are still not fully understood. Here we show that femtosecond stimulated Raman spectroscopy(9,10) provides sufficiently detailed and time-resolved vibrational spectra of the electronically excited chromophore of GFP to reveal skeletal motions involved in the proton transfer that produces the fluorescent form of the protein. In particular, we observe that the frequencies and intensities of two marker bands, the C-O and C=N stretching modes at opposite ends of the conjugated chromophore, oscillate out of phase with a period of 280 fs; we attribute these oscillations to impulsively excited low-frequency phenoxyl-ring motions, which optimize the geometry of the chromophore for ESPT. Our findings illustrate that femtosecond simulated Raman spectroscopy is a powerful approach to revealing the real-time nuclear dynamics that make up a multidimensional polyatomic reaction coordinate.	[Fang, Chong; Frontiera, Renee R.; Tran, Rosalie; Mathies, Richard A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mathies, RA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	ramathies@berkeley.edu	Frontiera, Renee/D-8131-2011; Fang, Chong/D-3681-2009	Fang, Chong/0000-0002-8879-1825; Frontiera, Renee/0000-0001-8218-7574	Mathies Royalty Fund	Mathies Royalty Fund	Plasmids were provided by R. Wachter. Wethank M. Marletta for the use of his laboratory facilities to express and purify GFP samples. We thank J. Dasgupta for discussions. This work was supported by the Mathies Royalty Fund.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Cerullo G, 2002, SCIENCE, V298, P2395, DOI 10.1126/science.1074685; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Coe JD, 2007, J PHYS CHEM A, V111, P11302, DOI 10.1021/jp072027b; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; *GAUSS INC, 2004, GAUSS 03; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KASHA M, 1986, J CHEM SOC FARAD T 2, V82, P2379, DOI 10.1039/f29868202379; Kennis JTM, 2004, P NATL ACAD SCI USA, V101, P17988, DOI 10.1073/pnas.0404262102; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Kukura P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238303; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Levine BG, 2007, ANNU REV PHYS CHEM, V58, P613, DOI 10.1146/annurev.physchem.57.032905.104612; Maddalo SL, 2006, PHOTOCHEM PHOTOBIOL, V82, P367, DOI 10.1562/2005-04-11-RA-485; Mandal D, 2004, J PHYS CHEM B, V108, P1102, DOI 10.1021/jp035816b; McCamant DW, 2005, J PHYS CHEM B, V109, P10449, DOI 10.1021/jp050095x; McCamant DW, 2004, REV SCI INSTRUM, V75, P4971, DOI 10.1063/1.1807566; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Shim S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356318; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Stoner-Ma D, 2006, J PHYS CHEM B, V110, P22009, DOI 10.1021/jp065326u; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; Weber W, 1999, P NATL ACAD SCI USA, V96, P6177, DOI 10.1073/pnas.96.11.6177; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; ZEWAIL AH, 1994, FEMTOCHEMISTRY ULTRA, P217; ZHU LY, 1994, SCIENCE, V266, P629, DOI 10.1126/science.7939716	29	354	361	3	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					200	U74		10.1038/nature08527	http://dx.doi.org/10.1038/nature08527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907490				2022-12-28	WOS:000271655100039
J	Harden, A; Brunton, G; Fletcher, A; Oakley, A				Harden, Angela; Brunton, Ginny; Fletcher, Adam; Oakley, Ann			Teenage pregnancy and social disadvantage: systematic review integrating controlled trials and qualitative studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIAL; SEX-EDUCATION; HEALTH-CARE; INTERVENTIONS; ENGLAND; PROGRAM; RISK	Objectives To determine the impact on teenage pregnancy of interventions that address the social disadvantage associated with early parenthood and to assess the appropriateness of such interventions for young people in the United Kingdom. Design Systematic review, including a statistical meta-analysis of controlled trials on interventions for early parenthood and a thematic synthesis of qualitative studies that investigated the views on early parenthood of young people living in the UK. Data sources 12 electronic bibliographic databases, five key journals, reference lists of relevant studies, study authors, and experts in the field. Review methods Two independent reviewers assessed the methodological quality of studies and abstracted data. Results Ten controlled trials and five qualitative studies were included. Controlled trials evaluated either early childhood interventions or youth development programmes. The overall pooled effect size showed that teenage pregnancy rates were 39% lower among individuals receiving an intervention than in those receiving standard practice or no intervention (relative risk 0.61; 95% confidence interval 0.48 to 0.77). Three main themes associated with early parenthood emerged from the qualitative studies: dislike of school; poor material circumstances and unhappy childhood; and low expectations for the future. Comparison of these factors related to teenage pregnancy with the content of the programmes used in the controlled trials indicated that both early childhood interventions and youth development programmes are appropriate strategies for reducing unintended teenage pregnancies. The programmes aim to promote engagement with school through learning support, ameliorate unhappy childhood through guidance and social support, and raise aspirations through career development and work experience. However, none of these approaches directly tackles all the societal, community, and family level factors that influence young people's routes to early parenthood. Conclusions A small but reliable evidence base supports the effectiveness and appropriateness of early childhood interventions and youth development programmes for reducing unintended teenage pregnancy. Combining the findings from both controlled trials and qualitative studies provides a strong evidence base for informing effective public policy.	[Harden, Angela] Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England; [Brunton, Ginny; Oakley, Ann] Univ London, Inst Educ, Social Sci Res Unit, London WC1H 0NR, England; [Fletcher, Adam] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7H, England	University of East London; University of London; University College London; UCL Institute of Education; University of London; London School of Hygiene & Tropical Medicine	Harden, A (corresponding author), Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England.	a.harden@uel.ac.uk			Department of Health	Department of Health	The review was funded by the Department of Health. AH was funded by a senior level research scientist in evidence synthesis award from the Department of Health. The researchers operated independently from the funders and the views expressed in this paper are those of the authors and not necessarily those of the Department of Health.	Acheson D., 1998, INDEPENDENT INQUIRY; Allen E, 2007, J EPIDEMIOL COMMUN H, V61, P20, DOI 10.1136/jech.2005.040865; Anand SS, 2006, INT J EPIDEMIOL, V35, P1239, DOI 10.1093/ije/dyl163; BERRINGTON A, 2005, CONSEQUENCES TEENAGE; Bonell C, 2006, BMJ-BRIT MED J, V333, P346, DOI 10.1136/bmj.333.7563.346; Bonell C, 2005, J EPIDEMIOL COMMUN H, V59, P223, DOI 10.1136/jech.2004.023374; BONELL C, 2004, CULTURE HLTH SEXUALI, V6, P1; Bonell CP, 2003, J EPIDEMIOL COMMUN H, V57, P871, DOI 10.1136/jech.57.11.871; Boulton M, 1996, J Eval Clin Pract, V2, P171, DOI 10.1111/j.1365-2753.1996.tb00041.x; Bryman A., 1994, ANAL QUALITATIVE DAT; CHEESBROUGH S, 2002, REV INT EVIDENCE PRE; Cobb A K, 1987, J Nurs Educ, V26, P138; *DEP ED SKILLS, TEEN PREGN ACC STRAT; DHALGREN G, 2007, EUROPEAN STRATEGIE 2; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; EGGER G, 2001, SYSTEMATIC REV HLTH; *EPPI CTR, 2002, GUID EXTR DAT QUAL A; Ermisch J., 2003, DOES TEEN BIRTH HAVE; Evans Tim, 2003, Inj Control Saf Promot, V10, P11, DOI 10.1076/icsp.10.1.11.14117; Fletcher A., 2008, Health Education, V108, P29, DOI 10.1108/09654280810842111; Graham H, 2006, J SOC POLICY, V35, P21, DOI 10.1017/S0047279405009360; GRAHAM H, 2006, EVIDENCE BASED APPRO; Harden A, 2004, J EPIDEMIOL COMMUN H, V58, P794, DOI 10.1136/jech.2003.014829; Harden A., 2005, INT J SOC RES METHOD, V8, P257, DOI DOI 10.1080/13645570500155078; Henderson M, 2007, BMJ-BRIT MED J, V334, P133, DOI 10.1136/bmj.39014.503692.55; Hoffman SD, 1998, FAM PLANN PERSPECT, V30, P236, DOI 10.2307/2991610; HOLGATE HS, 2006, TEENAGE PREGNANCY PA; KANE R, 2003, REDUCING RATE TEENAG; LIPSEY MW, 2001, METAANALYSIS; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MCDERMOTT E, 2005, J YOUTH STUD, V8, P59, DOI DOI 10.1080/13676260500063702; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; *MED SOC GROUP, 1996, MED SOCIOLOGY NEWS, V22, P69; Miles M., 2013, QUALITATIVE DATA ANA; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; *OFF NAT STAT, 2009, CONC STAT ENGL WAL 2; Orwin R.G., 1994, HDB RES SYNTHESIS; PEERSMAN G, 1997, REV GUIDELINES DATA; PEERSMAN G, 1996, REV EFFECTIVENESS SE; PEVALIN DJ, 2003, OUTCOMES CHILDHOOD A; Popay J, 1998, QUAL HEALTH RES, V8, P341, DOI 10.1177/104973239800800305; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; REES R, 2004, HLTH PROMOTION MEN W; *SOC EXCL UN, 1999, TEEN PREGN; Stephenson JM, 2004, LANCET, V364, P338, DOI 10.1016/S0140-6736(04)16722-6; Thomas J, 2004, BRIT MED J, V328, P1010, DOI 10.1136/bmj.328.7446.1010; Thomas J., 2003, CHILDREN HLTH EATING; THOMAS J, 2006, EPPI REV 3 0 ANAL MA; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; *UN INT CHILDR EM, 2001, 3 UNICEF INN RES CTR; UNICEF, 2007, CHILD POV PERSP OV C; Wellings K, 1999, J ROY SOC MED, V92, P277, DOI 10.1177/014107689909200603; Wiggins M., 2005, TEENAGE PARENTHOOD S; Wiggins M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2534; Zoritch B, 1998, SOC SCI MED, V47, P317, DOI 10.1016/S0277-9536(98)00037-9	55	145	152	1	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2009	339								b4254	10.1136/bmj.b4254	http://dx.doi.org/10.1136/bmj.b4254			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520HN	19910400	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000271834000003
J	Kawashima, SA; Yamagishi, Y; Honda, T; Ishiguro, K; Watanabe, Y				Kawashima, Shigehiro A.; Yamagishi, Yuya; Honda, Takashi; Ishiguro, Kei-ichiro; Watanabe, Yoshinori			Phosphorylation of H2A by Bub1 Prevents Chromosomal Instability Through Localizing Shugoshin	SCIENCE			English	Article							SISTER-CHROMATID COHESION; PROTEIN PHOSPHATASE 2A; FISSION YEAST BUB1; SPINDLE CHECKPOINT; MEIOSIS-I; CENTROMERIC PROTECTION; KINASE-ACTIVITY; KINETOCHORE; MITOSIS; LOCALIZATION	Bub1 is a multi-task protein kinase required for proper chromosome segregation in eukaryotes. Impairment of Bub1 in humans may lead to chromosomal instability (CIN) or tumorigenesis. Yet, the primary cellular substrate of Bub1 has remained elusive. Here, we show that Bub1 phosphorylates the conserved serine 121 of histone H2A in fission yeast Schizosaccharomyces pombe. The h2a-SA mutant, in which all cellular H2A-S121 is replaced by alanine, phenocopies the bub1 kinase-dead mutant (bub1-KD) in losing the centromeric localization of shugoshin proteins. Artificial tethering of shugoshin to centromeres largely restores the h2a-SA or bub1-KD-related CIN defects, a function that is evolutionally conserved. Thus, Bub1 kinase creates a mark for shugoshin localization and the correct partitioning of chromosomes.	[Kawashima, Shigehiro A.; Yamagishi, Yuya; Honda, Takashi; Ishiguro, Kei-ichiro; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Yamagishi, Yuya; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan; [Honda, Takashi; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Kawashima, Shigehiro/Q-6937-2017; Ishiguro, Kei-ichiro/K-3340-2019	Ishiguro, Kei-ichiro/0000-0002-7515-1511; Watanabe, Yoshinori/0000-0002-5488-4812	Japan Society for the Promotion of Science; Global Centers of Excellence Program; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript, F. Winston and the Yeast Genetic Resource Center for yeast strains, H. Masumoto for methods, and S. Ihara for injection instructions. We also thank all the members of our laboratory for their valuable support and discussion. This work was supported in part by the Japan Society for the Promotion of Science Research Fellowship (to. S. A. K. and Y.Y.) and Grant-in-Aid for Young Scientists (to K. I.), the Global Centers of Excellence Program, and a Grant-in-Aid for Specially Promoted Research (to Y.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Brittle AL, 2007, EXP CELL RES, V313, P2780, DOI 10.1016/j.yexcr.2007.04.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Fernius J, 2007, PLOS GENET, V3, P2312, DOI 10.1371/journal.pgen.0030213; Harvey AC, 2005, GENETICS, V170, P543, DOI 10.1534/genetics.104.038570; Hauf S, 2007, EMBO J, V26, P4475, DOI 10.1038/sj.emboj.7601880; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Williams GL, 2007, CELL CYCLE, V6, P1699, DOI 10.4161/cc.6.14.4493; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	40	337	347	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					172	177		10.1126/science.1180189	http://dx.doi.org/10.1126/science.1180189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965387				2022-12-28	WOS:000273394000026
J	Omland, T; de Lemos, JA; Sabatine, MS; Christophi, CA; Rice, MM; Jablonski, KA; Tjora, S; Domanski, MJ; Gersh, BJ; Rouleau, JL; Pfeffer, MA; Braunwald, E				Omland, Torbjorn; de Lemos, James A.; Sabatine, Marc S.; Christophi, Costas A.; Rice, Madeline Murguia; Jablonski, Kathleen A.; Tjora, Solve; Domanski, Michael J.; Gersh, Bernard J.; Rouleau, Jean L.; Pfeffer, Marc A.; Braunwald, Eugene		Prevention Events Angiotensin Conv	A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM MORTALITY; PROGNOSTIC VALUE; HEART; POPULATION; ELEVATION; TRIAL; RISK	BACKGROUND In most patients with stable coronary artery disease, plasma cardiac troponin T levels are below the limit of detection for the conventional assay. The distribution and determinants of very low circulating troponin T levels, as well as their association with cardiovascular events, in such patients are unknown. METHODS We used a new, high-sensitivity assay to determine the concentration of cardiac troponin T in plasma samples from 3679 patients with stable coronary artery disease and preserved left ventricular function. Results of the assay were analyzed in relation to the incidence of cardiovascular events during a median follow-up period of 5.2 years. RESULTS With the highly sensitive assay, concentrations of cardiac troponin T were at or above the limit of detection (0.001 mu g per liter) in 3593 patients (97.7%) and at or above the 99th percentile for apparently healthy subjects (0.0133 mu g per liter) in 407 patients (11.1%). After adjustment for other independent prognostic indicators, there was a strong and graded increase in the cumulative incidence of cardiovascular death (adjusted hazard ratio per unit increase in the natural logarithm of the troponin T level, 2.09; 95% confidence interval [CI], 1.60 to 2.74; P<0.001) and of heart failure (adjusted hazard ratio, 2.20; 95% CI, 1.66 to 2.90; P<0.001) in this study group. Increased risk associated with higher levels of troponin T was evident well below the limit of detection of conventional cardiac troponin T assays and below the 99th percentile of values in a healthy population. There was no association between troponin T levels as measured with the highly sensitive assay and the incidence of myocardial infarction (adjusted hazard ratio, 1.16; 95% CI, 0.97 to 1.40; P = 0.11). CONCLUSIONS After adjustment for other independent prognostic indicators, cardiac troponin T concentrations as measured with a highly sensitive assay were significantly associated with the incidence of cardiovascular death and heart failure but not with myocardial infarction in patients with stable coronary artery disease.	[Omland, Torbjorn] Akershus Univ Hosp, Div Med, NO-1478 Lorenskog, Norway; [Tjora, Solve] Akershus Univ Hosp, Ctr Lab Med, NO-1478 Lorenskog, Norway; [Omland, Torbjorn] Univ Oslo, Akershus Univ Hosp, Fac Div, Oslo, Norway; [Omland, Torbjorn] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Sabatine, Marc S.; Pfeffer, Marc A.; Braunwald, Eugene] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sabatine, Marc S.; Pfeffer, Marc A.; Braunwald, Eugene] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Christophi, Costas A.; Rice, Madeline Murguia; Jablonski, Kathleen A.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [Domanski, Michael J.] NHLBI, Bethesda, MD 20892 USA; [Gersh, Bernard J.] Mayo Clin, Div Cardiovasc Dis, Dept Med, Rochester, MN USA; [Rouleau, Jean L.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Rouleau, Jean L.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; George Washington University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; Universite de Montreal; Universite de Montreal	Omland, T (corresponding author), Akershus Univ Hosp, Div Med, NO-1478 Lorenskog, Norway.	torbjorn.omland@medisin.uio.no	Sabatine, Marc/AAJ-6751-2020; de Lemos, James/ABD-6669-2021	Sabatine, Marc/0000-0002-0691-3359; 	NHLBI NIH HHS [N01 HC065149-15] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065149] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Eggers KM, 2007, CIRCULATION, V116, P1907, DOI 10.1161/CIRCULATIONAHA.107.708529; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Gupta S, 2007, PROG CARDIOVASC DIS, V50, P151, DOI 10.1016/j.pcad.2007.01.002; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; James S, 2003, AM J MED, V115, P178, DOI 10.1016/S0002-9343(03)00348-6; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Roberts WL, 2001, CLIN CHEM, V47, P980; Roberts WL, 2001, CLIN CHEM, V47, P418; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Welsch R, 1980, REGRESSION DIAGNOSTI; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762	21	679	699	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2538	2547		10.1056/NEJMoa0805299	http://dx.doi.org/10.1056/NEJMoa0805299			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	19940289	Green Accepted, Bronze			2022-12-28	WOS:000273003700009
J	Yeung, N; Lin, YW; Gao, YG; Zhao, X; Russell, BS; Lei, LY; Miner, KD; Robinson, H; Lu, Y				Yeung, Natasha; Lin, Ying-Wu; Gao, Yi-Gui; Zhao, Xuan; Russell, Brandy S.; Lei, Lanyu; Miner, Kyle D.; Robinson, Howard; Lu, Yi			Rational design of a structural and functional nitric oxide reductase	NATURE			English	Article							DE-NOVO DESIGN; HEME-COPPER OXIDASE; 4-HELIX BUNDLE PROTEIN; CU-B CENTER; MYOGLOBIN; SITE; CONSTRUCTION; MODELS; O-2	Protein design provides a rigorous test of our knowledge about proteins and allows the creation of novel enzymes for biotechnological applications. Whereas progress has been made in designing proteins that mimic native proteins structurally(1-3), it is more difficult to design functional proteins(4-8). In comparison to recent successes in designing non-metalloproteins(4,6,7,9,10), it is even more challenging to rationally design metalloproteins that reproduce both the structure and function of native metalloenzymes(5,8,11-20). This is because protein metal-binding sites are much more varied than non-metal-containing sites, in terms of different metal ion oxidation states, preferred geometry and metal ion ligand donor sets. Because of their variability, it has been difficult to predict metal-binding site properties in silico, as many of the parameters, such as force fields, are ill-defined. Therefore, the successful design of a structural and functional metalloprotein would greatly advance the field of protein design and our understanding of enzymes. Here we report a successful, rational design of a structural and functional model of a metalloprotein, nitric oxide reductase (NOR), by introducing three histidines and one glutamate, predicted as ligands in the active site of NOR, into the distal pocket of myoglobin. A crystal structure of the designed protein confirms that the minimized computer model contains a haem/non-haem Fe-B centre that is remarkably similar to that in the crystal structure. This designed protein also exhibits NO reduction activity, and so models both the structure and function of NOR, offering insight that the active site glutamate is required for both iron binding and activity. These results show that structural and functional metalloproteins can be rationally designed in silico.	[Yeung, Natasha; Lin, Ying-Wu; Zhao, Xuan; Russell, Brandy S.; Lei, Lanyu; Lu, Yi] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gao, Yi-Gui] Univ Illinois, George L Clark Xray Facil, Urbana, IL 61801 USA; [Gao, Yi-Gui] Univ Illinois, Mat Lab 3M, Urbana, IL 61801 USA; [Miner, Kyle D.; Lu, Yi] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; 3M; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Brookhaven National Laboratory	Lu, Y (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	yi-lu@illinois.edu	Lu, Yi/GQQ-1069-2022; Lu, Yi/B-5461-2010; liu, yi/GXE-9662-2022	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709; Miner, Kyle/0000-0001-9562-2459	US National Institutes of Health [GM062211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062211] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Nilges for help with EPR analysis, S. L. Mullen and F. Sun for aiding in GC/MS data collection, E. Lee for help with computational modelling, N. M. Marshall for providing Azurin protein, J. R. Askim for help in Fe<INF>B</INF>Mb expression and purification, and T. Hayashi and P. Moenne-Loccoz for suggestions regarding N<INF>2</INF>O detection in solution. This work was supported by the US National Institutes of Health (GM062211).	Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bonner FT, 1996, METHOD ENZYMOL, V268, P50; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case MA, 2004, ACCOUNTS CHEM RES, V37, P754, DOI 10.1021/ar960245+; Cochran FV, 2005, J AM CHEM SOC, V127, P1346, DOI 10.1021/ja044129a; Collman JP, 2008, P NATL ACAD SCI USA, V105, P15660, DOI 10.1073/pnas.0808606105; Ghosh D, 2005, CURR OPIN CHEM BIOL, V9, P97, DOI 10.1016/j.cbpa.2005.02.005; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; Hendriks J, 1998, J BIOENERG BIOMEMBR, V30, P15, DOI 10.1023/A:1020547225398; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang SG, 2007, CURR OPIN CHEM BIOL, V11, P329, DOI 10.1016/j.cbpa.2007.05.006; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petros AK, 2006, INORG CHEM, V45, P9941, DOI 10.1021/ic052190q; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Sigman JA, 2000, J AM CHEM SOC, V122, P8192, DOI 10.1021/ja0015343; Taboy CH, 2002, METHOD ENZYMOL, V353, P187; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Wasser IM, 2005, J AM CHEM SOC, V127, P3310, DOI 10.1021/ja0458773; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Watanabe Y, 2005, PROG INORG CHEM, V54, P449, DOI 10.1002/0471725560.ch7; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; Yeung BKS, 1997, CHEM BIOL, V4, P215, DOI 10.1016/S1074-5521(97)90291-X; Zhao X, 2005, BIOCHEMISTRY-US, V44, P1210, DOI 10.1021/bi0479151; Zhao X, 2006, J AM CHEM SOC, V128, P6766, DOI 10.1021/ja058822p; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	41	194	195	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1079	U144		10.1038/nature08620	http://dx.doi.org/10.1038/nature08620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	19940850	Green Accepted			2022-12-28	WOS:000272996000052
J	Mehta, A; Beck, M; Elliott, P; Giugliani, R; Linhart, A; Sunder-Plassmann, G; Schiffmann, R; Barbey, F; Ries, M; Clarke, JTR				Mehta, A.; Beck, M.; Elliott, P.; Giugliani, R.; Linhart, A.; Sunder-Plassmann, G.; Schiffmann, R.; Barbey, F.; Ries, M.; Clarke, J. T. R.		Fabry Outcome Survey Investigators	Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data	LANCET			English	Article							RENAL-FUNCTION; BETA THERAPY; MANIFESTATIONS; DECLINE; GALACTOSIDASE; EFFICACY; SAFETY; PAIN; FOS	Background We analysed 5-year treatment with agalsidase alfa enzyme replacement therapy in patients with Fabry's disease who were enrolled in the Fabry Outcome Survey observational database (FOS). Methods Baseline and 5-year data were available for up to 181 adults (126 men) in FOS. Serial data for cardiac mass and function, renal function, pain, and quality of life were assessed. Safety and sensitivity analyses were done in patients with baseline and at least one relevant follow-up measurement during the 5 years (n=555 and n=475, respectively). Findings In patients with baseline cardiac hypertrophy, treatment resulted in a sustained reduction in left ventricular mass (LVM) index after 5 years (from 71.4 [SD 22.5] g/m(2.7) to 64.1 [18.7] g/m(2.7), p=0.0111) and a significant increase in midwall fractional shortening (MFS) from 14.3% (2.3) to 16.0% (3.8) after 3 years (p=0.02). In patients without baseline hypertrophy, LVM index and MFS remained stable. Mean yearly fall in estimated glomerular filtration rate versus baseline after 5 years of enzyme replacement therapy was -3.17 mL/min per 1.73 m(2) for men and -0.89 mL/min per 1.73 m(2) for women. Average pain, measured by Brief Pain Inventory score, improved significantly, from 3.7 (2.3) at baseline to 2.5 (2.4) after 5 years (p=0.0023). Quality of life, measured by deviation scores from normal EuroQol values, improved significantly, from -0.24 (0.3) at baseline to -0.17 (0.3) after 5 years (p=0.0483). Findings were confirmed by sensitivity analysis. No unexpected safety concerns were identified. Interpretation By comparison with historical natural history data for patients with Fabry's disease who were not treated with enzyme replacement therapy, long-term treatment with agalsidase alfa leads to substantial and sustained clinical benefits.	[Mehta, A.; Elliott, P.] UCL, London, England; [Beck, M.] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Giugliani, R.] Univ Fed Rio Grande do Sul, Gen Med Serv, HCPA, Porto Alegre, RS, Brazil; [Giugliani, R.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Linhart, A.] Charles Univ Prague, Prague, Czech Republic; [Sunder-Plassmann, G.] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria; [Schiffmann, R.] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Barbey, F.] Univ Lausanne Hosp, Lausanne, Switzerland; [Ries, M.] Shire Human Genet Therapies Inc, Cambridge, MA USA; [Clarke, J. T. R.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Clarke, J. T. R.] CHU Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	University of London; University College London; Johannes Gutenberg University of Mainz; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Charles University Prague; Medical University of Vienna; Baylor Scott & White Health; Baylor University Medical Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Shire Pharmaceuticals Limited; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Sherbrooke	Mehta, A (corresponding author), Royal Free Hosp, Dept Haematol, London NW3 2QG, England.	atul.mehta@royalfree.nhs.uk	Van Maldergem, Lionel/O-3242-2019; Inagemp, Inct/J-9451-2013; Elliott, Perry/AAR-3430-2020; HACHULLA, ERIC/R-8488-2018; Andres, Emmanuel/AAX-1502-2020; Giugliani, Roberto/G-4790-2015; Ries, Markus/AAE-4934-2020; Lubanda, Jean-Claude/O-1786-2017; Mehta, Atul/GPC-7364-2022; Linhart, Ales/O-2375-2017; Hendriksz, Christian/E-7377-2013; Nicholls, Kathleen/N-5002-2017; Torra, Roser/A-9983-2008	Van Maldergem, Lionel/0000-0001-8880-5214; Elliott, Perry/0000-0003-3383-3984; HACHULLA, ERIC/0000-0001-7432-847X; Andres, Emmanuel/0000-0002-7914-7616; Giugliani, Roberto/0000-0001-9655-3686; Ries, Markus/0000-0002-5054-5741; Lubanda, Jean-Claude/0000-0002-0285-9025; Linhart, Ales/0000-0002-3372-7850; BICHET, DANIEL-G/0000-0003-2856-6850; parini, rossella/0000-0003-4505-1306; bonny, olivier/0000-0003-4123-4279; Goizet, Cyril/0000-0002-1913-889X; Hendriksz, Christian/0000-0003-2179-3639; Nicholls, Kathleen/0000-0002-1297-8722; Ferrari, Paolo/0000-0002-9619-3104; Torra, Roser/0000-0001-8714-2332; Sunder-Plassmann, Gere/0000-0002-9253-9921	Shire HGT	Shire HGT	This study was funded by Shire HGT The FOS database is under the independent control of the FOS International Board. Editorial assistance was provided by Harriet Crofts (Oxford PharmaGenesis Ltd, Oxford, UK).	Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; BARBEY F, 2008, NDT PLUS, V1, P11; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; deSimone G, 1996, CIRCULATION, V93, P259, DOI 10.1161/01.CIR.93.2.259; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fellgiebel A, 2006, LANCET NEUROL, V5, P791, DOI 10.1016/S1474-4422(06)70548-8; Feriozzi S, 2009, AM J NEPHROL, V29, DOI 10.1159/000168482; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Hoffmann B, 2005, J MED GENET, V42, P247, DOI 10.1136/jmg.2004.025791; Hughes DA, 2008, HEART, V94, P153, DOI 10.1136/hrt.2006.104026; KAMPMANN C, 2006, FABRY DIS PERSPECTIV, P357; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 2002, NEW ENGL J MED, V347, P1505, DOI 10.1056/NEJMcp013462; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Linhart A, 2008, HEART, V94, P138, DOI 10.1136/hrt.2006.113886; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Mehta A, 2009, J MED GENET, V46, P548, DOI 10.1136/jmg.2008.065904; Ramaswami U, 2007, ACTA PAEDIATR, V96, P122, DOI 10.1111/j.1651-2227.2007.00029.x; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2007, J AM SOC NEPHROL, V18, P1576, DOI 10.1681/ASN.2006111263; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Schwarting A, 2006, CLIN NEPHROL, V66, P77; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; West M, 2009, J AM SOC NEPHROL, V20, P1132, DOI 10.1681/ASN.2008080870; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wraith JE, 2008, J PEDIATR-US, V152, P563, DOI 10.1016/j.jpeds.2007.09.007	31	198	211	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1986	1996		10.1016/S0140-6736(09)61493-8	http://dx.doi.org/10.1016/S0140-6736(09)61493-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EA	19959221				2022-12-28	WOS:000272727000022
J	Kesselheim, AS				Kesselheim, Aaron S.			The Supreme Court, Process Patents, and Medical Innovation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				BALDAS T, 2007, NATL LAW J      0716; Mullin, 2009, IP LAW BUSINESS  APR, P44	2	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2303	2306		10.1056/NEJMp0909658	http://dx.doi.org/10.1056/NEJMp0909658			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	19923562				2022-12-28	WOS:000272547600002
J	Chow, RT; Johnson, MI; Lopes-Martins, RAB; Bjordal, JM				Chow, Roberta T.; Johnson, Mark I.; Lopes-Martins, Rodrigo A. B.; Bjordal, Jan M.			Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials	LANCET			English	Review							LOW-POWER LASER; CERVICAL MYOFASCIAL PAIN; SKELETAL-MUSCLE FATIGUE; FORM HEALTH SURVEY; 830 NM LASER; DOUBLE-BLIND; DIODE-LASER; NEUROMUSCULAR-JUNCTIONS; ACUPUNCTURE POINTS; TRIGGER POINTS	Background Neck pain is a common and costly condition for which pharmacological management has limited evidence of efficacy and side-effects. Low-level laser therapy (LLLT) is a relatively uncommon, non-invasive treatment for neck pain, in which non-thermal laser irradiation is applied to sites of pain. We did a systematic review and meta-analysis of randomised controlled trials to assess the efficacy of LLLT in neck pain. Methods We searched computerised databases comparing efficacy of LLLT using any wavelength with placebo or with active control in acute or chronic neck pain. Effect size for the primary outcome, pain intensity, was defined as a pooled estimate of mean difference in change in mm on 100 mm visual analogue scale. Findings We identified 16 randomised controlled trials including a total of 820 patients. In acute neck pain, results of two trials showed a relative risk (RR) of 1.69 (95% Cl 1.22-2.33) for pain improvement of LLLT versus placebo. Five trials of chronic neck pain reporting categorical data showed an RR for pain improvement of 4.05 (2.74-5.98) of LLLT. Patients in 11 trials reporting changes in visual analogue scale had pain intensity reduced by 19.86 mm (10.04-29.68). Seven trials provided follow-up data for 1-22 weeks after completion of treatment, with short-term pain relief persisting in the medium term with a reduction of 22.07 mm (17.42-26.72). Side-effects from LLLT were mild and not different from those of placebo. Interpretation We show that LLLT reduces pain immediately after treatment in acute neck pain and up to 22 weeks after completion of treatment in patients with chronic neck pain.	[Chow, Roberta T.] Univ Sydney, Nerve Res Fdn, Brain & Mind Res Inst, Sydney, NSW 2050, Australia; [Johnson, Mark I.] Leeds Metropolitan Univ, Fac Hlth, Leeds LS1 3HE, W Yorkshire, England; [Lopes-Martins, Rodrigo A. B.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil; [Bjordal, Jan M.] Bergen Univ Coll, Inst Physiotherapy, Fac Hlth & Social Sci, Bergen, Norway; [Bjordal, Jan M.] Univ Bergen, Inst Publ Hlth & Primary Hlth Care, Sect Physiotherapy Sci, Bergen, Norway	University of Sydney; Leeds Beckett University; Universidade de Sao Paulo; Western Norway University of Applied Sciences; University of Bergen	Chow, RT (corresponding author), Univ Sydney, Nerve Res Fdn, Brain & Mind Res Inst, 100 Mallett St, Sydney, NSW 2050, Australia.	robertachow@iinet.net.au	Bjordal, Jan Magnus/T-7122-2019; Lopes-Martins, Rodrigo Alvaro/G-6972-2012; Lopes-Martins, Rodrigo A B/E-2013-2013	Lopes-Martins, Rodrigo Alvaro/0000-0003-4942-988X; Lopes-Martins, Rodrigo A B/0000-0002-4533-1335	Fundacao de Amparo do Estado de Sgo Paulo (FAPESP, Brazil); WALT; Norwegian Manual Therapy Association; Norwegian Neck and Back Congress; Norwegian Research Council; Norwegian Fund for Postgraduate Training in Physiotherapy; Grieg Foundation	Fundacao de Amparo do Estado de Sgo Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); WALT; Norwegian Manual Therapy Association; Norwegian Neck and Back Congress; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Fund for Postgraduate Training in Physiotherapy; Grieg Foundation	RTC is a member of the World Association for Laser Therapy (WALT), the Australian Medical Acupuncture College, the British Medical Acupuncture Society, the Australian Pain Society, the Australian Medical Association, and the Royal Australian College of General Practitioners. MIJ is a member of the International Association of the Study of Pain. RABL-M is funded by Fundacao de Amparo do Estado de Sgo Paulo (FAPESP, Brazil) and is scientific secretary of WALT, from which he has never received funding, grants, or fees. J M B is a member of the Norwegian Physiotherapy Association, Norwegian Sports Physiotherapy Society, Norwegian Society for Rheumatological and Orthopedic Physiotherapy, and has received research awards and grants from the Norwegian Manual Therapy Association, the Norwegian Neck and Back Congress, the Norwegian Research Council, the Norwegian Fund for Postgraduate Training in Physiotherapy, and the Grieg Foundation. He is also president of WALT, a position for which he has never received funding, grants, or fees.	Aigner N, 2006, WIEN KLIN WOCHENSCHR, V118, P95, DOI 10.1007/s00508-006-0530-4; Aimbire F, 2007, PHOTOMED LASER SURG, V25, P112, DOI 10.1089/pho.2006.1041; Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Albertini R, 2004, J PHOTOCH PHOTOBIO B, V74, P101, DOI 10.1016/j.jphotobiol.2004.03.002; Altan L, 2005, RHEUMATOL INT, V25, P23, DOI 10.1007/s00296-003-0396-y; BARNSLEY L, 2003, RHEUMATOLOGY, P567; BASFORD JR, 1995, LASER SURG MED, V16, P331, DOI 10.1002/lsm.1900160404; BAXTER GD, 1994, EXP PHYSIOL, V79, P227, DOI 10.1113/expphysiol.1994.sp003755; BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; Binder AI, 2007, BMJ-BRIT MED J, V334, P527, DOI 10.1136/bmj.39127.608299.80; Bjordal JM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-51; Bjordal JM, 2006, PHOTOMED LASER SURG, V24, P533; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Bjordal JM, 2006, PHOTOMED LASER SURG, V24, P158, DOI 10.1089/pho.2006.24.158; Bjordal JM, 2006, BRIT J SPORT MED, V40, P76, DOI 10.1136/bjsm.2005.020842; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; Bjordal JM, 2003, EUR J PAIN, V7, P181, DOI 10.1016/S1090-3801(02)00098-8; Bjordal JM., 2001, PHYS THER REV, V6, P91, DOI [10.1179/ptr.2001.6.2.91, DOI 10.1179/PTR.2001.6.2.91]; Bogduk Nikolai, 1998, Current Opinion in Rheumatology, V10, P110, DOI 10.1097/00002281-199803000-00004; Bogduk Nikolai, 2003, Phys Med Rehabil Clin N Am, V14, P455, DOI 10.1016/S1047-9651(03)00041-X; Borghouts JAJ, 1999, PAIN, V80, P629, DOI 10.1016/S0304-3959(98)00268-1; Brosseau L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002049.pub2; Campana Vilma R., 1999, Laser Therapy, V11, P36; CECCHERELLI F, 1989, CLIN J PAIN, V5, P301, DOI 10.1097/00002508-198912000-00005; Chow RT, 2007, J PERIPHER NERV SYST, V12, P28, DOI 10.1111/j.1529-8027.2007.00114.x; Chow RT, 2006, PAIN, V124, P201, DOI 10.1016/j.pain.2006.05.018; Chow RT, 2005, LASER SURG MED, V37, P46, DOI 10.1002/lsm.20193; Chow RT, 2004, J MUSCULOSKELET PAIN, V12, P71, DOI 10.1300/J094v12n02_09; Christie A, 2007, PHYS THER, V87, P1697, DOI 10.2522/ptj.20070039; Cousins MJ, 1999, ANESTHESIOLOGY, V91, P538, DOI 10.1097/00000542-199908000-00029; Djavid GE, 2007, AUST J PHYSIOTHER, V53, P155, DOI 10.1016/S0004-9514(07)70022-3; Dorsher PT, 2008, J ALTERN COMPLEM MED, V14, P353, DOI 10.1089/acm.2007.0810; Dundar U, 2007, CLIN RHEUMATOL, V26, P930, DOI 10.1007/s10067-006-0438-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enwemeka CS, 2004, PHOTOMED LASER SURG, V22, P323, DOI 10.1089/1549541041797841; Enwemeka CS, 2001, LASER THER, V13, P95; EssinkBot ML, 1997, MED CARE, V35, P522, DOI 10.1097/00005650-199705000-00008; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; FLOTER T, 1990, TOP MED, V4, P52; Gagliese L, 1997, PAIN, V70, P3, DOI 10.1016/0304-3959(77)90032-X; GROSS A, 1996, ONLINE J CURR CLIN T, V5, P1; GROSS AR, 2007, J RHEUMATOL, V34, P1; Gur A, 2004, LASER SURG MED, V35, P229, DOI 10.1002/lsm.20082; Gur A, 2003, LASER SURG MED, V33, P330, DOI 10.1002/lsm.10236; GURSOY B, 1996, LASER THER, V8, P18; Hakguder A, 2003, LASER SURG MED, V33, P339, DOI 10.1002/lsm.10241; Ilbuldu E, 2004, PHOTOMED LASER SURG, V22, P306; JADAD A, 1998, RANDOMISED CONTROLLE, P97; Jensen I, 2007, BEST PRACT RES CL RH, V21, P93, DOI 10.1016/j.berh.2006.10.003; KUDOH C, 1989, LASER THER, V1, P63; Laakso E. Liisa, 1997, Laser Therapy, V9, P67; Larsson R, 1999, PAIN, V79, P45, DOI 10.1016/S0304-3959(98)00144-4; LEAK AM, 1994, BRIT J RHEUMATOL, V33, P469; Li LC, 2005, J RHEUMATOL, V32, P21; LONGO L, 1991, J EUR MED LASER ASS, V3, P16; Lopes-Martins RAB, 2006, J APPL PHYSIOL, V101, P283, DOI 10.1152/japplphysiol.01318.2005; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MESTER E, 1972, ACTA CHIR HUNG, V13, P315; Nicolau RA, 2004, LASER SURG MED, V35, P236, DOI 10.1002/lsm.20087; Nicolau RA, 2004, LASER SURG MED, V34, P277, DOI 10.1002/lsm.20006; NUSSBAUM EL, 2007, PHYSIOTHER CAN, V59, P194; Ohshiro Toshio, 1996, Laser Therapy, V8, P185; OLAVI A, 1989, ACUPUNCTURE ELECTRO, V14, P9, DOI 10.3727/036012989816358560; Oron U, 2006, PHOTOMED LASER SURG, V24, P111, DOI 10.1089/pho.2006.24.111; Ozdemir F, 2001, CLIN RHEUMATOL, V20, P181, DOI 10.1007/s100670170061; Peloso P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000319.pub4; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Leal ECP, 2008, PHOTOMED LASER SURG, V26, P419, DOI 10.1089/pho.2007.2160; Leal ECP, 2009, LASER MED SCI, V24, P425, DOI 10.1007/s10103-008-0592-9; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; Sattayut S., 1999, Laser Therapy, V11, P88; SEIDEL U, 2002, DTSCH Z AKUPUNKTUR, V45, P258; SIENDENTOPF C, 2002, NEUROSCI LETT, V327, P3; Soriano Fernando, 1998, Laser Therapy, V10, P175; Soriano Fernando A., 1996, Laser Therapy, V8, P149; Stergioulas A, 2008, PHOTOMED LASER SURG, V26, P99, DOI 10.1089/pho.2007.2138; TAVERNA E, 1990, MINERVA ORTOP TRAUMA, V41, P631; Toya Shigeo, 1994, Laser Therapy, V6, P143; Trinh KV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004870.pub3; TSUCHIYA K, 1993, NEUROSCI LETT, V161, P65, DOI 10.1016/0304-3940(93)90141-7; TSUCHIYA K, 1994, BRAIN RES BULL, V34, P369, DOI 10.1016/0361-9230(94)90031-0; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; TUNER J, 1999, LOW LEVEL LASER THER, P101; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; VASSELJEN O, 1992, SCAND J REHABIL MED, V24, P37; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; WALKER J, 1983, NEUROSCI LETT, V43, P339, DOI 10.1016/0304-3940(83)90211-2; WALT, 2006, PHOTOMED LASER SURG, V24, P761, DOI 10.1089/PHO.2006.24.6W2; Webb R, 2003, SPINE, V28, P1195, DOI 10.1097/00007632-200306010-00021; Wheeler AH, 1999, SPINE, V24, P1290, DOI 10.1097/00007632-199907010-00004; Woodruff LD, 2004, PHOTOMED LASER SURG, V22, P241, DOI 10.1089/1549541041438623; *WORLD ASS LAS THE, 2005, REC ANT DOS LOW LEV; Yousefi-Nooraie R, 2007, COCHRANE DB SYST REV, V2; Zhang WY, 1996, J CLIN PHARM THER, V21, P261, DOI 10.1111/j.1365-2710.1996.tb01148.x	96	352	365	1	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1897	1908		10.1016/S0140-6736(09)61522-1	http://dx.doi.org/10.1016/S0140-6736(09)61522-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19913903				2022-12-28	WOS:000272646900023
J	Becker, T; Bhushan, S; Jarasch, A; Armache, JP; Funes, S; Jossinet, F; Gumbart, J; Mielke, T; Berninghausen, O; Schulten, K; Westhof, E; Gilmore, R; Mandon, EC; Beckmann, R				Becker, Thomas; Bhushan, Shashi; Jarasch, Alexander; Armache, Jean-Paul; Funes, Soledad; Jossinet, Fabrice; Gumbart, James; Mielke, Thorsten; Berninghausen, Otto; Schulten, Klaus; Westhof, Eric; Gilmore, Reid; Mandon, Elisabet C.; Beckmann, Roland			Structure of Monomeric Yeast and Mammalian Sec61 Complexes Interacting with the Translating Ribosome	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM; PROTEIN-TRANSLOCATION; SEQUENCE RECOGNITION; CHANNEL COMPLEX; BINDING; MEMBRANE; SECYEG; ARCHITECTURE; RECEPTOR	The trimeric Sec61/SecY complex is a protein-conducting channel (PCC) for secretory and membrane proteins. Although Sec complexes can form oligomers, it has been suggested that a single copy may serve as an active PCC. We determined subnanometer-resolution cryo-electron microscopy structures of eukaryotic ribosome-Sec61 complexes. In combination with biochemical data, we found that in both idle and active states, the Sec complex is not oligomeric and interacts mainly via two cytoplasmic loops with the universal ribosomal adaptor site. In the active state, the ribosomal tunnel and a central pore of the monomeric PCC were occupied by the nascent chain, contacting loop 6 of the Sec complex. This provides a structural basis for the activity of a solitary Sec complex in cotranslational protein translocation.	[Gilmore, Reid; Mandon, Elisabet C.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Becker, Thomas; Bhushan, Shashi; Jarasch, Alexander; Armache, Jean-Paul; Funes, Soledad; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Becker, Thomas; Bhushan, Shashi; Jarasch, Alexander; Armache, Jean-Paul; Funes, Soledad; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci, Dept Chem & Biochem, D-81377 Munich, Germany; [Funes, Soledad] Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Jossinet, Fabrice; Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France; [Gumbart, James; Schulten, Klaus] Univ Illinois, Beckman Inst, Dept Phys, Urbana, IL 61801 USA; [Mielke, Thorsten] Max Planck Inst Mol Genet, Ultrastrukturnetzwerk, D-14195 Berlin, Germany; [Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Munich; University of Munich; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mandon, EC (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, 364 Plantat St, Worcester, MA 01605 USA.	elisabet.mandon@umassmed.edu; beckmann@lmb.uni-muenchen.de	Armache, Jean-Paul/U-3113-2019; Schulten, Klaus/D-5561-2009; Funes, Soledad/A-1278-2010	Funes, Soledad/0000-0003-1815-1977; Jarasch, Alexander/0000-0002-6810-0425; Bhushan, Shashi/0000-0002-8514-5959; Armache, Jean-Paul/0000-0001-9195-2282	Deutsche Forschungsgemeinschaft [SFB594, SFB646, SFB 740]; Knut and Alice Wallenberg Foundation, Stockholm, Sweden; NIH [P41-RR05969, R01-GM067887, GM35687]; NSF [PHY0822613, MCA93S028]; European Union; Senatsverwaltung fur Wissenschaft; Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035687, R01GM067887] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Knut and Alice Wallenberg Foundation, Stockholm, Sweden(Knut & Alice Wallenberg Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Union(European Commission); Senatsverwaltung fur Wissenschaft; Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Dobberstein (Zentrum fur Molekulare Biologie der Universitat Heidelberg, Heidelberg, Germany) for microsomal membranes, B. Brugger (Biochemie-Zentrum der Universit at Heidelberg, Heidelberg, Germany) for lipid analysis, and J. Frauenfeld and E. van der Sluis for critical discussions. This research was supported by Deutsche Forschungsgemeinschaft grants SFB594, SFB646 ( to R. B. and T. B.), and SFB 740 ( to T. M.); Knut and Alice Wallenberg Foundation, Stockholm, Sweden ( to S. B.); NIH grants P41-RR05969, R01-GM067887 ( to K. S.), and GM35687 ( to R. G.); NSF grant PHY0822613 ( to K. S.); and the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum). Computer time for MDFF was provided through an NSF Large Resources Allocation Committee grant (MCA93S028). Coordinates of the atomic models and cryo-EM maps have been deposited in the PDB [ with accession numbers 2ww9 ( active Ssh), 2wwa ( inactive Ssh), and 2wwb ( mammalian translocon)] and in the 3D-EM database [EMD-1651 ( yeast) and EMD-1652 ( Mammalia)], respectively.	Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kalies KU, 2008, BBA-MOL CELL RES, V1783, P2375, DOI 10.1016/j.bbamcr.2008.08.005; Karaoglu D, 2001, BIOCHEMISTRY-US, V40, P12193, DOI 10.1021/bi0111911; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	36	222	227	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1369	1373		10.1126/science.1178535	http://dx.doi.org/10.1126/science.1178535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933108	Green Accepted			2022-12-28	WOS:000272351100033
J	Seidelt, B; Innis, CA; Wilson, DN; Gartmann, M; Armache, JP; Villa, E; Trabuco, LG; Becker, T; Mielke, T; Schulten, K; Steitz, TA; Beckmann, R				Seidelt, Birgit; Innis, C. Axel; Wilson, Daniel N.; Gartmann, Marco; Armache, Jean-Paul; Villa, Elizabeth; Trabuco, Leonardo G.; Becker, Thomas; Mielke, Thorsten; Schulten, Klaus; Steitz, Thomas A.; Beckmann, Roland			Structural Insight into Nascent Polypeptide Chain-Mediated Translational Stalling	SCIENCE			English	Article							PEPTIDYL TRANSFERASE CENTER; TNA OPERON EXPRESSION; RIBOSOMAL EXIT TUNNEL; TRYPTOPHAN INDUCTION; TRANSFER-RNA; MECHANISM; ARREST; REQUIRES; FEATURES	Expression of the Escherichia coli tryptophanase operon depends on ribosome stalling during translation of the upstream TnaC leader peptide, a process for which interactions between the TnaC nascent chain and the ribosomal exit tunnel are critical. We determined a 5.8 angstrom-resolution cryo-electron microscopy and single-particle reconstruction of a ribosome stalled during translation of the tnaC leader gene. The nascent chain was extended within the exit tunnel, making contacts with ribosomal components at distinct sites. Upon stalling, two conserved residues within the peptidyltransferase center adopted conformations that preclude binding of release factors. We propose a model whereby interactions within the tunnel are relayed to the peptidyltransferase center to inhibit translation. Moreover, we show that nascent chains adopt distinct conformations within the ribosomal exit tunnel.	[Innis, C. Axel; Steitz, Thomas A.] Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Seidelt, Birgit; Wilson, Daniel N.; Gartmann, Marco; Armache, Jean-Paul; Becker, Thomas; Beckmann, Roland] Univ Munich, Dept Chem & Biochem, CIPSM, D-81377 Munich, Germany; [Seidelt, Birgit; Wilson, Daniel N.; Gartmann, Marco; Armache, Jean-Paul; Becker, Thomas; Beckmann, Roland] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Villa, Elizabeth; Steitz, Thomas A.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Villa, Elizabeth; Trabuco, Leonardo G.; Schulten, Klaus] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Schulten, Klaus] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Yale University; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; University of Illinois System; University of Illinois Urbana-Champaign	Steitz, TA (corresponding author), Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	thomas.steitz@yale.edu; beckmann@lmb.uni-muenchen.de	Trabuco, Leonardo G/E-3191-2010; Wilson, Daniel/AAE-8504-2019; Steitz, Thomas A./C-6559-2009; Schulten, Klaus/D-5561-2009; Innis, Axel/P-9863-2019; Armache, Jean-Paul/U-3113-2019; Villa, Elizabeth/D-1811-2010; Innis, Axel/A-5927-2009	Wilson, Daniel/0000-0003-3816-3828; Innis, Axel/0000-0003-3153-9490; Villa, Elizabeth/0000-0003-4677-9809; Innis, Axel/0000-0003-3153-9490; Armache, Jean-Paul/0000-0001-9195-2282	Deutsche Forschungsgemeinschaft [SFB594, SFB646, SFB740, WI3285/1-1]; NIH [GM022778, P41-RR05969]; NSF [PHY0822613, MCA93S028]; European Union and Senatsverwaltung fur Wissenschaft; Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Union and Senatsverwaltung fur Wissenschaft(European Commission); Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grants from the Deutsche Forschungsgemeinschaft SFB594 and SFB646 ( to R. B.), SFB740 ( to T. M.), and WI3285/1-1 ( to D. N. W.); by NIH grants GM022778 ( to T. A. S.) and P41-RR05969 ( to K. S.); by NSF grant PHY0822613 ( to K. S.); and by the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum). Computer time for MDFF was provided through an NSF Large Resources Allocation Committee grant MCA93S028. Coordinates of the atomic models of TnaC-70S complex have been deposited in the PDB under accession numbers 2WWL (30S) and 2WWQ (50S). The cryo-EM map has been deposited in the 3D-EM database under accession number EMD-1657.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Cruz-Vera LR, 2008, J BACTERIOL, V190, P4791, DOI 10.1128/JB.00290-08; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; de Bakker PI, 2006, CURR OPIN STRUC BIOL, V16, P160, DOI 10.1016/j.sbi.2006.02.001; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Simonovic M, 2009, BBA-GENE REGUL MECH, V1789, P612, DOI 10.1016/j.bbagrm.2009.06.006; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yang R, 2009, J BACTERIOL, V191, P3445, DOI 10.1128/JB.00096-09; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002	26	207	212	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1412	1415		10.1126/science.1177662	http://dx.doi.org/10.1126/science.1177662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933110	Green Accepted			2022-12-28	WOS:000272351100046
J	Steinbrook, R				Steinbrook, Robert			Lobbying, Campaign Contributions, and Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ELECTION 2008; SECTOR					rsteinbrook@attglobal.net						KIRKPATRICK DD, 2009, NY TIMES        1010; KUTTNER R, 2009, AM PROSPECT     1027; PEAR R, 2009, NY TIMES        1114; Steinbrook R, 2008, NEW ENGL J MED, V359, P1313, DOI 10.1056/NEJMp0807073; Steinbrook R, 2007, NEW ENGL J MED, V357, P736, DOI 10.1056/NEJMp078151	5	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23								10.1056/NEJMp0910879	http://dx.doi.org/10.1056/NEJMp0910879			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ZM	19923565				2022-12-28	WOS:000272257100003
J	Ford, N; Nachega, JB; Engel, ME; Mills, EJ				Ford, Nathan; Nachega, Jean B.; Engel, Mark E.; Mills, Edward J.			Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials	LANCET			English	Article							SELF-ADMINISTERED THERAPY; INFECTED DRUG-USERS; ADHERENCE; HAART; RESISTANCE; TUBERCULOSIS; EFFICACY; FAILURE; DOT	Background Directly observed therapy has been recommended to improve adherence for patients with HIV infection who are on highly active antiretroviral therapy, but the benefit and cost-effectiveness of this approach has not been established conclusively. We did a systematic review and meta-analysis of randomised trials of directly observed versus self-administered antiretroviral treatment. Methods We did duplicate searches of databases (from inception to July 27, 2009), searchable websites of major HIV conferences (up to July, 2009), and lay publications and websites (March-July, 2009) to identify randomised trials assessing directly observed therapy to promote adherence to antiretroviral therapy in adults. Our primary outcome was virological suppression at study completion. We calculated relative risks (95% CIs), and pooled estimates using a random-effects method. Findings 12 studies met our inclusion criteria; four of these were done in groups that were judged to be at high risk of poor adherence (drug users and homeless people). Ten studies reported on the primary outcome (n=1862 participants); we calculated a pooled relative risk of 1.04 (95% CI 0.91-1.20, p=0.55), and noted moderate heterogeneity between the studies (I-2= 53.8%, 95% CI 0-75.7, p=0.0247) for directly observed versus self-administered treatment. Interpretation Directly observed antiretroviral therapy seems to offer no benefit over self-administered treatment, which calls into question the use of such an approach to support adherence in the general patient population.	[Ford, Nathan] Med Sans Frontieres, Cape Town, Western Cape, South Africa; [Nachega, Jean B.] Univ Stellenbosch, Dept Med, Cape Town, Western Cape, South Africa; [Nachega, Jean B.] Univ Stellenbosch, Ctr Infect Dis, Fac Hlth Sci, Cape Town, Western Cape, South Africa; [Nachega, Jean B.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Nachega, Jean B.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Nachega, Jean B.; Engel, Mark E.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	Stellenbosch University; Stellenbosch University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; University of Ottawa	Ford, N (corresponding author), Med Sans Frontieres, POB 27401,Rhine Rd, Cape Town, Western Cape, South Africa.	Nathan.ford@joburg.msf.org	Engel, Mark/AAP-6570-2020	Engel, Mark/0000-0002-1334-8829; Nachega, Jean/0000-0002-2862-4443	US National Institute of Allergy and Infections Diseases (NIAID); US National Institutes of Health [AI 553590]; NIAID/NIH [K23 AI068582-01]; Canadian Institutes of Health Research Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI068582] Funding Source: NIH RePORTER	US National Institute of Allergy and Infections Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research Canada(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JBN acknowledges research support from the US National Institute of Allergy and Infections Diseases (NIAID) and US National Institutes of Health (NIH; grant number AI 553590), and is the recipient of an NIAID/NIH Mentored Patient-Oriented Research Career Award (K23 AI068582-01). EJM is supported by a Canadian Institutes of Health Research Canada Research Chair. We thank Joanna Downer and Aline Raymond for administrative support.	Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; ARNSTEN J, 2009, 4 INT C HIV TREATM A; BANGSBERG D, 2009, 4 INT C HIV TREATM A; BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; BUSSMANN H, 2007, 14 C RETR OPP INF LO; Bussmann H, 2009, JAIDS-J ACQ IMM DEF, V51, P37, DOI 10.1097/QAI.0b013e31819ff102; DETSKY AS, 1985, ARCH INTERN MED, V145, P709, DOI 10.1001/archinte.145.4.709; ELLIOT D, 2008, 17 INT AIDS C MEX CI; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; GRODENSKY C, 2009, 4 INT C HIV TREATM A; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Gross R, 2009, ARCH INTERN MED, V169, P1224, DOI 10.1001/archinternmed.2009.172; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hedges LV, 2014, STAT METHODS META AN; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Liechty CA, 2003, AIDS, V17, P1383, DOI 10.1097/00002030-200306130-00013; Lucas GM, 2002, AIDS PATIENT CARE ST, V16, P527, DOI 10.1089/108729102761041083; Macalino GE, 2007, AIDS, V21, P1473, DOI 10.1097/QAD.0b013e32811ebf68; Maher D, 2003, BRIT MED J, V327, P822, DOI 10.1136/bmj.327.7419.822; Maru DSR, 2007, JAIDS-J ACQ IMM DEF, V46, P555, DOI 10.1097/QAI.0b013e318158c0bd; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Meade MO, 2001, AM J RESP CRIT CARE, V163, P490, DOI 10.1164/ajrccm.163.2.2006067; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; NAIDOO A, 2009, 5 IAS C HIV PATH TRE; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Page-Shipp LS, 2007, SEX TRANSM INFECT, V83, P383, DOI 10.1136/sti.2007.025585; Pearson CR, 2007, JAIDS-J ACQ IMM DEF, V46, P238, DOI 10.1097/QAI.0b013e318153f7ba; Pearson CR, 2006, JAIDS-J ACQ IMM DEF, V43, pS134, DOI 10.1097/01.qai.0000248339.82567.17; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Ram M., 2009, 16 C RETR OPP INF MO; Rigsby MO, 2000, J GEN INTERN MED, V15, P841, DOI 10.1046/j.1525-1497.2000.00127.x; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; ROSENBLUM M, 2009, 16 C RETR OPP INF MO; Sackett DL, 2001, CAN MED ASSOC J, V165, P1226; Sarna A, 2008, JAIDS-J ACQ IMM DEF, V48, P611, DOI 10.1097/QAI.0b013e3181806bf1; Sherer R, 1998, JAMA-J AM MED ASSOC, V280, P567, DOI 10.1001/jama.280.6.567; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; TAIWO BO, 2008, 3 INT C HIV TREATM A; Tam LWY, 2008, JAIDS-J ACQ IMM DEF, V49, P266, DOI 10.1097/QAI.0b013e318189a753; Verma Geetika, 2004, BMC Med Ethics, V5, pE2, DOI 10.1186/1472-6939-5-2; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Wohl AR, 2006, CLIN INFECT DIS, V42, P1619, DOI 10.1086/503906; World Health Organization, 1997, WHOTB97220	49	78	79	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2064	2071		10.1016/S0140-6736(09)61671-8	http://dx.doi.org/10.1016/S0140-6736(09)61671-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19954833				2022-12-28	WOS:000273122900029
J	Mann, ME; Zhang, ZH; Rutherford, S; Bradley, RS; Hughes, MK; Shindell, D; Ammann, C; Faluvegi, G; Ni, FB				Mann, Michael E.; Zhang, Zhihua; Rutherford, Scott; Bradley, Raymond S.; Hughes, Malcolm K.; Shindell, Drew; Ammann, Caspar; Faluvegi, Greg; Ni, Fenbiao			Global Signatures and Dynamical Origins of the Little Ice Age and Medieval Climate Anomaly	SCIENCE			English	Article							TROPICAL PACIFIC; PAST MILLENNIUM; TEMPERATURE; OSCILLATION; RECONSTRUCTION; VARIABILITY; SIMULATIONS; TRENDS	Global temperatures are known to have varied over the past 1500 years, but the spatial patterns have remained poorly defined. We used a global climate proxy network to reconstruct surface temperature patterns over this interval. The Medieval period is found to display warmth that matches or exceeds that of the past decade in some regions, but which falls well below recent levels globally. This period is marked by a tendency for La Nina-like conditions in the tropical Pacific. The coldest temperatures of the Little Ice Age are observed over the interval 1400 to 1700 C. E., with greatest cooling over the extratropical Northern Hemisphere continents. The patterns of temperature change imply dynamical responses of climate to natural radiative forcing changes involving El Nino and the North Atlantic Oscillation-Arctic Oscillation.	[Mann, Michael E.; Zhang, Zhihua] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Mann, Michael E.; Zhang, Zhihua] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Rutherford, Scott] Roger Williams Univ, Dept Environm Sci, Bristol, RI 02809 USA; [Bradley, Raymond S.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Hughes, Malcolm K.; Ni, Fenbiao] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Shindell, Drew; Faluvegi, Greg] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Ammann, Caspar] Natl Ctr Atmospher Res, Climate Global Dynam Div, Boulder, CO 80305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Massachusetts System; University of Massachusetts Amherst; University of Arizona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Center Atmospheric Research (NCAR) - USA	Mann, ME (corresponding author), Penn State Univ, Dept Meteorol, 503 Walker Bldg, University Pk, PA 16802 USA.	mann@meteo.psu.edu	Hughes, Malcolm/F-3350-2014; Bradley, Raymond S/P-9358-2015; Ammann, Caspar M/A-4899-2011; zhang, zh/GWV-4677-2022; Shindell, Drew/D-4636-2012; Mann, Michael E/B-8472-2017	Hughes, Malcolm/0000-0003-1062-3167; Bradley, Raymond S/0000-0002-4032-9519; Shindell, Drew/0000-0003-1552-4715; Mann, Michael E/0000-0003-3067-296X; Faluvegi, Gregory/0000-0001-9011-3663	National Science Foundation [ATM-0542356]; Office of Science (BER), U.S. Department of Energy [DE-FG02-98ER62604]; National Oceanic and Atmospheric Administration [NA16GP2914]; NASA's Atmospheric Chemistry, Modeling, and Analysis Program	National Science Foundation(National Science Foundation (NSF)); Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NASA's Atmospheric Chemistry, Modeling, and Analysis Program(National Aeronautics & Space Administration (NASA))	M.E.M. and Z.Z. gratefully acknowledge support from the ATM program of the National Science Foundation (grant ATM-0542356). R. S. B. acknowledges support from the Office of Science (BER), U.S. Department of Energy (grant DE-FG02-98ER62604). M. K. H. and F.B.N. were supported by the National Oceanic and Atmospheric Administration (grant NA16GP2914 from CCDD). D. T. S. and G. F. acknowledge support from NASA's Atmospheric Chemistry, Modeling, and Analysis Program.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Ammann CM, 2007, P NATL ACAD SCI USA, V104, P3713, DOI 10.1073/pnas.0605064103; Briffa KR, 2008, PHILOS T R SOC B, V363, P2271, DOI 10.1098/rstb.2007.2199; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Evans MN, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000590; Goosse H, 2006, CLIM DYNAM, V27, P165, DOI 10.1007/s00382-006-0128-6; Graham NE, 2007, CLIMATIC CHANGE, V83, P241, DOI [10.1007/s10584-007-9239-2, 10.1007/s 10584-007-9239-2]; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Luterbacher J, 1999, GEOPHYS RES LETT, V26, P2745, DOI 10.1029/1999GL900576; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; Shindell DT, 2003, J CLIMATE, V16, P4094, DOI 10.1175/1520-0442(2003)016<4094:VASFOC>2.0.CO;2; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; ZEBIAK SE, 1987, MON WEATHER REV, V115, P2262, DOI 10.1175/1520-0493(1987)115<2262:AMENO>2.0.CO;2	29	1483	1589	19	568	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1256	1260		10.1126/science.1177303	http://dx.doi.org/10.1126/science.1177303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965474	Green Published			2022-12-28	WOS:000272117900046
J	Subrahmanian, VS; Dickerson, J				Subrahmanian, V. S.; Dickerson, John			What Can Virtual Worlds and Games Do for National Security?	SCIENCE			English	Editorial Material									[Subrahmanian, V. S.] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; Univ Maryland, Inst Adv Comp Studies UMIACS, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Subrahmanian, VS (corresponding author), Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA.	vs@cs.umd.edu; johnd@umiacs.umd.edu	Subrahmanian, Venkatramanan/ABA-7399-2021					Aumann R J, 1995, REPEATED GAMES INCOM; DICKERSON J, 2008, P 2 INT C COMP CULT, P26; Herman ML, 2008, WARGAMING LEADERS ST; Khuller S, 2007, ANN MATH ARTIF INTEL, V51, P295, DOI 10.1007/s10472-008-9089-2; KOTT A, 2006, ADVERSARIAL REASONIN; Macedonia M, 2007, COMPUTER, V40, P99, DOI 10.1109/MC.2007.348; Martinez V, 2008, IEEE INTELL SYST, V23, P51, DOI 10.1109/MIS.2008.62; Schrodt PA, 2000, AM POLIT SCI REV, V94, P803, DOI 10.2307/2586209; Sliva A, 2009, MATHEMATICAL METHODS IN COUNTERTERRORISM, P253, DOI 10.1007/978-3-211-09442-6_15	9	5	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1201	1202		10.1126/science.1182660	http://dx.doi.org/10.1126/science.1182660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	524BD	19965459				2022-12-28	WOS:000272117900030
J	Krepkiy, D; Mihailescu, M; Freites, JA; Schow, EV; Worcester, DL; Gawrisch, K; Tobias, DJ; White, SH; Swartz, KJ				Krepkiy, Dmitriy; Mihailescu, Mihaela; Freites, J. Alfredo; Schow, Eric V.; Worcester, David L.; Gawrisch, Klaus; Tobias, Douglas J.; White, Stephen H.; Swartz, Kenton J.			Structure and hydration of membranes embedded with voltage-sensing domains	NATURE			English	Article							DEPENDENT K+ CHANNEL; MOLECULAR-DYNAMICS SIMULATIONS; NEUTRON-DIFFRACTION DATA; FOCUSED ELECTRIC-FIELD; PARTICLE MESH EWALD; POTASSIUM CHANNEL; GATING-CHARGE; X-RAY; LIPID-MEMBRANE; FUNCTIONAL RECONSTITUTION	Despite the growing number of atomic-resolution membrane protein structures, direct structural information about proteins in their native membrane environment is scarce. This problem is particularly relevant in the case of the highly charged S1-S4 voltage-sensing domains responsible for nerve impulses, where interactions with the lipid bilayer are critical for the function of voltage-activated ion channels. Here we use neutron diffraction, solid-state nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics simulations to investigate the structure and hydration of bilayer membranes containing S1-S4 voltage-sensing domains. Our results show that voltage sensors adopt transmembrane orientations and cause a modest reshaping of the surrounding lipid bilayer, and that water molecules intimately interact with the protein within the membrane. These structural findings indicate that voltage sensors have evolved to interact with the lipid membrane while keeping energetic and structural perturbations to a minimum, and that water penetrates the membrane, to hydrate charged residues and shape the transmembrane electric field.	[Mihailescu, Mihaela; Freites, J. Alfredo; Worcester, David L.; White, Stephen H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Mihailescu, Mihaela; Freites, J. Alfredo; Worcester, David L.; White, Stephen H.] Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA; [Freites, J. Alfredo; Tobias, Douglas J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Freites, J. Alfredo; Tobias, Douglas J.] Univ Calif Irvine, Inst Surface & Interface Sci, Irvine, CA 92697 USA; [Schow, Eric V.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Schow, Eric V.] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Mihailescu, Mihaela; Worcester, David L.; White, Stephen H.] NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Worcester, David L.] Univ Missouri, Div Biol, Columbia, MO 65211 USA; [Gawrisch, Klaus] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA; [Krepkiy, Dmitriy; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Institute of Standards & Technology (NIST) - USA; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	White, SH (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	stephen.white@uci.edu; swartzk@ninds.nih.gov	Freites, J. Alfredo/S-8027-2017; White, Stephen H/B-1053-2009; Tobias, Douglas J/B-6799-2015	Freites, J. Alfredo/0000-0001-5842-7443; White, Stephen H/0000-0001-8540-7907; 	Intramural Research Programs of the NINDS, NIH [GM86685]; National Institute on Alcohol Abuse and Alcoholism, NIH [GM74737]; National Institute of General Medical Science; US National Science Foundation (NSF) [CHE-0750175]; Division Of Chemistry [0750175] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074637, R01GM074737, P01GM086685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER	Intramural Research Programs of the NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Alcohol Abuse and Alcoholism, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank the US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) DNA sequencing facility for DNA sequencing, H. Jaffe in the NINDS protein sequencing facility for mass spectrometry and peptide sequencing and T. Kitaguchi for cloning KvAP. We also thank T. Kimura, M. Mayer, M. Milescu, J. Mindell and S. Silberberg for discussions. This work was supported by the Intramural Research Programs of the NINDS, NIH ( K. J. S.), and the National Institute on Alcohol Abuse and Alcoholism, NIH ( K. G.); NIH grants GM74737 ( S. H. W.) and Program Project GM86685 from the NINDS and the National Institute of General Medical Science ( S. H. W., D. J. T.); and US National Science Foundation (NSF) grant CHE-0750175 ( D. J. T.). We are grateful for allocation of computer time on the NSF-supported Teragrid resources provided by the Texas Advanced Computing Center, and the support of the National Institute of Standards and Technology, US Department of Commerce, in providing the neutron research facilities used for neutron diffraction experiments. The identification of any commercial product or trade name does not imply endorsement or recommendation by the US National Institute of Standards and Technology.	ABRAMS FS, 1993, BIOCHEMISTRY-US, V32, P10826, DOI 10.1021/bi00091a038; Ader C, 2009, J AM CHEM SOC, V131, P170, DOI 10.1021/ja806306e; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Benz RW, 2005, BIOPHYS J, V88, P805, DOI 10.1529/biophysj.104.046821; BLASIE JK, 1976, BROOKHAVEN SYM BIOL, pR58; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Freites JA, 2006, BIOPHYS J, V91, pL90, DOI 10.1529/biophysj.106.096065; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Grubmuller H, 1991, MOL SIMULAT, V6, P121, DOI 10.1080/08927029108022142; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hristova K, 1998, BIOPHYS J, V74, P2419, DOI 10.1016/S0006-3495(98)77950-0; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HURST RO, 1964, CAN J BIOCHEM PHYS, V42, P287, DOI 10.1139/o64-033; JACOBS RE, 1989, BIOCHEMISTRY-US, V28, P3421, DOI 10.1021/bi00434a042; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Laitko U, 2006, J GEN PHYSIOL, V127, P687, DOI 10.1085/jgp.200509394; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee A G, 1994, Methods Mol Biol, V27, P101; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lindahl E, 2008, CURR OPIN STRUC BIOL, V18, P425, DOI 10.1016/j.sbi.2008.02.003; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Soubias O, 2005, J AM CHEM SOC, V127, P13110, DOI 10.1021/ja0538942; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tabarean IV, 1999, BIOPHYS J, V77, P758, DOI 10.1016/S0006-3495(99)76930-4; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Treptow W, 2006, BIOPHYS J, V90, pL64, DOI 10.1529/biophysj.106.080754; Vamvouka M, 2008, PROTEIN SCI, V17, P506, DOI 10.1110/ps.073310008; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; WIENER MC, 1991, BIOPHYS J, V60, P568, DOI 10.1016/S0006-3495(91)82086-0; WIENER MC, 1991, BIOCHEMISTRY-US, V30, P6997, DOI 10.1021/bi00242a027; WORCESTER DL, 1976, J MOL BIOL, V100, P359, DOI 10.1016/S0022-2836(76)80068-X; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	81	160	160	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					473	U168		10.1038/nature08542	http://dx.doi.org/10.1038/nature08542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940918	Green Accepted, Green Submitted			2022-12-28	WOS:000272144200036
J	Pescovitz, MD; Greenbaum, CJ; Krause-Steinrauf, H; Becker, DJ; Gitelman, SE; Goland, R; Gottlieb, PA; Marks, JB; McGee, PF; Moran, AM; Raskin, P; Rodriguez, H; Schatz, DA; Wherrett, D; Wilson, DM; Lachin, JM; Skyler, JS				Pescovitz, Mark D.; Greenbaum, Carla J.; Krause-Steinrauf, Heidi; Becker, Dorothy J.; Gitelman, Stephen E.; Goland, Robin; Gottlieb, Peter A.; Marks, Jennifer B.; McGee, Paula F.; Moran, Antoinette M.; Raskin, Philip; Rodriguez, Henry; Schatz, Desmond A.; Wherrett, Diane; Wilson, Darrell M.; Lachin, John M.; Skyler, Jay S.		Type 1 Diabet TrialNet Anti-CD20	Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-CD20 MONOCLONAL-ANTIBODY; ANTIGEN-PRESENTING CELLS; IN-VIVO; RHEUMATOID-ARTHRITIS; AUTOIMMUNE; THERAPY; CYCLOSPORINE; TOLERANCE; RESPONSES	BACKGROUND The immunopathogenesis of type 1 diabetes mellitus is associated with T-lymphocyte autoimmunity. However, there is growing evidence that B lymphocytes play a role in many T-lymphocyte-mediated diseases. It is possible to achieve selective depletion of B lymphocytes with rituximab, an anti-CD20 monoclonal antibody. This phase 2 study evaluated the role of B-lymphocyte depletion in patients with type 1 diabetes. METHODS We conducted a randomized, double-blind study in which 87 patients between 8 and 40 years of age who had newly diagnosed type 1 diabetes were assigned to receive infusions of rituximab or placebo on days 1, 8, 15, and 22 of the study. The primary outcome, assessed 1 year after the first infusion, was the geometric mean area under the curve (AUC) for the serum C-peptide level during the first 2 hours of a mixed-meal tolerance test. Secondary outcomes included safety and changes in the glycated hemoglobin level and insulin dose. RESULTS At 1 year, the mean AUC for the level of C peptide was significantly higher in the rituximab group than in the placebo group. The rituximab group also had significantly lower levels of glycated hemoglobin and required less insulin. Between 3 months and 12 months, the rate of decline in C-peptide levels in the rituximab group was significantly less than that in the placebo group. CD19+ B lymphocytes were depleted in patients in the rituximab group, but levels increased to 69% of baseline values at 12 months. More patients in the rituximab group than in the placebo group had adverse events, mostly grade 1 or grade 2, after the first infusion. The reactions appeared to be minimal with subsequent infusions. There was no increase in infections or neutropenia with rituximab. CONCLUSIONS A four-dose course of rituximab partially preserved beta-cell function over a period of 1 year in patients with type 1 diabetes. The finding that B lymphocytes contribute to the pathogenesis of type 1 diabetes may open a new pathway for exploration in the treatment of patients with this condition. (ClinicalTrials.gov number, NCT00279305.)	[Pescovitz, Mark D.; Rodriguez, Henry] Indiana Univ Sch Med, Indianapolis, IN USA; [Greenbaum, Carla J.] Benaroya Res Inst, Seattle, WA USA; [Krause-Steinrauf, Heidi; McGee, Paula F.; Lachin, John M.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [Becker, Dorothy J.] Univ Pittsburgh, Pittsburgh, PA USA; [Gitelman, Stephen E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goland, Robin] Columbia Univ, New York, NY USA; [Gottlieb, Peter A.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Moran, Antoinette M.] Univ Minnesota, Minneapolis, MN USA; [Raskin, Philip] Univ Texas SW Med Sch, Dallas, TX USA; [Schatz, Desmond A.] Univ Florida, Gainesville, FL USA; [Wherrett, Diane] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wilson, Darrell M.] Stanford Univ, Stanford, CA 94305 USA	Indiana University System; Indiana University Bloomington; Benaroya Research Institute; George Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; Columbia University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Florida; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University	Pescovitz, MD (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, Type Diabet TrialNet Chairmans Off 1, POB 016960,D-110, Miami, FL 33136 USA.		Skyler, Jay S/F-4211-2016; Toledo, Frederico/G-9071-2013	Toledo, Frederico/0000-0002-6570-9948; Skyler, Jay/0000-0003-1136-8110; Lachin, John/0000-0001-9838-2841	National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; General Clinical Research Centers Program; Juvenile Diabetes Research Foundation International; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK103282, U01DK061058, R21DK077329, U01DK061034] Funding Source: NIH RePORTER	National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Type 1 Diabetes TrialNet Study Group, a clinical-trials network funded by the National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Human Development, and the General Clinical Research Centers Program; the Juvenile Diabetes Research Foundation International; and the American Diabetes Association.	Agarwal A, 2004, AM J TRANSPLANT, V4, P1357, DOI 10.1111/j.1600-6143.2004.00502.x; Bearden CM, 2005, AM J TRANSPLANT, V5, P50, DOI 10.1111/j.1600-6143.2003.00646.x; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Cattaneo C, 2006, LEUKEMIA LYMPHOMA, V47, P1013, DOI 10.1080/10428190500473113; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Fervenza FC, 2008, KIDNEY INT, V73, P117, DOI 10.1038/sj.ki.5002628; FEUTREN G, 1992, NEW ENGL J MED, V326, P1654, DOI 10.1056/NEJM199206183262502; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2652, DOI 10.1002/art.23732; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kim HJ, 1999, J IMMUNOL, V162, P3053; Lapointe R, 2003, CANCER RES, V63, P2836; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; MAHON JL, 1993, ANN NY ACAD SCI, V696, P351; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Noorchashm H, 1999, J IMMUNOL, V163, P743; Noorchashm H, 2003, IMMUNOL RES, V27, P443, DOI 10.1385/IR:27:2-3:443; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941; OCHS HD, 1971, J CLIN INVEST, V50, P2559, DOI 10.1172/JCI106756; Palmer JP, 2004, DIABETES, V53, P1934; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Pescovitz MD, 2004, PEDIATR TRANSPLANT, V8, P9, DOI 10.1046/j.1397-3142.2003.00135.x; Piro LD, 1999, ANN ONCOL, V10, P655, DOI 10.1023/A:1008389119525; REFF ME, 1994, BLOOD, V83, P435; Rivera A, 2001, INT IMMUNOL, V13, P1583, DOI 10.1093/intimm/13.12.1583; Schernthaner G, 1995, HORM METAB RES, V27, P547, DOI 10.1055/s-2007-980023; Serreze David V, 2003, Curr Dir Autoimmun, V6, P212; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sosenko JM, 2004, DIABETES, V53, pA425; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; YILMAZ MT, 1993, DIABETES RES CLIN PR, V19, P151, DOI 10.1016/0168-8227(93)90108-H	36	713	746	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2143	2152		10.1056/NEJMoa0904452	http://dx.doi.org/10.1056/NEJMoa0904452			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524BC	19940299	Green Accepted, Green Submitted			2022-12-28	WOS:000272117800008
J	Aanen, DK; Licht, HHD; Debets, AJM; Kerstes, NAG; Hoekstra, RF; Boomsma, JJ				Aanen, Duur K.; Licht, Henrik H. de Fine; Debets, Alfons J. M.; Kerstes, Niels A. G.; Hoekstra, Rolf F.; Boomsma, Jacobus J.			High Symbiont Relatedness Stabilizes Mutualistic Cooperation in Fungus-Growing Termites	SCIENCE			English	Article							MACROTERMES-NATALENSIS; EVOLUTION; TERMITOMYCES; AGRICULTURE; ISOPTERA; HOST; ANTS; INCOMPATIBILITY; TRANSMISSION; CONFLICT	It is unclear how mutualistic relationships can be stable when partners disperse freely and have the possibility of forming associations with many alternative genotypes. Theory predicts that high symbiont relatedness should resolve this problem, but the mechanisms to enforce this have rarely been studied. We show that African fungus-growing termites propagate single variants of their Termitomyces symbiont, despite initiating cultures from genetically variable spores from the habitat. High inoculation density in the substrate followed by fusion among clonally related mycelia enhances the efficiency of spore production in proportion to strain frequency. This positive reinforcement results in an exclusive lifetime association of each host colony with a single fungal symbiont and hinders the evolution of cheating. Our findings explain why vertical symbiont transmission in fungus-growing termites is rare and evolutionarily derived.	[Aanen, Duur K.; Debets, Alfons J. M.; Kerstes, Niels A. G.; Hoekstra, Rolf F.] Wageningen Univ, Genet Lab, NL-6700 AH Wageningen, Netherlands; [Licht, Henrik H. de Fine; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark	Wageningen University & Research; University of Copenhagen	Aanen, DK (corresponding author), Wageningen Univ, Genet Lab, NL-6700 AH Wageningen, Netherlands.	duur.aanen@wur.nl	de Fine Licht, Henrik Hjarvard/G-3307-2014; Boomsma, Jacobus J/M-2785-2014	de Fine Licht, Henrik Hjarvard/0000-0003-3326-5729; Boomsma, Jacobus J/0000-0002-3598-1609	Netherlands Organization for Scientific Research-Vidi; C. T. de Wit Graduate School for Production Ecology and Resource Conservation; Wageningen University, Netherlands; Danish National Research Foundation; Danish Natural Science Research Council-STENO	Netherlands Organization for Scientific Research-Vidi(Netherlands Organization for Scientific Research (NWO)); C. T. de Wit Graduate School for Production Ecology and Resource Conservation; Wageningen University, Netherlands(Netherlands Government); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council-STENO	We were supported by fellowships from the Netherlands Organization for Scientific Research-Vidi (D. K. A.); the C. T. de Wit Graduate School for Production Ecology and Resource Conservation, Wageningen University, Netherlands (D. K. A.); the Danish National Research Foundation (J. J. B.); and the Danish Natural Science Research Council-STENO (D. K. A.). We thank A. de Visser for help with statistical analyses and for comments on an earlier version of the manuscript, T. Nobre for comments, B. Nieuwenhuis for help with the figures, and the Forestry and Agricultural Biotechnology Institute (FABI) team led by M. Wingfield at the University of Pretoria for providing facilities during field and laboratory work.	Aanen DK, 2005, CURR BIOL, V15, P851, DOI 10.1016/j.cub.2005.03.043; Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Aanen DK, 2006, BIOL LETT-UK, V2, P209, DOI 10.1098/rsbl.2005.0424; Aanen DK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-115; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P189; Brandl R, 2007, MOL PHYLOGENET EVOL, V45, P239, DOI 10.1016/j.ympev.2007.07.007; BULL JJ, 1991, J THEOR BIOL, V149, P63, DOI 10.1016/S0022-5193(05)80072-4; Chamberlain M, 1997, ADV BOT RES, V24, P71; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Darlington Johanna P. E. C., 1994, P105; de Fine Licht HH, 2005, MYCOL RES, V109, P314, DOI 10.1017/S0953756204001844; EMERSON ALFRED E., 1955, FIELDIANA ZOOL, V37, P465; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Frank SA, 1997, AM NAT, V150, pS80, DOI 10.1086/286051; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Korb J, 2003, BEHAV ECOL SOCIOBIOL, V53, P65, DOI 10.1007/s00265-002-0559-y; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Licht HHF, 2006, MOL ECOL, V15, P3131, DOI 10.1111/j.1365-294X.2006.03008.x; Micali CO, 2003, FUNGAL GENET BIOL, V38, P209, DOI 10.1016/S1087-1845(02)00533-9; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Rouland-Lefevre C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P289; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Szathmary E, 1995, MAJOR TRANSITIONS EV; Wood T.G., 1989, P69; Worrall JJ, 1997, MYCOLOGIA, V89, P24, DOI 10.2307/3761169	34	103	108	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1103	1106		10.1126/science.1173462	http://dx.doi.org/10.1126/science.1173462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965427				2022-12-28	WOS:000271951000041
J	Lilford, RJ				Lilford, Richard J.			Should the NHS strive to eradicate all unexplained variation? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS		Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Lilford, RJ (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk						Black N, 1996, BRIT MED J, V312, P1215; Djulbegovic B, 2009, CANCER CONTROL, V16, P342, DOI 10.1177/107327480901600409; EDWARDS SJL, 1998, HLTH TECHNOL ASSESS, V2; EVERETT C, 1987, BRIT MED J, V295, P583, DOI 10.1136/bmj.295.6598.583; Gillies D, 2005, STUD HIST PHI PART C, V36, P159, DOI 10.1016/j.shpsc.2004.12.003; Gore A, 2007, ASSAULT REASON; Jones P, 1998, LANCET, V352, P1988, DOI 10.1016/S0140-6736(05)61334-7; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SILVERMAN W, 1980, PERINATAL AUDIT SURV, P110	10	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2009	339								b4809	10.1136/bmj.b4809	http://dx.doi.org/10.1136/bmj.b4809			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523TD	19926689				2022-12-28	WOS:000272096500006
J	Bosworth, HB; Olsen, MK; Grubber, JM; Neary, AM; Orr, MM; Powers, BJ; Adams, MB; Svetkey, LP; Reed, SD; Li, YH; Dolor, RJ; Oddone, EZ				Bosworth, Hayden B.; Olsen, Maren K.; Grubber, Janet M.; Neary, Alice M.; Orr, Melinda M.; Powers, Benjamin J.; Adams, Martha B.; Svetkey, Laura P.; Reed, Shelby D.; Li, Yanhong; Dolor, Rowena J.; Oddone, Eugene Z.			Two Self-management Interventions to Improve Hypertension Control A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; DIETARY PATTERNS; METAANALYSIS; MEDICATION; REDUCTION; EDUCATION; LITERACY; EXERCISE; ADULTS	Background: Fewer than 40% of persons with hypertension in the United States have adequate blood pressure (BP) control. Objective: To compare 2 self-management interventions for improving BP control among hypertensive patients. Design: A 2 x 2 randomized trial, stratified by enrollment site and patient health literacy status, with 2-year follow-up. (ClinicalTrials.gov registration number: NCT00123058) Setting: 2 university-affiliated primary care clinics. Patients: 636 hypertensive patients. Intervention: A centralized, blinded, and stratified randomization algorithm was used to randomly assign eligible patients to receive usual care, a behavioral intervention (bimonthly tailored, nurse-administered telephone intervention targeting hypertension-related behaviors), home BP monitoring 3 times weekly, or the behavioral intervention plus home BP monitoring. Measurements: The primary outcome was BP control at 6-month intervals over 24 months. Results: 475 patients (75%) completed the 24-month BP follow-up. At 24 months, improvements in the proportion of patients with BP control relative to the usual care group were 4.3% (95% CI, -4.5% to 12.9%) in the behavioral intervention group, 7.6% (CI, -1.9% to 17.0%) in the home BP monitoring group, and 11.0% (CI, 1.9%, 19.8%) in the combined intervention group. Relative to usual care, the 24-month difference in systolic BP was 0.6 mm Hg (CI, -2.2 to 3.4 mm Hg) for the behavioral intervention group, -0.6 mm Hg (CI, -3.6 to 2.3 mm Hg) for the BP monitoring group, and -3.9 mm Hg (CI, -6.9 to -0.9 mm Hg) for the combined intervention group; patterns were similar for diastolic BP. Limitation: Changes in medication use and diet were monitored only in intervention participants; 24-month outcome data were missing for 25% of participants, BP control was adequate at baseline in 73% of participants, and the study setting was an academic health center. Conclusion: Combined home BP monitoring and tailored behavioral telephone intervention improved BP control, systolic BP, and diastolic BP at 24 months relative to usual care.	[Bosworth, Hayden B.] Duke Univ, Ctr Hlth Serv Res Primary Care, Durham Vet Affairs Med Ctr, Ctr Aging & Human Dev,Duke Hypertens Ctr, Durham, NC 27703 USA; Duke Univ, Duke Clin Res Inst, Durham, NC 27703 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Bosworth, HB (corresponding author), Duke Univ, Ctr Hlth Serv Res Primary Care, Durham Vet Affairs Med Ctr, Ctr Aging & Human Dev,Duke Hypertens Ctr, 2424 Erwin Rd,Hock Plaza, Durham, NC 27703 USA.	hayden.bosworth@duke.edu	li, yan/GTI-4638-2022	Dolor, Rowena/0000-0001-7317-9468	National Heart, Lung, and Blood Institute [R01 HL070713]; Pfizer Foundation Health Communication Initiative Award; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070713] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer Foundation Health Communication Initiative Award; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By grant R01 HL070713 from the National Heart, Lung, and Blood Institute; a Pfizer Foundation Health Communication Initiative Award; and an Established Investigator Award from the American Heart Association (Dr. Bosworth).	Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Balding DJ, 2004, APPL LONGITUDINAL AN; Bosworth HB, 2008, PATIENT EDUC COUNS, V70, P338, DOI 10.1016/j.pec.2007.11.014; Bosworth HB, 2009, AM HEART J, V157, P450, DOI 10.1016/j.ahj.2008.11.003; Bosworth HB, 2005, CONTEMP CLIN TRIALS, V26, P155, DOI 10.1016/j.cct.2004.12.006; Bosworth HB, 2001, PSYCHOSOM MED, V63, P603, DOI 10.1097/00006842-200107000-00013; Boulware LE, 2001, AM J PREV MED, V21, P221, DOI 10.1016/S0749-3797(01)00356-7; CAMPBELL NRC, 1995, CAN J CARDIOL, V11, pH18; Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cutler Jeffrey A., 1991, Annals of Epidemiology, V1, P363, DOI 10.1016/1047-2797(91)90046-F; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Hedeker D., 2006, LONGITUDINAL DATA AN; Karanja NM, 1999, J AM DIET ASSOC, V99, pS19, DOI 10.1016/S0002-8223(99)00412-5; Kelley GA, 2000, HYPERTENSION, V35, P838, DOI 10.1161/01.HYP.35.3.838; Kincaid J. P., 1975, 875 NAV AIR STAT MEM; MORISKY DE, 1985, HEALTH EDUC QUART, V12, P35, DOI 10.1177/109019818501200104; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Pickering TG, 2008, J CARDIOVASC NURS, V23, P299, DOI 10.1097/01.JCN.0000317429.98844.04; Sacks FM, 1999, CLIN CARDIOL, V22, P6, DOI 10.1002/clc.4960221503; *SAS KNOWL BAS, SAMPL SAS NOT SAMPL; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; STAHL SM, 1984, AM J PUBLIC HEALTH, V74, P704, DOI 10.2105/AJPH.74.7.704; Svetkey LP, 1999, ARCH INTERN MED, V159, P285, DOI 10.1001/archinte.159.3.285; Svetkey LP, 1999, J AM DIET ASSOC, V99, pS96, DOI 10.1016/S0002-8223(99)00423-X; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	33	195	201	2	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					687	W224		10.7326/0000605-200911170-00148	http://dx.doi.org/10.7326/0000605-200911170-00148			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920269				2022-12-28	WOS:000272145100002
J	Aranegui, B; Florez, A; Garcia-Doval, I; Garcia-Cruz, A; de la Torre, C; Cruces, M				Aranegui, Beatriz; Florez, Angeles; Garcia-Doval, Ignacio; Garcia-Cruz, Aranzazu; de la Torre, Carlos; Cruces, Manuel			Lesson of the Week Generalised tetanus in a patient with a chronic ulcerated skin lesion	BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; IMMUNITY; DIPHTHERIA		[Aranegui, Beatriz; Florez, Angeles; Garcia-Doval, Ignacio; Garcia-Cruz, Aranzazu; de la Torre, Carlos; Cruces, Manuel] Hosp Prov, Dept Dermatol, Pontevedra 36002, Spain	Complexo Hospitalario Universitario de Pontevedra	Aranegui, B (corresponding author), Hosp Prov, Dept Dermatol, Complexo Hosp Pontevedra, Pontevedra 36002, Spain.	baranegui@gmail.com	Garcia-Doval, Ignacio/A-3703-2009	Garcia-Doval, Ignacio/0000-0002-6881-5260				Antona D., 2006, Bulletin Epidemiologique Hebdomadaire, P53; Bardenheier B, 1998, MMWR CDC Surveill Summ, V47, P1; Dhalla S, 2004, CAN J SURG, V47, P375; FLESHNER PR, 1988, AM J GASTROENTEROL, V83, P298; GERGEN P, 1995, NEW ENGL J MED, V332, P761, DOI 10.1056/NEJM199503233321201; Greco J B, 2001, Braz J Infect Dis, V5, P319; Health Protection Agency, 2003, TET INF HLTH PROF; Izurieta H S, 1997, MMWR CDC Surveill Summ, V46, P15; Katz KC, 2000, CAN MED ASSOC J, V163, P571; Korber A, 2008, DERMATOLOGY, V217, P69, DOI 10.1159/000127317; Maple PAC, 2000, VACCINE, V19, P167, DOI 10.1016/S0264-410X(00)00184-5; McQuillan GM, 2002, ANN INTERN MED, V136, P660, DOI 10.7326/0003-4819-136-9-200205070-00008; Mekkes JR, 2003, BRIT J DERMATOL, V148, P388, DOI 10.1046/j.1365-2133.2003.05222.x; *MIN SAN CONS GOB, 2009, VAC AD REC VAC DIFT; Panning CA, 1999, PHARMACOTHERAPY, V19, P885, DOI 10.1592/phco.19.10.885.31549; Pascual F Brian, 2003, MMWR Surveill Summ, V52, P1; Quinn HE, 2007, VACCINE, V25, P1304, DOI 10.1016/j.vaccine.2006.09.084; Rogers Lee C, 2006, Clin Podiatr Med Surg, V23, P769; Texier S, 2004, PRESSE MED, V33, P759, DOI 10.1016/S0755-4982(04)98733-7; *WHO, 2008, TET; 2006, WKLY EPIDEMIOL REC, P198	21	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 13	2009	339								b4419	10.1136/bmj.b4419	http://dx.doi.org/10.1136/bmj.b4419			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HO	19914951				2022-12-28	WOS:000271834100002
J	Schachman, HK; Cassman, M				Schachman, Howard K.; Cassman, Marvin			Ruth L. Kirschstein (1926-2009) RETROSPECTIVE	SCIENCE			English	Biographical-Item									[Schachman, Howard K.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schachman, HK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, QB3 Stanley Hall, Berkeley, CA 94720 USA.	howardschachman@berkeley.edu; mcassman@sbcglobal.net						KIRSCHSTEIN RL, PUBLICATION LIST	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					947	947		10.1126/science.1183756	http://dx.doi.org/10.1126/science.1183756			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965503				2022-12-28	WOS:000271712300024
J	Yazaki-Sugiyama, Y; Kang, S; Cateau, H; Fukai, T; Hensch, TK				Yazaki-Sugiyama, Yoko; Kang, Siu; Cateau, Hideyuki; Fukai, Tomoki; Hensch, Takao K.			Bidirectional plasticity in fast-spiking GABA circuits by visual experience	NATURE			English	Article							CRITICAL PERIOD PLASTICITY; DEPENDENT PLASTICITY; INTRACELLULAR BLOCKADE; MONOCULAR DEPRIVATION; OCULAR DOMINANCE; CORTEX; INHIBITION; RESPONSES; NEURONS; SYNAPSES	Experience-dependent plasticity in the brain requires balanced excitation-inhibition1. How individual circuit elements contribute to plasticity outcome in complex neocortical networks remains unknown. Here we report an intracellular analysis of ocular dominance plasticity-the loss of acuity and cortical responsiveness for an eye deprived of vision in early life2,3. Unlike the typical progressive loss of pyramidal-cell bias, direct recording from fast-spiking cells in vivo reveals a counterintuitive initial shift towards the occluded eye followed by a late preference for the open eye, consistent with a spike-timing-dependent plasticity rule for these inhibitory neurons. Intracellular pharmacology confirms a dynamic switch of GABA (c-aminobutyric acid) impact to pyramidal cells following deprivation in juvenile mice only. Together these results suggest that the bidirectional recruitment of an initially binocular GABA circuit may contribute to experience-dependent plasticity in the developing visual cortex.	[Yazaki-Sugiyama, Yoko; Hensch, Takao K.] CREST, JST, Osaka 5600082, Japan; [Yazaki-Sugiyama, Yoko; Hensch, Takao K.] RIKEN Brain Sci Inst, Lab Neuronal Circuit Dev, Saitama 3510198, Japan; [Kang, Siu; Cateau, Hideyuki; Fukai, Tomoki] RIKEN Brain Science Institute, Lab Neural Circuit Theory, Saitama 3510198, Japan	Japan Science & Technology Agency (JST); RIKEN; RIKEN			Hensch, Takao/L-4182-2019; Yazaki-Sugiyama, Yoko/G-4950-2015; Fukai, Tomoki/A-3936-2015; Cateau, Hideyuki/R-9446-2016	Yazaki-Sugiyama, Yoko/0000-0003-2052-4162; Fukai, Tomoki/0000-0001-6977-5638; Cateau, Hideyuki/0000-0002-8861-0916				Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; Erisir A, 2005, J COMP NEUROL, V485, P11, DOI 10.1002/cne.20507; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; INOMATA N, 1988, NEUROSCI RES, V6, P72, DOI 10.1016/0168-0102(88)90007-7; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mainardi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004342; Mancilla JG, 2001, VISUAL NEUROSCI, V18, P9, DOI 10.1017/S0952523801181022; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	30	142	144	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 12	2009	462	7270					218	221		10.1038/nature08485	http://dx.doi.org/10.1038/nature08485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907494				2022-12-28	WOS:000271655100048
J	Fujii, H; Chinnusamy, V; Rodrigues, A; Rubio, S; Antoni, R; Park, SY; Cutler, SR; Sheen, J; Rodriguez, PL; Zhu, JK				Fujii, Hiroaki; Chinnusamy, Viswanathan; Rodrigues, Americo; Rubio, Silvia; Antoni, Regina; Park, Sang-Youl; Cutler, Sean R.; Sheen, Jen; Rodriguez, Pedro L.; Zhu, Jian-Kang			In vitro reconstitution of an abscisic acid signalling pathway	NATURE			English	Article							PROTEIN PHOSPHATASES; GENE-EXPRESSION; IDENTIFICATION; TRANSDUCTION; RECEPTORS; INTERACTS; GROWTH; ABA	The phytohormone abscisic acid (ABA) regulates the expression of many genes in plants; it has critical functions in stress resistance and in growth and development(1-7). Several proteins have been reported to function as ABA receptors(8-13), and many more are known to be involved in ABA signalling(3,4,14). However, the identities of ABA receptors remain controversial and the mechanism of signalling from perception to downstream gene expression is unclear(15,16). Here we show that by combining the recently identified ABA receptor PYR1 with the type 2C protein phosphatase (PP2C) ABI1, the serine/threonine protein kinase SnRK2.6/OST1 and the transcription factor ABF2/AREB1, we can reconstitute ABA-triggered phosphorylation of the transcription factor in vitro. Introduction of these four components into plant protoplasts results in ABA-responsive gene expression. Protoplast and test-tube reconstitution assays were used to test the function of various members of the receptor, protein phosphatase and kinase families. Our results suggest that the default state of the SnRK2 kinases is an autophosphorylated, active state and that the SnRK2 kinases are kept inactive by the PP2Cs through physical interaction and dephosphorylation. We found that in the presence of ABA, the PYR/PYL (pyrabactin resistance 1/PYR1-like) receptor proteins can disrupt the interaction between the SnRK2s and PP2Cs, thus preventing the PP2C-mediated dephosphorylation of the SnRK2s and resulting in the activation of the SnRK2 kinases. Our results reveal new insights into ABA signalling mechanisms and define a minimal set of core components of a complete major ABA signalling pathway.	[Fujii, Hiroaki; Chinnusamy, Viswanathan; Park, Sang-Youl; Cutler, Sean R.; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Fujii, Hiroaki; Chinnusamy, Viswanathan; Zhu, Jian-Kang] 4700 King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal 239556900, Saudi Arabia; [Rodrigues, Americo; Rubio, Silvia; Antoni, Regina; Rodriguez, Pedro L.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, ES-46022 Valencia, Spain; [Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	University of California System; University of California Riverside; King Abdullah University of Science & Technology; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Harvard University; Massachusetts General Hospital	Zhu, JK (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Cutler, Sean R/D-6617-2011; Zhu, Jian-Kang/F-7658-2011; Rodriguez, Pedro L./K-4605-2014; Chinnusamy, Viswanathan/B-9079-2009; Rodrigues, Americo/F-9573-2010	Zhu, Jian-Kang/0000-0001-5134-731X; Rodriguez, Pedro L./0000-0002-5886-9425; Chinnusamy, Viswanathan/0000-0003-2174-9064; Rodrigues, Americo/0000-0002-5293-5583; Cutler, Sean/0000-0002-8593-0885; Fujii, Hiroaki/0000-0002-0013-5891	National Institutes of Health; MICIIN; CSIC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MICIIN; CSIC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Bressan for helpful discussions and for editing of the manuscript. This work was supported by National Institutes of Health grants ( J.- K. Z.) and MICIIN and CSIC fellowships ( S. R. and R. A.).	Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kuhn JM, 2003, CURR OPIN PLANT BIOL, V6, P463, DOI 10.1016/S1369-5266(03)00084-0; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pennisi E, 2009, SCIENCE, V324, P1012, DOI 10.1126/science.324_1012; Roelfsema MRG, 2005, NEW PHYTOL, V167, P665, DOI 10.1111/j.1469-8137.2005.01460.x; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	30	825	892	8	338	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					660	U138		10.1038/nature08599	http://dx.doi.org/10.1038/nature08599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19924127	Green Accepted, Green Submitted			2022-12-28	WOS:000272277900043
J	McShane, M; Smith, R				McShane, Martin; Smith, Richard			The NHS in the simulator	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Smith, Richard] UnitedHlth Chron Dis Initiat, London SW4 0LD, England; [McShane, Martin] NHS Lincolnshire, Lincoln LN4 2HN, England	University of Lincoln	Smith, R (corresponding author), UnitedHlth Chron Dis Initiat, London SW4 0LD, England.	richardswsmith@yahoo.co.uk						APPLLEBY J, 2009, COLD WILL IT BE PROS; *E ANGL ERG HLTH A, 1990, RUBB WINDM MARK SIM; Harvey S., 2009, WINDMILL 2009 NHS RE; HARVEY S, 2007, WINDMILL 2007 FUTURE	4	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 3	2009	339								b4868	10.1136/bmj.b4868	http://dx.doi.org/10.1136/bmj.b4868			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NT	19959584				2022-12-28	WOS:000272453400007
J	Hurtley, S				Hurtley, Stella			Location, Location, Location INTRODUCTION	SCIENCE			English	Editorial Material																			0	40	41	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1205	1205		10.1126/science.326.5957.1205	http://dx.doi.org/10.1126/science.326.5957.1205			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	524BD	19965460				2022-12-28	WOS:000272117900031
J	Yus, E; Maier, T; Michalodimitrakis, K; van Noort, V; Yamada, T; Chen, WH; Wodke, JAH; Guell, M; Martinez, S; Bourgeois, R; Kuhner, S; Raineri, E; Letunic, I; Kalinina, OV; Rode, M; Herrmann, R; Gutierrez-Gallego, R; Russell, RB; Gavin, AC; Bork, P; Serrano, L				Yus, Eva; Maier, Tobias; Michalodimitrakis, Konstantinos; van Noort, Vera; Yamada, Takuji; Chen, Wei-Hua; Wodke, Judith A. H.; Gueell, Marc; Martinez, Sira; Bourgeois, Ronan; Kuehner, Sebastian; Raineri, Emanuele; Letunic, Ivica; Kalinina, Olga V.; Rode, Michaela; Herrmann, Richard; Gutierrez-Gallego, Ricardo; Russell, Robert B.; Gavin, Anne-Claude; Bork, Peer; Serrano, Luis			Impact of Genome Reduction on Bacterial Metabolism and Its Regulation	SCIENCE			English	Article							MYCOPLASMA-PNEUMONIAE; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; MOLLICUTES; GENES; ANNOTATION; SEQUENCE; GROWTH	To understand basic principles of bacterial metabolism organization and regulation, but also the impact of genome size, we systematically studied one of the smallest bacteria, Mycoplasma pneumoniae. A manually curated metabolic network of 189 reactions catalyzed by 129 enzymes allowed the design of a defined, minimal medium with 19 essential nutrients. More than 1300 growth curves were recorded in the presence of various nutrient concentrations. Measurements of biomass indicators, metabolites, and C-13-glucose experiments provided information on directionality, fluxes, and energetics; integration with transcription profiling enabled the global analysis of metabolic regulation. Compared with more complex bacteria, the M. pneumoniae metabolic network has a more linear topology and contains a higher fraction of multifunctional enzymes; general features such as metabolite concentrations, cellular energetics, adaptability, and global gene expression responses are similar, however.	[van Noort, Vera; Yamada, Takuji; Chen, Wei-Hua; Kuehner, Sebastian; Letunic, Ivica; Kalinina, Olga V.; Rode, Michaela; Russell, Robert B.; Gavin, Anne-Claude; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Yus, Eva; Maier, Tobias; Michalodimitrakis, Konstantinos; Wodke, Judith A. H.; Gueell, Marc; Martinez, Sira; Bourgeois, Ronan; Raineri, Emanuele; Serrano, Luis] CRG, Barcelona 08003, Spain; [Yus, Eva; Maier, Tobias; Michalodimitrakis, Konstantinos; Wodke, Judith A. H.; Gueell, Marc; Martinez, Sira; Bourgeois, Ronan; Raineri, Emanuele; Serrano, Luis] Univ Pompeu Fabra, Barcelona 08003, Spain; [Kalinina, Olga V.; Herrmann, Richard] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia; [Gutierrez-Gallego, Ricardo] ZMBH, D-69120 Heidelberg, Germany; Univ Pompeu Fabra, Dept Expt & Hlth Sci, Inst Municipal Invest Med, Hosp del Mar, Barcelona 08003, Spain; [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Ruprecht Karls University Heidelberg; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; ICREA	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; luis.serrano@crg.es	van Noort, Vera/GWZ-9038-2022; van Noort, Vera/E-1053-2011; Herrmann, Richard/K-2809-2016; Bork, Peer/F-1813-2013; Russell, Robert/GWU-6389-2022; Letunic, Ivica/K-1102-2019; Letunic, Ivica/A-6032-2009; Kalinina, Olga V/M-8482-2016; Raineri, Emanuele/AAX-7874-2020; Chen, Weihua/GRS-9256-2022; Serrano, Luis/B-3355-2013; Güell, Marc/AAB-3054-2021; Russell, Rob/AAH-9145-2019; Güell, Marc/J-2970-2017	van Noort, Vera/0000-0002-8436-6602; Herrmann, Richard/0000-0003-2788-3715; Bork, Peer/0000-0002-2627-833X; Russell, Robert/0000-0002-7213-1398; Letunic, Ivica/0000-0003-3560-4288; Kalinina, Olga V/0000-0002-9445-477X; Serrano, Luis/0000-0002-5276-1392; Güell, Marc/0000-0003-4000-7912; Russell, Rob/0000-0002-1905-4717; Güell, Marc/0000-0003-4000-7912; Chen, Wei-Hua/0000-0003-2168-6147; Gutierrez Gallego, Ricardo/0000-0001-9639-2181; Gavin, Anne-Claude/0000-0003-4917-2340	ICREA Funding Source: Custom	ICREA(ICREA)		Cocaign-Bousquet M, 2002, APPL MICROBIOL BIOT, V60, P24, DOI 10.1007/s00253-002-1065-x; Dallo SF, 2000, MICROB PATHOGENESIS, V29, P301, DOI 10.1006/mpat.2000.0395; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; Even S, 2002, MOL MICROBIOL, V45, P1143, DOI 10.1046/j.1365-2958.2002.03086.x; Even S, 2003, MICROBIOL-SGM, V149, P1935, DOI 10.1099/mic.0.26146-0; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goebel W, 2006, CURR OPIN MICROBIOL, V9, P123, DOI 10.1016/j.mib.2006.02.011; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Halbedel S, 2004, J BACTERIOL, V186, P7936, DOI 10.1128/JB.186.23.7936-7943.2004; Halbedel S, 2007, J MOL BIOL, V371, P596, DOI 10.1016/j.jmb.2007.05.098; Halbedel S, 2007, J MOL MICROB BIOTECH, V12, P147, DOI 10.1159/000096470; Hasselbring BM, 2006, P NATL ACAD SCI USA, V103, P16478, DOI 10.1073/pnas.0608051103; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; MANOLUKAS JT, 1988, J GEN MICROBIOL, V134, P791; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; Pachkov M, 2007, GENE, V396, P215, DOI 10.1016/j.gene.2007.02.033; Pipe LZ, 2008, MOL BIOSYST, V4, P192, DOI 10.1039/b708241j; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Pollack JD, 1997, TRENDS MICROBIOL, V5, P413; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; PROFT T, 1994, MOL MICROBIOL, V13, P337, DOI 10.1111/j.1365-2958.1994.tb00427.x; Renesto P, 2003, LANCET, V362, P447, DOI 10.1016/S0140-6736(03)14071-8; SMART JB, 1987, APPL ENVIRON MICROB, V53, P533, DOI 10.1128/AEM.53.3.533-541.1987; Su HC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-63; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	34	218	225	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1263	1268		10.1126/science.1177263	http://dx.doi.org/10.1126/science.1177263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965476				2022-12-28	WOS:000272117900048
J	Biastoch, A; Boning, CW; Schwarzkopf, FU; Lutjeharms, JRE				Biastoch, A.; Boening, C. W.; Schwarzkopf, F. U.; Lutjeharms, J. R. E.			Increase in Agulhas leakage due to poleward shift of Southern Hemisphere westerlies	NATURE			English	Article							THERMOHALINE CIRCULATION; OCEAN; ATLANTIC; VARIABILITY; MODEL; ICE	The transport of warm and salty Indian Ocean waters into the Atlantic Ocean-the Agulhas leakage-has a crucial role in the global oceanic circulation(1) and thus the evolution of future climate. At present these waters provide the main source of heat and salt for the surface branch of the Atlantic meridional overturning circulation (MOC)(2). There is evidence from past glacial-to-interglacial variations in foraminiferal assemblages(3) and model studies(4) that the amount of Agulhas leakage and its corresponding effect on the MOC has been subject to substantial change, potentially linked to latitudinal shifts in the Southern Hemisphere westerlies(5). A progressive poleward migration of the westerlies has been observed during the past two to three decades and linked to anthropogenic forcing(6), but because of the sparse observational records it has not been possible to determine whether there has been a concomitant response of Agulhas leakage. Here we present the results of a high-resolution ocean general circulation model(7,8) to show that the transport of Indian Ocean waters into the South Atlantic via the Agulhas leakage has increased during the past decades in response to the change in wind forcing. The increased leakage has contributed to the observed salinification(9) of South Atlantic thermocline waters. Both model and historic measurements off South America suggest that the additional Indian Ocean waters have begun to invade the North Atlantic, with potential implications for the future evolution of the MOC.	[Biastoch, A.; Boening, C. W.; Schwarzkopf, F. U.] Leibniz Inst Meereswissensch, D-24105 Kiel, Germany; [Lutjeharms, J. R. E.] Univ Cape Town, Dept Oceanog, ZA-7700 Rondebosch, South Africa	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Cape Town	Biastoch, A (corresponding author), Leibniz Inst Meereswissensch, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	abiastoch@ifm-geomar.de	Boening, Claus/AAW-6387-2020; Biastoch, Arne/B-5219-2014; Boening, Claus W/HIR-8996-2022; Schwarzkopf, Franziska/P-7621-2019; Boening, Claus W/B-1686-2012	Boening, Claus/0000-0002-6251-5777; Biastoch, Arne/0000-0003-3946-4390; Boening, Claus W/0000-0002-6251-5777; Schwarzkopf, Franziska/0000-0002-2747-8456; Boening, Claus W/0000-0002-6251-5777	DFG [BO 907/2-2, SFB 754]; BMBF [SUA 07/004]; South African National Research Foundation	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); South African National Research Foundation(National Research Foundation - South Africa)	The integrations of the experiments have been performed at the Hochstleistungsrechenzentrum Stuttgart (HLRS) and the Computing Centre at Kiel University. We thank the NEMO, AGRIF and Ariane System Teams for their technical support. The analysis was supported by the DFG projects BO 907/2-2 and SFB 754 (TP A2, http://www.sfb754.de). J. R. E. L. received support from the International Bureau of the BMBF ( SUA 07/004) and from the South African National Research Foundation.	Alory G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028044; Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Barnier B, 2006, OCEAN DYNAM, V56, P543, DOI 10.1007/s10236-006-0082-1; Beranger K, 2006, OCEAN DYNAM, V56, P104, DOI 10.1007/s10236-006-0065-2; Biastoch A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035132; Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Biastoch A, 1999, GEOPHYS RES LETT, V26, P3321, DOI 10.1029/1999GL002349; Biastoch A, 2009, J PHYS OCEANOGR, V39, P2417, DOI 10.1175/2009JPO4184.1; Biastoch A, 2008, J CLIMATE, V21, P6599, DOI 10.1175/2008JCLI2404.1; Blanke B, 1999, J PHYS OCEANOGR, V29, P2753, DOI 10.1175/1520-0485(1999)029<2753:WWPITE>2.0.CO;2; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Cai W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024911; CONKRIGHT ME, 2002, WORLD OCEAN DATABASE, V1, P1; Curry R, 2005, SCIENCE, V308, P1772, DOI 10.1126/science.1109477; Debreu L, 2008, COMPUT GEOSCI-UK, V34, P8, DOI 10.1016/j.cageo.2007.01.009; DERUIJTER WPM, 2002, GEOPHYS RES LETT, V29, P1401, DOI DOI 10.1029/2001GL013714; Friocourt Y, 2005, J PHYS OCEANOGR, V35, P1206, DOI 10.1175/JPO2748.1; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Griffies SM, 2009, OCEAN MODEL, V26, P1, DOI 10.1016/j.ocemod.2008.08.007; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Large W. G., 2004, NCARTN460 STR CGD DI, DOI [10.5065/D6KK98Q6, DOI 10.5065/D6KK98Q6]; Latif M, 2006, J CLIMATE, V19, P4631, DOI 10.1175/JCLI3876.1; Lutjeharms JRE, 2006, AGULHAS CURRENT; MADEC G, 2006, 27 I P SIM LAPL; Matano RP, 2002, J PHYS OCEANOGR, V32, P1228, DOI 10.1175/1520-0485(2002)032<1228:LSFOTA>2.0.CO;2; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Oke PR, 2004, J CLIMATE, V17, P1040, DOI 10.1175/1520-0442(2004)017<1040:ORTCIT>2.0.CO;2; OU HW, 1986, J PHYS OCEANOGR, V16, P280, DOI 10.1175/1520-0485(1986)016<0280:SOAIBC>2.0.CO;2; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Ridderinkhof H, 2003, DEEP-SEA RES PT II, V50, P1933, DOI 10.1016/S0967-0645(03)00041-9; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rouault M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037987; Sen Gupta A, 2009, J CLIMATE, V22, P3047, DOI 10.1175/2008JCLI2827.1; Speich S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031583; Steele M, 2001, J CLIMATE, V14, P2079, DOI 10.1175/1520-0442(2001)014<2079:PAGOHW>2.0.CO;2; Swart S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004223; van Sebille E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036614; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; ZALESAK ST, 1979, J COMPUT PHYS, V31, P335, DOI 10.1016/0021-9991(79)90051-2	40	222	224	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					495	U188		10.1038/nature08519	http://dx.doi.org/10.1038/nature08519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940923				2022-12-28	WOS:000272144200041
J	Netzer, N; Goodenbour, JM; David, A; Dittmar, KA; Jones, RB; Schneider, JR; Boone, D; Eves, EM; Rosner, MR; Gibbs, JS; Embry, A; Dolan, B; Das, S; Hickman, HD; Berglund, P; Bennink, JR; Yewdell, JW; Pan, T				Netzer, Nir; Goodenbour, Jeffrey M.; David, Alexandre; Dittmar, Kimberly A.; Jones, Richard B.; Schneider, Jeffrey R.; Boone, David; Eves, Eva M.; Rosner, Marsha R.; Gibbs, James S.; Embry, Alan; Dolan, Brian; Das, Suman; Hickman, Heather D.; Berglund, Peter; Bennink, Jack R.; Yewdell, Jonathan W.; Pan, Tao			Innate immune and chemically triggered oxidative stress modifies translational fidelity	NATURE			English	Article							GENETIC-CODE; QUALITY-CONTROL; CELLS; EVOLUTION; ANTIOXIDANTS; MITOCHONDRIA; PROTEINS; CANDIDA	Translational fidelity, essential for protein and cell function, requires accurate transfer RNA (tRNA) aminoacylation. Purified aminoacyl-tRNA synthetases exhibit a fidelity of one error per 10,000 to 100,000 couplings(1,2). The accuracy of tRNA aminoacylation in vivo is uncertain, however, and might be considerably lower(3-6). Here we show that in mammalian cells, approximately 1% of methionine (Met) residues used in protein synthesis are aminoacylated to non-methionyl-tRNAs. Remarkably, Met-misacylation increases up to tenfold upon exposing cells to live or non-infectious viruses, toll-like receptor ligands or chemically induced oxidative stress. Met is misacylated to specific non-methionyl-tRNA families, and these Met-misacylated tRNAs are used in translation. Met-misacylation is blocked by an inhibitor of cellular oxidases, implicating reactive oxygen species (ROS) as the misacylation trigger. Among six amino acids tested, tRNA misacylation occurs exclusively with Met. As Met residues are known to protect proteins against ROS-mediated damage(7), we propose that Met-misacylation functions adaptively to increase Met incorporation into proteins to protect cells against oxidative stress. In demonstrating an unexpected conditional aspect of decoding mRNA, our findings illustrate the importance of considering alternative iterations of the genetic code.	[Netzer, Nir; David, Alexandre; Gibbs, James S.; Embry, Alan; Dolan, Brian; Das, Suman; Hickman, Heather D.; Berglund, Peter; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; [Goodenbour, Jeffrey M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dittmar, Kimberly A.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Jones, Richard B.; Eves, Eva M.; Rosner, Marsha R.] Univ Chicago, Ben May Inst, Chicago, IL 60637 USA; [Schneider, Jeffrey R.; Boone, David] Univ Chicago, Dept Med, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Chicago; University of Chicago; University of Chicago; University of Chicago	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	jyewdell@nih.gov; taopan@uchicago.edu	David, Alexandre/B-2447-2013; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Das, Suman/ABB-7273-2020; Das, Suman R/C-8760-2009; David, Alexandre/AAL-2758-2021	David, Alexandre/0000-0003-3365-1339; Das, Suman/0000-0003-2496-9724; David, Alexandre/0000-0003-3365-1339; Netzer, Nikolaus/0000-0001-7534-3575; Hickman, Heather/0000-0003-4168-4894	Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001014, ZIAAI000542, ZIAAI000653, ZIAAI000658] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to D. Klinman for his gift of CpG oligonucleotides and advice, A. Schilling for supervision and advice on mass spectrometry experiments, and C. Nicchitta, T. Pierson, P. Cluzel, R. Levine, A. Iwasaki and S. Amigorena for insight and advice. This work was supported by the Division of Intramural Research, the National Institute of Allergy and Infectious Diseases, and by National Institutes of Health extramural pilot projects.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Bender A, 2008, P NATL ACAD SCI USA, V105, P16496, DOI 10.1073/pnas.0802779105; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Cochella L, 2005, CURR BIOL, V15, pR536, DOI 10.1016/j.cub.2005.07.018; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Finkelstein JD, 2007, CLIN CHEM LAB MED, V45, P1694, DOI 10.1515/CCLM.2007.341; Freist W, 1998, J THEOR BIOL, V193, P19, DOI 10.1006/jtbi.1998.0672; HOFFMANN GW, 1974, J MOL BIOL, V86, P349, DOI 10.1016/0022-2836(74)90024-2; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Miranda I, 2006, YEAST, V23, P203, DOI 10.1002/yea.1350; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; USSERY MA, 1977, EUR J BIOCHEM, V72, P491, DOI 10.1111/j.1432-1033.1977.tb11272.x; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005	24	231	236	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					522	526		10.1038/nature08576	http://dx.doi.org/10.1038/nature08576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940929	Green Accepted			2022-12-28	WOS:000272144200048
J	Debenedetti, PG; Sarupria, S				Debenedetti, Pablo G.; Sarupria, Sapna			Hydrate Molecular Ballet	SCIENCE			English	Editorial Material							PRESSURE		[Debenedetti, Pablo G.; Sarupria, Sapna] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA	Princeton University	Debenedetti, PG (corresponding author), Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA.	pdebene@princeton.edu	Debenedetti, Pablo/ABD-1497-2021	Debenedetti, Pablo/0000-0003-1881-1728				Allen RJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2140273; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; Florusse LJ, 2004, SCIENCE, V306, P469, DOI 10.1126/science.1102076; Rochelle CA, 2009, GEOL SOC SPEC PUBL, V319, P171, DOI 10.1144/SP319.14; Schicks JM, 2004, ANGEW CHEM INT EDIT, V43, P3310, DOI 10.1002/anie.200453898; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Walsh MR, 2009, SCIENCE, V326, P1095, DOI 10.1126/science.1174010	10	23	25	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1070	1071		10.1126/science.1183027	http://dx.doi.org/10.1126/science.1183027			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965416				2022-12-28	WOS:000271951000027
J	Richards, S				Richards, Stephen			Should the NHS strive to eradicate all unexplained variation? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE		Oxfordshire Primary Care Trust, Oxford OX4 2LH, England		Richards, S (corresponding author), Oxfordshire Primary Care Trust, Oxford OX4 2LH, England.	lesley.corfield@oxfordshirepct.nhs.uk						BERWICK DM, 1991, MED CARE, V29, P1212, DOI 10.1097/00005650-199112000-00004; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Deming EW., 1986, OUT CRISIS; Institute of Medicine, 2001, CROSSING QUALITY CHA; *KINGS FUND, 2009, LOC VAR NHS SPEND PR; *NAT PRIM CAR RES, 2009, WHAT DIFF HAS QOF MA; *NHS I INN IMPR, 2009, CONV POT REAL 10 STE; *NHS SCOTL, STAT PROC CONTR TUT; 2009, HLTH SERVICE J  0910	9	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2009	339								b4811	10.1136/bmj.b4811	http://dx.doi.org/10.1136/bmj.b4811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523TD	19926690				2022-12-28	WOS:000272096500007
J	Turner, WR; Oppenheimer, M; Wilcove, DS				Turner, Will R.; Oppenheimer, Michael; Wilcove, David S.			A force to fight global warming	NATURE			English	Editorial Material									[Turner, Will R.] Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA 22202 USA; [Oppenheimer, Michael; Wilcove, David S.] Princeton Univ, Princeton, NJ 08544 USA	Conservation International; Princeton University	Turner, WR (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, 2011 Crystal Dr,Suite 500, Arlington, VA 22202 USA.	w.turner@conservation.org		Oppenheimer, Michael/0000-0002-9708-5914; Wilcove, David S./0000-0002-1354-0503				Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; IUCN, 2008, 2008 IUCN RED LIST T; Locke H., 2009, INT J WILDERNESS, V15, P7; Transparency International, 2009, GLOB CORR REP 2009	6	65	68	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					278	279		10.1038/462278a	http://dx.doi.org/10.1038/462278a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521DF	19924191				2022-12-28	WOS:000271899300018
J	Hamilton, W; Menon, U				Hamilton, William; Menon, Usha			Easily missed? Ovarian cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material							SYMPTOMS; DIAGNOSIS; INDEX; WOMEN; RISK		[Menon, Usha] UCL EGA Inst Womens Hlth, Acad Gynaecol Oncol, London W1T 7DN, England; [Hamilton, William] Univ Bristol, Acad Unit Primary Hlth Care, Dept Community Based Med, Bristol BS6 2AA, Avon, England	University of London; University College London; University of Bristol	Menon, U (corresponding author), UCL EGA Inst Womens Hlth, Acad Gynaecol Oncol, Maple House, London W1T 7DN, England.	u.menon@ucl.ac.uk	Menon, Usha/C-4716-2008; Hamilton, Willie/G-8612-2014	Menon, Usha/0000-0003-3708-1732; Hamilton, William/0000-0003-1611-1373	Department of Health [PDA/03/07/029] Funding Source: Medline; National Institute for Health Research [PDA/03/07/029] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Bankhead CR, 2008, BJOG-INT J OBSTET GY, V115, P1008, DOI 10.1111/j.1471-0528.2008.01772.x; Department of Health, 2009, OV CANC KEY MESS HLT; Fitch Margaret, 2002, Can Oncol Nurs J, V12, P152; Friedman GD, 2005, FAM PRACT, V22, P548, DOI 10.1093/fampra/cmi044; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Hamilton W, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2998; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Myers Evan R, 2006, Evid Rep Technol Assess (Full Rep), P1; National Institute for Health and Clinical Excellence, 2005, REF GUID SUSP CANC; Rufford BD, 2007, BJOG-INT J OBSTET GY, V114, P59, DOI 10.1111/j.1471-0528.2006.01153.x; Ryerson AB, 2007, OBSTET GYNECOL, V109, P1053, DOI 10.1097/01.AOG.0000260392.70365.5e; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2	13	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 18	2009	339								b4650	10.1136/bmj.b4650	http://dx.doi.org/10.1136/bmj.b4650			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TA	19923146	Green Accepted			2022-12-28	WOS:000272096200005
J	Homer, H; Gui, L; Carroll, J				Homer, Hayden; Gui, Liming; Carroll, John			A Spindle Assembly Checkpoint Protein Functions in Prophase I Arrest and Prometaphase Progression	SCIENCE			English	Article							MOUSE OOCYTES; PREVENTS ANEUPLOIDY; APC(CDH1) ACTIVITY; CYCLIN-B; M-PHASE; SECURIN; MAD2; PROTEOLYSIS; COMPLEX; ENTRY	Two critical stages of mammalian oocyte regulation are prophase I arrest, which is important for sustaining the oocyte pool, and the progression through meiosis I (MI) to produce fertilizable eggs. We have found that the spindle assembly checkpoint protein BubR1 regulates both stages in mouse oocytes. We show that oocytes depleted of BubR1 cannot sustain prophase I arrest and readily undergo germinal vesicle breakdown, a marker for reentry into MI. BubR1-depleted oocytes then arrest before completing MI, marked by failure of polar body extrusion. Both meiotic defects in BubR1-depleted oocytes are due to reduced activity of the master regulator known as the anaphase-promoting complex (APC), brought about through diminished levels of the APC coactivator Cdh1.	[Homer, Hayden] UCL, Oocyte & Embryo Res Lab, Dept Cell & Dev Biol, Div Biosci, London, England; UCL, Inst Womens Hlth, London, England	University of London; University College London; University of London; University College London	Homer, H (corresponding author), UCL, Oocyte & Embryo Res Lab, Dept Cell & Dev Biol, Div Biosci, London, England.	h.homer@ucl.ac.uk	Homer, Hayden/K-1517-2014; Holt, Janet E/B-2415-2013	Homer, Hayden/0000-0002-3104-0449; Carroll, John/0000-0001-9644-5861	Medical Research Council [082587/Z/07/Z]; Medical Research Council [G0400530] Funding Source: researchfish; MRC [G0400530] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Clinical Fellowship (082587/Z/07/Z) to H. H. J. C. is funded by a Medical Research Council grant. We thank S. Taylor, W. Earnshaw, and K. Wassmann for reagents.	Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Malmanche N, 2007, CURR BIOL, V17, P1489, DOI 10.1016/j.cub.2007.07.042; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	14	112	113	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					991	994		10.1126/science.1175326	http://dx.doi.org/10.1126/science.1175326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965510	Green Accepted			2022-12-28	WOS:000271712300039
J	Truog, RD				Truog, Robert D.			Screening Mammography and the "R" Word	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICES TASK-FORCE; BREAST-CANCER		[Truog, Robert D.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Truog, Robert D.] Childrens Hosp Boston, Div Crit Care Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA.							Ahern CH, 2009, CANCER EPIDEM BIOMAR, V18, P718, DOI 10.1158/1055-9965.EPI-08-0918; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; CREWDSON J, 2009, ATLANTIC        1119; GRADY D, 2009, NY TIMES        1103; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009	5	30	30	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2501	2503		10.1056/NEJMp0911447	http://dx.doi.org/10.1056/NEJMp0911447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	19940292				2022-12-28	WOS:000273003700003
J	Adamczyk, K; Premont-Schwarz, M; Pines, D; Pines, E; Nibbering, ETJ				Adamczyk, Katrin; Premont-Schwarz, Mirabelle; Pines, Dina; Pines, Ehud; Nibbering, Erik T. J.			Real-Time Observation of Carbonic Acid Formation in Aqueous Solution	SCIENCE			English	Article							C-13 ISOTOPIC FORMS; PROTON-TRANSFER; GLASSY SOLUTIONS; FTIR SPECTRA; BASE; HYDRATION; H2CO3; HYDROLYSIS; CATALYSIS; SURFACE	Despite the widespread importance of aqueous bicarbonate chemistry, its conjugate acid, carbonic acid, has remained uncharacterized in solution. Here we report the generation of deuterated carbonic acid in deuterium oxide solution by ultrafast protonation of bicarbonate and its persistence for nanoseconds. We follow the reaction dynamics upon photoexcitation of a photoacid by monitoring infrared-active marker modes with femtosecond time resolution. By fitting a kinetic model to the experimental data, we directly obtain the on-contact proton-transfer rate to bicarbonate, previously inaccessible with the use of indirect methods. A Marcus free-energy correlation supports an associated pK(a) (K-a is the acid dissociation constant) of 3.45 +/- 0.15, which is substantially lower than the value of 6.35 that is commonly assumed on the basis of the overall carbon dioxide-to-bicarbonate equilibrium. This result should spur further exploration of acid-base reactivity in carbon dioxide-rich aqueous environments such as those anticipated under sequestration schemes.	[Pines, Dina; Pines, Ehud] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Adamczyk, Katrin; Premont-Schwarz, Mirabelle; Nibbering, Erik T. J.] Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany	Ben Gurion University; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Pines, E (corresponding author), Ben Gurion Univ Negev, Dept Chem, POB 653, IL-84105 Beer Sheva, Israel.	epines@bgu.ac.il; nibberin@mbi-berlin.de			German-Israeli Foundation for Scientific Research and Development [GIF I-876-107.5]; James Franck German-Israel Binational Program in Laser-Matter Interaction	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); James Franck German-Israel Binational Program in Laser-Matter Interaction	This work was supported by the German-Israeli Foundation for Scientific Research and Development (grant GIF I-876-107.5 to E. T. J. N. and E. P.) and the James Franck German-Israel Binational Program in Laser-Matter Interaction (E. P.). We thank L. M. Tolbert for suggesting that we delve into the subject of carbonic acid.	Al-Hosney HA, 2004, J AM CHEM SOC, V126, P8068, DOI 10.1021/ja0490774; Bell R.P., 1973, PROTON CHEM; Brucato JR, 1997, ICARUS, V125, P135, DOI 10.1006/icar.1996.5561; Cox MJ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2889390; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Eigen M., 1961, Z PHYS CHEM FRANKFUR, V30, P130; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Genosar L, 2000, J PHYS CHEM A, V104, P6689, DOI 10.1021/jp000317l; Gerakines PA, 2000, ASTRON ASTROPHYS, V357, P793; Hage W, 1998, SCIENCE, V279, P1332, DOI 10.1126/science.279.5355.1332; Hage W, 1996, J CHEM SOC FARADAY T, V92, P3197, DOI 10.1039/ft9969203197; Hage W, 1996, J CHEM SOC FARADAY T, V92, P3183, DOI 10.1039/ft9969203183; Kumar PP, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2741552; Kump LR, 2000, ANNU REV EARTH PL SC, V28, P611, DOI 10.1146/annurev.earth.28.1.611; Kurtz I, 2008, AM J PHYSIOL-RENAL, V294, pF1009, DOI 10.1152/ajprenal.00475.2007; Lewis M, 2003, J PHYS CHEM A, V107, P6814, DOI 10.1021/jp034764n; Loerting T, 2000, ANGEW CHEM INT EDIT, V39, P892; Ludwig R, 2000, ANGEW CHEM INT EDIT, V39, P1421, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1421::AID-ANIE1421>3.0.CO;2-P; METZ B, 2005, WORKING GROUP 3 INTE; Millero FJ, 2007, CHEM REV, V107, P308, DOI 10.1021/cr0503557; Mohammed OF, 2005, SCIENCE, V310, P83, DOI 10.1126/science.1117756; Mohammed OF, 2007, CHEM PHYS, V341, P240, DOI 10.1016/j.chemphys.2007.06.040; Mohammed OF, 2007, ANGEW CHEM INT EDIT, V46, P1458, DOI 10.1002/anie.200603383; MOORE MH, 1991, SPECTROCHIM ACTA A, V47, P255, DOI 10.1016/0584-8539(91)80097-3; Nguyen MT, 2008, J PHYS CHEM A, V112, P10386, DOI 10.1021/jp804715j; Nguyen MT, 1997, J PHYS CHEM A, V101, P7379, DOI 10.1021/jp9701045; PINES E, 1983, J PHYS CHEM-US, V87, P4471, DOI 10.1021/j100245a029; Pines E, 1997, CHEM PHYS LETT, V281, P413, DOI 10.1016/S0009-2614(97)01245-1; POCKER Y, 1977, J AM CHEM SOC, V99, P6537, DOI 10.1021/ja00462a012; Rini M, 2003, SCIENCE, V301, P349, DOI 10.1126/science.1085762; SZABO A, 1989, J PHYS CHEM-US, V93, P6929, DOI 10.1021/j100356a011; Tautermann CS, 2002, CHEM-EUR J, V8, P66, DOI 10.1002/1521-3765(20020104)8:1<66::AID-CHEM66>3.0.CO;2-F; TERLOUW JK, 1987, ANGEW CHEM INT EDIT, V26, P354, DOI 10.1002/anie.198703541; Tolbert LM, 2002, ACCOUNTS CHEM RES, V35, P19, DOI 10.1021/ar990109f; Tossell JA, 2006, INORG CHEM, V45, P5961, DOI 10.1021/ic060459f; WIGHT CA, 1995, J PHYS CHEM-US, V99, P12125, DOI 10.1021/j100032a012; WISSBRUN KF, 1954, J PHYS CHEM-US, V58, P693, DOI 10.1021/j150519a004; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE	38	202	212	7	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1690	1694		10.1126/science.1180060	http://dx.doi.org/10.1126/science.1180060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19965381				2022-12-28	WOS:000272839000052
J	Wiederhecker, GS; Chen, L; Gondarenko, A; Lipson, M				Wiederhecker, Gustavo S.; Chen, Long; Gondarenko, Alexander; Lipson, Michal			Controlling photonic structures using optical forces	NATURE			English	Article							WAVE-GUIDES; CAVITY; RESONANCES; CHIP	The use of optical forces to manipulate small objects is well known. Applications include the manipulation of living cells by optical tweezers(1) and optical cooling in atomic physics(2). The miniaturization of optical systems ( to the micro and nanoscale) has resulted in very compliant systems with masses of the order of nanograms, rendering them susceptible to optical forces(3-6). Optical forces have been exploited to demonstrate chaotic quivering of microcavities(7), optical cooling of mechanical modes(8-11), actuation of a tapered-fibre waveguide and excitation of the mechanical modes of silicon nano-beams(12,13). Despite recent progress in this field(14-17), it is challenging to manipulate the optical response of photonic structures using optical forces; this is because of the large forces that are required to induce appreciable changes in the geometry of the structure. Here we implement a resonant structure whose optical response can be efficiently statically controlled using relatively weak attractive and repulsive optical forces. We demonstrate a static mechanical deformation of up to 20 nanometres in a silicon nitride structure, using three milliwatts of continuous optical power. Because of the sensitivity of the optical response to this deformation, such optically induced static displacement introduces resonance shifts spanning 80 times the intrinsic resonance linewidth.	[Wiederhecker, Gustavo S.; Chen, Long; Gondarenko, Alexander; Lipson, Michal] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA	Cornell University	Lipson, M (corresponding author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA.	ml292@cornell.edu	Wiederhecker, Gustavo/E-7456-2010	Wiederhecker, Gustavo/0000-0002-8216-6797	National Science Foundation [00446571]; Cornell University's Center for Nanoscale Systems; National Science Foundation; Cornell University and Industrial	National Science Foundation(National Science Foundation (NSF)); Cornell University's Center for Nanoscale Systems; National Science Foundation(National Science Foundation (NSF)); Cornell University and Industrial	This work was supported in part by the National Science Foundation under grant 00446571. We also acknowledge partial support by Cornell University's Center for Nanoscale Systems. This work was performed in part at the Cornell Nano-Scale Science and Technology Facility ( a member of the National Nanofabrication Users Network) which is supported by the National Science Foundation, its users, Cornell University and Industrial users. G. S. W. thanks S. Lee for help in preparing some of the Supplementary Information.	Anetsberger G, 2008, NAT PHOTONICS, V2, P627, DOI 10.1038/nphoton.2008.199; Antonoyiannakis MI, 1999, PHYS REV B, V60, P2363, DOI 10.1103/PhysRevB.60.2363; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; Bao MH, 2007, SENSOR ACTUAT A-PHYS, V136, P3, DOI 10.1016/j.sna.2007.01.008; Carmon T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167203; EICHENFIELD M, 2008, C LAS EL QUANT EL LA; Eichenfield M, 2009, NATURE, V459, P550, DOI 10.1038/nature08061; HANSCH TW, 1975, OPT COMMUN, V13, P68, DOI 10.1016/0030-4018(75)90159-5; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Kippenberg TJ, 2007, OPT EXPRESS, V15, P17172, DOI 10.1364/OE.15.017172; Li M, 2008, NATURE, V456, P480, DOI 10.1038/nature07545; Li M, 2009, NAT PHOTONICS, V3, P464, DOI 10.1038/NPHOTON.2009.116; Li M, 2009, NAT NANOTECHNOL, V4, P377, DOI [10.1038/NNANO.2009.92, 10.1038/nnano.2009.92]; Lin Q, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.103601; Ng J, 2005, OPT LETT, V30, P1956, DOI 10.1364/OL.30.001956; Povinelli ML, 2005, OPT LETT, V30, P3042, DOI 10.1364/OL.30.003042; Rakich PT, 2007, NAT PHOTONICS, V1, P658, DOI 10.1038/nphoton.2007.203; Roels J, 2009, NAT NANOTECHNOL, V4, P510, DOI [10.1038/nnano.2009.186, 10.1038/NNANO.2009.186]; Rosenberg J, 2009, NAT PHOTONICS, V3, P478, DOI 10.1038/NPHOTON.2009.137; Schliesser A, 2008, NAT PHYS, V4, P415, DOI 10.1038/nphys939; Sherwood-Droz N, 2008, OPT EXPRESS, V16, P15915, DOI 10.1364/OE.16.015915	21	280	284	3	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					633	U103		10.1038/nature08584	http://dx.doi.org/10.1038/nature08584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19915549	Green Submitted			2022-12-28	WOS:000272277900037
J	Goldacre, B				Goldacre, Ben			Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PUBLICATION; INHIBITORS		Univ Oxford Nuffield Coll, Oxford OX1 1NF, England	University of Oxford	Goldacre, B (corresponding author), Univ Oxford Nuffield Coll, Oxford OX1 1NF, England.	ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728				Alper BS, 2004, J MED LIBR ASSOC, V92, P429; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779	9	21	23	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 29	2009	339								b4949	10.1136/bmj.b4949	http://dx.doi.org/10.1136/bmj.b4949			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AY	19946143	Green Accepted			2022-12-28	WOS:000272186700002
J	Li, HY; Xin, HL; Muller, DA; Estroff, LA				Li, Hanying; Xin, Huolin L.; Muller, David A.; Estroff, Lara A.			Visualizing the 3D Internal Structure of Calcite Single Crystals Grown in Agarose Hydrogels	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; ELECTRON-MICROSCOPY; CRYSTALLIZATION; BIOMINERALIZATION; MORPHOLOGIES; FABRICATION; INTERFACES; MOLECULES; PHASE	Single crystals are usually faceted solids with homogeneous chemical compositions. Biogenic and synthetic calcite single crystals, however, have been found to incorporate macromolecules, spurring investigations of how large molecules are distributed within the crystals without substantially disrupting the crystalline lattice. Here, electron tomography reveals how random, three-dimensional networks of agarose nanofibers are incorporated into single crystals of synthetic calcite by allowing both high- and low-energy fiber/crystal interface facets to satisfy network curvatures. These results suggest that physical entrapment of polymer aggregates is a viable mechanism by which macromolecules can become incorporated inside inorganic single crystals. As such, this work has implications for understanding the structure and formation of biominerals as well as toward the development of new high-surface area, single-crystal composite materials.	[Li, Hanying; Estroff, Lara A.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Xin, Huolin L.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Estroff, LA (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	lae37@cornell.edu	Spratt, Brian G/A-1676-2009; Muller, David/A-7745-2010; Xin, Huolin L./E-2747-2010	Muller, David/0000-0003-4129-0473; Xin, Huolin L./0000-0002-6521-868X; Estroff, Lara/0000-0002-7658-1265	NSF [DMR 0845212]; New York State Office of Science, Technology, and Academic Research [C050017]; Cornell Center for Materials Research (CCMR), a Materials Research Science and Engineering Center of NSF [DMR 0520404]	NSF(National Science Foundation (NSF)); New York State Office of Science, Technology, and Academic Research; Cornell Center for Materials Research (CCMR), a Materials Research Science and Engineering Center of NSF	L. A. E. acknowledges partial support from NSF (DMR 0845212), the J. D. Watson Investigator Program (New York State Office of Science, Technology, and Academic Research contract C050017), and the Cornell Center for Materials Research (CCMR), a Materials Research Science and Engineering Center of NSF (DMR 0520404). H. L. X. and D. M. acknowledge the Semiconductor Research Corporation and CCMR. Particular acknowledgement is made of the use of the EM and polymer characterization facilities of CCMR.	Aizenberg J, 1997, J AM CHEM SOC, V119, P881, DOI 10.1021/ja9628821; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; De Yoreo JJ, 2004, SCIENCE, V306, P1301, DOI 10.1126/science.1100889; Du DX, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155503; Estroff LA, 2004, J AM CHEM SOC, V126, P2, DOI 10.1021/ja037614z; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Hyun JK, 2008, ULTRAMICROSCOPY, V109, P1, DOI 10.1016/j.ultramic.2008.07.003; Kulak AN, 2007, J AM CHEM SOC, V129, P3729, DOI 10.1021/ja067422e; Li C, 2008, ANGEW CHEM INT EDIT, V47, P2388, DOI 10.1002/anie.200705403; Li HY, 2007, CRYSTENGCOMM, V9, P1153, DOI 10.1039/b709068d; Li HY, 2007, J AM CHEM SOC, V129, P5480, DOI 10.1021/ja067901d; Li HY, 2009, ADV MATER, V21, P470, DOI 10.1002/adma.200801498; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Nudelman F, 2007, FARADAY DISCUSS, V136, P9, DOI 10.1039/b704418f; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Park RJ, 2002, ADV MATER, V14, P1167, DOI 10.1002/1521-4095(20020816)14:16<1167::AID-ADMA1167>3.0.CO;2-X; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Robach JS, 2005, J STRUCT BIOL, V151, P18, DOI 10.1016/j.jsb.2005.04.001; Sindhu S, 2007, ADV FUNCT MATER, V17, P1698, DOI 10.1002/adfm.200600547; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Song RQ, 2009, ANGEW CHEM INT EDIT, V48, P395, DOI 10.1002/anie.200803383; Travaille AM, 2003, J AM CHEM SOC, V125, P11571, DOI 10.1021/ja034624r; Volkmer D, 2004, J MATER CHEM, V14, P2249, DOI 10.1039/b403132f	30	218	223	12	316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1244	1247		10.1126/science.1178583	http://dx.doi.org/10.1126/science.1178583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965470				2022-12-28	WOS:000272117900042
J	Dash, SP; Sharma, S; Patel, RS; de Jong, MP; Jansen, R				Dash, Saroj P.; Sharma, Sandeep; Patel, Ram S.; de Jong, Michel P.; Jansen, Ron			Electrical creation of spin polarization in silicon at room temperature	NATURE			English	Article							INJECTION; RESONANCE; BARRIER; ABSORPTION; TRANSPORT	The control and manipulation of the electron spin in semiconductors is central to spintronics(1,2), which aims to represent digital information using spin orientation rather than electron charge. Such spin-based technologies may have a profound impact on nanoelectronics, data storage, and logic and computer architectures. Recently it has become possible to induce and detect spin polarization in otherwise non-magnetic semiconductors ( gallium arsenide and silicon) using all-electrical structures(3-9), but so far only at temperatures below 150 K and in n- type materials, which limits further development. Here we demonstrate room-temperature electrical injection of spin polarization into n-type and p-type silicon from a ferromagnetic tunnel contact, spin manipulation using the Hanle effect and the electrical detection of the induced spin accumulation. A spin splitting as large as 2.9 meV is created in n-type silicon, corresponding to an electron spin polarization of 4.6%. The extracted spin lifetime is greater than 140 ps for conduction electrons in heavily doped n- type silicon at 300 K and greater than 270 ps for holes in heavily doped p-type silicon at the same temperature. The spin diffusion length is greater than 230 nm for electrons and 310 nm for holes in the corresponding materials. These results open the way to the implementation of spin functionality in complementary silicon devices and electronic circuits operating at ambient temperature, and to the exploration of their prospects and the fundamental rules that govern their behaviour.	[Dash, Saroj P.; Sharma, Sandeep; Patel, Ram S.; de Jong, Michel P.; Jansen, Ron] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands	University of Twente	Jansen, R (corresponding author), Univ Twente, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.	ron.jansen@el.utwente.nl	Sharma, Sandeep/AAD-5241-2022; Dash, Saroj/G-5225-2010; Patel, Ram Shanker/E-7377-2010	Patel, Ram Shanker/0000-0003-3532-3961; Sharma, Sandeep/0000-0001-5475-1297	NWO-VIDI; Netherlands Foundation	NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); Netherlands Foundation(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the NWO-VIDI programme and the Netherlands Foundation for Fundamental Research on Matter.	Anderberg JM, 1997, PHYS REV B, V55, P13745, DOI 10.1103/PhysRevB.55.13745; Ando Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3130211; Appelbaum I, 2007, NATURE, V447, P295, DOI 10.1038/nature05803; Biagi R, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155325; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; CHENG JL, 2009, THEORY SPIN RELAXATI; Ciorga M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165321; Fabian J, 2007, ACTA PHYS SLOVACA, V57, P565, DOI 10.2478/v10155-010-0086-8; FEHER G, 1960, PHYS REV LETT, V5, P309, DOI 10.1103/PhysRevLett.5.309; Fert A, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184420; Hanbicki AT, 2002, APPL PHYS LETT, V80, P1240, DOI 10.1063/1.1449530; Jonker BT, 2007, NAT PHYS, V3, P542, DOI 10.1038/nphys673; KODERA H, 1966, J PHYS SOC JPN, V21, P1040, DOI 10.1143/JPSJ.21.1040; LEPINE DJ, 1970, PHYS REV B, V2, P2429, DOI 10.1103/PhysRevB.2.2429; Lou X, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.176603; Lou XH, 2007, NAT PHYS, V3, P197, DOI 10.1038/nphys543; Min BC, 2006, NAT MATER, V5, P817, DOI 10.1038/nmat1736; Motsnyi VF, 2002, APPL PHYS LETT, V81, P265, DOI 10.1063/1.1491010; Osipov VV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115322; Park BG, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217206; Patel RS, 2009, J APPL PHYS, V106, DOI 10.1063/1.3159638; Shang CH, 1998, PHYS REV B, V58, pR2917, DOI 10.1103/PhysRevB.58.R2917; SUCCI M, 1985, VACUUM, V35, P579, DOI 10.1016/0042-207X(85)90319-7; Tran M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.036601; van't Erve OMJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2817747; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	26	527	536	3	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					491	494		10.1038/nature08570	http://dx.doi.org/10.1038/nature08570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940922				2022-12-28	WOS:000272144200040
J	Giljohann, DA; Mirkin, CA				Giljohann, David A.; Mirkin, Chad A.			Drivers of biodiagnostic development	NATURE			English	Article							ULTRASENSITIVE DETECTION; COLORIMETRIC DETECTION; DNA; NANOPARTICLES; IMMUNOASSAY; MOLECULES; PROTEINS	The promise of point-of-care medical diagnostics - tests that can be carried out at the site of patient care is enormous, bringing the benefits of fast and reliable testing and allowing rapid decisions on the course of treatment to be made. To this end, much innovation is occurring in technologies for use in biodiagnostic tests. Assays based on nanomaterials, for example, are now beginning to make the transition from the laboratory to the clinic. But the potential for such assays to become part of routine medical testing depends on many scientific factors, including sensitivity, selectivity and versatility, as well as technological, financial and policy factors.	[Giljohann, David A.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Giljohann, David A.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010	Mirkin, Chad/0000-0002-6634-7627	US National Science Foundation; National Cancer Institute; National Institutes of Health; NATIONAL CANCER INSTITUTE [U54CA119341] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Patel for assistance with preparing Table 1. We also thank the US National Science Foundation, the National Cancer Institute and the National Institutes of Health for research support.	Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hirsch LR, 2003, ANAL CHEM, V75, P2377, DOI 10.1021/ac0262210; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Lee JS, 2007, ANGEW CHEM INT EDIT, V46, P4093, DOI 10.1002/anie.200700269; Liu JW, 2003, J AM CHEM SOC, V125, P6642, DOI 10.1021/ja034775u; McFarland AD, 2003, NANO LETT, V3, P1057, DOI 10.1021/nl034372s; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Soman CP, 2008, LANGMUIR, V24, P4399, DOI 10.1021/la704078u; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Thaxton CS, 2009, P NATL ACAD SCI USA, V106, P18437, DOI 10.1073/pnas.0904719106; Wang J, 2004, J AM CHEM SOC, V126, P3010, DOI 10.1021/ja031723w; Wang ZP, 2006, CLIN CHEM, V52, P1958, DOI 10.1373/clinchem.2006.071399; You CC, 2007, NAT NANOTECHNOL, V2, P318, DOI 10.1038/nnano.2007.99; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	33	601	621	11	360	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					461	464		10.1038/nature08605	http://dx.doi.org/10.1038/nature08605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940916	Green Accepted			2022-12-28	WOS:000272144200034
J	Jaspersen, SL; Hawley, RS				Jaspersen, Sue L.; Hawley, R. Scott			Pushing and Pulling: Microtubules Mediate Meiotic Pairing and Synapsis	CELL			English	Editorial Material							NUCLEAR-ENVELOPE; C. ELEGANS; PROTEIN		[Jaspersen, Sue L.; Hawley, R. Scott] Stowers Inst Med Res, Kansas City, MO USA; [Jaspersen, Sue L.; Hawley, R. Scott] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Hawley, R. Scott] Amer Canc Soc, Atlanta, GA 30329 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; American Cancer Society	Jaspersen, SL (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	slj@stowers.org; rsh@stowers.org		Hawley, R. Scott/0000-0002-6478-0494				Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; Chikashige Y, 2009, J CELL BIOL, V187, P413, DOI 10.1083/jcb.200902122; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Zhou K, 2009, J CELL BIOL, V186, P229, DOI 10.1083/jcb.200902101	8	7	7	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					861	863		10.1016/j.cell.2009.11.013	http://dx.doi.org/10.1016/j.cell.2009.11.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945372	Bronze			2022-12-28	WOS:000272169400009
J	Dickman, DK; Davis, GW				Dickman, Dion K.; Davis, Graeme W.			The Schizophrenia Susceptibility Gene dysbindin Controls Synaptic Homeostasis	SCIENCE			English	Article							HIPPOCAMPAL-FORMATION; TRANSMITTER RELEASE; DROSOPHILA; PROTEIN; GLUTAMATE; DTNBP1; RECEPTORS; DEFINES; CHANNEL; SYSTEM	The molecular mechanisms that achieve homeostatic stabilization of neural function remain largely unknown. To better understand how neural function is stabilized during development and throughout life, we used an electrophysiology-based forward genetic screen and assessed the function of more than 250 neuronally expressed genes for a role in the homeostatic modulation of synaptic transmission in Drosophila. This screen ruled out the involvement of numerous synaptic proteins and identified a critical function for dysbindin, a gene linked to schizophrenia in humans. We found that dysbindin is required presynaptically for the retrograde, homeostatic modulation of neurotransmission, and functions in a dose-dependent manner downstream or independently of calcium influx. Thus, dysbindin is essential for adaptive neural plasticity and may link altered homeostatic signaling with a complex neurological disease.	[Dickman, Dion K.; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	graeme.davis@ucsf.edu			A. P. Giannini Foundation; Jane Coffin Childs Memorial Fund; NIH [NS39313]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	A. P. Giannini Foundation; Jane Coffin Childs Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	members of the Davis laboratory for comments and discussion. Supported by postdoctoral fellowships from the A. P. Giannini Foundation and Jane Coffin Childs Memorial Fund (D. K. D.) and by NIH grant NS39313 (G. W. D.).	Benson MA, 2004, TRENDS NEUROSCI, V27, P516, DOI 10.1016/j.tins.2004.06.004; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Collier DA, 2003, EUR J PHARMACOL, V480, P177, DOI 10.1016/j.ejphar.2003.08.105; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Kendler KS, 2004, AM J PSYCHIAT, V161, P1533, DOI 10.1176/appi.ajp.161.9.1533; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Macleod GT, 2006, EUR J NEUROSCI, V23, P3230, DOI 10.1111/j.1460-9568.2006.04873.x; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Norton N, 2006, CURR OPIN PSYCHIATR, V19, P158, DOI 10.1097/01.yco.0000214341.52249.59; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Owen MJ, 2004, J CLIN INVEST, V113, P1255, DOI 10.1172/JCI200421470; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sodhi Monsheel, 2008, Expert Rev Neurother, V8, P1389, DOI 10.1586/14737175.8.9.1389; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Williams NM, 2005, SCHIZOPHRENIA BULL, V31, P800, DOI 10.1093/schbul/sbi061	27	158	160	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1127	1130		10.1126/science.1179685	http://dx.doi.org/10.1126/science.1179685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965435	Green Accepted			2022-12-28	WOS:000271951000049
J	Swanson-Wagner, RA; DeCook, R; Jia, Y; Bancroft, T; Ji, TM; Zhao, XF; Nettleton, D; Schnable, PS				Swanson-Wagner, Ruth A.; DeCook, Rhonda; Jia, Yi; Bancroft, Tim; Ji, Tieming; Zhao, Xuefeng; Nettleton, Dan; Schnable, Patrick S.			Paternal Dominance of Trans-eQTL Influences Gene Expression Patterns in Maize Hybrids	SCIENCE			English	Article							IDENTIFICATION; ARCHITECTURE; REVEALS; MOUSE	Heterosis refers to the superior performance of hybrid progeny relative to their inbred parents, but the mechanisms responsible are unknown. Hybrids between the maize inbred lines B73 and Mo17 exhibit heterosis regardless of cross direction. These reciprocal hybrids differ from each other phenotypically, and 30 to 50% of their genes are differentially expressed. We identified similar to 4000 expression quantitative trait loci (eQTL) that allowed us to identify markers linked to variation in expression. We found that over three-quarters of these eQTL act in trans (78%) and that 86% of these differentially regulate transcript accumulation in a manner consistent with gene expression in the hybrid being regulated exclusively by the paternally transmitted allele. This result suggests that widespread imprinting contributes to the regulation of gene expression in maize hybrids.	[Swanson-Wagner, Ruth A.; DeCook, Rhonda; Jia, Yi; Bancroft, Tim; Ji, Tieming; Zhao, Xuefeng; Nettleton, Dan; Schnable, Patrick S.] Iowa State Univ, Ames, IA 50011 USA	Iowa State University	Schnable, PS (corresponding author), Iowa State Univ, Ames, IA 50011 USA.	schnable@iastate.edu	Jia, Yi/F-7476-2010	Schnable, Patrick/0000-0001-9169-5204; Nettleton, Dan/0000-0002-6045-1036	NSF [DBI-0527192]; Iowa State University's Plant Sciences Institute	NSF(National Science Foundation (NSF)); Iowa State University's Plant Sciences Institute	We thank S. Hargreaves, M. Smith, M. Wilkening, T. Kemmerer, P. Lu, C.-T. Yeh, and L. Coffey for sample and data processing and the maize genome sequence project (NSF DBI-0527192) for sharing genome sequences before publication. Funding provided by Iowa State University's Plant Sciences Institute. Microarray and sequencing data are available at the National Center for Biotechnology Information GEO database in series GSE16136.	Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gonzalo M, 2007, HEREDITY, V99, P14, DOI 10.1038/sj.hdy.6800955; Goodrich JA, 2009, CRIT REV BIOCHEM MOL, V44, P3, DOI [10.1080/10409230802593995, 10.1080/10409230802593995 ]; Guo M, 2008, PLANT MOL BIOL, V66, P551, DOI 10.1007/s11103-008-9290-z; Hansen BG, 2008, TRENDS PLANT SCI, V13, P72, DOI 10.1016/j.tplants.2007.11.008; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Nogueira FTS, 2006, COLD SPRING HARB SYM, V71, P157, DOI 10.1101/sqb.2006.71.045; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schnable Patrick S., 2009, P457, DOI 10.1007/978-0-387-79418-1_23; Shi C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-22; SHULL G.H., 1908, J HERED, V4, P296; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Springer NM, 2007, PLANT CELL, V19, P2391, DOI 10.1105/tpc.107.052258; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Stupar RM, 2007, PLANT PHYSIOL, V145, P411, DOI 10.1104/pp.107.101428; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wittkopp PJ, 2006, GENETICS, V173, P1817, DOI 10.1534/genetics.105.054684; Yandeau-Nelson MD, 2006, GENETICS, V174, P101, DOI 10.1534/genetics.105.049270; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	32	87	89	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1118	1120		10.1126/science.1178294	http://dx.doi.org/10.1126/science.1178294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965432				2022-12-28	WOS:000271951000046
J	Tzeng, SR; Kalodimos, CG				Tzeng, Shiou-Ru; Kalodimos, Charalampos G.			Dynamic activation of an allosteric regulatory protein	NATURE			English	Article							CAMP RECEPTOR PROTEIN; CAP-DNA COMPLEX; ESCHERICHIA-COLI; ROTATIONAL DIFFUSION; CHEMICAL-EXCHANGE; NMR-SPECTROSCOPY; ORDER PARAMETERS; BINDING PROTEIN; CONFORMATIONAL ENTROPY; ANGSTROM RESOLUTION	Allosteric regulation is used as a very efficient mechanism to control protein activity in most biological processes, including signal transduction, metabolism, catalysis and gene regulation(1-6). Allosteric proteins can exist in several conformational states with distinct binding or enzymatic activity. Effectors are considered to function in a purely structural manner by selectively stabilizing a specific conformational state, thereby regulating protein activity. Here we show that allosteric proteins can be regulated predominantly by changes in their structural dynamics. We have used NMR spectroscopy and isothermal titration calorimetry to characterize cyclic AMP (cAMP) binding to the catabolite activator protein (CAP), a transcriptional activator that has been a prototype for understanding effector-mediated allosteric control of protein activity(7). cAMP switches CAP from the 'off' state (inactive), which binds DNA weakly and non-specifically, to the 'on' state (active), which binds DNA strongly and specifically. In contrast, cAMP binding to a single CAP mutant, CAP-S62F, fails to elicit the active conformation; yet, cAMP binding to CAP-S62F strongly activates the protein for DNA binding. NMR and thermodynamic analyses show that despite the fact that CAP-S62F-cAMP(2) adopts the inactive conformation, its strong binding to DNA is driven by a large conformational entropy originating in enhanced protein motions induced by DNA binding. The results provide strong evidence that changes in protein motions may activate allosteric proteins that are otherwise structurally inactive.	[Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018	Kalodimos, Charalampos/0000-0001-6354-2796; TZENG, SHIOU-RU/0000-0002-7180-0190	National Science Foundation (NSF) [MCB618259]	National Science Foundation (NSF)(National Science Foundation (NSF))	We are grateful to L. Kay for critical reading of the manuscript and valuable suggestions. We thank R. H. Ebright and Y. Ebright for providing the DNA fragment and N. Popovych for her help with the preparation of some CAP mutants. This work was supported by National Science Foundation (NSF) grant MCB618259 to C. G. K.	AIBA H, 1985, EMBO J, V4, P3329, DOI 10.1002/j.1460-2075.1985.tb04084.x; AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Baichoo N, 1997, BIOCHEMISTRY-US, V36, P10830, DOI 10.1021/bi970714v; Berg JM, 2006, BIOCHEMISTRY; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cavanagh J, 2000, NAT STRUCT BIOL, V7, P11, DOI 10.1038/71202; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; Dai JY, 2004, BIOCHEMISTRY-US, V43, P8901, DOI 10.1021/bi0499359; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hwang PM, 2001, J BIOMOL NMR, V20, P83, DOI 10.1023/A:1011226512421; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kay LE, 1998, NAT STRUCT BIOL, V5, P156, DOI 10.1038/nsb0298-156; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KIM J, 1992, P NATL ACAD SCI USA, V89, P9700, DOI 10.1073/pnas.89.20.9700; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; MacRaild CA, 2007, J MOL BIOL, V368, P822, DOI 10.1016/j.jmb.2007.02.055; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PALMER AG, MODELFREE; PALMER AG, CPMGFIT; PALMER AG, QUADRIC DIFFUSION; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Takeuchi K, 2007, J BIOMOL NMR, V38, P89, DOI 10.1007/s10858-007-9152-z; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Zhang FL, 2002, J AM CHEM SOC, V124, P12654, DOI 10.1021/ja027847a	53	289	291	5	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					368	U139		10.1038/nature08560	http://dx.doi.org/10.1038/nature08560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924217				2022-12-28	WOS:000271899300048
J	Bharucha, AE				Bharucha, Adil E.			Review: PPI use in pregnancy was not associated with increased congenital malformations, spontaneous abortion, or preterm delivery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Bharucha, AE (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							*TAP PHARM INC, 2004, PROD INF PREV 4 LANS; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-14	10.7326/0003-4819-151-10-200911170-02014	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920259				2022-12-28	WOS:000272145100025
J	Roy, PM; Durieux, P; Gillaizeau, F; Legall, C; Armand-Perroux, A; Martino, L; Hachelaf, M; Dubart, AE; Schmidt, J; Cristiano, M; Chretien, JM; Perrier, A; Meyer, G				Roy, Pierre-Marie; Durieux, Pierre; Gillaizeau, Florence; Legall, Catherine; Armand-Perroux, Aurore; Martino, Ludovic; Hachelaf, Mohamed; Dubart, Alain-Eric; Schmidt, Jeannot; Cristiano, Mirko; Chretien, Jean-Marie; Perrier, Arnaud; Meyer, Guy			A Computerized Handheld Decision-Support System to Improve Pulmonary Embolism Diagnosis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							VENOUS THROMBOEMBOLISM; STATISTICS NOTES; MANAGEMENT; PATIENT; IMPLEMENTATION; OUTCOMES	Background: Testing for pulmonary embolism often differs from that recommended by evidence-based guidelines. Objective: To assess the effectiveness of a handheld clinical decision-support system to improve the diagnostic work-up of suspected pulmonary embolism among patients in the emergency department. Design: Cluster randomized trial. Assignment was by random-number table, providers were not blinded, and outcome assessment was automated. (ClinicalTrials.gov registration number: NCT00188032) Setting: 20 emergency departments in France. Patients: 1103 and 1768 consecutive outpatients with suspected pulmonary embolism. Intervention: After a preintervention period involving 20 centers and 1103 patients, in which providers grew accustomed to inputting clinical data into handheld devices and investigators assessed baseline testing, emergency departments were randomly assigned to activation of a decision-support system on the devices (10 centers, 753 patients) or posters and pocket cards that showed validated diagnostic strategies (10 centers, 1015 patients). Measurements: Appropriateness of diagnostic work-up, defined as any sequence of tests that yielded a posttest probability less than 5% or greater than 85% (primary outcome) or as strict adherence to guideline recommendations (secondary outcome); number of tests per patient (secondary outcome). Results: The proportion of patients who received appropriate diagnostic work-ups was greater during the trial than in the preintervention period in both groups, but the increase was greater in the computer-based guidelines group (adjusted mean difference in increase, 19.3 percentage points favoring computer-based guidelines [95% CI, 2.9 to 35.6 percentage points]; P = 0.023). Among patients with appropriate work-ups, those in the computer-based guidelines group received slightly fewer tests than did patients in the paper guidelines group (mean tests per patient, 1.76 [SD, 0.98] vs. 2.25 [SD, 1.04]; P < 0.001). Limitation: The study was not designed to show a difference in the clinical outcomes of patients during follow-up. Conclusion: A handheld decision-support system improved diagnostic decision making for patients with suspected pulmonary embolism in the emergency department.	[Roy, Pierre-Marie] CHU Angers, Serv Urgences, F-49933 Angers 9, France; Univ Angers, Angers, France; Hop Europeen Georges Pompidou, Paris, France; Univ Paris 05, Paris, France; Ctr Hosp Victor Dupouy Argenteuil, Argenteuil, France; CHU Caen, F-14000 Caen, France; Ctr Hosp Chateauroux, Chateauroux, France; Ctr Hosp Univ Jean Minjoz, Besancon, France; Ctr Hosp Bethune, Beuvry, France; Ctr Hosp Univ Gabriel Montpied, Clermont Ferrand, France; Univ Clermont Ferrand 2, Clermont Ferrand, France; Ctr Hosp Lons Le Saunier, Lons Le Saunier, France; Univ Hosp Geneva, Geneva, Switzerland	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Franche-Comte; CHU Besancon; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); University of Geneva	Roy, PM (corresponding author), CHU Angers, Serv Urgences, F-49933 Angers 9, France.	pmroy@chu-angers.fr; florence.gillaizeau@egp.aphp.fr	Perrier, Arnaud/M-2263-2014; Chrétien, Jean-Marie/F-4232-2014; Roy, Pierre-Marie/AAA-7737-2022	Chrétien, Jean-Marie/0000-0003-1672-8306; 	French National Hospital Clinical Research Project	French National Hospital Clinical Research Project	Primary Funding Source: French National Hospital Clinical Research Project.	Berner ES, 2006, J AM MED INFORM ASSN, V13, P171, DOI 10.1197/jamia.M1961; Bochicchio GV, 2006, J AM COLL SURGEONS, V202, P459, DOI 10.1016/j.jamcollsurg.2005.11.010; Campbell IA, 2003, THORAX, V58, P470; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; Donner A, 1998, J R STAT SOC C-APPL, V47, P95, DOI 10.1111/1467-9876.00100; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Fesmire FM, 2003, ANN EMERG MED, V41, P257, DOI 10.1067/mem.2003.40; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Greiver M, 2005, CAN FAM PHYSICIAN, V51, P382; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Hagen PJ, 2001, NETH J MED, V59, P161, DOI 10.1016/S0300-2977(01)00154-1; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; McGregor JC, 2006, J AM MED INFORM ASSN, V13, P378, DOI 10.1197/jamia.M2049; Murray DM, 1998, DESIGN ANAL GROUP RA; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Shiffman RN, 2000, PEDIATRICS, V105, P767, DOI 10.1542/peds.105.4.767; Sintchenko V, 2005, J AM MED INFORM ASSN, V12, P398, DOI 10.1197/jamia.M1798; Stein PD, 2006, AM J MED, V119, P1048, DOI 10.1016/j.amjmed.2006.05.060; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; WONG ET, 1983, JAMA-J AM MED ASSOC, V249, P3076, DOI 10.1001/jama.249.22.3076	29	78	78	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					677	W223		10.7326/0003-4819-151-10-200911170-00003	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00003			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920268				2022-12-28	WOS:000272145100001
J	Lagoudakis, KG; Ostatnicky, T; Kavokin, AV; Rubo, YG; Andre, R; Deveaud-Pledran, B				Lagoudakis, K. G.; Ostatnicky, T.; Kavokin, A. V.; Rubo, Y. G.; Andre, R.; Deveaud-Pledran, B.			Observation of Half-Quantum Vortices in an Exciton-Polariton Condensate	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; SEMICONDUCTOR MICROCAVITIES; QUANTIZED VORTICES; POLARIZATION; LIGHT	Singly quantized vortices have already been observed in many systems, including the superfluid helium, Bose-Einstein condensates of dilute atomic gases, and condensates of exciton-polaritons in the solid state. Two-dimensional superfluids carrying spin are expected to demonstrate a different type of elementary excitations referred to as half-quantum vortices, characterized by a p rotation of the phase and a p rotation of the polarization vector when circumventing the vortex core. We detect half-quantum vortices in an exciton-polariton condensate by means of polarization-resolved interferometry, real-space spectroscopy, and phase imaging. Half-quantum vortices coexist with single-quantum vortices in our sample.	[Lagoudakis, K. G.; Deveaud-Pledran, B.] Ecole Polytech Fed Lausanne, IPEQ, CH-1015 Lausanne, Switzerland; [Ostatnicky, T.; Kavokin, A. V.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Kavokin, A. V.] Univ Roma Tor Vergata, Marie Curie Chair Excellence, I-00133 Rome, Italy; [Rubo, Y. G.] Univ Nacl Autonoma Mexico, Ctr Invest Energia, Temixco 62580, Morelos, Mexico; [Andre, R.] CNRS, Inst Neel, F-38042 Grenoble, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southampton; University of Rome Tor Vergata; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lagoudakis, KG (corresponding author), Ecole Polytech Fed Lausanne, IPEQ, CH-1015 Lausanne, Switzerland.	konstantinos.lagoudakis@epfl.ch	Rubo, Yuri/T-7283-2019; Ostatnický, Tomáš/C-2161-2017; Lagoudakis, Konstantinos G./ABF-6459-2020; Deveaud, Benoit/N-1947-2014; Kavokin, Alexey V/J-8610-2013; Deveaud, Benoit/A-4782-2013; Lagoudakis, Konstantinos G./ABF-6475-2020; Lagoudakis, Konstantinos G./I-8270-2014; KAVOKINE, ALEXIS/C-3601-2016; André, Régis/M-4629-2014	Rubo, Yuri/0000-0002-5016-2249; Ostatnický, Tomáš/0000-0001-5182-1501; Lagoudakis, Konstantinos G./0000-0002-4410-4755; Deveaud, Benoit/0000-0002-9776-6314; Deveaud, Benoit/0000-0002-9776-6314; Lagoudakis, Konstantinos G./0000-0002-4410-4755; Lagoudakis, Konstantinos G./0000-0002-4410-4755; KAVOKINE, ALEXIS/0000-0003-2713-1062; André, Régis/0000-0003-3035-4291	Quantum Photonics- National Centre of Competence in Research; Swiss National Science Foundation; Engineering and Physical Sciences Research Council; Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico	Quantum Photonics- National Centre of Competence in Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico	We thank Le Si Dang for crucial remarks and detailed proofreading of this manuscript. We also thank T. C. H. Liew, M. Toledo Solano, M. Wouters, B. Pietka, Y. Leger, M. Richard, A. Baas, G. Nardin, D. N. Krizhanovskii, D. Sanvitto, P. G. Lagoudakis, and V. Savona for enlightening discussions. K. G. L. and B. D.- P. thank the Quantum Photonics- National Centre of Competence in Research for financial support through the Swiss National Science Foundation. A. V. K. and Y. G. R. thank the Engineering and Physical Sciences Research Council and the Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico for support.	Amo A, 2009, NATURE, V457, P291, DOI 10.1038/nature07640; [Anonymous], 2003, BOSEEINSTEIN CONDENS; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; Donnelly R. J., 1991, QUANTIZED VORTICES H, V2; Fertig HA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.035703; GIRVIN SM, 1997, PERSPECTIVES QUANTUM, pCH5; Kasprzak J, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045326; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kato M, 2009, J PHYS CONF SER, V150, DOI 10.1088/1742-6596/150/5/052103; Kavokin A., 2017, MICROCAVITIES; Kirtley JR, 1996, PHYS REV LETT, V76, P1336, DOI 10.1103/PhysRevLett.76.1336; Klopotowski L, 2006, SOLID STATE COMMUN, V139, P511, DOI 10.1016/j.ssc.2006.07.016; Lagoudakis KG, 2008, NAT PHYS, V4, P706, DOI 10.1038/nphys1051; Liew TCH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.187401; Luk'yanchuk I. A., 1995, Superconductivity Review, V1, P207; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; Nardin G, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3126022; Panzarini G, 1999, PHYS REV B, V59, P5082, DOI 10.1103/PhysRevB.59.5082; Rubo YG, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106401; SALOMAA MM, 1987, REV MOD PHYS, V59, P533, DOI 10.1103/RevModPhys.59.533; Tsuei CC, 2002, PHYSICA C, V367, P1, DOI 10.1016/S0921-4534(01)00976-5; Utsunomiya S, 2008, NAT PHYS, V4, P700, DOI 10.1038/nphys1034; Volovik G.E., 2003, UNIVERSE HELIUM DROP; Yamashita M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.025302	24	241	245	10	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					974	976		10.1126/science.1177980	http://dx.doi.org/10.1126/science.1177980			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965506	Green Published, Green Submitted			2022-12-28	WOS:000271712300034
J	MacDonald, R				MacDonald, Rhona			Child abuse: stop the collusion and enhance the protection	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), The Lancet, London NW1 7BY, England.							*COMM INV, 2009, REP COMM INV CATH AR; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; *IR COMM, 2009, COMM INQ CHILD AB; *MAT CHILDH ADV IN, WELC MCAI MAT CHILDH; *ROYAL COLL PAED C, REC RESP CHILD MALTR; Solberg KE, 2009, LANCET, V374, P106, DOI 10.1016/S0140-6736(09)61270-8; UN, 1989, CONV RIGHTS CHILD	7	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 5	2009	374	9705					1878	1878		10.1016/S0140-6736(09)62075-4	http://dx.doi.org/10.1016/S0140-6736(09)62075-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19962559				2022-12-28	WOS:000272646900010
J	Bang, HJ; Edwards, AM; Bomback, AS; Ballantyne, CM; Brillon, D; Callahan, MA; Teutsch, SM; Mushlin, AI; Kern, LM				Bang, Heejung; Edwards, Alison M.; Bomback, Andrew S.; Ballantyne, Christie M.; Brillon, David; Callahan, Mark A.; Teutsch, Steven M.; Mushlin, Alvin I.; Kern, Lisa M.			Development and Validation of a Patient Self-assessment Score for Diabetes Risk	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; TYPE-2; PERFORMANCE; PREVENTION; MELLITUS; REASONS; PREDICT; ADULTS; MODEL; CARE	Background: National guidelines disagree on who should be screened for undiagnosed diabetes. No existing diabetes risk score is highly generalizable or widely followed. Objective: To develop a new diabetes screening score and compare it with other available screening instruments (Centers for Disease Control and Prevention, American Diabetes Association, and U. S. Preventive Services Task Force guidelines; 2 American Diabetes Association risk questionnaires; and the Rotterdam model). Design: Cross-sectional data. Setting: NHANES (National Health and Nutrition Examination Survey) 1999 to 2004 for model development and 2005 to 2006, plus a combined cohort of 2 community studies, ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study), for validation. Participants: U. S. adults aged 20 years or older. Measurements: A risk-scoring algorithm for undiagnosed diabetes, defined as fasting plasma glucose level of 7.0 mmol/L (126 mg/dL) or greater without known diabetes, was developed in the development data set. Logistic regression was used to determine which participant characteristics were independently associated with undiagnosed diabetes. The new algorithm and other methods were evaluated by standard diagnostic and feasibility measures. Results: Age, sex, family history of diabetes, history of hypertension, obesity, and physical activity were associated with undiagnosed diabetes. In NHANES (ARIC/CHS), the cut-point of 5 or more points selected 35% (40%) of persons for diabetes screening and yielded a sensitivity of 79% (72%), specificity of 67% (62%), positive predictive value of 10% (10%), and positive likelihood ratio of 2.39 (1.89). In contrast, the comparison scores yielded a sensitivity of 44% to 100%, specificity of 10% to 73%, positive predictive value of 5% to 8%, and positive likelihood ratio of 1.11 to 1.98. Limitation: Data during pregnancy were not available. Conclusion: This easy-to-implement diabetes screening score seems to demonstrate improvements over existing methods. Studies are needed to evaluate it in diverse populations in real-world settings.	[Bang, Heejung] Columbia Univ, Weill Cornell Med Coll, Dept Publ Hlth, Cornell Univ,Coll Phys & Surg, New York, NY 10065 USA; FOJP Serv Corp, New York, NY USA; Baylor Coll Med, Houston, TX 77030 USA; Ctr Cardiovasc Dis Prevent, Methodist DeBakey Heart Ctr, Houston, TX USA; Los Angeles Cty Dept Publ Hlth, Los Angeles, CA USA	Columbia University; Cornell University; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Los Angeles County Department of Public Health	Bang, HJ (corresponding author), Columbia Univ, Weill Cornell Med Coll, Dept Publ Hlth, Cornell Univ,Coll Phys & Surg, 402 E 67th St, New York, NY 10065 USA.	heb2013@med.cornell.edu	Ballantyne, Christie/A-6599-2008	Kern, Lisa/0000-0003-1191-8100; Ballantyne, Christie/0000-0002-6432-1730	Centers for Disease Control and Prevention; National Heart, Lung and Blood Institute; Clinical and Translational Science Center at Weill Cornell Medical College [UL1-RR024996]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007750] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Clinical and Translational Science Center at Weill Cornell Medical College; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The NHANES were supported by the Centers for Disease Control and Prevention. The ARIC and CHS studies were supported by the National Heart, Lung and Blood Institute. This manuscript was prepared by using public-use data sets (for NHANES) and limited-access data sets (for ARIC and CHS) and does not necessarily reflect the opinions or views of these studies or agencies.; By the Clinical and Translational Science Center at Weill Cornell Medical College (UL1-RR024996).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; [Anonymous], PREVENTING CHILDHOOD; [Anonymous], 2000, SAS STAT US GUID VER; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Bang H, 2007, ARCH INTERN MED, V167, P374, DOI 10.1001/archinte.167.4.374; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P833; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Feasel J, 2006, J AM COLL SURGEONS, V203, pS54, DOI 10.1016/j.jamcollsurg.2006.03.019; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Gonen M, 2007, ANAL RECEIVER OPERAT; Goyder EC, 1998, BRIT MED J, V316, P1505, DOI 10.1136/bmj.316.7143.1505; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; GRUNDY SM, NHLBI WORKSH CARD RI; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; HERMAN WH, 1995, DIABETES CARE, V18, P382, DOI 10.2337/diacare.18.3.382; Herman WH, 2009, ANN INTERN MED, V150, P812, DOI 10.7326/0003-4819-150-11-200906020-00010; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knudson PE, 1998, DIABETES CARE, V21, P1029, DOI 10.2337/diacare.21.6.1029b; Kshirsagar AV, 2008, ARCH INTERN MED, V168, P2466, DOI 10.1001/archinte.168.22.2466; Lawler FH, 2009, MAYO CLIN PROC, V84, P34, DOI 10.1016/S0025-6196(11)60805-7; Little R. J. A., 1987, STAT ANAL MISSING DA; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Rolka DB, 2001, DIABETES CARE, V24, P1899, DOI 10.2337/diacare.24.11.1899; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Sheehy AM, 2009, MAYO CLIN PROC, V84, P38, DOI 10.1016/S0025-6196(11)60806-9; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; 2003, CLIN MODIFICATION	47	188	189	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					775	W255		10.7326/0003-4819-151-11-200912010-00005	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EJ	19949143				2022-12-28	WOS:000272727900003
J	McMichael, AJ; Neira, M; Bertollini, R; Campbell-Lendrum, D; Hales, S				McMichael, A. J.; Neira, M.; Bertollini, R.; Campbell-Lendrum, D.; Hales, S.			Climate change: a time of need and opportunity for the health sector	LANCET			English	Editorial Material									[McMichael, A. J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; [Neira, M.; Bertollini, R.; Campbell-Lendrum, D.; Hales, S.] WHO, CH-1211 Geneva, Switzerland	Australian National University; World Health Organization	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	hales, simon/E-5768-2010	Hales, Simon/0000-0002-4529-7595				Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; CSDH, 2008, CLOS GAP GEN HLTH EQ; Egger G, 2003, Obes Rev, V4, P115, DOI 10.1046/j.1467-789X.2003.00100.x; *GLOB HUM FOR, 2009, HUM IMP REP CLIM CHA, P116; KELLAM K, 2001, MICROBIOL TODAY, V28, P16; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING HL; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Stern N. H., 2006, STERN REV EC CLIMATE; *UN, 1992, UN FRAM CONV CLIM CH; *UNFCC, 2009, SUBM PART ADH WORK G; Virchow R, 1941, MED HUMAN WELFARE, P93; WHO, 2008, CLIM CHANG HLTH RES	12	40	41	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2009	374	9707					2123	2125		10.1016/S0140-6736(09)62031-6	http://dx.doi.org/10.1016/S0140-6736(09)62031-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	19942278				2022-12-28	WOS:000273122900036
J	Troncoso, A; Bava, J				Troncoso, Alcides; Bava, Javier			Chromoblastomycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Troncoso, Alcides] Sch Med, Buenos Aires, DF, Argentina; [Bava, Javier] Univ La Plata, Buenos Aires, DF, Argentina	National University of La Plata	Troncoso, A (corresponding author), Sch Med, Buenos Aires, DF, Argentina.	microbiologiayparasitologia@yahoo.com.ar							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2165	2165		10.1056/NEJMicm0807060	http://dx.doi.org/10.1056/NEJMicm0807060			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524BC	19940301				2022-12-28	WOS:000272117800010
J	Larsson, EM; Langhammer, C; Zoric, I; Kasemo, B				Larsson, Elin M.; Langhammer, Christoph; Zoric, Igor; Kasemo, Bengt			Nanoplasmonic Probes of Catalytic Reactions	SCIENCE			English	Article							SURFACE-PLASMON RESONANCES; SENSING CHARACTERISTICS; NANOPARTICLES; SPECTROSCOPY; ADSORPTION; NANOSTRUCTURES; LITHOGRAPHY; SCIENCE; MODEL	Optical probes of heterogeneous catalytic reactions can be valuable tools for optimization and process control because they can operate under realistic conditions, but often probes lack sensitivity. We have developed a plasmonic sensing method for such reactions based on arrays of nanofabricated gold disks, covered by a thin (similar to 10 nanometer) coating (catalyst support) on which the catalyst nanoparticles are deposited. The sensing particles monitor changes in surface coverage of reactants during catalytic reaction through peak shifts in the optical extinction spectrum. Sensitivities to below 10(-3) monolayers are estimated. The capacity of the method is demonstrated for three catalytic reactions, CO and H-2 oxidation on Pt, and NOx conversion to N-2 on Pt/BaO.	[Larsson, Elin M.; Langhammer, Christoph; Zoric, Igor; Kasemo, Bengt] Chalmers, Dept Appl Phys, Chem Phys Grp, SE-41296 Gothenburg, Sweden	Chalmers University of Technology	Larsson, EM (corresponding author), Chalmers, Dept Appl Phys, Chem Phys Grp, SE-41296 Gothenburg, Sweden.	elarsson@chalmers.se	Langhammer, Christoph/G-5013-2010		Swedish foundation for strategic research; Chalmers Foundation; Swedish energy agency [N2E2]	Swedish foundation for strategic research(Swedish Foundation for Strategic Research); Chalmers Foundation; Swedish energy agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	The Swedish foundation for strategic research (program PhotoNano), the Chalmers Foundation, and the Swedish energy agency (project N2E2) are acknowledged for their financial support. We are grateful to S. Gustafsson and E. Olsson at our department for the TEM picture in Fig. 1D.	Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; BAR M, 1992, J CHEM PHYS, V96, P8595, DOI 10.1063/1.462312; Chan GH, 2007, NANO LETT, V7, P1947, DOI 10.1021/nl070648a; Dahlin AB, 2006, ANAL CHEM, V78, P4416, DOI 10.1021/ac0601967; Enders D, 2007, LANGMUIR, V23, P6119, DOI 10.1021/la063239n; ERTL G, 1994, SURF SCI, V299, P742, DOI 10.1016/0039-6028(94)90694-7; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; Fredriksson H, 2007, ADV MATER, V19, P4297, DOI 10.1002/adma.200700680; GOODMAN DW, 1995, CHEM REV, V95, P523, DOI 10.1021/cr00035a004; Hagglund C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2840676; Kreibig U., 1995, OPTICAL PROPERTIES M, DOI DOI 10.1007/978-3-662-09109-8; Langhammer C, 2006, NANO LETT, V6, P833, DOI 10.1021/nl060219x; LANGHAMMER C, 2009, Patent No. 18030; Langhammer C, 2008, NANO LETT, V8, P1461, DOI 10.1021/nl080453i; Larsson EM, 2007, NANO LETT, V7, P1256, DOI 10.1021/nl0701612; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Novo C, 2008, NAT NANOTECHNOL, V3, P598, DOI 10.1038/nnano.2008.246; PARKER DH, 1989, SURF SCI, V217, P489, DOI 10.1016/0039-6028(89)90443-3; Rindzevicius T, 2005, NANO LETT, V5, P2335, DOI 10.1021/nl0516355; Rindzevicius T, 2007, J PHYS CHEM C, V111, P11806, DOI 10.1021/jp072564w; Sherry LJ, 2006, NANO LETT, V6, P2060, DOI 10.1021/nl061286u; SOMORJAI GA, 1989, PROG SURF SCI, V30, P201, DOI 10.1016/0079-6816(89)90009-9; Somorjai GA, 2007, CATAL LETT, V115, P87, DOI 10.1007/s10562-007-9137-2; Szanyi J, 2005, J PHYS CHEM B, V109, P27, DOI 10.1021/jp044993p; Takahashi N, 1996, CATAL TODAY, V27, P63, DOI 10.1016/0920-5861(95)00173-5; Volkening S, 1999, PHYS REV LETT, V83, P2672, DOI 10.1103/PhysRevLett.83.2672; Wallin M, 2005, J PHYS CHEM B, V109, P9581, DOI 10.1021/jp044759z; Weick G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165421; Wong K, 1996, FARADAY DISCUSS, V105, P237, DOI 10.1039/fd9960500237; ZHDANOV VP, 1994, SURF SCI REP, V20, P111, DOI 10.1016/0167-5729(94)90009-4	30	316	322	2	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1091	1094		10.1126/science.1176593	http://dx.doi.org/10.1126/science.1176593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19933104				2022-12-28	WOS:000271951000037
J	Lamont, T; Scarpello, J				Lamont, Tara; Scarpello, John			Safety Alerts National Patient Safety Agency: combining stories with statistics to minimise harm	BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTS		[Lamont, Tara; Scarpello, John] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						Department of Health, 2006, SAF 1 REP PAT CLIN H; Lamont T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4459; *NAT PAT SAF AG, 2009, RAP RESP REP PREV DE; National Patient Safety Agency, 2008, RAP RESP REP RED RIS; National Patient Safety Agency, 2009, ACT SER RISKS PAT; Newman TB, 2003, BRIT MED J, V327, P1424, DOI 10.1136/bmj.327.7429.1424; *NHS, 2009, J HUBL FAITH NHS; O'Dowd A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4153; PANESAR SS, 2009, ROY SOC MED INT CONG, V102, P256; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Vincent C, 2007, BRIT MED J, V334, P51, DOI 10.1136/bmj.39071.441609.80	12	14	14	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 19	2009	339								b4489	10.1136/bmj.b4489	http://dx.doi.org/10.1136/bmj.b4489			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TD	19926688				2022-12-28	WOS:000272096500004
J	Lamont, T; Matthew, L; Cousins, D; Green, J				Lamont, Tara; Matthew, Linda; Cousins, David; Green, Jonathan			Safety Alerts Avoiding midazolam overdose: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Matthew, Linda; Cousins, David] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Green, Jonathan] British Soc Gastroenterol Endoscopy, London NW1 4LB, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						[Anonymous], 2004, SCOP OUR PRACT; British Society of Gastroenterology, 2003, SAF SED DUR END PROC; *COMM NPSA NHS PUR, 2009, NAT US QUANT SINGL E; QUINE MA, 1995, GUT, V36, P462, DOI 10.1136/gut.36.3.462	4	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 19	2009	339								b4459	10.1136/bmj.b4459	http://dx.doi.org/10.1136/bmj.b4459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TD	19926687				2022-12-28	WOS:000272096500003
J	Lui, CH; Liu, L; Mak, KF; Flynn, GW; Heinz, TF				Lui, Chun Hung; Liu, Li; Mak, Kin Fai; Flynn, George W.; Heinz, Tony F.			Ultraflat graphene	NATURE			English	Article							HYDROGENATION; SHEETS	Graphene, a single atomic layer of carbon connected by sp(2) hybridized bonds, has attracted intense scientific interest since its recent discovery(1). Much of the research on graphene has been directed towards exploration of its novel electronic properties, but the structural aspects of this model two-dimensional system are also of great interest and importance. In particular, microscopic corrugations have been observed on all suspended(2) and supported(3-8) graphene sheets studied so far. This rippling has been invoked to explain the thermodynamic stability of free-standing graphene sheets(9). Many distinctive electronic(10-12) and chemical(13-15) properties of graphene have been attributed to the presence of ripples, which are also predicted to give rise to new physical phenomena(16-26) that would be absent in a planar two-dimensional material. Direct experimental study of such novel ripple physics has, however, been hindered by the lack of flat graphene layers. Here we demonstrate the fabrication of graphene monolayers that are flat down to the atomic level. These samples are produced by deposition on the atomically flat terraces of cleaved mica surfaces. The apparent height variation in the graphene layers observed by high-resolution atomic force microscopy (AFM) is less than 25 picometres, indicating the suppression of any existing intrinsic ripples in graphene. The availability of such ultraflat samples will permit rigorous testing of the impact of ripples on various physical and chemical properties of graphene.	[Lui, Chun Hung; Mak, Kin Fai; Heinz, Tony F.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Lui, Chun Hung; Mak, Kin Fai; Heinz, Tony F.] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Liu, Li; Flynn, George W.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Heinz, TF (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	tony.heinz@columbia.edu	Liu, Li/E-8959-2013; Mak, Kin Fai/E-9004-2015; Heinz, Tony/K-7797-2015	Liu, Li/0000-0002-4852-1580; Mak, Kin Fai/0000-0002-5768-199X; Heinz, Tony/0000-0003-1365-9464; Lui, Chun Hung/0000-0002-1470-328X	DARPA; Nano Electronics Research Corporation (NERC) through the INDEX Center; National Science Foundation [CHE-07-01483]; US Department of Energy [DE-FG02-88-ER13937]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nano Electronics Research Corporation (NERC) through the INDEX Center(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE))	We thank E. B. Newton and S. Li for their assistance in sample preparation and J. Shan, H. G. Yan and Z. Q. Li for discussions. This work was supported by grants from DARPA through the CERA programme (to T. F. H.), from the Nano Electronics Research Corporation (NERC) through the INDEX Center (to T. F. H.), and from the National Science Foundation (grant CHE-07-01483 to G. W. F.). Equipment and material support was provided by the US Department of Energy (grant DE-FG02-88-ER13937 to G. W. F.).	Booth TJ, 2008, NANO LETT, V8, P2442, DOI 10.1021/nl801412y; BRAGG SL, 1965, CRYSTAL STRUCTURES M, pCH13; Brey L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.041403; Cortijo A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184205; de Juan F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165409; Deshpande A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205411; Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Fasolino A, 2007, NAT MATER, V6, P858, DOI 10.1038/nmat2011; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Geringer V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076102; Guinea F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205421; Guinea F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075422; Herbut IF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046403; Huertas-Hernando D, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155426; Ishigami M, 2007, NANO LETT, V7, P1643, DOI 10.1021/nl070613a; Katsnelson MI, 2008, PHILOS T R SOC A, V366, P195, DOI 10.1098/rsta.2007.2157; Kim EA, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/57007; Knox KR, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.201408; Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684; Martin J, 2008, NAT PHYS, V4, P144, DOI 10.1038/nphys781; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Morozov SV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016801; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Ryu S, 2008, NANO LETT, V8, P4597, DOI 10.1021/nl802940s; Stoberl U, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2968310; Stolyarova E, 2007, P NATL ACAD SCI USA, V104, P9209, DOI 10.1073/pnas.0703337104; Vozmediano MAH, 2008, J PHYS CONF SER, V129, DOI 10.1088/1742-6596/129/1/012001; Wehling TO, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/17003	28	531	539	13	510	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					339	341		10.1038/nature08569	http://dx.doi.org/10.1038/nature08569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924211				2022-12-28	WOS:000271899300041
J	Teixeira, MG; Barreto, ML				Teixeira, Maria Gloria; Barreto, Mauricio L.			Diagnosis and management of dengue	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEMORRHAGIC-FEVER; CLINICAL-MANIFESTATIONS; VECTOR CONTROL; CHILDREN; EPIDEMIC; SHOCK		[Teixeira, Maria Gloria; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil	Universidade Federal da Bahia	Teixeira, MG (corresponding author), Univ Fed Bahia, Inst Saude Colet, Rua Basilio Gama S-N, BR-40110040 Salvador, BA, Brazil.	magloria@ufba.br	Barreto, Mauricio L/B-1752-2008; Teixeira, Maria Gloria L C/G-4808-2012	Barreto, Mauricio L/0000-0002-0215-4930; Teixeira, Maria Gloria L C/0000-0003-3318-3408				Barreto ML, 2008, LANCET, V372, P205, DOI 10.1016/S0140-6736(08)61069-7; BEASLEY DW, 2008, DENGUE TROPICAL MED, V5, P29; BLANTON RE, 2008, EUR J HUM GENET, V13, P15; Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848; Chairulfatah A, 1995, ANN SOC BELG MED TR, V75, P291; COHEN SN, 1964, J PEDIATR, V68, P448, DOI DOI 10.1016/S0022-3476(66)80249-4; Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1; Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; ENDY TP, 2008, DENGUE TROPICAL MED, V5, P327; HALSTEAD SB, 2008, SOC BRAS VIROL, V13, P29; Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007; Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5; Kabra SK, 1999, T ROY SOC TROP MED H, V93, P294, DOI 10.1016/S0035-9203(99)90027-5; Kalayanarooj S., 1999, Dengue Bulletin, V23, P10; Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006; Mairuhu ATA, 2003, LANCET INFECT DIS, V3, P33, DOI 10.1016/S1473-3099(03)00487-0; MORENS DM, 2008, DENGUE TROPICAL MED, V5, P436; Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479; NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P392; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Ranjit Suchitra, 2005, Pediatr Crit Care Med, V6, P412, DOI 10.1097/01.PCC.0000163676.75693.BF; ROSEN L, 1986, B SOC PATHOL EXOT, V79, P342; Smart K, 2009, J TROP PEDIATRICS, V55, P145, DOI 10.1093/tropej/fmp046; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; *TAC DHF SE AS W P, 1975, GUID DIAGN TREATM SU; Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; de Souza VAUF, 2007, J CLIN VIROL, V39, P230, DOI 10.1016/j.jcv.2007.04.005; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Vazquez S, 2007, J CLIN VIROL, V39, P194, DOI 10.1016/j.jcv.2007.04.003; *WHO, 2009, DENG NET; WHO, 1997, DENG HAEM FEV DIAGN; *WHO, 2009, IMP DENG; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057	35	37	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2009	339								b4338	10.1136/bmj.b4338	http://dx.doi.org/10.1136/bmj.b4338			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TA	19923152				2022-12-28	WOS:000272096200001
J	Byeon, IJL; Meng, X; Jung, JW; Zhao, GP; Yang, RF; Ahn, JW; Shi, J; Concel, J; Aiken, C; Zhang, PJ; Gronenborn, AM				Byeon, In-Ja L.; Meng, Xin; Jung, Jinwon; Zhao, Gongpu; Yang, Ruifeng; Ahn, Jinwoo; Shi, Jiong; Concel, Jason; Aiken, Christopher; Zhang, Peijun; Gronenborn, Angela M.			Structural Convergence between Cryo-EM and NMR Reveals Intersubunit Interactions Critical for HIV-1 Capsid Function	CELL			English	Article							C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; CRYSTAL-STRUCTURES; MEMBRANE-PROTEINS; TUBULAR CRYSTALS; GAG POLYPROTEIN; VIRUS; RESOLUTION; ALIGNMENT; RECONSTRUCTIONS	Mature HIV-1 particles contain conical-shaped capsids that enclose the viral RNA genome and perform essential functions in the virus life cycle. Previous structural analysis of two-and three-dimensional arrays of the capsid protein (CA) hexamer revealed three interfaces. Here, we present a cryoEM study of a tubular assembly of CA and a high-resolution NMR structure of the CA C-terminal domain (CTD) dimer. In the solution dimer structure, the monomers exhibit different relative orientations compared to previous X-ray structures. The solution structure fits well into the EM density map, suggesting that the dimer interface is retained in the assembled CA. We also identified a CTD-CTD interface at the local three-fold axis in the cryoEM map and confirmed its functional importance by mutagenesis. In the tubular assembly, CA intermolecular interfaces vary slightly, accommodating the asymmetry present in tubes. This provides the necessary plasticity to allow for controlled virus capsid dis/assembly.	[Byeon, In-Ja L.; Meng, Xin; Jung, Jinwon; Zhao, Gongpu; Ahn, Jinwoo; Concel, Jason; Zhang, Peijun; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Yang, Ruifeng; Shi, Jiong; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Zhang, PJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	pez7@pitt.edu; amg100@pitt.edu	Aiken, Christopher/Y-9252-2019; zhao, gongpu/B-8151-2012; Jung, Jinwon/F-6038-2010	Gronenborn, Angela M/0000-0001-9072-3525; Jung, Jinwon/0000-0002-7981-3316	National Institutes of Health [GM082251, AI076121, GM085043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085043, P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Joanne Yeh for useful discussions and Dr. Teresa Brosenitsch for critical reading of the manuscript. We thank Drs. Koji Yonekura, Edward Egelman, and Niko Grigorieff for sharing their image processing software and Dr. Jing Zhou for technical assistance. This work is a contribution from the Pittsburgh Center for HIV Protein Interactions and was supported by the National Institutes of Health (GM082251, AI076121, and GM085043).	Aiken Christopher, 2009, V485, P41, DOI 10.1007/978-1-59745-170-3_4; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bosco DA, 2004, BIOCHEMISTRY-US, V43, P6110, DOI 10.1021/bi049841z; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Goddard T.D., 2004, SPARKY 3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Nermut MV, 1998, J STRUCT BIOL, V123, P143, DOI 10.1006/jsbi.1998.4024; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JM, 2008, EMBO J, V27, P1411, DOI 10.1038/emboj.2008.71; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; SATTLER M, 1995, J BIOMOL NMR, V5, P97, DOI 10.1007/BF00227475; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06; Yonekura K, 2000, ULTRAMICROSCOPY, V84, P15, DOI 10.1016/S0304-3991(00)00009-7; Yonekura K, 2007, ULTRAMICROSCOPY, V107, P1141, DOI 10.1016/j.ultramic.2007.01.013; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	56	194	198	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					780	790		10.1016/j.cell.2009.10.010	http://dx.doi.org/10.1016/j.cell.2009.10.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914170	Green Accepted, Bronze			2022-12-28	WOS:000271747200021
J	Howell, AS; Savage, NS; Johnson, SA; Bose, I; Wagner, AW; Zyla, TR; Nijhout, HF; Reed, MC; Goryachev, AB; Lew, DJ				Howell, Audrey S.; Savage, Natasha S.; Johnson, Sam A.; Bose, Indrani; Wagner, Allison W.; Zyla, Trevin R.; Nijhout, H. Frederik; Reed, Michael C.; Goryachev, Andrew B.; Lew, Daniel J.			Singularity in Polarization: Rewiring Yeast Cells to Make Two Buds	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SITE SELECTION; ACTIN CYTOSKELETON; CDC42 GTPASE; POLARITY; PROTEINS; CYCLE; PHOSPHORYLATION; MORPHOGENESIS; LOCALIZATION	For budding yeast to ensure formation of only one bud, cells must polarize toward one, and only one, site. Polarity establishment involves the Rho family GTPase Cdc42, which concentrates at polarization sites via a positive feedback loop. To assess whether singularity is linked to the specific Cdc42 feedback loop, we disabled the yeast cell's endogenous amplification mechanism and synthetically rewired the cells to employ a different positive feedback loop. Rewired cells violated singularity, occasionally making two buds. Even cells that made only one bud sometimes initiated two clusters of Cdc42, but then one cluster became dominant. Mathematical modeling indicated that, given sufficient time, competition between clusters would promote singularity. In rewired cells, competition occurred slowly and sometimes failed to develop a single "winning'' cluster before budding. Slowing competition in normal cells also allowed occasional formation of two buds, suggesting that singularity is enforced by rapid competition between Cdc42 clusters.	[Howell, Audrey S.; Bose, Indrani; Wagner, Allison W.; Zyla, Trevin R.; Lew, Daniel J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Savage, Natasha S.; Goryachev, Andrew B.] Univ Edinburgh, Sch Biol Sci, Ctr Syst Biol Edinburgh, Edinburgh EH9 3JR, Midlothian, Scotland; [Johnson, Sam A.] Duke Univ, Light Microscopy Core Facil, Durham, NC 27708 USA; [Johnson, Sam A.; Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Reed, Michael C.] Duke Univ, Dept Math, Durham, NC 27708 USA	Duke University; University of Edinburgh; Duke University; Duke University; Duke University	Lew, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	daniel.lew@duke.edu	Goryachev, Andrew B/A-6553-2013	Goryachev, Andrew B/0000-0002-1332-4819; McClure, Allison/0000-0002-5321-2483	National Science Foundation (NSF) [G001855]; UK Biotechnology and Biological Sciences Research Council [G001855]; National Institutes of Health [GM62300]; BBSRC [BB/G001855/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001855/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062300] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank David Amberg, Erfei Bi, Tony Bretscher, John Cooper, David Drubin, and Bruce Goode for advice and reagents and Steve Haase, Joe Heitman, Dan Kiehart, Sally Kornbluth, John York, and members of the Lew lab for comments on the manuscript. A. S. H. was supported by a National Science Foundation (NSF) predoctoral fellowship. Work by N.S.S. and A. B. G. was supported by UK Biotechnology and Biological Sciences Research Council grant G001855. Work by H.F.N. and M. C. R. was supported by NSF grant DMS-061670. This work was supported by National Institutes of Health grant GM62300 to D.J.L.	Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Grote E, 2000, MOL BIOL CELL, V11, P4051, DOI 10.1091/mbc.11.12.4051; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; JAFFE LA, 1976, NATURE, V261, P68, DOI 10.1038/261068a0; Keaton MA, 2008, MOL BIOL CELL, V19, P4006, DOI 10.1091/mbc.E08-03-0286; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	33	126	126	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					731	743		10.1016/j.cell.2009.10.024	http://dx.doi.org/10.1016/j.cell.2009.10.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914166	Green Accepted, Bronze			2022-12-28	WOS:000271747200017
J	Takara, TJ; Bell, SP				Takara, Thomas J.; Bell, Stephen P.			Putting Two Heads Together to Unwind DNA	CELL			English	Editorial Material							HELICASE; COMPLEX; REPLICATION; MECHANISM		[Takara, Thomas J.; Bell, Stephen P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Takara, Thomas J.; Bell, Stephen P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bell, SP (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	spbell@mit.edu		Bell, Stephen/0000-0002-2876-610X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Boskovic J, 2007, EMBO REP, V8, P678, DOI 10.1038/sj.embor.7401002; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007	9	11	12	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					652	654		10.1016/j.cell.2009.10.037	http://dx.doi.org/10.1016/j.cell.2009.10.037			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914158	Green Published, Bronze			2022-12-28	WOS:000271747200007
J	Tushir, JS; Zamore, PD; Zhang, Z				Tushir, Jogender S.; Zamore, Phillip D.; Zhang, Zhao			SnapShot: Mouse piRNAs, PIWI Proteins, and the Ping-Pong Cycle	CELL			English	Editorial Material							DROSOPHILA; GERMLINE; ELEMENTS		[Tushir, Jogender S.] Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tushir, JS (corresponding author), Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	9	9	9	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 13	2009	139	4					830	U5		10.1016/j.cell.2009.10.042	http://dx.doi.org/10.1016/j.cell.2009.10.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914174	Bronze			2022-12-28	WOS:000271747200026
J	Lunze, K				Lunze, Karsten			Health and human rights: no miracle in postconflict Chechnya	LANCET			English	Editorial Material									Boston Univ, Boston, MA 02118 USA	Boston University	Lunze, K (corresponding author), Boston Univ, Boston, MA 02118 USA.	karsten.lunze@post.harvard.edu	Lunze, Karsten/AAL-7240-2021	Lunze, Karsten/0000-0001-8495-0350				*COUNC EUR, 2008, LEG REM HUM RIGHTS V; *COUNC EUR COMM LE, 2009, SIT N CAUC REG SEC H; *FREED HOUS, 2009, WORST WORST WORLDS M; Kamhi A., 2006, INT J NOT FOR PROFIT, V9, P34; MENDELSON SE, 2009, VIOLENCE N CAUCASUS; *RIA NEWS AG, 2009, RUSS RUL OUT UN EXP; *UNICEF, ISS FAC CHILDR RUSS; *WHO, 2005, HLTH ACT N CAUC; *WHO REG OFF EUR, 2007, 1 RES EU REC DEV PRO; 2009, UN DAILY NEWS   0721	10	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1809	1810		10.1016/S0140-6736(09)61957-7	http://dx.doi.org/10.1016/S0140-6736(09)61957-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944853				2022-12-28	WOS:000272370200013
J	Sussman, MR; Phillips, GN				Sussman, Michael R.; Phillips, George N., Jr.			How Plant Cells Go to Sleep for a Long, Long Time	SCIENCE			English	Editorial Material									[Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sussman, MR (corresponding author), Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA.	msussman@wisc.edu						Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; YIN P, 2009, NAT STRUCT MOL BIOL	8	5	5	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1356	1357		10.1126/science.1184135	http://dx.doi.org/10.1126/science.1184135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965746				2022-12-28	WOS:000272351100027
J	Gostin, LO; Hanfling, D				Gostin, Lawrence O.; Hanfling, Dan			National Preparedness for a Catastrophic Emergency Crisis Standards of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Hanfling, Dan] Inova Hlth Syst, Falls Church, VA USA; [Hanfling, Dan] George Washington Univ, Dept Emergency Med, Washington, DC USA	Georgetown University; Inova Health System; George Washington University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*AG HEALTHC RES QU, 2005, AHRQ PUBL; Devereaux AV, 2008, CHEST, V133, p51S, DOI 10.1378/chest.07-2693; Fink S., 2009, NEW YORK TIMES MAGAZ, pMM28; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; *GOV ACC OFF, 2008, GAO PUBL, V8668; Hick JL, 2009, DISASTER MED PUBLIC, V3, pS59, DOI 10.1097/DMP.0b013e31819f1ae2; Hodge Jr James G., 2008, N Y U ANN SURV AM L, V64, P249; Hoffman S, 2008, GEORGETOWN LAW J, V96, P1913; Institute of Medicine, 2010, CRISIS STANDARDS CAR, P69	9	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2365	2366		10.1001/jama.2009.1780	http://dx.doi.org/10.1001/jama.2009.1780			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952324				2022-12-28	WOS:000272239000027
J	O'Connor, EA; Whitlock, EP; Beil, TL; Gaynes, BN				O'Connor, Elizabeth A.; Whitlock, Evelyn P.; Beil, Tracy L.; Gaynes, Bradley N.			Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review	ANNALS OF INTERNAL MEDICINE			English	Article							SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LATE-LIFE DEPRESSION; DISSEMINATING QUALITY IMPROVEMENT; COMORBIDITY SURVEY REPLICATION; DISEASE MANAGEMENT PROGRAMS; SERVICES-TASK-FORCE; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT	Background: In primary care settings, prevalence estimates of major depressive disorder range from 5% to 13% in all adults, with lower estimates in those older than 55 years (6% to 9%). In 2002, the U. S. Preventive Services Task Force (USPSTF) recommended screening adults for depression in clinical practices that have systems to ensure accurate diagnosis, effective treatment, and follow-up. Purpose: To conduct a targeted, updated systematic review for the U. S. Preventive Services Task Force about the benefits and harms of screening adult patients for depression in a primary care setting, the benefits of depression treatment in older adults, and the harms of depression treatment with antidepressant medications. Data Sources: MEDLINE, the Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, PsycINFO (1998 to 2007), expert suggestions, and bibliographies of recent systematic reviews. Study Selection: Fair-to good-quality randomized clinical trials or controlled clinical trials; systematic reviews; meta-analyses; and large observational studies of serious adverse events and early discontinuation due to adverse effects. All studies were published in English. Data Extraction: Two investigators abstracted, critically appraised, and synthesized 33 articles that met inclusion criteria. Data Synthesis: Nine fair-or good-quality trials indicate that primary care depression screening and care management programs with staff assistance, such as case management or mental health specialist involvement, can increase depression response and remission. Benefit was not evident in screening programs without staff assistance in depression care. Seven regulatory reviews or meta-analyses and 3 large cohort studies indicate no increased risk for completed suicide deaths with antidepressant treatment. Risk for suicidal behaviors was increased in young adults (aged 18 to 29 years) who received antidepressants, particularly those who received paroxetine, but was reduced in older adults. Limitation: Examination of harms was limited to serious adverse events, and existing systematic reviews were primarily used. Additional studies published from 2007 to 2008 extend this review. Conclusion: Depression screening programs without substantial staff-assisted depression care supports are unlikely to improve depression outcomes. Close monitoring of all adult patients who initiate antidepressant treatment, particularly those younger than 30 years, is important both for safety and to ensure optimal treatment.	[O'Connor, Elizabeth A.] Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA; Univ N Carolina, Chapel Hill, NC USA	Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill	O'Connor, EA (corresponding author), Kaiser Permanente Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	Elizabeth.OConnor@kpchr.org		Gaynes, Bradley/0000-0002-8283-5030	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality.	Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Aursnes I, 2008, PHARMACOEPIDEM DR S, V17, P707, DOI 10.1002/pds.1596; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; Barak Y, 2006, NEUROPSYCHOPHARMACOL, V31, P178, DOI 10.1038/sj.npp.1300863; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Beasley CM, 2007, J CLIN PSYCHOPHARM, V27, P682, DOI 10.1097/jcp.0b013e31815abf21; Beasley CM, 2000, J CLIN PSYCHIAT, V61, P722, DOI 10.4088/JCP.v61n1003; Bergus GR, 2005, J RURAL HEALTH, V21, P303, DOI 10.1111/j.1748-0361.2005.tb00099.x; Bosmans J, 2006, J GEN INTERN MED, V21, P1020, DOI 10.1111/j.1525-1497.2006.00555.x; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P839, DOI 10.1111/j.1532-5415.1994.tb06555.x; Cipriani A, 2007, CAN J PSYCHIAT, V52, P553, DOI 10.1177/070674370705200903; *COMM SAF MED, 2004, REP CSM EXP WORK GRO; Cooper-Kazaz R, 2008, INT J NEUROPSYCHOPH, V11, P685, DOI 10.1017/S1461145707008206; Coyne JC, 2003, ANN INTERN MED, V138, P767, DOI 10.7326/0003-4819-138-9-200305060-00017; Dalton SO, 2006, CNS DRUGS, V20, P143, DOI 10.2165/00023210-200620020-00005; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068; Ernst CL, 2004, HARVARD REV PSYCHIAT, V12, P14, DOI 10.1080/10673220490425924; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Gartlehner G, 2007, COMP EFFECTIVENESS R; Gaynes BN, 2005, GEN HOSP PSYCHIAT, V27, P87, DOI 10.1016/j.genhosppsych.2004.10.003; Gaynes BN, 2007, ANN FAM MED, V5, P126, DOI 10.1370/afm.641; Gensichen J, 2006, PSYCHOL MED, V36, P7, DOI 10.1017/S0033291705005568; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Gilbody S, 2006, BMJ-BRIT MED J, V332, P1027, DOI 10.1136/bmj.332.7548.1027; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; *GLAXOSMITHKLINE, 2006, BEIF DOC PAR AD SUIC; Goldberg D, 1998, BRIT J GEN PRACT, V48, P1840; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hammad TA, 2006, J CLIN PSYCHOPHARM, V26, P203, DOI 10.1097/01.jcp.0000203198.11453.95; Hansen RA, 2005, ANN INTERN MED, V143, P415, DOI 10.7326/0003-4819-143-6-200509200-00006; Hansen R, 2008, PSYCHIAT SERV, V59, P1121, DOI 10.1176/appi.ps.59.10.1121; Harman JS, 2006, J GEN INTERN MED, V21, P926, DOI 10.1007/BF02743139; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hickie IB, 2002, MED J AUSTRALIA, V177, pS111; Jarjoura D, 2004, J GEN INTERN MED, V19, P78, DOI 10.1111/j.1525-1497.2004.21249.x; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Katzman MA, 2007, J CLIN PSYCHIAT, V68, P1845, DOI 10.4088/JCP.v68n1204; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; LEVENSON M, 2006, DEC 13 M PSYCH DRUGS, P14; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Loke YK, 2008, ALIMENT PHARM THERAP, V27, P31, DOI 10.1111/j.1365-2036.2007.03541.x; Lyness JM, 1999, J GEN INTERN MED, V14, P249, DOI 10.1046/j.1525-1497.1999.00326.x; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; Marcinko D, 2007, PSYCHIAT DANUB, V19, P238; Marks DM, 2008, EXPERT OPIN DRUG SAF, V7, P783, DOI [10.1517/14740330802423168, 10.1517/14740330802423168 ]; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Moller HJ, 2008, EUR ARCH PSY CLIN N, V258, P3, DOI 10.1007/s00406-008-3002-1; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Mulrow CD, 2000, AM J MED, V108, P54, DOI 10.1016/S0002-9343(99)00316-2; *NAT I CLIN EXC, 2004, CLIN GUID NAT I CLIN, V23, P1; National Institute for Clinical Excellence, 2004, GUID DEV METH INF NA; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Neumeyer-Gromen A, 2004, MED CARE, V42, P1211, DOI 10.1097/00005650-200412000-00008; Olfson M, 2006, AM J PSYCHIAT, V163, P101, DOI 10.1176/appi.ajp.163.1.101; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Oxman TE, 2002, AM J GERIAT PSYCHIAT, V10, P256, DOI 10.1176/appi.ajgp.10.3.256; Palmer SC, 2003, J PSYCHOSOM RES, V54, P279, DOI 10.1016/S0022-3999(02)00640-2; Papakostas GI, 2008, EUR NEUROPSYCHOPHARM, V18, P122, DOI 10.1016/j.euroneuro.2007.07.005; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Pinquart M, 2007, AGING MENT HEALTH, V11, P645, DOI 10.1080/13607860701529635; Pirraglia Paul A., 2003, Prim Care Companion J Clin Psychiatry, V5, P153; Rahme E, 2008, J CLIN PSYCHIAT, V69, P349, DOI 10.4088/JCP.v69n0303; Rost K, 2002, BMJ-BRIT MED J, V325, P934, DOI 10.1136/bmj.325.7370.934; Rost K, 2000, GEN HOSP PSYCHIAT, V22, P66, DOI 10.1016/S0163-8343(00)00059-1; Rost K, 2001, J GEN INTERN MED, V16, P143, DOI 10.1111/j.1525-1497.2001.00537.x; Rubenstein LZ, 2007, J AM GERIATR SOC, V55, P166, DOI 10.1111/j.1532-5415.2007.01044.x; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Saperia J, 2006, BRIT MED J, V332, P1453, DOI 10.1136/bmj.332.7555.1453-a; Schreuders B, 2007, BRIT J GEN PRACT, V57, P886, DOI 10.3399/096016407782317829; Schulberg HC, 1998, INT J PSYCHIAT MED, V28, P421, DOI 10.2190/G23R-NGGN-K1P1-MQ8N; Schwenk TL, 1996, GEN HOSP PSYCHIAT, V18, P407, DOI 10.1016/S0163-8343(96)00062-X; Sherbourne CD, 2001, ARCH GEN PSYCHIAT, V58, P696, DOI 10.1001/archpsyc.58.7.696; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P213, DOI 10.1016/S0163-8343(02)00198-6; Sneed JR, 2008, AM J GERIAT PSYCHIAT, V16, P65, DOI 10.1097/JGP.0b013e3181256b1d; Solberg LI, 2005, J AM BOARD FAM PRACT, V18, P520, DOI 10.3122/jabfm.18.6.520; STONE M, 2006, DEC 13 M PSYCH DRUGS, P14; Storosum JG, 2001, AM J PSYCHIAT, V158, P1271, DOI 10.1176/appi.ajp.158.8.1271; Tata LJ, 2005, ALIMENT PHARM THERAP, V22, P175, DOI 10.1111/j.1365-2036.2005.02543.x; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; van Marwijk HWJ, 2008, BRIT J GEN PRACT, V58, P680, DOI 10.3399/bjgp08X342165; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Wang PS, 2003, INT J METH PSYCH RES, V12, P22, DOI 10.1002/mpr.139; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; WHITLOCK EP, 2009, SCREENING DEPRESSION; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Whooley MA, 2000, J GEN INTERN MED, V15, P293, DOI 10.1046/j.1525-1497.2000.04319.x; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; Williams JW, 2000, ANN INTERN MED, V132, P743, DOI 10.7326/0003-4819-132-9-200005020-00011; Wilson KCM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004853.pub2	104	182	186	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					793	W265		10.7326/0003-4819-151-11-200912010-00007	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00007			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EJ	19949145				2022-12-28	WOS:000272727900005
J	Paddison, CAM; Eborall, HC; Sutton, S; French, DP; Vasconcelos, J; Prevost, AT; Kinmonth, AL; Griffin, SJ				Paddison, Charlotte A. M.; Eborall, Helen C.; Sutton, Stephen; French, David P.; Vasconcelos, Joana; Prevost, A. Toby; Kinmonth, Ann-Louise; Griffin, Simon J.			Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOLOGICAL IMPACT; TYPE-2; RISK; PREVENTION; DIAGNOSIS; GLUCOSE; ANXIETY; DISEASE; ADULTS; COSTS	Objective To assess whether receiving a negative test result at primary care based stepwise diabetes screening results in false reassurance. Design Parallel group cohort study embedded in a randomised controlled trial. Setting 15 practices ( 10 screening, 5 control) in the ADDITION (Cambridge) trial. Participants 5334 adults ( aged 40-69) in the top quarter for risk of having undiagnosed type 2 diabetes ( 964 controls and 4370 screening attenders). Main outcome measures Perceived personal and comparative risk of diabetes, intentions for behavioural change, and self rated health measured after an initial random blood glucose test and at 3-6 and 12-15 months later (equivalent time points for controls). Results A linear mixed effects model with control for clustering by practice found no significant differences between controls and people who screened negative for diabetes in perceived personal risk, behavioural intentions, or self rated health after the first appointment or at 3-6 months or 12-15 months later. After the initial test, people who screened negative reported significantly ( but slightly) lower perceived comparative risk ( mean difference -0.16, 95% confidence interval -0.30 to -0.02; P=0.04) than the control group at the equivalent time point; no differences were evident at 3-6 and 12- 15 months. Conclusions A negative test result at diabetes screening does not seem to promote false reassurance, whether this is expressed as lower perceived risk, lower intentions for health related behavioural change, or higher self rated health. Implementing a widespread programme of primary care based stepwise screening for type 2 diabetes is unlikely to cause an adverse shift in the population distribution of plasma glucose and cardiovascular risk resulting from an increase in unhealthy behaviours arising from false reassurance among people who screen negative. Trial registration Current controlled trials ISRCTN99175498.	[Sutton, Stephen; Vasconcelos, Joana; Kinmonth, Ann-Louise] Univ Cambridge, Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England; [Eborall, Helen C.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [French, David P.] Coventry Univ, Appl Res Ctr Hlth & Lifestyle Intervent, Coventry CV1 5FB, W Midlands, England; [Prevost, A. Toby] Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England; [Griffin, Simon J.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge CB2 0QQ, England	University of Cambridge; University of Leicester; Coventry University; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge		camp3@medschl.cam.ac.uk	Griffin, Simon J/K-3106-2013; French, David P/K-7283-2012	Griffin, Simon J/0000-0002-2157-4797; French, David P/0000-0002-7663-7804; Prevost, A. Toby/0000-0003-1723-0796; Sutton, Stephen/0000-0003-1610-0404; Eborall, Helen/0000-0002-6023-3661	Wellcome Trust [071200/Z/03/Z, G0000753]; Medical Research Council; NHS RD; National Institute for Health Research (NIHR) School for Primary Care Research; Department of Health NIHR Programme [RP-PG-0606-1259]; ESRC; ESRC [ES/F04304X/1] Funding Source: UKRI; MRC [MC_U106179474, G0200391, G0001164] Funding Source: UKRI; Economic and Social Research Council [ES/F04304X/1] Funding Source: researchfish; Medical Research Council [G0001164, MC_U106179474, G0200391] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1259] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS RD; National Institute for Health Research (NIHR) School for Primary Care Research(National Institute for Health Research (NIHR)); Department of Health NIHR Programme(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a project grant from the Wellcome Trust (reference number 071200/Z/03/Z). The Cambridge ADDITION trial was funded by the Wellcome Trust ( reference number G0000753), the Medical Research Council, and NHS R&D support funding. A-LK and SJG are members of the National Institute for Health Research (NIHR) School for Primary Care Research. SJG receives support from the Department of Health NIHR Programme Grant funding scheme (RP-PG-0606-1259). The General Practice and Primary Care Research Unit is supported by NIHR funds. CAMP is funded by an ESRC postdoctoral fellowship.	Adriaanse MC, 2006, DIABETES-METAB RES, V22, P20, DOI 10.1002/dmrr.590; Adriaanse MC, 2004, DIABETIC MED, V21, P992, DOI 10.1111/j.1464-5491.2004.01276.x; Adriaanse MC, 2002, DIABETIC MED, V19, P406; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Department of Health, 2008, PUTT PREV 1 VASC CHE; Eborall H, 2007, BMJ-BRIT MED J, V335, P490, DOI 10.1136/bmj.39308.392176.BE; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-136; Farmer AJ, 2003, DIABETIC MED, V20, P996, DOI 10.1046/j.1464-5491.2003.01042.x; French DP, 2006, PSYCHO-ONCOL, V15, P498, DOI 10.1002/pon.980; French DP, 2009, J CLIN EPIDEMIOL, V62, P74, DOI 10.1016/j.jclinepi.2008.02.015; French DP, 2004, BRIT J CANCER, V91, P1887, DOI 10.1038/sj.bjc.6602224; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Goyder EC, 2008, BRIT MED J, V336, P1140, DOI 10.1136/bmj.39553.480706.80; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; KINLAY S, 1990, BRIT MED J, V300, P1545, DOI 10.1136/bmj.300.6739.1545; Maissi E, 2004, BMJ-BRIT MED J, V328, P1293, DOI 10.1136/bmj.328.7451.1293; Marteau TM, 1996, BRIT J GEN PRACT, V46, P577; Martin FH, 1908, SURG GYNECOL OBSTET, V7, P7; Petticrew M P, 2000, Health Technol Assess, V4, P1; Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0; Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0; Skinner TC, 2005, DIABETIC MED, V22, P1497, DOI 10.1111/j.1464-5491.2005.01680.x; Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617; TYMSTRA T, 1987, FAM PRACT, V4, P287, DOI 10.1093/fampra/4.4.287; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; WEINSTEIN ND, 1989, PRIM PREV P, V13, P142; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x	31	25	25	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2009	339								b4535	10.1136/bmj.b4535	http://dx.doi.org/10.1136/bmj.b4535			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NQ	19948642	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000272453100002
J	Yu, CM; Chan, JYS; Zhang, Q; Omar, R; Yip, GWK; Hussin, A; Fang, F; Lam, KH; Chan, HCK; Fung, JWH				Yu, Cheuk-Man; Chan, Joseph Yat-Sun; Zhang, Qing; Omar, Razali; Yip, Gabriel Wai-Kwok; Hussin, Azlan; Fang, Fang; Lam, Kai Huat; Chan, Hamish Chi-Kin; Fung, Jeffrey Wing-Hong			Biventricular Pacing in Patients with Bradycardia and Normal Ejection Fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR FUNCTION; TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; CARDIAC RESYNCHRONIZATION THERAPY; SICK SINUS SYNDROME; HEART-FAILURE; ATRIAL-FIBRILLATION; DUAL-CHAMBER; MITRAL REGURGITATION; NODE DISEASE; TRIAL	BACKGROUND Observational studies suggest that conventional right ventricular apical pacing may have a deleterious effect on left ventricular function. In this study, we examined whether biventricular pacing is superior to right ventricular apical pacing in preventing deterioration of left ventricular systolic function and cardiac remodeling in patients with bradycardia and a normal ejection fraction. METHODS In this prospective, double-blind, multicenter study, we randomly assigned 177 patients in whom a biventricular pacemaker had been successfully implanted to receive biventricular pacing (89 patients) or right ventricular apical pacing (88 patients). The primary end points were the left ventricular ejection fraction and left ventricular end-systolic volume at 12 months. RESULTS At 12 months, the mean left ventricular ejection fraction was significantly lower in the right-ventricular-pacing group than in the biventricular-pacing group (54.8 +/- 9.1% vs. 62.2 +/- 7.0%, P<0.001), with an absolute difference of 7.4 percentage points, whereas the left ventricular end-systolic volume was significantly higher in the right-ventricular-pacing group than in the biventricular-pacing group (35.7 +/- 16.3 ml vs. 27.6 +/- 10.4 ml, P<0.001), with a relative difference between the groups in the change from baseline of 25% (P<0.001). The deleterious effect of right ventricular apical pacing occurred in prespecified subgroups, including patients with and patients without preexisting left ventricular diastolic dysfunction. Eight patients in the right-ventricular-pacing group (9%) and one in the biventricular-pacing group (1%) had ejection fractions of less than 45% (P=0.02). There was one death in the right-ventricular-pacing group, and six patients in the right-ventricular-pacing group and five in the biventricular-pacing group were hospitalized for heart failure (P=0.74). CONCLUSIONS In patients with normal systolic function, conventional right ventricular apical pacing resulted in adverse left ventricular remodeling and in a reduction in the left ventricular ejection fraction; these effects were prevented by biventricular pacing. (Centre for Clinical Trials number, CUHK_CCT00037.)	[Yu, Cheuk-Man; Chan, Joseph Yat-Sun; Zhang, Qing; Yip, Gabriel Wai-Kwok; Fang, Fang; Fung, Jeffrey Wing-Hong] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Qing] Sichuan Univ, W China Hosp, Dept Cardiol, Chengdu 610064, Sichuan, Peoples R China; [Omar, Razali; Hussin, Azlan; Lam, Kai Huat] Natl Heart Inst, Dept Cardiol, Kuala Lumpur, Malaysia; [Chan, Hamish Chi-Kin] Alice Ho Miu Ling Nethersole Hosp, Dept Med, Tai Po, Hong Kong, Peoples R China; [Fung, Jeffrey Wing-Hong] N Dist Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Sichuan University; Institute Jantung Negara; Alice Ho Miu Ling Nethersole Hospital	Yu, CM (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	cmyu@cuhk.edu.hk	Fang, Fang/B-9912-2017; fang, Fang/A-7154-2010; YIP, Gabriel/A-8837-2008; Yu, Cheuk-man/P-3747-2015	Fang, Fang/0000-0002-4023-2928; fang, Fang/0000-0002-4023-2928; YIP, Gabriel/0000-0002-3859-7194; 	Medtronic	Medtronic(Medtronic)	Supported by Medtronic.	Cojoc A, 2006, J CARDIOVASC ELECTR, V17, P884, DOI 10.1111/j.1540-8167.2006.00504.x; Frias Patricio A, 2003, J Cardiovasc Electrophysiol, V14, P996, DOI 10.1046/j.1540-8167.2003.02483.x; Fung JWH, 2007, J CARDIOVASC ELECTR, V18, P735, DOI 10.1111/j.1540-8167.2007.00862.x; Gillis AM, 2006, PACE, V29, P697, DOI 10.1111/j.1540-8159.2006.00422.x; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Kanzaki H, 2004, J AM COLL CARDIOL, V44, P1619, DOI 10.1016/j.jacc.2004.07.036; Kapetanakis S, 2005, CIRCULATION, V112, P992, DOI 10.1161/CIRCULATIONAHA.104.474445; Kindermann M, 2006, J AM COLL CARDIOL, V47, P1927, DOI 10.1016/j.jacc.2005.12.056; Lieberman R, 2006, J AM COLL CARDIOL, V48, P1634, DOI 10.1016/j.jacc.2006.04.099; MAURER G, 1984, J AM COLL CARDIOL, V3, P986, DOI 10.1016/S0735-1097(84)80357-5; Nahlawi M, 2004, J AM COLL CARDIOL, V44, P1883, DOI 10.1016/j.jacc.2004.06.074; Nielsen JC, 2003, J AM COLL CARDIOL, V42, P614, DOI 10.1016/S0735-1097(03)00757-5; Nielsen JC, 1998, CIRCULATION, V97, P987; O'Keefe JH, 2005, AM J CARDIOL, V95, P771, DOI 10.1016/j.amjcard.2004.11.034; Oh J.K., 2006, ECHO MANUAL; Olshansky B, 2006, PACE, V29, P237, DOI 10.1111/j.1540-8159.2006.00329.x; PRINZEN FW, 1990, AM J PHYSIOL, V259, pH300, DOI 10.1152/ajpheart.1990.259.2.H300; Steinberg JS, 2005, J CARDIOVASC ELECTR, V16, P359, DOI 10.1046/j.1540-8167.2005.50038.x; Sugeng L, 2006, CIRCULATION, V114, P654, DOI 10.1161/CIRCULATIONAHA.106.626143; Sweeney MO, 2007, NEW ENGL J MED, V357, P1000, DOI 10.1056/NEJMoa071880; Sweeney MO, 2006, CIRCULATION, V113, P2082, DOI 10.1161/CIRCULATIONAHA.105.608356; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Thackray SDR, 2003, EUR HEART J, V24, P1143, DOI 10.1016/S0195-668X(03)00199-4; Thambo JB, 2004, CIRCULATION, V110, P3766, DOI 10.1161/01.CIR.0000150336.86033.8D; Tops LF, 2006, J AM COLL CARDIOL, V48, P1642, DOI 10.1016/j.jacc.2006.05.072; Tse HF, 2002, J AM COLL CARDIOL, V40, P1451, DOI 10.1016/S0735-1097(02)02169-1; Vanderheyden M, 1997, PACE, V20, P2422, DOI 10.1111/j.1540-8159.1997.tb06081.x; VASSALLO JA, 1986, J AM COLL CARDIOL, V7, P1228, DOI 10.1016/S0735-1097(86)80140-1; Wiggers CJ, 1925, AM J PHYSIOL, V73, P346, DOI 10.1152/ajplegacy.1925.73.2.346; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196; Zhang Q, 2005, AM J CARDIOL, V95, P126, DOI 10.1016/j.amjcard.2004.08.078	32	267	287	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2123	2134		10.1056/NEJMoa0907555	http://dx.doi.org/10.1056/NEJMoa0907555			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524BC	19915220				2022-12-28	WOS:000272117800006
J	Schwarzman, MR; Wilson, MP				Schwarzman, Megan R.; Wilson, Michael P.			New Science for Chemicals Policy	SCIENCE			English	Editorial Material							HEALTH; WILDLIFE		[Schwarzman, Megan R.; Wilson, Michael P.] Univ Calif Berkeley, Sch Publ Hlth, Ctr Occupat & Environm Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schwarzman, MR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Occupat & Environm Hlth, Berkeley, CA 94720 USA.	mschwarzman@berkeley.edu	Wilson, Michael/AAK-4918-2021		NCEH CDC HHS [5U19EH000097-04] Funding Source: Medline; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U19EH000097] Funding Source: NIH RePORTER	NCEH CDC HHS; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		*BERK CTR ENV PUBL, 5U19EH00009704 CDC U; Carpenter DO, 2002, ENVIRON HEALTH PERSP, V110, P25, DOI 10.1289/ehp.02110s125; Dernbach JC, 1997, HARVARD ENVIRON LAW, V21, P1; *EPA, 2009, ESS PRINC REF CHEM M; EPA (Environmental Protection Agency), 2006, PUBL EPA, V738-R-05-005; *EUR COMM ENV DIR, 2003, ASS IMP NEW CHEM POL; Gee D, 2006, ENVIRON HEALTH PERSP, V114, P152, DOI 10.1289/ehp.8134; Government Accounting Office (GAO), 2009, GAO09271; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; NILSSON AE, 2009, ARCTIC POLLUTION 200; NRC, 2008, SCI DEC ADV RISK ASS; NRC, 1984, TOX TEST STRAT DET N; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; *U MA LOW, 2009, STAT LEAD FORM REF C; *US CDCP, 2005, PUBL US CDCP; *US GOV ACC OFF, 2005, PUBL GAO, P18; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; WHO, 2002, GLOB ASS STAT OF THE; Wilson MP, 2009, ENVIRON HEALTH PERSP, V117, P1202, DOI 10.1289/ehp.0800404; Woodruff TJ, 2008, ENVIRON HEALTH PERSP, V116, P1568, DOI 10.1289/ehp.11516	21	45	47	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1065	1066		10.1126/science.1177537	http://dx.doi.org/10.1126/science.1177537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521UW	19965413	Green Submitted			2022-12-28	WOS:000271951000024
J	Smith, RJ; Verissimo, D; Leader-Williams, N; Cowling, RM; Knight, AT				Smith, Robert J.; Verissimo, Diogo; Leader-Williams, Nigel; Cowling, Richard M.; Knight, Andrew T.			Let the locals lead	NATURE			English	Editorial Material							CONSERVATION; AREAS		[Smith, Robert J.; Verissimo, Diogo; Leader-Williams, Nigel] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Cowling, Richard M.] Nelson Mandela Metropolitan Univ, Dept Bot, ZA-6031 Port Elizabeth, South Africa; [Knight, Andrew T.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7602 Matieland, South Africa	University of Kent; Nelson Mandela University; Stellenbosch University	Smith, RJ (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England.		Smith, Robert J/D-9660-2011; Verissimo, Diogo/D-2069-2009; Cowling, Richard/AFU-6261-2022; Knight, Andrew Thomas/C-8394-2009	Smith, Robert J/0000-0003-1599-9171; Knight, Andrew Thomas/0000-0002-6563-0500; Verissimo, Diogo/0000-0002-3519-6782				Balmford A, 2003, TRENDS ECOL EVOL, V18, P435, DOI 10.1016/S0169-5347(03)00217-9; Goodman PS, 2003, BIOSCIENCE, V53, P843, DOI 10.1641/0006-3568(2003)053[0843:AMEASP]2.0.CO;2; Knight AT, 2007, BIOSCIENCE, V57, P256, DOI 10.1641/B570309; Knight AT, 2006, S AFR J SCI, V102, P406; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Rodriguez JP, 2007, SCIENCE, V317, P755, DOI 10.1126/science.1145560; SMITH RJ, TRADE OFFS IN PRESS	7	108	111	2	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					280	281		10.1038/462280a	http://dx.doi.org/10.1038/462280a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521DF	19924192				2022-12-28	WOS:000271899300019
J	Kuklina, EV; Yoon, PW; Keenan, NL				Kuklina, Elena V.; Yoon, Paula W.; Keenan, Nora L.			Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; NATIONAL-HEALTH; DYSLIPIDEMIA; GUIDELINES; PREVENTION; DIAGNOSIS; QUALITY; RISK; CARE	Context Studies show that a large proportion of adults with high levels of low-density lipoprotein cholesterol (LDL-C) remain untreated or undertreated despite growing use of lipid-lowering medications. Objective To investigate trends in screening prevalence, use of cholesterol-lowering medications, and LDL-C levels across 4 study cycles (1999-2000, 20012002, 2003-2004, and 2005-2006). Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional, stratified, multistage probability sample survey of the US civilian, noninstitutionalized population. After we restricted the study sample to fasting participants aged 20 years or older (n=8018) and excluded pregnant women (n=464) and participants with missing data (n=510), our study sample consisted of 7044 participants. Main Outcome Measure High LDL-C levels, defined as levels above the specific goal for each risk category outlined in guidelines from the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III). All presented results are weighted and age-standardized to 2000 standard population estimates. Results Prevalence of high LDL-C levels among persons aged 20 years or older decreased from 31.5% in 1999-2000 to 21.2% in 2005-2006 (P<.001 for linear trend) but varied by risk category. By the 2005-2006 study cycle, prevalence of high LDL-C was 58.9%, 30.2%, and 11.0% for high-, intermediate-, and low-risk categories, respectively. Self-reported use of lipid-lowering medications increased from 8.0% to 13.4% (P<.001 for linear trend), but screening rates did not change significantly, remaining less than 70% (P=.16 for linear trend) during the study periods. Conclusions Among the NHANES population aged 20 years or older, the prevalence of high LDL-C levels decreased from 1999-2000 to 2005-2006. In the most recent period, the prevalence was 21.2%. JAMA. 2009; 302(19): 2104-2110	[Kuklina, Elena V.; Yoon, Paula W.; Keenan, Nora L.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Kuklina, EV (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-37, Atlanta, GA 30341 USA.	ekuklina@cdc.gov	Kuklina, Elena/AAF-3532-2020	Kuklina, Elena/0000-0002-9686-6495				*AETN, CLIN POL B SCREEN LI; Becker DJ, 2008, MAYO CLIN PROC, V83, P758, DOI 10.4065/83.7.758; *CDCP, RES ETH REV BOARD ER; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P117; Choi BG, 2006, CURR MOL MED, V6, P571, DOI 10.2174/156652406778018590; Christian AH, 2006, J GEN INTERN MED, V21, P231, DOI 10.1111/j.1525-1497.2006.00331.x; COOPER GR, 1990, SCAND J CLIN LAB INV, V50, P27, DOI 10.3109/00365519009091082; Ghandehari H, 2008, AM HEART J, V156, P112, DOI 10.1016/j.ahj.2008.03.005; Grundy SM, 2001, AM J CARDIOL, V88, p23J; Hildemann S, 2008, CURR MED RES OPIN, V24, P1659, DOI 10.1185/03007990802134755; Jacobs MJ, 2005, DIABETES RES CLIN PR, V70, P263, DOI 10.1016/j.diabres.2005.03.032; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Keevil JG, 2007, CIRCULATION, V115, P1363, DOI 10.1161/CIRCULATIONAHA.106.645473; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; Klingman D, 2005, AM HEART J, V150, P595, DOI 10.1016/j.ahj.2004.09.039; Ma YS, 2008, J AM DIET ASSOC, V108, P240, DOI 10.1016/j.jada.2007.10.047; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Morrison Alan, 2003, J Manag Care Pharm, V9, P544; Nag SS, 2007, J MANAGE CARE PHARM, V13, P652, DOI 10.18553/jmcp.2007.13.8.652; *RES TRIANGL I, 2004, SUDAAN EX MAN; Sisson SD, 2007, AM J CARDIOL, V99, P1234, DOI 10.1016/j.amjcard.2006.12.033; Stone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006; *US DEP HHS, 1999, NATH HLTH NUTR EX SU; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; 3 REPORT EXPERT PANE	26	98	100	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2104	2110		10.1001/jama.2009.1672	http://dx.doi.org/10.1001/jama.2009.1672			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920234				2022-12-28	WOS:000271873900019
J	Srivastava, R; Berry, JG; Hall, M; Downey, EC; O'Gorman, M; Dean, JM; Barnhart, DC				Srivastava, Rajendu; Berry, Jay G.; Hall, Matt; Downey, Earl C.; O'Gorman, Molly; Dean, J. Michael; Barnhart, Douglas C.			Reflux related hospital admissions after fundoplication in children with neurological impairment: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							LAPAROSCOPIC NISSEN FUNDOPLICATION; COMPLEX CHRONIC CONDITIONS; GASTROESOPHAGEAL-REFLUX; ANTIREFLUX PROCEDURES; ASPIRATION PNEUMONIA; NATIONAL TRENDS; COMPLICATIONS; GASTROSTOMY; OPERATIONS; MORTALITY	Objective To examine the impact of fundoplication on reflux related hospital admissions for children with neurological impairment. Design Retrospective, observational cohort study. Setting 42 children's hospitals in the United States. Participants 3721 children with neurological impairment born between 2000 and 2005 who had at least one hospital admission at a study hospital before their fundoplication. Intervention Fundoplication. Main outcome measures Incident rate ratio for reflux related hospital admissions, defined as the post-fundoplication admission rate divided by the pre-fundoplication admission rate. Results Of the 955 285 children born during the study period, 144 749 (15%) had neurological impairment. Of these, 27 720 (19%) were diagnosed as having gastro-oesophageal reflux disease, of whom 6716 (24%) had a fundoplication. Of these, 3721 (55%) had at least one previous hospital admission and were included in the study cohort. After fundoplication, hospital admissions decreased for any reflux related cause (incident rate ratio 0.69, 95% confidence interval 0.67 to 0.72; P<0.01), aspiration pneumonia (0.71, 0.62 to 0.81; P<0.01), gastro-oesophageal reflux disease (0.60, 0.57 to 0.63; P<0.01), and mechanical ventilation (0.40, 0.37 to 0.43; P<0.01), after adjustment for other patient and hospital related factors that may influence reflux related hospital admissions. Hospital admissions increased for asthma (incident rate ratio 1.52, 1.38 to 1.67; P<0.01) and remained constant for pneumonia (1.07, 0.98 to 1.17; P=0.16). Conclusions Children with neurological impairment who have fundoplication had reduced short term reflux related hospital admissions for aspiration pneumonia, gastro-oesophageal reflux disease, and mechanical ventilation. However, admissions for pneumonia remained constant and those for asthma increased after fundoplication. Comparative effectiveness data for other treatments (such as gastrojejunal feeding tubes) are unknown.	[Srivastava, Rajendu] Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Inpatient Med, Salt Lake City, UT 84112 USA; [Srivastava, Rajendu; Downey, Earl C.; O'Gorman, Molly; Dean, J. Michael; Barnhart, Douglas C.] Intermt Healthcare, Primary Childrens Med Ctr, Salt Lake City, UT USA; [Berry, Jay G.] Childrens Hosp, Complex Care Serv, Boston, MA 02115 USA; [Berry, Jay G.] Harvard Univ, Sch Med, Boston, MA USA; [Hall, Matt] Child Hlth Corp Amer, Shawnee Mission, KS USA; [Downey, Earl C.; Barnhart, Douglas C.] Univ Utah, Hlth Sci Ctr, Dept Surg, Div Pediat Surg, Salt Lake City, UT USA; [Downey, Earl C.] Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Pediat Gastroenterol, Salt Lake City, UT USA; [Dean, J. Michael] Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Pediat Crit Care, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Srivastava, R (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Inpatient Med, Salt Lake City, UT 84112 USA.	raj.srivastava@hsc.utah.edu	Hall, Matt/AAT-1349-2021	Hall, Matt/0000-0001-7778-5887	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH) [K23 HD052553, K23 HD058092]; Children's Health Research Center; Primary Children's Medical Center Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD058092] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD052553] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Health Research Center; Primary Children's Medical Center Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	RS and JGB are the recipients of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH) career development awards K23 HD052553 and K23 HD058092. This project was supported in part by the Children's Health Research Center at the University of Utah and Primary Children's Medical Center Foundation. None of the study funders had any role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The researchers had complete independence from the study funders.	ALBANESE CT, 1993, J PEDIATR-US, V123, P371, DOI 10.1016/S0022-3476(05)81734-2; Berry JG, 2007, ARCH PEDIAT ADOL MED, V161, P38, DOI 10.1001/archpedi.161.1.38; Berthelsen C L, 2000, Top Health Inf Manage, V21, P10; Bourne MC, 2003, PEDIATR SURG INT, V19, P537, DOI 10.1007/s00383-003-0985-6; Burd RS, 2002, J PEDIATR SURG, V37, P500, DOI 10.1053/jpsu.2002.30862; CHANEY RH, 1979, J MENT DEFIC RES, V23, P1; DEDINSKY GK, 1987, AM J SURG, V153, P177, DOI 10.1016/0002-9610(87)90810-5; DeFrances Carol J, 2007, Adv Data, P1; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Fonkalsrud EW, 1998, PEDIATRICS, V101, P419, DOI 10.1542/peds.101.3.419; Gilger MA, 2004, CLIN GASTROENTEROL H, V2, P978, DOI 10.1016/S1542-3565(04)00456-2; Goldin AB, 2006, PEDIATRICS, V118, P2326, DOI 10.1542/peds.2006-2212; Graham RJ, 2007, PEDIATRICS, V119, pE1280, DOI 10.1542/peds.2006-2471; Kremer B, 2002, J PEDIATR SURG, V37, P1556, DOI 10.1053/jpsu.2002.36184; Lasser MS, 2006, PEDIATRICS, V118, P1828, DOI 10.1542/peds.2006-1185; Lewis CW, 2003, ARCH OTOLARYNGOL, V129, P523, DOI 10.1001/archotol.129.5.523; Lorence Daniel P, 2003, J Health Care Finance, V29, P29; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; MARTINEZ DA, 1992, J PEDIATR SURG, V27, P267, DOI 10.1016/0022-3468(92)90324-Z; MARTINEZ DA, 1992, J PEDIATR SURG, V27, P983, DOI 10.1016/0022-3468(92)90544-H; Martinez DA, 1992, J PEDIATR SURG, V27, P271; MARTINEZ DA, 1992, J PEDIATR SURG, V27, P988; Maudsley G, 1999, ARCH DIS CHILD, V81, P390, DOI 10.1136/adc.81.5.390; Murphy Nancy, 2003, Curr Probl Pediatr Adolesc Health Care, V33, P146, DOI 10.1016/S1538-5442(03)00002-6; Partrick DA, 2007, CURR OPIN PEDIATR, V19, P333, DOI 10.1097/MOP.0b013e32815745bd; Plioplys AV, 1998, SOUTHERN MED J, V91, P161, DOI 10.1097/00007611-199802000-00009; Powers CJ, 2003, J PEDIATR SURG, V38, P886, DOI 10.1016/S0022-3468(03)00116-7; RICE H, 1991, J PEDIATR SURG, V26, P697, DOI 10.1016/0022-3468(91)90013-J; SONDHEIMER JM, 1979, J PEDIATR-US, V94, P710, DOI 10.1016/S0022-3476(79)80135-3; SPITZ L, 1993, ARCH DIS CHILD, V68, P347, DOI 10.1136/adc.68.3.347; Srivastava R, 2007, J HOSP MED, V2, P165, DOI 10.1002/jhm.167; Srivastava R, 2009, PEDIATRICS, V123, P338, DOI 10.1542/peds.2007-1740; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Veenker Erin, 2008, J Pediatr Nurs, V23, P400, DOI 10.1016/j.pedn.2007.08.012; Wales PW, 2002, J PEDIATR SURG, V37, P407, DOI 10.1053/jpsu.2002.30849	36	57	58	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2009	339								b4411	10.1136/bmj.b4411	http://dx.doi.org/10.1136/bmj.b4411			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TA	19923145	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000272096200002
J	Crump, B; Adil, M				Crump, Bernard; Adil, Mahmood			Can quality and productivity improve in a financially poorer NHS?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Crump, Bernard] Univ Warwick Campus, NHS Inst Innovat & Improvement, Coventry CV4 7AL, W Midlands, England	University of Warwick	Crump, B (corresponding author), Univ Warwick Campus, NHS Inst Innovat & Improvement, Coventry CV4 7AL, W Midlands, England.	bernard.crump@institute.nhs.uk						Appleby J, 2009, COLD WILL IT BE PROS; Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Bate P, 2007, ORG QUALITY IMPROVEM; Boaden R, 2008, QUALITY IMPROVEMENT; Darzi A., 2008, HIGH QUALITY CARE AL; Deming EW., 1986, OUT CRISIS; Healthcare Commission, 2009, INV MID STAFF NHS FD; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Juran J., 1999, QUALITY HDB; KANO N, 1996, GUIDE TQM SERVICE IN; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Lipley Nick, 2009, Nurs Manag (Harrow), V16, P4; Mitton C, 2006, APPL HEALTH ECON HEA, V5, P201, DOI 10.2165/00148365-200605040-00002; Nolan T., 2009, INCREASING EFFICIENC; Ovretveit J, 2000, Int J Health Care Qual Assur Inc Leadersh Health Serv, V13, P200, DOI 10.1108/09526860010372803; Ovretveit J., 2006, TESTING QUALITY COST; Ovretveit J, 2009, REV EVIDENCE WHICH I, P95; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; SONA C, 2006, AM J CRIT CARE, V15, P339; Street A, 2007, HEALTH ECON POLICY L, V2, P419, DOI 10.1017/S174413310700429X; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Wanless, 2002, SECURING OUR FUTURE	22	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 16	2009	339								b4638	10.1136/bmj.b4638	http://dx.doi.org/10.1136/bmj.b4638			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523SU	19917574				2022-12-28	WOS:000272095600004
J	Cai, L; Mostov, K				Cai, Liang; Mostov, Keith			Polarity Is Destiny	CELL			English	Editorial Material									[Cai, Liang; Mostov, Keith] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mostov, K (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	keith.mostov@ucsf.edu		mostov, keith/0000-0002-8123-6247	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194, R37AI025144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI053194-07, R37 AI025144-23, R37 AI025144, P01 AI053194] Funding Source: Medline; NIDDK NIH HHS [R01 DK074398-03, R01 DK074398] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	6	2	2	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					660	662		10.1016/j.cell.2009.10.040	http://dx.doi.org/10.1016/j.cell.2009.10.040			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914162	Green Accepted, Bronze			2022-12-28	WOS:000271747200011
J	Sabat, SR				Sabat, Steven R.			Dementia in developing countries: a tidal wave on the horizon	LANCET			English	Editorial Material									Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Georgetown University	Sabat, SR (corresponding author), Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.	Sabats@georgetown.edu						*ALZH REL DIS ASS, 2000, RAC TIM; [Anonymous], 2008, EXCELLENCE DEMENTIA; HARRIS PB, 2002, PERSON ALZHEIMERS DI; Hubbard G, 2003, AGEING SOC, V23, P99, DOI 10.1017/S0144686X02008991; Hughes J. C., 2006, ETHICAL ISSUES DEMEN; Keady J, 1996, J CLIN NURS, V5, P275, DOI 10.1111/jocn.1996.5.5.275; Kitwood T., 1997, DEMENTIA RECONSIDERE; Post SG, 1995, MORAL CHALLENGE ALZH; Sabat, 2006, DEMENTIA MIND MEANIN; SABAT SR, DEMENTIA IN PRESS; Sabat SR., 2001, EXPERIENCE ALZHEIMER; Snyder L, 2009, SPEAKING OUR MINDS W; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8	13	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1805	1806		10.1016/S0140-6736(09)62037-7	http://dx.doi.org/10.1016/S0140-6736(09)62037-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944851				2022-12-28	WOS:000272370200010
J	Chandran, V; Fronzes, R; Duquerroy, S; Cronin, N; Navaza, J; Waksman, G				Chandran, Vidya; Fronzes, Remi; Duquerroy, Stephane; Cronin, Nora; Navaza, Jorge; Waksman, Gabriel			Structure of the outer membrane complex of a type IV secretion system	NATURE			English	Article							AGROBACTERIUM VIRB10; PROTEINS; BIOGENESIS; MACHINERY; SOFTWARE	Type IV secretion systems are secretion nanomachines spanning the two membranes of Gram-negative bacteria. Three proteins, VirB7, VirB9 and VirB10, assemble into a 1.05 megadalton (MDa) core spanning the inner and outer membranes. This core consists of 14 copies of each of the proteins and forms two layers, the I and O layers, inserting in the inner and outer membrane, respectively. Here we present the crystal structure of a similar to 0.6 MDa outer-membrane complex containing the entire O layer. This structure is the largest determined for an outer-membrane channel and is unprecedented in being composed of three proteins. Unexpectedly, this structure identifies VirB10 as the outer-membrane channel with a unique hydrophobic double-helical transmembrane region. This structure establishes VirB10 as the only known protein crossing both membranes of Gram-negative bacteria. Comparison of the cryo-electron microscopy (cryo-EM) and crystallographic structures points to conformational changes regulating channel opening and closing.	[Chandran, Vidya; Fronzes, Remi; Cronin, Nora; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Chandran, Vidya; Fronzes, Remi; Cronin, Nora; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Duquerroy, Stephane] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris, France; [Duquerroy, Stephane] CNRS, URA 3015, F-75724 Paris, France; [Duquerroy, Stephane] Univ Paris 11, F-91405 Orsay, France; [Navaza, Jorge] Inst Biol Struct JP Ebel, Lab Microscopie Elect, F-38027 Grenoble 1, France	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	g.waksman@ucl.ac.uk	Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022	Fronzes, Remi/0000-0003-3031-9824; Cronin, Nora/0000-0002-4249-7313; Duquerroy, Stephane/0000-0003-4386-8013; Darbari, Vidya/0000-0002-3387-5108	Wellcome Trust [082227]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust grant 082227 to G. W. We thank A. Thompson and the staff of beamline PROXIMA 1 at Soleil, the staff of beamline ID14.4 at the European Synchrotron Radiation Facility, and H. Saibil, E. Orlova and P. Christie for comments on the manuscript. We thank A. Kumar for help in implementing the immunofluorescence experiments.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, CCP4 NEWSL, V42; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; JONES TA, 1992, CCP4 STUDY WEEKEND 1, P91; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KJELDGAARD M, 1994, CCP4 P, P59; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Meng GY, 2009, MOL MEMBR BIOL, V26, P136, DOI 10.1080/09687680802712422; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Sharff AJ, 2000, ACTA CRYSTALLOGR D, V56, P785, DOI 10.1107/S090744490000370X; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Gomis-Ruth FX, 2006, CURR OPIN STRUC BIOL, V16, P744, DOI 10.1016/j.sbi.2006.10.004	33	239	246	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1011	U66		10.1038/nature08588	http://dx.doi.org/10.1038/nature08588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	19946264	Green Submitted, Green Accepted			2022-12-28	WOS:000272996000037
J	Hambourger, M; Moore, TA				Hambourger, Michael; Moore, Thomas A.			Nailing Down Nickel for Electrocatalysis	SCIENCE			English	Editorial Material							HYDROGENASES		[Hambourger, Michael] Appalachian State Univ, AR Smith Dept Chem, Boone, NC 28608 USA; [Moore, Thomas A.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Moore, Thomas A.] Arizona State Univ, Ctr Bioenergy & Photosynthesis, Tempe, AZ 85287 USA	University of North Carolina; Appalachian State University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Hambourger, M (corresponding author), Appalachian State Univ, AR Smith Dept Chem, Boone, NC 28608 USA.	hambourgerms@appstate.edu; tmoore@asu.edu						Canaguier S, 2008, DALTON T, P315, DOI 10.1039/b713567j; DUBOIS MR, ACC CHEM RES; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Hambourger M, 2009, CHEM SOC REV, V38, P25, DOI 10.1039/b800582f; Jones RH, 2008, MAT HYDROGEN EC; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Lubitz W, 2008, ENERG ENVIRON SCI, V1, P15, DOI 10.1039/b808792j; Manthiram A, 2008, ENERG ENVIRON SCI, V1, P621, DOI 10.1039/b811802g; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Wilson AD, 2007, P NATL ACAD SCI USA, V104, P6951, DOI 10.1073/pnas.0608928104; Wilson AD, 2006, J AM CHEM SOC, V128, P358, DOI 10.1021/ja056442y	12	11	11	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1355	1356		10.1126/science.1183836	http://dx.doi.org/10.1126/science.1183836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965745				2022-12-28	WOS:000272351100026
J	Verschuren, D; Damste, JSS; Moernaut, J; Kristen, I; Blaauw, M; Fagot, M; Haug, GH				Verschuren, Dirk; Damste, Jaap S. Sinninghe; Moernaut, Jasper; Kristen, Iris; Blaauw, Maarten; Fagot, Maureen; Haug, Gerald H.		CHALLACEA Project Members	Half-precessional dynamics of monsoon rainfall near the East African Equator	NATURE			English	Article							ATLANTIC THERMOHALINE CIRCULATION; LAST GLACIAL MAXIMUM; MILLENNIAL-SCALE; CLIMATE; INSOLATION; HOLOCENE; COLLAPSE; TANZANIA; RECORD; BP	External climate forcings-such as long-term changes in solar insolation-generate different climate responses in tropical and high latitude regions(1). Documenting the spatial and temporal variability of past climates is therefore critical for understanding how such forcings are translated into regional climate variability. In contrast to the data-richmiddle and high latitudes, high-quality climate-proxy records from equatorial regions are relatively few(2-4), especially from regions experiencing the bimodal seasonal rainfall distribution associated with twice-annual passage of the Intertropical Convergence Zone. Here we present a continuous and well-resolved climate-proxy record of hydrological variability during the past 25,000 years from equatorial East Africa. Our results, based on complementary evidence from seismic-reflection stratigraphy and organic biomarker molecules in the sediment record of Lake Challa near Mount Kilimanjaro, reveal that monsoon rainfall in this region varied at half-precessional (similar to 11,500-year) intervals in phase with orbitally controlled insolation forcing. The southeasterly and northeasterly monsoons that advect moisture from the western Indian Ocean were strengthened in alternation when the inter-hemispheric insolation gradient was at a maximum; dry conditions prevailed when neither monsoon was intensified and modest local March or September insolation weakened the rain season that followed. On sub-millennial timescales, the temporal pattern of hydrological change on the East African Equator bears clear high-northern-latitude signatures, but on the orbital timescale it mainly responded to low-latitude insolation forcing. Predominance of low-latitude climate processes in this monsoon region can be attributed to the low-latitude position of its continental regions of surface air flow convergence, and its relative isolation from the Atlantic Ocean, where prominent meridional overturning circulation more tightly couples low-latitude climate regimes to high-latitude boundary conditions.	[Verschuren, Dirk; Fagot, Maureen] Univ Ghent, Dept Biol, Limnol Unit, B-9000 Ghent, Belgium; [Damste, Jaap S. Sinninghe] Univ Utrecht, Fac Geosci, NL-3508 TA Utrecht, Netherlands; [Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Moernaut, Jasper] Univ Ghent, Dept Geol & Soil Sci, Renard Ctr Marine Geol, B-9000 Ghent, Belgium; [Kristen, Iris] Geoforschungszentrum Potsdam, Sekt Klimadynam & Sedimente 3 3, D-14473 Potsdam, Germany; [Blaauw, Maarten] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT9 6AX, Antrim, North Ireland; [Haug, Gerald H.] ETH, Inst Geol, Dept Earth Sci, CH-8092 Zurich, Switzerland; [Haug, Gerald H.] Univ Potsdam, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, D-14476 Potsdam, Germany	Ghent University; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ghent University; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Queens University Belfast; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam	Verschuren, D (corresponding author), Univ Ghent, Dept Biol, Limnol Unit, Ledeganckstr 35, B-9000 Ghent, Belgium.	dirk.verschuren@UGent.be	Blaauw, Maarten/E-4539-2011; De Batist, Marc/F-5722-2012; Damste, Jaap S Sinninghe/F-6128-2011; Barker, Philip/J-5938-2012; Blaauw, Maarten/N-9576-2019; van der Plicht, Johannes/B-9994-2013; Moernaut, Jasper/R-5188-2018	Blaauw, Maarten/0000-0002-5680-1515; De Batist, Marc/0000-0002-1625-2080; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Blaauw, Maarten/0000-0002-5680-1515; Moernaut, Jasper/0000-0003-3164-4274; Hurrell, Elizabeth/0000-0003-4290-9047; Barker, Philip/0000-0002-5334-9201	Belgium (FWO-Vlaanderen); Denmark ( Danish National Research Council), Germany (DFG); The Netherlands (NWO); EuroCLIMATE; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Natural Environment Research Council [bgs04003, nigl010001] Funding Source: researchfish; NERC [bgs04003, nigl010001] Funding Source: UKRI	Belgium (FWO-Vlaanderen)(FWO); Denmark ( Danish National Research Council), Germany (DFG)(German Research Foundation (DFG)Danmarks Grundforskningsfond); The Netherlands (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); EuroCLIMATE(European Science Foundation (ESF)); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was sponsored by funding agencies in Belgium (FWO-Vlaanderen), Denmark ( Danish National Research Council), Germany (DFG) and The Netherlands (NWO) through the European Science Foundation (ESF) EuroCORES programme, EuroCLIMATE. Fieldwork was conducted with permission of the Kenyan Ministry of Education, Science and Technology (MOEST) and the Tanzania Commission for Science and Technology (COSTECH). We thank A. Alcantara, M. Kohler, S. Lauterbach, R. Niederreiter and S. Opitz for assistance with core collection and processing; D. Engstrom for 210 Pb dating, A. Berger, D. Fleitmann, J. Kutzbach and Z. Liu for discussion, and E. Odada for support. J. M. acknowledges the support of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).	Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker PA, 2001, SCIENCE, V292, P2307, DOI 10.1126/science.1059612; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Berger A, 2006, CLIM PAST, V2, P131, DOI 10.5194/cp-2-131-2006; Clement AC, 2004, CLIM DYNAM, V22, P327, DOI 10.1007/s00382-003-0375-8; Cruz FW, 2009, NAT GEOSCI, V2, P210, DOI 10.1038/NGEO444; Cruz FW, 2005, NATURE, V434, P63, DOI 10.1038/nature03365; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Garcin Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025531; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; KUTZBACH JE, 1981, SCIENCE, V214, P59, DOI 10.1126/science.214.4516.59; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mumbi CT, 2008, QUATERNARY RES, V69, P326, DOI 10.1016/j.yqres.2007.10.012; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Peyron O, 2000, QUATERNARY RES, V54, P90, DOI 10.1006/qres.2000.2136; Pinot S, 1999, CLIM DYNAM, V15, P857, DOI 10.1007/s003820050318; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Ruddiman WF, 2006, QUATERNARY SCI REV, V25, P657, DOI 10.1016/j.quascirev.2006.02.004; TAIBOT MR, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI DOI 10.1029/2006GC001465; Thevenon F, 2002, PALAEOGEOGR PALAEOCL, V187, P285, DOI 10.1016/S0031-0182(02)00481-9; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Verschuren D., 2008, NATURAL CLIMATE VARI, P189, DOI [DOI 10.1002/9781444300932.CH8, 10.1002/9781444300932.ch8]; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1	30	211	222	5	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	2009	462	7273					637	641		10.1038/nature08520	http://dx.doi.org/10.1038/nature08520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956257	Green Published			2022-12-28	WOS:000272277900038
J							US Preventive Serv Task Force	Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; QUALITY IMPROVEMENT; PHARMACOTHERAPY; PSYCHOTHERAPY; IMPACT	Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for depression in adults. Methods: The USPSTF examined evidence on the benefits and harms of screening primary care patients for depression, including direct evidence that depression screening programs improve health outcomes. The USPSTF did not reexamine evidence for those key questions that had strong, consistent evidence in the 2002 review, including questions about the accuracy of screening instruments in identifying depressed adult patients in primary care settings, and the efficacy of treatment of depressed adults with antidepressants or psychotherapy. New areas of evidence considered for this review (and not reviewed in 2002) include efficacy of treatment of depression in older adult patients, harms of screening for depression in primary care settings, and adverse events from treatment of depression in adults. Recommendations: The USPSTF recommends screening adults for depression when staff-assisted depression care supports are in place to assure accurate diagnosis, effective treatment, and follow-up. (Grade B recommendation) The USPSTF recommends against routinely screening adults for depression when staff-assisted depression care supports are not in place. There may be considerations that support screening for depression in an individual patient. (Grade C recommendation)	US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA	Agency for Healthcare Research & Quality	US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	*AM COLL OBST GYN, 2007, GUID WOM HLTH CAR RE, P294; [Anonymous], 2009, AHRQ PUBLICATION; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; Dalton SO, 2006, CNS DRUGS, V20, P143, DOI 10.2165/00023210-200620020-00005; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; *GLAXOSMITHKLINE, 2006, BRIEF DOC PAR AD SUI; Jarjoura D, 2004, J GEN INTERN MED, V19, P78, DOI 10.1111/j.1525-1497.2004.21249.x; LEVENSON M, 2006, DEC 13 M PSYCH DRUGS, P14; MacMillan HL, 2005, CAN MED ASSOC J, V172, P33, DOI 10.1503/cmaj.1030823; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; Pignone M, 2002, AHRQ PUBLICATION; Pinquart M., 2001, J MENTAL HLTH AGING, V7, P207; Pinquart M, 2006, AM J PSYCHIAT, V163, P1493, DOI 10.1176/appi.ajp.163.9.1493; Rost K, 2001, J GEN INTERN MED, V16, P143, DOI 10.1111/j.1525-1497.2001.00537.x; Rubenstein LZ, 2007, J AM GERIATR SOC, V55, P166, DOI 10.1111/j.1532-5415.2007.01044.x; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; STONE M, 2006, DEC 13 M PSYCH DRUGS, P14; Task Force on Community Preventive Services, 2009, GUID COMM PREV SERV; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; Wilson K., 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000561, 10.1002/14651858.CD000561]	23	294	295	2	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					784	W256		10.7326/0003-4819-151-11-200912010-00006	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EJ	19949144				2022-12-28	WOS:000272727900004
J	Pollard, TD; Cooper, JA				Pollard, Thomas D.; Cooper, John A.			Actin, a Central Player in Cell Shape and Movement	SCIENCE			English	Review							MYOSIN-II; MECHANISMS; RECONSTITUTION; ORGANIZATION; CYTOKINESIS; PLASMODIUM; EVOLUTION; DYNAMICS; MOTILITY; LISTERIA	The protein actin forms filaments that provide cells with mechanical support and driving forces for movement. Actin contributes to biological processes such as sensing environmental forces, internalizing membrane vesicles, moving over surfaces, and dividing the cell in two. These cellular activities are complex; they depend on interactions of actin monomers and filaments with numerous other proteins. Here, we present a summary of the key questions in the field and suggest how those questions might be answered. Understanding actin-based biological phenomena will depend on identifying the participating molecules and defining their molecular mechanisms. Comparisons of quantitative measurements of reactions in live cells with computer simulations of mathematical models will also help generate meaningful insights.	[Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Cooper, John A.] Washington Univ, Dept Cell Biol, St Louis, MO 63110 USA	Yale University; Yale University; Washington University (WUSTL)	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, Dept Mol Biophys & Biochem, POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Cooper, John/0000-0002-0933-4571	NIH [GM026132, GM026338, GM066311, GM38542, GM47337]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542, R01GM026132, R01GM047337, R01GM026338, P01GM066311, R37GM026132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH research grants GM026132, GM026338, GM066311, GM38542, and GM47337.	ADELMAN MR, 1969, BIOCHEMISTRY-US, V8, P4964, DOI 10.1021/bi00840a046; Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Anderson RB, 2006, ADV EXP MED BIOL, V589, P181; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; HATANO S, 1966, BIOCHIM BIOPHYS ACTA, V127, P488, DOI 10.1016/0304-4165(66)90402-8; HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mogilner A, 2006, DEV CELL, V11, P279, DOI 10.1016/j.devcel.2006.08.004; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pollard T.D., 2017, CELL BIOL, P543; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Vidali L, 2009, P NATL ACAD SCI USA, V106, P13341, DOI 10.1073/pnas.0901170106; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783	38	1291	1327	10	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1208	1212		10.1126/science.1175862	http://dx.doi.org/10.1126/science.1175862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965462	Green Accepted			2022-12-28	WOS:000272117900033
J	Wang, Y; Huang, YJ; Wang, JW; Cheng, C; Huang, WJ; Lu, PL; Xu, YN; Wang, PY; Yan, N; Shi, YG				Wang, Yi; Huang, Yongjian; Wang, Jiawei; Cheng, Chao; Huang, Weijiao; Lu, Peilong; Xu, Ya-Nan; Wang, Pengye; Yan, Nieng; Shi, Yigong			Structure of the formate transporter FocA reveals a pentameric aquaporin-like channel	NATURE			English	Article							ESCHERICHIA-COLI; PROTEIN; NITRATE; GLYCEROL; NARU; IDENTIFICATION; RECONSTITUTION; SOFTWARE; OPERON; FAMILY	FocA is a representative member of the formate-nitrite transporter family, which transports short-chain acids in bacteria, archaea, fungi, algae and parasites. The structure and transport mechanism of the formate-nitrite transporter family remain unknown. Here we report the crystal structure of Escherichia coli FocA at 2.25 angstrom resolution. FocA forms a symmetric pentamer, with each protomer consisting of six transmembrane segments. Despite a lack of sequence homology, the overall structure of the FocA protomer closely resembles that of aquaporin and strongly argues that FocA is a channel, rather than a transporter. Structural analysis identifies potentially important channel residues, defines the channel path and reveals two constriction sites. Unlike aquaporin, FocA is impermeable to water but allows the passage of formate. A structural and biochemical investigation provides mechanistic insights into the channel activity of FocA.	[Huang, Yongjian; Wang, Jiawei; Cheng, Chao; Huang, Weijiao; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Yongjian; Wang, Jiawei; Cheng, Chao; Huang, Weijiao; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Yi; Lu, Peilong; Shi, Yigong] Tsinghua Univ, Minist Educ Prot Sci Lab, Beijing 100084, Peoples R China; [Xu, Ya-Nan; Wang, Pengye] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Physics, CAS	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; 王, 鹏业/A-9811-2012; Huang, Yongjian/GPK-5986-2022	Wang, Jiawei/0000-0001-9893-8539; Huang, Yongjian/0000-0002-1168-6111; Shi, Yigong/0000-0003-2030-168X; Lu, Peilong/0000-0001-5894-9268; Wang, Peng-Ye/0000-0002-9765-0610; Huang, Weijiao/0000-0002-6253-7765	Ministry of Science and Technology of China [2009CB918801, 2009CB918802]; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation	We thank N. Shimizu, S. Baba and T. Kumasaka at the Spring-8 beamline BL41XU for assistance, and J. He and S. Huang for help at Shanghai Synchrotron Radiation Facility (SSRF). This work was supported by funds from the Ministry of Science and Technology of China ( grants 2009CB918801 and 2009CB918802), Tsinghua University 985 Phase II funds, Project 30888001 supported by National Natural Science Foundation of China, and the Beijing Municipal Commissions of Education and Science and Technology. N. Y. acknowledges support from the Yuyuan Foundation and Li's Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; CARBREY JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; Clegg SJ, 2006, MICROBIOL-SGM, V152, P2091, DOI 10.1099/mic.0.28688-0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nolling J, 1997, J BACTERIOL, V179, P899; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Stephenson M, 1932, BIOCHEM J, V26, P712, DOI 10.1042/bj0260712; Stroud RM, 2003, ADV PROTEIN CHEM, V63, P291; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WHITE WB, 1992, J BACTERIOL, V174, P4997, DOI 10.1128/JB.174.15.4997-5004.1992	38	118	119	7	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					467	U158		10.1038/nature08610	http://dx.doi.org/10.1038/nature08610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940917				2022-12-28	WOS:000272144200035
J	Leveille, SG; Jones, RN; Kiely, DK; Hausdorff, JM; Shmerling, RH; Guralnik, JM; Kiel, DP; Lipsitz, LA; Bean, JF				Leveille, Suzanne G.; Jones, Richard N.; Kiely, Dan K.; Hausdorff, Jeffrey M.; Shmerling, Robert H.; Guralnik, Jack M.; Kiel, Douglas P.; Lipsitz, Lewis A.; Bean, Jonathan F.			Chronic Musculoskeletal Pain and the Occurrence of Falls in an Older Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER-EXTREMITY FUNCTION; EXECUTIVE FUNCTION; PREVENTING FALLS; DISABLED WOMEN; KNEE PAIN; COMMUNITY; RISK; OSTEOARTHRITIS; HEALTH; CLASSIFICATION	Context Chronic pain is a major contributor to disability in older adults; however, the potential role of chronic pain as a risk factor for falls is poorly understood. Objective To determine whether chronic musculoskeletal pain is associated with an increased occurrence of falls in a cohort of community-living older adults. Design, Setting, and Participants The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly (MOBILIZE) Boston Study is a population-based longitudinal study of falls involving 749 adults aged 70 years and older. Participants were enrolled from September 2005 through January 2008. Main Outcome Measure Participants recorded falls on monthly calendar postcards mailed to the study center during an 18-month period. Results There were 1029 falls reported during the follow-up. A report of 2 or more locations of musculoskeletal pain at baseline was associated with greater occurrence of falls. The age-adjusted rates of falls per person-year were 1.18 (95% confidence interval [CI], 1.13-1.23) for the 300 participants with 2 or more sites of joint pain, 0.90 (95% CI, 0.87-0.92) for the 181 participants with single-site pain, and 0.78 (95% CI, 0.74-0.81) for the 267 participants with no joint pain. Similarly, more severe or disabling pain at baseline was associated with higher fall rates (P < .05). The association persisted after adjusting for multiple confounders and fall risk factors. The greatest risk for falls was observed in persons who had 2 or more pain sites (adjusted rate ratio [RR], 1.53; 95% CI, 1.17-1.99), and those in the highest tertiles of pain severity (adjusted RR, 1.53; 95% CI, 1.12-2.08) and pain interference with activities (adjusted RR, 1.53; 95% CI, 1.15-2.05), compared with their peers with no pain or those in the lowest tertiles of pain scores. Conclusions Chronic pain measured according to number of locations, severity, or pain interference with daily activities was associated with greater risk of falls in older adults. JAMA. 2009;302(20):2214-2221	[Leveille, Suzanne G.] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Leveille, Suzanne G.; Jones, Richard N.; Shmerling, Robert H.; Kiel, Douglas P.; Lipsitz, Lewis A.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Leveille, Suzanne G.; Jones, Richard N.; Hausdorff, Jeffrey M.; Shmerling, Robert H.; Kiel, Douglas P.; Lipsitz, Lewis A.; Bean, Jonathan F.] Harvard Univ, Sch Med, Boston, MA USA; [Jones, Richard N.; Kiely, Dan K.; Kiel, Douglas P.; Lipsitz, Lewis A.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Bean, Jonathan F.] Spaulding Rehabil Hosp, Boston, MA USA; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	University of Massachusetts System; University of Massachusetts Boston; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Hebrew SeniorLife; Harvard University; Spaulding Rehabilitation Hospital; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Leveille, SG (corresponding author), Univ Massachusetts, Coll Nursing & Hlth Sci, 100 Morrissey Blvd, Boston, MA 02125 USA.	suzanne.leveille@umb.edu	Leveille, Suzanne G/ACS-6588-2022; Bean, Jonathan F/F-5798-2017; Jones, Richard Norman/J-3488-2013	Leveille, Suzanne G/0000-0003-0427-1580; Bean, Jonathan F/0000-0001-8385-8210; Jones, Richard Norman/0000-0002-1049-218X; Kiel, Douglas/0000-0001-8474-0310	National Institute on Aging Research Nursing Home Program Project [P01AG004390]; Intramural Research Program, National Institute on Aging, NIH; Pfizer Inc; NATIONAL INSTITUTE ON AGING [ZIAAG007310, P01AG004390] Funding Source: NIH RePORTER	National Institute on Aging Research Nursing Home Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pfizer Inc(Pfizer); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant P01AG004390 from the National Institute on Aging Research Nursing Home Program Project. Dr Guralnik's time was funded by the Intramural Research Program, National Institute on Aging, NIH. The coding of the medication data for the MOBILIZE Boston Study was supported by an unrestricted grant from Pfizer Inc, none of which was to support salary, stipends, or other funding except for salaries for research staff who were not involved in this article.	ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Arden NK, 2006, ARTHRIT RHEUM-ARTHR, V55, P610, DOI 10.1002/art.22088; Ben-Itzhak R, 2008, J AM GERIATR SOC, V56, P695, DOI 10.1111/j.1532-5415.2007.01623.x; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Blyth FM, 2007, EUR J PAIN, V11, P564, DOI 10.1016/j.ejpain.2006.08.001; Cleeland CS, 1989, ADV PAIN RES THER, P391, DOI DOI 10.1093/BRAIN/113.5.1589; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; Curtin L R, 1995, Healthy People 2000 Stat Notes, P1; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Eaton W.W., 2004, USE PSYCHOL TESTING, V3; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eggermont LHP, 2009, J GERONTOL A-BIOL, V64, P763, DOI 10.1093/gerona/glp016; ESCOBAR JI, 1986, J NERV MENT DIS, V174, P607, DOI 10.1097/00005053-198610000-00005; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Gorina Yelena, 2005, Aging Trends, P1; Graven-Nielsen T, 2002, MUSCLE NERVE, V26, P708, DOI 10.1002/mus.10225; Guralnik J.M., 1995, WOMENS HLTH AGING ST; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Lamb SE, 2000, ANN RHEUM DIS, V59, P331, DOI 10.1136/ard.59.5.331; Leveille S. G., 2009, J PAIN MANAGEMENT, V1, P329; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Leveille SG, 2001, ANN INTERN MED, V135, P1038, DOI 10.7326/0003-4819-135-12-200112180-00007; Leveille SG, 2007, PAIN, V128, P69, DOI 10.1016/j.pain.2006.08.031; Leveille Suzanne G, 2008, BMC Geriatr, V8, P16, DOI 10.1186/1471-2318-8-16; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pahor M, 1999, AM J PUBLIC HEALTH, V89, P930, DOI 10.2105/AJPH.89.6.930; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Samelson EJ, 2008, AM J EPIDEMIOL, V168, P1444, DOI 10.1093/aje/kwn277; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; The American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x	48	330	340	3	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2214	2221		10.1001/jama.2009.1738	http://dx.doi.org/10.1001/jama.2009.1738			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523NI	19934422	Green Accepted			2022-12-28	WOS:000272080500025
J	Olasveengen, TM; Sunde, K; Brunborg, C; Thowsen, J; Steen, PA; Wik, L				Olasveengen, Theresa M.; Sunde, Kjetil; Brunborg, Cathrine; Thowsen, Jon; Steen, Petter A.; Wik, Lars			Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL LIAISON COMMITTEE; EUROPEAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; ADRENALINE EPINEPHRINE; CHEST COMPRESSIONS; QUALITY; VASOPRESSIN	Context Intravenous access and drug administration are included in advanced cardiac life support (ACLS) guidelines despite a lack of evidence for improved outcomes. Epinephrine was an independent predictor of poor outcome in a large epidemiological study, possibly due to toxicity of the drug or cardiopulmonary resuscitation (CPR) interruptions secondary to establishing an intravenous line and drug administration. Objective To determine whether removing intravenous drug administration from an ACLS protocol would improve survival to hospital discharge after out-of-hospital cardiac arrest. Design, Setting, and Patients Prospective, randomized controlled trial of consecutive adult patients with out-of-hospital nontraumatic cardiac arrest treated within the emergency medical service system in Oslo, Norway, between May 1, 2003, and April 28, 2008. Interventions Advanced cardiac life support with intravenous drug administration or ACLS without access to intravenous drug administration. Main Outcome Measures The primary outcome was survival to hospital discharge. The secondary outcomes were 1-year survival, survival with favorable neurological outcome, hospital admission with return of spontaneous circulation, and quality of CPR (chest compression rate, pauses, and ventilation rate). Results Of 1183 patients for whom resuscitation was attempted, 851 were included; 418 patients were in the ACLS with intravenous drug administration group and 433 were in the ACLS with no access to intravenous drug administration group. The rate of survival to hospital discharge was 10.5% for the intravenous drug administration group and 9.2% for the no intravenous drug administration group (P=.61), 32% vs 21%, respectively, (P<.001) for hospital admission with return of spontaneous circulation, 9.8% vs 8.1% (P=.45) for survival with favorable neurological outcome, and 10% vs 8%(P=.53) for survival at 1 year. The quality of CPR was comparable and within guideline recommendations for both groups. After adjustment for ventricular fibrillation, response interval, witnessed arrest, or arrest in a public location, there was no significant difference in survival to hospital discharge for the intravenous group vs the no intravenous group (adjusted odds ratio, 1.15; 95% confidence interval, 0.69-1.91). Conclusion Compared with patients who received ACLS without intravenous drug administration following out-of-hospital cardiac arrest, patients with intravenous access and drug administration had higher rates of short-term survival with no statistically significant improvement in survival to hospital discharge, quality of CPR, or long-term survival. Trial Registration clinicaltrials.gov Identifier: NCT00121524 JAMA. 2009; 302(20): 2222-2229	[Olasveengen, Theresa M.; Wik, Lars] Oslo Univ Hosp, Expt Med Res Inst, N-0407 Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Clin Res Ctr, N-0407 Oslo, Norway; [Wik, Lars] Oslo Univ Hosp, Natl Competence Ctr Emergency Med, N-0407 Oslo, Norway; [Olasveengen, Theresa M.] Oslo Univ Hosp, Dept Anesthesiol, N-0407 Oslo, Norway; [Thowsen, Jon; Steen, Petter A.] Oslo Univ Hosp, Dept Ambulance, N-0407 Oslo, Norway; [Sunde, Kjetil] Oslo Univ Hosp, Surg Intens Care Unit, N-0407 Oslo, Norway; [Steen, Petter A.] Oslo Univ Hosp, Fac Div UUH, N-0407 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Olasveengen, TM (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, N-0407 Oslo, Norway.	t.m.olasveengen@medisin.uio.no			Eastern Norway Regional Health Authority; Oslo University Hospital; Norwegian Air Ambulance Foundation; Laerdal Foundation for Acute Medicine; Anders Jahres Fund	Eastern Norway Regional Health Authority; Oslo University Hospital; Norwegian Air Ambulance Foundation; Laerdal Foundation for Acute Medicine; Anders Jahres Fund	Funding/Support: The study was supported by grants from the Eastern Norway Regional Health Authority, Oslo University Hospital, Norwegian Air Ambulance Foundation, Laerdal Foundation for Acute Medicine, and the Anders Jahres Fund.	*2005 AM HEART ASS, 2005, CIRCULATION, V112, P58, DOI DOI 10.1161/CIRCULATIONAHA.105.16657; American Heart Association, 2000, CIRCULATION, V102, P1, DOI [10.1161/circ.102.suppl_1.I-1, DOI 10.1161/CIRC.102.SUPPL_1.I-1]; Angelos MG, 2008, RESUSCITATION, V77, P101, DOI 10.1016/j.resuscitation.2007.10.017; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P32; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Ewy GA, 2009, J AM COLL CARDIOL, V53, P149, DOI 10.1016/j.jacc.2008.05.066; Gazmuri RJ, 2007, RESUSCITATION, V75, P400, DOI 10.1016/j.resuscitation.2007.09.008; Grogaard HK, 2007, J AM COLL CARDIOL, V50, P1093, DOI 10.1016/j.jacc.2007.05.028; Holmberg M, 2002, RESUSCITATION, V54, P37, DOI 10.1016/S0300-9572(02)00048-5; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; Morgenstern H, 1982, EPIDEMIOLOGIC RES PR, P403; Morris DC, 2008, NEW ENGL J MED, V359, P1624, DOI 10.1056/NEJMc081591; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Odegaard S, 2007, RESUSCITATION, V74, P127, DOI 10.1016/j.resuscitation.2006.12.006; OTTO CW, 1984, ANN EMERG MED, V13, P840, DOI 10.1016/S0196-0644(84)80455-2; PEARSON JW, 1963, AM HEART J, V66, P210, DOI 10.1016/0002-8703(63)90036-X; Pocock SJ., 1983, CLIN TRIALS PRACTICA; Pytte M, 2006, RESUSCITATION, V71, P369, DOI 10.1016/j.resuscitation.2006.05.003; Ristagno G, 2007, CRIT CARE MED, V35, P2145, DOI 10.1097/01.CCM.0000280427.76175.D2; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; STUEVEN HA, 1984, ANN EMERG MED, V13, P815, DOI 10.1016/S0196-0644(84)80447-3; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; TANG WC, 1995, CIRCULATION, V92, P3089, DOI 10.1161/01.CIR.92.10.3089; Vandycke C, 2000, RESUSCITATION, V45, P161, DOI 10.1016/S0300-9572(00)00188-X; Virkkunen I, 2008, RESUSCITATION, V77, P207, DOI 10.1016/j.resuscitation.2007.12.006; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389	36	336	345	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2222	2229		10.1001/jama.2009.1729	http://dx.doi.org/10.1001/jama.2009.1729			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934423				2022-12-28	WOS:000272080500026
J	Thiery, JP; Acloque, H; Huang, RYJ; Nieto, MA				Thiery, Jean Paul; Acloque, Herve; Huang, Ruby Y. J.; Angela Nieto, M.			Epithelial-Mesenchymal Transitions in Development and Disease	CELL			English	Review							EPIDERMAL-GROWTH-FACTOR; CANCER STEM-CELLS; NF-KAPPA-B; TRANSCRIPTION FACTOR SNAIL; PERITONEAL MESOTHELIAL CELLS; GENE REGULATORY NETWORK; NEURAL CREST; E-CADHERIN; TGF-BETA; DOWN-REGULATION		[Thiery, Jean Paul; Huang, Ruby Y. J.] ASTAR, IMCB, Singapore 138673, Singapore; [Thiery, Jean Paul] Ctr Expt Therapeut, Singapore 138669, Singapore; [Thiery, Jean Paul; Huang, Ruby Y. J.] Natl Univ Singapore, Canc Sci Inst, Singapore 117456, Singapore; [Acloque, Herve; Angela Nieto, M.] Inst Neurociencias CSIC UMH, Alacant 03550, Spain; [Huang, Ruby Y. J.] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119074, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); National University of Singapore	Thiery, JP (corresponding author), ASTAR, IMCB, 61 Biopolis Dr, Singapore 138673, Singapore.	jpthiery@imcb.a-star.edu.sg; anieto@umh.es	Datta, Sayantan/D-1369-2010; Thiery, Jean Paul/M-9387-2019; Huang, Ruby Yun-Ju/AAE-8854-2019; Nieto, M. Angela/A-6531-2008; Thiery, Jean Paul/H-1550-2011	Huang, Ruby Yun-Ju/0000-0001-6376-3185; Nieto, M. Angela/0000-0002-3538-840X; Acloque, Herve/0000-0003-4761-1055; Thiery, Jean Paul/0000-0003-0478-5020	Spanish Ministry of Science and Innovation [BFU2005-05772, BFU2008-01042, NAN2004-09230-C04, CSD2007-00017, CSD2007-00023]; Generalitat Valenciana [2008/049]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	We are very grateful to all the members of our labs for continuous encouraging discussions. Work in our laboratories is supported by grants from A*STAR and CSI Singapore to J. P. T. and R. Y. H and from the Spanish Ministry of Science and Innovation (BFU2005-05772, BFU2008-01042, NAN2004-09230-C04; CONSOLIDER-INGENIO 2010 CSD2007-00017 and CSD2007-00023) and the Generalitat Valenciana (Prometeo 2008/049) to M. A. N.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Ahmed S, 2007, DEV BIOL, V309, P193, DOI 10.1016/j.ydbio.2007.06.018; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Billottet C, 2008, J CELL BIOCHEM, V104, P826, DOI 10.1002/jcb.21667; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Broders-Bondon F, 2007, DEV DYNAM, V236, P2555, DOI 10.1002/dvdy.21273; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Chu YS, 2006, J BIOL CHEM, V281, P2901, DOI 10.1074/jbc.M506185200; Chua KN, 2008, DRUG DISCOV TODAY, V4, P261; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Coles EG, 2007, DEV BIOL, V312, P533, DOI 10.1016/j.ydbio.2007.09.056; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Dudas M, 2007, ACTA HISTOCHEM, V109, P1, DOI 10.1016/j.acthis.2006.05.009; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Egea J, 2008, GENE DEV, V22, P3349, DOI 10.1101/gad.486708; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fendrich V, 2007, ENDOCR-RELAT CANCER, V14, P865, DOI 10.1677/ERC-07-0108; Fiaschi M, 2007, J BIOL CHEM, V282, P36090, DOI 10.1074/jbc.M704280200; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gilbert SF, 2006, DEV BIOL; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Guemar L, 2007, DEV BIOL, V310, P113, DOI 10.1016/j.ydbio.2007.07.031; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Johansson KA, 2002, CLIN GENET, V62, P14, DOI 10.1034/j.1399-0004.2002.620102.x; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kajiyama H, 2007, INT J ONCOL, V31, P277; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Knutson KL, 2006, J IMMUNOL, V177, P1526, DOI 10.4049/jimmunol.177.3.1526; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lyons JG, 2008, CANCER RES, V68, P4525, DOI 10.1158/1078-0432.CCR-07-6735; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann JR, 2006, CANCER RES, V66, P6649, DOI 10.1158/0008-5472.CAN-06-1787; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martinez-Alvarez C, 2004, DEV BIOL, V265, P207, DOI 10.1016/j.ydbio.2003.09.022; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercado-Pimentel ME, 2007, CELLS TISSUES ORGANS, V185, P146, DOI 10.1159/000101315; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Mitiku N, 2007, DEV CELL, V13, P897, DOI 10.1016/j.devcel.2007.10.004; Monsoro-Burq AH, 2005, INT J DEV BIOL, V49, P301, DOI 10.1387/ijdb.041953am; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Morales AV, 2007, EMBO REP, V8, P104, DOI 10.1038/sj.embor.7400867; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Saika S, 2004, LAB INVEST, V84, P1259, DOI 10.1038/labinvest.3700151; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Shida T, 2006, CANCER BIOL THER, V5, P1530, DOI 10.4161/cbt.5.11.3458; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Shrader M, 2007, MOL CANCER THER, V6, P277, DOI 10.1158/1535-7163.MCT-06-0513; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Taneyhill LA, 2007, DEVELOPMENT, V134, P1481, DOI 10.1242/dev.02834; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Teddy JM, 2004, DEVELOPMENT, V131, P6141, DOI 10.1242/dev.01534; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; THUAULT S, 2008, J BIOL CHEM, V174, P175; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; Valdes F, 2002, MOL CANCER RES, V1, P68; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wan XB, 2008, CARCINOGENESIS, V29, P1930, DOI 10.1093/carcin/bgn176; Wanami LS, 2008, EXP CELL RES, V314, P2448, DOI 10.1016/j.yexcr.2008.05.004; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang XY, 2008, BBA-MOL BASIS DIS, V1782, P51, DOI 10.1016/j.bbadis.2007.11.002; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Whiteman EL, 2008, ONCOGENE, V27, P3875, DOI 10.1038/onc.2008.9; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wu SY, 2008, DEV BIOL, V319, P406, DOI 10.1016/j.ydbio.2008.04.003; Wu Shu-Yu, 2007, Birth Defects Research, V81, P241, DOI 10.1002/bdrc.20113; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang L, 2008, WD SCI P COMP ENG, V1, P295, DOI 10.1142/9789812799470_0048; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhan Y, 2006, DEVELOPMENT, V133, P2359, DOI 10.1242/dev.02383; Zhang J, 2008, PERITON DIALYSIS INT, V28, P497; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	220	7279	7619	38	1359	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					871	890		10.1016/j.cell.2009.11.007	http://dx.doi.org/10.1016/j.cell.2009.11.007			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945376	Bronze			2022-12-28	WOS:000272169400013
J	Rollman, BL; Belnap, BH; LeMenager, MS; Mazumdar, S; Houck, PR; Counihan, PJ; Kapoor, WN; Schulberg, HC; Reynolds, CF				Rollman, Bruce L.; Belnap, Bea Herbeck; LeMenager, Michelle S.; Mazumdar, Sati; Houck, Patricia R.; Counihan, Peter J.; Kapoor, Wishwa N.; Schulberg, Herbert C.; Reynolds, Charles F., III			Telephone-Delivered Collaborative Care for Treating Post-CABG Depression A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; ARTERY-BYPASS-SURGERY; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; ENHANCING RECOVERY; HEALTH-STATUS; CORONARY; DISEASE; HEART; INTERVENTION	Context Depressive symptoms commonly follow coronary artery bypass graft (CABG) surgery and are associated with less positive clinical outcomes. Objective To test the effectiveness of telephone-delivered collaborative care for post-CABG depression vs usual physician care. Design, Setting, and Participants Single-blind effectiveness trial at 7 university-based and community hospitals in or near Pittsburgh, Pennsylvania. Participants were 302 post-CABG patients with depression (150, intervention; 152, usual care) and a comparison group of 151 randomly sampled post-CABG patients without depression recruited between March 2004 and September 2007 and observed as outpatients until June 2008. Intervention Eight months of telephone-delivered collaborative care provided by nurses working with patients' primary care physicians and supervised by a psychiatrist and primary care physician from this study. Main Outcome Measures Mental health-related quality of life (HRQL) measured by the Short Form-36 Mental Component Summary (SF-36 MCS) at 8-month follow-up; secondary outcome measures included assessment of mood symptoms (Hamilton Rating Scale for Depression [HRS-D]), physical HRQL (SF-36 PCS), and functional status (Duke Activity Status Index [DASI]); and hospital readmissions. Results The intervention patients reported greater improvements in mental HRQL (all P <= .02) (SF-36 MCS: Delta, 3.2 points; 95% confidence interval [CI], 0.5-6.0), physical functioning (DASI: Delta, 4.6 points; 95% CI, 1.9-7.3), and mood symptoms (HRS-D: Delta, 3.1 points; 95% CI, 1.3-4.9); and were more likely to report a 50% or greater decline in HRS-D score from baseline (50.0% vs 29.6%; number needed to treat, 4.9 [95% CI, 3.2-10.4]) than usual care patients (P < .001). Men with depression were particularly likely to benefit from the intervention (SF-36 MCS: Delta, 5.7 points; 95% CI, 2.2-9.2; P = .001). However, the mean HRQL and physical functioning of intervention patients did not reach that of the nondepressed comparison group. Conclusion Compared with usual care, telephone-delivered collaborative care for treatment of post-CABG depression resulted in improved HRQL, physical functioning, and mood symptoms at 8-month follow-up. Trial Registration clinicaltrials.gov Identifier: NCT00091962 JAMA. 2009; 302(19): 2095-2103	[Rollman, Bruce L.; Belnap, Bea Herbeck; LeMenager, Michelle S.; Kapoor, Wishwa N.] Ctr Res Hlth Care, Div Gen Internal Med, Pittsburgh, PA USA; [Schulberg, Herbert C.] Weill Cornell Med Coll, Dept Psychiat, White Plains, NY USA; [Counihan, Peter J.] Univ Pittsburgh, Sch Med, Cardiovasc Inst, Pittsburgh, PA USA; [Counihan, Peter J.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Mazumdar, Sati] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rollman, BL (corresponding author), Ste 600,230 McKee Pl, Pittsburgh, PA 15213 USA.	rollmanbl@upmc.edu		Herbeck Belnap, Bea/0000-0001-6572-9896	NIH [R01 HL70000, P30 MH71944]; UPMC Endowed Chair in Geriatric Psychiatry; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH071944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPMC Endowed Chair in Geriatric Psychiatry; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding/Support: This work was supported by NIH grants R01 HL70000 (Dr Rollman) and P30 MH71944 (Dr Reynolds), and by the UPMC Endowed Chair in Geriatric Psychiatry (Dr Reynolds).	*AG HLTH CAR POL R, 1993, AHCPR PUBL; AYANIAN JZ, 1995, JAMA-J AM MED ASSOC, V274, P1767, DOI 10.1001/jama.274.22.1767; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Burg MM, 2003, PSYCHOSOM MED, V65, P508, DOI 10.1097/01.PSY.0000077509.39465.79; Bute BP, 2003, PSYCHOSOM MED, V65, P944, DOI 10.1097/01.PSY.0000097342.24933.A2; Carney RM, 2008, AM J MED, V121, P20, DOI 10.1016/j.amjmed.2008.09.010; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; Churchill R, 2001, HEALTH TECHNOL ASSES, V5, P1, DOI DOI 10.3310/HTA5350; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Con A H, 1999, J Cardiopulm Rehabil, V19, P152, DOI 10.1097/00008483-199905000-00002; Connerney I, 2001, LANCET, V358, P1766, DOI 10.1016/S0140-6736(01)06803-9; Davidson KW, 2006, PSYCHOSOM MED, V68, P645, DOI 10.1097/01.psy.0000233233.48738.22; Doering LV, 2005, AM J CRIT CARE, V14, P316; Eagle Kim A, 2004, Circulation, V110, pe340; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FrasureSmith N, 1997, LANCET, V350, P473, DOI 10.1016/S0140-6736(97)02142-9; Freedland KE, 2002, PSYCHOSOM MED, V64, P897, DOI 10.1097/01.PSY.0000028826.64279.29; Freedland KE, 2009, ARCH GEN PSYCHIAT, V66, P387, DOI 10.1001/archgenpsychiatry.2009.7; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Goyal TM, 2005, PSYCHOSOM MED, V67, P759, DOI 10.1097/01.psy.0000174046.40566.80; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Honig A, 2007, PSYCHOSOM MED, V69, P606, DOI 10.1097/PSY.0b013e31814b260d; Katon W, 2002, DEPRESSION HELPBOOK; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mallik S, 2005, CIRCULATION, V111, P271, DOI 10.1161/01.CIR.0000152102.29293.D7; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; National Institute of Health, NIH POL REP RAC ETHN; O'Connor CM, 2008, J CARD FAIL, V14, P797, DOI 10.1016/j.cardfail.2008.10.011; Oxlad M, 2006, J PSYCHOSOM RES, V61, P775, DOI 10.1016/j.jpsychores.2006.09.008; Pignay-Demaria V, 2003, ANN THORAC SURG, V75, P314, DOI 10.1016/S0003-4975(02)04391-6; Pirraglia PA, 1999, INT J GERIATR PSYCH, V14, P668, DOI 10.1002/(SICI)1099-1166(199908)14:8<668::AID-GPS988>3.0.CO;2-9; PRIEN RF, 1991, ARCH GEN PSYCHIAT, V48, P796; Qaseem A, 2008, ANN INTERN MED, V149, P725, DOI 10.7326/0003-4819-149-10-200811180-00007; Reynolds CF, 2001, INT J GERIATR PSYCH, V16, P602, DOI 10.1002/gps.466; Rollman BL, 2009, PSYCHOSOM MED, V71, P217, DOI 10.1097/PSY.0b013e3181970c1c; Rumsfeld JS, 2004, ANN THORAC SURG, V77, P1508, DOI 10.1016/j.athoracsur.2003.10.056; Schneiderman N, 2004, PSYCHOSOM MED, V66, P475, DOI 10.1097/01.psy.0000133217.96180.e8; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Vaccarino V, 2003, CIRCULATION, V108, P2642, DOI 10.1161/01.CIR.0000097117.28614.D8; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Watson EK, 1996, AUST NZ J PUBL HEAL, V20, P359, DOI 10.1111/j.1467-842X.1996.tb01046.x; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003	59	242	242	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2095	2103		10.1001/jama.2009.1670	http://dx.doi.org/10.1001/jama.2009.1670			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520UG	19918088	Green Accepted, Bronze			2022-12-28	WOS:000271873900018
J	Loh, E; Dussurget, O; Gripenland, J; Vaitkevicius, K; Tiensuu, T; Mandin, P; Repoila, F; Buchrieser, C; Cossart, P; Johansson, J				Loh, Edmund; Dussurget, Olivier; Gripenland, Jonas; Vaitkevicius, Karolis; Tiensuu, Teresa; Mandin, Pierre; Repoila, Francis; Buchrieser, Carmen; Cossart, Pascale; Johansson, Jorgen			A trans-Acting Riboswitch Controls Expression of the Virulence Regulator PrfA in Listeria monocytogenes	CELL			English	Article							SMALL NONCODING RNAS; GENE-EXPRESSION; S-ADENOSYLMETHIONINE; ANTISENSE MECHANISM; RIBOSOME-BINDING; VIBRIO-CHOLERAE; OUTER-MEMBRANE; TRANSLATION; TRANSCRIPTION; IDENTIFICATION	Riboswitches are RNA elements acting in cis, controlling expression of their downstream genes through a metabolite-induced alteration of their secondary structure. Here, we demonstrate that two S-adenosylmethionine (SAM) riboswitches, SreA and SreB, can also function in trans and act as noncoding RNAs in Listeria monocytogenes. SreA and SreB control expression of the virulence regulator PrfA by binding to the 5'-untranslated region of its mRNA. Absence of the SAM riboswitches SreA and SreB increases the level of PrfA and virulence gene expression in L. monocytogenes. Thus, the impact of the SAM riboswitches on PrfA expression highlights a link between bacterial virulence and nutrient availability. Together, our results uncover an unexpected role for riboswitches and a distinct class of regulatory noncoding RNAs in bacteria.	[Dussurget, Olivier; Mandin, Pierre; Repoila, Francis; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Loh, Edmund; Gripenland, Jonas; Vaitkevicius, Karolis; Tiensuu, Teresa; Johansson, Jorgen] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Loh, Edmund; Gripenland, Jonas; Vaitkevicius, Karolis; Tiensuu, Teresa; Johansson, Jorgen] Umea Univ, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden; [Dussurget, Olivier; Mandin, Pierre; Repoila, Francis; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Dussurget, Olivier; Mandin, Pierre; Repoila, Francis; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Buchrieser, Carmen] Inst Pasteur, CNRS, URA 2171, UP Biol Bacteries Intracellulaires, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Umea University; Umea University; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr; jorgen.johansson@molbiol.umu.se	Vaitkevicius, Karolis/R-9714-2016	Vaitkevicius, Karolis/0000-0001-9309-3653; Johansson, Jorgen/0000-0002-0904-497X; Dussurget, Olivier/0000-0001-9924-0837; gripenland, jonas/0000-0002-9445-8586; Mandin, Pierre/0000-0002-4870-941X; Loh, Edmund/0000-0001-7050-566X; Buchrieser, Carmen/0000-0003-3477-9190; Repoila, Francis/0000-0001-5149-9698	Wenner-Gren Foundations, Umea University; Swedish Research Council [2008-58X-15144-05-3, 621-2006-4450]; EU (BacRNA 2005) [018618]; Institut Pasteur (GPH 9); INSERM; INRA; ERC; ANR [ANR-05-MIIM-026-01]	Wenner-Gren Foundations, Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU (BacRNA 2005)(European Commission); Institut Pasteur (GPH 9); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; ERC(European Research Council (ERC)European Commission); ANR(French National Research Agency (ANR))	We thank S. Gottesman, T. Geissmann, and B. Guo, for critical reading of the manuscript. We thank A. Toledo-Arana and M. Vergassola for computer predictions, Christophe Rusniok for data submission, N. Sesto and T. Geissmann for technical assistance, and S. Engelmann for SigB antibody. J.J. is supported by the Wenner-Gren Foundations, Umea University, the Swedish Research Council (grants 2008-58X-15144-05-3 and 621-2006-4450), and EU (BacRNA 2005 contract number 018618). Work in the laboratory of P. C. received financial support from Institut Pasteur (GPH 9), INSERM, INRA, EU (BacRNA 2005 contract number 018618), ERC, and ANR (ANR-05-MIIM-026-01). P. C. is an international research scholar from the Howard Hughes Medical Institute.	Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Johansson J, 2003, TRENDS MICROBIOL, V11, P280, DOI 10.1016/S0966-842X(03)00118-5; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lu C, 2008, NAT STRUCT MOL BIOL, V15, P1076, DOI 10.1038/nsmb.1494; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Renzoni A, 1999, MOL MICROBIOL, V34, P552, DOI 10.1046/j.1365-2958.1999.01621.x; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Whitford PC, 2009, BIOPHYS J, V96, pL7, DOI 10.1016/j.bpj.2008.10.033; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967	32	264	274	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					770	779		10.1016/j.cell.2009.08.046	http://dx.doi.org/10.1016/j.cell.2009.08.046			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914169	Bronze			2022-12-28	WOS:000271747200020
J	Dworkin, LD; Cooper, CJ				Dworkin, Lance D.; Cooper, Christopher J.			Renal-Artery Stenosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATHEROSCLEROTIC RENOVASCULAR DISEASE; NEPHROGENIC SYSTEMIC FIBROSIS; BALLOON ANGIOPLASTY; STENT PLACEMENT; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; MORPHOLOGIC EVIDENCE; VASCULAR-DISEASE; RANDOMIZED-TRIAL; NATURAL-HISTORY		[Dworkin, Lance D.] Brown Univ, Dept Med, Warren Alpert Sch, Providence, RI 02912 USA; [Cooper, Christopher J.] Univ Toledo, Div Cardiol, Toledo, OH 43606 USA	Brown University; University System of Ohio; University of Toledo	Dworkin, LD (corresponding author), Brown Univ, Dept Med, Warren Alpert Sch, Providence, RI 02912 USA.				National Institutes of Health; AstraZeneca; Pfizer; Cordis; Centocor; Arteriocyte; GlaxoSmithKline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL071556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Cordis; Centocor; Arteriocyte; GlaxoSmithKline(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Drs. Dworkin and Cooper report being named as study chair and principal investigator, respectively, on the ongoing CORAL trial of the management of renal-artery stenosis, which is sponsored by the National Institutes of Health and for which they report receiving grant support from AstraZeneca, Pfizer, and Cordis; and Dr. Cooper, receiving grants from Centocor, Arteriocyte, GlaxoSmithKline, Pfizer, and Cordis. No other potential conflict of interest relevant to this article was reported.	Balk E, 2006, ANN INTERN MED, V145, P901, DOI 10.7326/0003-4819-145-12-200612190-00143; Bates MC, 2007, CATHETER CARDIO INTE, V69, P1037, DOI 10.1002/ccd.21121; Bax L, 2003, J NEPHROL, V16, P807; Bax L, 2009, ANN INTERN MED, V150, P840, DOI 10.7326/0003-4819-150-12-200906160-00119; Burket MW, 2000, AM HEART J, V139, P64, DOI 10.1016/S0002-8703(00)90310-7; Canavese C, 2008, J NEPHROL, V21, P324; Caps MT, 1998, KIDNEY INT, V53, P735, DOI 10.1046/j.1523-1755.1998.00805.x; Chabova V, 2000, MAYO CLIN PROC, V75, P437; Cohen MG, 2005, AM HEART J, V150, P1204, DOI 10.1016/j.ahj.2005.02.019; Conlon PJ, 2001, KIDNEY INT, V60, P1490, DOI 10.1046/j.1523-1755.2001.00953.x; DESIMONE G, 1992, J HYPERTENS, V10, P725; Dorros G, 1998, CIRCULATION, V98, P642, DOI 10.1161/01.CIR.98.7.642; Ehmke H, 1999, HYPERTENSION, V33, P954, DOI 10.1161/01.HYP.33.4.954; GAVRAS H, 1971, LANCET, V2, P19; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1745, DOI 10.1093/ndt/gfl294; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hackam DG, 2008, AM HEART J, V156, P549, DOI 10.1016/j.ahj.2008.05.013; Hansen KJ, 2002, J VASC SURG, V36, P443, DOI 10.1067/mva.2002.127351; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hocher B, 1999, HYPERTENSION, V33, P816, DOI 10.1161/01.HYP.33.3.816; HORVATH JS, 1982, Q J MED, V51, P139; HRICIK DE, 1983, NEW ENGL J MED, V308, P373, DOI 10.1056/NEJM198302173080706; HUNT JC, 1974, ARCH INTERN MED, V133, P988, DOI 10.1001/archinte.133.6.988; Iglesias JI, 2000, AM J MED, V109, P642, DOI 10.1016/S0002-9343(00)00605-7; Kalra PA, 2005, KIDNEY INT, V68, P293, DOI 10.1111/j.1523-1755.2005.00406.x; Korner P I, 1995, Blood Press Suppl, V2, P6; Krijnen P, 2004, J HUM HYPERTENS, V18, P91, DOI 10.1038/sj.jhh.1001641; Losito A, 1996, AM J HYPERTENS, V9, P1062, DOI 10.1016/0895-7061(96)00199-9; Missouris CG, 2000, HEART, V83, P152, DOI 10.1136/heart.83.2.152; Mistry S, 2007, J HUM HYPERTENS, V21, P511, DOI 10.1038/sj.jhh.1002185; Modrall JG, 2008, J VASC SURG, V48, P317, DOI 10.1016/j.jvs.2008.03.014; Nordmann AJ, 2003, AM J MED, V114, P44, DOI 10.1016/S0002-9343(02)01396-7; OLIN JW, 1995, ANN INTERN MED, V122, P833, DOI 10.7326/0003-4819-122-11-199506010-00004; Pizzolo F, 2004, J VASC SURG, V39, P140, DOI 10.1016/S0741-5214(03)01018-8; ROBERTS JC, 1959, CIRCULATION, V20, P511, DOI 10.1161/01.CIR.20.4.511; ROBERTS JC, 1959, CIRCULATION, V20, P520, DOI 10.1161/01.CIR.20.4.520; ROBERTSON AL, 1971, SCIENCE, V172, P1138, DOI 10.1126/science.172.3988.1138; Rocha-Singh K, 2005, J AM COLL CARDIOL, V46, P776, DOI 10.1016/j.jacc.2004.11.073; ROSSI G, 1992, AM J HYPERTENS, V5, P8, DOI 10.1093/ajh/5.1.8; Simon G, 2000, AM J HYPERTENS, V13, P1189, DOI 10.1016/S0895-7061(00)01179-1; Slovut DP, 2004, NEW ENGL J MED, V350, P1862, DOI 10.1056/NEJMra032393; Suresh M, 2000, NEPHROL DIAL TRANSPL, V15, P631, DOI 10.1093/ndt/15.5.631; Uzu T, 1997, AM J KIDNEY DIS, V29, P733, DOI 10.1016/S0272-6386(97)90127-X; van de Ven PJG, 1999, LANCET, V353, P282, DOI 10.1016/S0140-6736(98)04432-8; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Vasbinder GBC, 2004, ANN INTERN MED, V141, P674, DOI 10.7326/0003-4819-141-9-200411020-00007; WAHLANDER H, 1992, HYPERTENSION, V19, P25, DOI 10.1161/01.HYP.19.1.25; WEIBULL H, 1993, J VASC SURG, V18, P841, DOI 10.1016/0741-5214(93)90340-R; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Williams GJ, 2007, AM J ROENTGENOL, V188, P798, DOI 10.2214/AJR.06.0355; Wright JT, 2006, JAMA-J AM MED ASSOC, V295, P2726; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; YAMAZAKI T, 1994, J HYPERTENS, V12, pS153; ZIERLER RE, 1994, J VASC SURG, V19, P250, DOI 10.1016/S0741-5214(94)70100-8	54	99	105	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1972	1978		10.1056/NEJMcp0809200	http://dx.doi.org/10.1056/NEJMcp0809200			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907044	Green Accepted			2022-12-28	WOS:000271660500011
J	Tomlinson, M; Swartz, L; Officer, A; Chan, KY; Rudan, I; Saxena, S				Tomlinson, Mark; Swartz, Leslie; Officer, Alana; Chan, Kit Yee; Rudan, Igor; Saxena, Shekhar			Research priorities for health of people with disabilities: an expert opinion exercise	LANCET			English	Article							RESEARCH INVESTMENTS; SETTING PRIORITIES; CARE; DIARRHEA	International evidence shows that people with disabilities have many unmet health and rehabilitation needs, face barriers in accessing mainstream health-care services, and consequently have poor health. Inadequate specific information is available about the prevalence and patterns of health conditions of people with disabilities, effective interventions, and policy-relevant research about what works to improve health and functioning of people with disabilities. In view of the urgency of the issues at stake and scarcity of resources, research contributing to improvement of health of people with disabilities needs to be prioritised. We invited 82 stakeholders to list and score research options, with the priority-setting method of the Child Health and Nutrition Research Initiative. 83 research questions were assessed for answerability, applicability, sensitivity support within the context, and equity. The leading research priority was identification of barriers that people with disabilities have in accessing health services at different levels, and finding the best possible strategies to integrate their needs into primary health-care systems and ensure local delivery. Results showed that addressing specific impairments is secondary to ensuring that health systems provide adequately for all people with disabilities. Our findings are a call for urgent attention to the issue of access to appropriate health care for people with disabilities, especially in low-income and middle-income countries.	[Tomlinson, Mark; Swartz, Leslie] Univ Stellenbosch, Dept Psychol, ZA-7602 Matieland, South Africa; [Officer, Alana] WHO, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva, Switzerland; [Saxena, Shekhar] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland; [Chan, Kit Yee] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Stellenbosch University; World Health Organization; World Health Organization; University of Melbourne; University of Split; University of Edinburgh	Tomlinson, M (corresponding author), Univ Stellenbosch, Dept Psychol, Private Bag X1, ZA-7602 Matieland, South Africa.	markt@sun.ac.za	Swartz, Leslie/A-5168-2008; Rudan, Igor/I-1467-2012	Swartz, Leslie/0000-0003-1741-5897; Rudan, Igor/0000-0001-6993-6884; Chan, Kit Yee/0000-0002-3465-8383				Bates DW, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1775; Coleman R, 2002, B WORLD HEALTH ORGAN, V80, P378; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; Kersten P, 2000, DISABIL REHABIL, V22, P737, DOI 10.1080/09638280050192016; Kirschner KL, 2007, JAMA-J AM MED ASSOC, V297, P1121, DOI 10.1001/jama.297.10.1121; MacLachlan M, 2009, DISABILITY & INTERNATIONAL DEVELOPMENT: TOWARDS INCLUSIVE GLOBAL HEALTH, P1, DOI 10.1007/978-0-387-93840-0; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Rudan I, 2008, CROAT MED J, V49, P307, DOI 10.3325/cmj.2008.3.307; Rudan I, 2007, CROAT MED J, V48, P595; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Tomlinson M, 2007, PLOS MED, V4, P1293, DOI 10.1371/journal.pmed.0040259; United Nations (UN) General Assembly, 2007, CONV RIGHTS PERS DIS; *UNOHCHR WHO, 2008, 31 UNOHCHR WHO; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; 2007, LANCET, V370, P1241	16	95	95	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1857	1862		10.1016/S0140-6736(09)61910-3	http://dx.doi.org/10.1016/S0140-6736(09)61910-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944866				2022-12-28	WOS:000272370200031
J	Grassley, C				Grassley, Chuck			Health Care Reform -- A Republican View.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2397	2399		10.1056/NEJMp0911111	http://dx.doi.org/10.1056/NEJMp0911111			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	533CE	19923559				2022-12-28	WOS:000272798900001
J	Nishimura, N; Hitomi, K; Arvai, AS; Rambo, RP; Hitomi, C; Cutler, SR; Schroeder, JI; Getzoff, ED				Nishimura, Noriyuki; Hitomi, Kenichi; Arvai, Andrew S.; Rambo, Robert P.; Hitomi, Chiharu; Cutler, Sean R.; Schroeder, Julian I.; Getzoff, Elizabeth D.			Structural Mechanism of Abscisic Acid Binding and Signaling by Dimeric PYR1	SCIENCE			English	Article							PROTEIN PHOSPHATASE 2C; X-RAY; NEGATIVE REGULATOR; GUARD-CELLS; ARABIDOPSIS; ABI1; TRANSDUCTION; GERMINATION; EXPRESSION; UPSTREAM	The phytohormone abscisic acid (ABA) acts in seed dormancy, plant development, drought tolerance, and adaptive responses to environmental stresses. Structural mechanisms mediating ABA receptor recognition and signaling remain unknown but are essential for understanding and manipulating abiotic stress resistance. Here, we report structures of pyrabactin resistance 1 (PYR1), a prototypical PYR/PYR1-like (PYL)/regulatory component of ABA receptor (RCAR) protein that functions in early ABA signaling. The crystallographic structure reveals an alpha/beta helix-grip fold and homodimeric assembly, verified in vivo by coimmunoprecipitation. ABA binding within a large internal cavity switches structural motifs distinguishing ABA-free "open-lid" from ABA-bound "closed-lid" conformations. Small-angle x-ray scattering suggests that ABA signals by converting PYR1 to a more compact, symmetric closed-lid dimer. Site-directed PYR1 mutants designed to disrupt hormone binding lose ABA-triggered interactions with type 2C protein phosphatase partners in planta.	[Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Nishimura, Noriyuki; Schroeder, Julian I.] Univ Calif San Diego, Cell & Dev Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Hitomi, Kenichi; Rambo, Robert P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Cutler, Sean R.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Riverside	Getzoff, ED (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edg@scripps.edu	Cutler, Sean R/D-6617-2011; Nishimura, Noriyuki/E-3580-2010	Nishimura, Noriyuki/0000-0003-2946-3124; Schroeder, Julian/0000-0002-3283-5972	NIH [GM060396, ES010337, GM37684]; NSF [MCB-0918220, IOS0820508]; U. S. Department of Energy [DE-FG02-03ER15449, DE-AC02-05CH11231]; LBNL-LDRI; The Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684, R01GM060396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); LBNL-LDRI; The Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Bhabha, J. Christie, M. Hammel, G. L. Hura, D. G. Mendoza-Cozatl, M. E. Pique, D. S. Shin, and J. A. Tainer for discussions, plus the Structurally Integrated BiologY for Life Sciences beamline staff and Arabidopsis Biological Resource Center. This research was supported by NIH grants GM060396, ES010337 ( J. I. S.), and GM37684 ( E. D. G.); NSF grants MCB-0918220 ( J. I. S.) and IOS0820508 ( S. R. C.); U. S. Department of Energy grants DE-FG02-03ER15449 ( J. I. S.) plus DE-AC02-05CH11231 and LBNL-LDRI ( R. P. R.); and The Skaggs Institute for Chemical Biology ( K. H.). J. I. S. and E. D. G. conceived of the project; E. D. G., J. I. S., K. H., N. N., A. S. A., and R. P. R. designed research; N. N., K. H., A. S. A., R. P. R., and C. H. performed experiments; S. R. C. provided reagents and results before publication; K. H., N. N., A. S. A., R. P. R., J. I. S., and E. D. G. analyzed data; and E. D. G., J. I. S., K. H., and N. N. wrote the paper. Crystallographic coordinates and structure factors are deposited in the Protein Data Bank with accession code	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; EAGLES CF, 1963, NATURE, V199, P874, DOI 10.1038/199874a0; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; OHKUMA K, 1963, SCIENCE, V142, P1592, DOI 10.1126/science.142.3599.1592; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; SONDHEIM.E, 1971, SCIENCE, V174, P829, DOI 10.1126/science.174.4011.829; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128	34	354	393	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1373	1379		10.1126/science.1181829	http://dx.doi.org/10.1126/science.1181829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933100	Green Accepted			2022-12-28	WOS:000272351100034
J	Koh, J; Tee, A				Koh, Jansen; Tee, Augustine			Tuberculous Abscess Manifesting as Unilateral Gynecomastia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koh, Jansen; Tee, Augustine] Changi Gen Hosp, Singapore, Singapore	Changi General Hospital	Koh, J (corresponding author), Changi Gen Hosp, Singapore, Singapore.	jansenkoh@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2270	2270		10.1056/NEJMicm0809026	http://dx.doi.org/10.1056/NEJMicm0809026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19955527				2022-12-28	WOS:000272257100010
J	Tu, JV; Donovan, LR; Lee, DS; Wang, JT; Austin, PC; Alter, DA; Ko, DT				Tu, Jack V.; Donovan, Linda R.; Lee, Douglas S.; Wang, Julie T.; Austin, Peter C.; Alter, David A.; Ko, Dennis T.			Effectiveness of Public Report Cards for Improving the Quality of Cardiac Care The EFFECT Study: A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY EVENTS; OF-CARE; HEART-FAILURE; INFORMED-CONSENT; PERFORMANCE DATA; GLOBAL REGISTRY; INDICATORS; HOSPITALS; MORTALITY	Context Publicly released report cards on hospital performance are increasingly common, but whether they are an effective method for improving quality of care remains uncertain. Objective To evaluate whether the public release of data on cardiac quality indicators effectively stimulates hospitals to undertake quality improvement activities that improve health care processes and patient outcomes. Design, Setting, and Patients Population-based cluster randomized trial (Enhanced Feedback for Effective Cardiac Treatment [EFFECT]) of 86 hospital corporations in Ontario, Canada, with patients admitted for acute myocardial infarction (AMI) or congestive heart failure (CHF). Intervention Participating hospital corporations were randomized to early (January 2004) or delayed (September 2005) feedback of a public report card on their baseline performance (between April 1999 and March 2001) on a set of 12 process-of-care indicators for AMI and 6 for CHF. Follow-up performance data (between April 2004 and March 2005) also were collected. Main Outcome Measures The coprimary outcomes were composite AMI and CHF indicators based on 12 AMI and 6 CHF process-of-care indicators. Secondary outcomes were the individual process-of-care indicators, a hospital report card impact survey, and all-cause AMI and CHF mortality. Results The publication of the early feedback hospital report card did not result in a significant systemwide improvement in the early feedback group in either the composite AMI process-of-care indicator (absolute change, 1.5%; 95% confidence interval [CI], -2.2% to 5.1%; P = .43) or the composite CHF process-of-care indicator (absolute change, 0.6%; 95% CI, -4.5% to 5.7%; P = .81). During the follow-up period, the mean 30-day AMI mortality rates were 2.5% lower (95% CI, 0.1% to 4.9%; P = .045) in the early feedback group compared with the delayed feedback group. The hospital mortality rates for CHF were not significantly different. Conclusion Public release of hospital-specific quality indicators did not significantly improve composite process-of-care indicators for AMI or CHF. Trial Registration clinicaltrials.gov Identifier: NCT00187460 JAMA. 2009;302(21):2330-2337	[Tu, Jack V.; Donovan, Linda R.; Lee, Douglas S.; Wang, Julie T.; Austin, Peter C.; Alter, David A.; Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Tu, Jack V.; Ko, Dennis T.] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON M4N 3M5, Canada; [Tu, Jack V.; Lee, Douglas S.; Alter, David A.; Ko, Dennis T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Tu, Jack V.; Austin, Peter C.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tu, Jack V.; Austin, Peter C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Lee, Douglas S.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Alter, David A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Alter, David A.] Toronto Rehabil Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Tu, JV (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	tu@ices.on.ca		Tu, Jack/0000-0003-0111-722X; Austin, Peter/0000-0003-3337-233X; Ko, Dennis/0000-0001-6840-8051; Lee, Douglas/0000-0001-7078-745X	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Ontario Ministry of Health and Long-Term Care; Tier 1 Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Tier 1 Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	The EFFECT study was supported by a Canadian Institutes of Health Research team grant in cardiovascular outcomes research to the Canadian Cardiovascular Outcomes Research Team; it was initially funded by a Canadian Institutes of Health Research Interdisciplinary Health Research Team grant and a grant from the Heart and Stroke Foundation of Canada. The Institute for Clinical Evaluative Sciences is supported by an operating grant from the Ontario Ministry of Health and Long-Term Care. Dr Tu is supported by a Tier 1 Canada Research Chair in Health Services Research and a career investigator award from the Heart and Stroke Foundation of Ontario. Dr Lee is supported by a Clinician Scientist Award from the Canadian Institutes of Health Research. Drs Austin and Alter are supported by Career Investigator Awards from the Heart and Stroke Foundation of Ontario. Dr Ko is supported by a Clinician Scientist Award from the Heart and Stroke Foundation of Ontario.	Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Fonarow GC, 2005, ARCH INTERN MED, V165, P1469, DOI 10.1001/archinte.165.13.1469; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Jollis JG, 1998, NEW ENGL J MED, V338, P983, DOI 10.1056/NEJM199804023381410; Ko DT, 2008, CAN J CARDIOL, V24, P839, DOI 10.1016/S0828-282X(08)70192-2; Lee DS, 2003, CAN J CARDIOL, V19, P357; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee TH, 2004, NEW ENGL J MED, V350, P2409, DOI 10.1056/NEJMsb041193; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Miller FG, 2008, NEW ENGL J MED, V358, P765, DOI 10.1056/NEJMp0800136; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Steinbrook R, 2006, NEW ENGL J MED, V355, P1847, DOI 10.1056/NEJMp068222; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Tu JV, 2004, QUALITY CARDIAC CARE; TU JV, 2005, QUALITY CARDIAC CARE; Ukoumunne OC, 2001, STAT MED, V20, P417, DOI 10.1002/1097-0258(20010215)20:3<417::AID-SIM802>3.0.CO;2-G; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239	26	180	180	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2330	2337		10.1001/jama.2009.1731	http://dx.doi.org/10.1001/jama.2009.1731			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19923205	Bronze			2022-12-28	WOS:000272239000021
J	Ernst, ME; Moser, M				Ernst, Michael E.; Moser, Marvin			Drug Therapy Use of Diuretics in Patients with Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LIPID-LOWERING TREATMENT; ISOLATED SYSTOLIC HYPERTENSION; HIGH-BLOOD-PRESSURE; PROSPECTIVELY-DESIGNED OVERVIEWS; MAJOR CARDIOVASCULAR EVENTS; JOINT NATIONAL COMMITTEE; LONG-TERM; ANTIHYPERTENSIVE TREATMENT; CLINICAL-OUTCOMES; RESISTANT HYPERTENSION		[Ernst, Michael E.] Univ Iowa, Coll Pharm, Dept Pharm Practice & Sci, Iowa City, IA 52242 USA; [Ernst, Michael E.] Univ Iowa, Dept Family Med, Carver Coll Med, Iowa City, IA USA; [Moser, Marvin] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA	University of Iowa; University of Iowa; Yale University	Ernst, ME (corresponding author), Univ Iowa Hosp & Clin, Dept Family Med, 200 Hawkins Dr,01291-A PFP, Iowa City, IA 52242 USA.	michael-ernst@uiowa.edu						ALMESHARI K, 1993, J AM SOC NEPHROL, V3, P1878; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1990, Circulation, V82, P1616; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BEERMANN B, 1980, CLIN PHARMACOKINET, V5, P221, DOI 10.2165/00003088-198005030-00003; BENGTSSON C, 1975, BMJ-BRIT MED J, V1, P197, DOI 10.1136/bmj.1.5951.197; BEYER KH, 1958, SCIENCE, V127, P146, DOI 10.1126/science.127.3290.146; Black HR, 2008, DIABETES CARE, V31, P353, DOI 10.2337/dc07-1452; BOWLUS WE, 1964, CLIN PHARMACOL THER, V5, P708; Brater DC, 1998, NEW ENGL J MED, V339, P387, DOI 10.1056/NEJM199808063390607; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Carter BL, 2008, HYPERTENSION, V52, P30, DOI 10.1161/HYPERTENSIONAHA.108.114389; Carter BL, 2004, HYPERTENSION, V43, P4, DOI 10.1161/01.HYP.0000103632.19915.0E; CARVALHO JGRD, 1977, CLIN PHARMACOL THER, V22, P875; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Curb JD, 1997, JAMA-J AM MED ASSOC, V277, P1356; CUSHMAN WC, 1991, ARCH INTERN MED, V151, P1954, DOI 10.1001/archinte.151.10.1954; DIETERLE W, 1976, EUR J CLIN PHARMACOL, V10, P37, DOI 10.1007/BF00561547; Dussol B, 2005, NEPHROL DIAL TRANSPL, V20, P349, DOI 10.1093/ndt/gfh650; Elliott WJ, 2008, J CLIN HYPERTENS, V10, P856, DOI 10.1111/j.1751-7176.2008.00029.x; Ellison DH, 1999, SEMIN NEPHROL, V19, P581; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; ELLISON DH, 1991, ANN INTERN MED, V114, P886, DOI 10.7326/0003-4819-114-10-886; Ernst ME, 2006, HYPERTENSION, V47, P352, DOI 10.1161/01.HYP.0000203309.07140.d3; FINNERTY FA, 1984, AM J CARDIOL, V53, P1304, DOI 10.1016/0002-9149(84)90084-5; FINNERTY FA, 1977, ANGIOLOGY, V28, P125, DOI 10.1177/000331977702800209; FINNERTY FA, 1976, ANGIOLOGY, V27, P738, DOI 10.1177/000331977602701210; Franse LV, 2000, HYPERTENSION, V35, P1025, DOI 10.1161/01.HYP.35.5.1025; FREIS ED, 1958, JAMA-J AM MED ASSOC, V166, P137, DOI 10.1001/jama.1958.02990020025004; FREIS ED, 1995, ANN INTERN MED, V122, P223, DOI 10.7326/0003-4819-122-3-199502010-00011; GIFFORD RW, 1961, CIRCULATION, V24, P1197, DOI 10.1161/01.CIR.24.5.1197; Grimm RH, 1997, ARCH INTERN MED, V157, P638, DOI 10.1001/archinte.157.6.638; Hasannejad H, 2004, J PHARMACOL EXP THER, V308, P1021, DOI 10.1124/jpet.103.059139; Hughes AD, 2004, J RENIN-ANGIO-ALDO S, V5, P155, DOI 10.3317/jraas.2004.034; JACKSON EK, 2006, GOODMAN GILMANS PHAR, P737; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Kim GH, 2004, AM J NEPHROL, V24, P595, DOI 10.1159/000082314; KNAUF H, 1995, J CARDIOVASC PHARM, V26, P394, DOI 10.1097/00005344-199509000-00008; Kostis JB, 2005, AM J CARDIOL, V95, P29, DOI 10.1016/j.amjcard.2004.08.059; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; LUNDJOHANSEN P, 1970, ACTA MED SCAND, V187, P509; Mancia G, 2007, J HYPERTENS, V25, P2184; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; MATERSON BJ, 1994, NEW ENGL J MED, V330, P1689, DOI 10.1056/NEJM199406093302316; MCINNES GT, 1992, J HYPERTENS, V10, P317; Messerli FH, 2008, CIRCULATION, V117, P2706, DOI 10.1161/CIRCULATIONAHA.107.695007; Moser M, 1998, JAMA-J AM MED ASSOC, V279, P1813, DOI 10.1001/jama.279.22.1813; MOSER M, 1959, AM J CARDIOL, V3, P214, DOI 10.1016/0002-9149(59)90289-9; Muntner P, 2009, HYPERTENSION, V53, P617, DOI 10.1161/HYPERTENSIONAHA.108.120154; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; Nishizaka MK, 2003, AM J HYPERTENS, V16, P925, DOI 10.1016/S0895-7061(03)01032-X; NOVELLO FC, 1957, J AM CHEM SOC, V79, P2028, DOI 10.1021/ja01565a079; PATON RR, 1977, J CLIN PHARMACOL, V17, P243, DOI 10.1177/009127007701700409; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P43, DOI 10.1001/jama.292.1.43-c; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; RAM CVS, 1981, ARCH INTERN MED, V141, P1015, DOI 10.1001/archinte.141.8.1015; Report of the joint national committee on detection evaluation and treatment of high blood pressure, 1977, JAMA, V237, P255; RIESS W, 1977, EUR J CLIN PHARMACOL, V12, P375, DOI 10.1007/BF00562454; ROOS JC, 1981, EUR J CLIN PHARMACOL, V19, P107, DOI 10.1007/BF00568396; Saha C, 2005, HYPERTENSION, V46, P481, DOI 10.1161/01.HYP.0000179582.42830.1d; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; SHAH S, 1978, AM HEART J, V95, P611, DOI 10.1016/0002-8703(78)90303-4; SICA DA, 2007, HYPERTENSION COMPANI; Southworth H, 1937, P SOC EXP BIOL MED, V36, P58; STAMLER R, 1987, JAMA-J AM MED ASSOC, V257, P1484, DOI 10.1001/jama.257.11.1484; Strauss MB, 1938, B JOHNS HOPKINS HOSP, V63, P41; Taler SJ, 2002, HYPERTENSION, V39, P982, DOI 10.1161/01.HYP.0000016176.16042.2F; TARAZI RC, 1970, CIRCULATION, V41, P709, DOI 10.1161/01.CIR.41.4.709; Temperini C, 2008, ORG BIOMOL CHEM, V6, P2499, DOI 10.1039/b800767e; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turnbull F, 2003, LANCET, V362, P1527; Turnbull F, 2008, EUR HEART J, V29, P2669, DOI 10.1093/eurheartj/ehn427; WELLING PG, 1986, BIOPHARM DRUG DISPOS, V7, P501, DOI 10.1002/bdd.2510070602; Whelton PK, 2005, ARCH INTERN MED, V165, P1401, DOI 10.1001/archinte.165.12.1401; WILSON IM, 1959, CIRCULATION, V20, P1028, DOI 10.1161/01.CIR.20.6.1028; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Wright JT, 2008, ARCH INTERN MED, V168, P207, DOI 10.1001/archinternmed.2007.66; Wright JT, 2009, ARCH INTERN MED, V169, P832, DOI 10.1001/archinternmed.2009.60; WRIGHT JM, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001841.PUB2; Zhou MS, 2008, J HYPERTENS, V26, P494, DOI 10.1097/HJH.0b013e3282f3e39d	87	149	172	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2153	2164		10.1056/NEJMra0907219	http://dx.doi.org/10.1056/NEJMra0907219			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524BC	19940300				2022-12-28	WOS:000272117800009
J	Baumgardt, M; Karlsson, D; Terriente, J; Diaz-Benjumea, FJ; Thor, S				Baumgardt, Magnus; Karlsson, Daniel; Terriente, Javier; Diaz-Benjumea, Fernando J.; Thor, Stefan			Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; DROSOPHILA CNS; NEUROBLAST COMPETENCE; NEURAL PROLIFERATION; IDENTITY FACTORS; GENE-EXPRESSION; NETWORK MOTIFS; CELL IDENTITY; HUNCHBACK	Neural progenitors generate distinct cell types at different stages, but the mechanisms controlling these temporal transitions are poorly understood. In the Drosophila CNS, a cascade of transcription factors, the "temporal gene cascade," has been identified that acts to alter progenitor competence over time. However, many CNS lineages display broad temporal windows, and it is unclear how broad windows progress into subwindows that generate unique cell types. We have addressed this issue in an identifiable Drosophila CNS lineage and find that a broad castor temporal window is subdivided by two different feed-forward loops, both of which are triggered by castor itself. The first loop acts to specify a unique cell fate, whereas the second loop suppresses the first loop, thereby allowing for the generation of alternate cell fates. This mechanism of temporal and "subtemporal" genes acting in opposing feed-forward loops may be used by many stem cell lineages to generate diversity.	[Baumgardt, Magnus; Karlsson, Daniel; Thor, Stefan] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Terriente, Javier; Diaz-Benjumea, Fernando J.] Univ Autonoma Madrid Canto Blanco, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Linkoping University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Thor, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	stefan.thor@liu.se	Thor, Stefan/Y-5804-2019; Diaz-Benjumea, Fernando/K-7667-2014; Terriente, Javier/M-3292-2014	Thor, Stefan/0000-0001-5095-541X; Diaz-Benjumea, Fernando/0000-0003-3007-2489; Terriente, Javier/0000-0002-0426-9862	Swedish Research Council; Swedish Strategic Research Foundation; Knut and Alice Wallenberg foundation; Swedish "Hjarnfonden," "Cancerfonden"; Swedish Royal Academy of Sciences; Spanish Ministerio de Ciencia e Innovacion [BFU2008-04683-CO2-01/BMC]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish "Hjarnfonden," "Cancerfonden"(Swedish Cancer Society); Swedish Royal Academy of Sciences; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We are grateful to S. Cohen, M. Crozatier, A. DiAntonio, C. Q. Doe, L. Fessler, A. Gould, R. Holmgren, K. Jagla, T. M. Laufer, W. Odenwald, R. Pflanz, J. Skeath, P. H. Taghert, A. Uv, D. Vasiliauskas, A. Vincent, the Drosophila Genomic Resource Center, the Developmental Studies Hybridoma Bank, and the Bloomington Stock Center for sharing antibodies, fly lines, and DNA. We thank D. van Meyel, I. Miguel-Aliaga, A. Gould and J. B. Thomas for critically reading the manuscript. H. Ekman and A. Angel provided excellent technical assistance. This work was supported by the Swedish Research Council, the Swedish Strategic Research Foundation, the Knut and Alice Wallenberg foundation, the Swedish "Hjarnfonden," "Cancerfonden," the Swedish Royal Academy of Sciences (support to S. T.), and the Spanish Ministerio de Ciencia e Innovacion (grant BFU2008-04683-CO2-01/BMC to F. J. D.).	Allan DW, 2005, NEURON, V45, P689, DOI 10.1016/j.neuron.2005.01.026; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Atkinson S, 2008, CELL TISSUE RES, V331, P23, DOI 10.1007/s00441-007-0536-x; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Brody T, 2002, DEVELOPMENT, V129, P3763; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Clements M, 2003, DEV DYNAM, V226, P67, DOI 10.1002/dvdy.10209; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; DOE CQ, 1993, TRENDS NEUROSCI, V16, P510, DOI 10.1016/0166-2236(93)90195-R; Felix JT, 2007, DEVELOPMENT, V134, P1845, DOI 10.1242/dev.003830; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; Mettler U, 2006, DEVELOPMENT, V133, P429, DOI 10.1242/dev.02229; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P5837, DOI 10.1242/dev.01447; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Novotny T, 2002, DEVELOPMENT, V129, P1027; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Park DK, 2004, DEV BIOL, V269, P95, DOI 10.1016/j.ydbio.2004.01.015; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; Vogler G, 2008, DEV BIOL, V319, P78, DOI 10.1016/j.ydbio.2008.04.008; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006	53	130	130	3	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					969	982		10.1016/j.cell.2009.10.032	http://dx.doi.org/10.1016/j.cell.2009.10.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945380	Bronze, Green Submitted			2022-12-28	WOS:000272169400020
J	Penkner, AM; Fridkin, A; Gloggnitzer, J; Baudrimont, A; Machacek, T; Woglar, A; Csaszar, E; Pasierbek, P; Ammerer, G; Gruenbaum, Y; Jantsch, V				Penkner, Alexandra M.; Fridkin, Alexandra; Gloggnitzer, Jiradet; Baudrimont, Antoine; Machacek, Thomas; Woglar, Alexander; Csaszar, Edina; Pasierbek, Pawel; Ammerer, Gustav; Gruenbaum, Yosef; Jantsch, Verena			Meiotic Chromosome Homology Search Involves Modifications of the Nuclear Envelope Protein Matefin/SUN-1	CELL			English	Article							C-ELEGANS MEIOSIS; CAENORHABDITIS-ELEGANS; FISSION YEAST; SUN-DOMAIN; SACCHAROMYCES-CEREVISIAE; SYNAPSIS; PROPHASE; RECOMBINATION; TELOMERES; ATTACHMENT	Genome haploidization during meiosis depends on recognition and association of parental homologous chromosomes. The C. elegans SUN/KASH domain proteins Matefin/SUN-1 and ZYG-12 have a conserved role in this process. They bridge the nuclear envelope, connecting the cytoplasm and the nucleoplasm to transmit forces that allow chromosome movement and homolog pairing and prevent nonhomologous synapsis. Here, we show that Matefin/SUN-1 forms rapidly moving aggregates at putative chromosomal attachment sites in the meiotic transition zone (TZ). We analyzed requirements for aggregate formation and identified multiple phosphotarget residues in the nucleoplasmic domain of Matefin/SUN-1. These CHK-2 dependent phosphorylations occur in leptotene/zygotene, diminish during pachytene and are involved in pairing. Mimicking phosphorylation causes an extended TZ and univalents at diakinesis. Our data suggest that the properties of the nuclear envelope are altered during the time window when homologs are sorted and Matefin/SUN-1 aggregates form, thereby controling the movement, homologous pairing and interhomolog recombination of chromosomes.	[Penkner, Alexandra M.; Gloggnitzer, Jiradet; Baudrimont, Antoine; Machacek, Thomas; Woglar, Alexander; Jantsch, Verena] Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, A-1030 Vienna, Austria; [Fridkin, Alexandra; Gruenbaum, Yosef] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Csaszar, Edina; Ammerer, Gustav] Univ Vienna, Max F Perutz Labs, Mass Spectrometry Unit, A-1030 Vienna, Austria; [Pasierbek, Pawel] Res Inst Mol Pathol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Hebrew University of Jerusalem; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Penkner, AM (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, Waehringer Guertel 18, A-1030 Vienna, Austria.	alexandra.penkner@univie.ac.at; moloko@cc.huji.ac.il; verena.jantsch@univie.ac.at	Jantsch, Verena/A-3910-2017	Jantsch, Verena/0000-0002-1978-682X; Baudrimont, Antoine/0000-0001-9410-6356	FWF [P-21107, SFB-F3402]; WWTF [LS05009]; University of Vienna [I031-B]; Elise-Richter; DOC; Israel Science Foundation; Clore scholarship	FWF(Austrian Science Fund (FWF)); WWTF; University of Vienna; Elise-Richter(Austrian Science Fund (FWF)); DOC; Israel Science Foundation(Israel Science Foundation); Clore scholarship	We thank Christian Pflugl, Ella Kaplan, Sonja Kolar, and Sophie Wohrer for technical assistance. We are grateful to Chris Malone, Tony Hyman, Abby Dernburg, Anton Gartner, Anne Villeneuve, Monique Zetka, and the Caenorhabditis Genetics Center for strains, plasmids, and antibodies. We are indebted to Abby Dernburg for sharing unpublished results. We are grateful to Peter Carlton, Cecile Brocard, and Simon Boulton for helpful suggestions. We thank Iain Wilson, Maria Siomos, Yudith Yanowitz, and Josef Loidl for discussion. This work was supported by grants from the FWF (P-21107 and SFB-F3402), the WWTF (LS05009), the University of Vienna (I031-B), as well as an Elise-Richter grant to V. J., a DOC scholarship to A. W., an Israel Science Foundation grant to Y. G., and a Clore scholarship to A. F.	Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Alsheimer M., 2009, V5, P81, DOI 10.1159/000166621; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bhalla N, 2008, ANNU REV CELL DEV BI, V24, P397, DOI 10.1146/annurev.cellbio.23.090506.123245; Carlton PM, 2006, PLOS GENET, V2, P119, DOI 10.1371/journal.pgen.0020012; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding DQ, 1998, J CELL SCI, V111, P701; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; GOLDSTEIN P, 1982, CHROMOSOMA, V84, P585, DOI 10.1007/BF00292857; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Kosaka H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000196; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Pawlowski WP, 2005, TRENDS CELL BIOL, V15, P674, DOI 10.1016/j.tcb.2005.10.005; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Perona R, 2008, CLIN TRANSL ONCOL, V10, P538, DOI 10.1007/s12094-008-0248-5; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smolikov S, 2007, GENETICS, V176, P2015, DOI 10.1534/genetics.107.072413; Smolikov S, 2007, GENETICS, V176, P2027, DOI 10.1534/genetics.107.076968; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; Tang X, 2006, J CELL BIOL, V173, P845, DOI 10.1083/jcb.200602152; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233	52	142	155	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					920	933		10.1016/j.cell.2009.10.045	http://dx.doi.org/10.1016/j.cell.2009.10.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19913286	Bronze			2022-12-28	WOS:000272169400016
J	Birnbaum, J; Cowling, K; Foreman, K; Fullman, N; Gubbins, P; Levin-Rector, A; Makela, S; Marcus, J; Myerson, R; Schneider, M				Birnbaum, Jeanette; Cowling, Krycia; Foreman, Kyle; Fullman, Nancy; Gubbins, Paul; Levin-Rector, Alison; Makela, Susanna; Marcus, Jacob; Myerson, Rebecca; Schneider, Matthew			Sceptical optimism: a new take on global health data	LANCET			English	Editorial Material									[Birnbaum, Jeanette; Cowling, Krycia; Foreman, Kyle; Fullman, Nancy; Gubbins, Paul; Levin-Rector, Alison; Makela, Susanna; Marcus, Jacob; Myerson, Rebecca; Schneider, Matthew] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation	Birnbaum, J (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	ihme-pbfs@u.washington.edu	Myerson, Rebecca/AAD-4861-2019; Levin-Rector, Alison/AAA-6756-2020	Myerson, Rebecca/0000-0001-7567-936X; Cowling, Krycia/0000-0003-2489-5390				[Anonymous], 2009, LANCET, V373, P2083, DOI 10.1016/S0140-6736(09)61128-4; Breman J, 2006, CONQUERING MALARIA D; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; KELLY TD, 2006, HIST STAT MINERAL MA; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; *WEATH UND, 1970, HIST SEATTL BOEING; *WHO, 2005, AFR D COST EFF RES M	9	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1730	1731		10.1016/S0140-6736(09)61426-4	http://dx.doi.org/10.1016/S0140-6736(09)61426-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ID	19910042				2022-12-28	WOS:000272207700007
J	Feuillet, C; Eversole, K				Feuillet, Catherine; Eversole, Kellye			Solving the Maze	SCIENCE			English	Editorial Material							MAIZE GENOME		[Feuillet, Catherine] UMR INRA UBP, Genet Divers & Ecophysiol Cereals, F-63100 Clermont Ferrand, France; [Eversole, Kellye] Eversole Associates, Bethesda, MD 20814 USA	INRAE; Universite Clermont Auvergne (UCA)	Feuillet, C (corresponding author), UMR INRA UBP, Genet Divers & Ecophysiol Cereals, F-63100 Clermont Ferrand, France.	catherine.feuillet@clermont.inra.fr	Eversole, Kellye/AAN-6141-2020	Eversole, Kellye/0000-0002-8784-4913				BENNETZEN J, 2009, HDB MAIZE GENETICS G, V2; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Coe EH, 1998, P NATL ACAD SCI USA, V95, P2029, DOI 10.1073/pnas.95.5.2029; CornelisMC, 2011, PLOS GENET, V7; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Rabinowicz PD, 2006, CURR OPIN PLANT BIOL, V9, P149, DOI 10.1016/j.pbi.2006.01.015; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Vielle-Calzada JP, 2009, SCIENCE, V326, P1078, DOI 10.1126/science.1178437; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047	11	8	10	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1071	+		10.1126/science.1183463	http://dx.doi.org/10.1126/science.1183463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965417				2022-12-28	WOS:000271951000028
J	Rudoy, JD; Voss, JL; Westerberg, CE; Paller, KA				Rudoy, John D.; Voss, Joel L.; Westerberg, Carmen E.; Paller, Ken A.			Strengthening Individual Memories by Reactivating Them During Sleep	SCIENCE			English	Article							CONSOLIDATION		[Rudoy, John D.; Voss, Joel L.; Westerberg, Carmen E.; Paller, Ken A.] Northwestern Univ, Evanston, IL 60208 USA; [Voss, Joel L.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign	Paller, KA (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.	kap@northwestern.edu	Paller, Ken/M-2676-2019	Voss, Joel/0000-0003-4180-9335; Paller, Ken/0000-0003-4415-4143	NSF [BCS-0818912]; National Institute of Neurological Disorders and Stroke; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066725] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NSF under grant BCS-0818912, by the National Institute of Neurological Disorders and Stroke, and by the Alzheimer's Association.	Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Paller K.A., 2009, ENCY NEUROSCIENCE, P741, DOI [DOI 10.1016/B978-008045046-9.00770-1, 10.1016/B978-008045046-9.00770-1]; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004	6	303	325	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1079	1079		10.1126/science.1179013	http://dx.doi.org/10.1126/science.1179013			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965421	Green Accepted			2022-12-28	WOS:000271951000032
J	Erwin, D				Erwin, Douglas			A call to the custodians of deep time	NATURE			English	Editorial Material							DIVERSITY		[Erwin, Douglas] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Erwin, Douglas] Santa Fe Inst, Santa Fe, NM 87501 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute	Erwin, D (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA.	erwind@si.edu		Erwin, Douglas/0000-0003-2518-5614				Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186	4	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					282	283		10.1038/462282a	http://dx.doi.org/10.1038/462282a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924193				2022-12-28	WOS:000271899300020
J	Meng, JQ; Liu, GD; Zhang, WT; Zhao, L; Liu, HY; Jia, XW; Mu, DX; Liu, SY; Dong, XL; Zhang, J; Lu, W; Wang, GL; Zhou, Y; Zhu, Y; Wang, XY; Xu, ZY; Chen, CT; Zhou, XJ				Meng, Jianqiao; Liu, Guodong; Zhang, Wentao; Zhao, Lin; Liu, Haiyun; Jia, Xiaowen; Mu, Daixiang; Liu, Shanyu; Dong, Xiaoli; Zhang, Jun; Lu, Wei; Wang, Guiling; Zhou, Yong; Zhu, Yong; Wang, Xiaoyang; Xu, Zuyan; Chen, Chuangtian; Zhou, X. J.			Coexistence of Fermi arcs and Fermi pockets in a high-T-c copper oxide superconductor	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; QUANTUM OSCILLATIONS; SURFACE; BI2SR2CACU2O8+DELTA; EVOLUTION; PSEUDOGAP; STATE; GAP	In the pseudogap state of the high-transition-temperature (high-T-c) copper oxide superconductors(1), angle-resolved photoemission (ARPES) measurements have seen Fermi arcs-that is, open-ended gapless sections in the large Fermi surface(2-8)-rather than a closed loop expected of an ordinary metal. This is all the more puzzling because Fermi pockets (small closed Fermi surface features) have been suggested by recent quantum oscillation measurements(9-14). The Fermi arcs cannot be understood in terms of existing theories, although there is a solution in the form of conventional Fermi surface pockets associated with competing order, but with a back side that is for detailed reasons invisible to photoemission probes(15). Here we report ARPES measurements of Bi2Sr2-xLaxCuO6+delta (La-Bi2201) that reveal Fermi pockets. The charge carriers in the pockets are holes, and the pockets show an unusual dependence on doping: they exist in underdoped but not overdoped samples. A surprise is that these Fermi pockets appear to coexist with the Fermi arcs. This coexistence has not been expected theoretically.	[Meng, Jianqiao; Liu, Guodong; Zhang, Wentao; Zhao, Lin; Liu, Haiyun; Jia, Xiaowen; Mu, Daixiang; Liu, Shanyu; Dong, Xiaoli; Zhang, Jun; Lu, Wei; Zhou, X. J.] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Natl Lab Superconduct, Beijing 100190, Peoples R China; [Wang, Guiling; Zhou, Yong; Zhu, Yong; Wang, Xiaoyang; Xu, Zuyan; Chen, Chuangtian] Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS	Zhou, XJ (corresponding author), Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Natl Lab Superconduct, Beijing 100190, Peoples R China.	XJZhou@aphy.iphy.ac.cn	Zhou, Yong/G-2314-2011; Mou, Daixiang/D-1752-2014; Lu, Wei/AAE-2921-2022; ZHANG, Wentao/B-3626-2011; Liu, Haiyun/AAE-8457-2020; Meng, Jianqiao/D-2667-2013; Meng, Jianqiao/W-1261-2018	Mou, Daixiang/0000-0002-1316-4384; Lu, Wei/0000-0002-4150-8674; ZHANG, Wentao/0000-0001-8904-1252; Liu, Haiyun/0000-0002-3584-4778; Meng, Jianqiao/0000-0003-3168-9819; Meng, Jianqiao/0000-0003-3168-9819; Dong, Xiaoli/0000-0002-6268-2049	NSFC; MOST of China; Chinese Academy of Sciences	NSFC(National Natural Science Foundation of China (NSFC)); MOST of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank D.-H. Lee, P. A. Lee, S. Sachdev, Z.-X. Shen, X. G. Wen, Z. Y. Weng, T. Xiang, G. M. Zhang and F. C. Zhang for discussions. This work was supported by the NSFC, the MOST of China and the Chinese Academy of Sciences.	AEBI P, 1994, PHYS REV LETT, V72, P2757, DOI 10.1103/PhysRevLett.72.2757; Bangura AF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047004; Chakravarty S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.100504; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Chakravarty S, 2008, P NATL ACAD SCI USA, V105, P8835, DOI 10.1073/pnas.0804002105; Chang J, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/10/103016; DING H, 1995, PHYS REV LETT, V74, P2784, DOI 10.1103/PhysRevLett.74.2784; Ding H, 1997, PHYS REV LETT, V78, P2628, DOI 10.1103/PhysRevLett.78.2628; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Hossain MA, 2008, NAT PHYS, V4, P527, DOI 10.1038/nphys998; Jaudet C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.187005; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Kaul RK, 2008, NAT PHYS, V4, P28, DOI 10.1038/nphys790; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; Lee WS, 2007, NATURE, V450, P81, DOI 10.1038/nature06219; Marshall DS, 1996, PHYS REV LETT, V76, P4841, DOI 10.1103/PhysRevLett.76.4841; Meng JQ, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/4/045010; Meng JQ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.024514; Nakayama K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.054505; Ng TK, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.172509; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; NORMAN MR, 1998, PHYS REV B, V57; Ono S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104512; OSTERWALDER J, 1995, APPL PHYS A-MATER, V60, P247; Sebastian SE, 2008, NATURE, V454, P200, DOI 10.1038/nature07095; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Yang HB, 2008, NATURE, V456, P77, DOI 10.1038/nature07400; Yang KY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174501; Yelland EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047003	32	188	194	4	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					335	338		10.1038/nature08521	http://dx.doi.org/10.1038/nature08521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924210	Green Submitted			2022-12-28	WOS:000271899300040
J	McAlister, FA				McAlister, Finlay A.			Review: Low BP targets do not reduce mortality or CV events in hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOOD-PRESSURE		Univ Alberta, Edmonton, AB, Canada	University of Alberta	McAlister, FA (corresponding author), Univ Alberta, Edmonton, AB, Canada.		McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341				Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turnbull F, 2003, LANCET, V362, P1527	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-6	10.7326/0003-4819-151-10-200911170-02006	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920264				2022-12-28	WOS:000272145100017
J	Ng, B				Ng, Bradley			Use of antipsychotic drugs was associated with increased risk for hyperglycemia in older patients with diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Robina Hosp, Gold Coast, Qld, Australia		Ng, B (corresponding author), Robina Hosp, Gold Coast, Qld, Australia.								0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-12	10.7326/0003-4819-151-10-200911170-02012	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920257				2022-12-28	WOS:000272145100023
J	Hartley, JL; Davenport, M; Kelly, DA				Hartley, Jane L.; Davenport, Mark; Kelly, Deirdre A.			Biliary atresia	LANCET			English	Review							ORTHOTOPIC LIVER-TRANSPLANTATION; REOVIRUS TYPE-3 INFECTION; SINGLE-CENTER EXPERIENCE; KASAI PORTOENTEROSTOMY; GROWTH-FACTOR; MATERNAL MICROCHIMERISM; DIFFERENTIAL-DIAGNOSIS; POLYSPLENIA SYNDROME; EPITHELIAL-CELLS; MURINE MODEL	Biliary atresia is a rare disease of infancy, which has changed within 30 years from being fatal to being a disorder for which effective palliative surgery or curative liver transplantation, or both, are available. Good outcomes for infants depend on early referral and timely Kasai portoenterostomy, and thus a high index of suspicion is needed for investigation of infants with persistent jaundice. In centres with much experience of treating this disorder, up to 60% of children will achieve biliary drainage after Kasai portoenterostomy and will have serum bilirubin within the normal range within 6 months. 80% of children who attain satisfactory biliary drainage will reach adolescence with a good quality of life without undergoing liver transplantation. Although much is known about management of biliary atresia, many aspects are poorly understood, including its pathogenesis. Several hypotheses exist, implicating genetic predisposition and dysregulation of immunity, but the cause is probably multifactorial, with obliterative extrahepatic cholangiopathy as the common endpoint. Researchers are focused on identification of relevant genetic and immune factors and understanding serum and hepatic factors that drive liver fibrosis after Kasai portoenterostomy. These factors might become therapeutic targets to halt the inevitable development of cirrhosis and need for liver transplantation.	[Hartley, Jane L.; Kelly, Deirdre A.] Birmingham Childrens Hosp NHS Trust, Liver Unit, Birmingham B4 6NH, W Midlands, England; [Hartley, Jane L.; Kelly, Deirdre A.] Univ Birmingham, Birmingham, W Midlands, England; [Davenport, Mark] Kings Coll Hosp London, Paediat Liver Ctr, London, England; [Davenport, Mark] Kings Coll London, Dept Paediat Surg, London WC2R 2LS, England	University of Birmingham; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Hartley, JL (corresponding author), Birmingham Childrens Hosp NHS Trust, Liver Unit, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England.	jane.hartley@bch.nhs.uk	Davenport, Mark/AAZ-5775-2020	Davenport, Mark/0000-0002-0938-2717	Medical Research Council; Newlife; Children's Liver Fund; Birmingham Children's Hospital Research Foundation; Children's Liver Disease Foundation; DAK; Astellas; Novartis; Roche; Wellcome Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newlife; Children's Liver Fund; Birmingham Children's Hospital Research Foundation; Children's Liver Disease Foundation; DAK; Astellas(Astellas Pharmaceuticals); Novartis(Novartis); Roche(Roche Holding); Wellcome Trust(Wellcome Trust)	JLH has received research funding from Medical Research Council, Newlife, Children's Liver Fund, and Birmingham Children's Hospital Research Foundation. MD has received research grants to investigate the cause, epidemiology, and treatment of biliary atresia from the Children's Liver Disease Foundation (1999-2008). DAK has received honoraria for provision of professional advice on development of immunosuppressive protocols for after liver transplantation; and educational and research grants to undertake clinical trials post-transplantation from Astellas, Novartis, and Roche; and research grants from the Wellcome Trust (2002-03) and the Children's Liver Disease Foundation (2006-08).	Allen SR, 2007, J VIROL, V81, P1671, DOI 10.1128/JVI.02094-06; Arikan C, 2006, J PEDIATR GASTR NUTR, V42, P77, DOI 10.1097/01.mpg.0000192247.55583.fa; Arikan C, 2008, DIGEST DIS SCI, V53, P2000, DOI 10.1007/s10620-007-9914-1; Azar G, 2002, J PEDIATR GASTR NUTR, V34, P212, DOI 10.1097/00005176-200202000-00020; Baker A, 2007, PEDIATR TRANSPLANT, V11, P825, DOI 10.1111/j.1399-3046.2007.00792.x; Barshes NR, 2005, LIVER TRANSPLANT, V11, P1193, DOI 10.1002/lt.20509; BEATH SV, 1993, ARCH DIS CHILD, V69, P545, DOI 10.1136/adc.69.5.545; *BIL ATR, 2004, EBAR; Caponcelli E, 2008, J PEDIATR SURG, V43, P1619, DOI 10.1016/j.jpedsurg.2007.12.058; Carvalho E, 2005, GASTROENTEROLOGY, V129, P713, DOI 10.1053/j.gastro.205.05.052; Chardot C, 1999, HEPATOLOGY, V30, P606, DOI 10.1002/hep.510300330; Chardot C, 1999, J HEPATOL, V31, P1006, DOI 10.1016/S0168-8278(99)80312-2; Chen CL, 2006, AM J TRANSPLANT, V6, P2672, DOI 10.1111/j.1600-6143.2006.01528.x; Cowles RA, 2008, J PEDIATR SURG, V43, P1605, DOI 10.1016/j.jpedsurg.2008.04.012; Davenport M, 2004, J PEDIATR SURG, V39, P575, DOI 10.1016/j.jpedsurg.2003.12.014; Davenport M, 2004, LANCET, V363, P1354, DOI 10.1016/S0140-6736(04)16045-5; Davenport M, 2001, J PEDIATR SURG, V36, P1017, DOI 10.1053/jpsu.2001.24730; Davenport M, 2008, ANN SURG, V247, P694, DOI 10.1097/SLA.0b013e3181638627; Davenport M, 2007, HEPATOLOGY, V46, P1821, DOI 10.1002/hep.21873; Davenport M, 2006, J PEDIATR-US, V149, P393, DOI 10.1016/j.jpeds.2006.05.030; Davit-Spraul A, 2008, J PEDIATR GASTR NUTR, V46, P111, DOI 10.1097/01.mpg.0000304465.60788.f4; Diem HVT, 2003, TRANSPLANTATION, V75, P1692, DOI 10.1097/01.TP.0000062570.83203.A3; Dillon PW, 2001, J PEDIATR SURG, V36, P80, DOI 10.1053/jpsu.2001.20013; Dutta S, 2007, J LAPAROENDOSC ADV S, V17, P258, DOI 10.1089/lap.2006.0112; Rendon-Macias ME, 2008, TURKISH J PEDIATR, V50, P253; Erickson N, 2008, HEPATOLOGY, V47, P1567, DOI 10.1002/hep.22229; Escobar MA, 2006, J PEDIATR SURG, V41, P99, DOI 10.1016/j.jpedsurg.2005.10.072; Esteves E, 2002, PEDIATR SURG INT, V18, P737, DOI 10.1007/s00383-002-0791-6; GAUTIER M, 1976, J PEDIATR-US, V89, P704, DOI 10.1016/S0022-3476(76)80787-1; Gilmour SM, 1997, J NUCL MED, V38, P1279; Gyorffy A, 2008, HEPATO-GASTROENTEROL, V55, P1189; Harada K, 2007, HEPATOLOGY, V46, P1146, DOI 10.1002/hep.21797; HARPER P, 1990, AUST VET J, V67, P18, DOI 10.1111/j.1751-0813.1990.tb07385.x; Hayashida M, 2007, J PEDIATR SURG, V42, P2097, DOI 10.1016/j.jpedsurg.2007.08.039; Hol L, 2008, EUR J GASTROEN HEPAT, V20, P227, DOI 10.1097/MEG.0b013e3282cfb716; Honsawek S, 2008, HEPATO-GASTROENTEROL, V55, P1184; Houben C, 2006, J PEDIATR SURG, V41, P1159, DOI 10.1016/j.jpedsurg.2006.01.066; HOUWEN RHJ, 1988, Z KINDERCHIR, V43, P68; Howard ER, 2001, J PEDIATR SURG, V36, P892, DOI 10.1053/jpsu.2001.23965; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; Hsieh CS, 2008, J PEDIATR SURG, V43, P1333, DOI 10.1016/j.jpedsurg.2007.09.007; Hsu HY, 2001, CLIN EXP IMMUNOL, V126, P84, DOI 10.1046/j.1365-2249.2001.01558.x; Huang L, 2008, EUR J PEDIATR SURG, V18, P224, DOI 10.1055/s-2008-1038483; Huang YH, 2008, J PEDIATR SURG, V43, P2016, DOI 10.1016/j.jpedsurg.2008.03.037; Humphrey TM, 2007, RADIOLOGY, V244, P845, DOI 10.1148/radiol.2443061051; Iida T, 2009, PEDIATR TRANSPLANT, V13, P1048, DOI 10.1111/j.1399-3046.2008.01094.x; Iinuma Y, 2000, J PEDIATR SURG, V35, P545, DOI 10.1053/jpsu.2000.0350545; Kelly D. A., 2003, Nutrition in pediatrics: basic science and clinical applications, P686; Kobayashi K, 2008, J PEDIATR SURG, V43, P1566, DOI 10.1016/j.jpedsurg.2008.03.051; Kuebler JF, 2006, PEDIATR RES, V59, P790, DOI 10.1203/01.pdr.0000219860.96732.09; KULKARNI PB, 1977, AM J DIS CHILD, V131, P442, DOI 10.1001/archpedi.1977.02120170068013; Kuroda T, 2005, J PEDIATR SURG, V40, P1852, DOI 10.1016/j.jpedsurg.2005.08.026; Larrosa-Haro A, 2001, J PEDIATR GASTR NUTR, V32, P311, DOI 10.1097/00005176-200103000-00015; Lykavieris P, 2005, HEPATOLOGY, V41, P366, DOI 10.1002/hep.20547; Mack CL, 2007, GASTROENTEROLOGY, V133, P278, DOI 10.1053/j.gastro.2007.04.032; McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3; MINER PB, 1980, GASTROENTEROLOGY, V79, P212; MORECKI R, 1982, NEW ENGL J MED, V307, P481, DOI 10.1056/NEJM198208193070806; Muraji T, 2008, PEDIATRICS, V121, P517, DOI 10.1542/peds.2007-0568; Mushtaq I, 1999, BRIT MED J, V319, P471, DOI 10.1136/bmj.319.7208.471; Narayanaswamy B, 2007, HEPATOLOGY, V46, P180, DOI 10.1002/hep.21701; Petersen C, 2005, ACTA PAEDIATR, V94, P526, DOI 10.1080/08035250410023845; Phavichitr N, 2008, ASIAN PAC J ALLERGY, V26, P57; Powell JE, 2003, J MED SCREEN, V10, P112, DOI 10.1258/096914103769010996; Rauschenfels S, 2009, EUR J PEDIATR, V168, P469, DOI 10.1007/s00431-008-0774-2; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; ROBERTS EA, 2008, DIS LIVER BILIARY SY, P57; Roquete MLV, 2008, J PEDIAT-BRAZIL, V84, P331, DOI [10.2223/JPED.1811, 10.1590/S0021-75572008000400008]; Saito T, 2004, J HEPATOL, V40, P203, DOI 10.1016/j.jhep.2003.10.025; Serinet MO, 2006, HEPATOLOGY, V44, P75, DOI 10.1002/hep.21219; SHEARER MJ, BLOOD REV, V23, P49; Shen C, 2008, WORLD J PEDIATR, V4, P123, DOI 10.1007/s12519-008-0024-8; Shih HH, 2005, PEDIATRICS, V116, P437, DOI 10.1542/peds.2004-1900; Shimadera S, 2007, J PEDIATR SURG, V42, P1555, DOI 10.1016/j.jpedsurg.2007.04.018; Shinkai M, 2006, J PEDIATR SURG, V41, P950, DOI 10.1016/j.jpedsurg.2006.01.060; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; SILVEIRA TR, 1991, BRAZ J MED BIOL RES, V24, P67; SMITH BM, 1991, J PEDIATR SURG, V26, P1331, DOI 10.1016/0022-3468(91)90613-X; Sokol RJ, 2003, J PEDIATR GASTR NUTR, V36, P1, DOI 10.1097/00005176-200301000-00001; Szavay PO, 2002, EUR J PEDIATR SURG, V12, P248, DOI 10.1055/s-2002-34477; Takaya J, 2007, EUR J PEDIATR, V166, P211, DOI 10.1007/s00431-006-0230-0; TAN CEL, 1994, J PEDIATR SURG, V29, P1459, DOI 10.1016/0022-3468(94)90144-9; Tatekawa Y, 2001, J PEDIATR SURG, V36, P436, DOI 10.1053/jpsu.2001.21600; The NS, 2007, AM J MED GENET A, V143A, P2274, DOI 10.1002/ajmg.a.31926; Toyoki Y, 2008, TRANSPL P, V40, P2494, DOI 10.1016/j.transproceed.2008.08.043; Utterson EC, 2005, J PEDIATR-US, V147, P180, DOI 10.1016/j.jpeds.2005.04.073; van Mourik IDM, 2000, J PEDIATR GASTR NUTR, V30, P269, DOI 10.1097/00005176-200003000-00011; Varela-Fascinetto G, 1998, ANN SURG, V227, P583, DOI 10.1097/00000658-199804000-00022; Vejchapipat P, 2008, EUR J PEDIATR SURG, V18, P415, DOI 10.1055/s-2008-1038950; Wada H, 2007, J PEDIATR SURG, V42, P2090, DOI 10.1016/j.jpedsurg.2007.08.035; Wu ET, 2001, PEDIATR SURG INT, V17, P390; YANG H, 2008, STEROIDS SHOULD BE A; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; Yoon PW, 1997, PEDIATRICS, V99, P376, DOI 10.1542/peds.99.3.376	94	551	620	6	86	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 14	2009	374	9702					1704	1713		10.1016/S0140-6736(09)60946-6	http://dx.doi.org/10.1016/S0140-6736(09)60946-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522LP	19914515				2022-12-28	WOS:000271999700027
J	Alarcon, C; Zaromytidou, AI; Xi, QR; Gao, S; Yu, JZ; Fujisawa, S; Barlas, A; Miller, AN; Manova-Todorova, K; Macias, MJ; Sapkota, G; Pan, DJ; Massague, J				Alarcon, Claudio; Zaromytidou, Alexia-Ileana; Xi, Qiaoran; Gao, Sheng; Yu, Jianzhong; Fujisawa, Sho; Barlas, Afsar; Miller, Alexandria N.; Manova-Todorova, Katia; Macias, Maria J.; Sapkota, Gopal; Pan, Duojia; Massague, Joan			Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-beta Pathways	CELL			English	Article							CELL CONTACT INHIBITION; RNA-POLYMERASE-II; IN-VITRO; SIGNALING PATHWAYS; TERMINAL DOMAIN; HIPPO PATHWAY; SIZE-CONTROL; DROSOPHILA; GROWTH; PROLIFERATION	TGF-beta and BMP receptor kinases activate Smad transcription factors by C-terminal phosphorylation. We have identified a subsequent agonist-induced phosphorylation that plays a central dual role in Smad transcriptional activation and turnover. As receptor-activated Smads form transcriptional complexes, they are phosphorylated at an interdomain linker region by CDK8 and CDK9, which are components of transcriptional mediator and elongation complexes. These phosphorylations promote Smad transcriptional action, which in the case of Smad1 is mediated by the recruitment of YAP to the phosphorylated linker sites. An effector of the highly conserved Hippo organ size control pathway, YAP supports Smad1-dependent transcription and is required for BMP suppression of neural differentiation of mouse embryonic stem cells. The phosphorylated linker is ultimately recognized by specific ubiquitin ligases, leading to proteasome-mediated turnover of activated Smad proteins. Thus, nuclear CDK8/9 drive a cycle of Smad utilization and disposal that is an integral part of canonical BMP and TGF-beta pathways.	[Pan, Duojia; Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Alarcon, Claudio; Zaromytidou, Alexia-Ileana; Xi, Qiaoran; Gao, Sheng; Miller, Alexandria N.; Sapkota, Gopal; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Fujisawa, Sho; Barlas, Afsar; Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; [Macias, Maria J.] Inst Biomed Res, Struct & Computat Biol Programme, Barcelona 08028, Spain; [Yu, Jianzhong; Pan, Duojia] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Johns Hopkins University	Massague, J (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	massaguj@mskcc.org	Sapkota, Gopal/C-7300-2014; Macias, Maria J/K-3898-2014; Yu, Jianzhong/F-6050-2010	Sapkota, Gopal/0000-0001-9931-3338; Macias, Maria J/0000-0002-6915-963X; Massague, Joan/0000-0001-9324-8408; Miller, Alexandria N./0000-0003-3986-7923	NIH [CA34610, EY015708, BFU2008-02795]; NATIONAL CANCER INSTITUTE [R37CA034610, P30CA008748, R01CA034610] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Yaffe, R. P. Fisher, and F. Liu for reagents; S. Malik, S. Tavazoie, D. Nguyen, S. Keeney, and R. Benezra for helpful discussions; X.H.-F. Zhang for valuable help with microarray analysis; E. Lai for providing the S2 Cells; and M. Squatrito, M. Tavazoie, E. Montalvo, P.Y. Chen, and N. Fan for technical support. This work was supported by NIH grants CA34610 (J. M.), EY015708 (D. P.), and BFU2008-02795 (M. J. M.). J. M. and D. P. are investigators of the Howard Hughes Medical Institute.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Blain SW, 2000, J BIOL CHEM, V275, P32066, DOI 10.1074/jbc.M006496200; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Durand LO, 2005, J VIROL, V79, P6757, DOI 10.1128/JVI.79.11.6757-6762.2005; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Omura-Minamisawa M, 2000, CANCER RES, V60, P6573; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; PAN D, 2007, GENE DEV, V17, P3023; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shapiro GI, 2004, CLIN CANCER RES, V10, p4270S, DOI 10.1158/1078-0432.CCR-040020; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	58	533	550	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					757	769		10.1016/j.cell.2009.09.035	http://dx.doi.org/10.1016/j.cell.2009.09.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914168	Green Accepted, Bronze			2022-12-28	WOS:000271747200019
J	Genander, M; Halford, MM; Xu, NJ; Eriksson, M; Yu, ZR; Qiu, ZZ; Martling, A; Greicius, G; Thakar, S; Catchpole, T; Chumley, MJ; Zdunek, S; Wang, CG; Holm, T; Goff, SP; Pettersson, S; Pestell, RG; Henkemeyer, M; Frisen, J				Genander, Maria; Halford, Michael M.; Xu, Nan-Jie; Eriksson, Malin; Yu, Zuoren; Qiu, Zhaozhu; Martling, Anna; Greicius, Gedas; Thakar, Sonal; Catchpole, Timothy; Chumley, Michael J.; Zdunek, Sofia; Wang, Chenguang; Holm, Torbjorn; Goff, Stephen P.; Pettersson, Sven; Pestell, Richard G.; Henkemeyer, Mark; Frisen, Jonas			Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor Suppression	CELL			English	Article							COLORECTAL-CANCER PROGRESSION; RECEPTOR TYROSINE KINASE; CENTRAL-NERVOUS-SYSTEM; CYCLIN D1; BETA-CATENIN; PHOSPHATIDYLINOSITOL-3 KINASE; ADULT NEUROGENESIS; IN-VIVO; MIGRATION; EXPRESSION	Signaling proteins driving the proliferation of stem and progenitor cells are often encoded by protooncogenes. EphB receptors represent a rare exception; they promote cell proliferation in the intestinal epithelium and function as tumor suppressors by controlling cell migration and inhibiting invasive growth. We show that cell migration and proliferation are controlled independently by the receptor EphB2. EphB2 regulated cell positioning is kinase-independent and mediated via phosphatidylinositol 3-kinase, whereas EphB2 tyrosine kinase activity regulates cell proliferation through an Abl-cyclin D1 pathway. Cyclin D1 regulation becomes uncoupled from EphB signaling during the progression from adenoma to colon carcinoma in humans, allowing continued proliferation with invasive growth. The dissociation of EphB2 signaling pathways enables the selective inhibition of the mitogenic effect without affecting the tumor suppressor function and identifies a pharmacological strategy to suppress adenoma growth.	[Genander, Maria; Eriksson, Malin; Zdunek, Sofia; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Halford, Michael M.; Xu, Nan-Jie; Thakar, Sonal; Catchpole, Timothy; Chumley, Michael J.; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Yu, Zuoren; Wang, Chenguang; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Qiu, Zhaozhu; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Martling, Anna; Holm, Torbjorn] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Greicius, Gedas; Pettersson, Sven] Natl Canc Ctr Singapore, Dept Cellular & Mol Res, Lab Inflammat Biol, Singapore 169612, Singapore; [Greicius, Gedas; Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; University of Texas System; University of Texas Southwestern Medical Center Dallas; Jefferson University; Columbia University; Howard Hughes Medical Institute; Karolinska Institutet; Karolinska University Hospital; National Cancer Centre Singapore (NCCS); Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	XU, Nan-Jie/AAJ-4363-2020; Pettersson, Sven/F-9511-2015; Xu, Nan-Jie/N-3391-2016; Qiu, Zhaozhu/F-4171-2010; Goff, Stephen P/K-6337-2014; Yu, Zuoren/G-5684-2010	XU, Nan-Jie/0000-0003-2147-3352; Xu, Nan-Jie/0000-0003-2147-3352; Goff, Stephen P/0000-0003-0693-5547; Henkemeyer, Mark/0000-0002-7525-1061; Genander, Maria/0000-0002-2428-8040; Martling, Anna/0000-0001-5998-4735; Greicius, Gediminas/0000-0001-8333-787X	NIH [R01CA70896, R01CA75503, R01CA86072, 2R01 MH66332]; Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Swedish Cancer Society; Swedish Research Council; Knut och Alice Wallenbergs Stiftelse; Karolinska Institute; Tobias Foundation; NIH Cancer Center [P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA070896, R01CA086072, R01CA075503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Karolinska Institute(Karolinska Institutet); Tobias Foundation; NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank F. Granath, J. Holmberg, L. Huminiecki, J. Lindholm, A. Simon, and members of the Frisen lab for valuable discussions, M.-L. Spangberg and M. Toro for technical assistance, and Novartis for providing Gleevec and AEW-541. This study was supported by grants from the NIH (R01CA70896, R01CA75503, and R01CA86072 to R. G. P. and 2R01 MH66332 to M. H.), the Dr. Ralph and Marian C. Falk Medical Research Trust, the Pennsylvania Department of Health (which specifically disclaims responsibility for analyses, interpretations, or conclusions) (R. G. P.), the Swedish Cancer Society, the Swedish Research Council, Knut och Alice Wallenbergs Stiftelse, the Karolinska Institute, and the Tobias Foundation (J. F.). The Kimmel Cancer Center was supported by the NIH Cancer Center Core grant P30CA56036 (R. G. P).	Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davalos V, 2006, CANCER RES, V66, P8943, DOI 10.1158/0008-5472.CAN-05-4640; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Donovan EA, 2008, CRIT REV ONCOL HEMAT, V66, P91, DOI 10.1016/j.critrevonc.2007.09.003; Dufour A, 2006, DEVELOPMENT, V133, P4415, DOI 10.1242/dev.02623; Gu C, 2001, MOL CELL BIOL, V21, P4579, DOI 10.1128/MCB.21.14.4579-4597.2001; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Harbott LK, 2005, MOL CELL NEUROSCI, V30, P1, DOI 10.1016/j.mcn.2005.05.002; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Lynch PM, 2007, DIGESTION, V76, P68, DOI 10.1159/000108395; Maekawa H, 2003, ARTERIOSCL THROM VAS, V23, P2008, DOI 10.1161/01.ATV.0000096655.56262.56; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869	38	131	136	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					679	692		10.1016/j.cell.2009.08.048	http://dx.doi.org/10.1016/j.cell.2009.08.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914164	Bronze, Green Accepted			2022-12-28	WOS:000271747200013
J	Kesavan, G; Sand, FW; Greiner, TU; Johansson, JK; Kobberup, S; Wu, XW; Brakebusch, C; Semb, H				Kesavan, Gokul; Sand, Fredrik Wolfhagen; Greiner, Thomas Uwe; Johansson, Jenny Kristina; Kobberup, Sune; Wu, Xunwei; Brakebusch, Cord; Semb, Henrik			Cdc42-Mediated Tubulogenesis Controls Cell Specification	CELL			English	Article							EPITHELIAL POLARITY; CDC42; LINEAGE; MORPHOGENESIS; EXPRESSION; COMPLEX; PAR-3; PKC	Understanding how cells polarize and coordinate tubulogenesis during organ formation is a central question in biology. Tubulogenesis often coincides with cell-lineage specification during organ development. Hence, an elementary question is whether these two processes are independently controlled, or whether proper cell specification depends on formation of tubes. To address these fundamental questions, we have studied the functional role of Cdc42 in pancreatic tubulogenesis. We present evidence that Cdc42 is essential for tube formation, specifically for initiating microlumen formation and later for maintaining apical cell polarity. Finally, we show that Cdc42 controls cell specification non-cell-autonomously by providing the correct microenvironment for proper control of cell-fate choices of multipotent progenitors. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Kesavan, Gokul; Sand, Fredrik Wolfhagen; Greiner, Thomas Uwe; Johansson, Jenny Kristina; Kobberup, Sune; Semb, Henrik] Lund Univ, BMC, Stem Cell Ctr, SE-22184 Lund, Sweden; [Wu, Xunwei; Brakebusch, Cord] Univ Copenhagen, BRIC, Inst Biomed, DK-2100 Copenhagen, Denmark	Lund University; University of Copenhagen	Semb, H (corresponding author), Lund Univ, BMC, Stem Cell Ctr, SE-22184 Lund, Sweden.	henrik.semb@med.lu.se	Wu, Xunwei/J-9014-2018	Wu, Xunwei/0000-0002-0822-1700; Semb, Henrik/0000-0002-6747-787X; Kesavan, Gokul/0000-0002-2828-1460; Brakebusch, Cord/0000-0002-9342-1634	Swedish Research Council; Stem Cell Center Lund University; Swedish Foundation for Strategic Research; NIH Beta Cell Biology Consortium	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stem Cell Center Lund University; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NIH Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Durbeej, B. Margolis, S. Ohno, C. Wright, and the Beta Cell Biology Consortium for providing antibodies; G. Gu and P. Serup for providing Cre lines; I. Artner, P. Nyeng, and Y. Fischer for comments on the manuscript; V. F. Gregoire for quantifying mitotic index; J. Ameri for QPCR; M. Magnusson and C. Ekenstierna for mouse breeding; U. Hacker for helpful discussions; and R. Wallen for the TEM analysis. This work was supported by the Swedish Research Council, Stem Cell Center Lund University, Swedish Foundation for Strategic Research, and NIH Beta Cell Biology Consortium.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887; Crisera CA, 2000, DIABETES, V49, P936, DOI 10.2337/diabetes.49.6.936; Duvillie B, 2006, DIABETES, V55, P582, DOI 10.2337/diabetes.55.03.06.db05-0839; Edsbagge J, 2005, DEVELOPMENT, V132, P1085, DOI 10.1242/dev.01643; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gittes GK, 1996, DEVELOPMENT, V122, P439; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Li ZX, 2004, DEV BIOL, V269, P252, DOI 10.1016/j.ydbio.2004.01.043; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Percival AC, 1999, EXP CELL RES, V247, P123, DOI 10.1006/excr.1998.4322; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOROKIN LM, 1992, EXP CELL RES, V201, P137, DOI 10.1016/0014-4827(92)90357-E; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	35	183	183	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					791	801		10.1016/j.cell.2009.08.049	http://dx.doi.org/10.1016/j.cell.2009.08.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914171	Bronze, Green Submitted			2022-12-28	WOS:000271747200022
J	Connolly, JAD; Schmidt, MW; Solferino, G; Bagdassarov, N				Connolly, James A. D.; Schmidt, Max W.; Solferino, Giulio; Bagdassarov, Nikolai			Permeability of asthenospheric mantle and melt extraction rates at mid-ocean ridges	NATURE			English	Article							OCEANIC UPPER-MANTLE; UPWELLING MANTLE; BENEATH; DISEQUILIBRIA; GENERATION; TRANSPORT; FLOW; CONSEQUENCES; CONSTRAINTS; COMPACTION	Magmatic production on Earth is dominated by asthenospheric melts of basaltic composition that have mostly erupted at mid-ocean ridges. The timescale for segregation and transport of these melts, which are ultimately responsible for formation of the Earth's crust, is critically dependent on the permeability of the partly molten asthenospheric mantle, yet this permeability is known mainly from semi-empirical and analogue models(1-6). Here we use a high-pressure, high-temperature centrifuge, at accelerations of 400g-700g, to measure the rate of basalt melt flow in olivine aggregates with porosities of 5-12 per cent. The resulting permeabilities are consistent with a microscopic model in which melt is completely connected, and are one to two orders of magnitude larger than predicted by current parameterizations(4,7). Extrapolation of the measurements to conditions characteristic(8) of asthenosphere below mid-ocean ridges yields proportionally higher transport speeds. Application of these results in a model(9) of porous-media channelling instabilities(10) yields melt transport times of similar to 1-2.5 kyr across the entire asthenosphere, which is sufficient to preserve the observed Th-230 excess of mid-ocean-ridge basalts and the mantle signatures of even shorter-lived isotopes such as Ra-226 (refs 5,11-14).	[Connolly, James A. D.; Schmidt, Max W.; Solferino, Giulio] ETH, Inst Mineral & Petr, CH-8092 Zurich, Switzerland; [Bagdassarov, Nikolai] Goethe Univ Frankfurt, Inst Geowissensch, D-60438 Frankfurt, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Goethe University Frankfurt	Schmidt, MW (corresponding author), ETH, Inst Mineral & Petr, CH-8092 Zurich, Switzerland.	max.schmidt@erdw.ethz.ch	Schmidt, Max/A-1676-2008; Solferino, Giulio/ABA-8343-2020; connolly, james a d/A-7931-2013	Solferino, Giulio/0000-0002-3172-500X; connolly, james a d/0000-0001-5060-4281; Bagdassarov, Nikolai/0000-0003-0674-3078; Schmidt, Max W./0000-0002-3870-5781	ETH [TH 20/03-2]; SNF [200020-111725-1]	ETH(ETH Zurich); SNF	Discussion with G. Hirth improved this work, which was supported by ETH grant TH 20/03-2 and by SNF grant 200020-111725-1.	BOTTINGA Y, 1972, AM J SCI, V272, P438, DOI 10.2475/ajs.272.5.438; Bouilhol P, 2009, LITHOS, V107, P17, DOI 10.1016/j.lithos.2008.07.004; Cheadle MJ, 2004, GEOLOGY, V32, P757, DOI 10.1130/G20495.1; Connolly JAD, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004213; Connolly JAD, 1997, GEOLOGY, V25, P591, DOI 10.1130/0091-7613(1997)025<0591:RIMAEI>2.3.CO;2; Connolly JAD, 2000, TECTONOPHYSICS, V324, P137, DOI 10.1016/S0040-1951(00)00084-6; DAINES MJ, 1994, GEOPHYS RES LETT, V21, P145, DOI 10.1029/93GL03052; DIENES JK, 1982, ISSUES ROCK MECHANIC, P86; Faul UH, 2001, NATURE, V410, P920, DOI 10.1038/35073556; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; Holtzman BK, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000258; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; Kelemen PB, 1997, PHILOS T R SOC A, V355, P283, DOI 10.1098/rsta.1997.0010; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; Lundstrom CC, 2003, REV MINERAL GEOCHEM, V52, P175, DOI 10.2113/0520175; MAALOE S, 1982, CONTRIB MINERAL PETR, V81, P350, DOI 10.1007/BF00371689; MCKENZIE D, 1984, J PETROL, V25, P713, DOI 10.1093/petrology/25.3.713; McKenzie D, 2000, CHEM GEOL, V162, P81, DOI 10.1016/S0009-2541(99)00126-6; MERCIER JCC, 1980, J GEOPHYS RES, V85, P6293, DOI 10.1029/JB085iB11p06293; Renner J, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000369; RICHARDSON C, 1994, EARTH PLANET SC LETT, V128, P425, DOI 10.1016/0012-821X(94)90160-0; Rubin KH, 2005, NATURE, V437, P534, DOI 10.1038/nature03993; Salters VJM, 1999, EARTH PLANET SC LETT, V166, P15, DOI 10.1016/S0012-821X(98)00271-4; Schmidt MW, 2006, SCIENCE, V312, P1646, DOI 10.1126/science.1126690; SOBOLEV AV, 1993, NATURE, V363, P151, DOI 10.1038/363151a0; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3; SPIEGELMAN M, 1987, EARTH PLANET SC LETT, V83, P137, DOI 10.1016/0012-821X(87)90057-4; Spiegelman M, 2001, J GEOPHYS RES-SOL EA, V106, P2061, DOI 10.1029/2000JB900240; Stracke A, 2006, EARTH PLANET SC LETT, V244, P97, DOI 10.1016/j.epsl.2006.01.057; Van Orman JA, 2006, GEOCHIM COSMOCHIM AC, V70, P4797, DOI 10.1016/j.gca.2006.07.005; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; Wark DA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001575; WILKINSON DS, 1975, ACTA METALL MATER, V23, P1277, DOI 10.1016/0001-6160(75)90136-4	35	77	79	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					209	U83		10.1038/nature08517	http://dx.doi.org/10.1038/nature08517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907492				2022-12-28	WOS:000271655100041
J	Pusey, J				Pusey, James			Global Darwin: Revolutionary road	NATURE			English	Editorial Material									Bucknell Univ, Lewisburg, PA 17837 USA	Bucknell University	Pusey, J (corresponding author), Bucknell Univ, 701 Moore Ave, Lewisburg, PA 17837 USA.	pusey@bucknell.edu							0	7	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 12	2009	462	7270					162	163		10.1038/462162a	http://dx.doi.org/10.1038/462162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	517YM	19907478				2022-12-28	WOS:000271655100023
J	Knipscheer, P; Raschle, M; Smogorzewska, A; Enoiu, M; Ho, TV; Scharer, OD; Elledge, SJ; Walter, JC				Knipscheer, Puck; Raeschle, Markus; Smogorzewska, Agata; Enoiu, Milica; Ho, The Vinh; Schaerer, Orlando D.; Elledge, Stephen J.; Walter, Johannes C.			The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							MONOUBIQUITINATED FANCD2; S-PHASE; PROTEINS	Fanconi anemia is a human cancer predisposition syndrome caused by mutations in 13 Fanc genes. The disorder is characterized by genomic instability and cellular hypersensitivity to chemicals that generate DNA interstrand cross-links (ICLs). A central event in the activation of the Fanconi anemia pathway is the mono-ubiquitylation of the FANCI-FANCD2 complex, but how this complex confers ICL resistance remains enigmatic. Using a cell-free system, we showed that FANCI-FANCD2 is required for replication-coupled ICL repair in S phase. Removal of FANCD2 from extracts inhibits both nucleolytic incisions near the ICL and translesion DNA synthesis past the lesion. Reversal of these defects requires ubiquitylated FANCI-FANCD2. Our results show that multiple steps of the essential S-phase ICL repair mechanism fail when the Fanconi anemia pathway is compromised.	[Knipscheer, Puck; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Raeschle, Markus] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Smogorzewska, Agata; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Smogorzewska, Agata] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Enoiu, Milica; Schaerer, Orlando D.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Ho, The Vinh; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Ho, The Vinh; Schaerer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Scharer, Orlando/B-8908-2008; Schärer, Orlando D./AAF-8613-2021; Smogorzewska, Agata/B-8891-2011	Scharer, Orlando/0000-0003-2425-2715; Smogorzewska, Agata/0000-0001-6285-1562; Walter, Johannes/0000-0002-4186-7570	NIH [GM62267]; Leukemia and Lymphoma Society [1406-07]; New York State of Science, Technology and Academic Research (NYSTAR) [C040069]; Swiss Cancer League [OCS-01413-08-2003]; Dutch Cancer Society [T32CA09216]; Burroughs Wellcome Fund; Max Planck Institute; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM062267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); New York State of Science, Technology and Academic Research (NYSTAR); Swiss Cancer League; Dutch Cancer Society(KWF Kankerbestrijding); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Max Planck Institute(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM62267 and Leukemia and Lymphoma Society Award 1406-07 to J. C. W.; New York State of Science, Technology and Academic Research (NYSTAR) Faculty Development Award C040069 and Swiss Cancer League grant OCS-01413-08-2003 to O. D. S.; and a Dutch Cancer Society fellowship to P. K. A. S. was supported by T32CA09216 to the Pathology Department at the Massachusetts General Hospital and by the Burroughs Wellcome Fund. S. J. E. is an investigator of the Howard Hughes Medical Institute. We thank M. Hoatlin for the Xenopus FANCD2 cDNA, K. Cimprich for phospho-Rad1 antibody, and the Walter laboratory for feedback. M. R. thanks S. Jentsch and the Max Planck Institute for generous support. The Xenopus FANCI cDNA sequence was deposited to the National Center for Biotechnology Information, NIH, database (accession no. GU144566).	Akkari YMN, 2001, MOL GENET METAB, V74, P403, DOI 10.1006/mgme.2001.3259; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Klein HL, 2009, CELL, V138, P20, DOI 10.1016/j.cell.2009.06.039; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004	17	384	392	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1698	1701		10.1126/science.1182372	http://dx.doi.org/10.1126/science.1182372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19965384	Green Accepted			2022-12-28	WOS:000272839000054
J	Anker, SD; Colet, JC; Filippatos, G; Willenheimer, R; Dickstein, K; Drexler, H; Luscher, TF; Bart, B; Banasiak, W; Niegowska, J; Kirwan, B; Mori, C; Rothe, BV; Pocock, SJ; Poole-Wilson, PA; Ponikowski, P				Anker, Stefan D.; Comin Colet, Josep; Filippatos, Gerasimos; Willenheimer, Ronnie; Dickstein, Kenneth; Drexler, Helmut; Luescher, Thomas F.; Bart, Boris; Banasiak, Waldemar; Niegowska, Joanna; Kirwan, Bridget-Anne; Mori, Claudio; Rothe, Barbara von Eisenhart; Pocock, Stuart J.; Poole-Wilson, Philip A.; Ponikowski, Piotr		FAIR-HF Trial Investigators	Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS IRON; WORK CAPACITY; HEALTH-STATUS; TASK-FORCE; ANEMIA; DIAGNOSIS; EXERCISE; ERYTHROPOIETIN; COLLABORATION; ASSOCIATION	Background: Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had heart failure, reduced left ventricular ejection fraction, and iron deficiency, either with or without anemia. Methods: We enrolled 459 patients with chronic heart failure of New York Heart Association (NYHA) functional class II or III, a left ventricular ejection fraction of 40% or less (for patients with NYHA class II) or 45% or less (for NYHA class III), iron deficiency (ferritin level <100 microg per liter or between 100 and 299 microg per liter, if the transferrin saturation was <20%), and a hemoglobin level of 95 to 135 g per liter. Patients were randomly assigned, in a 2:1 ratio, to receive 200 mg of intravenous iron (ferric carboxymaltose) or saline (placebo). The primary end points were the self-reported Patient Global Assessment and NYHA functional class, both at week 24. Secondary end points included the distance walked in 6 minutes and the health-related quality of life. Results: Among the patients receiving ferric carboxymaltose, 50% reported being much or moderately improved, as compared with 28% of patients receiving placebo, according to the Patient Global Assessment (odds ratio for improvement, 2.51; 95% confidence interval [CI], 1.75 to 3.61). Among the patients assigned to ferric carboxymaltose, 47% had an NYHA functional class I or II at week 24, as compared with 30% of patients assigned to placebo (odds ratio for improvement by one class, 2.40; 95% CI, 1.55 to 3.71). Results were similar in patients with anemia and those without anemia. Significant improvements were seen with ferric carboxymaltose in the distance on the 6-minute walk test and quality-of-life assessments. The rates of death, adverse events, and serious adverse events were similar in the two study groups. Conclusions: Treatment with intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency, with or without anemia, improves symptoms, functional capacity, and quality of life; the side-effect profile is acceptable. (ClinicalTrials.gov number, NCT00520780.) N Engl J Med 2009;361:2436-48.	[Anker, Stefan D.] Charite, Campus Virchow Klinikum, Dept Cardiol, D-13353 Berlin, Germany; [Anker, Stefan D.] Ctr Clin & Basic Res, Rome, Italy; [Comin Colet, Josep] Hosp del Mar, Barcelona, Spain; [Comin Colet, Josep] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Filippatos, Gerasimos] Univ Athens, Hosp Attikon, GR-10679 Athens, Greece; [Willenheimer, Ronnie] Heart Hlth Grp, Malmo, Sweden; [Willenheimer, Ronnie] Lund Univ, Malmo, Sweden; [Dickstein, Kenneth] Stavanger Univ Hosp, Stavanger, Norway; [Dickstein, Kenneth] Univ Bergen, Bergen, Norway; [Drexler, Helmut] Hannover Med Sch, D-30623 Hannover, Germany; [Luescher, Thomas F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Kirwan, Bridget-Anne] SOCAR Res, Nyon, Switzerland; [Mori, Claudio; Rothe, Barbara von Eisenhart] Vifor Pharma, Glattbrugg, Switzerland; [Bart, Boris] Russian State Med Univ, Outpatient Diagnost Consulting Ctr 1, Moscow 117437, Russia; [Banasiak, Waldemar; Ponikowski, Piotr] Mil Hosp, Wroclaw, Poland; [Niegowska, Joanna] Sp zOO, Telmont Ctr Med, Ctr Med, Warsaw, Poland; [Ponikowski, Piotr] Med Univ, Wroclaw, Poland; [Pocock, Stuart J.] London Sch Hyg & Trop Med, London, England; [Poole-Wilson, Philip A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center Clinical & Basic Research; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; National & Kapodistrian University of Athens; University Hospital Attikon; Lund University; Stavanger University Hospital; University of Bergen; Hannover Medical School; University of Zurich; University Zurich Hospital; Vifor Pharma; Pirogov Russian National Research Medical University; Wroclaw Medical University; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Anker, SD (corresponding author), Charite, Campus Virchow Klinikum, Dept Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany.	s.anker@cachexia.de	Ponikowski, Piotr/O-6454-2015; González-Costello, José/AAX-8465-2021; Boldueva, Svetlana/AAH-3862-2019; Comin-Colet, Josep/AAM-3000-2021; Filippatos, Gerasimos/ABA-4656-2021; Nedogoda, Sergey V/O-4656-2014; Girelli, Domenico/B-1183-2008; Bragina, Anna E/E-4581-2017; Mareev, Vyacheslav Yurievich/Q-1375-2017	Ponikowski, Piotr/0000-0002-3391-7064; González-Costello, José/0000-0002-7437-3630; Boldueva, Svetlana/0000-0002-1898-084X; Comin-Colet, Josep/0000-0001-8780-720X; Nedogoda, Sergey V/0000-0001-5981-1754; Girelli, Domenico/0000-0001-9684-1899; Bragina, Anna E/0000-0002-2699-1610; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; Kirwan, Bridget-Anne/0000-0002-3814-3598	Vifor Pharma	Vifor Pharma	Sponsored by Vifor Pharma.	Anker SD, 2009, EUR J HEART FAIL, V11, P1084, DOI 10.1093/eurjhf/hfp140; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AP, 2006, J AM COLL CARDIOL, V48, P1225, DOI 10.1016/j.jacc.2006.07.015; Clark AL, 1996, J AM COLL CARDIOL, V28, P1092, DOI 10.1016/S0735-1097(96)00323-3; DAVIES KJA, 1982, AM J PHYSIOL, V242, pE418, DOI 10.1152/ajpendo.1982.242.6.E418; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Fairbanks V, 2001, WILLIAMS HEMATOLOGY; GANZONI AM, 1970, SCHWEIZ MED WSCHR, V100, P301; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; MASSIE BM, 1988, CIRCULATION, V78, P320, DOI 10.1161/01.CIR.78.2.320; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Nanas JN, 2006, J AM COLL CARDIOL, V48, P2485, DOI 10.1016/j.jacc.2006.08.034; Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036; Opasich C, 2005, EUR HEART J, V26, P2232, DOI 10.1093/eurheartj/ehi388; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Satija P, 2008, CNS DRUGS, V22, P497, DOI 10.2165/00023210-200822060-00004; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; Usmanov RI, 2008, J NEPHROL, V21, P236	25	1203	1251	0	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2436	2448		10.1056/NEJMoa0908355	http://dx.doi.org/10.1056/NEJMoa0908355			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	19920054	Green Published, Green Accepted			2022-12-28	WOS:000272798900008
J	Dang, L; White, DW; Gross, S; Bennett, BD; Bittinger, MA; Driggers, EM; Fantin, VR; Jang, HG; Jin, S; Keenan, MC; Marks, KM; Prins, RM; Ward, PS; Yen, KE; Liau, LM; Rabinowitz, JD; Cantley, LC; Thompson, CB; Heiden, MGV; Su, SM				Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Heiden, Matthew G. Vander; Su, Shinsan M.			Cancer-associated IDH1 mutations produce 2-hydroxyglutarate	NATURE			English	Article							TANDEM MASS-SPECTROMETRY; ACID; D-2-HYDROXYGLUTARATE	Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers. These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyse conversion of isocitrate to alpha-ketoglutarate. However, only a single copy of the gene is mutated in tumours, raising the possibility that the mutations do not result in a simple loss of function. Here we show that cancer-associated IDH1 mutations result in a new ability of the enzyme to catalyse the NADPH-dependent reduction of alpha-ketoglutarate to R(2)-2-hydroxyglutarate (2HG). Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert alpha-ketoglutarate to 2HG. Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumours in patients with inborn errors of 2HG metabolism. Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG. These data demonstrate that the IDH1 mutations result in production of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.	[Dang, Lenny; White, David W.; Gross, Stefan; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Yen, Katharine E.; Heiden, Matthew G. Vander; Su, Shinsan M.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Bennett, Bryson D.; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem & Integrat Genom, Princeton, NJ 08544 USA; [Prins, Robert M.; Liau, Linda M.] Univ Calif Los Angeles, Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Ward, Patrick S.; Thompson, Craig B.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Agios Pharmaceuticals; Princeton University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Su, SM (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	michael.su@agios.com	Rabinowitz, Joshua/GPP-4019-2022; Cantley, Lewis C/D-1800-2014; Prins, Robert/AAX-1155-2021; Ward, Patrick/H-2361-2014	Rabinowitz, Joshua/0000-0002-1247-4727; Cantley, Lewis C/0000-0002-1298-7653; Liau, Linda/0000-0002-4053-0052; Ward, Patrick/0000-0001-6437-8174; Prins, Robert/0000-0002-6282-6583; Dang, Lenny/0000-0002-2073-6109	NIH [R21 CA128620]; NATIONAL CANCER INSTITUTE [P01CA104838, R21CA128620, R01CA105463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank R. K. Suto, R. S. Brown and E. Fontano at Xtal BioStructures for performing crystallographic studies, and S. Wang at ChemPartner for assistance with biochemical experiments. Wethank G. Petsko for his review of the structure data. We also thank T. Mak, N. Wu, L. Tartaglia, J. Saunders, F. Salituro and D. Schenkein for discussions and/or comments on the manuscript. Asterand, PLC provided some of the glioma specimens and SeqWright Inc. assisted with genomic DNA SNP analysis. J. D. R. is supported by NIH R21 CA128620.	Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Kolker S, 2002, NEUROPEDIATRICS, V33, P225, DOI 10.1055/s-2002-36741; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Lu WY, 2006, J AM SOC MASS SPECTR, V17, P37, DOI 10.1016/j.jasms.2005.09.001; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Tsacopoulos M, 2002, J PHYSIOL-PARIS, V96, P283, DOI 10.1016/S0928-4257(02)00017-7; Wajner M, 2004, J INHERIT METAB DIS, V27, P427, DOI 10.1023/B:BOLI.0000037353.13085.e2; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	26	2465	2614	5	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					739	U52		10.1038/nature08617	http://dx.doi.org/10.1038/nature08617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19935646	Green Accepted			2022-12-28	WOS:000272559900029
J	Amir, E; Seruga, B; Freedman, O; Clemons, M				Amir, Eitan; Seruga, Bostjan; Freedman, Orit; Clemons, Mark			Lesson of the Week Amenorrhoea, menopause, and endocrine therapy for breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AROMATASE INHIBITORS; PREMENOPAUSAL WOMEN; CHEMOTHERAPY; TAMOXIFEN; CAUTION; TRIAL		[Clemons, Mark] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Clemons, M (corresponding author), Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M5G 2M9, Canada.	mclemons@toh.on.ca	Amir, Eitan/L-6052-2019	Amir, Eitan/0000-0002-3706-525X				Abe O, 1998, LANCET, V352, P930; American Cancer Society, 2007, BREAST CANC FACTS FI; Anderson RA, 2006, HUM REPROD, V21, P2583, DOI 10.1093/humrep/del201; Bukulmez O, 2004, CURR OPIN OBSTET GYN, V16, P231, DOI 10.1097/00001703-200406000-00005; *CANC CAR ONT PUBL, CANC YOUNG AD CAN; Clarke M, 1998, LANCET, V351, P1451; Clemons M, 2007, BREAST CANCER RES TR, V104, P115, DOI 10.1007/s10549-006-9401-y; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; DELRIO G, 1986, TUMORI, V72, P53, DOI 10.1177/030089168607200108; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Hargis JB, 2006, CANCER INVEST, V24, P174, DOI 10.1080/07357900500524538; Kwee J, 2008, FERTIL STERIL, V90, P737, DOI 10.1016/j.fertnstert.2007.07.1293; Lum SS, 1997, AM J SURG, V173, P399, DOI 10.1016/S0002-9610(97)00072-X; Mitwally MFM, 2001, FERTIL STERIL, V75, P305, DOI 10.1016/S0015-0282(00)01705-2; Overlie I, 1999, ACTA OBSTET GYN SCAN, V78, P642, DOI 10.1034/j.1600-0412.1999.780714.x; Petrek JA, 2006, J CLIN ONCOL, V24, P1045, DOI 10.1200/JCO.2005.03.3969; Sacco M, 2003, J CLIN ONCOL, V21, P2276, DOI 10.1200/JCO.2003.06.116; Schinzinger A, 1889, BEILAGE CENTRALBLATT, V16, P55; Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814; Smith IE, 2006, J CLIN ONCOL, V24, P2444, DOI 10.1200/JCO.2005.05.3694; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Tham YL, 2007, AM J CLIN ONCOL-CANC, V30, P126, DOI 10.1097/01.coc.0000251398.57630.4f; Vital-Reyes V, 2004, J REPROD MED, V49, P989; Winer EP, 2003, J CLIN ONCOL, V21, P2597, DOI 10.1200/JCO.2003.04.596	24	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2009	339								b4261	10.1136/bmj.b4261	http://dx.doi.org/10.1136/bmj.b4261			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NT	19959583				2022-12-28	WOS:000272453400001
J	Davies, M				Davies, Marika			Ethical debate Are advance directives legally binding or simply the starting point for discussion on patients' best interests? Legal advice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Med Protect Soc Ltd, London W1G 0PS, England		Davies, M (corresponding author), Med Protect Soc Ltd, London W1G 0PS, England.	stella.zegge@mps.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2009	339								b4693	10.1136/bmj.b4693	http://dx.doi.org/10.1136/bmj.b4693			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AW	19942668				2022-12-28	WOS:000272186500009
J	Daw, R; Tonzani, S				Daw, Rosamund; Tonzani, Stefano			BIOMATERIALS	NATURE			English	Editorial Material														Daw, Rosamund/0000-0003-2015-3410					0	3	3	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 26	2009	462	7272					425	425		10.1038/462425a	http://dx.doi.org/10.1038/462425a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940911	Bronze			2022-12-28	WOS:000272144200029
J	Huebsch, N; Mooney, DJ				Huebsch, Nathaniel; Mooney, David J.			Inspiration and application in the evolution of biomaterials	NATURE			English	Article							MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; HYDROGELS; MATRICES; CULTURE; DIFFERENTIATION; ACTIVATION; INTERFACES; NANOWIRES; DELIVERY	Biomaterials, traditionally defined as materials used in medical devices, have been used since antiquity, but recently their degree of sophistication has increased significantly. Biomaterials made today are routinely information rich and incorporate biologically active components derived from nature. In the future, biomaterials will assume an even greater role in medicine and will find use in a wide variety of non-medical applications through biologically inspired design and incorporation of dynamic behaviour.	[Huebsch, Nathaniel; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Huebsch, Nathaniel] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Mooney, David J.] Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT)	Mooney, DJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St,319 Pierce Hall, Cambridge, MA 02138 USA.	mooneyd@seas.harvard.edu		Huebsch, Nathaniel/0000-0002-3329-0214; Mooney, David/0000-0001-6299-1194	US National Institutes of Health; National Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013033] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank D. Ingber for discussions. We acknowledge funding from the US National Institutes of Health (National Institute of Dental and Craniofacial Research). N. H. is supported by a National Science Foundation Graduate Research Fellowship.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]; Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b; EDELMAN ER, 1987, J BIOMED MATER RES, V21, P339, DOI 10.1002/jbm.820210307; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077; Jeong KH, 2006, SCIENCE, V312, P557, DOI 10.1126/science.1123053; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; KING RG, 2007, ESTIMATES MED DEVICE; Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x; Mroz T, 2008, SPINE J, V8, p41S; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Needleman DJ, 2004, P NATL ACAD SCI USA, V101, P16099, DOI 10.1073/pnas.0406076101; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; PARK TG, 1992, J APPL POLYM SCI, V46, P659, DOI 10.1002/app.1992.070460413; Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI 10.1073/pnas.0B019BB105; Podual K, 2000, J CONTROL RELEASE, V67, P9, DOI 10.1016/S0168-3659(00)00195-4; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; SHAHANI S, 2006, PHM006F BUS COMM CO; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1; Shin K, 2007, J BIOMED MATER RES A, V83A, P1076, DOI 10.1002/jbm.a.31437; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tsapis N, 2002, P NATL ACAD SCI USA, V99, P12001, DOI 10.1073/pnas.182233999; Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m; Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732	50	541	555	18	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					426	432		10.1038/nature08601	http://dx.doi.org/10.1038/nature08601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940912	Green Accepted			2022-12-28	WOS:000272144200030
J	Jonkers, I; Barakat, TS; Achame, EM; Monkhorst, K; Kenter, A; Rentmeester, E; Grosveld, F; Grootegoed, JA; Gribnau, J				Jonkers, Iris; Barakat, Tahsin Stefan; Achame, Eskeatnaf Mulugeta; Monkhorst, Kim; Kenter, Annegien; Rentmeester, Eveline; Grosveld, Frank; Grootegoed, J. Anton; Gribnau, Joost			RNF12 Is an X-Encoded Dose-Dependent Activator of X Chromosome Inactivation	CELL			English	Article							XIST GENE; ANTISENSE TRANSCRIPTION; ES CELLS; RNA; CHOICE; PLURIPOTENCY; PROBABILITY; TRANSGENE; NUCLEUS; REPEAT	In somatic cells of female placental mammals, one X chromosome is inactivated to minimize sex-related dosage differences of X-encoded genes. Random X chromosome inactivation (XCI) in the embryo is a stochastic process, in which each X has an independent probability to initiate XCI, triggered by the nuclear concentration of one or more X-encoded XCI-activators. Here, we identify the E3 ubiquitin ligase RNF12 as an important XCI-activator. Additional copies of mouse Rnf12 or human RNF12 result in initiation of XCI in male mouse ES cells and on both X chromosomes in a substantial percentage of female mouse ES cells. This activity is dependent on an intact open reading frame of Rnf12 and correlates with the transgenic expression level of RNF12. Initiation of XCI is markedly reduced in differentiating female heterozygous Rnf12(+/-) ES cells. These findings provide evidence for a dose-dependent role of RNF12 in the XCI counting and initiation process.	[Jonkers, Iris; Barakat, Tahsin Stefan; Achame, Eskeatnaf Mulugeta; Kenter, Annegien; Rentmeester, Eveline; Grootegoed, J. Anton; Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands; [Jonkers, Iris; Grosveld, Frank] Univ Med Ctr, Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Monkhorst, Kim] Univ Med Ctr, Erasmus MC, Dept Expt Pathol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gribnau, J (corresponding author), Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands.	j.gribnau@erasmusmc.nl	Mulugeta, Eskeatnaf/AAZ-7471-2020; Barakat, Stefan/X-8234-2019; Mulugeta, Eskeatnaf/H-2640-2016	Mulugeta, Eskeatnaf/0000-0003-4045-4835; Barakat, Stefan/0000-0003-1231-1562; Mulugeta, Eskeatnaf/0000-0003-4045-4835	HFSP CDA; NWO-VIDI; TOP; Dutch government [03038]	HFSP CDA; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); TOP; Dutch government	We would like to thank Nilhan Gunhanlar, Cristina Gontan Pardo, Akiko Inagaki, Bas de Hoon, and Maureen Eijpe for help with experiments. We also thank all department members for helpful discussions. This work was supported by HFSP CDA, NWO-VIDI, and TOP grants to J. G. and a grant from the Dutch government (BSIK programme 03038, SCDD).	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Becker Thomas, 2003, Methods in Cell Science, V25, P85, DOI 10.1023/B:MICS.0000006895.03556.9b; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Heard E, 1999, MOL CELL BIOL, V19, P3156; Her YR, 2009, J BIOL CHEM, V284, P8557, DOI 10.1074/jbc.M806702200; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Migeon BR, 2001, GENOMICS, V71, P156, DOI 10.1006/geno.2000.6421; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Monkhorst K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005616; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohhata T, 2008, DEVELOPMENT, V135, P227, DOI 10.1242/dev.008490; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Sado T, 2002, CYTOGENET GENOME RES, V99, P115, DOI 10.1159/000071582; Sado T, 2006, DEVELOPMENT, V133, P4925, DOI 10.1242/dev.02670; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	36	172	175	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					999	1011		10.1016/j.cell.2009.10.034	http://dx.doi.org/10.1016/j.cell.2009.10.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945382	Bronze			2022-12-28	WOS:000272169400022
J	Levental, KR; Yu, HM; Kass, L; Lakins, JN; Egeblad, M; Erler, JT; Fong, SFT; Csiszar, K; Giaccia, A; Weninger, W; Yamauchi, M; Gasser, DL; Weaver, VM				Levental, Kandice R.; Yu, Hongmei; Kass, Laura; Lakins, Johnathon N.; Egeblad, Mikala; Erler, Janine T.; Fong, Sheri F. T.; Csiszar, Katalin; Giaccia, Amato; Weninger, Wolfgang; Yamauchi, Mitsuo; Gasser, David L.; Weaver, Valerie M.			Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling	CELL			English	Article							FOCAL ADHESION KINASE; BREAST-CANCER CELLS; LYSYL OXIDASE; MAMMARY TUMORIGENESIS; EXTRACELLULAR-MATRIX; MALIGNANT PHENOTYPE; FIBROTIC FOCUS; TGF-BETA; METASTASIS; CARCINOMA	Tumors are characterized by extracellular matrix (ECM) remodeling and stiffening. The importance of ECM remodeling to cancer is appreciated; the relevance of stiffening is less clear. We found that breast tumorigenesis is accompanied by collagen crosslinking, ECM stiffening, and increased focal adhesions. Induction of collagen crosslinking stiffened the ECM, promoted focal adhesions, enhanced PI3 kinase (PI3K) activity, and induced the invasion of an oncogene-initiated epithelium. Inhibition of integrin signaling repressed the invasion of a premalignant epithelium into a stiffened, crosslinked ECM and forced integrin clustering promoted focal adhesions, enhanced PI3K signaling, and induced the invasion of a premalignant epithelium. Consistently, reduction of lysyl oxidase-mediated collagen crosslinking prevented MMTV-Neu-induced fibrosis, decreased focal adhesions and PI3K activity, impeded malignancy, and lowered tumor incidence. These data show how collagen crosslinking can modulate tissue fibrosis and stiffness to force focal adhesions, growth factor signaling and breast malignancy.	[Levental, Kandice R.; Weaver, Valerie M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Levental, Kandice R.; Weaver, Valerie M.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Yu, Hongmei; Kass, Laura; Lakins, Johnathon N.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Erler, Janine T.; Giaccia, Amato] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Egeblad, Mikala; Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Fong, Sheri F. T.; Csiszar, Katalin] Univ Hawaii Manoa, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA; [Weninger, Wolfgang] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; [Yamauchi, Mitsuo] Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA; [Gasser, David L.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of Hawaii System; University of Hawaii Manoa; The Wistar Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Weaver, VM (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	valerie.weaver@ucsfmedctr.org	Peng, Chunwei/F-6788-2010; Egeblad, Mikala/GNP-0620-2022	Weaver, Valerie marie/0000-0003-4786-6752; Weninger, Wolfgang/0000-0003-3133-8699; Levental, Kandice/0000-0002-2234-3683; Erler, Janine/0000-0001-8675-6527; Egeblad, Mikala/0000-0002-3371-1445	NIH [R01-CA078731, T32HL00795404, R01-CA057621]; DOD [W81XWH-05-1-330]; DOE [A107165]; CIRM [RS1-00449]; NCI [U54CA143836]; NATIONAL CANCER INSTITUTE [R01CA057621, U54CA143836, R01CA078731, R01CA138818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); DOE(United States Department of Energy (DOE)); CIRM(California Institute for Regenerative Medicine); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ignatoski for the ErbB2 construct, M. P. Marinkovich for the BM165 antibody, P. Mrass for two-photon microscopy guidance, and R. G. Wells for mentoring of K. R. L. The work was supported by grants NIH R01-CA078731, DOD W81XWH-05-1-330, DOE A107165, CIRM RS1-00449, and NCI U54CA143836 to V. M. W. NIH T32HL00795404 supported K. R. L., and NIH R01-CA057621 supported M. E.	Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bierie B, 2009, J CLIN INVEST, V119, P1571, DOI 10.1172/JCI37480; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Colpaert CG, 2003, BREAST CANCER RES TR, V81, P137, DOI 10.1023/A:1025702330207; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Decitre M, 1998, LAB INVEST, V78, P143; Erler JT, 2006, CANCER RES, V66, P10238, DOI 10.1158/0008-5472.CAN-06-3197; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K; Hasebe T, 1997, JPN J CANCER RES, V88, P590, DOI 10.1111/j.1349-7006.1997.tb00423.x; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; KOUKOULIS GK, 1993, J SUBMICR CYTOL PATH, V25, P285; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Oleggini R, 2007, MATRIX BIOL, V26, P494, DOI 10.1016/j.matbio.2007.02.003; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Pfeiffer BJ, 2005, MATRIX BIOL, V24, P451, DOI 10.1016/j.matbio.2005.07.001; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Szauter KM, 2005, PATHOL BIOL, V53, P448, DOI 10.1016/j.patbio.2004.12.033; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200; Zutter MM, 1998, J MAMMARY GLAND BIOL, V3, P191, DOI 10.1023/A:1018798907544	60	2617	2675	20	531	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					891	906		10.1016/j.cell.2009.10.027	http://dx.doi.org/10.1016/j.cell.2009.10.027			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19931152	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000272169400014
J	Nora, EP; Heard, E				Nora, Elphege P.; Heard, Edith			X Chromosome Inactivation: When Dosage Counts	CELL			English	Editorial Material							PLURIPOTENCY; CHOICE		[Nora, Elphege P.; Heard, Edith] Inst Pasteur, INSERM, CNRS, UMR3215,U934, F-75724 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Heard, E (corresponding author), Inst Pasteur, INSERM, CNRS, UMR3215,U934, F-75724 Paris 05, France.	edith.heard@curie.fr	Nora, Elphège/AAW-9646-2021; Heard, Edith/D-7197-2017	Nora, Elphège/0000-0002-8347-4396; Heard, Edith/0000-0001-8052-7117				Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Heard E, 1999, MOL CELL BIOL, V19, P3156; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a	9	6	6	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					865	867		10.1016/j.cell.2009.11.009	http://dx.doi.org/10.1016/j.cell.2009.11.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945374	Bronze			2022-12-28	WOS:000272169400011
J	de Mendoza-Asensi, D; Planas, K				de Mendoza-Asensi, Diego; Planas, Kenneth			Air in the Portal and Mesenteric Veins	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[de Mendoza-Asensi, Diego; Planas, Kenneth] Joan XXIII Univ Hosp, Tarragona, Spain		de Mendoza-Asensi, D (corresponding author), Joan XXIII Univ Hosp, Tarragona, Spain.	kplanas@gmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2079	2079		10.1056/NEJMicm0808878	http://dx.doi.org/10.1056/NEJMicm0808878			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19923579				2022-12-28	WOS:000271898600012
J	Jacobson, A				Jacobson, Anne			Going Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jvlgato@ameritech.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2071	2072		10.1001/jama.2009.1559	http://dx.doi.org/10.1001/jama.2009.1559			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920225				2022-12-28	WOS:000271873900001
J	Nelson, HD; Tyne, K; Naik, A; Bougatsos, C; Chan, BK; Humphrey, L				Nelson, Heidi D.; Tyne, Kari; Naik, Arpana; Bougatsos, Christina; Chan, Benjamin K.; Humphrey, Linda			Screening for Breast Cancer: An Update for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							SWEDISH 2-COUNTY TRIAL; SELF-EXAMINATION; FOLLOW-UP; UNITED-STATES; RANDOMIZED-TRIAL; AGE 40; MAMMOGRAPHY; OVERDIAGNOSIS; MORTALITY; WOMEN	Background: This systematic review is an update of evidence since the 2002 U. S. Preventive Services Task Force recommendation on breast cancer screening. Purpose: To determine the effectiveness of mammography screening in decreasing breast cancer mortality among average-risk women aged 40 to 49 years and 70 years or older, the effectiveness of clinical breast examination and breast self-examination, and the harms of screening. Data Sources: Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the fourth quarter of 2008), MEDLINE (January 2001 to December 2008), reference lists, and Web of Science searches for published studies and Breast Cancer Surveillance Consortium for screening mammography data. Study Selection: Randomized, controlled trials with breast cancer mortality outcomes for screening effectiveness, and studies of various designs and multiple data sources for harms. Data Extraction: Relevant data were abstracted, and study quality was rated by using established criteria. Data Synthesis: Mammography screening reduces breast cancer mortality by 15% for women aged 39 to 49 years (relative risk, 0.85 [95% credible interval, 0.75 to 0.96]; 8 trials). Data are lacking for women aged 70 years or older. Radiation exposure from mammography is low. Patient adverse experiences are common and transient and do not affect screening practices. Estimates of overdiagnosis vary from 1% to 10%. Younger women have more false-positive mammography results and additional imaging but fewer biopsies than older women. Trials of clinical breast examination are ongoing; trials for breast self-examination showed no reductions in mortality but increases in benign biopsy results. Limitation: Studies of older women, digital mammography, and magnetic resonance imaging are lacking. Conclusion: Mammography screening reduces breast cancer mortality for women aged 39 to 69 years; data are insufficient for older women. False-positive mammography results and additional imaging are common. No benefit has been shown for clinical breast examination or breast self-examination.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Women & Childrens Hlth Res Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mailcode BICC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu			AHRQ [290-02-0024]; Veteran's Administration Women's Health Fellowship; Oregon Health & Science University Department of Surgery in conjunction with the Human Investigators Program; National Cancer Institute-funded BCSC [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; NATIONAL CANCER INSTITUTE [U01CA063740, U01CA063736, U01CA086076, U01CA070040, U01CA086082, U01CA063731, U01CA069976, U01CA070013] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Veteran's Administration Women's Health Fellowship; Oregon Health & Science University Department of Surgery in conjunction with the Human Investigators Program; National Cancer Institute-funded BCSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Oregon Evidence-based Practice Center under contract to the AHRQ (contract 290-02-0024); the Veteran's Administration Women's Health Fellowship (Dr. Tyne); and the Oregon Health & Science University Department of Surgery in conjunction with the Human Investigators Program (Dr. Naik). Data collection for some of this work was supported by the National Cancer Institute-funded BCSC cooperative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040). The collection of cancer incidence data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. A full description of these sources is available at http://breastscreening.cancer.gov/work/acknowledgement.html.	*AM CANC SOC, STAT 2008; American Cancer Society, BREAST CANC FACTS FI; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Badgwell BD, 2008, J CLIN ONCOL, V26, P2482, DOI 10.1200/JCO.2007.12.8058; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Baxter N, 2001, CAN MED ASSOC J, V164, P1837; Bedrosian I, 2003, CANCER-AM CANCER SOC, V98, P468, DOI 10.1002/cncr.11490; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Boulos S, 2005, BREAST, V14, P340, DOI 10.1016/j.breast.2005.07.002; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Chagpar AB, 2007, J SURG RES, V140, P214, DOI 10.1016/j.jss.2007.01.034; D'Orsi CJ, 2003, BREAST IMAGING REPOR, P229; Day NE, 2005, BREAST CANCER RES, V7, P228, DOI 10.1186/bcr1321; de Koning HJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1369; *DEV COR TEAM, 2006, R LANG ENV STAT COMP; Drossaert CHC, 2001, J MED SCREEN, V8, P204, DOI 10.1136/jms.8.4.204; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Flobbe K, 2003, ARCH INTERN MED, V163, P1194, DOI 10.1001/archinte.163.10.1194; Galit W, 2007, MATURITAS, V57, P109, DOI 10.1016/j.maturitas.2007.01.010; HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317; Hackshaw AK, 2003, BRIT J CANCER, V88, P1047, DOI 10.1038/sj.bjc.6600847; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Humphrey L, 2002, SCREEN BREAST CANC; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; John EM, 2007, INT J CANCER, V121, P386, DOI 10.1002/ijc.22668; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; KOSTERS JP, COCHRANE DATABASE SY; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Mushlin AI, 1998, AM J PREV MED, V14, P143, DOI 10.1016/S0749-3797(97)00019-6; National Cancer Institute, BREAST CANC SURV CON; Nelson H, 2009, SCREENING BREAST CAN; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olivotto IA, 1998, NEW ENGL J MED, V339, P560; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Ries L, 1975, SEER CANC STAT REV; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Semiglazov V. F., 2003, Voprosy Onkologii (St. Petersburg), V49, P434; Semiglazov V. P., 1999, Voprosy Onkologii (St. Petersburg), V45, P265; SEMIGLAZOV VF, 1992, EUR J EPIDEMIOL, V8, P498, DOI 10.1007/BF00146366; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Spelic DC, 2003, DOSE IMAGE QUALITY M; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Thomas A., 2006, R NEWS, V6, P17; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Tripathy D, 2005, BREAST J, V11, pS30, DOI 10.1111/j.1075-122X.2005.217166.x; Tu SP, 2006, J CANCER EDUC, V21, P175, DOI 10.1207/s15430154jce2103_18; *US NAT I HLTH, CANC CONTR RES; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048; Yen MF, 2003, EUR J CANCER, V39, P1746, DOI 10.1016/S0959-8049(03)00260-0; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	65	841	932	0	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					727	W242		10.7326/0003-4819-151-10-200911170-00009	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00009			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920273	Green Accepted			2022-12-28	WOS:000272145100006
J	Pramanik, J				Pramanik, Jogenananda			Disclosure of genetic risk for Alzheimer disease did not increase anxiety or depression in asymptomatic adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Allianze Coll Med Sci, Palau Penang, Malaysia		Pramanik, J (corresponding author), Allianze Coll Med Sci, Palau Penang, Malaysia.							Butow PN, 2003, MED J AUSTRALIA, V178, P77, DOI 10.5694/j.1326-5377.2003.tb05069.x; Weiss DSMC, 1997, ASSESSING PSYCHOL TR	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-9	10.7326/0003-4819-151-10-200911170-02009	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920267				2022-12-28	WOS:000272145100020
J	Bollenbach, T; Quan, S; Chait, R; Kishony, R				Bollenbach, Tobias; Quan, Selwyn; Chait, Remy; Kishony, Roy			Nonoptimal Microbial Response to Antibiotics Underlies Suppressive Drug Interactions	CELL			English	Article							RIBOSOMAL-RNA SYNTHESIS; RATE-DEPENDENT CONTROL; ESCHERICHIA-COLI; GENE-EXPRESSION; GROWTH-RATE; SUBINHIBITORY CONCENTRATIONS; TRANSCRIPTIONAL MODULATION; CELL-SIZE; DNA; REPLICATION	Suppressive drug interactions, in which one antibiotic can actually help bacterial cells to grow faster in the presence of another, occur between protein and DNA synthesis inhibitors. Here, we show that this suppression results from nonoptimal regulation of ribosomal genes in the presence of DNA stress. Using GFP-tagged transcription reporters in Escherichia coli, we find that ribosomal genes are not directly regulated by DNA stress, leading to an imbalance between cellular DNA and protein content. To test whether ribosomal gene expression under DNA stress is nonoptimal for growth rate, we sequentially deleted up to six of the seven ribosomal RNA operons. These synthetic manipulations of ribosomal gene expression correct the protein-DNA imbalance, lead to improved survival and growth, and completely remove the suppressive drug interaction. A simple mathematical model explains the nonoptimal regulation in different nutrient environments. These results reveal the genetic mechanism underlying an important class of suppressive drug interactions.	[Bollenbach, Tobias; Chait, Remy; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Quan, Selwyn] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Harvard University; Stanford University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	Bollenbach, Tobias/AAK-3206-2020	Bollenbach, Tobias/0000-0003-4398-476X; Chait, Remy/0000-0003-0876-3187	National Institutes of Health [R01GM081617]; Alexander von Humboldt foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank U. Alon, J. Collins, M. Elowitz, M. Ernebjerg, A. Gassett, A. Hilfinger, E. Kelsic, M. Kohanski, D. Landgraf, R. Milo, A. Palmer, D. Rudner, M. Springer, M. Staller, C. Squires, E. Toprak, I. Wapinski, R. Ward, P. Yeh, and all members of the Kishony lab for discussions, comments, and technical help; and M. Traxler for his gift of strains. This work was supported in part by National Institutes of Health Grant R01GM081617 (to R. K.). T. B. acknowledges funding from the Alexander von Humboldt foundation.	Asai T, 1999, J BACTERIOL, V181, P3803, DOI 10.1128/JB.181.12.3803-3809.1999; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Brazas MD, 2005, DRUG DISCOV TODAY, V10, P1245, DOI 10.1016/S1359-6446(05)03566-X; Bremer H, 1996, ESCHERICHIA COLI SAL; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; FRAENKEL DG, 1961, BIOCHIM BIOPHYS ACTA, V53, P96, DOI 10.1016/0006-3002(61)90797-1; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GAAL T, 1990, P NATL ACAD SCI USA, V87, P5533, DOI 10.1073/pnas.87.14.5533; GEORGOPAPADAKOU NH, 1991, ANTIMICROB AGENTS CH, V35, P2645, DOI 10.1128/AAC.35.12.2645; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; GUAN LN, 1992, J ANTIMICROB CHEMOTH, V29, P529, DOI 10.1093/jac/29.5.529; Guido NJ, 2007, BIOPHYS J, V93, pL55, DOI 10.1529/biophysj.107.118687; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Izutsu K, 2001, GENES CELLS, V6, P665, DOI 10.1046/j.1365-2443.2001.00457.x; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Keener J, 1996, ESCHERICHIA COLI SAL, V2, P1417; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; KHAN SR, 1972, BIOCHEM BIOPH RES CO, V48, P169, DOI 10.1016/0006-291X(72)90358-0; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; KURLAND CG, 1962, J MOL BIOL, V4, P388, DOI 10.1016/S0022-2836(62)80019-9; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Liebermeister W, 2004, BIOSYSTEMS, V76, P261, DOI 10.1016/j.biosystems.2004.05.022; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Loewe S., 1928, ERGEBN PHYSL, V27, P47, DOI [10.1007/BF02322290, DOI 10.1007/BF02322290]; MASON DJ, 1995, ANTIMICROB AGENTS CH, V39, P2752, DOI 10.1128/AAC.39.12.2752; Mesak LR, 2008, ANTIMICROB AGENTS CH, V52, P3394, DOI 10.1128/AAC.01599-07; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; PIDDOCK LJV, 1990, ANTIMICROB AGENTS CH, V34, P2331, DOI 10.1128/AAC.34.12.2331; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Radman M, 1975, Basic Life Sci, V5A, P355; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; SMITH RJ, 1973, BIOCHEM J, V136, P249, DOI 10.1042/bj1360249; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P6670, DOI 10.1128/AEM.70.11.6670-6677.2004; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Tsui WHW, 2004, CHEM BIOL, V11, P1307, DOI 10.1016/j.chembiol.2004.07.010; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	76	156	156	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					707	718		10.1016/j.cell.2009.10.025	http://dx.doi.org/10.1016/j.cell.2009.10.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914165	Green Accepted, Bronze			2022-12-28	WOS:000271747200015
J	Macilwain, C				Macilwain, Colin			The RAE: An Assessment Too Far?	CELL			English	Editorial Material																			0	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 13	2009	139	4					643	646		10.1016/j.cell.2009.10.041	http://dx.doi.org/10.1016/j.cell.2009.10.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914155	Bronze			2022-12-28	WOS:000271747200004
J	Webb, CHT; Riccitelli, NJ; Ruminski, DJ; Luptak, A				Webb, Chiu-Ho T.; Riccitelli, Nathan J.; Ruminski, Dana J.; Luptak, Andrej			Widespread Occurrence of Self-Cleaving Ribozymes	SCIENCE			English	Article							HEPATITIS-DELTA-VIRUS; RNA		[Webb, Chiu-Ho T.; Luptak, Andrej] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Riccitelli, Nathan J.; Luptak, Andrej] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Ruminski, Dana J.; Luptak, Andrej] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Luptak, A (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	aluptak@uci.edu			University of California, Irvine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094929] Funding Source: NIH RePORTER	University of California, Irvine(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Luptak laboratory, G. Weiss, and J. Kieft for comments and A. James for A. gambiae samples. This work was supported by the University of California, Irvine. A. L. is a member of the Chao Family Comprehensive Cancer Center. The GenBank accession numbers for the confirmed ribozymes are BK006878 to BK006897.	BEEN MD, 1992, BIOCHEMISTRY-US, V31, P11843, DOI 10.1021/bi00162a024; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308	5	134	134	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					953	953		10.1126/science.1178084	http://dx.doi.org/10.1126/science.1178084			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965505	Green Accepted, Green Submitted			2022-12-28	WOS:000271712300026
J	Mayama, S; Tamura, M; Hanawa, T; Matsumoto, T; Ishii, M; Pyo, TS; Suto, H; Naoi, T; Kudo, T; Hashimoto, J; Nishiyama, S; Kuzuhara, M; Hayashi, M				Mayama, Satoshi; Tamura, Motohide; Hanawa, Tomoyuki; Matsumoto, Tomoaki; Ishii, Miki; Pyo, Tae-Soo; Suto, Hiroshi; Naoi, Takahiro; Kudo, Tomoyuki; Hashimoto, Jun; Nishiyama, Shogo; Kuzuhara, Masayuki; Hayashi, Masahiko			Direct Imaging of Bridged Twin Protoplanetary Disks in a Young Multiple Star	SCIENCE			English	Article							MAIN-SEQUENCE STARS; OPHIUCHUS; CONSTRAINTS; BINARIES; SYSTEMS; TAURUS	Studies of the structure and evolution of protoplanetary disks are important for understanding star and planet formation. Here we present the direct image of an interacting binary protoplanetary system. Both circumprimary and circumsecondary disks are resolved in the near-infrared. There is a bridge of infrared emission connecting the two disks and a long spiral arm extending from the circumprimary disk. Numerical simulations show that the bridge corresponds to gas flow and a shock wave caused by the collision of gas rotating around the primary and secondary stars. Fresh material streams along the spiral arm, consistent with the theoretical scenarios in which gas is replenished from a circummultiple reservoir.	[Mayama, Satoshi; Tamura, Motohide; Hashimoto, Jun; Hayashi, Masahiko] Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan; [Tamura, Motohide; Suto, Hiroshi; Naoi, Takahiro; Kudo, Tomoyuki; Hashimoto, Jun; Hayashi, Masahiko] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Ishii, Miki; Pyo, Tae-Soo] Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Hanawa, Tomoyuki] Chiba Univ, Ctr Frontier Sci, Inage Ku, Chiba 2638522, Japan; [Matsumoto, Tomoaki] Hosei Univ, Fac Humanity & Environm, Chiyoda Ku, Tokyo 1028160, Japan; [Nishiyama, Shogo] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Kuzuhara, Masayuki] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Chiba University; Hosei University; Kyoto University; University of Tokyo	Mayama, S (corresponding author), Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan.	mayama_satoshi@soken.ac.jp		Nishiyama, S./0000-0002-9440-7172; Pyo, Tae-Soo/0000-0002-3273-0804; Hayashi, Masahiko/0000-0002-4790-7940	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This report is based on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. The Hubble Space Telescope data presented here were obtained from the Multimission Archive at the Space Telescope Science Institute (MAST). The numerical simulations were performed on a Hitachi SR110000 at the Institute of Media and Information Technology, Chiba University, Japan. S. M. acknowledges a fellowship from the Japan Society for the Promotion of Science. This work is supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Andrews SM, 2007, ASTROPHYS J, V659, P705, DOI 10.1086/511741; Andrews SM, 2005, ASTROPHYS J, V619, pL175, DOI 10.1086/427325; ARTYMOWICZ P, 1994, ASTROPHYS J, V421, P651, DOI 10.1086/173679; CHINI R, 1981, ASTRON ASTROPHYS, V99, P346; Correia S, 2006, ASTRON ASTROPHYS, V459, P909, DOI 10.1051/0004-6361:20065545; GHEZ AM, 1993, ASTRON J, V106, P2005, DOI 10.1086/116782; Greaves JS, 2005, SCIENCE, V307, P68, DOI 10.1126/science.1101979; GREENE TP, 1994, ASTROPHYS J, V434, P614, DOI 10.1086/174763; LEINERT C, 1993, ASTRON ASTROPHYS, V278, P129; Lombardi M, 2008, ASTRON ASTROPHYS, V480, P785, DOI 10.1051/0004-6361:20079110; Natta A, 2006, ASTRON ASTROPHYS, V452, P245, DOI 10.1051/0004-6361:20054706; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Takami H, 2003, P SOC PHOTO-OPT INS, V4839, P21, DOI 10.1117/12.459239; Tamura M, 2000, P SOC PHOTO-OPT INS, V4008, P1153, DOI 10.1117/12.395434; White RJ, 2001, ASTROPHYS J, V556, P265, DOI 10.1086/321542	16	45	45	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					306	308		10.1126/science.1179679	http://dx.doi.org/10.1126/science.1179679			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	19965388	Green Submitted			2022-12-28	WOS:000273629700035
J	van Doorn, GS; Edelaar, P; Weissing, FJ				van Doorn, G. Sander; Edelaar, Pim; Weissing, Franz J.			On the Origin of Species by Natural and Sexual Selection	SCIENCE			English	Article							SYMPATRIC SPECIATION; HANDICAP PRINCIPLE; FEMALE CHOICE; MATE CHOICE; EVOLUTION; ENVIRONMENT; PREFERENCES; HYPOTHESIS; PARADOX; ECOLOGY	Ecological speciation is considered an adaptive response to selection for local adaptation. However, besides suitable ecological conditions, the process requires assortative mating to protect the nascent species from homogenization by gene flow. By means of a simple model, we demonstrate that disruptive ecological selection favors the evolution of sexual preferences for ornaments that signal local adaptation. Such preferences induce assortative mating with respect to ecological characters and enhance the strength of disruptive selection. Natural and sexual selection thus work in concert to achieve local adaptation and reproductive isolation, even in the presence of substantial gene flow. The resulting speciation process ensues without the divergence of mating preferences, avoiding problems that have plagued previous models of speciation by sexual selection.	[van Doorn, G. Sander] Santa Fe Inst, Santa Fe, NM 87501 USA; [van Doorn, G. Sander] Univ Bern, Inst Ecol & Evolut, CH-3032 Hinterkappelen, Switzerland; [Edelaar, Pim; Weissing, Franz J.] Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; [Edelaar, Pim] Uppsala Univ, Dept Anim Ecol, S-75236 Uppsala, Sweden; [Edelaar, Pim] CSIC, Estac Biol Donana, Dept Conservat Biol, Seville 41092, Spain	The Santa Fe Institute; University of Bern; University of Groningen; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	van Doorn, GS (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	sander.vandoorn@iee.unibe.ch	Edelaar, Pim/P-5650-2014; van Doorn, G. Sander/G-3247-2011	Edelaar, Pim/0000-0003-4649-6366; van Doorn, G. Sander/0000-0002-4703-3788; Weissing, Franz J./0000-0003-3281-663X	Netherlands Organization for Scientific Research; European Commission Marie Curie Outgoing International Fellowship	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission Marie Curie Outgoing International Fellowship(European Commission)	This work was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (G. S. v. D.) and a European Commission Marie Curie Outgoing International Fellowship grant (P. E.). This paper reflects the authors' opinion only. We thank A. Leeuw for exploratory simulations; D. Visser for creating Fig. 1; and I. Olivieri, T. van Dooren, M. Maan, and two anonymous reviewers for constructive comments.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; [Anonymous], 1861, ORIGIN SPECIES MEANS; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bussiere LF, 2008, GENETICA, V134, P69, DOI 10.1007/s10709-007-9220-z; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Coyne J.A., 2004, SPECIATION; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dolgin ES, 2006, J EVOLUTION BIOL, V19, P1894, DOI 10.1111/j.1420-9101.2006.01168.x; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Gavrilets S, 2005, EVOLUTION, V59, P696; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kokko H, 2008, GENETICA, V134, P55, DOI 10.1007/s10709-008-9249-7; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Proulx SR, 2001, EVOLUTION, V55, P2401; Reinhold K, 2004, ORG DIVERS EVOL, V4, P157, DOI 10.1016/j.ode.2003.10.002; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; van Doorn GS, 2004, AM NAT, V163, P709, DOI 10.1086/383619	29	236	239	1	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1704	1707		10.1126/science.1181661	http://dx.doi.org/10.1126/science.1181661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19965377	Bronze, Green Submitted			2022-12-28	WOS:000272839000056
J	Friel, S; Dangour, AD; Garnett, T; Lock, K; Chalabi, Z; Roberts, I; Butler, A; Butler, CD; Waage, J; McMichael, AJ; Haines, A				Friel, Sharon; Dangour, Alan D.; Garnett, Tara; Lock, Karen; Chalabi, Zaid; Roberts, Ian; Butler, Ainslie; Butler, Colin D.; Waage, Jeff; McMichael, Anthony J.; Haines, Andy			Health and Climate Change 4 Public health benefits of strategies to reduce greenhouse-gas emissions: food and agriculture	LANCET			English	Article							CONSUMPTION PATTERNS; FATTY-ACIDS; DIETARY-FAT; NUTRITION; LIVESTOCK; MORTALITY; DISEASES; TRENDS; IMPACT; TAXES	Agricultural food production and agriculturally-related change in land use substantially contribute to greenhouse-gas emissions worldwide. Four-fifths of agricultural emissions arise from the livestock sector. Although livestock products are a source of some essential nutrients, they provide large amounts of saturated fat, which is a known risk factor for cardiovascular disease. We considered potential strategies for the agricultural sector to meet the target recommended by the UK Committee on Climate Change to reduce UK emissions from the concentrations recorded in 1990 by 80% by 2050, which would require a 50% reduction by 2030. With use of the UK as a case study, we identified that a combination of agricultural technological improvements and a 30% reduction in livestock production would be needed to meet this target; in the absence of good emissions data from Brazil, we assumed for illustrative purposes that the required reductions would be the same for our second case study in Sao Paulo city. We then used these data to model the potential benefits of reduced consumption of livestock products on the burden of ischaemic heart disease: disease burden would decrease by about 15% in the UK (equivalent to 2850 disability-adjusted life-years [DALYs] per million population in 1 year) and 16% in Sao Paulo city (equivalent to 2180 DALYs per million population in 1 year). Although likely to yield benefits to health, such a strategy will probably encounter cultural, political, and commercial resistance, and face technical challenges. Coordinated intersectoral action is needed across agricultural, nutritional, public health, and climate change communities worldwide to provide affordable, healthy, low-emission diets for all societies.	[Friel, Sharon; Butler, Ainslie; Butler, Colin D.; McMichael, Anthony J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; [Dangour, Alan D.; Lock, Karen; Chalabi, Zaid; Roberts, Ian; Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Garnett, Tara] Univ Surrey, Food Climate Res Network, Guildford GU2 5XH, Surrey, England; [Waage, Jeff] London Int Dev Ctr, London, England	Australian National University; University of London; London School of Hygiene & Tropical Medicine; University of Surrey	Friel, S (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.	Sharon.friel@anu.edu.au	Butler, Colin D./H-2267-2019; Butler, Ainslie/P-8343-2015	Butler, Colin D./0000-0002-2942-5294; Butler, Ainslie/0000-0001-8668-0761; Dangour, Alan/0000-0001-6908-1273; Haines, Andy/0000-0002-8053-4605; Friel, Sharon/0000-0002-8345-5435	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; Engineering and Physical Sciences Research Council [GR/T29123/01] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies. For their expert advice, we thank A Aikenhead (International Association for the Study of Obesity, London, UK), R Beaglehole (University of Auckland, Auckland, New Zealand), M A de Castro (University of Sao Paulo, Sao Paulo city, Brazil), G Edwards-Jones (Bangor University, Bangor, UK), R M Fisberg (University of Sao Paulo, Sao Paulo city, Brazil), R Jackson (University of Auckland, Auckland, New Zealand), P C Jaime (University of Sao Paulo, Sao Paulo city, Brazil), G Jones (ADAS, Wolverhampton, UK), M Lawrence (Deakin University, Burwood, VIC, Australia), C Mathers (WHO, Geneva, Switzerland), and R Uauy (London School of Hygiene and Tropical Medicine, London, UK).	ADAS (Agricultural Land Advisory Service), 2009, RMP 5142 AN POL INST; AEA, 2009, GREENH GAS INV ENGL; Alexandratos N, 2008, POPUL DEV REV, V34, P663, DOI 10.1111/j.1728-4457.2008.00245.x; Allard V, 2007, AGR ECOSYST ENVIRON, V121, P47, DOI 10.1016/j.agee.2006.12.004; Allender S., 2008, CORONARY HEART DIS S; [Anonymous], 2008, WORLD HLTH STAT 2008; Bates CJ, 2000, NATL DIET NUTR SURVE; Bellarby J., 2008, COOL FARMING CLIMATE; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; Cederberg C., 2009, 792 SIK SWED I FOOD; COTTRILL B, 2007, OPPORTUNITIES IMPLIC; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI 10.1079/PHN2004666; Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002; *DAN AC TECHN SCI, 2007, EC NUTR POL TOOLS US; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; DENKE MA, 1991, AM J CLIN NUTR, V54, P1036, DOI 10.1093/ajcn/54.6.1036; *DEP ENV FOOD RUR, 2007, AGR UK; Department of Economic and Social Affairs Population Division., 2008, WORLD POP PROSP 2008; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Elmadfa I, 2009, ANN NUTR METAB, V54, P8, DOI 10.1159/000220822; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fearnside PM, 2000, ADV SOIL S, P231; Finch S, 1998, NATL DIET NUTR SURVE; Fisberg RM, 2006, J AM DIET ASSOC, V106, P2067, DOI 10.1016/j.jada.2006.09.010; Food and Agriculture Organization of the United Nations, 2006, LIV LONG SHAD ENV IS; Friel S, 2008, LANCET, V372, P1677, DOI 10.1016/S0140-6736(08)61692-X; Garnett T., 2008, COOKING STORM FOOD G; Garnett T, 2009, ENVIRON SCI POLICY, V12, P491, DOI 10.1016/j.envsci.2009.01.006; Gerbens-Leenes PW, 2002, ECOL ECON, V42, P185, DOI 10.1016/S0921-8009(02)00049-6; Gold Mark, 2004, GLOBAL BENEFITS EATI; Goodland R, 1997, ECOL ECON, V23, P189, DOI 10.1016/S0921-8009(97)00579-X; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; Hawkes C, 2007, AM J PUBLIC HEALTH, V97, P1962, DOI 10.2105/AJPH.2006.101162; Henderson L, 2003, NATL DIET NUTR SURVE; HMGovernment, 2009, UK LOW CARB TRANS PL; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Hunt JR, 2002, NUTR REV, V60, P127, DOI 10.1301/00296640260093788; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; KEYS A, 1984, AM J CLIN NUTR, V40, P351, DOI 10.1093/ajcn/40.2.351; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lock Karen, 2009, BMJ, V339, pb2403, DOI 10.1136/bmj.b2403; Mangels AR, 2003, J AM DIET ASSOC, V103, P748, DOI 10.1053/jada.2003.50142; Marlow HJ, 2009, AM J CLIN NUTR, V89, pS1699, DOI 10.3945/ajcn.2009.26736Z; MASON C, 2009, BBC NEWS        0512; McAlpine CA, 2009, GLOBAL ENVIRON CHANG, V19, P21, DOI 10.1016/j.gloenvcha.2008.10.008; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Monteiro CA, 2000, REV SAUDE PUBL, V34, P251, DOI 10.1590/S0034-89102000000300007; Moran D., 2008, UK MARGINAL ABATEMEN; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Nellemann C, 2009, ENV FOOD CRISIS THE; Pekka P, 2002, PUBLIC HEALTH NUTR, V5, P245, DOI 10.1079/PHN2001300; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Ratnayake WMN, 2009, EUR J CLIN NUTR, V63, P808, DOI 10.1038/ejcn.2008.39; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Sen A., 1983, POVERTY FAMINES ESSA; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Smith K, 2009, NEW SCI, V202, P24, DOI 10.1016/S0262-4079(09)61702-4; Smith P, 2007, CLIMATE CHANGE 2007; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; *SWED NAT FOOD ADM, ENV EFF FOOD CHOIC; Thiebaut ACM, 2009, JNCI-J NATL CANCER I, V101, P1001, DOI 10.1093/jnci/djp168; THOW AM, 2009, PUBLIC HEALTH NUTR, V12, P1; Thow AM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-5; UK Committee on Climate Change, 2008, BUILD LOW CARB EC UK; *UN FAO, FAOSTAT FOOD CONS DA; USA-Department of Agriculture, 2008, RIS FOOD PRIC INT FO; Uusitalo U, 1996, BRIT MED J, V313, P1044, DOI 10.1136/bmj.313.7064.1044; Walker P, 2005, PUBLIC HEALTH NUTR, V8, P348, DOI 10.1079/PHN2005727; *WHO, 2003, TECHN REP SER WHO, V916; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Williams A., 2006, FINAL REPORT DEFRA P; World Bank, 2008, INT TRADE CLIMATE CH; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	80	319	321	5	143	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					2016	2025		10.1016/S0140-6736(09)61753-0	http://dx.doi.org/10.1016/S0140-6736(09)61753-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19942280				2022-12-28	WOS:000272727000025
J	Kampmann, M; Blobel, G				Kampmann, Martin; Blobel, Guenter			Nascent Proteins Caught in the Act	SCIENCE			English	Editorial Material							CONDUCTING CHANNEL; TRANSLATING RIBOSOME; ESCHERICHIA-COLI; ARCHITECTURE		[Kampmann, Martin] Howard Hughes Med Inst, New York, NY USA; Rockefeller Univ, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Kampmann, M (corresponding author), Howard Hughes Med Inst, New York, NY USA.	martin.kampmann@rockefeller.edu; blobel@rockefeller.edu		Kampmann, Martin/0000-0002-3819-7019	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	11	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1352	1353		10.1126/science.1183690	http://dx.doi.org/10.1126/science.1183690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965743				2022-12-28	WOS:000272351100024
J	Rink, JC; Gurley, KA; Elliott, SA; Alvarado, AS				Rink, Jochen C.; Gurley, Kyle A.; Elliott, Sarah A.; Alvarado, Alejandro Sanchez			Planarian Hh Signaling Regulates Regeneration Polarity and Links Hh Pathway Evolution to Cilia	SCIENCE			English	Article							ZINC-FINGER PROTEIN; SONIC HEDGEHOG; ZEBRAFISH EMBRYO; STEM-CELLS; GENE; DROSOPHILA; HOMOLOG; MOUSE; CONSERVATION; MICE	The Hedgehog (Hh) signaling pathway plays multiple essential roles during metazoan development, homeostasis, and disease. Although core protein components are highly conserved, the variations in Hh signal transduction mechanisms exhibited by existing model systems ( Drosophila, fish, and mammals) are difficult to understand. We characterized the Hh pathway in planarians. Hh signaling is essential for establishing the anterior/posterior axis during regeneration by modulating wnt expression. Moreover, RNA interference methods to reduce signal transduction proteins Cos2/Kif27/Kif7, Fused, or Iguana do not result in detectable Hh signaling defects; however, these proteins are essential for planarian ciliogenesis. Our study expands the understanding of Hh signaling in the animal kingdom and suggests an ancestral mechanistic link between Hh signaling and the function of cilia.	[Rink, Jochen C.; Gurley, Kyle A.; Elliott, Sarah A.; Alvarado, Alejandro Sanchez] Univ Utah, Howard Hughes Med Inst, Dept Neurobiol & Anat, Sch Med, Salt Lake City, UT 84103 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Alvarado, AS (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Neurobiol & Anat, Sch Med, 401 MREB,20 N 1900 E, Salt Lake City, UT 84103 USA.	sanchez@neuro.utah.edu			NIH National Institute of General Medical Sciences [RO-1 GM57260]; European Molecular Biology Association [F32GM082016]; Howard Hughes Medical Institute investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057260, F32GM082016, R01GM057260] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Molecular Biology Association; Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Sanchez laboratory for helpful comments and C. Adler for sharing data on iguana. Work supported by NIH National Institute of General Medical Sciences grants RO-1 GM57260 to A. S. A. and F32GM082016 to K. A. G. J. C. R. was funded by the European Molecular Biology Association. A. S. A. is a Howard Hughes Medical Institute investigator. All sequences associated with this study have been deposited in GenBank and have accession numbers GQ337474 to GQ337490.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Burglin Thomas R, 2006, WormBook, P1; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kang DM, 2003, DEVELOPMENT, V130, P1645, DOI 10.1242/dev.00395; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Marigo V, 1996, DEVELOPMENT, V122, P1225; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0	38	173	179	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1406	1410		10.1126/science.1178712	http://dx.doi.org/10.1126/science.1178712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933103	Green Accepted			2022-12-28	WOS:000272351100044
J	Jagsi, R; Motomura, AR; Griffith, KA; Rangarajan, S; Ubel, PA				Jagsi, Reshma; Motomura, Amy R.; Griffith, Kent A.; Rangarajan, Soumya; Ubel, Peter A.			Sex Differences in Attainment of Independent Funding by Career Development Awardees	ANNALS OF INTERNAL MEDICINE			English	Article							ACADEMIC MEDICINE; GENDER-GAP; PHYSICIAN-SCIENTISTS; WOMEN PHYSICIANS; FACULTY; PROMOTION	Background: Concerns have been raised about the career pipeline in academic medicine, including whether women with a demonstrated commitment to research succeed at the same rate as male colleagues. Objective: To determine the subsequent academic success of recipients of National Institutes of Health (NIH) career development awards. Setting: United States. Participants: 2784 of 2799 (99.5%) recipients of K08 and K23 awards for whom sex could be ascertained from the NIH Computer Retrieval of Information on Scientific Projects database and other publicly available sources. Measurements: Actuarial rates at which recipients of K08 and K23 awards from 1997 to 2003 went on to receive R01 awards. Sex-specific rates of R01 award attainment were calculated by using the Kaplan-Meier method, and sex differences were assessed by using a Cox proportional hazards model. Results: Overall, 31.4% of the 1919 K08 awardees and 43.7% of the 865 K23 awardees were female (P < 0.001). Women were less likely than men to receive an R01 award (P < 0.001). The actuarial rate of R01 award attainment at 5 years was 22.7% overall, 18.8% among women, and 24.8% among men. At 10 years, the rate was 42.5% overall, 36.2% among women, and 45.6% among men. Sex persisted as an independent significant predictor of R01 award attainment (hazard ratio, 0.79 [95% CI, 0.68 to 0.92]; P = 0.002) in multivariate analysis controlling for K award type, year of award, funding institute, institution, and specialty. Limitation: Whether the lower rate of R01 award achievement among women is due to lower rates of application or lower rates of success in application could not be determined. Conclusion: Only a minority of K awardees studied achieved R01 award funding during the period assessed, and a significant sex disparity was evident.	[Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Jagsi, R (corresponding author), Univ Michigan, Dept Radiat Oncol, UHB2C490,SPC 5010,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rjagsi@med.umich.edu		Jagsi, Reshma/0000-0001-6562-1228; Rangarajan, Soumya/0000-0003-3842-6069	American Medical Association's Women Physicians' Congress	American Medical Association's Women Physicians' Congress	In part by the American Medical Association's Women Physicians' Congress, through a grant from the Joan F. Giambalvo Memorial Fund.	[Anonymous], 1988, WOMEN ACAD OUTSIDERS; Association of Professors of Medicine, 2007, REC REV NAT PHYS SCI; Babcock L, 2003, WOMEN DONT ASK: NEGOTIATION AND THE GENDER DIVIDE, P1; BLAND CJ, 1986, J MED EDUC, V61, P22; Brown AJ, 2003, J WOMENS HEALTH, V12, P999, DOI 10.1089/154099903322643929; Bruce ML, 2003, AM J GERIAT PSYCHIAT, V11, P356, DOI 10.1176/appi.ajgp.11.3.356; Buckley LM, 2000, ACAD MED, V75, P283, DOI 10.1097/00001888-200003000-00021; Carr PL, 1998, ANN INTERN MED, V129, P532, DOI 10.7326/0003-4819-129-7-199810010-00004; COLLINS KA, 1989, B MED LIBR ASSOC, V77, P8; Dickler HB, 2007, JAMA-J AM MED ASSOC, V297, P2496, DOI 10.1001/jama.297.22.2496; Donowitz M, 2007, GASTROENTEROLOGY, V132, P477, DOI 10.1053/j.gastro.2006.12.023; Guelich JM, 2002, J INVEST MED, V50, P412, DOI 10.1136/jim-50-06-01; Hamel MB, 2006, NEW ENGL J MED, V355, P310, DOI 10.1056/NEJMe068143; Henderson L, 2001, FINAL REPORT 3 FOCUS; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; Kotchen TA, 2006, J INVEST MED, V54, P13, DOI 10.2310/6650.2005.05026; LEADLEY J, 2008, WOMEN US ACAD MED ST; LEVINSON W, 1991, WESTERN J MED, V154, P423; Ley TJ, 2008, SCIENCE, V322, P1472, DOI 10.1126/science.1165878; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; National Academy of Sciences National Academy of Engineering Institute of Medicine of the National Academies, 2006, BIAS BARR FULF POT W; *NIH, 2001, NIH SUPP ALL I FISC; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; *OFF EXTR RES, 2009, K KIOSK NIH EXTR TRA; *OFF EXTR RES, 2007, SUCC RAT NIH COMP AP; *OFF EXTR RES, 2008, WOM RES INV WOM NIH; *OFF EXTR RES, 2005, SEX GEND BIOM SCI WO; Palepu A, 1998, ACAD MED, V73, P318, DOI 10.1097/00001888-199803000-00021; Ramanan RA, 2002, AM J MED, V112, P336, DOI 10.1016/S0002-9343(02)01032-X; Sirridge M S, 1985, J Am Med Womens Assoc (1972), V40, P51; Solomon SS, 2003, J INVEST MED, V51, P149, DOI 10.1136/jim-51-03-17; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022	33	151	151	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					804	W268		10.7326/0003-4819-151-11-200912010-00009	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EJ	19949146				2022-12-28	WOS:000272727900006
J	Guell, M; van Noort, V; Yus, E; Chen, WH; Leigh-Bell, J; Michalodimitrakis, K; Yamada, T; Arumugam, M; Doerks, T; Kuhner, S; Rode, M; Suyama, M; Schmidt, S; Gavin, AC; Bork, P; Serrano, L				Gueell, Marc; van Noort, Vera; Yus, Eva; Chen, Wei-Hua; Leigh-Bell, Justine; Michalodimitrakis, Konstantinos; Yamada, Takuji; Arumugam, Manimozhiyan; Doerks, Tobias; Kuehner, Sebastian; Rode, Michaela; Suyama, Mikita; Schmidt, Sabine; Gavin, Anne-Claude; Bork, Peer; Serrano, Luis			Transcriptome Complexity in a Genome-Reduced Bacterium	SCIENCE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; ESCHERICHIA-COLI; IDENTIFICATION; EXPRESSION; GENES	To study basic principles of transcriptome organization in bacteria, we analyzed one of the smallest self-replicating organisms, Mycoplasma pneumoniae. We combined strand-specific tiling arrays, complemented by transcriptome sequencing, with more than 252 spotted arrays. We detected 117 previously undescribed, mostly noncoding transcripts, 89 of them in antisense configuration to known genes. We identified 341 operons, of which 139 are polycistronic; almost half of the latter show decaying expression in a staircase-like manner. Under various conditions, operons could be divided into 447 smaller transcriptional units, resulting in many alternative transcripts. Frequent antisense transcripts, alternative transcripts, and multiple regulators per gene imply a highly dynamic transcriptome, more similar to that of eukaryotes than previously thought.	[van Noort, Vera; Chen, Wei-Hua; Yamada, Takuji; Arumugam, Manimozhiyan; Doerks, Tobias; Kuehner, Sebastian; Rode, Michaela; Suyama, Mikita; Schmidt, Sabine; Gavin, Anne-Claude; Bork, Peer] EMBL, Heidelberg, Germany; [Gueell, Marc; Yus, Eva; Leigh-Bell, Justine; Michalodimitrakis, Konstantinos; Serrano, Luis] Univ Pompeu Fabra, CRG, Barcelona, Spain; [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Bork, P (corresponding author), EMBL, Heidelberg, Germany.	bork@embl.de; luis.serrano@crg.es	Arumugam, Manimozhiyan/AAJ-2394-2020; Serrano, Luis/B-3355-2013; Güell, Marc/AAB-3054-2021; Arumugam, Manimozhiyan/E-1211-2011; Güell, Marc/J-2970-2017; van Noort, Vera/E-1053-2011; van Noort, Vera/GWZ-9038-2022; Chen, Weihua/GRS-9256-2022; Bork, Peer/F-1813-2013	Arumugam, Manimozhiyan/0000-0002-0886-9101; Serrano, Luis/0000-0002-5276-1392; Güell, Marc/0000-0003-4000-7912; Arumugam, Manimozhiyan/0000-0002-0886-9101; Güell, Marc/0000-0003-4000-7912; van Noort, Vera/0000-0002-8436-6602; Bork, Peer/0000-0002-2627-833X; Schmidt, Steffen/0000-0001-9077-6010; Suyama, Mikita/0000-0001-9526-3193; Chen, Wei-Hua/0000-0003-2168-6147; Gavin, Anne-Claude/0000-0003-4917-2340	Foundation Marcelino Botin; Ministry of Education of Spain (MEC)-Consolider; European Research Council; Spanish MEC-Formacion Profesorado Universitario; Netherlands Organization for Scientific Research; ICREA Funding Source: Custom	Foundation Marcelino Botin; Ministry of Education of Spain (MEC)-Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); Spanish MEC-Formacion Profesorado Universitario; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ICREA(ICREA)	We thank the Genomics core facility at EMBL (Heidelberg, Germany), J. Lozano for help with statistical analysis, and the Ultrasequencing Unit at CRG. This work was funded by the Foundation Marcelino Botin, the Ministry of Education of Spain (MEC)-Consolider, and the European Research Council. M. G. is funded by the Spanish MEC-Formacion Profesorado Universitario. V.N. is funded by the Netherlands Organization for Scientific Research.	Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Boue S, 2003, BIOESSAYS, V25, P1031, DOI 10.1002/bies.10371; BRANTL S, 1994, EMBO J, V13, P3599, DOI 10.1002/j.1460-2075.1994.tb06667.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Budin-Verneuil A, 2004, LAIT, V84, P61, DOI 10.1051/lait:2003033; Chang LJ, 2008, BIOCHEM BIOPH RES CO, V367, P213, DOI 10.1016/j.bbrc.2007.12.124; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; Henz SR, 2007, PLANT PHYSIOL, V144, P1247, DOI 10.1104/pp.107.100396; Hooper SD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100112; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Washio T, 1998, NUCLEIC ACIDS RES, V26, P5456, DOI 10.1093/nar/26.23.5456; Weiner J, 2000, NUCLEIC ACIDS RES, V28, P4488, DOI 10.1093/nar/28.22.4488; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	25	325	339	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1268	1271		10.1126/science.1176951	http://dx.doi.org/10.1126/science.1176951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965477				2022-12-28	WOS:000272117900049
J	Berkman, PA				Berkman, Paul Arthur			International spaces promote peace	NATURE			English	Editorial Material									[Berkman, Paul Arthur] Univ Cambridge, Scott Polar Res Inst, Arctic Ocean Geopolit Programme, Cambridge CB2 1TN, England; [Berkman, Paul Arthur] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of Cambridge; University of California System; University of California Santa Barbara	Berkman, PA (corresponding author), Univ Cambridge, Scott Polar Res Inst, Arctic Ocean Geopolit Programme, Cambridge CB2 1TN, England.	paul.berkman@spri.cam.ac.uk							0	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 26	2009	462	7272					412	413		10.1038/462412a	http://dx.doi.org/10.1038/462412a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	524LG	19940900				2022-12-28	WOS:000272144200020
J	Blum, JA; Freeman, K; Dart, RC; Cooper, RJ				Blum, Jared A.; Freeman, Kalev; Dart, Richard C.; Cooper, Richelle J.			Requirements and Definitions in Conflict of Interest Policies of Medical Journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ROFECOXIB LITIGATION; PUBLICATIONS; DISCLOSURES; AUTHORSHIP; DOCUMENTS	Context Conflicts of interest (COIs) may influence medical literature. However, it is unclear whether medical journals have consistent policies for defining and soliciting COI disclosures. Objective To determine the prevalence of author COI policies, requirements for signed disclosure statements, and variability in COI definitions among medical journals. Design A cross-sectional survey of Instructions for Authors and manuscript submission documents, including authorship responsibility forms, for high-impact medical journals across 35 subject categories available from March through October 2008. Main Outcome Measure Presence of language referring to COI disclosure in the Instructions for Authors or manuscript submission documents. Results Of 256 journals, 89% had author COI policies. Fifty-four percent required authors to sign a disclosure statement, and 77% provided definitions of COI. Most definitions were limited to direct financial relationships; a minority of journals requested disclosure of other potential conflicts such as personal relationships (42%), paid expert testimony (42%), relationships with other organizations (26%), or travel grants (12%). The prevalence of policies varied by subject category: all internal medicine, respiratory medicine, and toxicology journals studied had comprehensive COI definitions, with 19 of these 24 journals requiring signed disclosure attestations. In contrast, 6 of 19 geriatrics, radiology, and rehabilitation journals requested author COI disclosure. Most journals that officially endorsed International Committee of Medical Journal Editors guidelines had COI policies (68/69), compared with 84% of journals not endorsing the guidelines (158/187). Conclusions In 2008, most medical journals with relatively high impact factors had author COI policies available for public review. Among journals, there was substantial variation in policies for solicitation of author COIs and in definitions of COI. JAMA. 2009; 302(20): 2230-2234	[Freeman, Kalev] Univ Vermont, Coll Med, Burlington, VT 05405 USA; [Blum, Jared A.] Brown Univ, Coll Med, Providence, RI 02912 USA; [Dart, Richard C.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Dart, Richard C.] Denver Hlth & Hosp Author, Denver, CO USA; [Cooper, Richelle J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Vermont; Brown University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Freeman, K (corresponding author), Univ Vermont, Coll Med, Given Bldg D312, Burlington, VT 05405 USA.	kalev.freeman@uvm.edu		Dart, Richard/0000-0001-5989-9354				Ancker JS, 2007, SCI ENG ETHICS, V13, P147, DOI 10.1007/s11948-007-9011-z; Cooper RJ, 2006, J GEN INTERN MED, V21, P1248, DOI 10.1111/j.1525-1497.2006.00598.x; Davidoff F, 2001, JAMA-J AM MED ASSOC, V286, P1232, DOI 10.1001/jama.286.10.1232; Drazen JM, 2002, NEW ENGL J MED, V346, P1901, DOI 10.1056/NEJMe020074; DRAZEN JM, JAMA-J AM MED ASSOC, DOI DOI 10.1001/JAMA.2009.1542; *ED PRACT I MED, CONFL INT MED RES; Flanagin A, 2006, JAMA-J AM MED ASSOC, V296, P220, DOI 10.1001/jama.296.2.220; Horton R, 2004, LANCET, V363, P820, DOI 10.1016/S0140-6736(04)15699-7; *INT COMM MED J, BIOM J WRIT ED UNPUB; *ISI WEB KNOWL, 2006 JCR SCI ED; Jacobs AK, 2004, J AM COLL CARDIOL, V44, P1736, DOI 10.1016/j.jacc.2004.08.040; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; RELMAN AS, 1984, NEW ENGL J MED, V310, P1182, DOI 10.1056/NEJM198405033101809; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; Thorp AW, 2007, ANN EMERG MED, V50, P188, DOI 10.1016/j.annemergmed.2006.11.019; *WAME ED POL PUBL, CONFL INT PEER REV M; Weinfurt KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002128; 2004, CMAJ, V171, P1313	20	97	100	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2230	2234		10.1001/jama.2009.1669	http://dx.doi.org/10.1001/jama.2009.1669			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934424	Bronze			2022-12-28	WOS:000272080500027
J	Kelly, HW				Kelly, H. William			beta(2)-receptor polymorphisms in asthma	LANCET			English	Editorial Material							ACTING BETA-AGONISTS; BETA(2)-ADRENERGIC RECEPTOR; ALBUTEROL; SAFETY		Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Kelly, HW (corresponding author), Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	hwkelly@salud.unm.edu						[Anonymous], [No title captured]; Beasley R, 2009, EUR RESPIR J, V33, P3, DOI 10.1183/09031936.00163408; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Jaeschke R, 2008, AM J RESP CRIT CARE, V178, P1009, DOI 10.1164/rccm.200804-494OC; Kelly HW, 2006, PHARMACOTHERAPY, V26, p164S, DOI 10.1592/phco.26.9part2.164S; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; *US NIH, 2007, GUID DIAGN MAN ASTHM; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 21	2009	374	9703					1726	1728		10.1016/S0140-6736(09)61639-1	http://dx.doi.org/10.1016/S0140-6736(09)61639-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19932345				2022-12-28	WOS:000272207700005
J	Gill, JL; Williams, JW; Jackson, ST; Lininger, KB; Robinson, GS				Gill, Jacquelyn L.; Williams, John W.; Jackson, Stephen T.; Lininger, Katherine B.; Robinson, Guy S.			Pleistocene Megafaunal Collapse, Novel Plant Communities, and Enhanced Fire Regimes in North America	SCIENCE			English	Article							LATE QUATERNARY EXTINCTIONS; CLIMATE-CHANGE; SPORORMIELLA; VEGETATION; STATE; USA	Although the North American megafaunal extinctions and the formation of novel plant communities are well-known features of the last deglaciation, the causal relationships between these phenomena are unclear. Using the dung fungus Sporormiella and other paleoecological proxies from Appleman Lake, Indiana, and several New York sites, we established that the megafaunal decline closely preceded enhanced fire regimes and the development of plant communities that have no modern analogs. The loss of keystone megaherbivores may thus have altered ecosystem structure and function by the release of palatable hardwoods from herbivory pressure and by fuel accumulation. Megafaunal populations collapsed from 14,800 to 13,700 years ago, well before the final extinctions and during the Bolling-Allerod warm period. Human impacts remain plausible, but the decline predates Younger Dryas cooling and the extraterrestrial impact event proposed to have occurred 12,900 years ago.	[Gill, Jacquelyn L.; Williams, John W.; Lininger, Katherine B.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Gill, Jacquelyn L.; Williams, John W.] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Jackson, Stephen T.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Robinson, Guy S.] Fordham Univ, Dept Nat Sci, New York, NY 10023 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wyoming; Fordham University	Gill, JL (corresponding author), Univ Wisconsin, Dept Geog, Madison, WI 53706 USA.		GIll, Jacquelyn/F-1454-2011; Gill, Jacquelyn/HCH-8486-2022; Lininger, Katherine/GNM-6596-2022	Lininger, Katherine/0000-0003-0378-9505; robinson, guy/0000-0002-0007-4785; Jackson, Stephen/0000-0002-1487-4652	NSF [DEB-0716471, DEB-0716951]; Graduate School; Climate, People and Environment Program at the University of Wisconsin	NSF(National Science Foundation (NSF)); Graduate School; Climate, People and Environment Program at the University of Wisconsin	We thank E. Grimm, J. Mason, and S. Hotchkiss for discussions and T. Minckley, S. Lucas, J. Marsicek, D. Alhambra, G. Schellinger, and S. Hernandez for field and laboratory assistance. Initial core analyses were performed at the National Lacustrine Core Facility at the University of Minnesota. This work was supported by NSF (grants DEB-0716471 and DEB-0716951)and the Graduate School and the Climate, People and Environment Program at the University of Wisconsin.	AHMED SI, 1972, CAN J BOTANY, V50, P419, DOI 10.1139/b72-061; Alroy John, 1999, P105; Bartlein PJ, 1998, QUATERNARY SCI REV, V17, P549, DOI 10.1016/S0277-3791(98)00012-2; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Burney DA, 2003, P NATL ACAD SCI USA, V100, P10800, DOI 10.1073/pnas.1534700100; COLEY PD, 1987, NEW PHYTOL, V106, P251; Danell K., 2006, LARGE HERBIVORE ECOL; Davis OK, 2006, PALAEOGEOGR PALAEOCL, V237, P40, DOI 10.1016/j.palaeo.2005.11.028; Fiedel S, 2004, J ARCHAEOL SCI, V31, P121, DOI 10.1016/j.jas.2003.06.004; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Grimm EC, 2009, QUATERNARY RES, V72, P301, DOI 10.1016/j.yqres.2009.05.006; Johnson CN, 2009, P ROY SOC B-BIOL SCI, V276, P2509, DOI 10.1098/rspb.2008.1921; Joyce DJ, 2006, QUATERN INT, V142, P44, DOI 10.1016/j.quaint.2005.03.004; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Marlon JR, 2009, P NATL ACAD SCI USA, V106, P2519, DOI 10.1073/pnas.0808212106; Martin PS, 1984, QUATERNARY EXTINCTIO; MCINNES PF, 1992, ECOLOGY, V73, P2059, DOI 10.2307/1941455; Overstreet David F., 1997, Current Research in the Pleistocene, V14, P70; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Pinter N., 2008, GSA TODAY, V18, P37, DOI [10.1130/GSAT01801GW.1, DOI 10.1130/GSAT01801GW.1]; PRENTICE IC, 1991, ECOLOGY, V72, P2038, DOI 10.2307/1941558; Raper D, 2009, QUATERNARY RES, V71, P490, DOI 10.1016/j.yqres.2009.01.010; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Robinson GS, 2005, ECOL MONOGR, V75, P295, DOI 10.1890/03-4064; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; van Geel B, 2008, QUATERNARY RES, V69, P361, DOI 10.1016/j.yqres.2008.02.004; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams JW, 2001, ECOLOGY, V82, P3346	30	376	391	8	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1100	1103		10.1126/science.1179504	http://dx.doi.org/10.1126/science.1179504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965426	Green Published			2022-12-28	WOS:000271951000040
J	Colgin, LL; Denninger, T; Fyhn, M; Hafting, T; Bonnevie, T; Jensen, O; Moser, MB; Moser, EI				Colgin, Laura Lee; Denninger, Tobias; Fyhn, Marianne; Hafting, Torkel; Bonnevie, Tora; Jensen, Ole; Moser, May-Britt; Moser, Edvard I.			Frequency of gamma oscillations routes flow of information in the hippocampus	NATURE			English	Article							ENTORHINAL CORTEX; BEHAVING RAT; NEURONAL SYNCHRONIZATION; SPATIAL REPRESENTATION; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; THETA-RHYTHM; CA1; MEMORY; MODULATION	Gamma oscillations are thought to transiently link distributed cell assemblies that are processing related information(1,2), a function that is probably important for network processes such as perception(1-3), attentional selection(4) and memory(5,6). This 'binding' mechanism requires that spatially distributed cells fire together with millisecond range precision(7,8); however, it is not clear how such coordinated timing is achieved given that the frequency of gamma oscillations varies substantially across space and time, from similar to 25 to almost 150 Hz(1,9-13). Here we show that gamma oscillations in the CA1 area of the hippocampus split into distinct fast and slow frequency components that differentially couple CA1 to inputs from the medial entorhinal cortex, an area that provides information about the animal's current position(14-17), and CA3, a hippocampal subfield essential for storage of such information(14,18,19). Fast gamma oscillations in CA1 were synchronized with fast gamma in medial entorhinal cortex, and slow gamma oscillations in CA1 were coherent with slow gamma in CA3. Significant proportions of cells in medial entorhinal cortex and CA3 were phase-locked to fast and slow CA1 gamma waves, respectively. The two types of gamma occurred at different phases of the CA1 theta rhythm and mostly on different theta cycles. These results point to routeing of information as a possible function of gamma frequency variations in the brain and provide a mechanism for temporal segregation of potentially interfering information from different sources.	[Colgin, Laura Lee; Denninger, Tobias; Fyhn, Marianne; Hafting, Torkel; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway; [Colgin, Laura Lee; Denninger, Tobias; Fyhn, Marianne; Hafting, Torkel; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, MTFS, NO-7489 Trondheim, Norway; [Jensen, Ole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Radboud University Nijmegen	Colgin, LL (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, NO-7489 Trondheim, Norway.	laura.colgin@ntnu.no; edvard.moser@ntnu.no	Jensenq, Ole/D-2120-2010	Jensenq, Ole/0000-0001-8193-8348; Colgin, Laura/0000-0002-4853-8913; Hafting, Torkel/0000-0002-0928-3487	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank A. M. Amundsgaard, K. Haugen, K. Jenssen, E. Sjulstad, R. Skjerpeng and H. Waade for technical assistance, M. P. Witter for assistance with recording site localization, E. J. Henriksen and K. Jezek for donating rats for supplementary analyses, C. A. Barnes for helpful comments on the manuscript and G. Buzsaki and a number of other colleagues for helpful discussions. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Norwegian Research Council.	Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CHARPAK S, 1995, EUR J NEUROSCI, V7, P1548, DOI 10.1111/j.1460-9568.1995.tb01150.x; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kay Leslie M, 2003, J Integr Neurosci, V2, P31, DOI 10.1142/S0219635203000196; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; von der Malsburg C., 1994, MODELS NEURAL NETWOR, P95, DOI [DOI 10.1007/978-1-4612-4320-5_2, 10.1007/978-1-4612-4320-5_2]; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	30	848	862	3	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					353	U119		10.1038/nature08573	http://dx.doi.org/10.1038/nature08573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924214				2022-12-28	WOS:000271899300045
J	Gouridis, G; Karamanou, S; Gelis, I; Kalodimos, CG; Economou, A				Gouridis, Giorgos; Karamanou, Spyridoula; Gelis, Ioannis; Kalodimos, Charalampos G.; Economou, Anastassios			Signal peptides are allosteric activators of the protein translocase	NATURE			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; SEQUENCE RECOGNITION; SECY COMPLEX; SECRETION; MEMBRANE; CHANNEL; MOTOR; MUTATIONS; DOMAINS	Extra-cytoplasmic polypeptides are usually synthesized as 'preproteins' carrying amino-terminal, cleavable signal peptides(1) and secreted across membranes by translocases. The main bacterial translocase comprises the SecYEG protein-conducting channel and the peripheral ATPase motor SecA(2,3). Most proteins destined for the periplasm and beyond are exported post-translationally by SecA(2,3). Preprotein targeting to SecA is thought to involve signal peptides(4) and chaperones like SecB(5,6). Here we show that signal peptides have a new role beyond targeting: they are essential allosteric activators of the translocase. On docking on their binding groove on SecA, signal peptides act in trans to drive three successive states: first, 'triggering' that drives the translocase to a lower activation energy state; second, 'trapping' that engages non-native preprotein mature domains docked with high affinity on the secretion apparatus; and third, 'secretion' during which trapped mature domains undergo several turnovers of translocation in segments(7). A significant contribution by mature domains renders signal peptides less critical in bacterial secretory protein targeting than currently assumed. Rather, it is their function as allosteric activators of the translocase that renders signal peptides essential for protein secretion. A role for signal peptides and targeting sequences as allosteric activators may be universal in protein translocases.	[Gouridis, Giorgos; Karamanou, Spyridoula; Economou, Anastassios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; [Gouridis, Giorgos; Economou, Anastassios] Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece; [Gelis, Ioannis; Kalodimos, Charalampos G.] Rutgers State Univ, Piscataway, NJ 08854 USA	Foundation for Research & Technology - Hellas (FORTH); University of Crete; Rutgers State University New Brunswick	Economou, A (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	aeconomo@imbb.forth.gr	Karamanou, Spyridoula/H-7485-2018; Economou, Anastassios/P-8292-2017; Kalodimos, Charalampos/Q-9846-2018; Gouridis, GIORGOS/ABF-7948-2021	Karamanou, Spyridoula/0000-0002-8803-1404; Economou, Anastassios/0000-0002-1770-507X; Kalodimos, Charalampos/0000-0001-6354-2796; Gouridis, GIORGOS/0000-0002-2255-0455	European Community [LSHC-CT-2006-037834/Streptomics]; Greek General Secretariat of Research and the European Regional Development Fund [PENED03ED623]; US National Institutes of Health [GM73854]; American Heart Association; Onassis Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	European Community(European Commission); Greek General Secretariat of Research and the European Regional Development Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Onassis Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We are grateful to G. Dimitrakopoulos for help with MATLAB; M. Koukaki for constructs and materials; D. Boyd, S. Schulman and V. Koronakis for gifts of strains, plasmids and protocols; A. Kohen for advice on Arrhenius plots; A. Kuhn and K. Tokatlidis for comments. The research leading to these results has received funding from the European Community's Sixth Framework Programme (FP6/2002-2007) under grant agreement LSHC-CT-2006-037834/Streptomics (to A. E.), the Greek General Secretariat of Research and the European Regional Development Fund (PENED03ED623; to A. E.), the US National Institutes of Health grant GM73854 (to C. G. K.) and a Scientist Development Grant by the American Heart Association (to C. G. K.). G. G. is an Onassis Foundation predoctoral fellow.	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; OSBORNE RS, 1993, EMBO J, V12, P3391, DOI 10.1002/j.1460-2075.1993.tb06013.x; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Shimizu H, 1997, MOL MICROBIOL, V26, P1013, DOI 10.1046/j.1365-2958.1997.6392003.x; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Stan G, 2006, P NATL ACAD SCI USA, V103, P4433, DOI 10.1073/pnas.0600433103; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Vrontou E, 2004, J BIOL CHEM, V279, P22490, DOI 10.1074/jbc.M401008200; Zhou JH, 2005, MOL MICROBIOL, V58, P349, DOI 10.1111/j.1365-2958.2005.04842.x	30	105	106	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					363	U132		10.1038/nature08559	http://dx.doi.org/10.1038/nature08559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924216	Green Accepted			2022-12-28	WOS:000271899300047
J	Messiaen, L; Yao, S; Brems, H; Callens, T; Sathienkijkanchai, A; Denayer, E; Spencer, E; Arn, P; Babovic-Vuksanovic, D; Bay, C; Bobele, G; Cohen, BH; Escobar, L; Eunpu, D; Grebe, T; Greenstein, R; Hachen, R; Irons, M; Kronn, D; Lemire, E; Leppig, K; Lim, C; McDonald, M; Narayanan, V; Pearn, A; Pedersen, R; Powell, B; Shapiro, LR; Skidmore, D; Tegay, D; Thiese, H; Zackai, EH; Vijzelaar, R; Taniguchi, K; Ayada, T; Okamoto, F; Yoshimura, A; Parret, A; Korf, B; Legius, E				Messiaen, Ludwine; Yao, Suxia; Brems, Hilde; Callens, Tom; Sathienkijkanchai, Achara; Denayer, Ellen; Spencer, Emily; Arn, Pamela; Babovic-Vuksanovic, Dusica; Bay, Carolyn; Bobele, Gary; Cohen, Bruce H.; Escobar, Luis; Eunpu, Deborah; Grebe, Theresa; Greenstein, Robert; Hachen, Rachel; Irons, Mira; Kronn, David; Lemire, Edmond; Leppig, Kathleen; Lim, Cynthia; McDonald, Marie; Narayanan, Vinodh; Pearn, Amy; Pedersen, Robert; Powell, Berkley; Shapiro, Lawrence R.; Skidmore, David; Tegay, David; Thiese, Heidi; Zackai, Elaine H.; Vijzelaar, Raymon; Taniguchi, Koji; Ayada, Toranoshin; Okamoto, Fuyuki; Yoshimura, Akihiko; Parret, Annabel; Korf, Bruce; Legius, Eric			Clinical and Mutational Spectrum of Neurofibromatosis Type 1-like Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPRED1; RASA1	Context Autosomal dominant inactivating sprouty-related EVH1 domain containing protein 1 (SPRED1) mutations have recently been described in individuals presenting mainly with cafe au lait macules (CALMs), axillary freckling, and macrocephaly. The extent of the clinical spectrum of this new disorder needs further delineation. Objective To determine the frequency, mutational spectrum, and phenotype of neurofibromatosis type 1-like syndrome (NFLS) in a large cohort of patients. Design, Setting, and Participants In a cross-sectional study, 23 unrelated probands carrying a SPRED1 mutation identified through clinical testing participated with their families in a genotype-phenotype study (2007-2008). In a second cross-sectional study, 1318 unrelated anonymous samples collected in 2003-2007 from patients with a broad range of signs typically found in neurofibromatosis type 1 (NF1) but no detectable NF1 germline mutation underwent SPRED1 mutation analysis. Main Outcome Measures Comparison of aggregated clinical features in patients with or without a SPRED1 or NF1 mutation. Functional assays were used to evaluate the pathogenicity of missense mutations. Results Among 42 SPRED1-positive individuals from the clinical cohort, 20 (48%; 95% confidence interval [CI], 32%-64%) fulfilled National Institutes of Health (NIH) NF1 diagnostic criteria based on the presence of more than 5 CALMs with or without freckling or an NF1-compatible family history. None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas. In the anonymous cohort of 1318 individuals, 34 different SPRED1 mutations in 43 probands were identified: 27 pathogenic mutations in 34 probands and 7 probable nonpathogenic missense mutations in 9 probands. Of 94 probands with familial CALMs with or without freckling and no other NF1 features, 69 (73%; 95% CI, 63%-80%) had an NF1 mutation and 18 (19%; 95% CI, 12%-29%) had a pathogenic SPRED1 mutation. In the anonymous cohort, 1.9% (95% CI, 1.2%-2.9%) of individuals with the clinical diagnosis of NF1 according to the NIH criteria had NFLS. Conclusions A high SPRED1 mutation detection rate was found in NF1 mutation negative families with an autosomal dominant phenotype of CALMs with or without freckling and no other NF1 features. Among individuals in this study, NFLS was not associated with the peripheral and central nervous system tumors seen in NF1. JAMA. 2009; 302(19): 2111-2118	[Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL 35294 USA; [Brems, Hilde; Denayer, Ellen; Legius, Eric] Catholic Univ Louvain, Dept Human Genet, B-3000 Leuven, Belgium; [Arn, Pamela; Eunpu, Deborah] Nemours Childrens Clin, Jacksonville, FL USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Coll Med, Rochester, MN USA; [Bay, Carolyn] Univ Kentucky, Dept Pediat, Div Clin Biochem Genet & Dysmorphol, Lexington, KY 40506 USA; [Bobele, Gary] Driscoll Childrens Hosp, Corpus Christi, TX USA; [Cohen, Bruce H.] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA; [Escobar, Luis] St Vincent Childrens Hosp, Med Genet & Neurodev Ctr, Indianapolis, IN USA; [Grebe, Theresa; Lim, Cynthia; Narayanan, Vinodh] St Josephs Hosp, Phoenix Genet Program & Child Neurol, Phoenix, AZ USA; [Greenstein, Robert] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Div Human Genet, Hartford, CT USA; [Hachen, Rachel; Zackai, Elaine H.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Human Genet, Philadelphia, PA 19104 USA; [Irons, Mira] Childrens Hosp Boston, Div Genet, Boston, MA USA; [Kronn, David; Shapiro, Lawrence R.] New York Med Coll, Div Med Genet & Inherited Metab Dis, Dept Pediat, Valhalla, NY 10595 USA; [Kronn, David; Shapiro, Lawrence R.] Maria Fareri Childrens Hosp, Westchester Med Ctr, Valhalla, NY USA; [Lemire, Edmond; Pearn, Amy] Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada; [Leppig, Kathleen; Thiese, Heidi] Univ Washington, Genet Serv, Grp Hlth Cooperat, Seattle, WA 98195 USA; [Leppig, Kathleen; Thiese, Heidi] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [McDonald, Marie] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Pedersen, Robert] Tripler AMC, Honolulu, HI USA; [Powell, Berkley] Childrens Hosp Cent Calif, Madera, CA USA; [Skidmore, David] Dalhousie Univ, Dept Pediat, Maritime Med Genet Serv, Halifax, NS, Canada; [Tegay, David] New York Coll Osteopath Med, Old Westbury, NY USA; [Vijzelaar, Raymon] MRC Holland, Amsterdam, Netherlands; [Taniguchi, Koji; Ayada, Toranoshin; Okamoto, Fuyuki; Yoshimura, Akihiko] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 812, Japan; [Taniguchi, Koji; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo, Japan; [Taniguchi, Koji; Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Parret, Annabel] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany	University of Alabama System; University of Alabama Birmingham; Mayo Clinic; University of Kentucky; Cleveland Clinic Foundation; St. Joseph's Hospital and Medical Center; University of Connecticut; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Boston Children's Hospital; New York Medical College; Westchester Medical Center; University of Saskatchewan; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Dalhousie University; New York Institute Technology; Kyushu University; Keio University; Japan Science & Technology Agency (JST); European Molecular Biology Laboratory (EMBL)	Messiaen, L (corresponding author), Univ Alabama Birmingham, Dept Genet, Med Genom Lab, 720 20th St S, Birmingham, AL 35294 USA.	lmessiaen@genetics.uab.edu	Vijzelaar, Raymon/D-6311-2016; Korf, Bruce R/H-4882-2012; Brems, Hilde/AAN-4075-2020; Yoshimura, Akihiko/K-5515-2013; Legius, Eric/H-1735-2011	Parret, Annabel/0000-0003-0635-8890; Arn, Pamela/0000-0002-8441-7764; Narayanan, Vinodh/0000-0002-0658-3847; Tegay, David/0000-0002-1573-9954; Pearn, Amy/0000-0001-9566-0463; Spencer, Emily/0000-0003-2650-4357	National Institute of Child Health and Human Development UAB Intellectual and Developmental Disabilities Research Center [P30-HD038985]; Institute for Promotion of Innovation Through Science and Technology, Flanders, Belgium; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0096.02]; Federal Office for Scientific, Technical and Cultural Affairs of Belgium [P5/25]; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation in Japan; Children's Tumor Foundation Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development UAB Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Institute for Promotion of Innovation Through Science and Technology, Flanders, Belgium; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Federal Office for Scientific, Technical and Cultural Affairs of Belgium; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); Children's Tumor Foundation Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding/Support: This work was supported by National Institute of Child Health and Human Development UAB Intellectual and Developmental Disabilities Research Center grant P30-HD038985(to Drs Messiaen and Korf); the Institute for Promotion of Innovation Through Science and Technology, Flanders, Belgium (to Ms Brems); research grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0096.02; to Dr Legius); the Interuniversity Attraction Poles, granted by the Federal Office for Scientific, Technical and Cultural Affairs of Belgium (2007-2011; P5/25; to Dr Legius); a Concerted Action Grant from Katholieke Universiteit Leuven; special Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Dr Yoshimura); and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation in Japan (to Dr Yoshimura); and a Children's Tumor Foundation Young Investigator Award (to Dr Parret). The Wilderman family provided a donation (to Dr Messiaen) to help support NF1 research for children with cafe au lait spots only.	ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Bremmer JN, 2007, STUD HIS ANTH REL, V1, P1; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Denayer E, 2008, J MED GENET, V45, P695, DOI 10.1136/jmg.2007.055772; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Friedman JM, 1999, AM J MED GENET, V89, P1; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Pasmant E, 2009, J MED GENET, V46, P425, DOI 10.1136/jmg.2008.065243; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	17	119	122	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2111	2118		10.1001/jama.2009.1663	http://dx.doi.org/10.1001/jama.2009.1663			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920235	Bronze			2022-12-28	WOS:000271873900020
J	Chen, YG; Wang, XF				Chen, Ye-Guang; Wang, Xiao-Fan			Finale: The Last Minutes of Smads	CELL			English	Editorial Material							BETA; PHOSPHORYLATION; LINKER		[Chen, Ye-Guang] Tsinghua Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Tsinghua University; Duke University	Chen, YG (corresponding author), Tsinghua Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn; wang0011@mc.duke.edu	Chen, Ye-Guang/L-6998-2019					Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Zhang W, 2009, P NATL ACAD SCI USA, V106, P15679, DOI 10.1073/pnas.0908279106; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	9	4	4	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 13	2009	139	4					658	660		10.1016/j.cell.2009.10.038	http://dx.doi.org/10.1016/j.cell.2009.10.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914161	Bronze			2022-12-28	WOS:000271747200010
J	Kett, M; van Ommeren, M				Kett, Maria; van Ommeren, Mark			Disability, conflict, and emergencies	LANCET			English	Editorial Material							SERVICE		[Kett, Maria] UCL, Leonard Cheshire Cente Disabil & Inclus Dev, London WC1H 0BT, England; [van Ommeren, Mark] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	University of London; University College London; World Health Organization	Kett, M (corresponding author), UCL, Leonard Cheshire Cente Disabil & Inclus Dev, London WC1H 0BT, England.	m.kett@ucl.ac.uk	Kett, Maria/AAA-3421-2022	Kett, Maria/0000-0002-1975-7674				Atijosan O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002851; CEVRA N, 2009, J DISABIL INT DEV, V1, P4; Department for International Development, 2000, DISABILITY POVERTY D; dos Santos-Zingale M, 2006, DISABIL SOC, V21, P243, DOI 10.1080/09687590600617428; Jones L, 2009, LANCET, V374, P654, DOI 10.1016/S0140-6736(09)61253-8; Kett, 2007, DISABILITY DISASTERS; PARR AR, 1987, DISASTERS, V11, P148, DOI 10.1111/j.1467-7717.1987.tb00629.x; Rockhold P, 2009, J DISABIL INT DEV, V1, P4; Silove D, 2004, AUST NZ J PSYCHIAT, V38, P929, DOI 10.1080/j.1440-1614.2004.01483.x; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; van Ommeren M, 2003, LANCET, V362, P574, DOI 10.1016/S0140-6736(03)14123-2; Women's Commission for Refugee Women and Children, 2008, DIS REF CONFL AFF PO	12	23	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1801	1803		10.1016/S0140-6736(09)62024-9	http://dx.doi.org/10.1016/S0140-6736(09)62024-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944849				2022-12-28	WOS:000272370200008
J	Treasure, J; Claudino, AM; Zucker, N				Treasure, Janet; Claudino, Angelica M.; Zucker, Nancy			Eating disorders	LANCET			English	Article							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; COMPULSIVE PERSONALITY-DISORDER; PLACEBO-CONTROLLED TRIAL; BODY-MASS INDEX; ANOREXIA-NERVOSA; BULIMIA-NERVOSA; DOUBLE-BLIND; ANXIETY DISORDERS; FAMILY-THERAPY	This Seminar adds to the previous Lancet Seminar about eating disorders, published in 2003, with an emphasis on the biological contributions to illness onset and maintenance. The diagnostic criteria are in the process of review, and the probable four new categories are: anorexia nervosa, bulimia nervosa, binge eating disorder, and eating disorder not otherwise specified. These categories will also be broader than they were previously, which will affect the population prevalence; the present lifetime prevalence of all eating disorders is about 5%. Eating disorders can be associated with profound and protracted physical and psychosocial morbidity. The causal factors underpinning eating disorders have been clarified by understanding about the central control of appetite. Cultural, social, and interpersonal elements can trigger onset, and changes in neural networks can sustain the illness. Overall, apart from studies reporting pharmacological treatments for binge eating disorder, advances in treatment for adults have been scarce, other than interest in new forms of treatment delivery.	[Treasure, Janet] Kings Coll London, Inst Psychiat, Sect Eating Disorders, London SE5 8AF, England; [Claudino, Angelica M.] Univ Fed Sao Paulo, Dept Psychiat, Eating Disorders Programme, Sao Paulo, Brazil; [Zucker, Nancy] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Zucker, Nancy] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of London; King's College London; Universidade Federal de Sao Paulo (UNIFESP); Duke University; Duke University	Treasure, J (corresponding author), Kings Coll London, Inst Psychiat, Sect Eating Disorders, De Crespigny Pk,Denmark Hill, London SE5 8AF, England.	janet.treasure@kcl.ac.uk	Claudino, Angélica M./GWQ-5511-2022; Claudino, Angélica M/G-5330-2012; Pritchett-Corning, Kathleen R/E-7675-2011; Zamora, Cristina Cuesta/E-2864-2016	Claudino, Angélica M./0000-0002-0209-9409; Claudino, Angélica M/0000-0002-0209-9409; Pritchett-Corning, Kathleen R/0000-0002-1888-4751; Zamora, Cristina Cuesta/0000-0003-1121-9561; Treasure, Janet/0000-0003-0871-4596	UK Department of Health National Institute for Health Research (NIHR) [RP.PG.0606.1043]; Institute of Psychiatry, King's College London; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Ministry of Education, Brazil; US National Institutes of Health [K23.MH.070418]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH070418] Funding Source: NIH RePORTER	UK Department of Health National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Institute of Psychiatry, King's College London; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education, Brazil; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the anonymous reviewers for their comments on early drafts of this Seminar. JT was partly funded by a UK Department of Health National Institute for Health Research (NIHR) Programme Grant for Applied Research (reference number RP.PG.0606.1043) and receives support from the NIHR Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London. The views expressed herein are not necessarily those of the Department of Health or NIHR. AMC was funded by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Ministry of Education, Brazil, with a post-doctoral grant at the Institute of Psychiatry, King's College London, during 2008 (during the writing and review process of this Seminar). NZ is partly funded by the US National Institutes of Health (K23.MH.070418).	Agras WS, 1997, J CONSULT CLIN PSYCH, V65, P343, DOI 10.1037/0022-006X.65.2.343; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; American Psychiatric Association, 2006, PRACT GUID TREATM PA, P1097; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; Appolinario JC, 2003, ARCH GEN PSYCHIAT, V60, P1109, DOI 10.1001/archpsyc.60.11.1109; Avena NM, 2007, EXP CLIN PSYCHOPHARM, V15, P481, DOI 10.1037/1064-1297.15.5.481; Bacaltchuk J, 2003, COCHRANE DB SYST REV, V4; Bacanu SA, 2005, AM J MED GENET B, V139B, P61, DOI 10.1002/ajmg.b.30226; Baker JH, 2007, INT J EAT DISORDER, V40, P673, DOI 10.1002/eat.20472; Bergen AW, 2003, CNS NEUROL DISORD-DR, V2, P41, DOI 10.2174/1568007033338760; Berkman ND, 2007, INT J EAT DISORDER, V40, P293, DOI 10.1002/eat.20369; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Bissada H, 2008, AM J PSYCHIAT, V165, P1281, DOI 10.1176/appi.ajp.2008.07121900; Boggiano MM, 2007, INT J OBESITY, V31, P1357, DOI 10.1038/sj.ijo.0803614; Bosanac P, 2005, AUST NZ J PSYCHIAT, V39, P146, DOI 10.1111/j.1440-1614.2005.01536.x; Brambilla F, 2007, INT CLIN PSYCHOPHARM, V22, P197, DOI 10.1097/YIC.0b013e328080ca31; Brownley KA, 2007, INT J EAT DISORDER, V40, P337, DOI 10.1002/eat.20370; Bulik CM, 2004, DRUG TODAY, V40, P741, DOI 10.1358/dot.2004.40.9.850494; Bulik CM, 2003, AM J HUM GENET, V72, P200, DOI 10.1086/345801; Bulik CM, 2007, ANNU REV NUTR, V27, P263, DOI 10.1146/annurev.nutr.27.061406.093713; Bulik CM, 2009, INT J EAT DISORDER, V42, P9, DOI 10.1002/eat.20578; Byford S, 2007, BRIT J PSYCHIAT, V191, P436, DOI 10.1192/bjp.bp.107.036806; Calero-Elvira A, 2009, EUR EAT DISORD REV, V17, P243, DOI 10.1002/erv.936; Castro-Fornieles J, 2008, J PSYCHIATR RES, V43, P331, DOI 10.1016/j.jpsychires.2008.03.013; Chen EY, 2008, INT J EAT DISORDER, V41, P505, DOI 10.1002/eat.20522; Chen H, 2008, EUR EAT DISORD REV, V16, P375, DOI 10.1002/erv.837; Claudino A. M., 2006, COCHRANE DB SYST REV, V1; Claudino AM, 2007, J CLIN PSYCHIAT, V68, P1324, DOI 10.4088/JCP.v68n0901; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Crow SJ, 2009, INT J EAT DISORDER, V42, P1, DOI 10.1002/eat.20576; Currin L, 2005, BRIT J PSYCHIAT, V186, P132, DOI 10.1192/bjp.186.2.132; Davison GC, 2007, APPL PREV PSYCHOL, V12, P19, DOI 10.1016/j.appsy.2007.07.008; Ferreira JED, 2008, APPETITE, V51, P249, DOI 10.1016/j.appet.2008.02.015; Devlin MJ, 2007, OBESITY, V15, P1702, DOI 10.1038/oby.2007.203; Devlin MJ, 2005, OBES RES, V13, P1077, DOI 10.1038/oby.2005.126; Eddy KT, 2008, AM J PSYCHIAT, V165, P245, DOI 10.1176/appi.ajp.2007.07060951; Eiro M, 2002, NEW ENGL J MED, V346, P140, DOI 10.1056/NEJM200201103460218; Eisler I, 2007, J CHILD PSYCHOL PSYC, V48, P552, DOI 10.1111/j.1469-7610.2007.01726.x; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8; Fairburn CG, 2007, INT J EAT DISORDER, V40, pS107, DOI 10.1002/eat.20460; Fairburn Christopher G., 1993, P361; Fairburn CG, 2009, AM J PSYCHIAT, V166, P311, DOI 10.1176/appi.ajp.2008.08040608; Favaro A, 2006, ARCH GEN PSYCHIAT, V63, P82, DOI 10.1001/archpsyc.63.1.82; Fichter MM, 2008, INT J EAT DISORDER, V41, P577, DOI 10.1002/eat.20539; Fittig E, 2008, EUR EAT DISORD REV, V16, P341, DOI 10.1002/erv.883; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Gadalla T, 2007, ARCH WOMEN MENT HLTH, V10, P133, DOI 10.1007/s00737-007-0184-x; Gillberg IC, 1996, COMPR PSYCHIAT, V37, P23, DOI 10.1016/S0010-440X(96)90046-2; Godart NT, 2003, PSYCHIAT RES, V117, P245, DOI 10.1016/S0165-1781(03)00038-6; Golay A, 2005, OBES RES, V13, P1701, DOI 10.1038/oby.2005.208; Gowers S, 2004, J CHILD PSYCHOL PSYC, V45, P63, DOI 10.1046/j.0021-9630.2003.00309.x; Grilo CM, 2005, BIOL PSYCHIAT, V57, P1193, DOI 10.1016/j.biopsych.2005.03.001; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Guerdjikova AI, 2008, HUM PSYCHOPHARM CLIN, V23, P1, DOI 10.1002/hup.899; Hailey D, 2008, CAN J PSYCHIAT, V53, P769, DOI 10.1177/070674370805301109; Halmi KA, 2005, INT J EAT DISORDER, V38, P371, DOI 10.1002/eat.20190; Harrison A, 2009, CLIN PSYCHOL PSYCHOT, V16, P348, DOI 10.1002/cpp.628; Hay P, 2004, AUST NZ J PSYCHIAT, V38, P659, DOI 10.1080/j.1440-1614.2004.01449.x; Hay P.J., 2004, COCHRANE DB SYST REV, V3; HAY PJ, 2008, CLIN EVID       0612; HAY PPJ, 2008, COCHRANE DB SYST REV, V1; HEBEBRAND J, 1995, HUM GENET, V95, P1; Hedges DW, 2003, J CLIN PSYCHIAT, V64, P1449, DOI 10.4088/JCP.v64n1208; Hjern A, 2006, BRIT J PSYCHIAT, V189, P428, DOI 10.1192/bjp.bp.105.018820; Hollander E, 2007, CNS SPECTRUMS, V12, P5, DOI 10.1017/S1092852900002467; Hudson JI, 2007, INT J EAT DISORDER, V40, pS76, DOI 10.1002/eat.20457; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Hudson JI, 2006, ARCH GEN PSYCHIAT, V63, P313, DOI 10.1001/archpsyc.63.3.313; IE GD, 2007, ARCH GEN PSYCHIAT, V64, P1049; Jacobi C, 2004, PSYCHOL BULL, V130, P19, DOI 10.1037/0033-2909.130.1.19; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Javaras KN, 2008, INT J EAT DISORDER, V41, P174, DOI 10.1002/eat.20484; Kaplan AS, 2009, PSYCHOL MED, V39, P1037, DOI 10.1017/S003329170800442X; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Kaye WH, 2001, BIOL PSYCHIAT, V49, P644, DOI 10.1016/S0006-3223(00)01013-1; Keel PK, 2008, J CLIN CHILD ADOLESC, V37, P39, DOI 10.1080/15374410701817832; Keel PK, 2005, INT J EAT DISORDER, V38, P99, DOI 10.1002/eat.20168; Keys A, 1950, BIOL HUMAN STARVATIO; Klump KL, 2009, INT J EAT DISORDER, V42, P97, DOI 10.1002/eat.20589; Lee M, 2004, CLIN PSYCHOL REV, V24, P215, DOI 10.1016/j.cpr.2003.10.004; Liao PC, 2009, J CLIN EXP NEUROPSYC, V31, P455, DOI 10.1080/13803390802251378; Lilenfeld LRR, 2006, CLIN PSYCHOL REV, V26, P299, DOI 10.1016/j.cpr.2005.10.003; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; Lock J, 2005, J AM ACAD CHILD PSY, V44, P632, DOI 10.1097/01.chi.0000161647.82775.0a; Lopez C, 2008, PSYCHOL MED, V38, P1393, DOI 10.1017/S0033291708003486; Mangweth B, 2003, PSYCHOL MED, V33, P1319, DOI 10.1017/S0033291703008250; Marcus MD, 2009, INT J EAT DISORDER, V42, P739, DOI 10.1002/eat.20725; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; McElroy SL, 2007, BIOL PSYCHIAT, V61, P1039, DOI 10.1016/j.biopsych.2006.08.008; McElroy SL, 2007, J CLIN PSYCHIAT, V68, P390, DOI 10.4088/JCP.v68n0306; McElroy SL, 2006, BIPOLAR DISORD, V8, P686, DOI 10.1111/j.1399-5618.2006.00401.x; McElroy SL, 2006, J CLIN PSYCHIAT, V67, P1897, DOI 10.4088/JCP.v67n1209; Mehler PS, 2009, INT J EAT DISORDER, V42, P195, DOI 10.1002/eat.20593; Micali N, 2007, BRIT J PSYCHIAT, V190, P255, DOI 10.1192/bjp.bp.106.020768; Milano W, 2005, ADV THER, V22, P278, DOI 10.1007/BF02849936; Mitchell JE, 2008, BEHAV RES THER, V46, P581, DOI 10.1016/j.brat.2008.02.004; Mitchell JE, 2007, INT J EAT DISORDER, V40, P95, DOI 10.1002/eat.20343; Nakazato M, 2009, PSYCHOL MED, V39, P1029, DOI 10.1017/S0033291708004108; *NAT COLL CTR AC C, 2006, NUTR SUPP AD NICE CL, V32; National Collaborating Centre for Mental Health, 2004, NAT CLIN PRACT GUID; Nazar BP, 2008, REV BRAS PSIQUIATR, V30, P384, DOI 10.1590/S1516-44462008000400014; Neumark-Sztainer D, 2000, ARCH PEDIAT ADOL MED, V154, P569, DOI 10.1001/archpedi.154.6.569; Nickel C, 2005, INT J EAT DISORDER, V38, P295, DOI 10.1002/eat.20202; Olivry E, 1999, PRESSE MED, V28, P100; Pallister E, 2008, CLIN PSYCHOL REV, V28, P366, DOI 10.1016/j.cpr.2007.07.001; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Patton GC, 2008, BRIT J PSYCHIAT, V192, P294, DOI 10.1192/bjp.bp.106.031112; Perkins SJ, 2006, COCHRANE DB SYST REV, V3; Pope HG, 2006, AM J PSYCHIAT, V163, P2181, DOI 10.1176/appi.ajp.163.12.2181; Reas DL, 2008, OBESITY, V16, P2024, DOI 10.1038/oby.2008.333; Ribases M, 2005, EUR J HUM GENET, V13, P428, DOI 10.1038/sj.ejhg.5201351; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Robinson P, 2008, EUR EAT DISORD REV, V16, P84, DOI 10.1002/erv.818; Romano SJ, 2002, AM J PSYCHIAT, V159, P96, DOI 10.1176/appi.ajp.159.1.96; Schmidt U, 2007, AM J PSYCHIAT, V164, P591, DOI 10.1176/appi.ajp.164.4.591; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Shapiro JR, 2007, INT J EAT DISORDER, V40, P321, DOI 10.1002/eat.20372; Shoebridge P, 2000, BRIT J PSYCHIAT, V176, P132, DOI 10.1192/bjp.176.2.132; Sollid CP, 2004, AM J OBSTET GYNECOL, V190, P206, DOI 10.1016/S0002-9378(03)00900-1; Stefano Sergio Carlos, 2008, Eat Behav, V9, P129, DOI 10.1016/j.eatbeh.2007.03.006; Stein A, 2006, BRIT J PSYCHIAT, V189, P324, DOI 10.1192/bjp.bp.105.014316; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Strober M, 2007, INT J EAT DISORDER, V40, pS46, DOI 10.1002/eat.20429; Sysko R, 2008, INT J EAT DISORDER, V41, P97, DOI 10.1002/eat.20475; Thomas JJ, 2009, PSYCHOL BULL, V135, P407, DOI 10.1037/a0015326; Van Den Eynde F, 2009, CHILD ADOL PSYCH CL, V18, P95, DOI 10.1016/j.chc.2008.07.016; Vocks S., 2009, INT J EAT DISORDER, V43, P207, DOI [10.1002/eat.20696, DOI 10.1002/EAT.20696]; VON HA, 2008, AUST NZ J PSYCHIAT, V42, P108; Wade TD, 2000, AM J PSYCHIAT, V157, P469, DOI 10.1176/appi.ajp.157.3.469; Wade TD, 2007, INT J EAT DISORDER, V40, P679, DOI 10.1002/eat.20461; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Wagner A, 2010, INT J EAT DISORDER, V43, P289, DOI 10.1002/eat.20699; Walsh BT, 2006, JAMA-J AM MED ASSOC, V295, P2605, DOI 10.1001/jama.295.22.2605; Walsh BT, 2009, INT J EAT DISORDER, V42, P754, DOI 10.1002/eat.20722; Wentz E, 2005, EUR CHILD ADOLES PSY, V14, P431, DOI 10.1007/s00787-005-0494-3; *WHO EUR, 2005, MENT HLTH CHILDR AD; Wilfley DE, 2002, ARCH GEN PSYCHIAT, V59, P713, DOI 10.1001/archpsyc.59.8.713; Wilfley DE, 2008, AM J PSYCHIAT, V165, P51, DOI 10.1176/appi.ajp.2007.06121970; Wilfley DE, 2007, INT J EAT DISORDER, V40, pS123, DOI 10.1002/eat.20436; Williams PM, 2008, AM FAM PHYSICIAN, V77, P187; Williamson DA, 2007, INT J EAT DISORDER, V40, pS72, DOI 10.1002/eat.20473; Wilson GT, 2007, AM PSYCHOL, V62, P199, DOI 10.1037/0003-066X.62.3.199; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; ZABLANA M, 2009, EUR EAT DISORD REV, V17, P327; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; Zucker N L, 2006, Eat Weight Disord, V11, P78; Zucker NL, 2007, PSYCHOL BULL, V133, P976, DOI 10.1037/0033-2909.133.6.976	150	481	494	3	234	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					583	593		10.1016/S0140-6736(09)61748-7	http://dx.doi.org/10.1016/S0140-6736(09)61748-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	19931176				2022-12-28	WOS:000274941900032
J	Lanford, RE; Hildebrandt-Eriksen, ES; Petri, A; Persson, R; Lindow, M; Munk, ME; Kauppinen, S; Orum, H				Lanford, Robert E.; Hildebrandt-Eriksen, Elisabeth S.; Petri, Andreas; Persson, Robert; Lindow, Morten; Munk, Martin E.; Kauppinen, Sakari; Orum, Henrik			Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection	SCIENCE			English	Article							GENE-EXPRESSION; INTERFERON-ALPHA; CHIMPANZEES; RIBAVIRIN; LIVER; KINETICS	The liver-expressed microRNA-122 (miR-122) is essential for hepatitis C virus (HCV) RNA accumulation in cultured liver cells, but its potential as a target for antiviral intervention has not been assessed. We found that treatment of chronically infected chimpanzees with a locked nucleic acid (LNA)-modified oligonucleotide (SPC3649) complementary to miR-122 leads to long-lasting suppression of HCV viremia, with no evidence of viral resistance or side effects in the treated animals. Furthermore, transcriptome and histological analyses of liver biopsies demonstrated derepression of target mRNAs with miR-122 seed sites, down-regulation of interferon-regulated genes, and improvement of HCV-induced liver pathology. The prolonged virological response to SPC3649 treatment without HCV rebound holds promise of a new antiviral therapy with a high barrier to resistance.	[Hildebrandt-Eriksen, Elisabeth S.; Petri, Andreas; Persson, Robert; Lindow, Morten; Munk, Martin E.; Kauppinen, Sakari; Orum, Henrik] Santaris Pharma, DK-2970 Horsholm, Denmark; [Lanford, Robert E.] SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX 78227 USA; [Lanford, Robert E.] SW Fdn Biomed Res, SW Natl Primate Res Ctr, San Antonio, TX 78227 USA; [Kauppinen, Sakari] Univ Aalborg, Copenhagen Inst Technol, DK-2750 Ballerup, Denmark	Texas Biomedical Research Institute; Texas Biomedical Research Institute; Aalborg University	Orum, H (corresponding author), Santaris Pharma, Kogle Alle 6, DK-2970 Horsholm, Denmark.	hoe@santaris.com			Danish National Advanced Technology Foundation; NIH [P51 RR13986]; National Center for Research Resources [C06 RR 12087]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986, C06RR012087] Funding Source: NIH RePORTER	Danish National Advanced Technology Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank D. Chavez, B. Guerra, and H. Lee for excellent technical assistance; K. Brasky for veterinary support; L. Giavedoni for immunological analyses; P. Giclas for complement analyses; and E. Dick for pathology examinations. Supported by a grant from the Danish National Advanced Technology Foundation (S. K.); the primate studies performed at the Southwest National Primate Research Center are supported by NIH base grant P51 RR13986 and by the National Center for Research Resources (Research Facilities Improvement Program grant C06 RR 12087). The expression microarray data have been deposited in the ArrayExpress repository under accession number E-MEXP-2375. The GEO accession number for the sequencing data is GSE18919. E. S. H-E., A. P., and S. K. have a pending patent on the method of treatment.	Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Chen CM, 2007, ANTIMICROB AGENTS CH, V51, P4290, DOI 10.1128/AAC.00723-07; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; Lanford RE, 2007, HEPATOLOGY, V46, P999, DOI 10.1002/hep.21776; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105	18	1301	1419	1	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					198	201		10.1126/science.1178178	http://dx.doi.org/10.1126/science.1178178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965718	Green Accepted			2022-12-28	WOS:000273394000034
J	Liu, FQ; Marquardt, S; Lister, C; Swiezewski, S; Dean, C				Liu, Fuquan; Marquardt, Sebastian; Lister, Clare; Swiezewski, Szymon; Dean, Caroline			Targeted 3 ' Processing of Antisense Transcripts Triggers Arabidopsis FLC Chromatin Silencing	SCIENCE			English	Article							AUTONOMOUS PATHWAY; FLOWERING-TIME; RNA; FCA; TERMINATION; REGULATORS; PROTEINS; REQUIRES; REVEALS; LOCUS	Noncoding RNA is emerging as an important regulator of gene expression in many organisms. We are characterizing RNA-mediated chromatin silencing of the Arabidopsis major floral repressor gene, FLC. Through suppressor mutagenesis, we identify a requirement for CstF64 and CstF77, two conserved RNA 3'-end-processing factors, in FLC silencing. However, FLC sense transcript 3' processing is not affected in the mutants. Instead, CstF64 and CstF77 are required for 3' processing of FLC antisense transcripts. A specific RNA-binding protein directs their activity to a proximal antisense polyadenylation site. This targeted processing triggers localized histone demethylase activity and results in reduced FLC sense transcription. Targeted 3' processing of antisense transcripts may be a common mechanism triggering transcriptional silencing of the corresponding sense gene.	[Liu, Fuquan; Marquardt, Sebastian; Lister, Clare; Swiezewski, Szymon; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Liu, Fuquan/AGD-6751-2022; Marquardt, Sebastian/AAU-8009-2021; Marquardt, Sebastian/C-2902-2015; Marquardt, Sebastian/B-7606-2013	Marquardt, Sebastian/0000-0003-1709-2717; Marquardt, Sebastian/0000-0003-1709-2717; Swiezewski, Szymon/0000-0002-2007-2779; Dean, Caroline/0000-0002-6555-3525	BBSRC [BBS/E/J/000CA305, BB/G01406X/1, BB/D010799/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D010799/1, BB/G01406X/1, BBS/E/J/000CA305] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Bai Y, 2007, MOL CELL, V25, P863, DOI 10.1016/j.molcel.2007.01.034; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Manzano D, 2009, P NATL ACAD SCI USA, V106, P8772, DOI 10.1073/pnas.0903444106; MINVIELLESEBASTIA L, 1991, MOL CELL BIOL, V11, P3075, DOI 10.1128/MCB.11.6.3075; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Mylne J, 2004, COLD SPRING HARB SYM, V69, P457, DOI 10.1101/sqb.2004.69.457; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Simonelig M, 1996, GENETICS, V142, P1225; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	26	300	318	11	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					94	97		10.1126/science.1180278	http://dx.doi.org/10.1126/science.1180278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19965720				2022-12-28	WOS:000273395400039
J	Pandey, M; Syed, S; Donmez, I; Patel, G; Ha, T; Patel, SS				Pandey, Manjula; Syed, Salman; Donmez, Ilker; Patel, Gayatri; Ha, Taekjip; Patel, Smita S.			Coordinating DNA replication by means of priming loop and differential synthesis rate	NATURE			English	Article							LAGGING-STRAND SYNTHESIS; RING-SHAPED HELICASE; ESCHERICHIA-COLI; MINICIRCLE SUBSTRATE; REPLISOME; PRIMASE; PROCESSIVITY; DEFICIENT; MECHANISM; TEMPLATE	Genomic DNA is replicated by two DNA polymerase molecules, one of which works in close association with the helicase to copy the leading-strand template in a continuous manner while the second copies the already unwound lagging-strand template in a discontinuous manner through the synthesis of Okazaki fragments(1,2). Considering that the lagging-strand polymerase has to recycle after the completion of every Okazaki fragment through the slowsteps of primer synthesis and hand-off to the polymerase(3-5), it is not understood how the two strands are synthesized with the same net rate(6-9). Here we show, using the T7 replication proteins(10,11), that RNA primers are made 'on the fly' during ongoing DNA synthesis and that the leading-strand T7 replisome does not pause during primer synthesis, contrary to previous reports(12,13). Instead, the leading-strand polymerase remains limited by the speed of the helicase(14); it therefore synthesizes DNA more slowly than the lagging-strand polymerase. We show that the primase-helicase T7 gp4 maintains contact with the priming sequence during ongoing DNA synthesis; the nascent lagging-strand template therefore organizes into a priming loop that keeps the primer in physical proximity to the replication complex. Our findings provide three synergistic mechanisms of coordination: first, primers are made concomitantly with DNA synthesis; second, the priming loop ensures efficient primer use and hand-off to the polymerase; and third, the lagging-strand polymerase copies DNA faster, which allows it to keep up with leading-strand DNA synthesis overall.	[Syed, Salman; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Pandey, Manjula; Donmez, Ilker; Patel, Gayatri; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ha, T (corresponding author), Howard Hughes Med Inst, Urbana, IL 61801 USA.	tjha@illinois.edu; patelss@umdnj.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	NIH [GM55310, GM065367]; NSF [0822613, 0646550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM055310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. M. Drain for a critical reading of the paper, K. Picha and S. Patel for preparation of the minicircle DNA, and S. Arslan and K. S. Lee for help with single-molecule FRET data analysis. This work was supported by NIH grants GM55310 ( S. S. P.) and GM065367 ( T. H.) and NSF grants 0822613 and 0646550 ( T. H.). T. H. is an investigator with the Howard Hughes Medical Institute.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Donmez I, 2008, EMBO J, V27, P1718, DOI 10.1038/emboj.2008.100; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Sanborn ME, 2007, J PHYS CHEM B, V111, P11064, DOI 10.1021/jp072912u; SELICK HE, 1987, DNA REPLICATION RECO, P183; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; WU CA, 1992, J BIOL CHEM, V267, P4030; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106	31	85	87	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					940	U137		10.1038/nature08611	http://dx.doi.org/10.1038/nature08611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19924126	Green Accepted			2022-12-28	WOS:000272795400047
J	Fraser, JS; Clarkson, MW; Degnan, SC; Erion, R; Kern, D; Alber, T				Fraser, James S.; Clarkson, Michael W.; Degnan, Sheena C.; Erion, Renske; Kern, Dorothee; Alber, Tom			Hidden alternative structures of proline isomerase essential for catalysis	NATURE			English	Article							CYCLOPHILIN-A INSIGHTS; X-RAY-DIFFRACTION; CHEMICAL-EXCHANGE; NMR-SPECTROSCOPY; RIBONUCLEASE-A; PROTEIN; DYNAMICS; TEMPERATURE; SIMULATIONS; TRANSITION	A long-standing challenge is to understand at the atomic level how protein dynamics contribute to enzyme catalysis. X-ray crystallography can provide snapshots of conformational substates sampled during enzymatic reactions(1), while NMR relaxation methods reveal the rates of interconversion between substates and the corresponding relative populations(1,2). However, these current methods cannot simultaneously reveal the detailed atomic structures of the rare states and rationalize the finding that intrinsic motions in the free enzyme occur on a timescale similar to the catalytic turnover rate. Here we introduce dual strategies of ambient-temperature X-ray crystallographic data collection and automated electron-density sampling to structurally unravel interconverting substates of the human proline isomerase, cyclophilin A (CYPA, also known as PPIA). A conservative mutation outside the active site was designed to stabilize features of the previously hidden minor conformation. This mutation not only inverts the equilibrium between the substates, but also causes large, parallel reductions in the conformational interconversion rates and the catalytic rate. These studies introduce crystallographic approaches to define functional minor protein conformations and, in combination with NMR analysis of the enzyme dynamics in solution, show how collective motions directly contribute to the catalytic power of an enzyme.	[Fraser, James S.; Degnan, Sheena C.; Erion, Renske; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol QB3, Berkeley, CA 94720 USA; [Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	University of California System; University of California Berkeley; Brandeis University; Howard Hughes Medical Institute	Alber, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol QB3, Berkeley, CA 94720 USA.	dkern@brandeis.edu; tom@ucxray.berkeley.edu		Fraser, James/0000-0002-5080-2859; Clarkson, Michael W/0000-0002-4323-3424	US NSF; Canadian NSERC; US National Institutes of Health; US Department of Energy Office of Basic Energy Sciences; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048958] Funding Source: NIH RePORTER	US NSF(National Science Foundation (NSF)); Canadian NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Marqusee and B. Krantz for discussions; S. Classen, G. Meigs, J. Holton, A. Samelson, N. Echols, P. Afonine, and the Phenix team for technical support; J. Tainer for access to Rigaku free-mounting device at ALS Beamline 12.3.1; J. Pelton and D. Wemmer for providing essential help and access to NMR facilities. J. S. F. was supported by US NSF and Canadian NSERC fellowships. This work was funded by the US National Institutes of Health ( to T. A.) and the US National Institutes of Health, the US Department of Energy Office of Basic Energy Sciences, and the Howard Hughes Medical Institute ( to D. K.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarwal PK, 2004, PROTEINS, V56, P449, DOI 10.1002/prot.20135; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; Halle B, 2004, P NATL ACAD SCI USA, V101, P4793, DOI 10.1073/pnas.0308315101; Hamelberg D, 2009, J AM CHEM SOC, V131, P147, DOI 10.1021/ja806146g; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Ke HM, 2004, FRONT BIOSCI-LANDMRK, V9, P2285, DOI 10.2741/1396; Kiefersauer R, 2000, J APPL CRYSTALLOGR, V33, P1223, DOI 10.1107/S0021889800008049; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; LANG PT, PROTEIN SCI UNPUB; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Trzesniak D, 2006, PROTEIN SCI, V15, P2544, DOI 10.1110/ps.062356406; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	45	347	348	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					669	U149		10.1038/nature08615	http://dx.doi.org/10.1038/nature08615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956261	Green Accepted, Green Submitted			2022-12-28	WOS:000272277900045
J	McWilliams, JM; Meara, E; Zaslavsky, AM; Ayanian, JZ				McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.			Medicare Spending for Previously Uninsured Adults	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-INSURANCE COVERAGE; OBSTRUCTIVE PULMONARY-DISEASE; MARGINAL STRUCTURAL MODELS; FLUTICASONE PROPIONATE; CAUSAL INFERENCE; PATIENT OUTCOMES; FOLLOW-UP; CARE; DECLINE; REPLACEMENT	Background: Medicare spending after age 65 years may be higher for previously uninsured adults if suboptimal care before this age leads to irreversible complications, persistently elevated clinical risks, or delay of costly elective procedures. Objective: To compare Medicare spending for previously uninsured and insured adults by using Medicare claims data. Design: Longitudinal survey data and linked Medicare claims datf were used to compare Medicare spending for beneficiaries age 65 to 74 years who were previously insured or previously uninsured before age 65 years. An inverse-probability-of-treatment weighting technique was used to adjust for fixed and time-varying sociodemographic and health characteristics before age 65 years. Condition-specific hospitalizations were compared, and their contribution to differences in Medicare spending was estimated. Setting: Nationally representative Health and Retirement Study, 1992 to 2006. Participants: 2951 continuously insured adults and 1616 adults who were continuously or intermittently uninsured before age 65 years. Measurements: Mean adjusted annual Medicare spending (total and by type of service) and annual rates of condition-specific Results: Adjusted annual total Medicare spending was significantly higher for previously uninsured than previously insured adults ($5796 vs. $4773; difference, $1023 [95% CI, $29 to $2016]; P = 0.044). Among relevant clinical subgroups, previously uninsured adults had higher adjusted annual hospitalization rates than previously insured adults for complications related to cardiovascular disease or diabetes (9.1% vs. 6.4%; P = 0.002) and for joint replacements (2.5% vs. 1.3%; P = 0.006). Differences in these hospitalizations accounted for 65.7% of the $644 difference in annual Medicare inpatient spending between all previously uninsured and insured adults. Limitation: Unobserved confounders could have explained spending differences. Conclusion: Costs of expanded coverage before age 65 years may be partially offset by subsequent reductions in Medicare spending after age 65 years, particularly for uninsured adults with cardiovascular disease, diabetes, or severe arthritis.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; National Bureau of Economic Research	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu		Meara, Ellen/0000-0003-0211-1970	Commonwealth Fund [20060485]	Commonwealth Fund	By the Commonwealth Fund (grant 20060485).	Altose MD, 2000, NEW ENGL J MED, V343, P1902; [Anonymous], INCOMPLETE DATA SAMP; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Baker DW, 2002, MED CARE, V40, P1126, DOI 10.1097/00005650-200211000-00013; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Card D, 2008, AM ECON REV, V98, P2242, DOI 10.1257/aer.98.5.2242; Chernew M, 2005, HEALTH SERV RES, V40, P1021, DOI 10.1111/j.1475-6773.2005.00409.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; *CTR MED MED SERV, 2004, PERS HLTH CAR SPEND; CZAJKA JL, 1992, J BUS ECON STAT, V10, P117, DOI 10.2307/1391671; Decker SL, 2005, J HUM RESOUR, V40, P948, DOI 10.3368/jhr.XL.4.948; DENAVASWALT C, 2008, P60235 US CENS BUR; Dor A, 2006, HEALTH SERV RES, V41, P759, DOI 10.1111/j.1475-6773.2006.00513.x; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P947, DOI 10.1001/jama.299.8.947; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gruber J, 2009, NEW ENGL J MED, V360, P437, DOI 10.1056/NEJMp0810203; Hadley J, 2006, HEALTH SERV RES, V41, P429, DOI 10.1111/j.1475-6773.2005.00491.x; Hadley J, 2008, HEALTH AFFAIR, V27, pW399, DOI 10.1377/hlthaff.27.5.w399; Hamel MB, 2008, ARCH INTERN MED, V168, P1430, DOI 10.1001/archinte.168.13.1430; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Heck DA, 1998, CLIN ORTHOP RELAT R, P93, DOI 10.1097/00003086-199811000-00015; HEERINGA SG, 1995, TECHNICAL DESCRIPTIO, V2009; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; *I MED COMM CONS H, 2009, AM UN CRIS CONS HLTH; Kalton G, 2007, STAT MED, V26, P1675, DOI 10.1002/sim.2796; LAUPACIS A, 1993, J BONE JOINT SURG AM, V75A, P1619, DOI 10.2106/00004623-199311000-00006; Levy H, 2008, INQUIRY-J HEALTH CAR, V45, P365, DOI 10.5034/inquiryjrnl_45.04.365; Lohr S.L., 1999, SAMPLING DESIGN ANAL; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2009, MILBANK Q, V87, P443, DOI 10.1111/j.1468-0009.2009.00564.x; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Monheit AC, 2008, INQUIRY-J HEALTH CAR, V45, P153, DOI 10.5034/inquiryjrnl_45.02.153; MURRAY DG, 1995, JAMA-J AM MED ASSOC, V273, P1950, DOI 10.1001/jama.1995.03520480070043; NEWHOUSE JP, 1993, HEALTH AFFAIR, V12, P152, DOI 10.1377/hlthaff.12.suppl_1.152; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Reilly JJ, 2008, NEW ENGL J MED, V359, P1616, DOI 10.1056/NEJMe0807387; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rubin D.B., 2002, STAT ANAL MISSING DA; SHEILS J, 2001, 441 COMM FUND; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; *U MI, 2009, HLTH RET STUD 1992 2; van Essen G J, 1998, J Qual Clin Pract, V18, P135; Ward L, 2007, ANN INTERN MED, V146, P768, DOI 10.7326/0003-4819-146-11-200706050-00005; Wilper AP, 2008, ANN INTERN MED, V149, P170, DOI 10.7326/0003-4819-149-3-200808050-00006; 2008, EC REPORT PRESIDENT	64	30	30	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					757	W250		10.7326/0000605-200912010-00149	http://dx.doi.org/10.7326/0000605-200912010-00149			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EJ	19949141				2022-12-28	WOS:000272727900001
J	Wang, Y; Forsyth, DW; Savage, B				Wang, Yun; Forsyth, Donald W.; Savage, Brian			Convective upwelling in the mantle beneath the Gulf of California	NATURE			English	Article							EAST PACIFIC RISE; MIDOCEAN RIDGE BASALTS; SENSITIVITY KERNELS; SPREADING CENTERS; MELT GENERATION; OCEAN RIDGES; LOW-VELOCITY; ATTENUATION; SEGMENTATION; ANISOTROPY	In the past six million years, Baja California has rifted obliquely apart from North America, opening up the Gulf of California(1). Between transform faults, seafloor spreading and rifting is well established in several basins. Other than hotspot-dominated Iceland, the Gulf of California is the only part of the world's seafloor-spreading system that has been surrounded by enough seismometers to provide horizontal resolution of upper-mantle structure at a scale of 100 kilometres over a distance great enough to include several spreading segments. Such resolution is needed to address the long-standing debate about the relative importance of dynamic and passive upwelling in the shallow mantle beneath spreading centres. Here we use Rayleigh-wave tomography to image the shear velocity in the upper 200 kilometres or so of the mantle. Low shear velocities similar to those beneath the East Pacific Rise oceanic spreading centre underlie the entire length of the Gulf, but there are three concentrated locations of anomalously low velocities spaced about 250 kilometres apart. These anomalies are 40 to 90 kilometres beneath the surface, at which depths petrological studies indicate that extensive melting of passively upwelling mantle should begin(2,3). We interpret these seismic velocity anomalies as indicating that partial melting triggers dynamic upwelling driven by either the buoyancy of retained melt or by the reduced density of depleted mantle.	[Wang, Yun; Forsyth, Donald W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Savage, Brian] Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA	Brown University; University of Rhode Island	Wang, Y (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	yun_wang@brown.edu		Savage, Brian/0000-0002-9252-6282	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This research was supported by the MARGINS programme of the National Science Foundation.	Asimow PD, 2001, J PETROL, V42, P963, DOI 10.1093/petrology/42.5.963; AXEN G, 1995, GEOLOGY, V23, P515, DOI 10.1130/0091-7613(1995)023<0515:ESOTMG>2.3.CO;2; BATIZA R, 1978, GEOL SOC AM BULL, V89, P1309, DOI 10.1130/0016-7606(1978)89<1309:GPAGOI>2.0.CO;2; BUCK WR, 1989, GEOPHYS RES LETT, V16, P641, DOI 10.1029/GL016i007p00641; Choblet G, 2001, EARTH PLANET SC LETT, V184, P589, DOI 10.1016/S0012-821X(00)00330-7; Clayton R, 2004, MARGINS NEWSLETT, V13, P1; FAUL UH, 2004, J GEOPHYS RES, V109, DOI DOI 10.1029/2003B002407; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; Hammond WC, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001789; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10975, DOI 10.1029/2000JB900041; Harmon N, 2009, EARTH PLANET SC LETT, V278, P96, DOI 10.1016/j.epsl.2008.11.025; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; Magde LS, 1997, J GEOPHYS RES-SOL EA, V102, P20571, DOI 10.1029/97JB01278; MARTIN A, 2008, AGU FALL M ABSTR; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; PARMENTIER EM, 1990, NATURE, V348, P325, DOI 10.1038/348325a0; Ritzwoller MH, 2004, EARTH PLANET SC LETT, V226, P69, DOI 10.1016/j.epsl.2004.07.032; Stixrude L, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB002965; STOCK JM, 1989, TECTONICS, V8, P99, DOI 10.1029/TC008i001p00099; Toomey DR, 2007, NATURE, V446, P409, DOI 10.1038/nature05679; Yang YJ, 2007, EARTH PLANET SC LETT, V258, P260, DOI 10.1016/j.epsl.2007.03.040; Yang Y, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004180; Yang YJ, 2006, GEOPHYS J INT, V166, P1148, DOI 10.1111/j.1365-246X.2006.02972.x; Zhang X, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030631; Zhang X, 2009, EARTH PLANET SC LETT, V279, P255, DOI 10.1016/j.epsl.2009.01.003; Zhou Y, 2004, GEOPHYS J INT, V158, P142, DOI 10.1111/j.1365-246X.2004.02324.x	28	83	83	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					499	U192		10.1038/nature08552	http://dx.doi.org/10.1038/nature08552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940924				2022-12-28	WOS:000272144200042
J	Woodcock, J				Woodcock, Janet			A Difficult Balance - Pain Management, Drug Safety, and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2009, M MAT JUN 29 2009 JO; Bailey JE, 2009, ANN EMERG MED, V53, P419, DOI 10.1016/j.annemergmed.2008.07.015; *DRUG AB WARN NETW, 2008, DHHS PUBL SMA; *NSDUH, 2009, REP TRENDS NONM US P	4	109	111	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2105	2107		10.1056/NEJMp0908913	http://dx.doi.org/10.1056/NEJMp0908913			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	524BC	19940297				2022-12-28	WOS:000272117800001
J	King, A				King, Anthony			Researchers Find Their Nemo	CELL			English	Editorial Material																			0	8	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					843	846		10.1016/j.cell.2009.11.019	http://dx.doi.org/10.1016/j.cell.2009.11.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945369	Bronze			2022-12-28	WOS:000272169400006
J	Maren, S				Maren, Stephen			An Acid-Sensing Channel Sows Fear and Panic	CELL			English	Editorial Material							NEURONS; MEMORY		[Maren, Stephen] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Maren, Stephen] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Maren, S (corresponding author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	maren@umich.edu	Maren, Stephen/B-6182-2014; Maren, Stephen/A-7091-2009	Maren, Stephen/0000-0002-9342-7411; Maren, Stephen/0000-0002-9342-7411				Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Griez EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000987; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; PASCOE JP, 1985, BRAIN RES BULL, V14, P331, DOI 10.1016/0361-9230(85)90194-7; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X	9	9	9	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					867	869		10.1016/j.cell.2009.11.008	http://dx.doi.org/10.1016/j.cell.2009.11.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945375	Green Published, Bronze			2022-12-28	WOS:000272169400012
J	Schnable, PS; Ware, D; Fulton, RS; Stein, JC; Wei, FS; Pasternak, S; Liang, CZ; Zhang, JW; Fulton, L; Graves, TA; Minx, P; Reily, AD; Courtney, L; Kruchowski, SS; Tomlinson, C; Strong, C; Delehaunty, K; Fronick, C; Courtney, B; Rock, SM; Belter, E; Du, FY; Kim, K; Abbott, RM; Cotton, M; Levy, A; Marchetto, P; Ochoa, K; Jackson, SM; Gillam, B; Chen, WZ; Yan, L; Higginbotham, J; Cardenas, M; Waligorski, J; Applebaum, E; Phelps, L; Falcone, J; Kanchi, K; Thane, T; Scimone, A; Thane, N; Henke, J; Wang, T; Ruppert, J; Shah, N; Rotter, K; Hodges, J; Ingenthron, E; Cordes, M; Kohlberg, S; Sgro, J; Delgado, B; Mead, K; Chinwalla, A; Leonard, S; Crouse, K; Collura, K; Kudrna, D; Currie, J; He, RF; Angelova, A; Rajasekar, S; Mueller, T; Lomeli, R; Scara, G; Ko, A; Delaney, K; Wissotski, M; Lopez, G; Campos, D; Braidotti, M; Ashley, E; Golser, W; Kim, H; Lee, S; Lin, JK; Dujmic, Z; Kim, W; Talag, J; Zuccolo, A; Fan, C; Sebastian, A; Kramer, M; Spiegel, L; Nascimento, L; Zutavern, T; Miller, B; Ambroise, C; Muller, S; Spooner, W; Narechania, A; Ren, LY; Wei, S; Kumari, S; Faga, B; Levy, MJ; McMahan, L; Van Buren, P; Vaughn, MW; Ying, K; Yeh, CT; Emrich, SJ; Jia, Y; Kalyanaraman, A; Hsia, AP; Barbazuk, WB; Baucom, RS; Brutnell, TP; Carpita, NC; Chaparro, C; Chia, JM; Deragon, JM; Estill, JC; Fu, Y; Jeddeloh, JA; Han, YJ; Lee, H; Li, PH; Lisch, DR; Liu, SZ; Liu, ZJ; Nagel, DH; McCann, MC; SanMiguel, P; Myers, AM; Nettleton, D; Nguyen, J; Penning, BW; Ponnala, L; Schneider, KL; Schwartz, DC; Sharma, A; Soderlund, C; Springer, NM; Sun, Q; Wang, H; Waterman, M; Westerman, R; Wolfgruber, TK; Yang, LX; Yu, Y; Zhang, LF; Zhou, SG; Zhu, Q; Bennetzen, JL; Dawe, RK; Jiang, JM; Jiang, N; Presting, GG; Wessler, SR; Aluru, S; Martienssen, RA; Clifton, SW; McCombie, WR; Wing, RA; Wilson, RK				Schnable, Patrick S.; Ware, Doreen; Fulton, Robert S.; Stein, Joshua C.; Wei, Fusheng; Pasternak, Shiran; Liang, Chengzhi; Zhang, Jianwei; Fulton, Lucinda; Graves, Tina A.; Minx, Patrick; Reily, Amy Denise; Courtney, Laura; Kruchowski, Scott S.; Tomlinson, Chad; Strong, Cindy; Delehaunty, Kim; Fronick, Catrina; Courtney, Bill; Rock, Susan M.; Belter, Eddie; Du, Feiyu; Kim, Kyung; Abbott, Rachel M.; Cotton, Marc; Levy, Andy; Marchetto, Pamela; Ochoa, Kerri; Jackson, Stephanie M.; Gillam, Barbara; Chen, Weizu; Yan, Le; Higginbotham, Jamey; Cardenas, Marco; Waligorski, Jason; Applebaum, Elizabeth; Phelps, Lindsey; Falcone, Jason; Kanchi, Krishna; Thane, Thynn; Scimone, Adam; Thane, Nay; Henke, Jessica; Wang, Tom; Ruppert, Jessica; Shah, Neha; Rotter, Kelsi; Hodges, Jennifer; Ingenthron, Elizabeth; Cordes, Matt; Kohlberg, Sara; Sgro, Jennifer; Delgado, Brandon; Mead, Kelly; Chinwalla, Asif; Leonard, Shawn; Crouse, Kevin; Collura, Kristi; Kudrna, Dave; Currie, Jennifer; He, Ruifeng; Angelova, Angelina; Rajasekar, Shanmugam; Mueller, Teri; Lomeli, Rene; Scara, Gabriel; Ko, Ara; Delaney, Krista; Wissotski, Marina; Lopez, Georgina; Campos, David; Braidotti, Michele; Ashley, Elizabeth; Golser, Wolfgang; Kim, HyeRan; Lee, Seunghee; Lin, Jinke; Dujmic, Zeljko; Kim, Woojin; Talag, Jayson; Zuccolo, Andrea; Fan, Chuanzhu; Sebastian, Aswathy; Kramer, Melissa; Spiegel, Lori; Nascimento, Lidia; Zutavern, Theresa; Miller, Beth; Ambroise, Claude; Muller, Stephanie; Spooner, Will; Narechania, Apurva; Ren, Liya; Wei, Sharon; Kumari, Sunita; Faga, Ben; Levy, Michael J.; McMahan, Linda; Van Buren, Peter; Vaughn, Matthew W.; Ying, Kai; Yeh, Cheng-Ting; Emrich, Scott J.; Jia, Yi; Kalyanaraman, Ananth; Hsia, An-Ping; Barbazuk, W. Brad; Baucom, Regina S.; Brutnell, Thomas P.; Carpita, Nicholas C.; Chaparro, Cristian; Chia, Jer-Ming; Deragon, Jean-Marc; Estill, James C.; Fu, Yan; Jeddeloh, Jeffrey A.; Han, Yujun; Lee, Hyeran; Li, Pinghua; Lisch, Damon R.; Liu, Sanzhen; Liu, Zhijie; Nagel, Dawn Holligan; McCann, Maureen C.; SanMiguel, Phillip; Myers, Alan M.; Nettleton, Dan; Nguyen, John; Penning, Bryan W.; Ponnala, Lalit; Schneider, Kevin L.; Schwartz, David C.; Sharma, Anupma; Soderlund, Carol; Springer, Nathan M.; Sun, Qi; Wang, Hao; Waterman, Michael; Westerman, Richard; Wolfgruber, Thomas K.; Yang, Lixing; Yu, Yeisoo; Zhang, Lifang; Zhou, Shiguo; Zhu, Qihui; Bennetzen, Jeffrey L.; Dawe, R. Kelly; Jiang, Jiming; Jiang, Ning; Presting, Gernot G.; Wessler, Susan R.; Aluru, Srinivas; Martienssen, Robert A.; Clifton, Sandra W.; McCombie, W. Richard; Wing, Rod A.; Wilson, Richard K.			The B73 Maize Genome: Complexity, Diversity, and Dynamics	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; ARABIDOPSIS-THALIANA; PLANT; GENES; RETROTRANSPOSONS; METHYLATION; DIVERGENCE; GENETICS; SORGHUM; CORN	We report an improved draft nucleotide sequence of the 2.3-gigabase genome of maize, an important crop plant and model for biological research. Over 32,000 genes were predicted, of which 99.8% were placed on reference chromosomes. Nearly 85% of the genome is composed of hundreds of families of transposable elements, dispersed nonuniformly across the genome. These were responsible for the capture and amplification of numerous gene fragments and affect the composition, sizes, and positions of centromeres. We also report on the correlation of methylation-poor regions with Mu transposon insertions and recombination, and copy number variants with insertions and/or deletions, as well as how uneven gene losses between duplicated regions were involved in returning an ancient allotetraploid to a genetically diploid state. These analyses inform and set the stage for further investigations to improve our understanding of the domestication and agricultural improvements of maize.	[Wilson, Richard K.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; Iowa State Univ, Ctr Plant Genom, Ames, IA 50011 USA; Iowa State Univ, Dept Agron, Ames, IA 50011 USA; Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; Iowa State Univ, Ctr Carbon Capturing Crops, Ames, IA 50011 USA; Robert Holley Ctr Agr & Hlth, N Atlantic Area, USDA, Ithaca, NY 14853 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Arizona, Arizona Genom Inst, Sch Plant Sci, Tucson, AZ 85721 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, BIO5 Inst Collaborat Res, Tucson, AZ 85721 USA; Iowa State Univ, Dept Elect & Comp Engn, Ames, IA 50011 USA; Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; Univ Florida, Dept Bot, Gainesville, FL 32611 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; Univ Perpignan, CNRS, F-66025 Perpignan, France; Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; NimbleGen, Madison, WI 53711 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Univ Calif Berkeley, Dept Plant Biol, Berkeley, CA 94720 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Iowa State Univ, Dept Stat, Ames, IA 50011 USA; Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14850 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Wisconsin, Lab Mol & Computat Genom, Dept Chem, Genet Lab, Madison, WI 53706 USA; Univ Arizona, BIO5 Inst Collaborat Res, Tucson, AZ 85721 USA; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; Indian Inst Technol, Bombay 400076, Maharashtra, India; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Cold Spring Harbor Laboratory; University of Arizona; University of Arizona; Iowa State University; University of Notre Dame; Washington State University; State University System of Florida; University of Florida; University System of Georgia; University of Georgia; Cornell University; Boyce Thompson Institute for Plant Research; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; University System of Georgia; University of Georgia; Roche Holding; Roche NimbleGen; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; Iowa State University; University of Southern California; University of Southern California; University of Southern California; Cornell University; University of Hawaii System; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Washington University (WUSTL)	Wilson, RK (corresponding author), Washington Univ, Genome Ctr, St Louis, MO 63108 USA.	rwilson@wustl.edu	Wilson, Matthew H/K-3193-2013; Zhou, Shiguo/B-3832-2011; Brutnell, Thomas/M-2840-2013; Springer, Nathan/F-2680-2013; Rajasekar, Shanmugam/U-2222-2019; Chaparro, Cristian/D-1427-2015; McCann, Maureen C/T-9258-2017; JIA, YI/E-9675-2010; Wilson, Richard K./AAF-4139-2019; Deragon, Jean-Marc/C-5174-2008; Jiang, Jiming/A-9614-2009; Zhu, Qihui/N-2625-2013; Li, Ping/GYV-4914-2022; Lisch, Damon/A-9414-2010; Jiang, Ning/G-6546-2012; Ponnala, Lalit/B-2354-2010; Sharma, Anupma/F-1221-2015; He, Ruifeng/F-1418-2010; Jiang, Jiming/V-6060-2019; SanMiguel, Phillip J/I-2196-2015; Stern, David B/H-7852-2012; Zuccolo, Andrea/H-5636-2019; Yang, Lixing/A-7073-2013; Zhang, Jianwei/D-2488-2009; Chia, Jer-Ming/C-9992-2012; Jia, Yi/F-7476-2010; Wing, Rod A/Z-2885-2019; Wang, Hao/C-7651-2009	Zhou, Shiguo/0000-0001-7421-2506; Brutnell, Thomas/0000-0002-3581-8211; Springer, Nathan/0000-0002-7301-4759; Chaparro, Cristian/0000-0002-5162-349X; McCann, Maureen C/0000-0001-6956-4216; Wilson, Richard K./0000-0002-1992-1358; Jiang, Jiming/0000-0002-6435-6140; Sharma, Anupma/0000-0002-6201-7639; Jiang, Jiming/0000-0002-6435-6140; SanMiguel, Phillip J/0000-0002-3742-9527; Zuccolo, Andrea/0000-0001-7574-0714; Wing, Rod A/0000-0001-6633-6226; Estill, James/0000-0003-1020-2928; Wang, Hao/0000-0002-9634-8778; , Dawn/0000-0001-8996-3572; Waligorski, Jason/0000-0001-8422-6004; Schnable, Patrick/0000-0001-9169-5204; McCombie, W. Richard/0000-0003-1899-0682; Barbazuk, William/0000-0002-0909-4563; Yu, Yeisoo/0000-0002-8410-0310; Chinwalla, Asif/0000-0001-7831-3996; Yeh, Cheng-Ting/0000-0002-1392-2018; Zhang, Jianwei/0000-0001-8030-5346; Deragon, Jean-Marc/0000-0002-2476-4932; Lisch, Damon/0000-0002-8693-8651; Nettleton, Dan/0000-0002-6045-1036; Vaughn, Matthew/0000-0002-1384-4283; Baucom, Regina/0000-0001-7960-498X; Penning, Bryan/0000-0002-0374-8693	NSF [DBI-0527192, DBI-0607123, DBI-0421671, DBI-0321467, DBI-0321711, DBI-0333074, DBI-0501818, DBI-0501857, DBI-0701736, DBI-0703273, DBI-0703908]; USDA Cooperative State Research, Education, and Extension Service [2005-35301-15715, 2007-35301-18372]; USDA-ARS [408934, 413089]; Office of Science (Biological and Environmental Research); U. S. Department of Energy [DE-FG02-08ER64702]	NSF(National Science Foundation (NSF)); USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Office of Science (Biological and Environmental Research)(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE))	The Maize Genome Sequencing Project supported by NSF award DBI-0527192 (R. K. W., S. W. C., R. S. F., R. A. W., P. S. S., S. A., L. S., D. W., W. R. M., R. A. M.). The Maize Transposable Element Consortium and the Maize Centromere Consortium supported by NSF awards DBI-0607123 (S. R. W., J. L. B., R. K. D., N. J., P. S. M.) and DBI-0421671 (R. K. D., J. J., G. G. P.). Also supported by NSF grants DBI-0321467 (D. W.), DBI-0321711 (P. S. S.), DBI-0333074 (D. W.), DBI-0501818 (D. C. S.), DBI-0501857 (Y. Y.), DBI-0701736 (T. P. B., Q. S.), DBI-0703273 (R. A. M.), and DBI-0703908 (D. W.), and by USDA National Research Initiative Grants 2005-35301-15715 and 2007-35301-18372 from the USDA Cooperative State Research, Education, and Extension Service (P. S. S.) and from the USDA-ARS (408934 and 413089) to D. W., and from the Office of Science (Biological and Environmental Research), U. S. Department of Energy, grant DE-FG02-08ER64702 to N. C. C. and M. C. M. Sequences of the reference chromosomes have been deposited in GenBank as accession numbers CM000777 to CM000786. RNA-sequence reads have been deposited in the Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo) as accession numbers GSE16136, GSE16868, and GSE16916. Centromeric sequences have been deposited in the National Center for Biotechnology Information, NIH, Trace Archive as accessions 1757396377 to 1757412600 and 2185189231 to 2185200942.	Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; BENNETZEN J, 2009, HDB MAIZE GENETICS G; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; *CP NAT CORN GROW, TABL SHOW CORN HARV; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Duvick DN, 1999, SCIENCE, V286, P418, DOI 10.1126/science.286.5439.418; Emrich SJ, 2007, GENETICS, V175, P429, DOI 10.1534/genetics.106.064006; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fu Y, 2005, P NATL ACAD SCI USA, V102, P12282, DOI 10.1073/pnas.0503394102; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Jia Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000737; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; LAL S, 2008, HDB MAIZE GENETICS G, P329; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; McClintock B, 1929, SCIENCE, V69, P629, DOI 10.1126/science.69.1798.629; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Penning BW, 2009, PLANT PHYSIOL, V151, P1703, DOI 10.1104/pp.109.136804; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Sharma A, 2008, P NATL ACAD SCI USA, V105, P15470, DOI 10.1073/pnas.0805694105; Sharma A, 2008, MOL GENET GENOMICS, V279, P133, DOI 10.1007/s00438-007-0302-5; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tate JA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-80; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Tian Chao-Guang, 2005, Acta Genetica Sinica, V32, P519; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000728; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Yang LX, 2009, P NATL ACAD SCI USA, V106, P12832, DOI 10.1073/pnas.0905563106; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang WL, 2008, PLANT CELL, V20, P25, DOI 10.1105/tpc.107.057083; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711	51	2733	2984	18	619	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1112	1115		10.1126/science.1178534	http://dx.doi.org/10.1126/science.1178534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965430				2022-12-28	WOS:000271951000044
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIP FRACTURE; MISSING DATA; MULTIPLE IMPUTATION; CARDIOVASCULAR RISK; HORMONE-THERAPY; SMOKING; REPLACEMENT; DISEASE; MODEL; CORTICOSTEROIDS	Objective To develop and validate two new fracture risk algorithms (QFractureScores) for estimating the individual risk of osteoporotic fracture or hip fracture over 10 years. Design Prospective open cohort study with routinely collected data from 357 general practices to develop the scores and from 178 practices to validate the scores. Setting General practices in England and Wales. Participants 1 183 663 women and 1 174 232 men aged 30-85 in the derivation cohort, who contributed 7 898 208 and 8 049 306 person years of observation, respectively. There were 24 350 incident diagnoses of osteoporotic fracture in women and 7934 in men, and 9302 incident diagnoses of hip fracture in women and 5424 in men. Main outcome measures First (incident) diagnosis of osteoporotic fracture (vertebral, distal radius, or hip) and incident hip fracture recorded in general practice records. Results Use of hormone replacement therapy (HRT), age, body mass index (BMI), smoking status, recorded alcohol use, parental history of osteoporosis, rheumatoid arthritis, cardiovascular disease, type 2 diabetes, asthma, tricyclic antidepressants, corticosteroids, history of falls, menopausal symptoms, chronic liver disease, gastrointestinal malabsorption, and other endocrine disorders were significantly and independently associated with risk of osteoporotic fracture in women. Some variables were significantly associated with risk of osteoporotic fracture but not with risk of hip fracture. The predictors for men for osteoporotic and hip fracture were age, BMI, smoking status, recorded alcohol use, rheumatoid arthritis, cardiovascular disease, type 2 diabetes, asthma, tricyclic antidepressants, corticosteroids, history of falls, and liver disease. The hip fracture algorithm had the best performance among men and women. It explained 63.94% of the variation in women and 63.19% of the variation in men. The D statistic values for discrimination were highest for hip fracture in women (2.73) and men (2.68) and were over twice the magnitude of the corresponding values for osteoporotic fracture. The ROC statistics for hip fracture were also high: 0.89 in women and 0.86 for men versus 0.79 and 0.69, respectively, for the osteoporotic fracture outcome. The algorithms were well calibrated with predicted risks closely matching observed risks. The QFractureScore for hip fracture also had good performance for discrimination and calibration compared with the FRAX (fracture risk assessment) algorithm. Conclusions These new algorithms can predict risk of fracture in primary care populations in the UK without laboratory measurements and are therefore suitable for use in both clinical settings and for self assessment (www.qfracture.org). QFractureScores could be used to identify patients at high risk of fracture who might benefit from interventions to reduce their risk.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Tower Bldg,Univ Pk, Nottingham NG2 7RD, England.	Julia.hippisley-cox@nltworld.com	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Bagger YZ, 2004, BONE, V34, P728, DOI 10.1016/j.bone.2003.12.021; Banks E, 2004, JAMA-J AM MED ASSOC, V291, P2212, DOI 10.1001/jama.291.18.2212; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Card T, 2004, GUT, V53, P251, DOI 10.1136/gut.2003.026799; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Clark TG, 2003, J CLIN EPIDEMIOL, V56, P28, DOI 10.1016/S0895-4356(02)00539-5; Cornuz J, 1999, AM J MED, V106, P311, DOI 10.1016/S0002-9343(99)00022-4; Dawson Hughes B, 2008, OSTEOPOROSIS INT, V19, P449; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Diaz MN, 1997, BONE, V20, P145, DOI 10.1016/S8756-3282(96)00331-6; GROUP TAM, 1989, BMJ-BRIT MED J, V298, P573; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; HOLLENBACH KA, 1993, AM J PUBLIC HEALTH, V83, P1265, DOI 10.2105/AJPH.83.9.1265; Holt TA, 2008, BRIT J GEN PRACT, V58, P192, DOI 10.3399/bjgp08X277302; Howard L, 2007, BRIT J PSYCHIAT, V190, P129, DOI 10.1192/bjp.bp.106.023671; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P15, DOI 10.1007/s00198-004-1688-0; Kush RD, 2008, NEW ENGL J MED, V358, P1738, DOI 10.1056/NEJMsb0800209; McCloskey EV, 2007, J BONE MINER RES, V22, P135, DOI 10.1359/JBMR.061008; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Moayyeri A, 2008, OSTEOPOROSIS INT, V19, P591, DOI 10.1007/s00198-007-0528-4; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; *NAT OST GUID GROU, 2008, GUID DIAGN MAN OST P; *NIH CLIN EXC, 2008, AL ET RIS RAL STRONT; *NIH CLIN EXC, 2008, SYST REV CLIN EFF PR; PARKER M, 2001, HIP PROTECTORS PREVE; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SPECTOR TD, 1993, BRIT MED J, V306, P558, DOI 10.1136/bmj.306.6877.558; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; van Staa TP, 2001, BRIT J CLIN PHARMACO, V51, P601, DOI 10.1046/j.0306-5251.2001.bjcp.1385.x; van Staa TP, 2001, J BONE MINER RES, V16, P581, DOI 10.1359/jbmr.2001.16.3.581; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Vestergaard P, 2003, J INTERN MED, V254, P572, DOI 10.1111/j.1365-2796.2003.01232.x; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; West J, 2004, PUBLIC HEALTH, V118, P576, DOI 10.1016/j.puhe.2004.02.006; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization (WHO), 2004, WHO SCI GROUP ASS OS; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	55	287	293	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2009	339								b4229	10.1136/bmj.b4229	http://dx.doi.org/10.1136/bmj.b4229			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TD	19926696	Green Published, hybrid			2022-12-28	WOS:000272096500002
J	Lee, BS; Burr, GW; Shelby, RM; Raoux, S; Rettner, CT; Bogle, SN; Darmawikarta, K; Bishop, SG; Abelson, JR				Lee, Bong-Sub; Burr, Geoffrey W.; Shelby, Robert M.; Raoux, Simone; Rettner, Charles T.; Bogle, Stephanie N.; Darmawikarta, Kristof; Bishop, Stephen G.; Abelson, John R.			Observation of the Role of Subcritical Nuclei in Crystallization of a Glassy Solid	SCIENCE			English	Article							LASER-INDUCED CRYSTALLIZATION; AMORPHOUS TE ALLOYS; MEDIUM-RANGE ORDER; PHASE-CHANGE; CRYSTAL NUCLEATION; DATA-STORAGE; THIN-FILMS; MICROSCOPY; GROWTH; GE2SB2TE5	Phase transformation generally begins with nucleation, in which a small aggregate of atoms organizes into a different structural symmetry. The thermodynamic driving forces and kinetic rates have been predicted by classical nucleation theory, but observation of nanometer-scale nuclei has not been possible, except on exposed surfaces. We used a statistical technique called fluctuation transmission electron microscopy to detect nuclei embedded in a glassy solid, and we used a laser pump-probe technique to determine the role of these nuclei in crystallization. This study provides a convincing proof of the time- and temperature-dependent development of nuclei, information that will play a critical role in the development of advanced materials for phase-change memories.	[Lee, Bong-Sub; Bogle, Stephanie N.; Darmawikarta, Kristof; Abelson, John R.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Lee, Bong-Sub; Bogle, Stephanie N.; Darmawikarta, Kristof; Bishop, Stephen G.; Abelson, John R.] Univ Illinois, Coordinated Sci Lab, Urbana, IL 61801 USA; [Burr, Geoffrey W.; Shelby, Robert M.; Raoux, Simone; Rettner, Charles T.] IBM Almaden Res Ctr, IBM Macronix Phase Change Random Access Memory Jo, San Jose, CA 95120 USA; [Bishop, Stephen G.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; International Business Machines (IBM); University of Illinois System; University of Illinois Urbana-Champaign	Abelson, JR (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	abelson@illinois.edu	Lee, Bong-Sub/G-4144-2012; Raoux, Simone/G-3920-2016; Bogle, Stephanie/G-5798-2011	Abelson, John/0000-0002-9040-1910	IBM-UIUC; NSF [DMR 04-12939, DMR 07-06267, DMR 06-05890]; U. S. Department of Energy [DE-FG02-07ER46453, DE-FG02-07ER46471]	IBM-UIUC(International Business Machines (IBM)); NSF(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE))	We thank Y. Xiao, M. Jurich, Y.-C. Chen, M. Salinga, and M. Hitzbleck for their help with thin- film growth and thermal treatments. This material is based on work conducted under IBM-UIUC joint study agreement and is supported by NSF under awards DMR 04-12939 and DMR 07-06267. The FTEM technique was available thanks to collaborative support under award DMR 06-05890. FTEM, AFM, and thermal treatments were carried out, in part, in the Frederick Seitz Materials Research Laboratory Central Facilities, University of Illinois, which are partially supported by the U. S. Department of Energy under grants DE-FG02-07ER46453 and DE-FG02-07ER46471.	Bez R, 2009, PHASE CHANGE MAT SCI, P355, DOI 10.1007/978-0-387-84874-7_16; Bogle SN, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/45/455204; Christian J.W., 1975, EQUILIB GEN KINET TH; COOMBS JH, 1995, J APPL PHYS, V78, P4906, DOI 10.1063/1.359779; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Goldfarb I, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.025501; Greer AL, 2005, NATURE, V437, P1246, DOI 10.1038/4371246a; Jesson DE, 2000, PHYS REV LETT, V84, P330, DOI 10.1103/PhysRevLett.84.330; Kalb J, 2004, APPL PHYS LETT, V84, P5240, DOI 10.1063/1.1764591; Kalb J, 2003, J APPL PHYS, V93, P2389, DOI 10.1063/1.1540227; Kashchiev D., 2000, NUCL BASIC THEORY AP; KELTON KF, 1991, SOLID STATE PHYS, V45, P75; KRIVANEK OL, 1976, NATURE, V262, P454, DOI 10.1038/262454a0; Kwon MH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430067; Matsunaga T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184116; PARGELLIS AN, 1989, J VAC SCI TECHNOL A, V7, P27, DOI 10.1116/1.575762; Raoux S, 2008, IBM J RES DEV, V52, P465, DOI 10.1147/rd.524.0465; Senkader S, 2004, J APPL PHYS, V95, P504, DOI 10.1063/1.1633984; Treacy MMJ, 2005, REP PROG PHYS, V68, P2899, DOI 10.1088/0034-4885/68/12/R06; Treacy MMJ, 1996, ACTA CRYSTALLOGR A, V52, P212, DOI 10.1107/S0108767395012876; Voyles PM, 2003, SOL ENERG MAT SOL C, V78, P85, DOI 10.1016/S0927-0248(02)00434-8; Weidenhof V, 2001, J APPL PHYS, V89, P3168, DOI 10.1063/1.1351868; Wen J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3079514; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Zhang KQ, 2004, NATURE, V429, P739, DOI 10.1038/nature02630; Ziegler S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2184428; [No title captured]; [No title captured]	28	145	144	6	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					980	984		10.1126/science.1177483	http://dx.doi.org/10.1126/science.1177483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965508				2022-12-28	WOS:000271712300036
J	Tarr, A; Iheanacho, I				Tarr, Andrea; Iheanacho, Ike			Uncertainties Page Should we use bath emollients for atopic eczema?	BRITISH MEDICAL JOURNAL			English	Editorial Material							DERMATITIS		[Tarr, Andrea; Iheanacho, Ike] BMJ Grp, London WC1H 9JR, England		Iheanacho, I (corresponding author), BMJ Grp, London WC1H 9JR, England.	iiheanacho@bmjgroup.com						[Anonymous], 2006, GUID MAN AT ECZ; BATHHEXTALL F, 2006, ATOPIC ECZEMA; CARR A, 2007, PHARM J, V278, P319; Drug & Therapeutics Bulletin, 2007, DRUG THER B, V45, P73; Grimalt R, 2007, DERMATOLOGY, V214, P61, DOI 10.1159/000096915; Hoare C, 2000, Health Technol Assess, V4, P1; *INF CTR HLTH SOC, 2009, PRESCR COST AN ENGL; *NIH CLIN EXC, 2007, AT ECZ CHILDR; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767	9	13	13	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 13	2009	339								b4273	10.1136/bmj.b4273	http://dx.doi.org/10.1136/bmj.b4273			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HO	19914950				2022-12-28	WOS:000271834100001
J	Zehr, JP; Kudela, RM				Zehr, Jonathan P.; Kudela, Raphael M.			Photosynthesis in the Open Ocean	SCIENCE			English	Editorial Material							PHYTOPLANKTON; ENVIRONMENT		[Zehr, Jonathan P.; Kudela, Raphael M.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, 1156 High St, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Zehr, Jonathan P/B-3513-2014	Zehr, Jonathan P/0000-0002-5691-5408				Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303	11	26	29	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					945	946		10.1126/science.1181277	http://dx.doi.org/10.1126/science.1181277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965502				2022-12-28	WOS:000271712300023
J	Samarasekera, IV				Samarasekera, Indira V.			Universities need a new social contract	NATURE			English	Editorial Material									Univ Alberta, Edmonton, AB, Canada	University of Alberta	Samarasekera, IV (corresponding author), Univ Alberta, Edmonton, AB, Canada.	indira.samarasekera@ualberta.ca							0	14	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 12	2009	462	7270					160	161		10.1038/462160a	http://dx.doi.org/10.1038/462160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	517YM	19907477				2022-12-28	WOS:000271655100022
J	Rosengren, AH; Jokubka, R; Tojjar, D; Granhall, C; Hansson, O; Li, DQ; Nagaraj, V; Reinbothe, TM; Tuncel, J; Eliasson, L; Groop, L; Rorsman, P; Salehi, A; Lyssenko, V; Luthman, H; Renstrom, E				Rosengren, Anders H.; Jokubka, Ramunas; Tojjar, Damon; Granhall, Charlotte; Hansson, Ola; Li, Dai-Qing; Nagaraj, Vini; Reinbothe, Thomas M.; Tuncel, Jonatan; Eliasson, Lena; Groop, Leif; Rorsman, Patrik; Salehi, Albert; Lyssenko, Valeriya; Luthman, Holger; Renstrom, Erik			Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELLS; EXOCYTOSIS; LOCI; IDENTIFICATION; ACTIVATION; SECRETION; DEFECTS; RISK	Several common genetic variations have been associated with type 2 diabetes, but the exact disease mechanisms are still poorly elucidated. Using congenic strains from the diabetic Goto-Kakizaki rat, we identified a 1.4-megabase genomic locus that was linked to impaired insulin granule docking at the plasma membrane and reduced beta cell exocytosis. In this locus, Adra2a, encoding the alpha2A-adrenergic receptor [alpha(2A)AR], was significantly overexpressed. Alpha(2A) AR mediates adrenergic suppression of insulin secretion. Pharmacological receptor antagonism, silencing of receptor expression, or blockade of downstream effectors rescued insulin secretion in congenic islets. Furthermore, we identified a single-nucleotide polymorphism in the human ADRA2A gene for which risk allele carriers exhibited overexpression of alpha(2A) AR, reduced insulin secretion, and increased type 2 diabetes risk. Human pancreatic islets from risk allele carriers exhibited reduced granule docking and secreted less insulin in response to glucose; both effects were counteracted by pharmacological alpha(2A) AR antagonists.	[Rosengren, Anders H.; Jokubka, Ramunas; Tojjar, Damon; Granhall, Charlotte; Hansson, Ola; Nagaraj, Vini; Reinbothe, Thomas M.; Eliasson, Lena; Groop, Leif; Salehi, Albert; Lyssenko, Valeriya; Luthman, Holger; Renstrom, Erik] Lund Univ, Ctr Diabet, SE-20502 Malmo, Sweden; [Li, Dai-Qing] Tianjin Med Univ, Tianjin Metab Dis Hosp, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Tuncel, Jonatan] Karolinska Inst, Dept Med Biochem & Biophys, Sect Med Inflammat Res, SE-17177 Stockholm, Sweden; [Rorsman, Patrik] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	Lund University; Tianjin Medical University; Karolinska Institutet; University of Oxford	Renstrom, E (corresponding author), Lund Univ, Ctr Diabet, SE-20502 Malmo, Sweden.	erik.renstrom@med.lu.se	Salehi, Albert/F-7768-2018; Eliasson, Lena/E-9294-2012; Hansson, Ola/F-1793-2011; Rorsman, Patrik/A-4331-2016; Rosengren, Anders/E-8371-2012; Nagaraj, Vini/P-3866-2019; Tuluc, Petronel/C-2527-2011; Reinbothe, Thomas M./N-1532-2014	Salehi, Albert/0000-0001-6120-3539; Eliasson, Lena/0000-0002-6467-5029; Hansson, Ola/0000-0002-7394-7639; Rorsman, Patrik/0000-0001-7578-0767; Rosengren, Anders/0000-0002-9333-5736; Nagaraj, Vini/0000-0001-6959-3623; Tuncel, Jonatan/0000-0001-6749-2327; Reinbothe, Thomas M./0000-0002-8934-6109	Swedish Research Council; European Foundation for the Study of Diabetes; Novo Nordisk and Albert Pahlsson foundations; Kungliga Fysiografiska Sallskapet; Nordic Centre of Excellence in Disease Genetics (NCoEDG); Lund University Diabetes Centre; Knut and Alice Wallenberg Foundation; Novo Nordisk Fonden [NNF10OC1013350] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Foundation for the Study of Diabetes; Novo Nordisk and Albert Pahlsson foundations; Kungliga Fysiografiska Sallskapet; Nordic Centre of Excellence in Disease Genetics (NCoEDG); Lund University Diabetes Centre; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank I. Lundquist and T. Andersson for help with the in vivo and fura-2 data, and B.-M. Nilsson and M. Neptin for technical assistance. Supported by project grants from the Swedish Research Council, the European Foundation for the Study of Diabetes, the Novo Nordisk and Albert Pahlsson foundations (E. R), Kungliga Fysiografiska Sallskapet (A. R.), The Nordic Centre of Excellence in Disease Genetics (NCoEDG) (R.J.), a Linnaeus grant to the Lund University Diabetes Centre, and the Knut and Alice Wallenberg Foundation. Access to human pancreatic islets was granted by J. Taneera in collaboration with the Nordic Network for Clinical Islet Transplantation	Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Devedjian JC, 2000, DIABETOLOGIA, V43, P899, DOI 10.1007/s001250051467; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Fagerholm V, 2004, EUR J PHARMACOL, V505, P243, DOI 10.1016/j.ejphar.2004.10.023; Finley JC, 2004, J APPL PHYSIOL, V96, P2231, DOI 10.1152/japplphysiol.00527.2003; GALITZKY J, 1990, J PHARMACOL EXP THER, V252, P312; Galli J, 1999, DIABETES, V48, P2463, DOI 10.2337/diabetes.48.12.2463; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Granhall C, 2006, DIABETES, V55, P3494, DOI 10.2337/db06-0796; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hoy M, 2003, EUR J PHARMACOL, V466, P213, DOI 10.1016/S0014-2999(03)01537-1; Lin JM, 2001, DIABETES, V50, P2737, DOI 10.2337/diabetes.50.12.2737; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Philipp M, 2002, AM J PHYSIOL-REG I, V283, pR287, DOI 10.1152/ajpregu.00123.2002; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Small KM, 2006, P NATL ACAD SCI USA, V103, P5472, DOI 10.1073/pnas.0601345103; Svetkey LP, 1996, HYPERTENSION, V27, P1210, DOI 10.1161/01.HYP.27.6.1210; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	24	194	207	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					217	220		10.1126/science.1176827	http://dx.doi.org/10.1126/science.1176827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965390				2022-12-28	WOS:000273394000039
J	Selker, HP; Wood, AJJ				Selker, Harry P.; Wood, Alastair J. J.			Industry Influence on Comparative-Effectiveness Research Funded through Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Selker, Harry P.] Tufts Univ, Clin & Translat Sci Inst, Boston, MA 02111 USA; [Selker, Harry P.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Wood, Alastair J. J.] Weill Cornell Med Sch, New York, NY USA; [Wood, Alastair J. J.] Symphony Capital, New York, NY USA	Tufts University; Tufts Medical Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Selker, HP (corresponding author), Tufts Univ, Clin & Translat Sci Inst, Boston, MA 02111 USA.								0	17	18	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2595	2597		10.1056/NEJMp0910747	http://dx.doi.org/10.1056/NEJMp0910747			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	19923560				2022-12-28	WOS:000273181300004
J	Gruber, J				Gruber, Jonathan			Getting the Facts Straight on Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gruber, J (corresponding author), MIT, Cambridge, MA 02139 USA.							GRUBER J, 2009, IMPACTS SENATE HIGH; *KAIS FAM FDN, MED SAV PERSP COMP 2; *OFF HLTH HUM SERV, REC SPEC COMM HLTH C	3	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2497	2499		10.1056/NEJMp0911715	http://dx.doi.org/10.1056/NEJMp0911715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	19955515				2022-12-28	WOS:000273003700001
J	Clifford, GM				Clifford, Gary M.			Global access to HPV vaccination: what are we waiting for?	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; COST-EFFECTIVENESS; INFECTION; HEALTH; WOMEN		Int Agcy Res Canc, F-69372 Lyon 08, France	World Health Organization; International Agency for Research on Cancer (IARC)	Clifford, GM (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	clifford@iarc.fr						David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; Diaz M, 2008, BRIT J CANCER, V99, P230, DOI 10.1038/sj.bjc.6604462; FERLAY J, 2004, GLOBOCAN 2002 INCIDE; Goldie SJ, 2008, REPROD HEALTH MATTER, V16, P86, DOI 10.1016/S0968-8080(08)32409-4; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Villa LL, 2007, J INFECT DIS, V196, P1438, DOI 10.1086/522864; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741	12	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1948	1949		10.1016/S0140-6736(09)61789-X	http://dx.doi.org/10.1016/S0140-6736(09)61789-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19962186				2022-12-28	WOS:000272727000005
J	Bhatt, DL; Lincoff, AM; Gibson, CM; Stone, GW; McNulty, S; Montalescot, G; Kleiman, NS; Goodman, SG; White, HD; Mahaffey, KW; Pollack, CV; Manoukian, SV; Widimsky, P; Chew, DP; Cura, F; Manukov, I; Tousek, F; Jafar, MZ; Arneja, J; Skerjanec, S; Harrington, RA				Bhatt, Deepak L.; Lincoff, A. Michael; Gibson, C. Michael; Stone, Gregg W.; McNulty, Steven; Montalescot, Gilles; Kleiman, Neal S.; Goodman, Shaun G.; White, Harvey D.; Mahaffey, Kenneth W.; Pollack, Charles V., Jr.; Manoukian, Steven V.; Widimsky, Petr; Chew, Derek P.; Cura, Fernando; Manukov, Ivan; Tousek, Frantisek; Jafar, M. Zubair; Arneja, Jaspal; Skerjanec, Simona; Harrington, Robert A.		CHAMPION PLATFORM Investigators	Intravenous Platelet Blockade with Cangrelor during PCI.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; MYOCARDIAL-INFARCTION; ANTIPLATELET-THERAPY; ELUTING STENTS; CLOPIDOGREL; TRIAL; ASPIRIN; PRETREATMENT; PRASUGREL	Background: Intravenous cangrelor, a rapid-acting, reversible adenosine diphosphate (ADP) receptor antagonist, might reduce ischemic events during percutaneous coronary intervention (PCI). Methods: In this double-blind, placebo-controlled study, we randomly assigned 5362 patients who had not been treated with clopidogrel to receive either cangrelor or placebo at the time of PCI, followed by 600 mg of clopidogrel. The primary end point was a composite of death, myocardial infarction, or ischemia-driven revascularization at 48 hours. Enrollment was stopped when an interim analysis concluded that the trial would be unlikely to show superiority for the primary end point. Results: The primary end point occurred in 185 of 2654 patients receiving cangrelor (7.0%) and in 210 of 2641 patients receiving placebo (8.0%) (odds ratio in the cangrelor group, 0.87; 95% confidence interval [CI], 0.71 to 1.07; P=0.17) (modified intention-to-treat population adjusted for missing data). In the cangrelor group, as compared with the placebo group, two prespecified secondary end points were significantly reduced at 48 hours: the rate of stent thrombosis, from 0.6% to 0.2% (odds ratio, 0.31; 95% CI, 0.11 to 0.85; P=0.02), and the rate of death from any cause, from 0.7% to 0.2% (odds ratio, 0.33; 95% CI, 0.13 to 0.83; P=0.02). There was no significant difference in the rate of blood transfusion (1.0% in the cangrelor group and 0.6% in the placebo group, P=0.13), though major bleeding on one scale was increased in the cangrelor group, from 3.5% to 5.5% (P<0.001), because of more groin hematomas. Conclusions: The use of periprocedural cangrelor during PCI was not superior to placebo in reducing the primary end point. The prespecified secondary end points of stent thrombosis and death were lower in the cangrelor group, with no significant increase in the rate of transfusion. Further study of intravenous ADP blockade with cangrelor may be warranted. (ClinicalTrials.gov number, NCT00385138.) N Engl J Med 2009;361:2330-41.	[Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA 02132 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gibson, C. Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Lincoff, A. Michael] Cleveland Clin, Cleveland, OH USA; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Jafar, M. Zubair] Hudson Valley Heart Ctr, Poughkeepsie, NY USA; [McNulty, Steven; Mahaffey, Kenneth W.; Harrington, Robert A.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Montalescot, Gilles] Hop La Pitie Salpetriere, Inst Cardiol, Paris, France; [Kleiman, Neal S.] Methodist Hosp, Methodist DeBakey Heart Ctr, Houston, TX 77030 USA; [Goodman, Shaun G.] St Michaels Hosp, Div Cardiol, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada; [Goodman, Shaun G.] Canadian Heart Res Ctr, Toronto, ON, Canada; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; [Pollack, Charles V., Jr.] Univ Penn, Penn Hosp, Philadelphia, PA 19104 USA; [Manoukian, Steven V.] Sarah Cannon Res Inst, Nashville, TN USA; [Manoukian, Steven V.] Hosp Corp Amer, Nashville, TN USA; [Widimsky, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Chew, Derek P.] Flinders Univ S Australia, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Cura, Fernando] Inst Cardiovasc Buenos Aires, Dept Intervent Cardiol, Buenos Aires, DF, Argentina; [Manukov, Ivan] St Georges Univ Hosp, Clin Invas Cardiol, Plovdiv, Bulgaria; [Tousek, Frantisek] Reg Hosp, Ceske Budejovice, Czech Republic; [Arneja, Jaspal] Arneja Heart Inst, Nagpur, Maharashtra, India; [Skerjanec, Simona] Medicines Co, Parsippany, NJ USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Cleveland Clinic Foundation; Columbia University; Cardiovascular Research Foundation (CRF); Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Canadian Heart Research Centre; University of Toronto; Auckland City Hospital; University of Pennsylvania; Pennsylvania Medicine; Sarah Cannon Research Institute; Hospital Corporation of America; Charles University Prague; Flinders Medical Centre; Flinders University South Australia; Instituto Cardiovascular de Buenos Aires (ICBA)	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	dlbhattmd@post.harvard.edu	Kočka, Viktor/K-7552-2017; Widimsky, Petr/P-8088-2016; De+Servi, Stefano/AAT-2631-2021; Leonardi, Sergio/AAK-1490-2020; Cortese, Bernardo/M-4374-2016; Leonardi, Sergio/K-4334-2018; Gibson, C. Michael/AAE-8212-2019; Boldueva, Svetlana/AAH-3862-2019; Vasilieva, Elena/B-2137-2016	Kočka, Viktor/0000-0002-2806-0545; Widimsky, Petr/0000-0001-5686-7752; Leonardi, Sergio/0000-0002-4800-6132; Cortese, Bernardo/0000-0002-5808-7810; Leonardi, Sergio/0000-0002-4800-6132; Boldueva, Svetlana/0000-0002-1898-084X; Vasilieva, Elena/0000-0003-4111-0874; Lopez-Palop, Ramon/0000-0003-4385-7939; Brilakis, Emmanouil/0000-0001-9416-9701; Chew, Derek/0000-0003-3593-296X	Medicines Company	Medicines Company	Supported by the Medicines Company.	Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Bhatt DL, 2009, NEW ENGL J MED, V361, P940, DOI 10.1056/NEJMp0806848; Bhatt DL, 2005, CIRCULATION, V112, P906, DOI 10.1161/CIRCULATIONAHA.104.483297; Bhatt DL, 2002, J AM COLL CARDIOL, V39, P9, DOI 10.1016/S0735-1097(01)01713-2; HARRINGTON RA, 1995, J AM COLL CARDIOL, V25, P1693, DOI 10.1016/0735-1097(95)00091-H; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Meadows TA, 2007, CIRC RES, V100, P1261, DOI 10.1161/01.RES.0000264509.36234.51; Medina HM, 2007, CLIN CARDIOL, V30, P4, DOI 10.1002/clc.20237; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610; Prasad A, 2009, J AM COLL CARDIOL, V54, P477, DOI 10.1016/j.jacc.2009.03.063; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Schomig A, 2009, NEW ENGL J MED, V361, P1108, DOI 10.1056/NEJMe0906549; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	24	460	497	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2330	2341		10.1056/NEJMoa0908629	http://dx.doi.org/10.1056/NEJMoa0908629			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	19915222				2022-12-28	WOS:000272547600007
J	Chan, M				Chan, Margaret			Cutting carbon, improving health	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva, Switzerland.	MediaEnquiries@who.int						Lim V, 2009, LANCET, V374, P973, DOI 10.1016/S0140-6736(09)61641-X; McMichael A. J., 2004, COMP QUANTIFICATION; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; WHO, 2008, CLIM CHANG HLTH RES; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Medical Association, 2009, WMA DECL DELH HLTH C	6	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1870	1871		10.1016/S0140-6736(09)61993-0	http://dx.doi.org/10.1016/S0140-6736(09)61993-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19942272				2022-12-28	WOS:000272646900005
J	Gick, B; Derrick, D				Gick, Bryan; Derrick, Donald			Aero-tactile integration in speech perception	NATURE			English	Article							STIMULATION; HEARING; PUFFS; STILL; HAND	Visual information from a speaker's face can enhance(1) or interfere with(2) accurate auditory perception. This integration of information across auditory and visual streams has been observed in functional imaging studies(3,4), and has typically been attributed to the frequency and robustness with which perceivers jointly encounter event-specific information from these two modalities(5). Adding the tactile modality has long been considered a crucial next step in understanding multisensory integration. However, previous studies have found an influence of tactile input on speech perception only under limited circumstances, either where perceivers were aware of the task(6,7) or where they had received training to establish a cross-modal mapping(8-10). Here we show that perceivers integrate naturalistic tactile information during auditory speech perception without previous training. Drawing on the observation that some speech sounds produce tiny bursts of aspiration (such as English 'p')(11), we applied slight, inaudible air puffs on participants' skin at one of two locations: the right hand or the neck. Syllables heard simultaneously with cutaneous air puffs were more likely to be heard as aspirated ( for example, causing participants to mishear 'b' as 'p'). These results demonstrate that perceivers integrate event-relevant tactile information in auditory perception in much the same way as they do visual information.	[Gick, Bryan; Derrick, Donald] Univ British Columbia, Dept Linguist, Vancouver, BC V6T 1Z4, Canada; [Gick, Bryan] Haskins Labs Inc, New Haven, CT 06511 USA	University of British Columbia; Yale University; Haskins Laboratories	Gick, B (corresponding author), Univ British Columbia, Dept Linguist, Vancouver, BC V6T 1Z4, Canada.	gick@interchange.ubc.ca		Derrick, Donald/0000-0002-0519-7565	Natural Sciences and Engineering Council of Canada; National Institutes of Health [DC-02717]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002717] Funding Source: NIH RePORTER	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by a Discovery Grant from the Natural Sciences and Engineering Council of Canada to B. G., and by a National Institutes of Health Grant DC-02717 to Haskins Laboratories. We acknowledge the contributions of Y. Ikegami for initial piloting, R. Lee for piloting tapping protocols, L. McLeod for help setting up the University of British Columbia system, G. Ramsay and J. Wang for building switch mechanisms, S. Renardy for organizing protocols, D. H. Whalen for discussion and students of the University of British Columbia's Interdisciplinary Speech Research Laboratory for organizing participants and other assistance.	BERNSTEIN LE, 1991, J ACOUST SOC AM, V90, P2971, DOI 10.1121/1.401771; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Derrick D, 2009, J ACOUST SOC AM, V125, P2272, DOI 10.1121/1.3081496; Diehl, 1989, ECOL PSYCHOL, V1, P1, DOI [10.1207/s15326969eco0102_2, DOI 10.1207/s15326969eco0102_2]; Diez FJ, 2003, J HEAT TRANS-T ASME, V125, P204, DOI 10.1115/1.1532019; DIEZ FJ, 2002, ASME, V124, P460; FOWLER CA, 1991, J EXP PSYCHOL HUMAN, V17, P816, DOI 10.1037/0096-1523.17.3.816; Fu KMG, 2003, J NEUROSCI, V23, P7510; Gick B, 2008, J ACOUST SOC AM, V123, pEL72, DOI 10.1121/1.2884349; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mizobuchi K, 2000, CLIN NEUROPHYSIOL, V111, P1577, DOI 10.1016/S1388-2457(00)00368-0; REED CM, 1989, J SPEECH HEAR RES, V32, P921, DOI 10.1044/jshr.3204.921; SABAH NH, 1974, J APPL PHYSIOL, V36, P256, DOI 10.1152/jappl.1974.36.2.256; Sangras R, 2002, J HEAT TRANS-T ASME, V124, P460, DOI 10.1115/1.1421047; SPARKS DW, 1978, J ACOUST SOC AM, V63, P246, DOI 10.1121/1.381720; STEVENS KN, 1998, ACOUSTIC PHONETICS, pCH7; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; WEINSTEIN SIDNEY, 1968, P195	21	110	113	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 26	2009	462	7272					502	504		10.1038/nature08572	http://dx.doi.org/10.1038/nature08572			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940925	Green Accepted			2022-12-28	WOS:000272144200043
J	Ziemann, AE; Allen, JE; Dahdaleh, NS; Drebot, II; Coryell, MW; Wunsch, AM; Lynch, CM; Faraci, FM; Howard, MA; Welsh, MJ; Wemmie, JA				Ziemann, Adam E.; Allen, Jason E.; Dahdaleh, Nader S.; Drebot, Iuliia I.; Coryell, Matthew W.; Wunsch, Amanda M.; Lynch, Cynthia M.; Faraci, Frank M.; Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.			The Amygdala Is a Chemosensor that Detects Carbon Dioxide and Acidosis to Elicit Fear Behavior	CELL			English	Article							SENSING ION CHANNELS; PANIC DISORDER; EXOCYTOSED PROTONS; BRAIN; 1A; HYPERVENTILATION; NEURONS; MEMORY; CELLS; PH	The amygdala processes and directs inputs and outputs that are key to fear behavior. However, whether it directly senses fear-evoking stimuli is unknown. Because the amygdala expresses acid-sensing ion channel-1a (ASIC1a), and ASIC1a is required for normal fear responses, we hypothesized that the amygdala might detect a reduced pH. We found that inhaled CO2 reduced brain pH and evoked fear behavior in mice. Eliminating or inhibiting ASIC1a markedly impaired this activity, and localized ASIC1a expression in the amygdala rescued the CO2-induced fear deficit of ASIC1a null animals. Buffering pH attenuated fear behavior, whereas directly reducing pH with amygdala microinjections reproduced the effect of CO2. These data identify the amygdala as an important chemosensor that detects hypercarbia and acidosis and initiates behavioral responses. They also give a molecular explanation for how rising CO2 concentrations elicit intense fear and provide a foundation for dissecting the bases of anxiety and panic disorders.	[Ziemann, Adam E.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ziemann, Adam E.] Univ Iowa, Med Scientist Training Program, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Dahdaleh, Nader S.; Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Neurosurg, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Allen, Jason E.; Drebot, Iuliia I.; Wunsch, Amanda M.; Wemmie, John A.] Univ Iowa, Dept Psychiat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Lynch, Cynthia M.; Faraci, Frank M.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Coryell, Matthew W.; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Neurosci Program, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Welsh, MJ (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu; john-wemmie@uiowa.edu		Wunsch, Amanda/0000-0002-2292-439X; Welsh, Michael/0000-0002-1646-6206; Howard, Matthew/0000-0003-3935-8889; Wemmie, John/0000-0001-7531-9065; Faraci, Frank/0000-0002-0203-1690	ADAA; NARSAD; VA Merit Award; University of Iowa Interdisciplinary Training Program in Pain Research NINDS [T32NS045549];  [1R01MH085724-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549] Funding Source: NIH RePORTER	ADAA; NARSAD(NARSAD); VA Merit Award(US Department of Veterans Affairs); University of Iowa Interdisciplinary Training Program in Pain Research NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Sam Hartman, Huiyu Gong, and Runping Wang for assistance. We also thank Dr. Mark Chapleau for use of the plethysmography and the University of Iowa Gene Vector Core. This work was supported by Young Investigator Awards from ADAA and NARSAD, VA Merit Award, and 1R01MH085724-01 (to J. A. W.) and by the University of Iowa Interdisciplinary Training Program in Pain Research NINDS T32NS045549 (to A. E. Z.). M. J. W. is an Investigator of the Howard Hughes Medical Institute.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; [Anonymous], [No title captured]; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Chen CH, 2009, J PHYSIOL-LONDON, V587, P1727, DOI 10.1113/jphysiol.2008.166918; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Dratcu L, 2000, PROG NEURO-PSYCHOPH, V24, P1069, DOI 10.1016/S0278-5846(00)00130-5; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Friedman SD, 2006, AM J PSYCHIAT, V163, P710, DOI 10.1176/appi.ajp.163.4.710; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Griez E, 1998, J PSYCHOSOM RES, V45, P493, DOI 10.1016/S0022-3999(98)00027-0; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kaila Kai, 1998, P309; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Maddock RJ, 2001, J NEUROPSYCH CLIN N, V13, P22, DOI 10.1176/appi.neuropsych.13.1.22; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; MAYHAN WG, 1988, MICROVASC RES, V35, P179, DOI 10.1016/0026-2862(88)90061-1; MITCHELL RA, 1965, J APPL PHYSIOL, V20, P443, DOI 10.1152/jappl.1965.20.3.443; Mongeluzi DL, 2003, BEHAV MODIF, V27, P620, DOI 10.1177/0145445503256316; Nattie Eugene, 1998, P535; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Palmer MJ, 2003, J NEUROSCI, V23, P11332; PAPP LA, 1993, AM J PSYCHIAT, V150, P1149; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; Rabinak CA, 2008, BEHAV NEUROSCI, V122, P1284, DOI 10.1037/a0012903; Rassovsky Y, 2003, J ANXIETY DISORD, V17, P1, DOI 10.1016/S0887-6185(02)00181-0; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; SANDERSON WC, 1989, ARCH GEN PSYCHIAT, V46, P157; Schnizler MK, 2009, J BIOL CHEM, V284, P2697, DOI 10.1074/jbc.M805110200; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Smoller JW, 1996, AM J RESP CRIT CARE, V154, P6, DOI 10.1164/ajrccm.154.1.8680700; Sullivan GM, 2003, BIOL PSYCHIAT, V53, P863, DOI 10.1016/S0006-3223(02)01733-X; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; ZANDBERGEN J, 1989, Hillside Journal of Clinical Psychiatry, V11, P185; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2009, J NEUROSCI, V29, P8438, DOI 10.1523/JNEUROSCI.1284-09.2009	56	287	292	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					1012	1021		10.1016/j.cell.2009.10.029	http://dx.doi.org/10.1016/j.cell.2009.10.029			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945383	Green Accepted, Bronze			2022-12-28	WOS:000272169400023
J	Vielle-Calzada, JP; de la Vega, OM; Hernandez-Guzman, G; Ibarra-Laclette, E; Alvarez-Mejia, C; Vega-Arreguin, JC; Jimenez-Moraila, B; Fernandez-Cortes, A; Corona-Armenta, G; Herrera-Estrella, L; Herrera-Estrella, A				Vielle-Calzada, Jean-Philippe; Martinez de la Vega, Octavio; Hernandez-Guzman, Gustavo; Ibarra-Laclette, Enrique; Alvarez-Mejia, Cesar; Vega-Arreguin, Julio C.; Jimenez-Moraila, Beatriz; Fernandez-Cortes, Araceli; Corona-Armenta, Guillermo; Herrera-Estrella, Luis; Herrera-Estrella, Alfredo			The Palomero Genome Suggests Metal Effects on Domestication	SCIENCE			English	Article							MAIZE		[Vielle-Calzada, Jean-Philippe; Martinez de la Vega, Octavio; Hernandez-Guzman, Gustavo; Ibarra-Laclette, Enrique; Alvarez-Mejia, Cesar; Vega-Arreguin, Julio C.; Jimenez-Moraila, Beatriz; Fernandez-Cortes, Araceli; Corona-Armenta, Guillermo; Herrera-Estrella, Luis; Herrera-Estrella, Alfredo] CINVESTAV, Lab Nacl Genom Biodiversidad, Irapuato 36500, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Herrera-Estrella, L (corresponding author), CINVESTAV, Lab Nacl Genom Biodiversidad, Km 9-6 Libramiento Norte Carretera Irapuato Leon, Irapuato 36500, Mexico.	lherrera@ira.cinvestav.mx	Herrera-Estrella, Luis/ABC-7431-2020; Martinez, Octavio/F-3951-2014; Herrera-Estrella, Alfredo/F-3185-2011; Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Herrera-Estrella, Luis/AAL-2472-2020; Herrera-Estrella, Alfredo/J-8210-2019; Estrella, Luis R Herrera/G-7351-2011	Martinez, Octavio/0000-0002-7590-0041; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Luis/0000-0001-7936-3856; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Estrella, Luis R Herrera/0000-0001-7936-3856; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490; Vega-Arreguin, Julio C./0000-0002-4509-4122; Hernandez-Guzman, Gustavo/0000-0002-3686-8122; Alvarez-Mejia, Cesar/0000-0002-1016-4557	Consejo Nacional de Ciencia y Tecnologia; la Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion [ZEA-2006]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); la Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion	We thank D. Torrent (Barcelona Supercomputing Center, Spain) for facilities and technical support; J. Sanchez, J. M. Hernandez Casillas, and Centro Internacional de Mejoramiento de Maiz y Trigo (CIMMYT) for access to their seed collections; G. Palomino and G. Acosta for help with flow cytometry; J. Bennetzen, S. Wessler, and N. Jiang for help with repetitive DNA analysis; J. Sanchez and A. Avendano (Centro Universitario de Ciencias Biologicas y Agropecuarias) for providing plant material; J. Doebley, J. Yan, and C. Bedolla for backup DNA samples; and two anonymous reviewers for helpful suggestions. Funded by Consejo Nacional de Ciencia y Tecnologia and the ZEA-2006 grant from la Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion. Genbank assession numbers are GU112491 to GU112502.	Briggs WH, 2007, GENETICS, V177, P1915, DOI 10.1534/genetics.107.076497; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; DORWEILER J, 1993, SCIENCE, V262, P233, DOI 10.1126/science.262.5131.233; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299	8	55	60	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1078	1078		10.1126/science.1178437	http://dx.doi.org/10.1126/science.1178437			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965420				2022-12-28	WOS:000271951000031
J	Allam, AH; Thompson, RC; Wann, LS; Miyamoto, MI; Thomas, GS				Allam, Adel H.; Thompson, Randall C.; Wann, L. Samuel; Miyamoto, Michael I.; Thomas, Gregory S.			Computed Tomographic Assessment of Atherosclerosis in Ancient Egyptian Mummies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Allam, Adel H.] Al Azhar Med Sch, Cairo, Egypt; [Thompson, Randall C.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Wann, L. Samuel] Wisconsin Heart Hosp, Milwaukee, WI USA; [Miyamoto, Michael I.] Univ Calif San Diego, San Diego, CA 92103 USA; [Thomas, Gregory S.] Univ Calif Irvine, Irvine, CA USA	Egyptian Knowledge Bank (EKB); Al Azhar University; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of California System; University of California San Diego; University of California System; University of California Irvine	Allam, AH (corresponding author), Al Azhar Med Sch, Cairo, Egypt.	gthomas9@mac.com		Miyamoto, Michael/0000-0002-8204-2815				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Darby W. J., 1977, FOOD GIFT OSIRIS, V1; Long AR., 1931, ARCH PATHOL, V12, P92; Ruffer MA, 1911, J PATHOL BACTERIOL, V15, P453, DOI 10.1002/path.1700150403	5	58	60	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2091	2094		10.1001/jama.2009.1641	http://dx.doi.org/10.1001/jama.2009.1641			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920233	Bronze			2022-12-28	WOS:000271873900017
J	Nelson, HD; Fu, RW; Griffin, JC; Nygren, P; Smith, B; Humphrey, L				Nelson, Heidi D.; Fu, Rongwei; Griffin, Jessica C.; Nygren, Peggy; Smith, Beth; Humphrey, Linda			Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer	ANNALS OF INTERNAL MEDICINE			English	Review							SURGICAL ADJUVANT BREAST; BONE-MINERAL DENSITY; HEALTHY POSTMENOPAUSAL WOMEN; CONTINUING OUTCOMES RELEVANT; HORMONE-REPLACEMENT THERAPY; RANDOMIZED CONTROLLED-TRIAL; VERTEBRAL FRACTURE RISK; BOWEL PROJECT P-1; QUALITY-OF-LIFE; PREVENTION TRIAL	Background: Trials demonstrate the efficacy of medications to reduce the risk for invasive breast cancer. Purpose: To summarize benefits and harms of tamoxifen citrate, raloxifene, and tibolone to reduce the risk for primary breast cancer. Data Sources: MEDLINE and Cochrane databases from inception to January 2009, Web of Science, trial registries, and manufacturer information. Study Selection: Predefined eligibility criteria were used to select articles. English-language reports of randomized, controlled trials (RCTs) for benefits and RCTs and observational studies for harms were included. Data Extraction: Two reviewers assessed study data, quality, and applicability. Data Synthesis: Seven placebo-controlled RCTs and 1 head-to-head trial provide results for main outcomes. Tamoxifen (risk ratio, 0.70 [95% CI, 0.59 to 0.82]; 4 trials), raloxifene (risk ratio, 0.44 [CI, 0.27 to 0.71]; 2 trials), and tibolone (risk ratio, 0.32 [CI, 0.13 to 0.80]; 1 trial) reduce risk for invasive breast cancer compared with placebo by 7 to 10 per 1000 women per year. Tamoxifen and raloxifene reduce estrogen receptor-positive breast cancer but not estrogen receptor-negative breast cancer, noninvasive breast cancer, or mortality. All medications reduce fractures. Tamoxifen (risk ratio, 1.93 [CI, 1.41 to 2.64]; 4 trials) and raloxifene (risk ratio, 1.60 [CI, 1.15 to 2.23]; 2 trials) increase thromboembolic events by 4 to 7 per 1000 women per year; raloxifene causes fewer events than tamoxifen. Tamoxifen increases risk for endometrial cancer (risk ratio, 2.13 [CI, 1.36 to 3.32]; 3 trials) compared with placebo by 4 per 1000 women per year and causes cataracts compared with raloxifene. Tibolone causes strokes in older women. Limitations: Bias, trial heterogeneity, and a dearth of head-to-head trials limit this review. Data are lacking on doses, duration, and timing of the medications; long-term effects; and nonwhite and premenopausal women. Conclusion: Three medications reduce risk for primary breast cancer but increase risk for thromboembolic events (tamoxifen, raloxifene), endometrial cancer (tamoxifen), or stroke (tibolone).	Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Women & Childrens Hlth Res Ctr, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mailcode BICC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu	Smith, Beth A./D-2914-2014	Smith, Beth A./0000-0003-2531-5394	Agency for Healthcare Research and Quality, Rockville, Maryland [290-2007-10057-1]	Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript is based on research conducted by the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality, Rockville, Maryland ( contract 290-2007-10057-1).	Agency for Healthcare Research and Quality, METH REF GU IN PRESS; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Bots NL, 2003, CONTROL CLIN TRIALS, V24, P752, DOI 10.1016/S0197-2456(03)00096-5; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Chalas E, 2005, AM J OBSTET GYNECOL, V192, P1230, DOI 10.1016/j.ajog.2004.12.083; Christodoulakos GE, 2006, MATURITAS, V53, P413, DOI 10.1016/j.maturitas.2005.07.003; Cohen FJ, 2000, OBSTET GYNECOL, V95, P104, DOI 10.1016/S0029-7844(99)00554-2; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Day R, 2001, ANN NY ACAD SCI, V949, P143; Day R, 2001, J NATL CANCER I, V93, P1615, DOI 10.1093/jnci/93.21.1615; Decensi A, 2005, CIRCULATION, V111, P650, DOI 10.1161/01.CIR.0000154545.84124.AC; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duvernoy CS, 2005, MENOPAUSE, V12, P444, DOI 10.1097/01.GME.0000151653.02620.89; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Ettinger B, 2008, OBSTET GYNECOL, V112, P653, DOI 10.1097/AOG.0b013e3181809e25; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Food and Drug Administration (U.S.), 2015, FDA APPR DRUG PROD; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2001, ANN NY ACAD SCI, V949, P286; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P4717, DOI 10.1210/jc.86.10.4717; Goldstein SR, 2005, MENOPAUSE, V12, P160, DOI 10.1097/00042192-200512020-00010; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grady D, 2008, J NATL CANCER I, V100, P854, DOI 10.1093/jnci/djn153; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hudita D, 2003, Eur Rev Med Pharmacol Sci, V7, P117; Johnell O, 2004, J FAM PRACTICE, V53, P789; Johnston CC, 2000, ARCH INTERN MED, V160, P3444, DOI 10.1001/archinte.160.22.3444; Jolly EE, 2003, MENOPAUSE, V10, P337, DOI 10.1097/01.GME.0000058772.59606.2A; Keech CA, 2005, CURR MED RES OPIN, V21, P135, DOI 10.1185/030079904X18045; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Landgren MB, 2002, BJOG-INT J OBSTET GY, V109, P1109, DOI 10.1111/j.1471-0528.2002.02020.x; Langer RD, 2006, AM J OBSTET GYNECOL, V195, P1320, DOI 10.1016/j.ajog.2006.03.045; Lippman ME, 2006, CLIN CANCER RES, V12, P5242, DOI 10.1158/1078-0432.CCR-06-0688; Lufkin EG, 1998, J BONE MINER RES, V13, P1747, DOI 10.1359/jbmr.1998.13.11.1747; Lundstrom E, 2002, AM J OBSTET GYNECOL, V186, P717, DOI 10.1067/mob.2002.121896; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; McClung MR, 2006, MENOPAUSE, V13, P377, DOI 10.1097/01.gme.0000188736.69617.4f; Meunier PJ, 1999, OSTEOPOROSIS INT, V10, P330, DOI 10.1007/s001980050236; Morii H, 2003, OSTEOPOROSIS INT, V14, P793, DOI 10.1007/s00198-003-1424-1; Nelson HD, 2009, COMP EFFECTIVENESS M; Nickelsen T, 1999, PSYCHONEUROENDOCRINO, V24, P115, DOI 10.1016/S0306-4530(98)00041-9; Onalan G, 2005, TOHOKU J EXP MED, V207, P223, DOI 10.1620/tjem.207.223; Palacios S, 2004, AM J OBSTET GYNECOL, V191, P121, DOI 10.1016/j.ajog.2003.10.701; Parazzini F, 1997, OBSTET GYNECOL, V90, P453, DOI 10.1016/S0029-7844(97)00295-0; Powles T, 1998, LANCET, V352, P98; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Silverman SL, 2004, J AM GERIATR SOC, V52, P1543, DOI 10.1111/j.1532-5415.2004.52420.x; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Swanson SG, 2006, MENOPAUSE, V13, P917, DOI 10.1097/01.gme.0000247016.41007.c9; Veronesi A, 1998, TUMORI, V84, P372, DOI 10.1177/030089169808400312; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 2003, J NATL CANCER I, V95, P160, DOI 10.1093/jnci/95.2.160; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Vogel VG, 2006, ANN NY ACAD SCI, V1089, P127, DOI 10.1196/annals.1386.010; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445	72	67	67	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					703	W235		10.7326/0000605-200911170-00147	http://dx.doi.org/10.7326/0000605-200911170-00147			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920271				2022-12-28	WOS:000272145100004
J	Wood, P; Peckham, D				Wood, Philip; Peckham, Daniel			Rational Testing Investigating recurrent respiratory infections in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMON VARIABLE IMMUNODEFICIENCY; INTRAVENOUS IMMUNOGLOBULIN; PREVENTION; PNEUMONIA; EFFICACY		[Wood, Philip] St James Univ Hosp, Dept Clin Immunol, Leeds LS9 7TF, W Yorkshire, England; [Peckham, Daniel] St James Univ Hosp, Dept Resp Med, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; Saint James's University Hospital	Wood, P (corresponding author), St James Univ Hosp, Dept Clin Immunol, Leeds LS9 7TF, W Yorkshire, England.	philip.wood@leedsth.nhs.uk		Peckham, Daniel/0000-0001-7723-1868				Aghamohammadi A, 2004, FEMS IMMUNOL MED MIC, V40, P113, DOI 10.1016/S0928-8244(03)00304-3; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Cancer Research UK, 2008, CANCERSTATS INC UK; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Joshi AY, 2009, MAYO CLIN PROC, V84, P16, DOI [10.4065/84.1.16, 10.1016/S0025-6196(11)60802-1]; Kainulainen L, 2001, J CLIN IMMUNOL, V21, P145, DOI 10.1023/A:1011012023616; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; *ROYAL COLL GEN PR, 2007, ANN PREV REP 2007; Wood P, 2007, CLIN EXP IMMUNOL, V149, P410, DOI 10.1111/j.1365-2249.2007.03432.x	11	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 12	2009	339								b4118	10.1136/bmj.b4118	http://dx.doi.org/10.1136/bmj.b4118			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HN	19910402				2022-12-28	WOS:000271834000002
J	Konstam, MA; Neaton, JD; Dickstein, K; Drexler, H; Komajda, M; Martinez, FA; Riegger, GAJ; Malbecq, W; Smith, RD; Guptha, S; Poole-Wilson, PA				Konstam, Marvin A.; Neaton, James D.; Dickstein, Kenneth; Drexler, Helmut; Komajda, Michel; Martinez, Felipe A.; Riegger, Gunter A. J.; Malbecq, William; Smith, Ronald D.; Guptha, Soneil; Poole-Wilson, Philip A.		HEAAL Investigators	Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial	LANCET			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; MYOCARDIAL-INFARCTION; ANTAGONIST LOSARTAN; MORTALITY; MORBIDITY; CAPTOPRIL; VALSARTAN; CANDESARTAN; INTOLERANT	Background Angiotensin-receptor blockers (ARBs) are effective treatments for patients with heart failure, but the relation between dose and clinical outcomes has not been explored. We compared the effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure. Methods This double-blind trial was undertaken in 255 sites in 30 countries. 3846 patients with heart failure of New York Heart Association class II-IV, left-ventricular ejection fraction 40% or less, and intolerance to angiotensin-converting-enzyme (ACE) inhibitors were randomly assigned to losartan 150 mg (n=1927) or 50 mg daily (n=1919). Allocation was by block randomisation stratified by Centre and presence or absence of P-blocker therapy, and all patients and investigators were masked to assignment. The primary endpoint was death or admission for heart failure. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00090259. Findings Six patients in each group were excluded because of poor data quality. With 4.7-year median follow-up in each group (IQR 3.7-5.5 for losartan 150 mg; 3.4-5.5 for losartan 50 mg), 828 (43%) patients in the 150 mg group versus 889 (46%) in the 50 ring group died or were admitted for heart failure (hazard ratio [HR] 0.90, 95% CI 0.82-0.99; p=0.027). For the two primary endpoint components, 635 patients in the 150 mg group versus 665 in the 50 ring group died (HR 0.94, 95% CI 0.84-1.04; p=0.24), and 450 versus 503 patients were admitted for heart failure (0.87,0.76-0.98; p=0.025). Renal impairment (n=454 vs 317), hypotension (203 vs 145), and hyperkalaemia (195 vs 131) were more common in the 150 mg group than in the 50 mg group, but these adverse events did not lead to significantly more treatment discontinuations in the 150 mg group. Interpretation Losartan 150 mg daily reduced the rate of death or admission for heart failure in patients with heart failure, reduced left-ventricular ejection fraction, and intolerance to ACE inhibitors compared with losartan 50 ring daily. These findings show the value of up-titrating ARB doses to confer clinical benefit.	[Konstam, Marvin A.] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA; [Neaton, James D.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Dickstein, Kenneth] Stavanger Univ Hosp, Stavanger, Norway; [Dickstein, Kenneth] Univ Bergen, Inst Internal Med, Bergen, Norway; [Drexler, Helmut] Hannover Med Sch, D-30623 Hannover, Germany; [Komajda, Michel] Univ Paris 06, Grp Hosp Pitie Salpetriere, Paris, France; [Martinez, Felipe A.] Natl Univ Cordoba, Rusculleda Fdn Clin Res, Cordoba, Argentina; [Riegger, Gunter A. J.] Univ Hosp Regensburg, Regensburg, Germany; [Malbecq, William] MSD Europe, Brussels, Belgium; [Smith, Ronald D.; Guptha, Soneil] Merck & Co Inc, Whitehouse Stn, NJ USA; [Poole-Wilson, Philip A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Tufts Medical Center; Tufts University; University of Minnesota System; University of Minnesota Twin Cities; Stavanger University Hospital; University of Bergen; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; National University of Cordoba; University of Regensburg; Merck & Company; Merck & Company; Imperial College London	Konstam, MA (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Box 108,800 Washington St, Boston, MA 02111 USA.	mkonstam@tuftsmedicalcenter.org	Urina-Triana, Miguel A/H-2605-2016; Yusof, Zurkurnai/AAA-5893-2021; Manolis, Antonis/F-5003-2014; van Veldhuisen, Dirk Jan/E-8967-2014	Urina-Triana, Miguel A/0000-0001-6003-4622; Manolis, Antonis/0000-0002-0336-4745; Lloyd, Guy/0000-0003-1958-6606; Lanas, Fernando/0000-0003-3595-9759; Hittinger, Luc/0000-0003-1933-5815; Loeys, Tom/0000-0003-4551-5502; Volpe, Massimo/0000-0002-9642-8380	Merck & Co, Inc. Whitehouse Station, NJ, USA	Merck & Co, Inc. Whitehouse Station, NJ, USA(Merck & Company)	This study was supported by Merck & Co, Inc. Whitehouse Station, NJ, USA. We thank our investigators and their patients for their participation, Brenda Vanslembrouck for coordinating clinical drug supply, and Rachid Massaad and Deborah Wentworth for statistical analyses. The authors wish to dedicate this report to the memories of Prof Philip A Poole-Wilson and Prof Helmut Drexler.	Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Carr AA, 2005, AM J CARDIOL, V96, P1530, DOI 10.1016/j.amjcard.2005.07.061; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; DZAU VJ, 1993, J HYPERTENS, V11, pS13; GOTTLIEB SS, 1993, CIRCULATION, V88, P1602, DOI 10.1161/01.CIR.88.4.1602; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Konstam MA, 2005, AM HEART J, V150, P123, DOI 10.1016/j.ahj.2004.10.035; Konstam MA, 2008, EUR J HEART FAIL, V10, P899, DOI 10.1016/j.ejheart.2008.07.004; Krum H, 2004, EUR J HEART FAIL, V6, P937, DOI 10.1016/j.ejheart.2004.09.005; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Maggioni AP, 2002, J AM COLL CARDIOL, V40, P1414, DOI 10.1016/S0735-1097(02)02304-5; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Nanas JN, 2000, J AM COLL CARDIOL, V36, P2090, DOI 10.1016/S0735-1097(00)01025-1; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; RegitzZagrosek V, 1995, EUR HEART J, V16, P86, DOI 10.1093/eurheartj/16.suppl_N.86; Therneau TM, 2000, MODELING SURVIVAL DA; Weber M, 1997, CLIN THER, V19, P604, DOI 10.1016/S0149-2918(97)80086-0	22	426	436	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1840	1848		10.1016/S0140-6736(09)61913-9	http://dx.doi.org/10.1016/S0140-6736(09)61913-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527MC	19922995				2022-12-28	WOS:000272370200029
J	Krum, H				Krum, Henry			Optimising management of chronic heart failure	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; ENALAPRIL; MORTALITY; LOSARTAN; MORBIDITY; CAPTOPRIL; DOSAGES		Monash Univ, Dept Epidemiol & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia	Monash University	Krum, H (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu						Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brunner-La Rocca HP, 1999, AM HEART J, V138, P654, DOI 10.1016/S0002-8703(99)70179-1; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Gullestad L, 1999, J AM COLL CARDIOL, V34, P2061, DOI 10.1016/S0735-1097(99)00495-7; KONSTAM MA, 2009, LANCET; Nanas JN, 2000, J AM COLL CARDIOL, V36, P2090, DOI 10.1016/S0735-1097(00)01025-1; Pacher R, 1996, EUR HEART J, V17, P1223; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Poole-Wilson P, 1998, EUR HEART J, V19, P481	11	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1808	1809		10.1016/S0140-6736(09)61992-9	http://dx.doi.org/10.1016/S0140-6736(09)61992-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527MC	19922996				2022-12-28	WOS:000272370200012
J	Pisani, E; Whitworth, J; Zaba, B; Abou-Zahr, C				Pisani, Elizabeth; Whitworth, James; Zaba, Basia; Abou-Zahr, Carla			Time for fair trade in research data	LANCET			English	Editorial Material									[Whitworth, James] Wellcome Trust Res Labs, London, England; [Zaba, Basia] London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1, England; [Abou-Zahr, Carla] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization		pisani@ternyata.org		Pisani, Elizabeth/0000-0002-3674-631X				Arzberger P., 2004, DATA SCI J, V3, P135, DOI DOI 10.2481/DSJ.3.135; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; Chokshi DA, 2006, B WORLD HEALTH ORGAN, V84, P382, DOI 10.2471/BLT.06.029843; Groves T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1252; Mascalzoni D, 2008, PLOS MED, V5, P1302, DOI 10.1371/journal.pmed.0050192; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; *SHERPA PROJ, RES FUND OP ACC POL; *WELLC TRUST WHO, 2008, SHAR PUBL HLTH DAT C; ANN APPL STAT UNPUB	9	28	28	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					703	705		10.1016/S0140-6736(09)61486-0	http://dx.doi.org/10.1016/S0140-6736(09)61486-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JW	19913902				2022-12-28	WOS:000275211200007
J	Grandison, RC; Piper, MDW; Partridge, L				Grandison, Richard C.; Piper, Matthew D. W.; Partridge, Linda			Amino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila	NATURE			English	Article							NATURAL-SELECTION; REPRODUCTION; FOOD; MELANOGASTER; LONGEVITY; SURVIVAL; GROWTH	Dietary restriction extends healthy lifespan in diverse organisms and reduces fecundity(1,2). It is widely assumed to induce adaptive reallocation of nutrients from reproduction to somatic maintenance, aiding survival of food shortages in nature(3-6). If this were the case, long life under dietary restriction and high fecundity under full feeding would be mutually exclusive, through competition for the same limiting nutrients. Here we report a test of this idea in which we identified the nutrients producing the responses of lifespan and fecundity to dietary restriction in Drosophila. Adding essential amino acids to the dietary restriction condition increased fecundity and decreased lifespan, similar to the effects of full feeding, with other nutrients having little or no effect. However, methionine alone was necessary and sufficient to increase fecundity as much as did full feeding, but without reducing lifespan. Reallocation of nutrients therefore does not explain the responses to dietary restriction. Lifespan was decreased by the addition of amino acids, with an interaction between methionine and other essential amino acids having a key role. Hence, an imbalance in dietary amino acids away from the ratio optimal for reproduction shortens lifespan during full feeding and limits fecundity during dietary restriction. Reduced activity of the insulin/insulin-like growth factor signalling pathway extends lifespan in diverse organisms(7), and we find that it also protects against the shortening of lifespan with full feeding. In other organisms, including mammals, it may be possible to obtain the benefits to lifespan of dietary restriction without incurring a reduction in fecundity, through a suitable balance of nutrients in the diet.	[Grandison, Richard C.; Piper, Matthew D. W.; Partridge, Linda] UCL, Inst Healthy Ageing, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Partridge, L (corresponding author), UCL, Inst Healthy Ageing, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.	l.partridge@ucl.ac.uk	Partridge, Linda/A-5501-2010; Piper, Matthew/C-1714-2008; Partridge, Linda/E-7342-2015	Piper, Matthew/0000-0003-3245-7219; Partridge, Linda/0000-0001-9615-0094; Grandison, Richard/0000-0002-4552-0494	Wellcome Trust Strategic Award; Research into Ageing	Wellcome Trust Strategic Award(Wellcome Trust); Research into Ageing	We acknowledge funding from a Wellcome Trust Strategic Award to L. P. ( M. D. W. P. and L. P.) and Research into Ageing ( R. C. G. and L. P.). We would also like to thank M. Hoddinott for technical support as well as S. Pletcher and E. Blanc for assistance with statistical analyses.	Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Clancy David J., 2001, Drosophila Information Service, V84, P168; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Crawley MJ, 2005, STAT INTRO USING R, P103; DEMARTE ML, 1986, MECH AGEING DEV, V36, P161, DOI 10.1016/0047-6374(86)90017-5; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; HARRISON DE, 1989, GROWTH DEVELOP AGING, V53, P3; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Millward DJ, 2008, AM J CLIN NUTR, V87, p1576S, DOI 10.1093/ajcn/87.5.1576S; O'Brien DM, 2008, CURR BIOL, V18, pR155, DOI 10.1016/j.cub.2008.01.021; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Sang J.H., 1978, P159; SANG JH, 1961, J EXP BIOL, V38, P793; Selesniemi K, 2008, AGING CELL, V7, P622, DOI 10.1111/j.1474-9726.2008.00409.x; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Weindruch R., 1988, RETARDATION AGING DI; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	36	500	515	3	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1061	U121		10.1038/nature08619	http://dx.doi.org/10.1038/nature08619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	19956092	Green Submitted, Green Accepted			2022-12-28	WOS:000272996000048
J	Reyes, N; Ginter, C; Boudker, O				Reyes, Nicolas; Ginter, Christopher; Boudker, Olga			Transport mechanism of a bacterial homologue of glutamate transporters	NATURE			English	Article							DEPENDENT ASPARTATE TRANSPORTER; GATED ANION CONDUCTANCE; AMINO-ACID TRANSPORTERS; PYROCOCCUS-HORIKOSHII; EXTRACELLULAR GATE; NEUROTRANSMITTER TRANSPORTERS; SULFHYDRYL MODIFICATION; INDIVIDUAL SUBUNITS; MEMBRANE-TRANSPORT; PERMEATION PATHWAY	Glutamate transporters are integral membrane proteins that catalyse a thermodynamically uphill uptake of the neurotransmitter glutamate from the synaptic cleft into the cytoplasm of glia and neuronal cells by harnessing the energy of pre-existing electrochemical gradients of ions. Crucial to the reaction is the conformational transition of the transporters between outward and inward facing states, in which the substrate binding sites are accessible from the extracellular space and the cytoplasm, respectively. Here we describe the crystal structure of a double cysteine mutant of a glutamate transporter homologue from Pyrococcus horikoshii, Glt(Ph), which is trapped in the inward facing state by cysteine crosslinking. Together with the previously determined crystal structures of Glt(Ph) in the outward facing state, the structure of the crosslinked mutant allows us to propose a molecular mechanism by which Glt(Ph) and, by analogy, mammalian glutamate transporters mediate sodium-coupled substrate uptake.	[Reyes, Nicolas; Ginter, Christopher; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave,Box 75, New York, NY 10065 USA	Cornell University	Boudker, O (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave,Box 75, New York, NY 10065 USA.	olb2003@med.cornell.edu		Reyes, Nicolas/0000-0001-6618-8307	National Institute of Health; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064357] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Patel and H. Li for the help with isothermal titration calorimetry and H. Weinstein for constructive criticism. X-ray diffraction data were measured at X25 beamline at the National Synchrotron Light Source. This work was supported by the National Institute of Health (O.B.) and by a Jane Coffin Childs Memorial Fund postdoctoral fellowship (N.R.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; *COMP COLL PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, P760; CRISMAN TJ, P NATL ACAD IN PRESS; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dieckmann GR, 1997, J AM CHEM SOC, V119, P6195, DOI 10.1021/ja964351i; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Gouaux E, 2009, PHILOS T R SOC B, V364, P149, DOI 10.1098/rstb.2008.0181; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Leighton BH, 2002, J BIOL CHEM, V277, P29847, DOI 10.1074/jbc.M202508200; Manceau A, 2008, DALTON T, P1421, DOI 10.1039/b718372k; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATLAK CLIFFORD S., 1957, BULL MATH BIOPHYS, V19, P209, DOI 10.1007/BF02477764; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Seal RP, 1998, METHOD ENZYMOL, V296, P318; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Shlaifer I, 2007, MOL PHARMACOL, V71, P1341, DOI 10.1124/mol.106.032607; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	51	330	335	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					880	885		10.1038/nature08616	http://dx.doi.org/10.1038/nature08616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19924125	Green Accepted			2022-12-28	WOS:000272795400034
J	Siegel, B; Nolan, L				Siegel, Bruce; Nolan, Lea			Leveling the Field -- Ensuring Equity through National Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Siegel, Bruce; Nolan, Lea] George Washington Univ, Sch Publ Hlth & Hlth Serv, Ctr Hlth Care Qual, Washington, DC 20052 USA	George Washington University	Siegel, B (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Ctr Hlth Care Qual, Washington, DC 20052 USA.							*COMM WAYS MEANS S, 2008, ADDR DISP HLTH HLTH; Institute of Medicine, 2009, RAC ETHN LANG DAT ST; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; *KAIS FAM FDN, 2009, LOW INC AD AG 65 MAN; MCHUGH M, 2009, MED CARE RES RE 0427	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2401	2403		10.1056/NEJMp0909323	http://dx.doi.org/10.1056/NEJMp0909323			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	533CE	19955518				2022-12-28	WOS:000272798900003
J	Markandya, A; Armstrong, BG; Hales, S; Chiabai, A; Criqui, P; Mima, S; Tonne, C; Wilkinson, P				Markandya, Anil; Armstrong, Ben G.; Hales, Simon; Chiabai, Aline; Criqui, Patrick; Mima, Silvana; Tonne, Cathryn; Wilkinson, Paul			Health and Climate Change 3 Public health benefits of strategies to reduce greenhouse-gas emissions: low-carbon electricity generation	LANCET			English	Article							AIR-POLLUTION; ANCILLARY BENEFITS; EXPOSURE; IMPACTS; ENERGY; POLICY	In this report, the third in this Series on health and climate change, we assess the changes in particle air pollution emissions and consequent effects on health that are likely to result from greenhouse-gas mitigation measures in the electricity generation sector in the European Union (EU), China, and India. We model the effect in 2030 of policies that aim to reduce total carbon dioxide (CO2) emissions by 50% by 2050 globally compared with the effect of emissions in 1990. We use three models: the POLES model, which identifies the distribution of production modes that give the desired CO2 reductions and associated costs; the GAINS model, which estimates fine particulate matter with aerodynamic diameter 2.5 mu m or less (PM2.5) concentrations; and a model to estimate the effect of PM2.5 on mortality on the basis of the WHO'S Comparative Risk Assessment methods. Changes in modes of production of electricity to reduce CO2 emissions would, in all regions, reduce PM2.5 and deaths caused by it, with the greatest effect in India and the smallest in the EU. Health benefits greatly offset costs of greenhouse-gas mitigation, especially in India where pollution is high and costs of mitigation are low. Our estimates are approximations but suggest dear health gains (co-benefits) through decarbonising electricity production, and provide additional information about the extent of such gains.	[Markandya, Anil; Chiabai, Aline] BC3, Bilbao, Spain; [Markandya, Anil; Chiabai, Aline] Univ Bath, Bath BA2 7AY, Avon, England; [Armstrong, Ben G.; Tonne, Cathryn; Wilkinson, Paul] London Sch Hyg & Trop Med, London WC1, England; [Hales, Simon] WHO, CH-1211 Geneva, Switzerland; [Criqui, Patrick; Mima, Silvana] Univ Grenoble, Grenoble, France; [Criqui, Patrick; Mima, Silvana] CNRS, Grenoble, France	Basque Centre for Climate Change (BC3); University of Bath; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Markandya, A (corresponding author), BC3, Gran Via 35-2, Bilbao, Spain.	anil.markandya@bc3research.org	hales, simon/E-5768-2010; CHIABAI, ALINE/M-7447-2013; Tonne, Cathryn/F-5020-2017; Azkarate, Ainhoa/K-9087-2013; Markandya, Anil/K-9381-2013	Tonne, Cathryn/0000-0003-3919-8264; Azkarate, Ainhoa/0000-0003-0471-3094; Hales, Simon/0000-0002-4529-7595; armstrong, benedict/0000-0003-4407-0409; Chiabai, Aline/0000-0002-0792-640X; Wilkinson, Paul/0000-0001-7456-259X	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies. We thank Colin Mathers (WHO, Geneva, Switzerland), who supplied the global burden of disease data from on which the burden estimates presented here are based.	[Anonymous], 2008, GAINS ASIA TOOL COMB; Aunan K, 2004, ENERG POLICY, V32, P567, DOI 10.1016/S0301-4215(03)00156-3; Bollen JC, 2009, 5001116005 PBL NETH; Burtraw D, 2003, J ENVIRON ECON MANAG, V45, P650, DOI 10.1016/S0095-0696(02)00022-0; Bussolo M, 2001, OECD DEV CTR WORKING, V182; CAO J, 2008, 0810 EFD; COHEN AJ, 2004, COMP ASSESSMENT RISK; CRIQUI P, 2008, POLES, V5; Dessus S, 2003, ENVIRON RESOUR ECON, V25, P287, DOI 10.1023/A:1024469430532; EEA (European Environment Agency), 2006, AIR QUAL ANC BEN CLI; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Frischknecht R, 2000, ENVIRON IMPACT ASSES, V20, P159, DOI 10.1016/S0195-9255(99)00042-6; Holland M, 2006, ASSESSING AIR POLLUT; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; JOH S, 2003, INT J SUSTAIN DEV, V6, P311; Koornneef J, 2009, ENRGY PROCED, V1, P3787, DOI 10.1016/j.egypro.2009.02.179; Krol M, 2005, ATMOS CHEM PHYS, V5, P417, DOI 10.5194/acp-5-417-2005; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKinley G, 2005, ENVIRON SCI TECHNOL, V39, P1954, DOI 10.1021/es035183e; Metz B., 2005, IPCC SPECIAL REPORT; Metz B., 2001, CLIMATE CHANGE 2001; Metz ORDB, 2007, CLIMATE CHANGE 2007; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Morgenstern RD, 2004, J ENVIRON DEV, V13, P140, DOI DOI 10.1177/1070496503260972; *OECD, 2000, P IPCC COSP WORKSH; Schreiber A, 2009, INT J LIFE CYCLE ASS, V14, P547, DOI 10.1007/s11367-009-0102-8; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Wang XD, 1999, ENVIRON SCI TECHNOL, V33, P3056, DOI 10.1021/es981360d; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; [No title captured]	33	115	118	10	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					2006	2015		10.1016/S0140-6736(09)61715-3	http://dx.doi.org/10.1016/S0140-6736(09)61715-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19942282				2022-12-28	WOS:000272727000024
J	Boch, J; Scholze, H; Schornack, S; Landgraf, A; Hahn, S; Kay, S; Lahaye, T; Nickstadt, A; Bonas, U				Boch, Jens; Scholze, Heidi; Schornack, Sebastian; Landgraf, Angelika; Hahn, Simone; Kay, Sabine; Lahaye, Thomas; Nickstadt, Anja; Bonas, Ulla			Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors	SCIENCE			English	Article							ORYZAE PV. ORYZAE; BACTERIAL AVIRULENCE PROTEIN; GENE-EXPRESSION; HOST-PLANT; RECOGNITION; AVRBS3; RICE; ACTIVATION; RESISTANCE; CELL	The pathogenicity of many bacteria depends on the injection of effector proteins via type III secretion into eukaryotic cells in order to manipulate cellular processes. TAL (transcription activator-like) effectors from plant pathogenic Xanthomonas are important virulence factors that act as transcriptional activators in the plant cell nucleus, where they directly bind to DNA via a central domain of tandem repeats. Here, we show how target DNA specificity of TAL effectors is encoded. Two hypervariable amino acid residues in each repeat recognize one base pair in the target DNA. Recognition sequences of TAL effectors were predicted and experimentally confirmed. The modular protein architecture enabled the construction of artificial effectors with new specificities. Our study describes the functionality of a distinct type of DNA binding domain and allows the design of DNA binding domains for biotechnology.	[Boch, Jens; Scholze, Heidi; Schornack, Sebastian; Landgraf, Angelika; Hahn, Simone; Kay, Sabine; Lahaye, Thomas; Nickstadt, Anja; Bonas, Ulla] Univ Halle Wittenberg, Inst Biol, Dept Genet, D-06099 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Boch, J (corresponding author), Univ Halle Wittenberg, Inst Biol, Dept Genet, Weinbergweg 10, D-06099 Halle, Saale, Germany.	jens.boch@genetik.uni-halle.de	Ha, Dat Thinh/D-4995-2015; Schornack, Sebastian/AAE-4897-2020; Schornack, Sebastian/A-3650-2011; Wilson, Matthew H/K-3193-2013	Ha, Dat Thinh/0000-0003-4260-4876; Schornack, Sebastian/0000-0002-7836-5881; Schornack, Sebastian/0000-0002-7836-5881; 	Deutsche Forschungsgemeinschaft [SPP 1212, SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Streubel, A. Richter, and P. Romer for kindly providing constructs; T. Gonzalez for advice on anthocyanin synthesis; and R. Kahmann for helpful suggestions on the manuscript. A patent covering the findings is pending. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SPP 1212 to J. B. and U. B. and SFB 648 to U. B.).	Bai JF, 2000, MOL PLANT MICROBE IN, V13, P1322, DOI 10.1094/MPMI.2000.13.12.1322; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Schornack S, 2005, MOL PLANT MICROBE IN, V18, P1215, DOI 10.1094/MPMI-18-1215; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Yang B, 2005, MOL PLANT MICROBE IN, V18, P142, DOI 10.1094/MPMI-18-0142; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824	26	1748	2278	24	501	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1509	1512		10.1126/science.1178811	http://dx.doi.org/10.1126/science.1178811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19933107				2022-12-28	WOS:000272623600050
J	Wilkinson, P; Smith, KR; Davies, M; Adair, H; Armstrong, BG; Barrett, M; Bruce, N; Haines, A; Hamilton, I; Oreszczyn, T; Ridley, I; Tonne, C; Chalabi, Z				Wilkinson, Paul; Smith, Kirk R.; Davies, Michael; Adair, Heather; Armstrong, Ben G.; Barrett, Mark; Bruce, Nigel; Haines, Andy; Hamilton, Ian; Oreszczyn, Tadj; Ridley, Ian; Tonne, Cathryn; Chalabi, Zaid			Health and Climate Change 1 Public health benefits of strategies to reduce greenhouse-gas emissions: household energy	LANCET			English	Article							INDOOR AIR-POLLUTION; LONG-TERM EXPOSURE; RESPIRATORY HEALTH; LUNG-CANCER; CHILDREN; MORTALITY; HOME; IMPACTS; SMOKE; MOLD	Energy used in dwellings is an important target for actions to avert climate change. Properly designed and implemented, such actions could have major co-benefits for public health. To investigate, we examined the effect of hypothetical strategies to improve energy efficiency in UK housing stock and to introduce 150 million low-emission household cookstoves in India. Methods similar to those of WHO's Comparative Risk Assessment exercise were applied to assess the effect on health that changes in the indoor environment could have. For UK housing, the magnitude and even direction of the changes in health depended on details of the intervention, but interventions were generally beneficial for health. For a strategy of combined fabric, ventilation, fuel switching, and behavioural changes, we estimated 850 fewer disability-adjusted life-years (DALYs), and a saving of 0.6 megatonnes of carbon dioxide (CO2), per million population in 1 year (on the basis of calculations comparing the health of the 2010 population with and without the specified outcome measures). The cookstove programme in India showed substantial benefits for acute lower respiratory infection in children, chronic obstructive pulmonary disease, and ischaemic heart disease. Calculated on a similar basis to the UK case study, the avoided burden of these outcomes was estimated to be 12 500 fewer DALYs and a saving of 0.1-0.2 megatonnes CO2-equivalent per million population in 1 year, mostly in short-lived greenhouse pollutants. Household energy interventions have potential for important co-benefits in pursuit of health and climate goals.	[Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, PEHRU, London WC1E 7HT, England; [Smith, Kirk R.; Adair, Heather] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Davies, Michael; Hamilton, Ian; Ridley, Ian] UCL, Bartlett Sch Grad Studies, London, England; [Barrett, Mark; Oreszczyn, Tadj] UCL, Energy Inst, London, England; [Bruce, Nigel] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; University of London; University College London; University of London; University College London; University of Liverpool	Wilkinson, P (corresponding author), Univ London London Sch Hyg & Trop Med, PEHRU, Keppel St, London WC1E 7HT, England.	paul.wilkinson@lshtm.ac.uk	Hamilton, Ian/O-6234-2014; Tonne, Cathryn/F-5020-2017; Hamilton, Ian/O-6756-2019; Davies, Michael/GWV-2527-2022	Hamilton, Ian/0000-0003-2582-2361; Tonne, Cathryn/0000-0003-3919-8264; Hamilton, Ian/0000-0003-2582-2361; armstrong, benedict/0000-0003-4407-0409; RIDLEY, Ian Alexander/0000-0001-9240-5088; Davies, Michael/0000-0003-2173-7063; Haines, Andy/0000-0002-8053-4605; Barrett, Mark/0000-0003-3655-2424; Oreszczyn, Tadeusz/0000-0002-9667-7336; Wilkinson, Paul/0000-0001-7456-259X	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; Engineering and Physical Sciences Research Council [EP/D506859/1] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish; EPSRC [EP/D506859/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies. We thank Colin Mathers (WHO, Geneva, Switzerland) for his kind assistance in providing health data, Sumi Mehta for assistance with data, and Zoe Chafe for comments.	Barnard Lucy F. Telfar, 2008, Reviews on Environmental Health, V23, P203; BARNES DF, 1993, WORLD BANK RES OBSER, V8, P119, DOI 10.1093/wbro/8.2.119; *COMM CLIM CHANG, 2008, 1 CLIM CHANG COMM 1; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; *DEP BUS INN SKILL, 2008, EN CONS UK; *DEP ENV FOOD RUR, 2009, NAT ATM EM INV UK CO; *DEP ENV FOOD RUR, 2007, AIR QUAL STRAT ENGL, V2; *DEP TRAD IND, 2005, HOM SAF NETW CARB MO; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Evans J, 2000, J EPIDEMIOL COMMUN H, V54, P677, DOI 10.1136/jech.54.9.677; Ezzati M., 2004, GLOBAL REGIONAL BURD; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Gilbertson J, 2006, SOC SCI MED, V63, P946, DOI 10.1016/j.socscimed.2006.02.021; *GOLD STAND FDN, GOLD STAND PREM QUAL; GOLDEMBERG J, 2000, WORLD ENERGY ASSESSM, pCH10; Gray A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3110; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Harrington BE, 2005, HEALTH SOC CARE COMM, V13, P259, DOI 10.1111/j.1365-2524.2005.00558.x; Howden-Chapman P, 2007, BMJ-BRIT MED J, V334, P460, DOI 10.1136/bmj.39070.573032.80; Howden-Chapman P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1411; HUTTON G, 2007, GUIDELINES CONDUCTIN; Hutton G., 2006, EVALUATION COSTS BEN; *IND I POP STUD, 2006, NAT FAM HLTH SURV; Jetter JJ, 2009, BIOMASS BIOENERG, V33, P294, DOI 10.1016/j.biombioe.2008.05.014; Kapil U, 2000, J Indian Med Assoc, V98, P559; KAPIL U, 2000, J INDIAN MED ASSOC, V98, P571; KAPIL U, 2000, J INDIAN MED ASSOC, V98, P562; Lai HK, 2004, ATMOS ENVIRON, V38, P6399, DOI 10.1016/j.atmosenv.2004.07.013; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lee Peter N, 2006, J Stroke Cerebrovasc Dis, V15, P190, DOI 10.1016/j.jstrokecerebrovasdis.2006.05.002; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Lowe JA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014012; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; Martinez-Donate AP, 2009, PREV MED, V48, P207, DOI 10.1016/j.ypmed.2008.12.011; MEHTA S, 2002, THESIS U CALIFORNIA; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; Metz B., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1017/CBO9780511546013; Millman A, 2008, PEDIATRICS, V122, P620, DOI 10.1542/peds.2007-3143; *MIN INF BROADC GO, 2005, R GANDH GRAM VID YOJ; Mishra V, 2007, INT J EPIDEMIOL, V36, P117, DOI 10.1093/ije/dyl234; Monastersky R, 2009, NATURE, V458, P1091, DOI 10.1038/4581091a; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; Oreszczyn T, 2006, INDOOR BUILT ENVIRON, V15, P125, DOI 10.1177/1420326X06063051; ORESZCZYN T, 2000, CUTTING COST COLD AF, P122; PANDEY MR, 1989, LANCET, V1, P427; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Peat JK, 1998, ALLERGY, V53, P120, DOI 10.1111/j.1398-9995.1998.tb03859.x; Perera FP, 2008, ENVIRON HEALTH PERSP, V116, P987, DOI 10.1289/ehp.11173; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Qian ZM, 2004, J EXPO ANAL ENV EPID, V14, pS78, DOI 10.1038/sj.jea.7500362; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Ramanathan V, 2009, ATMOS ENVIRON, V43, P37, DOI 10.1016/j.atmosenv.2008.09.063; Simoni M, 2005, OCCUP ENVIRON MED, V62, P616, DOI 10.1136/oem.2004.018291; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; SMITH K, 2004, COMP QUANTIFICATION, V2, P143; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; SMITH KR, 1993, WORLD DEV, V21, P941, DOI 10.1016/0305-750X(93)90053-C; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; SMITH KR, 1995, ENERGY SUSTAIN DEV, V1, P23; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; *US EN INF ADM, DAT TABL H 1CO2 WORL; Walker JJ, 2006, EUR J PUBLIC HEALTH, V16, P463, DOI 10.1093/eurpub/cki186; *WARM FRONT STUD G, 2004, HLTH IMP ENGL HOM EN; *WHO, DIS INJ REG EST 2004; *WHO, 2009, WHO GUID IND AIR DAM; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Wilkinson P, 2001, COLD COMFORT SOCIAL; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0; World Health Organization, 2006, WHO HOUS EN DAT; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	74	258	260	1	129	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1917	1929		10.1016/S0140-6736(09)61713-X	http://dx.doi.org/10.1016/S0140-6736(09)61713-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19942273				2022-12-28	WOS:000272646900025
J	Woodcock, J; Edwards, P; Tonne, C; Armstrong, BG; Ashiru, O; Banister, D; Beevers, S; Chalabi, Z; Chowdhury, Z; Cohen, A; Franco, OH; Haines, A; Hickman, R; Lindsay, G; Mittal, I; Mohan, D; Tiwari, G; Woodward, A; Roberts, I				Woodcock, James; Edwards, Phil; Tonne, Cathryn; Armstrong, Ben G.; Ashiru, Olu; Banister, David; Beevers, Sean; Chalabi, Zaid; Chowdhury, Zohir; Cohen, Aaron; Franco, Oscar H.; Haines, Andy; Hickman, Robin; Lindsay, Graeme; Mittal, Ishaan; Mohan, Dinesh; Tiwari, Geetam; Woodward, Alistair; Roberts, Ian			Health and Climate Change 2 Public health benefits of strategies to reduce greenhouse-gas emissions: urban land transport	LANCET			English	Article							PHYSICAL-ACTIVITY; BREAST-CANCER; RISK; WALKING; MORTALITY; DISEASE; INJURY; METAANALYSIS; DEMENTIA; EXERCISE	We used Comparative Risk Assessment methods to estimate the health effects of alternative urban land transport scenarios for two settings-London, UK, and Delhi, India. For each setting, we compared a business-as-usual 2030 projection (without policies for reduction of greenhouse gases) with alternative scenarios-lower-carbon-emission motor vehicles, increased active travel, and a combination of the two. We developed separate models that linked transport scenarios with physical activity, air pollution, and risk of road traffic injury. in both cities, we noted that reduction in carbon dioxide emissions through an increase in active travel and less use of motor vehicles had larger health benefits per million population (7332 disability-adjusted life-years [DALYs] in London, and 12 516 in Delhi in 1 year) than from the increased use of lower-emission motor vehicles (160 DALYs in London, and 1696 in Delhi). However, combination of active travel and lower-emission motor vehicles would give the largest benefits (7439 DALYs in London, 12 995 in Delhi), notably from a reduction in the number of years of life lost from ischaemic heart disease (10-19% in London, 11-25% in Delhi). Although uncertainties remain, climate change mitigation in transport should benefit public health substantially. Policies to increase the acceptability, appeal, and safety of active urban travel, and discourage travel in private motor vehicles would provide larger health benefits than would policies that focus solely on lower-emission motor vehicles.	[Tonne, Cathryn; Armstrong, Ben G.; Chalabi, Zaid] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Ashiru, Olu] Takedo Int, London, England; [Woodcock, James; Edwards, Phil; Roberts, Ian] Dept Epidemiol & Populat Hlth, London, England; [Banister, David; Hickman, Robin] Univ Oxford, Oxford Univ Ctr, Sch Geog & Environm, Oxford, England; [Beevers, Sean] Kings Coll London, Environm Res Grp, Sch Biomed & Hlth Sci, London WC2R 2LS, England; [Chowdhury, Zohir] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA; [Franco, Oscar H.] Univ Warwick, Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Lindsay, Graeme; Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Mittal, Ishaan; Mohan, Dinesh; Tiwari, Geetam] Indian Inst Technol Delhi, Transport Res & Injury Prevent Programme, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of London; King's College London; California State University System; San Diego State University; Health Effects Institute (HEI); University of Warwick; University of Auckland; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Woodcock, J (corresponding author), Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Res Unit, Keppel St, London WC1E 7HT, England.	james.woodcock@lshtm.ac.uk	Tonne, Cathryn/F-5020-2017; Franco, Óscar H/ABE-2305-2020; Mohan, Dinesh/E-3475-2010; Woodcock, James/AAH-6753-2021; Tiwari, Geetam/ABH-5766-2020	Tonne, Cathryn/0000-0003-3919-8264; Franco, Óscar H/0000-0002-4606-4929; Mohan, Dinesh/0000-0002-3251-2946; Woodcock, James/0000-0003-4769-5375; armstrong, benedict/0000-0003-4407-0409; Edwards, Phil/0000-0003-4431-8822; Woodward, Alistair/0000-0001-5425-6018; Haines, Andy/0000-0002-8053-4605	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; Medical Research Council [G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies or the Health Effects Institute or its sponsors. We thank K Blackball and L Felix (both London School of Hygiene and Tropical Medicine, London, UK) for help with die searches; I Dowie (London School of Hygiene and Tropical Medicine) and M Joffe (imperial College, London, UK) for commenting on drafts of the report; P Wilkinson (London School of Hygiene and Tropical Medicine) for methodological advice; C Mathers (WHO, Geneva, Switzerland) for provision of data; C Fuller (Environmental Research Group, School of Biomedical and Health Sciences, King's College London, London, UK) for help with the air pollution modelling; and R West (University College London, London, UK) for advice about physical activity and smoking cessation. Slides for teaching are available for download.	Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; *AIR QUAL GROUP, 2007, AIR QUAL CLIM CHANG; Andre M, 2009, ATMOS ENVIRON, V43, P986, DOI 10.1016/j.atmosenv.2008.03.013; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Ball K, 2009, OBESITY, V17, P66, DOI 10.1038/oby.2008.497; BANISTER D, 2009, CITIES MOBILITY CLIM; Bhalla K, 2007, RISK ANAL, V27, P125, DOI 10.1111/j.1539-6924.2006.00864.x; BULL F, 2003, COMP QUANTIFICATION; Carslaw DC, 2005, ATMOS ENVIRON, V39, P4793, DOI 10.1016/j.atmosenv.2005.06.023; *COP CIT CYCL, BIC ACC 2008; Cozens PM, 2008, URBAN POLICY RES, V26, P429, DOI 10.1080/08111140802084759; Daley A, 2008, J CLIN PSYCHOL MED S, V15, P140, DOI 10.1007/s10880-008-9105-z; *DEP HLTH, HLTH SURV ENGL 2003; *DEP TRANSP, 2003, TRANSP SOC EXCL MAK; *DEP TRANSP, 2008, TRANSP STAT GREAT BR; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; Edwards P, 2009, INT J EPIDEMIOL, V38, P1137, DOI 10.1093/ije/dyp172; Favez JY, 2009, ATMOS ENVIRON, V43, P996, DOI 10.1016/j.atmosenv.2008.03.037; FRANCO M, 2009, CMAJ, V178, P1032; Gehl J., 1987, LIFE BUILDINGS USING, VVolume 23; Greater London Authority, 2007, ACT TOD PROT TOM MAY; GRUNDY C, BMJ IN PRESS; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Harriss DJ, 2009, COLORECTAL DIS, V11, P689, DOI 10.1111/j.1463-1318.2009.01767.x; HICKMAN R, 2008, BREAKING TREND VISIO; HICKMAN R, 2009, VISIONING BACKCASTIN; HICKMAN R, 2009, TRANSPORTATION RES R; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kahn R., 2007, CLIMATE CHANGE 2007; KELLY F, 2009, ASSESSMENT IMPACT CO; Krzyzanowski M., 2004, COMP QUANTIFICATION, P1353; Kumar Rajesh, 2006, Indian Heart J, V58, P126; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; *MIN TRANSP PUBL W, 2009, CYCL NETH; Mohan D., 2009, ROAD SAFETY INDIA CH; Mohan Dinesh, 2008, Salud pública Méx, V50, ps93; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; *NHS, 2004, LEAST 5 WEEK EV IMP; NICAJ L, 2006, BICYCLIST FATALITIES; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; *NYC DOT, 2008, SAF STREETS NYC TRAF; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Peden M., 2004, WORLD REPORT ROAD TR; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; ROBERTS I, 1995, BRIT MED J, V310, P91, DOI 10.1136/bmj.310.6972.91; ROBERTS I, 1995, EPIDEMIOLOGY, V6, P169, DOI 10.1097/00001648-199503000-00014; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; *STATS19, STATS 19 HELP FIL; Tehard B, 2006, CANCER EPIDEM BIOMAR, V15, P57, DOI 10.1158/1055-9965.EPI-05-0603; Tiwari G, 2002, CITIES, V19, P95, DOI 10.1016/S0264-2751(02)00004-5; TIWARI G, 1998, BICYCLE MASTER PLAN; Tonne C, 2008, OCCUP ENVIRON MED, V65, P620, DOI 10.1136/oem.2007.036533; *TRANSP LOND, 2001, LOND AR TRANSP SURV; *URB EM, SIMPL INT MOD BETT A; Ussher MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub3; *W SMITH ASS, 2008, TRAFF TRANSP POL STR; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; World Health Organization (WHO), STEPWISE APPR SURV S; Zheng H, 2009, EUR J EPIDEMIOL, V24, P181, DOI 10.1007/s10654-009-9328-9; LONDON TRAVEL REPORT	69	682	686	8	317	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1930	1943		10.1016/S0140-6736(09)61714-1	http://dx.doi.org/10.1016/S0140-6736(09)61714-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19942277				2022-12-28	WOS:000272646900026
J	Redlener, I; Grant, R				Redlener, Irwin; Grant, Roy			America's Safety Net and Health Care Reform - What Lies Ahead?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Redlener, Irwin] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Redlener, Irwin; Grant, Roy] Childrens Hlth Fund, New York, NY USA	Columbia University	Redlener, I (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.							American Hospital Association, 2009, EC CRIS TOLL PAT COM; Dorn Stan, 2008, UNINSURED DYING IT U; *G WASH U SCH PUBL, 2008, ACC TRANSF BUILD PRI; *GEN ACC OFF, 2008, GAO08723; SCHROEDER A, 2009, EC RECESSION NONPROF	5	22	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2201	2204		10.1056/NEJMp0910597	http://dx.doi.org/10.1056/NEJMp0910597			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ZM	19955523				2022-12-28	WOS:000272257100001
J	Smith, SR				Smith, Steven R.			A Look at the Low-Carbohydrate Diet	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Florida Hosp, Burnham Inst, Translat Res Inst, Orlando, FL USA	Adventist Health Services; AdventHealth	Smith, SR (corresponding author), Florida Hosp, Burnham Inst, Translat Res Inst, Orlando, FL USA.		Smith, Steven/HDM-9496-2022	Smith, Steven/0000-0002-5098-8147				FOO SY, 2009, P NATL ACAD SCI 0824; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Smith SR, 2006, J CLIN ENDOCR METAB, V91, P2506, DOI 10.1210/jc.2006-1018; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953	5	16	16	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2286	2288		10.1056/NEJMcibr0908756	http://dx.doi.org/10.1056/NEJMcibr0908756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19955530				2022-12-28	WOS:000272257100016
J	Myers, JE; Tsiouris, SJ				Myers, Julie E.; Tsiouris, Simon J.			Is there a place for directly observed therapy in HAART?	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; ADHERENCE; HIV		[Tsiouris, Simon J.] Columbia Univ, Div Infect Dis, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Ctr Infect Dis Epidemiol Res, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University; Columbia University	Tsiouris, SJ (corresponding author), Columbia Univ, Div Infect Dis, Coll Phys & Surg, New York, NY 10032 USA.	st326@columbia.edu						Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gordon CM, 2006, JAIDS-J ACQ IMM DEF, V43, pS36, DOI 10.1097/01.qai.0000248347.87512.ba; Gross R, 2009, ARCH INTERN MED, V169, P1224, DOI 10.1001/archinternmed.2009.172; Harries AD, 2004, T ROY SOC TROP MED H, V98, P695, DOI 10.1016/j.trstmh.2004.05.002; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO STOP TB PARTN, STOP TB STRAT BUILD	11	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2030	2032		10.1016/S0140-6736(09)61991-7	http://dx.doi.org/10.1016/S0140-6736(09)61991-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	19954831				2022-12-28	WOS:000273122900005
J	Hanada, R; Leibbrandt, A; Hanada, T; Kitaoka, S; Furuyashiki, T; Fujihara, H; Trichereau, J; Paolino, M; Qadri, F; Plehm, R; Klaere, S; Komnenovic, V; Mimata, H; Yoshimatsu, H; Takahashi, N; von Haeseler, A; Bader, M; Kilic, SS; Ueta, Y; Pifl, C; Narumiya, S; Penninger, JM				Hanada, Reiko; Leibbrandt, Andreas; Hanada, Toshikatsu; Kitaoka, Shiho; Furuyashiki, Tomoyuki; Fujihara, Hiroaki; Trichereau, Jean; Paolino, Magdalena; Qadri, Fatimunnisa; Plehm, Ralph; Klaere, Steffen; Komnenovic, Vukoslav; Mimata, Hiromitsu; Yoshimatsu, Hironobu; Takahashi, Naoyuki; von Haeseler, Arndt; Bader, Michael; Kilic, Sara Sebnem; Ueta, Yoichi; Pifl, Christian; Narumiya, Shuh; Penninger, Josef M.			Central control of fever and female body temperature by RANKL/RANK	NATURE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; FEBRILE RESPONSE; MICE LACKING; C-FOS; RECEPTOR; INFLAMMATION; MECHANISMS; DENOSUMAB; PROTEIN; LIGAND	Receptor-activator of NF-kappa B ligand (TNFSF11, also known as RANKL, OPGL, TRANCE and ODF) and its tumour necrosis factor (TNF)-family receptor RANK are essential regulators of bone remodelling, lymph node organogenesis and formation of a lactating mammary gland(1-4). RANKL and RANK are also expressed in the central nervous system(5,6). However, the functional relevance of RANKL/RANK in the brain was entirely unknown. Here we report that RANKL and RANK have an essential role in the brain. In both mice and rats, central RANKL injections trigger severe fever. Using tissue-specific Nestin-Cre and GFAP-Cre rank(floxed) deleter mice, the function of RANK in the fever response was genetically mapped to astrocytes. Importantly, Nestin-Cre and GFAP-Cre rank(floxed) deleter mice are resistant to lipopolysaccharide-induced fever as well as fever in response to the key inflammatory cytokines IL-1 beta and TNF alpha. Mechanistically, RANKL activates brain regions involved in thermoregulation and induces fever via the COX2-PGE(2)/EP3R pathway. Moreover, female Nestin-Cre and GFAP-Cre rank(floxed) mice exhibit increased basal body temperatures, suggesting that RANKL and RANK control thermoregulation during normal female physiology. We also show that two children with RANK mutations exhibit impaired fever during pneumonia. These data identify an entirely novel and unexpected function for the key osteoclast differentiation factors RANKL/RANK in female thermoregulation and the central fever response in inflammation.	[Hanada, Reiko; Leibbrandt, Andreas; Hanada, Toshikatsu; Trichereau, Jean; Paolino, Magdalena; Komnenovic, Vukoslav; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Kitaoka, Shiho; Furuyashiki, Tomoyuki; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Fujihara, Hiroaki; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Kitakyushu, Fukuoka 8078555, Japan; [Qadri, Fatimunnisa; Plehm, Ralph; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Klaere, Steffen; von Haeseler, Arndt] Ctr Integrated Bioinformat, Max F Perutz Labs, A-1030 Vienna, Austria; [Mimata, Hiromitsu; Yoshimatsu, Hironobu] Oita Univ, Fac Med, Oita 8795593, Japan; [Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano 3990781, Japan; [Kilic, Sara Sebnem] Uludag Univ, Fac Med, TR-16059 Bursa, Turkey; [Pifl, Christian] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Kyoto University; University of Occupational & Environmental Health - Japan; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Oita University; Matsumoto Dental University; Uludag University; Medical University of Vienna	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	von Haeseler, Arndt/HCI-9958-2022; Penninger, Josef M/I-6860-2013; Furuyashiki, Tomoyuki/AAG-5283-2019; Bader, Michael/K-2124-2013; Klaere, Steffen/B-4202-2013; Furuyashiki, Tomoyuki/B-8760-2014; Paolino, Magdalena/AAN-9417-2020; Kilic, Sara Sebnem/AAH-1658-2021	von Haeseler, Arndt/0000-0002-3366-4458; Penninger, Josef M/0000-0002-8194-3777; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Klaere, Steffen/0000-0002-4570-6109; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Bader, Michael/0000-0003-4780-4164; Paolino, Magdalena/0000-0001-9724-9029; Pifl, Christian/0000-0003-1456-4264; kilic, sara sebnem/0000-0001-8571-2581	UEHARA Foundation; Japan Foundation for Applied Enzymology; Austrian Ministry for Science and Research; Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU ( AustroMouse); EU Marie Curie Excellence; EU ERC	UEHARA Foundation(Uehara Memorial Foundation); Japan Foundation for Applied Enzymology; Austrian Ministry for Science and Research; Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU ( AustroMouse); EU Marie Curie Excellence(European Commission); EU ERC(European Research Council (ERC)European Commission)	We thank C. Xia, A. Muto, T. Mizoguchi, T. Katakai, T. Mitsumori, D. Sakata, T. Matsuoka, I. Williams, M. Iehara, T. Katafuchi, K. Matsuo, J. Wojciechowski, C. Theussl, T. Nakashima, T. Wada and R. Koglgruber for their assistance and all members of our laboratory for discussions. We thank E. Wagner for the c-Fos-GFP reporter mice and M. Kopf for the IL-1R alpha mutant mice. This work was in part supported by UEHARA Foundation and Japan Foundation for Applied Enzymology grants. S. K. and A. v. H. are supported by the Austrian Ministry for Science and Research (GEN-AU Bioinformatics Integration Network II) and the Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF). J. M. P. is supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU ( AustroMouse), an EU Marie Curie Excellence Grant, and an EU ERC Advanced Grant.	Blatteis CM, 2005, PROSTAG OTH LIPID M, V76, P1, DOI 10.1016/j.prostaglandins.2005.01.001; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; ISSELBACHER KJ, 1994, HARRISONS PRINCIPLES, V2, P2021; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marino S, 2000, GENE DEV, V14, P994; McDermott MF, 2007, TRENDS MOL MED, V13, P381, DOI 10.1016/j.molmed.2007.07.005; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233	22	174	179	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					505	509		10.1038/nature08596	http://dx.doi.org/10.1038/nature08596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940926				2022-12-28	WOS:000272144200044
J	Kent, DM; Trikalinos, TA				Kent, David M.; Trikalinos, Thomas A.			Therapeutic Innovations, Diminishing Returns, and Control Rate Preservation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CLOPIDOGREL; ASPIRIN; TRIALS; STENTS		[Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Kent, DM (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, 800 Washington St,Box 63, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org			NCRR NIH HHS [UL1 RR025752, UL1 RR025752-015980, UL1 RR025752-027213] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 1988, LANCET, V2, P349; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kent DM, 2008, AM HEART J, V155, P624, DOI 10.1016/j.ahj.2007.11.005; Nordmann AJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005313; Pasceri V, 2007, AM HEART J, V153, P749, DOI 10.1016/j.ahj.2007.02.016; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6	10	22	23	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2254	2256		10.1001/jama.2009.1679	http://dx.doi.org/10.1001/jama.2009.1679			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934428	Green Accepted			2022-12-28	WOS:000272080500032
J	Sewell, MD; Rosendahl, K; Eastwood, DM				Sewell, M. D.; Rosendahl, K.; Eastwood, D. M.			Developmental dysplasia of the hip	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NEONATAL HIP; CONGENITAL DISLOCATION; PAVLIK HARNESS; ULTRASOUND; INSTABILITY; NEWBORN		[Sewell, M. D.; Eastwood, D. M.] Royal Natl Orthopaed Hosp, Catterall Unit, Stanmore HA7 4LP, Middx, England; [Rosendahl, K.; Eastwood, D. M.] Great Ormond St Hosp Sick Children, Dept Radiol, London WC1N 3JH, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Eastwood, DM (corresponding author), Royal Natl Orthopaed Hosp, Catterall Unit, Stanmore HA7 4LP, Middx, England.	d.m.eastwood@btinternet.com		Sewell, Mathew/0000-0003-0948-2985				Atalar H, 2007, INT ORTHOP, V31, P145, DOI 10.1007/s00264-006-0097-8; Boere-Boonekamp MM, 1998, AM J PUBLIC HEALTH, V88, P285, DOI 10.2105/AJPH.88.2.285; Cashman JP, 2002, J BONE JOINT SURG BR, V84B, P418, DOI 10.1302/0301-620X.84B3.12230; Chan A, 1997, ARCH DIS CHILD-FETAL, V76, pF94, DOI 10.1136/fn.76.2.F94; Clegg J, 1999, J BONE JOINT SURG BR, V81B, P852, DOI 10.1302/0301-620X.81B5.9746; DONNAN L, 2008, DEV DYSPLASIA HIP DV; Furnes O, 2001, J BONE JOINT SURG BR, V83B, P579, DOI 10.1302/0301-620X.83B4.11223; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; GRAF R, 1980, ARCH ORTHOP TRAUM SU, V97, P117, DOI 10.1007/BF00450934; Holen KJ, 1999, J BONE JOINT SURG BR, V81B, P846, DOI 10.1302/0301-620X.81B5.9502; Holen KJ, 2002, J BONE JOINT SURG BR, V84B, P886, DOI 10.1302/0301-620X.84B6.12093; Ihme N, 2008, ORTHOPADE, V37, P541, DOI 10.1007/s00132-008-1237-1; Kamath SU, 2004, J PEDIATR ORTHOPED, V24, P265, DOI 10.1097/01241398-200405000-00005; Kleijnen J, 2005, SYSTEMATIC REV CLIN; KRIKLER SJ, 1992, J BONE JOINT SURG BR, V74, P701, DOI 10.1302/0301-620X.74B5.1527116; LECK I, 2000, ANTENATAL NEONATAL S, P398; Lewis K, 1999, J PEDIATR ORTHOPED, V19, P760, DOI 10.1097/00004694-199911000-00013; MACNICOL MF, 1990, J BONE JOINT SURG BR, V72, P1057, DOI 10.1302/0301-620X.72B6.2246288; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; National Screening Committee, 2004, CHILD HLTH SUBGR REP; ROSENDAHL K, 1994, PEDIATRICS, V94, P47; Rosendahl K, 1996, ACTA PAEDIATR, V85, P64, DOI 10.1111/j.1651-2227.1996.tb13892.x; ROSENDAHL K, 2009, PAEDIATRICS IN PRESS; Schwend RM, 2007, J PEDIATR ORTHOPED, V27, P607, DOI 10.1097/BPO.0b013e318142551e; Shipman SA, 2006, PEDIATRICS, V117, pE557, DOI 10.1542/peds.2005-1597; SMAC. (Standing Medical advice committee), 1986, ARCH DIS CHILD, V61, P921; TREDWELL SJ, 1981, J PEDIATR ORTHOPED, V1, P61, DOI 10.1097/01241398-198101010-00009; VIERE RG, 1990, J BONE JOINT SURG AM, V72A, P238, DOI 10.2106/00004623-199072020-00011; von Kries R, 2003, LANCET, V362, P1883, DOI 10.1016/S0140-6736(03)14957-4; WILKINSON JA, 1992, CLIN ORTHOP RELAT R, V281, P75; Wood MK, 2000, J PEDIATR ORTHOPED, V20, P302, DOI 10.1097/00004694-200005000-00006	31	55	61	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2009	339								b4454	10.1136/bmj.b4454	http://dx.doi.org/10.1136/bmj.b4454			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525AU	19934187				2022-12-28	WOS:000272186300009
J	Ebbing, M; Bonaa, KH; Nygard, O; Arnesen, E; Ueland, PM; Nordrehaug, JE; Rasmussen, K; Njolstad, I; Refsum, H; Nilsen, DW; Tverdal, A; Meyer, K; Vollset, SE				Ebbing, Marta; Bonaa, Kaare Harald; Nygard, Ottar; Arnesen, Egil; Ueland, Per Magne; Nordrehaug, Jan Erik; Rasmussen, Knut; Njolstad, Inger; Refsum, Helga; Nilsen, Dennis W.; Tverdal, Aage; Meyer, Klaus; Vollset, Stein Emil			Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B-12	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MICROBIOLOGICAL ASSAY; GENETIC POLYMORPHISMS; CARDIOVASCULAR EVENTS; FOOD FORTIFICATION; COLORECTAL-CANCER; FOLATE INTAKE; METABOLISM; RISK; HOMOCYSTEINE	Context Recently, concern has been raised about the safety of folic acid, particularly in relation to cancer risk. Objective To evaluate effects of treatment with B vitamins on cancer outcomes and all-cause mortality in 2 randomized controlled trials. Design, Setting, and Participants Combined analysis and extended follow-up of participants from 2 randomized, double-blind, placebo-controlled clinical trials (Norwegian Vitamin Trial and Western Norway B Vitamin Intervention Trial). A total of 6837 patients with ischemic heart disease were treated with B vitamins or placebo between 1998 and 2005, and were followed up through December 31, 2007. Interventions Oral treatment with folic acid (0.8 mg/d) plus vitamin B-12 (0.4 mg/d) and vitamin B-6 (40 mg/d) (n=1708); folic acid (0.8 mg/d) plus vitamin B-12 (0.4 mg/d) (n=1703); vitamin B-6 alone (40 mg/d) (n=1705); or placebo (n=1721). Main Outcome Measures Cancer incidence, cancer mortality, and all-cause mortality. Results During study treatment, median serum folate concentration increased more than 6-fold among participants given folic acid. After a median 39 months of treatment and an additional 38 months of posttrial observational follow-up, 341 participants (10.0%) who received folic acid plus vitamin B-12 vs 288 participants (8.4%) who did not receive such treatment were diagnosed with cancer (hazard ratio [HR], 1.21; 95% confidence interval [CI], 1.03-1.41; P=.02). A total of 136 (4.0%) who received folic acid plus vitamin B-12 vs 100 (2.9%) who did not receive such treatment died from cancer (HR, 1.38; 95% CI, 1.07-1.79; P=.01). A total of 548 patients (16.1%) who received folic acid plus vitamin B-12 vs 473 (13.8%) who did not receive such treatment died from any cause (HR, 1.18; 95% CI, 1.04-1.33; P=.01). Results were mainly driven by increased lung cancer incidence in participants who received folic acid plus vitamin B-12. Vitamin B-6 treatment was not associated with any significant effects. Conclusion Treatment with folic acid plus vitamin B-12 was associated with increased cancer outcomes and all-cause mortality in patients with ischemic heart disease in Norway, where there is no folic acid fortification of foods. Trial Registration clinicaltrials.gov Identifier: NCT00671346 JAMA. 2009; 302(19): 2119-2126	[Ebbing, Marta; Nygard, Ottar; Nordrehaug, Jan Erik] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Bonaa, Kaare Harald; Rasmussen, Knut] Univ Hosp N Norway, Dept Heart Dis, Tromso, Norway; [Bonaa, Kaare Harald; Arnesen, Egil; Njolstad, Inger] Univ Tromso, Dept Community Med, Tromso, Norway; [Rasmussen, Knut] Univ Tromso, Dept Clin Med, Tromso, Norway; [Nygard, Ottar; Ueland, Per Magne; Nordrehaug, Jan Erik; Nilsen, Dennis W.] Univ Bergen, Inst Med, Bergen, Norway; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Refsum, Helga] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Nilsen, Dennis W.] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Tverdal, Aage; Vollset, Stein Emil] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Meyer, Klaus] Bevital AS, Bergen, Norway; [Vollset, Stein Emil] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway	University of Bergen; Haukeland University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Bergen; University of Oslo; University of Oxford; Stavanger University Hospital; Norwegian Institute of Public Health (NIPH); University of Bergen	Ebbing, M (corresponding author), Haukeland Hosp, Dept Heart Dis, Jonas Liesvei 65, N-5021 Bergen, Norway.	marta.ebbing@helse-bergen.no	Refsum, Helga/A-4073-2010; Nilsen, Dennis/AAM-4344-2020; Ueland, Per M/C-7340-2013; Njolstad, Inger/X-3784-2019	Tverdal, Aage/0000-0002-2909-5678; Ueland, Per Magne/0000-0002-1903-0571	Advanced Research Program and Research Council of Norway; Norwegian Foundation for Health and Rehabilitation; Norwegian Council on Cardiovascular Disease; Norwegian Heart and Lung Patient Organization; Norwegian Red Cross; Northern Norway Regional Health Authority; Western Norway Regional Health Authority; Norwegian Ministry of Health and Care Services; University of Tromso, Tromso, Norway; University of Bergen, Bergen, Norway; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; Foundation to Promote Research Into Functional Vitamin B<INF>12</INF> Deficiency, Bergen, Norway	Advanced Research Program and Research Council of Norway(Research Council of Norway); Norwegian Foundation for Health and Rehabilitation; Norwegian Council on Cardiovascular Disease; Norwegian Heart and Lung Patient Organization; Norwegian Red Cross; Northern Norway Regional Health Authority; Western Norway Regional Health Authority; Norwegian Ministry of Health and Care Services; University of Tromso, Tromso, Norway; University of Bergen, Bergen, Norway; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; Foundation to Promote Research Into Functional Vitamin B<INF>12</INF> Deficiency, Bergen, Norway	Funding/Support: The NORVIT and WENBIT trials were funded by the Advanced Research Program and Research Council of Norway; the Norwegian Foundation for Health and Rehabilitation; The Norwegian Council on Cardiovascular Disease; the Norwegian Heart and Lung Patient Organization; the Norwegian Red Cross; the Northern Norway Regional Health Authority; the Western Norway Regional Health Authority; the Norwegian Ministry of Health and Care Services; the University of Tromso, Tromso, Norway; the University of Bergen, Bergen, Norway; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; the Foundation to Promote Research Into Functional Vitamin B<INF>12</INF> Deficiency, Bergen, Norway; by an unrestricted private donation; and by Alpharma Inc, Copenhagen, Denmark, who provided study medication. The posttrial follow-up was supported by the Norwegian Foundation for Health and Rehabilitation; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; the University of Tromso, Tromso, Norway; and by the University of Bergen, Bergen, Norway.	Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; Bazzano LA, 2009, AM J MED SCI, V338, P48, DOI 10.1097/MAJ.0b013e3181aaefd6; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; *CANC REG NORW, 2008, CANC NORW 2007 CANC; Cho E, 2006, INT J CANCER, V118, P970, DOI 10.1002/ijc.21441; Clarke R, 2008, BRIT J NUTR, V100, P1054, DOI 10.1017/S0007114508958001; CLEVES M, 2008, COX MODEL DIAGNOSTIC, P197; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Fredriksen A, 2007, HUM MUTAT, V28, P856, DOI 10.1002/humu.20522; Hoey L, 2007, AM J CLIN NUTR, V86, P1405, DOI 10.1093/ajcn/86.5.1405; Institute of Medicine, 1998, DIET REF INT THIAM R; Kalmbach RD, 2008, AM J CLIN NUTR, V88, P763, DOI 10.1093/ajcn/88.3.763; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; LARSEN IK, 2007, CANC NORWAY 2006 CAN, pS1; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Maberly G., 2008, Morbidity and Mortality Weekly Report, V57, P8; Mariolis P., 2006, Morbidity and Mortality Weekly Report, V55, P1145; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Meyer K, 2009, CLIN CHEM, V55, P139, DOI 10.1373/clinchem.2008.115378; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; Pfeiffer CM, 2007, AM J CLIN NUTR, V86, P718, DOI 10.1093/ajcn/86.3.718; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Rosenberg IH, 2005, AM J CLIN NUTR, V82, P279, DOI 10.1093/ajcn/82.2.279; Sanjoaquin MA, 2005, INT J CANCER, V113, P825, DOI 10.1002/ijc.20648; Slatore CG, 2008, AM J RESP CRIT CARE, V177, P524, DOI 10.1164/rccm.200709-1398OC; Smith AD, 2008, AM J CLIN NUTR, V87, P517; *STAT NORW, CAUS DEATHS 2007; Stevens VL, 2006, AM J EPIDEMIOL, V163, P989, DOI 10.1093/aje/kwj126; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P1822, DOI 10.1158/1055-9965.EPI-07-2937; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Wright AJA, 2007, BRIT J NUTR, V98, P667, DOI 10.1017/S0007114507777140; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555	40	274	284	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2119	2126		10.1001/jama.2009.1622	http://dx.doi.org/10.1001/jama.2009.1622			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920236				2022-12-28	WOS:000271873900021
J	Levine, RJ; Vatten, LJ; Horowitz, GL; Qian, C; Romundstad, PR; Yu, KF; Hollenberg, AN; Hellevik, AI; Asvold, BO; Karumanchi, SA				Levine, Richard J.; Vatten, Lars J.; Horowitz, Gary L.; Qian, Cong; Romundstad, Pal R.; Yu, Kai F.; Hollenberg, Anthony N.; Hellevik, Alf I.; Asvold, Bjorn O.; Karumanchi, S. Ananth			Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREGNANCY; HYPOTHYROIDISM; SUNITINIB; TRIAL; MECHANISMS; ANTIBODIES; CALCIUM; DISEASE; HEALTH; WOMEN	Objective To determine if pre-eclampsia is associated with reduced thyroid function during and after pregnancy. Design Nested case-control study during pregnancy and population based follow-up study after pregnancy. Setting Calcium for Pre-eclampsia Prevention trial of healthy pregnant nulliparous women in the United States during 1992-5, and a Norwegian population based study (Nord-Trondelag Health Study or HUNT-2) during 1995-7 with linkage to the medical birth registry of Norway. Participants All 141 women (cases) in the Calcium for Preeclampsia Prevention trial with serum measurements before 21 weeks' gestation (baseline) and after onset of pre-eclampsia (before delivery), 141 normotensive controls with serum measurements at similar gestational ages, and 7121 women in the Nord-Trondelag Health Study whose first birth had occurred in 1967 or later and in whom serum levels of thyroid stimulating hormone had been subsequently measured. Main outcome measures Thyroid function tests and human chorionic gonadotrophin and soluble fms-like tyrosine kinase 1 concentrations in the Calcium for Preeclampsia Prevention cohort and odds ratios for levels of thyroid stimulating hormone above the reference range, according to pre-eclampsia status in singleton pregnancies before the Nord-Trondelag Health Study. Results In predelivery specimens of the Calcium for Preeclampsia Prevention cohort after the onset of preeclampsia, thyroid stimulating hormone levels increased 2.42 times above baseline compared with a 1.48 times increase in controls. The ratio of the predelivery to baseline ratio of cases to that of the controls was 1.64 (95% confidence interval 1.29 to 2.08). Free triiodothyronine decreased more in the women with preeclampsia than in the controls (case ratio to control ratio 0.96, 95% confidence interval 0.92 to 0.99). The predelivery specimens but not baseline samples from women with pre-eclampsia were significantly more likely than those from controls to have concentrations of thyroid stimulating hormone above the reference range (adjusted odds ratio 2.2, 95% confidence interval 1.1 to 4.4). Both in women who developed pre-eclampsia and in normotensive controls the increase in thyroid stimulating hormone concentration between baseline and predelivery specimens was strongly associated with increasing quarters of predelivery soluble fms-like tyrosine kinase 1 (P for trend 0.002 and <0.001, respectively). In the Nord-Trondelag Health Study, women with a history of pre-eclampsia in their first pregnancy were more likely than other women (adjusted odds ratio 1.7, 95% confidence interval 1.1 to 2.5) to have concentrations of thyroid stimulating hormone above the reference range (>3.5 mIU/l). In particular, they were more likely to have high concentrations of thyroid stimulating hormone without thyroid peroxidase antibodies (adjusted odds ratio 2.6, 95% confidence interval 1.3 to 5.0), suggesting hypothyroid function in the absence of an autoimmune process. This association was especially strong (5.8, 1.3 to 25.5) if pre-eclampsia had occurred in both the first and the second pregnancies. Conclusion Increased serum concentration of soluble fms-like tyrosine kinase 1 during pre-eclampsia is associated with subclinical hypothyroidism during pregnancy. Pre-eclampsia may also predispose to reduced thyroid function in later years.	[Levine, Richard J.; Yu, Kai F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, US Dept HHS, Div Epidemiol Stat & Prevent Res, Bethesda, MD 20892 USA; [Vatten, Lars J.; Romundstad, Pal R.; Hellevik, Alf I.] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway; [Horowitz, Gary L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Horowitz, Gary L.; Hollenberg, Anthony N.; Karumanchi, S. Ananth] Harvard Univ, Sch Med, Boston, MA USA; [Qian, Cong] Glotech, Rockville, MD USA; [Hollenberg, Anthony N.; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Karumanchi, S. Ananth] Howard Hughes Med Inst, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Norwegian University of Science & Technology (NTNU); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute	Levine, RJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, US Dept HHS, Div Epidemiol Stat & Prevent Res, Bethesda, MD 20892 USA.	LevineRJ@mail.nih.gov; sananth@bidmc.harvard.edu	Vatten, Lars/AAF-9380-2022; Karumanchi, Subbian Ananth/AAI-1694-2021; Vatten, Lars/AFK-2073-2022		Eunice Kennedy Shriver National Institute of Child Health and Human Development [N01-HD-5-3398]; National Institute of Child Health and Human Development [N01-HD-1-3121-3126, N01-HD-3154, N01-HD-5-3246]; National Heart, Lung, and Blood Institute; Norwegian University of Science and Technology; Central Norway Regional Health Authority; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000373] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD053246, ZIAHD000864, N01HD013121] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Norwegian University of Science and Technology; Central Norway Regional Health Authority; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (contract N01-HD-5-3398) and by salary support from the intramural research programme of the National Institutes of Health. The Calcium for Preeclampsia Prevention trial was supported by the National Institute of Child Health and Human Development (contracts N01-HD-1-3121-3126, N01-HD-3154, and N01-HD-5-3246), with cofunding from the National Heart, Lung, and Blood Institute. SAK is supported by a clinical scientist award by the Burroughs Wellcome Fund and is an investigator of the Howard Hughes Medical Institute and an established investigator of the American Heart Association. The Nord-Trondelag Health Study is a collaborative effort of the Norwegian University of Science and Technology, the Norwegian Institute of Public Health, and the Nord-Trondelag County Council. This substudy of the Nord-Trondelag Health Study was supported by the Norwegian University of Science and Technology and by the Central Norway Regional Health Authority.	[Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; Asvold BO, 2008, ARCH INTERN MED, V168, P855, DOI 10.1001/archinte.168.8.855; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Bjoro T, 2000, EUR J ENDOCRINOL, V143, P639, DOI 10.1530/eje.0.1430639; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Feldman DR, 2009, J CLIN ONCOL, V27, P1432, DOI 10.1200/JCO.2008.19.0108; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Holmen JM K., 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI [10.5324/nje.v13i1.305, DOI 10.1093/eurheartj/eht019]; Holston AM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.033; Hubel CA, 2000, BRIT J OBSTET GYNAEC, V107, P776, DOI 10.1111/j.1471-0528.2000.tb13340.x; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; LAO TT, 1990, BRIT J OBSTET GYNAEC, V97, P71, DOI 10.1111/j.1471-0528.1990.tb01719.x; Larijani B, 2004, GYNECOL ENDOCRINOL, V18, P97, DOI 10.1080/09513590310001652973; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levine RJ, 1996, CONTROL CLIN TRIALS, V17, P442, DOI 10.1016/S0197-2456(96)00106-7; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Risau W, 1998, KIDNEY INT, V54, pS3, DOI 10.1046/j.1523-1755.1998.06701.x; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; *ROCH DIAGN, 2004, EL THYR TESTS, P5; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Wolter P, 2008, BRIT J CANCER, V99, P448, DOI 10.1038/sj.bjc.6604497; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E	35	60	65	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2009	339								b4336	10.1136/bmj.b4336	http://dx.doi.org/10.1136/bmj.b4336			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523SZ	19920004	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000272096100002
J	Pibouleau, L; Boutron, I; Reeves, BC; Nizard, R; Ravaud, P				Pibouleau, Leslie; Boutron, Isabelle; Reeves, Barnaby C.; Nizard, Remy; Ravaud, Philippe			Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXTERNAL VALIDITY; CONSORT STATEMENT; VOLUME; EXPLANATION; OUTCOMES; HIP	Objective To compare the reporting of essential applicability data from randomised controlled trials and non-randomised studies evaluating four new orthopaedic surgical procedures. Data sources Medline and the Cochrane central register of controlled trials. Study selection All articles of comparative studies assessing total hip or knee arthroplasty carried out by a minimally invasive approach or computer assisted navigation system. Data extraction Items judged to be essential for interpreting the applicability of findings about such procedures were identified by a survey of a sample of orthopaedic surgeons (77 of 512 completed the survey). Reports were evaluated for data describing these "essential" items and the number of centres and surgeons involved in the trials. When data on the number of centres and surgeons were not reported, the corresponding author of the selected trials was contacted. Results 84 articles were identified (38 randomised controlled trials, 46 non-randomised studies). The median percentage (interquartile range) of essential items reported for non-randomised studies compared with randomised controlled trials was 38% (25-63%) versus 44% (38-45%) for items about patients, 71% (43-86%) versus 71% (57-86%) for items considered essential for all interventions, and 38% (25-50%) versus 50% (25-50%) for items about the context of care. More than 80% of both study types were single centre studies, with one or two participating surgeons. Conclusion The reporting of data related to the applicability of results was poor in published articles of both non-randomised studies and randomised controlled trials and did not differ by study design. The applicability of results from the trials and studies was similar in terms of number of centres and surgeons involved and the reproducibility of the intervention.	[Pibouleau, Leslie; Boutron, Isabelle; Ravaud, Philippe] INSERM, U738, Paris, France; [Pibouleau, Leslie; Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Pibouleau, Leslie; Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, Fac Med, Paris, France; [Pibouleau, Leslie] French Natl Author Hlth, Dept Assessment Med Devices, St Denis, France; [Boutron, Isabelle] Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford OX2 6UD, England; [Nizard, Remy] Hop Lariboisiere, AP HP, Serv Chirurg Orthoped & Traumatol, F-75475 Paris, France; [Nizard, Remy] Univ Paris Diderot, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Boutron, I (corresponding author), INSERM, U738, Paris, France.	isabelle.boutron@bch.aphp.fr	ravaud, philippe/C-1694-2009; Nizard, Remy/R-5845-2019	Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241	Societe Francaise de Rhumatologie and the Lavoisier Program (Ministere des Affaires etrangeres et europeennes)	Societe Francaise de Rhumatologie and the Lavoisier Program (Ministere des Affaires etrangeres et europeennes)	IB is supported by a grant from the Societe Francaise de Rhumatologie and the Lavoisier Program (Ministere des Affaires etrangeres et europeennes). The Funders were not involved in the conduct of the study or preparation of the manuscript.	Abel U, 1999, J CLIN EPIDEMIOL, V52, P487; Ahmad N, 2009, ARTHRIT RHEUM-ARTHR, V61, P361, DOI 10.1002/art.24279; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Black N, 1996, BRIT MED J, V312, P1215; Bonell C, 2006, BMJ-BRIT MED J, V333, P346, DOI 10.1136/bmj.333.7563.346; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Cook RC, 2003, AM J SURG, V185, P305, DOI 10.1016/S0002-9610(02)01404-6; DEKKERS OM, 2009, INT J EPIDEMIOL, V17, P1; Dimick JB, 2004, ARCH SURG-CHICAGO, V139, P137, DOI 10.1001/archsurg.139.2.137; Dreyfuss D, 2005, INTENS CARE MED, V31, P345, DOI 10.1007/s00134-004-2493-0; Epstein AM, 2002, NEW ENGL J MED, V346, P1161, DOI 10.1056/NEJM200204113461512; Flather M, 2006, CLIN TRIALS, V3, P508, DOI 10.1177/1740774506073464; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; Langham J, 2009, STROKE, V40, P111, DOI 10.1161/STROKEAHA.108.517805; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Norton EC, 1998, HEALTH SERV RES, V33, P1191; Persaud N, 2006, J EVAL CLIN PRACT, V12, P450, DOI 10.1111/j.1365-2753.2006.00730.x; Petersen MK, 2007, ACTA ORTHOP, V78, P12, DOI 10.1080/17453670610013367; Reeves BC, 2007, BRIT J NEUROSURG, V21, P318, DOI 10.1080/02688690701534748; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	24	16	17	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2009	339								b4538	10.1136/bmj.b4538	http://dx.doi.org/10.1136/bmj.b4538			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523SZ	19920015	Green Published, hybrid			2022-12-28	WOS:000272096100003
J	Stephenson, J				Stephenson, Jo			Management of Health Care Doctors in management	BRITISH MEDICAL JOURNAL			English	Editorial Material												jo@jostephenson.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 16	2009	339								b4595	10.1136/bmj.b4595	http://dx.doi.org/10.1136/bmj.b4595			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523SU	19917573				2022-12-28	WOS:000272095600003
J	Ebrahim, SH; Memish, ZA; Uyeki, TM; Khoja, TKAM; Marano, N; McNabb, SJN				Ebrahim, Shahul H.; Memish, Ziad A.; Uyeki, Timothy M.; Khoja, Tawfi K. A. M.; Marano, Nina; McNabb, Scott J. N.			Pandemic H1N1 and the 2009 Hajj	SCIENCE			English	Editorial Material							INFLUENZA-A H1N1; PNEUMONIA; PILGRIMS		[Ebrahim, Shahul H.; Uyeki, Timothy M.; Marano, Nina; McNabb, Scott J. N.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia; [Khoja, Tawfi K. A. M.] Council Gulf States, Hlth Minist Council Cooperat, Execut Board, Riyadh, Saudi Arabia	Centers for Disease Control & Prevention - USA; Ministry of Health - Saudi Arabia	Ebrahim, SH (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	Sbe2@cdc.gov	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Alborzi A, 2009, J TRAVEL MED, V16, P239, DOI 10.1111/j.1708-8305.2009.00301.x; ALNAJA BA, 2009, ARAB NEWS       0919; Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8; [Anonymous], 2002, J ISLAMIC FIQH COUNC, V13; Arishi H, 2000, JAMA-J AM MED ASSOC, V284, P2989; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hayden EC, 2009, NATURE, V459, P756, DOI 10.1038/459756a; MAHDI W, 2009, NATIONAL ABU DH 0728; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; *MOH, KINGD SAUD AR; Neuzil Kathleen M, 2009, N Engl J Med, V361, pe59, DOI 10.1056/NEJMe0908224; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rashid H, 2008, VACCINE, V26, P4809, DOI 10.1016/j.vaccine.2008.07.001; Stone R, 2009, SCIENCE, V325, P1482, DOI 10.1126/science.325_1482; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; WHO, 2009, WHO GUID PHARM MAN P; *WHO, 2009, TECHN M REP JEDD KIN; Wilder-Smith A, 2002, LANCET, V360, P644, DOI 10.1016/S0140-6736(02)09796-9; 2009, ALJAZEERA       0723; 2009, ARAB NEWS       0811; 2009, ARAB NEWS       1007	24	63	65	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					938	940		10.1126/science.1183210	http://dx.doi.org/10.1126/science.1183210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518SB	19933105				2022-12-28	WOS:000271712300018
J	Trani, JF				Trani, Jean-Francois			Screening children for disability	LANCET			English	Editorial Material							VALIDITY		UCL, Leonard Cheshire Ctr Inclus Dev & Disabil, London WC1H 0BT, England	University of London; University College London	Trani, JF (corresponding author), UCL, Leonard Cheshire Ctr Inclus Dev & Disabil, London WC1H 0BT, England.	rmhkjtr@ucl.ac.uk	Trani, Jean-Francois/M-1946-2014					Altman BM, 2006, RES SOC SCI DISABIL, V4, P263, DOI 10.1016/S1479-3547(05)04014-5; [Anonymous], ALTER EUR J DISABIL; Burchardt T, 2004, DISABIL SOC, V19, P735, DOI 10.1080/0968759042000284213; Dubois JL, 2009, ALTER, V3, P192, DOI 10.1016/j.alter.2009.04.003; DURKIN MS, 1994, EPIDEMIOLOGY, V5, P283, DOI 10.1097/00001648-199405000-00005; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; Groce N, 2006, RES SOC SCI DISABIL, V4, P41, DOI 10.1016/S1479-3547(05)04004-2; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Mitra S., 2006, J DISABIL POLICY STU, V16, P236, DOI DOI 10.1177/10442073060160040501; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Mung'ala-Odera V, 2004, NEUROEPIDEMIOLOGY, V23, P67, DOI 10.1159/000073977; Trani JF, 2008, ALTER, V2, P44, DOI 10.1016/j.alter.2007.10.003; United Nations, UN CONV RIGHTS PERS; WHO, 2001, WHO INT CLASS FUNCT	14	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1806	1807		10.1016/S0140-6736(09)61996-6	http://dx.doi.org/10.1016/S0140-6736(09)61996-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944852				2022-12-28	WOS:000272370200011
J	Hu, H; Martina, M; Jonas, P				Hu, Hua; Martina, Marco; Jonas, Peter			Dendritic Mechanisms Underlying Rapid Synaptic Activation of Fast-Spiking Hippocampal Interneurons	SCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; GATED K+ CHANNELS; ACTION-POTENTIALS; RAT HIPPOCAMPUS; IN-VIVO; FEEDFORWARD INHIBITION; SOMATOSENSORY CORTEX; RECURRENT INHIBITION; ACTIVE PROPAGATION; DENTATE GYRUS	Fast-spiking, parvalbumin-expressing basket cells (BCs) are important for feedforward and feedback inhibition. During network activity, BCs respond with short latency and high temporal precision. It is thought that the specific properties of input synapses are responsible for rapid recruitment. However, a potential contribution of active dendritic conductances has not been addressed. We combined confocal imaging and patch-clamp techniques to obtain simultaneous somatodendritic recordings from BCs. Action potentials were initiated in the BC axon and backpropagated into the dendrites with reduced amplitude and little activity dependence. These properties were explained by a high K+ to Na+ conductance ratio in BC dendrites. Computational analysis indicated that dendritic K+ channels convey unique integration properties to BCs, leading to the rapid and temporally precise activation by excitatory inputs.	[Hu, Hua; Martina, Marco; Jonas, Peter] Univ Freiburg, Inst Physiol 1, D-79108 Freiburg, Germany; [Hu, Hua] Univ Oslo, Dept Physiol, Inst Basic Med Sci, NO-0317 Oslo, Norway; [Hu, Hua] Univ Oslo, CMBN, NO-0317 Oslo, Norway; [Martina, Marco] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jonas, Peter] Freiburg Inst Adv Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Oslo; University of Oslo; Northwestern University; Feinberg School of Medicine	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol 1, Engesserstr 4, D-79108 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de		martina, marco/0000-0002-9648-2918; Jonas, Peter/0000-0001-5001-4804; Hu, Hua/0000-0001-8187-4735				ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Du J, 1996, J NEUROSCI, V16, P506; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kaiser KMM, 2001, J PHYSIOL-LONDON, V535, P17, DOI 10.1111/j.1469-7793.2001.t01-1-00017.x; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; NORENBERG A, 2010, P NATL ACAD SCI USA, DOI DOI 10.1013/PNAS.0910716107; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SIK A, 1995, J NEUROSCI, V15, P6651; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart G, 2007, DENDRITES; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0	45	133	133	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					52	58		10.1126/science.1177876	http://dx.doi.org/10.1126/science.1177876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19965717				2022-12-28	WOS:000273395400027
J	Annas, GJ				Annas, George J.			Abortion Politics and Health Insurance Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2007, NEW ENGL J MED, V356, P2201, DOI 10.1056/NEJMhle072595; Sharlet Jeff, 2008, FAMILY SECRET FUNDAM	2	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2589	2591		10.1056/NEJMp0911513	http://dx.doi.org/10.1056/NEJMp0911513			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	19955513				2022-12-28	WOS:000273181300001
J	Sawaya, GF				Sawaya, George F.			Cervical-Cancer Screening - New Guidelines and the Balance between Benefits and Harms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sawaya, George F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Sawaya, George F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Sawaya, GF (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.							*AM COLL OBST GYN, 2009, OBSTET GYNECOL, V114, P1409; American College of Obstetricians and Gynecologist, 2008, OBSTET GYNECOL, V112, P1419, DOI DOI 10.1097/AOG.0B013E318192497C; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Sawaya GF, 2003, NEW ENGL J MED, V349, P1501, DOI 10.1056/NEJMoa035419	5	28	28	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2503	2505		10.1056/NEJMp0911380	http://dx.doi.org/10.1056/NEJMp0911380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	19940285				2022-12-28	WOS:000273003700004
J	Iglehart, JK				Iglehart, John K.			Settling in for a Long Debate.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Elmendorf W., 2009, COMMUNICATION   1130; STARR P, 2009, NY TIMES        1129, P9	2	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25								10.1056/NEJMp0911757	http://dx.doi.org/10.1056/NEJMp0911757			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	533CE	19955514				2022-12-28	WOS:000272798900004
J	Abdo, AA; Ackermann, M; Ajello, M; Axelsson, M; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Celik, O; Chaty, S; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Cominsky, LR; Conrad, J; Corbel, S; Corbet, R; Dermer, CD; de Palma, F; Digel, SW; Silva, EDE; Drell, PS; Dubois, R; Dubus, G; Dumora, D; Farnier, C; Favuzzi, C; Fegan, SJ; Focke, WB; Fortin, P; Frailis, M; Fusco, P; Gargano, F; Gehrels, N; Germani, S; Giavitto, G; Giebels, B; Giglietto, N; Giordano, F; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guillemot, L; Guiriec, S; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Hill, AB; Hjalmarsdotter, L; Horan, D; Hughes, RE; Jackson, MS; Johannesson, G; Johnson, AS; Johnson, TJ; Johnson, WN; Kamae, T; Katagiri, H; Kawai, N; Kerr, M; Knodlseder, J; Kocian, ML; Koerding, E; Kuss, M; Lande, J; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Madejski, GM; Makeev, A; Marchand, L; Marelli, M; Max-Moerbeck, W; Mazziotta, MN; McColl, N; McEnery, JE; Meurer, C; Michelson, PF; Migliari, S; Mitthumsiri, W; Mizuno, T; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Omodei, N; Ong, RA; Ormes, JF; Paneque, D; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Piron, F; Pooley, G; Porter, TA; Pottschmidt, K; Raino, S; Rando, R; Ray, PS; Razzano, M; Rea, N; Readhead, A; Reimer, A; Reimer, O; Richards, JL; Rochester, LS; Rodriguez, J; Rodriguez, AY; Romani, RW; Ryde, F; Sadrozinski, HFW; Sander, A; Parkinson, PMS; Sgro, C; Siskind, EJ; Smith, DA; Smith, PD; Spinelli, P; Starck, JL; Stevenson, M; Strickman, MS; Suson, DJ; Takahashi, H; Tanaka, T; Thayer, JB; Thompson, DJ; Tibaldo, L; Tomsick, JA; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Vasileiou, V; Vilchez, N; Vitale, V; Waite, AP; Wang, P; Wilms, J; Winer, BL; Wood, KS; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Axelsson, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Celik, Oe; Chaty, S.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Cominsky, L. R.; Conrad, J.; Corbel, S.; Corbet, R.; Dermer, C. D.; de Palma, F.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dubus, G.; Dumora, D.; Farnier, C.; Favuzzi, C.; Fegan, S. J.; Focke, W. B.; Fortin, P.; Frailis, M.; Fusco, P.; Gargano, F.; Gehrels, N.; Germani, S.; Giavitto, G.; Giebels, B.; Giglietto, N.; Giordano, F.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Hill, A. B.; Hjalmarsdotter, L.; Horan, D.; Hughes, R. E.; Jackson, M. S.; Johannesson, G.; Johnson, A. S.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kawai, N.; Kerr, M.; Knoedlseder, J.; Kocian, M. L.; Koerding, E.; Kuss, M.; Lande, J.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Makeev, A.; Marchand, L.; Marelli, M.; Max-Moerbeck, W.; Mazziotta, M. N.; McColl, N.; McEnery, J. E.; Meurer, C.; Michelson, P. F.; Migliari, S.; Mitthumsiri, W.; Mizuno, T.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Omodei, N.; Ong, R. A.; Ormes, J. F.; Paneque, D.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Piron, F.; Pooley, G.; Porter, T. A.; Pottschmidt, K.; Raino, S.; Rando, R.; Ray, P. S.; Razzano, M.; Rea, N.; Readhead, A.; Reimer, A.; Reimer, O.; Richards, J. L.; Rochester, L. S.; Rodriguez, J.; Rodriguez, A. Y.; Romani, R. W.; Ryde, F.; Sadrozinski, H. F. -W.; Sander, A.; Parkinson, P. M. Saz; Sgro, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spinelli, P.; Starck, J. -L.; Stevenson, M.; Strickman, M. S.; Suson, D. J.; Takahashi, H.; Tanaka, T.; Thayer, J. B.; Thompson, D. J.; Tibaldo, L.; Tomsick, J. A.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vasileiou, V.; Vilchez, N.; Vitale, V.; Waite, A. P.; Wang, P.; Wilms, J.; Winer, B. L.; Wood, K. S.; Ylinen, T.; Ziegler, M.		Fermi LAT Collaboration	Modulated High-Energy Gamma-Ray Emission from the Microquasar Cygnus X-3	SCIENCE			English	Article							X-RAY; SEARCH	Microquasars are accreting black holes or neutron stars in binary systems with associated relativistic jets. Despite their frequent outburst activity, they have never been unambiguously detected emitting high-energy gamma rays. The Fermi Large Area Telescope (LAT) has detected a variable high-energy source coinciding with the position of the x-ray binary and microquasar Cygnus X-3. Its identification with Cygnus X-3 is secured by the detection of its orbital period in gamma rays, as well as the correlation of the LAT flux with radio emission from the relativistic jets of Cygnus X-3. The gamma-ray emission probably originates from within the binary system, opening new areas in which to study the formation of relativistic jets.	[Abdo, A. A.; Cheung, C. C.; Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Ray, P. S.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Abdo, A. A.; Cheung, C. C.] Natl Acad Sci, Natl Res Council Res Associate, Washington, DC 20001 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tanaka, T.; Thayer, J. B.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tanaka, T.; Thayer, J. B.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Axelsson, M.; Hjalmarsdotter, L.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Axelsson, M.; Conrad, J.; Hjalmarsdotter, L.; Jackson, M. S.; Meurer, C.; Ryde, F.; Ylinen, T.] AlbaNova, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Baldini, L.; Bellazzini, R.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Chaty, S.; Corbel, S.; Grenier, I. A.; Koerding, E.; Rodriguez, J.; Starck, J. -L.; Tibaldo, L.] Univ Paris Diderot, CNRS, CEA Saclay, Lab AIM,CEA IRFU,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Giavitto, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Giavitto, G.; Longo, F.] Univ Trieste, Dipartmento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Takahashi, H.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Sander, A.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Fortin, P.; Giebels, B.; Horan, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caliandro, G. A.; Rea, N.; Rodriguez, A. Y.; Torres, D. F.] CSIC, IEEC, Inst Ciencies Espai, Barcelona 08193, Spain; [Caraveo, P. A.; Marelli, M.] Ist Astrofis Spaziale & Fis Cosm, INAF, I-20133 Milan, Italy; [Celik, Oe; Corbet, R.; Gehrels, N.; Harding, A. K.; Hays, E.; Johnson, T. J.; McEnery, J. E.; Pottschmidt, K.; Thompson, D. J.; Vasileiou, V.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Celik, Oe; Vasileiou, V.] CRESST, Greenbelt, MD 20771 USA; [Celik, Oe; Corbet, R.; Vasileiou, V.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Celik, Oe; Corbet, R.; Vasileiou, V.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Cohen-Tanugi, J.; Farnier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Meurer, C.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Corbel, S.] Inst Univ France, F-75005 Paris, France; [Dubus, G.; Hill, A. B.] Univ Grenoble 1, CNRS, UMR 5571, Lab Astrophys Grenoble LAOG, F-38041 Grenoble 09, France; [Dumora, D.; Grondin, M. -H.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Smith, D. A.] Univ Bordeaux, CEN Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Dumora, D.; Grondin, M. -H.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Smith, D. A.] CEN Bordeaux Gradignan, CNRS, UMR 5797, IN2P3, F-33175 Gradignan, France; [Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [Frailis, M.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Gehrels, N.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Gehrels, N.; Johnson, T. J.; McEnery, J. E.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Gehrels, N.; Johnson, T. J.; McEnery, J. E.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Guillemot, L.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Guiriec, S.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA; [Hanabata, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Jackson, M. S.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Kawai, N.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Vilchez, N.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Knoedlseder, J.; Marchand, L.; McColl, N.; Ong, R. A.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Max-Moerbeck, W.; Readhead, A.; Richards, J. L.; Stevenson, M.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Migliari, S.] ESAC, Madrid 28691, Spain; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Pooley, G.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA; [Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Rea, N.] Sterrenkundig Inst Anton Pannekoek, NL-1095 SJ Amsterdam, Netherlands; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Tomsick, J. A.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Torres, D. F.] ICREA, Barcelona, Spain; [Tramacere, A.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Wilms, J.] Erlangen Ctr Astroparticle Phys, D-91058 Erlangen, Germany; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden	United States Department of Defense; United States Navy; Naval Research Laboratory; National Academies of Sciences, Engineering & Medicine; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stockholm University; Oskar Klein Centre; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University System of Ohio; Ohio State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Max Planck Society; University of Alabama System; University of Alabama Huntsville; Hiroshima University; Royal Institute of Technology; Tokyo Institute of Technology; RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; George Mason University; University of California System; University of California Los Angeles; California Institute of Technology; European Space Agency; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; University of Cambridge; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Amsterdam; University of Innsbruck; University of Innsbruck; Purdue University System; Purdue University; University of California System; University of California Berkeley; ICREA; University of Rome Tor Vergata; University of Erlangen Nuremberg; Linnaeus University; University of Kalmar	Abdo, AA (corresponding author), USN, Res Lab, Div Space Sci, Washington, DC 20375 USA.	stephane.corbel@cea.fr; Robin.Corbet@nasa.gov; Guillaume.Dubus@obs.ujf-grenoble.fr	Jóhannesson, Guðlaugur/O-8741-2015; Nolan, Patrick L/A-5582-2009; Sgrò, Carmelo/K-3395-2016; Gargano, Fabio/O-8934-2015; Caraveo, Patrizia/AAL-5708-2020; Moskalenko, Igor V/A-1301-2007; Tosti, Gino/E-9976-2013; Max-Moerbeck, Walter/AAU-5773-2020; Torres, Diego F./AAF-7931-2019; Torres, Diego F./O-9422-2016; cohen-tanugi, Johann/ABB-1481-2021; Takahashi, Hiromitsu H/T-2713-2017; tramacere, andrea/B-9424-2012; Gehrels, Neil/D-2971-2012; Jóhannesson, Guðlaugur/ABC-7216-2020; lubrano, pasquale/F-7269-2012; Gargano, Fabio/AAD-5121-2021; Parkinson, Pablo Miguel Saz/I-7980-2013; Giglietto, Nicola/Y-2425-2019; Morselli, Aldo/G-6769-2011; Hays, Elizabeth/D-3257-2012; Torres, Diego F/ABD-7940-2020; Mazziotta, Mario N/O-8867-2015; Bastieri, Denis/AAC-5917-2020; Rando, Riccardo/O-1302-2019; Max-Moerbeck, Walter/N-8042-2018; Thompson, David J/D-2939-2012; Rea, Nanda/I-2853-2015; giglietto, nicola/I-8951-2012; Wilms, Joern/C-8116-2013; Johnson, Neil/G-3309-2014; Kuss, Michael W/H-8959-2012; Harding, Alice K/D-3160-2012; Starck, Jean-Luc/D-9467-2011; Loparco, Francesco/O-8847-2015; Reimer, Olaf/A-3117-2013; Rodriguez, Jerome/GMX-5000-2022; McEnery, Julie E/D-6612-2012; Baldini, Luca/E-5396-2012; Rando, Riccardo/M-7179-2013; Reimer, Anita/K-5822-2015; Chaty, Sylvain/B-8671-2016	Jóhannesson, Guðlaugur/0000-0003-1458-7036; Gargano, Fabio/0000-0002-5055-6395; Caraveo, Patrizia/0000-0003-2478-8018; Moskalenko, Igor V/0000-0001-6141-458X; Max-Moerbeck, Walter/0000-0002-5491-5244; Torres, Diego F./0000-0002-1522-9065; Torres, Diego F./0000-0002-1522-9065; cohen-tanugi, Johann/0000-0001-9022-4232; Takahashi, Hiromitsu H/0000-0001-6314-5897; tramacere, andrea/0000-0002-8186-3793; Jóhannesson, Guðlaugur/0000-0003-1458-7036; lubrano, pasquale/0000-0003-0221-4806; Gargano, Fabio/0000-0002-5055-6395; Giglietto, Nicola/0000-0002-9021-2888; Morselli, Aldo/0000-0002-7704-9553; Mazziotta, Mario N/0000-0001-9325-4672; Bastieri, Denis/0000-0002-6954-8862; Rando, Riccardo/0000-0001-6992-818X; Max-Moerbeck, Walter/0000-0002-5491-5244; Thompson, David J/0000-0001-5217-9135; Rea, Nanda/0000-0003-2177-6388; giglietto, nicola/0000-0002-9021-2888; Wilms, Joern/0000-0003-2065-5410; Starck, Jean-Luc/0000-0003-2177-7794; Loparco, Francesco/0000-0002-1173-5673; Reimer, Olaf/0000-0001-6953-1385; Reimer, Anita/0000-0001-8604-7077; Porter, Troy/0000-0002-2621-4440; Casandjian, Jean-Marc/0000-0003-1404-0524; SPINELLI, Paolo/0000-0001-6688-8864; Kerr, Matthew/0000-0002-0893-4073; Ciprini, Stefano/0000-0002-0712-2479; Fusco, Piergiorgio/0000-0002-9383-2425; de Palma, Francesco/0000-0001-5898-2834; Dubus, Guillaume/0000-0002-5130-2514; Buson, Sara/0000-0002-3308-324X; Hill, Adam/0000-0003-3470-4834; Tosti, Gino/0000-0002-0839-4126; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Ong, Rene/0000-0002-4837-5253; Ray, Paul/0000-0002-5297-5278; Cecchi, Claudia/0000-0002-2192-8233; Tanaka, Takaaki/0000-0002-4383-0368; Monzani, Maria Elena/0000-0002-8254-5308; Cameron, Robert/0000-0003-0942-2747; Giavitto, Gianluca/0000-0002-7629-6499; Sadrozinski, Hartmut/0000-0003-0019-5410; Omodei, Nicola/0000-0002-5448-7577; Cheung, Chi (Teddy)/0000-0002-4377-0174; Pesce-Rollins, Melissa/0000-0003-1790-8018; Chaty, Sylvain/0000-0002-5769-8601; Baldini, Luca/0000-0002-9785-7726; Rodriguez, Jerome/0000-0002-4151-4468; Katagiri, Hideaki/0000-0003-2347-8819; Johnson, Tyrel/0000-0002-2771-472X; Pepe, Monica/0000-0001-5624-4010; Frailis, Marco/0000-0002-7400-2135; Ackermann, Markus/0000-0001-8952-588X; Murgia, Simona/0000-0003-0516-9422; Grenier, Isabelle/0000-0003-3274-674X; Sgro', Carmelo/0000-0001-5676-6214; Tibaldo, Luigi/0000-0001-7523-570X	NASA; Department of Energy in the United States; CEA/Institut de Recherches sur les lois Fondamentales de l'Univers and l'Institut National de Physique Nucleaire et de Physique des Particules/CNRS in France; Agenzia Spaziale Italiana and Istituto Nazionale di Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology; National Laboratory for High Energy Physics; Japan Aerospace Exploration Agency in Japan; Wallenberg Foundation; Swedish Research Council; National Space Board in Sweden; Istituto Nazionale di Astrofisica in Italy; Centre National d'Etudes Spatiales in France; K. A. Wallenberg Foundation; European Community [ERC-StG-200911]; ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); Department of Energy in the United States(United States Department of Energy (DOE)); CEA/Institut de Recherches sur les lois Fondamentales de l'Univers and l'Institut National de Physique Nucleaire et de Physique des Particules/CNRS in France(French Atomic Energy CommissionCentre National de la Recherche Scientifique (CNRS)); Agenzia Spaziale Italiana and Istituto Nazionale di Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Laboratory for High Energy Physics; Japan Aerospace Exploration Agency in Japan; Wallenberg Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board in Sweden; Istituto Nazionale di Astrofisica in Italy(Istituto Nazionale Astrofisica (INAF)); Centre National d'Etudes Spatiales in France(Centre National D'etudes Spatiales); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Community(European Commission); ICREA(ICREA)	The Fermi LAT Collaboration acknowledges support from a number of agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and the Department of Energy in the United States; CEA/Institut de Recherches sur les lois Fondamentales de l'Univers and l'Institut National de Physique Nucleaire et de Physique des Particules/CNRS in France; the Agenzia Spaziale Italiana and Istituto Nazionale di Fisica Nucleare in Italy; the Ministry of Education, Culture, Sports, Science and Technology, National Laboratory for High Energy Physics (KEK), and Japan Aerospace Exploration Agency in Japan; and the K. A. Wallenberg Foundation, Swedish Research Council and National Space Board in Sweden. Additional support from the Istituto Nazionale di Astrofisica in Italy and the Centre National d'Etudes Spatiales in France for science analysis during the operations phase is also gratefully acknowledged. J. C. is a Royal Swedish Academy of Sciences Research Fellow, funded by a grant from the K. A. Wallenberg Foundation. G. D. and A. B. H. are funded by contract ERC-StG-200911 from the European Community.	Abdo AA, 2009, ASTROPHYS J LETT, V701, pL123, DOI 10.1088/0004-637X/701/2/L123; BONNETBIDAUD JM, 1988, PHYS REP, V170, P325, DOI 10.1016/0370-1573(88)90083-X; Borione A, 1997, PHYS REV D, V55, P1714, DOI 10.1103/PhysRevD.55.1714; Camilo F, 2009, ASTROPHYS J, V705, P1, DOI 10.1088/0004-637X/705/1/1; CARRAMINANA A, 1992, ASTRON ASTROPHYS, V264, P127; Dubus G, 2006, ASTRON ASTROPHYS, V456, P801, DOI 10.1051/0004-6361:20054779; FENDER R, 2006, CAMBRIDGE ASTROPHYSI, V39; GIACCONI R, 1967, ASTROPHYS J, V148, pL119, DOI 10.1086/180028; Hanson MM, 2000, ASTROPHYS J, V541, P308, DOI 10.1086/309419; HERMSEN W, 1987, ASTRON ASTROPHYS, V175, P141; Hjalmarsdotter L, 2009, MON NOT R ASTRON SOC, V392, P251, DOI 10.1111/j.1365-2966.2008.14036.x; LAMB RC, 1977, ASTROPHYS J, V212, pL63, DOI 10.1086/182376; Ling ZX, 2009, ASTROPHYS J, V695, P1111, DOI 10.1088/0004-637X/695/2/1111; Miller-Jones JCA, 2004, ASTROPHYS J, V600, P368, DOI 10.1086/379706; Mioduszewski AJ, 2001, ASTROPHYS J, V553, P766, DOI 10.1086/320965; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; Mori M, 1997, ASTROPHYS J, V476, P842, DOI 10.1086/303667; OFLAHERTY KS, 1992, ASTROPHYS J, V396, P674, DOI 10.1086/171748; Ong RA, 1998, PHYS REP, V305, P94; PARSIGNAULT DR, 1972, NATURE-PHYS SCI, V239, P123, DOI 10.1038/physci239123a0; PRINGLE JE, 1974, NATURE, V247, P21, DOI 10.1038/247021a0; Singh NS, 2002, ASTRON ASTROPHYS, V392, P161, DOI 10.1051/0004-6361:20020923; Szostek A, 2008, MON NOT R ASTRON SOC, V388, P1001, DOI 10.1111/j.1365-2966.2008.13479.x; Tudose V, 2007, MON NOT R ASTRON SOC, V375, pL11, DOI 10.1111/j.1745-3933.2006.00264.x; vanKerkwijk MH, 1996, ASTRON ASTROPHYS, V314, P521; WEEKES TC, 1988, PHYS REP, V160, P1, DOI 10.1016/0370-1573(88)90177-9	27	192	193	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1512	1516		10.1126/science.1182174	http://dx.doi.org/10.1126/science.1182174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19965378				2022-12-28	WOS:000272623600051
J	Sobolevsky, AI; Rosconi, MP; Gouaux, E				Sobolevsky, Alexander I.; Rosconi, Michael P.; Gouaux, Eric			X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor	NATURE			English	Article							LIGAND-BINDING DOMAIN; KAINATE RECEPTORS; NMDA RECEPTORS; FUNCTIONAL EXPRESSION; ALLOSTERIC MODULATORS; MOLECULAR-MECHANISMS; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURES; K+ CHANNELS; DESENSITIZATION	Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system and function by opening a transmembrane ion channel upon binding of glutamate. Despite their crucial role in neurobiology, the architecture and atomic structure of an intact ionotropic glutamate receptor are unknown. Here we report the crystal structure of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive, homotetrameric, rat GluA2 receptor at 3.6 angstrom resolution in complex with a competitive antagonist. The receptor harbours an overall axis of two-fold symmetry with the extracellular domains organized as pairs of local dimers and with the ion channel domain exhibiting four-fold symmetry. A symmetry mismatch between the extracellular and ion channel domains is mediated by two pairs of conformationally distinct subunits, A/C and B/D. Therefore, the stereochemical manner in which the A/C subunits are coupled to the ion channel gate is different from the B/D subunits. Guided by the GluA2 structure and site-directed cysteine mutagenesis, we suggest that GluN1 and GluN2A NMDA (N-methyl-D-aspartate) receptors have a similar architecture, with subunits arranged in a 1-2-1-2 pattern. We exploit the GluA2 structure to develop mechanisms of ion channel activation, desensitization and inhibition by non-competitive antagonists and pore blockers.	[Sobolevsky, Alexander I.; Rosconi, Michael P.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	NIH National Research Service Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS049767, R01NS038631] Funding Source: NIH RePORTER	NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the personnel at beamlines 5.0.2, 8.2.1 and 8.2.2 of the Advanced Light Source and at beamline 24-ID-E of the Advanced Photon Source. We also thank T. Homrichhausen for help with cloning and FSEC screening; L. Vaskalis for assistance with illustrations; and Gouaux laboratory members for discussion. M. P. R. was supported by an individual NIH National Research Service Award. This work was supported by the NIH. E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alt A, 2006, BIOCHEM PHARMACOL, V71, P1273, DOI 10.1016/j.bcp.2005.12.022; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cowan WM, 2001, SYNAPSES, P1; CURTIS DR, 1959, NATURE, V183, P611, DOI 10.1038/183611a0; DINGLEDINE R, 1999, PHARMACOL REV, V7, P61; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hayashi T, 1954, KEIO J MED, V3; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Labrie V, 2010, NEUROSCI BIOBEHAV R, V34, P351, DOI 10.1016/j.neubiorev.2009.08.002; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky A.I., 2003, RECENT RES DEV PHYSL, P1; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	89	778	789	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					745	U66		10.1038/nature08624	http://dx.doi.org/10.1038/nature08624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19946266	Green Accepted			2022-12-28	WOS:000272559900030
J	Sarewitz, D				Sarewitz, Daniel			A tale of two sciences	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	2009	462	7273					566	566		10.1038/462566a	http://dx.doi.org/10.1038/462566a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	526HH	19956236	Bronze			2022-12-28	WOS:000272277900013
J	Weinberg, Z; Perreault, J; Meyer, MM; Breaker, RR				Weinberg, Zasha; Perreault, Jonathan; Meyer, Michelle M.; Breaker, Ronald R.			Exceptional structured noncoding RNAs revealed by bacterial metagenome analysis	NATURE			English	Article							COMPARATIVE GENOMICS; SECONDARY STRUCTURE; SEQUENCE-ANALYSIS; 6S RNA; IDENTIFICATION; REGULATOR; DATABASE; RIBOSWITCHES; EXPRESSION; DIVERSITY	Estimates of the total number of bacterial species(1-3) indicate that existing DNA sequence databases carry only a tiny fraction of the total amount of DNA sequence space represented by this division of life. Indeed, environmental DNA samples have been shown to encode many previously unknown classes of proteins(4) and RNAs5. Bioinformatics searches(6-10) of genomic DNA from bacteria commonly identify new noncoding RNAs (ncRNAs)(10-12) such as riboswitches(13,14). In rare instances, RNAs that exhibit more extensive sequence and structural conservation across a wide range of bacteria are encountered(15,16). Given that large structured RNAs are known to carry out complex biochemical functions such as protein synthesis and RNA processing reactions, identifying more RNAs of great size and intricate structure is likely to reveal additional biochemical functions that can be achieved by RNA. We applied an updated computational pipeline(17) to discover ncRNAs that rival the known large ribozymes in size and structural complexity or that are among the most abundant RNAs in bacteria that encode them. These RNAs would have been difficult or impossible to detect without examining environmental DNA sequences, indicating that numerous RNAs with extraordinary size, structural complexity, or other exceptional characteristics remain to be discovered in unexplored sequence space.	[Weinberg, Zasha; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Weinberg, Zasha; Perreault, Jonathan; Meyer, Michelle M.; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, Box 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Perreault, Jonathan/0000-0003-4726-6319; Breaker, Ronald/0000-0002-2165-536X; Weinberg, Zasha/0000-0002-6681-3624	NIH [RR19895-02]; Canadian Institutes of Health Research and National Institutes of Health; Howard Hughes Medical Institute Investigator; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778, F32GM079974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research and National Institutes of Health(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Carriero and R. Bjornson for assisting our use of the Yale Life Sciences High Performance Computing Center (NIH grant RR19895-02), T. Gruczka for advice and assistance in ocean water collection, J. Yang for assistance with the analysis of the dct-1 motif, D. Rodrigues for E. sibiricum, D. Bryant for A. maxima genomic DNA and P. O'Donoghue, M. Hammond, N. Sudarsan, S. Li, J. Barrick, Z. Yao, W. L. Ruzzo and E. Tseng for advice. J. P. and M. M. M. were supported by postdoctoral fellowships from the Canadian Institutes of Health Research and National Institutes of Health, respectively. R. R. B. is a Howard Hughes Medical Institute Investigator.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; [Anonymous], BACTERIOPHAGES METHO; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Dai LX, 2002, NUCLEIC ACIDS RES, V30, P1091, DOI 10.1093/nar/30.5.1091; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; HAAS ES, 1994, P NATL ACAD SCI USA, V91, P2527, DOI 10.1073/pnas.91.7.2527; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; PACE NR, 1999, RNA WORLD, P113; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Puerta-Fernandez E, 2006, P NATL ACAD SCI USA, V103, P19490, DOI 10.1073/pnas.0607493103; REGULSKI EE, 2008, METHODS MOL BIOL, V419; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2009, CURR OPIN STRUC BIOL, V19, P260, DOI 10.1016/j.sbi.2009.04.002; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tseng Huei-Hun, 2009, Journal of Bioinformatics and Computational Biology, V7, P373, DOI 10.1142/S0219720009004126; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Weinberg Z, 2006, BIOINFORMATICS, V22, P35, DOI 10.1093/bioinformatics/bti743; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; WU TF, 1989, NUCLEIC ACIDS RES, V17, P3501, DOI 10.1093/nar/17.9.3501; YAO Z, 2008, THESIS U WASHINGTON; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zwieb C, 1999, NUCLEIC ACIDS RES, V27, P2063, DOI 10.1093/nar/27.10.2063	62	75	76	2	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					656	U131		10.1038/nature08586	http://dx.doi.org/10.1038/nature08586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956260	Green Accepted			2022-12-28	WOS:000272277900042
J	Tzoulaki, I; Liberopoulos, G; Ioannidis, JPA				Tzoulaki, Ioanna; Liberopoulos, George; Ioannidis, John P. A.			Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; INTIMA-MEDIA THICKNESS; APPARENTLY HEALTHY-MEN; ANKLE BRACHIAL INDEX; MIDDLE-AGED MEN; CARDIOVASCULAR-DISEASE; PROGNOSTIC VALUE; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME	Context With heightened interest in predictive medicine, many studies try to document information that can improve prediction of major clinical outcomes. Objective To evaluate the reported design and analysis of studies that examined whether additional predictors improve predictive performance when added to the Framingham risk score (FRS), one of the most widely validated and cited clinical prediction scores. Study Selection Two independent investigators searched 1908 articles citing the article that described the FRS in 1998 until September 2009 through the ISI Web of Knowledge database. Articles were eligible if they included any analyses comparing the predictive performance of the FRS vs the FRS plus some additional predictor for a prospectively assessed outcome. Data Analyses We recorded information on FRS calculation, modeling of additional predictors, outcomes assessed, population evaluated, subgroup analysis documentation, and flaws in the methods that may have affected the reported improvements in predictive ability. We also evaluated the correlation of reported design and analysis features with the predictive model discrimination and improvements with the additional predictors. Results We evaluated 79 eligible articles. Forty-nine studies (62%) did not calculate the FRS as it has been proposed, 15 (19%) modeled the additional predictor in more than 1 way and presented only the best-fit or area-under-the-curve (AUC) results for only 1 model, 41 (52%) did not examine the original outcome that the FRS was developed for, 33 (42%) studied a population different from what the FRS was intended for, and 25 (32%) claimed improved prediction in 1 subgroup but only 7 (9%) formally tested subgroup differences. Evaluation of independence in multivariable regressions, discrimination in AUC, calibration, and reclassification were reported in 77, 36, 7, and 7 studies, respectively, but these methods were adequately documented in only 60, 13, 4, and 2 studies, respectively. Overall, 63 studies (80%) claimed some improved prediction. Increase in AUC was larger when the predictive performance of the FRS was lower (rho = -0.57, P < .001). Increase in AUC was significantly larger when evaluation of independence in multivariable regression or discrimination in AUC analysis was not adequately documented and when the additional predictor had been modeled in more than 1 way and only 1 model was reported for AUC. Conclusion The majority of examined studies claimed that they found factors that could offer additional predictive value beyond what the FRS could achieve; however, most had flaws in their design, analyses, and reporting that cast some doubt on the reliability of the claims for improved prediction. JAMA. 2009;302(21):2345-2352	[Liberopoulos, George; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Tzoulaki, Ioanna] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Tufts Med Ctr, Boston, MA 02111 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	University of Ioannina; Imperial College London; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts University; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Tzoulaki, Ioanna/C-1381-2008; Tzoulaki, Ioanna/ABE-6269-2020; Ioannidis, John P. A./G-9836-2011	Tzoulaki, Ioanna/0000-0002-4275-9328; 				Acevedo M, 2002, ARTERIOSCL THROM VAS, V22, P1042, DOI 10.1161/01.ATV.0000020007.25154.62; Allison M, 2008, NAT BIOTECHNOL, V26, P509, DOI 10.1038/nbt0508-509; Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Arsenault BJ, 2007, EUR HEART J, V28, P2770, DOI 10.1093/eurheartj/ehm390; Balady GJ, 2004, CIRCULATION, V110, P1920, DOI 10.1161/01.CIR.0000143226.40607.71; Baldassarre D, 2007, ATHEROSCLEROSIS, V191, P403, DOI 10.1016/j.atherosclerosis.2006.04.008; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Brugger-Andersen T, 2008, THROMB RES, V123, P60, DOI 10.1016/j.thromres.2008.01.012; Cao JJ, 2008, ATHEROSCLEROSIS, V197, P806, DOI 10.1016/j.atherosclerosis.2007.07.029; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Corona AJ, 2005, KIDNEY INT, V68, pS34, DOI 10.1111/j.1523-1755.2005.09706.x; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; Dekker JM, 2005, CIRCULATION, V112, P666, DOI 10.1161/CIRCULATIONAHA.104.516948; Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Folsom AR, 2003, DIABETES CARE, V26, P2777, DOI 10.2337/diacare.26.10.2777; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gallo WT, 2006, OCCUP ENVIRON MED, V63, P683, DOI 10.1136/oem.2006.026823; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gulati M, 2005, AM J CARDIOL, V96, P369, DOI 10.1016/j.amjcard.2005.03.078; Hansen TW, 2006, J HYPERTENS, V24, P2247, DOI 10.1097/01.hjh.0000249703.57478.78; Hassinen M, 2006, ARCH INTERN MED, V166, P444; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hu G, 2007, EUR HEART J, V28, P492, DOI 10.1093/eurheartj/ehl475; Humphries SE, 2007, CLIN CHEM, V53, P8, DOI 10.1373/clinchem.2006.074591; Hunt KJ, 2001, ULTRASOUND MED BIOL, V27, P357, DOI 10.1016/S0301-5629(00)00353-7; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Ioannidis JPA, 2008, AM J EPIDEMIOL, V168, P374, DOI 10.1093/aje/kwn156; Ioannidis JPA, 1998, LANCET, V352, P590, DOI 10.1016/S0140-6736(98)22034-4; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jahnke C, 2007, CIRCULATION, V115, P1769, DOI 10.1161/CIRCULATIONAHA.106.652016; Jeppesen J, 2007, J AM COLL CARDIOL, V49, P2112, DOI 10.1016/j.jacc.2007.01.088; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Koerselman J, 2005, AM J CARDIOL, V96, P390, DOI 10.1016/j.amjcard.2005.03.083; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Lee J, 2008, CLIN ENDOCRINOL, V69, P225, DOI 10.1111/j.1365-2265.2008.03174.x; Levitzky YS, 2008, AM J CARDIOL, V101, P326, DOI 10.1016/j.amjcard.2007.08.032; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mainous AG, 2008, J AM BOARD FAM MED, V21, P408, DOI 10.3122/jabfm.2008.05.080046; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Meisinger C, 2005, EUR HEART J, V26, P271, DOI 10.1093/eurheartj/ehi003; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Moller CS, 2007, HEART, V93, P1104, DOI 10.1136/hrt.2006.109116; Mora S, 2005, CIRCULATION, V111, P1871, DOI 10.1161/01.CIR.0000161956.75255.7B; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Morrison AC, 2008, CEREBROVASC DIS, V26, P420, DOI 10.1159/000155637; Nawrot TS, 2004, J HUM HYPERTENS, V18, P279, DOI 10.1038/sj.jhh.1001669; Olsen MH, 2006, J HYPERTENS, V24, P775, DOI 10.1097/01.hjh.0000217862.50735.dc; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pischon T, 2007, EUR J EPIDEMIOL, V22, P429, DOI 10.1007/s10654-007-9141-2; Price JF, 2007, J CLIN EPIDEMIOL, V60, P1067, DOI 10.1016/j.jclinepi.2007.01.011; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sajadieh A, 2005, EUR HEART J, V26, P1402, DOI 10.1093/eurheartj/ehi169; Sajadieh A, 2006, AM J CARDIOL, V97, P1351, DOI 10.1016/j.amjcard.2005.11.067; Salameh MJ, 2008, J GEN INTERN MED, V23, P1423, DOI 10.1007/s11606-008-0694-x; Schousboe JT, 2008, J BONE MINER RES, V23, P409, DOI 10.1359/JBMR.071024; Schouten BWV, 2008, INT J IMPOT RES, V20, P92, DOI 10.1038/sj.ijir.3901604; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Simmons RK, 2008, ARCH INTERN MED, V168, P1209, DOI 10.1001/archinte.168.11.1209; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Weiner DE, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.05.054; Williams JE, 2002, STROKE, V33, P13, DOI 10.1161/hs0102.101625; Wilson PWF, 2008, CIRCULATION, V118, P124, DOI 10.1161/CIRCULATIONAHA.108.772962; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zakai NA, 2007, J THROMB HAEMOST, V5, P1128, DOI 10.1111/j.1538-7836.2007.02528.x	96	208	209	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2345	2352		10.1001/jama.2009.1757	http://dx.doi.org/10.1001/jama.2009.1757			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952321				2022-12-28	WOS:000272239000023
J	Buchenau, J				Buchenau, Juergen			Global Darwin: Multicultural mergers	NATURE			English	Editorial Material									Univ N Carolina, Dept Hist, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Buchenau, J (corresponding author), Univ N Carolina, Dept Hist, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	jbuchenau@uncc.edu							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					284	285		10.1038/462284a	http://dx.doi.org/10.1038/462284a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521DF	19924194				2022-12-28	WOS:000271899300021
J	Choy, E; Digumarthy, SR; Koplin, SA				Choy, Edwin; Digumarthy, Subba R.; Koplin, Stephanie A.			A Man with Cough, Hoarseness, and Abnormalities on Chest Imaging Ewing's sarcoma of the bone, with metastasis to the lung and mediastinal lymph nodes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EWS CHIMERIC TRANSCRIPTS; PROGNOSTIC IMPACT; TUMOR; IFOSFAMIDE; ETOPOSIDE; INSULIN; FUSION		[Choy, Edwin] Massachusetts Gen Hosp, Div Med Oncol, Dept Med, Boston, MA 02114 USA; [Digumarthy, Subba R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Koplin, Stephanie A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Choy, Edwin] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Digumarthy, Subba R.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Koplin, Stephanie A.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Choy, E (corresponding author), Massachusetts Gen Hosp, Div Med Oncol, Dept Med, Boston, MA 02114 USA.			Choy, Edwin/0000-0001-9896-8084				Abudu A, 1999, BRIT J CANCER, V79, P1185, DOI 10.1038/sj.bjc.6690190; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; BENJAMIN RS, 2007, ACTIVITY R1507 FULLY; Caudill Jonathan S C, 2007, Adolesc Med State Art Rev, V18, P62; Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108, DOI 10.1200/JCO.2000.18.17.3108; de Alava E, 2000, AM J PATHOL, V156, P849, DOI 10.1016/S0002-9440(10)64953-X; de Alava E, 1998, J CLIN ONCOL, V16, P1248, DOI 10.1200/JCO.1998.16.4.1248; de Alava E, 2000, CANCER-AM CANCER SOC, V89, P783, DOI 10.1002/1097-0142(20000815)89:4<783::AID-CNCR10>3.0.CO;2-Q; Gerald WL, 1998, J CLIN ONCOL, V16, P3028, DOI 10.1200/JCO.1998.16.9.3028; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Honoki K, 2007, CANCER-AM CANCER SOC, V110, P1351, DOI 10.1002/cncr.22908; Juergens C, 2006, PEDIATR BLOOD CANCER, V47, P22, DOI 10.1002/pbc.20820; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; MALAGON HD, 2005, SEMIN DIAGN PATHOL, V22, P230; *NAT CANC I, 2009, NCI CLIN TRIALS SEAR; OLMOS D, 2008, 44 ANN M AM SOC CLIN; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2009, NAT REV CANCER, V9, P224, DOI 10.1038/nrc2605; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; Wei G, 2000, CANCER-AM CANCER SOC, V89, P793, DOI 10.1002/1097-0142(20000815)89:4<793::AID-CNCR11>3.0.CO;2-M; Zoubek A, 1996, J CLIN ONCOL, V14, P1245, DOI 10.1200/JCO.1996.14.4.1245; ZOUBEK A, 1994, BRIT J CANCER, V70, P908, DOI 10.1038/bjc.1994.419	23	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2080	2087		10.1056/NEJMcpc0907804	http://dx.doi.org/10.1056/NEJMcpc0907804			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19923580				2022-12-28	WOS:000271898600014
J	Hidalgo, M; Maitra, A				Hidalgo, Manuel; Maitra, Anirban			The Hedgehog Pathway and Pancreatic Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITION		[Hidalgo, Manuel] Ctr Nacl Invest Oncol, Clin Res Program, Madrid, Spain; [Maitra, Anirban] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA	Johns Hopkins University	Hidalgo, M (corresponding author), Ctr Nacl Invest Oncol, Clin Res Program, Madrid, Spain.		HIDALGO, MANUEL/I-4995-2015	HIDALGO, MANUEL/0000-0002-3765-3318				Feldmann G, 2008, GUT, V57, P1420, DOI 10.1136/gut.2007.148189; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360	5	84	86	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2094	2096		10.1056/NEJMcibr0905857	http://dx.doi.org/10.1056/NEJMcibr0905857			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19923581				2022-12-28	WOS:000271898600017
J	Lu, R; Markowetz, F; Unwin, RD; Leek, JT; Airoldi, EM; MacArthur, BD; Lachmann, A; Rozov, R; Ma'ayan, A; Boyer, LA; Troyanskaya, OG; Whetton, AD; Lemischka, IR				Lu, Rong; Markowetz, Florian; Unwin, Richard D.; Leek, Jeffrey T.; Airoldi, Edoardo M.; MacArthur, Ben D.; Lachmann, Alexander; Rozov, Roye; Ma'ayan, Avi; Boyer, Laurie A.; Troyanskaya, Olga G.; Whetton, Anthony D.; Lemischka, Ihor R.			Systems-level dynamic analyses of fate change in murine embryonic stem cells	NATURE			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; SELF-RENEWAL; GENE-EXPRESSION; NANOG; PLURIPOTENCY; NETWORK; MOUSE; CHROMATIN; OCT4; DIFFERENTIATION	Molecular regulation of embryonic stem cell (ESC) fate involves a coordinated interaction between epigenetic(1-4), transcriptional(5-10) and translational(11,12) mechanisms. It is unclear how these different molecular regulatory mechanisms interact to regulate changes in stem cell fate. Here we present a dynamic systems-level study of cell fate change in murine ESCs following a well-defined perturbation. Global changes in histone acetylation, chromatin-bound RNA polymerase II, messenger RNA (mRNA), and nuclear protein levels were measured over 5 days after downregulation of Nanog, a key pluripotency regulator(13-15). Our data demonstrate how a single genetic perturbation leads to progressive widespread changes in several molecular regulatory layers, and provide a dynamic view of information flow in the epigenome, transcriptome and proteome. We observe that a large proportion of changes in nuclear protein levels are not accompanied by concordant changes in the expression of corresponding mRNAs, indicating important roles for translational and post-translational regulation of ESC fate. Gene-ontology analysis across different molecular layers indicates that although chromatin reconfiguration is important for altering cell fate, it is preceded by transcription-factor- mediated regulatory events. The temporal order of gene expression alterations shows the order of the regulatory network reconfiguration and offers further insight into the gene regulatory network. Our studies extend the conventional systems biology approach to include many molecular species, regulatory layers and temporal series, and underscore the complexity of the multi-layer regulatory mechanisms responsible for changes in protein expression that determine stem cell fate.	[Lu, Rong; Lemischka, Ihor R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Markowetz, Florian; Airoldi, Edoardo M.; Troyanskaya, Olga G.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Markowetz, Florian; Airoldi, Edoardo M.; Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Unwin, Richard D.; Whetton, Anthony D.] Univ Manchester, Wolfson Mol Imaging Ctr,Sch Canc & Imaging Sci, Manchester Acad Hlth Sci Ctr, Stem Cell & Leukaemia Prote Lab, Manchester M20 4QL, Lancs, England; [Leek, Jeffrey T.; MacArthur, Ben D.; Rozov, Roye; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Leek, Jeffrey T.; MacArthur, Ben D.; Rozov, Roye; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [MacArthur, Ben D.; Lachmann, Alexander; Ma'ayan, Avi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [MacArthur, Ben D.; Lachmann, Alexander; Ma'ayan, Avi] Mt Sinai Sch Med, Syst Biol Ctr New York, New York, NY 10029 USA; [Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Princeton University; Princeton University; Princeton University; University of Manchester; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT)	Lemischka, IR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	rlu@stanford.edu; ihor.lemischka@mssm.edu	Markowetz, Florian/H-6883-2019; Airoldi, Edoardo/A-8575-2009; Unwin, Richard/C-1258-2008; Troyanskaya, Olga G/B-1968-2010; Ma'ayan, Avi/AAG-3131-2019; Lachmann, Alexander/AAF-1940-2020	Markowetz, Florian/0000-0002-2784-5308; Unwin, Richard/0000-0001-7955-9111; Ma'ayan, Avi/0000-0002-6904-1017; Lachmann, Alexander/0000-0002-1982-7652; MacArthur, Ben/0000-0002-5396-9750; Leek, Jeffrey/0000-0002-2873-2671; WHETTON, ANTHONY D/0000-0002-1098-3878; Troyanskaya, Olga/0000-0002-5676-5737; Airoldi, Edoardo/0000-0002-3512-0542	NIH; BBSRC; Leukaemia Research UK; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia Research UK; US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Storton for technical support, and E. Wieschaus, Y. Shi, S. Tavazoie and N. Slavov for constructive discussions. We also acknowledge the laboratories of the following people for providing antibodies for western blot: A. Okuda, J. Flint and Y. Kang. This work was supported by the NIH, and in part supported by the BBSRC and Leukaemia Research UK. O.G.T., F. M. and E. M. A. were partially supported by the NIH and US National Science Foundation.	Airoldi EM, 2007, PLOS COMPUT BIOL, V3, P2421, DOI 10.1371/journal.pcbi.0030252; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang WY, 2008, CELL STEM CELL, V2, P410, DOI 10.1016/j.stem.2008.04.009; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Spooncer E, 2008, MOL CELL PROTEOMICS, V7, P573, DOI 10.1074/mcp.M700292-MCP200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	37	215	220	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					358	U126		10.1038/nature08575	http://dx.doi.org/10.1038/nature08575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924215	Green Published, Green Accepted			2022-12-28	WOS:000271899300046
J	Lettieri, CJ; Shah, AA; Holley, AB; Kelly, WF; Chang, AS; Roop, SA				Lettieri, Christopher J.; Shah, Anita A.; Holley, Aaron B.; Kelly, William F.; Chang, Audrey S.; Roop, Stuart A.		CPAP ASAP Trial	Effects of a Short Course of Eszopiclone on Continuous Positive Airway Pressure Adherence A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							OBSTRUCTIVE SLEEP-APNEA; NASAL CPAP THERAPY; QUALITY-OF-LIFE; 1ST 3 MONTHS; APNOEA/HYPOPNOEA SYNDROME; APNEA/HYPOPNEA SYNDROME; PATIENT COMPLIANCE; HYPERTENSION; ASSOCIATION; VARIABILITY	Background: Adherence to short-term continuous positive airway pressure (CPAP) may predict long-term use. Unfortunately, initial CPAP intolerance may lead to poor adherence or abandonment of therapy. Objective: To determine whether a short course of eszopiclone at the onset of therapy improves long-term CPAP adherence more than placebo in adults with obstructive sleep apnea. Design: Parallel randomized, placebo-controlled trial from March 2007 to December 2008. Randomization, maintained and concealed centrally by pharmacy personnel, was computer-generated using fixed blocks of 10. Referring physicians, investigators, and patients were blinded to the treatment assignment until after the final data were collected. (ClinicalTrials.gov registration number: NCT00612157) Setting: Academic sleep disorder center. Patients: 160 adults (mean age, 45.7 years [SD, 7.3]; mean apnea-hypopnea index, 36.9 events/h [ SD, 23]) with newly diagnosed obstructive sleep apnea initiating CPAP. Intervention: Eszopiclone, 3 mg (n = 76), or matching placebo (n = 78) for the first 14 nights of CPAP. Measurements: Use of CPAP was measured weekly for 24 weeks. Adherence to CPAP (primary outcome) and the rate of CPAP discontinuation and improvements in symptoms (secondary outcomes) were compared. Follow-up at 1, 3, and 6 months was completed by 150, 136, and 120 patients, respectively. Results: Patients in the eszopiclone group used CPAP for 20.8% more nights (95% CI, 7.2% to 34.4%; P = 0.003), 1.3 more hours per night for all nights (CI, 0.4 to 2.2 hours; P = 0.005), and 1.1 more hours per night of CPAP use (CI, 0.2 to 2.1 hours; P = 0.019). The hazard ratio for discontinuation of CPAP was 1.90 (CI, 1.1 to 3.4; P = 0.033) times higher in the placebo group. Side effects were reported in 7.1% of patients and did not differ between groups. Limitations: Patients had severe obstructive sleep apnea treated at a specialized sleep center with frequent follow-up; results may not be generalizable to different settings. Patients' tolerance to CPAP and their reasons for discontinuation were not assessed. Conclusion: Compared with placebo, a short course of eszopiclone during the first 2 weeks of CPAP improved adherence and led to fewer patients discontinuing therapy.	[Lettieri, Christopher J.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Lettieri, CJ (corresponding author), Walter Reed Army Med Ctr, 6900 Georgia Ave,NW, Washington, DC 20307 USA.	christopher.lettieri@us.army.mil		Lettieri, Christopher/0000-0001-7950-2908	Henry M. Jackson Foundation for the Advancement of Military Medicine	Henry M. Jackson Foundation for the Advancement of Military Medicine	By Sepracor to the Henry M. Jackson Foundation for the Advancement of Military Medicine.	Aloia MS, 2005, J CLIN SLEEP MED, V1, P346; Aloia Mark S, 2007, Behav Sleep Med, V5, P229; Anstead M, 1998, Curr Opin Pulm Med, V4, P351, DOI 10.1097/00063198-199811000-00008; Bradshaw DA, 2006, CHEST, V130, P1369, DOI 10.1378/chest.130.5.1369; Budhiraja R, 2007, SLEEP, V30, P320; Chervin RD, 1997, SLEEP, V20, P284, DOI 10.1093/sleep/20.4.284; Collen J, 2009, CHEST, V135, P704, DOI 10.1378/chest.08-2182; EDINGER JD, 1994, PERCEPT MOTOR SKILL, V78, P1116, DOI 10.2466/pms.1994.78.3c.1116; ENGLEMAN HM, 1994, THORAX, V49, P263, DOI 10.1136/thx.49.3.263; Engleman HM, 2003, SLEEP MED REV, V7, P81, DOI 10.1053/smrv.2001.0197; HOFFSTEIN V, 1992, AM REV RESPIR DIS, V145, P841, DOI 10.1164/ajrccm/145.4_Pt_1.841; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; JOHNS MW, 1993, CHEST, V103, P30, DOI 10.1378/chest.103.1.30; Kryger M, 2007, SLEEP BREATH, V11, P159, DOI 10.1007/s11325-006-0096-4; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Likar LL, 1997, CHEST, V111, P1273, DOI 10.1378/chest.111.5.1273; McArdle N, 1999, AM J RESP CRIT CARE, V159, P1108, DOI 10.1164/ajrccm.159.4.9807111; Meslier N, 1998, EUR RESPIR J, V12, P185, DOI 10.1183/09031936.98.12010185; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Noseda A, 2004, CHEST, V126, P31, DOI 10.1378/chest.126.1.31; Pelayo R, 2007, CHEST, V131, P1616, DOI 10.1378/chest.06-3036; Pepin JL, 1999, AM J RESP CRIT CARE, V160, P1124, DOI 10.1164/ajrccm.160.4.9802027; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; REEVESHOCHE MK, 1994, AM J RESP CRIT CARE, V149, P149, DOI 10.1164/ajrccm.149.1.8111574; Rosenberg R, 2007, SLEEP MED, V8, P464, DOI 10.1016/j.sleep.2006.10.007; SHEPARD JW, 1992, CLIN CHEST MED, V13, P437; Stephane BA, 2002, CR PHYS, V3, P239, DOI 10.1016/S1631-0705(02)01303-8; Stepnowsky CJ, 2002, SLEEP, V25, P758, DOI 10.1093/sleep/25.7.758; Veale D, 2002, QUAL LIFE RES, V11, P389, DOI 10.1023/A:1015599326110; Weaver TE, 1997, SLEEP, V20, P278, DOI 10.1093/sleep/20.4.278; Weaver TE, 1997, SLEEP, V20, P835; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG	33	86	92	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					696	W225		10.7326/0003-4819-151-10-200911170-00006	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920270				2022-12-28	WOS:000272145100003
J	Simon, JA				Simon, Joel A.			Review: Evidence for the effectiveness of vitamin D and calcium for reducing CV outcomes, cancer, and death is limited	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							D SUPPLEMENTATION		[Simon, Joel A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Simon, Joel A.] Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Simon, JA (corresponding author), San Francisco VA Med Ctr, San Francisco, CA USA.							Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-5	10.7326/0003-4819-151-10-200911170-02005	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920263				2022-12-28	WOS:000272145100016
J	Zhou, RY; Niwa, S; Homma, N; Takei, Y; Hirokawa, N				Zhou, Ruyun; Niwa, Shinsuke; Homma, Noriko; Takei, Yosuke; Hirokawa, Nobutaka			KIF26A Is an Unconventional Kinesin and Regulates GDNF-Ret Signaling in Enteric Neuronal Development	CELL			English	Article							MICE LACKING GDNF; MICROTUBULE-ASSOCIATED PROTEINS; MULTIPLE ENDOCRINE NEOPLASIA; TYROSINE KINASE; NERVOUS-SYSTEM; HIRSCHSPRUNGS-DISEASE; PATHWAY; TRANSPORT; KIDNEY; MOTOR	The kinesin superfamily proteins (KIFs) are motor proteins that transport organelles and protein complexes in a microtubule- and ATP-dependent manner. We identified KIF26A as a new member of the murine KIFs. KIF26A is a rather atypical member as it lacks ATPase activity. Mice with a homozygous deletion of Kif26a developed a megacolon with enteric nerve hyperplasia. Kif26a(-/-) enteric neurons showed hypersensitivity for GDNF-Ret signaling, and we find that KIF26A suppressed GDNF-Ret signaling by direct binding and inhibition of Grb2, an essential component of GDNF/Akt/ERK signaling. We therefore propose that the unconventional kinesin KIF26A plays a key role in enteric nervous system development by repressing a cell growth signaling pathway.	[Zhou, Ruyun; Niwa, Shinsuke; Homma, Noriko; Takei, Yosuke; Hirokawa, Nobutaka] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Takei, Yosuke/I-1828-2015	Takei, Yosuke/0000-0002-5026-8027; NIWA, SHINSUKE/0000-0002-8367-9228	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Miyajima (University of Tokyo) for GST-RBD, J. Miyazaki (Osaka University) for the CAG-Cre mice, Kazusa DNA Research Institute for the KIAA1236 clone, and L. E. Samelson (National Institutes of Health) for Grb2 cDNA. We also thank Y. Tanaka, K. Nakajima, R. Nitta, and H. Ueno for their supervision and discussion, H. Sato, H. Fukuda, M. Sugaya, N. Onouchi, T. Akamatsu, and T. Aizawa for their technical assistance, and all other members of the Hirokawa laboratory for their help and discussion. This work was supported by a grant in aid for specially promoted research to N. H. and also by a Global COE Program from the Ministry of Education, Science, Sports, and Culture of Japan.	ATHOW AC, 1991, ARCH DIS CHILD, V66, P1300, DOI 10.1136/adc.66.11.1300; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CARNEY JA, 1977, MAYO CLIN PROC, V52, P543; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Focke PJ, 2001, J NEUROBIOL, V47, P306, DOI 10.1002/neu.1037; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HIDAKA M, 1991, BIOCHEM BIOPH RES CO, V180, P1490, DOI 10.1016/S0006-291X(05)81364-6; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lin Z, 2003, AUTON NEUROSCI-BASIC, V107, P9, DOI 10.1016/S1566-0702(03)00077-8; Matsui T, 2002, EMBO J, V21, P1021, DOI 10.1093/emboj/21.5.1021; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Ohiwa M, 1997, BIOCHEM BIOPH RES CO, V237, P747, DOI 10.1006/bbrc.1997.7225; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHLIWA M, 2002, MOL MOTORS; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; TAKEMURA R, 1992, J CELL SCI, V103, P953; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	39	73	80	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					802	813		10.1016/j.cell.2009.10.023	http://dx.doi.org/10.1016/j.cell.2009.10.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914172	Bronze			2022-12-28	WOS:000271747200023
J	Gottlieb, CA; Maenner, MJ; Cappa, C; Durkin, MS				Gottlieb, Carissa A.; Maenner, Matthew J.; Cappa, Claudia; Durkin, Maureen S.			Child disability screening, nutrition, and early learning in 18 countries with low and middle incomes: data from the third round of UNICEF's Multiple Indicator Cluster Survey (2005-06)	LANCET			English	Article							10 QUESTIONS SCREEN; SEVERELY MALNOURISHED CHILDREN; PSYCHOSOCIAL STIMULATION; RISK-FACTORS; INTELLECTUAL DISABILITY; VALIDITY; SUPPLEMENTATION; RELIABILITY; IMPAIRMENT; PREVALENCE	Background Child disability is an emerging global health priority. To address the need for internationally comparable information about the frequency and situation of children with disabilities, UNICEF has recommended that countries include the Ten Questions screen for disability in the Multiple indicator Cluster Survey (MICS) programme. We examined child disability screening and its association with nutrition and early learning in countries with low and middle incomes. Methods Cross-sectional data for the percentage of children screening positive for or at risk of disability were obtained for 191199 children aged 2-9 years in 18 countries participating in the third round of MICS in 2005-06. Screening results were descriptively analysed according to sociodemographic, nutritional, early-learning, and schooling variables. We constructed a weighted analysis to account for the sampling design in every country and tested for differences within countries using chi(2) analyses. Findings A median 23% (range 3-48) of children aged 2-9 years screened positive for disability in the 18 participating countries. For children aged 2-4 years, screening positive for disability was significantly more likely in children who were not breastfed versus those who were (median 36% [9-56] vs 26% [4-51]) in eight of 18 countries, in children who had not received vitamin A supplementation versus those who had (36% [7-53] vs 29% [4-50]) in five of ten countries assessed, in children who met criteria for stunting (26% [6-54]) or being underweight (36% [3-61]) versus those who did not (25% [3-42] and 26% [4-43], respectively) in five of 15 countries assessed for stunting and in seven of 15 countries assessed for being underweight, and in those who participated in few early-learning activities versus others (31% [7-54] vs 24% [4-51]) in eight of 18 countries. Children aged 6-9 years who did not attend school screened positive for disability more often than did children attending school (29% [2-83] vs 22% [3-47]) in eight of 18 countries. Interpretation Our results draw attention to the need for improved global capacity to assess and provide services for children at risk of disability. Further research is needed in countries with low and middle incomes to understand and address the role of nutritional deficiencies and restricted access to learning opportunities as both potential antecedents of childhood disability and consequences of discrimination.	[Gottlieb, Carissa A.; Maenner, Matthew J.; Durkin, Maureen S.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53726 USA; [Durkin, Maureen S.] Univ Wisconsin, Dept Pediat, Madison, WI 53726 USA; [Maenner, Matthew J.; Durkin, Maureen S.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53726 USA; [Maenner, Matthew J.; Durkin, Maureen S.] Univ Wisconsin, Waisman Ctr, Madison, WI 53726 USA; [Cappa, Claudia] UNICEF, Div Policy & Practice, Stat & Monitoring Sect, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; UNICEF	Durkin, MS (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, 789 WARF,610 Walnut St, Madison, WI 53726 USA.	mdurkin@wisc.edu	Durkin, Maureen/B-7834-2015		UNICEF; Department of Population Health Sciences, University of Wisconsin-Madison, USA	UNICEF; Department of Population Health Sciences, University of Wisconsin-Madison, USA	We thank people who participated in MICS3, including the staff who assisted with data collection, the survey respondents, and the statisticians; and other colleagues at UNICEF and the Department of Population Health Sciences, University of Wisconsin-Madison, USA, for their valuable insights and important contributions to the idea, design, initiation, and implementation of the project. This research was funded by UNICEF and the Department of Population Health Sciences, University of Wisconsin-Madison, USA.	Belmont L., 1986, SCI TECHNOLOGY MENTA, P389; Christianson AL, 2002, J INTELL DISABIL RES, V46, P179, DOI 10.1046/j.1365-2788.2002.00390.x; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; DURKIN M, 1991, INT J MENT HEALTH, V20, P47, DOI 10.1080/00207411.1991.11449195; Durkin M, 2008, MONITORING CHILD DIS; DURKIN MS, 1994, EPIDEMIOLOGY, V5, P283, DOI 10.1097/00001648-199405000-00005; DURKIN MS, 1995, J CLIN EPIDEMIOL, V48, P657, DOI 10.1016/0895-4356(94)00163-K; Durkin MS, 2000, AM J EPIDEMIOL, V152, P1024, DOI 10.1093/aje/152.11.1024; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GRANTHAMMCGREGOR S, 1994, CHILD DEV, V65, P428; GRANTHAMMCGREGOR S, 1987, PEDIATRICS, V79, P247; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Hamadani JD, 2006, J NUTR, V136, P2645, DOI 10.1093/jn/136.10.2645; *I MED COMM NERV S, 2001, NEUR PSYCH DEV DIS M, P113; Khan NZ, 1998, DEV MED CHILD NEUROL, V40, P749, DOI 10.1111/j.1469-8749.1998.tb12343.x; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Mung'ala-Odera V, 2006, INT J EPIDEMIOL, V35, P683, DOI 10.1093/ije/dyl023; Mung'ala-Odera V, 2004, NEUROEPIDEMIOLOGY, V23, P67, DOI 10.1159/000073977; *NAT STAT OFF THAI, THAIL MULT IND CLUST; Singhi P, 2007, J TROP PEDIATRICS, V53, P383, DOI 10.1093/tropej/fmm047; Thorburn M, 1992, Int J Rehabil Res, V15, P115, DOI 10.1097/00004356-199206000-00003; UN Enable, FREQ ASK QUEST REG C; UNICEF, CHILD MON SIT CHILDR; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; World Bank, WORLD DEV IND DAT PO; World Health Organization, 2002, COMMON LANGUAGE FUNC; World Health Organization, WHO GLOB DAT CHILD G; Yaqoob M, 2004, J INTELL DISABIL RES, V48, P663, DOI 10.1111/j.1365-2788.2003.00573.x; ZAMAN SS, 1990, INT J EPIDEMIOL, V19, P613, DOI 10.1093/ije/19.3.613	32	84	85	3	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1831	1839		10.1016/S0140-6736(09)61871-7	http://dx.doi.org/10.1016/S0140-6736(09)61871-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527MC	19944864				2022-12-28	WOS:000272370200028
J	Officer, A; Grace, NE				Officer, Alana; Grace, Nora Ellen			Key concepts in disability	LANCET			English	Editorial Material									[Officer, Alana] WHO, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva 27, Switzerland; [Grace, Nora Ellen] UCL, Leonard Cheshire Ctr Disabil & Inclus Dev, London, England	World Health Organization; University of London; University College London	Officer, A (corresponding author), WHO, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva 27, Switzerland.	officera@who.int		Groce, Nora/0000-0002-7885-7042				Department for International Development, 2005, RED POV TACKL SOC EX; HAHN H, 1988, J SOC ISSUES, V44, P39, DOI 10.1111/j.1540-4560.1988.tb02047.x; Metts R., 2004, DIS DEV RES AG M NOV; Oliver Michael, 1990, POLITICS DISABLEMENT; Robine JM, 2004, J GERONTOL A-BIOL, V59, P590, DOI 10.1093/gerona/59.6.M590; UN High Commissioner for Human Rights, 2006, CONV RIGHTS PERS DIS; WHO, 2001, WHO INT CLASS FUNCT; World Health Assembly, 2001, INT CLASS FUNCT DIS; World Health Organization, 2005, 58 WORLD HLTH ASS GE, P16	9	28	28	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1795	1796		10.1016/S0140-6736(09)61527-0	http://dx.doi.org/10.1016/S0140-6736(09)61527-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944845				2022-12-28	WOS:000272370200004
J	Podolsky, DK				Podolsky, DK			Inflammatory bowel disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACTIVE CROHNS-DISEASE; DISTAL ULCERATIVE-COLITIS; NECROSIS-FACTOR-ALPHA; RECOMBINANT HUMAN INTERLEUKIN-10; PLACEBO-CONTROLLED TRIAL; GENOME-WIDE SEARCH; DOUBLE-BLIND; LONG-TERM; MONOCLONAL-ANTIBODY; MAINTENANCE TREATMENT		Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Podolsky, DK (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.				NCRR NIH HHS [UL1 RR024139] Funding Source: Medline; NIDDK NIH HHS [P30 DK43351] Funding Source: Medline; NIDDK NIH HHS [R01 DK077905-01A2, R01 DK077905, DK P30-34989, U01 DK62429, R01 DK072373, R01DK077905, RC1 DK086800, U01 DK062429, U01 DK062422, R01DK072373, U01 DK062429-03, U01 DK062422-10] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Bauditz J, 2002, GUT, V50, P196, DOI 10.1136/gut.50.2.196; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Bouhnik Y, 1996, LANCET, V347, P215, DOI 10.1016/S0140-6736(96)90402-X; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cariappa A, 1998, GUT, V43, P210, DOI 10.1136/gut.43.2.210; Cohen RD, 2000, AM J GASTROENTEROL, V95, P3469; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Corominas H, 2000, AM J GASTROENTEROL, V95, P2313; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; D'Haens G, 2001, GASTROENTEROLOGY, V120, P1323, DOI 10.1053/gast.2001.23983; DANIELSSON A, 1992, SCAND J GASTROENTERO, V27, P9, DOI 10.3109/00365529209011158; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Ehrenpreis ED, 1999, GASTROENTEROLOGY, V117, P1271, DOI 10.1016/S0016-5085(99)70276-3; ELSON CO, 1999, MUCOSAL IMMUNOLOGY, P1007; Evans JMM, 1997, GUT, V40, P619, DOI 10.1136/gut.40.5.619; Farrell RJ, 2000, GUT, V47, P514, DOI 10.1136/gut.47.4.514; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2000, GASTROENTEROLOGY, V118, pA874, DOI 10.1016/S0016-5085(00)85637-1; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; Green JRB, 1998, GASTROENTEROLOGY, V114, P15, DOI 10.1016/S0016-5085(98)70627-4; Greenberg GR, 1996, GASTROENTEROLOGY, V110, P45, DOI 10.1053/gast.1996.v110.pm8536887; GRIFFITHS AM, 1995, GASTROENTEROLOGY, V108, P1056, DOI 10.1016/0016-5085(95)90203-1; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 1998, GASTROENTEROLOGY, V115, P525, DOI 10.1016/S0016-5085(98)70131-3; HANAUER SB, 1993, AM J GASTROENTEROL, V88, P1343; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; KOIZUMI M, 1992, GASTROENTEROLOGY, V103, P840, DOI 10.1016/0016-5085(92)90015-Q; Kornbluth A, 1997, AM J GASTROENTEROL, V92, P1424; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Lewis JD, 2000, GASTROENTEROLOGY, V118, P1018, DOI 10.1016/S0016-5085(00)70353-2; Lewis JD, 2001, GASTROENTEROLOGY, V121, P1080, DOI 10.1053/gast.2001.28703; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; LINDBERG E, 1988, GUT, V29, P352, DOI 10.1136/gut.29.3.352; Loftus EV, 2001, GASTROENTEROLOGY, V121, P1239; Lopez-Cubero SO, 1998, GASTROENTEROLOGY, V114, P433, DOI 10.1016/S0016-5085(98)70525-6; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mahmud N, 2001, GUT, V49, P552, DOI 10.1136/gut.49.4.552; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Negoro K, 1999, GASTROENTEROLOGY, V117, P1062, DOI 10.1016/S0016-5085(99)70390-2; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oren R, 1996, GASTROENTEROLOGY, V110, P1416, DOI 10.1053/gast.1996.v110.pm8613046; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Peeters M, 2001, AM J GASTROENTEROL, V96, P730, DOI 10.1111/j.1572-0241.2001.03613.x; Prantera C, 1999, GASTROENTEROLOGY, V116, P521, DOI 10.1016/S0016-5085(99)70172-1; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Ricart E, 2001, AM J GASTROENTEROL, V96, P722, DOI 10.1111/j.1572-0241.2001.03612.x; RIGAUD D, 1991, GUT, V32, P1492, DOI 10.1136/gut.32.12.1492; Rioux JD, 1998, GASTROENTEROLOGY, V115, P1062, DOI 10.1016/S0016-5085(98)70074-5; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; Sandborn WJ, 2001, GASTROENTEROLOGY, V120, P1330, DOI 10.1053/gast.2001.24042; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Sandborn WJ, 1997, ANN INTERN MED, V126, P364, DOI 10.7326/0003-4819-126-5-199703010-00004; Sands BE, 1999, GASTROENTEROLOGY, V117, P58, DOI 10.1016/S0016-5085(99)70550-0; Sans M, 2001, GASTROENTEROLOGY, V120, P1162, DOI 10.1053/gast.2001.23252; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SAXON A, 1990, J ALLERGY CLIN IMMUN, V86, P202, DOI 10.1016/S0091-6749(05)80067-3; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Slonim AE, 2000, NEW ENGL J MED, V342, P1633, DOI 10.1056/NEJM200006013422203; Stack WA, 1997, LANCET, V349, P521, DOI 10.1016/S0140-6736(97)80083-9; STANGE EF, 1995, GASTROENTEROLOGY, V109, P774, DOI 10.1016/0016-5085(95)90384-4; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Sutherland LR, 1997, INFLAMM BOWEL DIS, V3, P65, DOI 10.1002/ibd.3780030202; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; ten Hove T, 2002, GUT, V50, P206, DOI 10.1136/gut.50.2.206; Thomsen OO, 1998, NEW ENGL J MED, V339, P370, DOI 10.1056/NEJM199808063390603; THOMSEN OO, 2001, NEW ENGL J MED, V345, P1652; Toms C, 2001, MICROBES INFECT, V3, P929, DOI 10.1016/S1286-4579(01)01454-X; Turunen UM, 1998, GASTROENTEROLOGY, V115, P1072, DOI 10.1016/S0016-5085(98)70076-9; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; vanDeventer SJH, 1997, GASTROENTEROLOGY, V113, P383, DOI 10.1053/gast.1997.v113.pm9247454; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Vasiliauskas EA, 1999, GASTROENTEROLOGY, V117, P1278, DOI 10.1016/S0016-5085(99)70277-5; Vermeire S, 2001, GASTROENTEROLOGY, V120, P827, DOI 10.1053/gast.2001.22546	95	3184	3360	31	535	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					417	429		10.1056/NEJMra020831	http://dx.doi.org/10.1056/NEJMra020831			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	19923578				2022-12-28	WOS:000177672400007
J	Homoud, MK				Homoud, Munther K.			Prolonged PR intervals were associated with increased risk for atrial fibrillation, pacemaker implantation, and mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOCK		Tufts Med Ctr, Boston, MA USA	Tufts Medical Center	Homoud, MK (corresponding author), Tufts Med Ctr, Boston, MA USA.							Agarwal YK, 2003, AM J CARDIOL, V91, P882, DOI 10.1016/S0002-9149(03)00027-4; Josephson ME, 2008, CLIN CARDIAC ELECTRO, P93; PACKARD JM, 1954, CIRCULATION, V10, P384, DOI 10.1161/01.CIR.10.3.384; SCHNITTGER I, 1988, J AM COLL CARDIOL, V11, P83, DOI 10.1016/0735-1097(88)90170-2	4	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-13	10.7326/0003-4819-151-10-200911170-02013	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920258				2022-12-28	WOS:000272145100024
J	Caplan, AL				Caplan, Arthur L.			Unlicensed pandemic influenza A H1N1 vaccines	LANCET			English	Editorial Material									[Caplan, Arthur L.] Univ Penn, Ctr Vaccine Eth & Policy, Philadelphia, PA 19104 USA; [Caplan, Arthur L.] Childrens Hosp Philadelphia, Wistar Inst Vaccine Ctr, Philadelphia, PA 19104 USA; [Caplan, Arthur L.] Childrens Hosp Philadelphia, Vaccine Educ Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Caplan, AL (corresponding author), Univ Penn, Ctr Vaccine Eth & Policy, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu						[Anonymous], 2009, LANCET, V374, P358; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; *MSNBC, 2009, US SHAR SWIN FLU VAC; Neuzil KM, 2009, J INFECT DIS, V200, P835, DOI 10.1086/605507; Nightingale SL, 2007, EMERG INFECT DIS, V13, P1046, DOI 10.3201/eid1307.061188; *STRAT ADV GROUP E, 2009, WKLY EPIDEMIOL REC, V84, P301; *WHO, 2009, B WORLD HEALTH ORGAN, V87, P645	7	196	209	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 6	2010	375	9713					444	445		10.1016/S0140-6736(09)61675-5	http://dx.doi.org/10.1016/S0140-6736(09)61675-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	558PV	19914708				2022-12-28	WOS:000274757900009
